Citrus Sinensis ID: 027738
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 219 | 2.2.26 [Sep-21-2011] | |||||||
| Q39193 | 361 | Serine/threonine-protein | yes | no | 0.904 | 0.548 | 0.929 | 1e-109 | |
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.908 | 0.549 | 0.914 | 1e-107 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.899 | 0.530 | 0.908 | 1e-105 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.908 | 0.549 | 0.894 | 1e-105 | |
| Q940H6 | 362 | Serine/threonine-protein | no | no | 0.899 | 0.544 | 0.914 | 1e-105 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.899 | 0.545 | 0.86 | 1e-100 | |
| P43291 | 363 | Serine/threonine-protein | no | no | 0.817 | 0.493 | 0.865 | 2e-92 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.817 | 0.528 | 0.882 | 2e-92 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.817 | 0.528 | 0.877 | 5e-92 | |
| Q9C958 | 361 | Serine/threonine-protein | no | no | 0.817 | 0.495 | 0.865 | 6e-92 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 395 bits (1015), Expect = e-109, Method: Compositional matrix adjust.
Identities = 185/199 (92%), Positives = 195/199 (97%), Gaps = 1/199 (0%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLLR EYDGK+
Sbjct: 180 TPAYIAPEVLLRQEYDGKI 198
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (996), Expect = e-107, Method: Compositional matrix adjust.
Identities = 182/199 (91%), Positives = 190/199 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHD DRY+ VRDIGSGNFGVARLMR + +LVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLL+ EYDGK+
Sbjct: 181 TPAYIAPEVLLKKEYDGKI 199
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 380 bits (977), Expect = e-105, Method: Compositional matrix adjust.
Identities = 179/197 (90%), Positives = 189/197 (95%)
Query: 4 DRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
DRA+LTVGP MDMPIMHDSDRY+ VRDIGSGNFGVARLMRD+ T ELVAVKYIERG+KID
Sbjct: 12 DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71
Query: 64 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 123
+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDEAR+
Sbjct: 72 DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191
Query: 184 PAYIAPEVLLRHEYDGK 200
PAYIAPEVLL+ EYDGK
Sbjct: 192 PAYIAPEVLLKKEYDGK 208
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (973), Expect = e-105, Method: Compositional matrix adjust.
Identities = 178/199 (89%), Positives = 191/199 (95%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MD A+ + +D+PIMHDSDRYDFV+DIGSGNFGVARLM D+VTKELVAVKYIERG+KI
Sbjct: 1 MDPATNSPIMPIDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPE+LLR EYDGK+
Sbjct: 181 TPAYIAPEILLRQEYDGKL 199
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (973), Expect = e-105, Method: Compositional matrix adjust.
Identities = 182/199 (91%), Positives = 192/199 (96%), Gaps = 2/199 (1%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLL+ EYDGKV
Sbjct: 179 TPAYIAPEVLLKKEYDGKV 197
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (934), Expect = e-100, Method: Compositional matrix adjust.
Identities = 172/200 (86%), Positives = 189/200 (94%), Gaps = 3/200 (1%)
Query: 3 MDRASLTVGP-AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK 61
M+RA+ GP M+MPIMHD DRY+ V++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1 MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58
Query: 62 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 121
IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181
RFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 182 GTPAYIAPEVLLRHEYDGKV 201
GTPAYIAPEVLL+ EYDGK+
Sbjct: 179 GTPAYIAPEVLLKKEYDGKI 198
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (867), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 155/179 (86%), Positives = 171/179 (95%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+DIG+GNFGVARLM+ K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHLAI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK+
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 338 bits (867), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 158/179 (88%), Positives = 171/179 (95%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ ++DIGSGNFGVA+L+RD TKEL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL R EYDGKV
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKV 180
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (863), Expect = 5e-92, Method: Compositional matrix adjust.
Identities = 157/179 (87%), Positives = 171/179 (95%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ ++DIGSGNFGVA+L+RD TKEL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL R EYDGKV
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKV 180
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 6e-92, Method: Compositional matrix adjust.
Identities = 155/179 (86%), Positives = 170/179 (94%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+DIG+GNFGVARLMR K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL R EYDGK+
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 219 | ||||||
| 255562649 | 362 | Serine/threonine-protein kinase SAPK10, | 0.908 | 0.549 | 0.954 | 1e-110 | |
| 449460610 | 363 | PREDICTED: serine/threonine-protein kina | 0.908 | 0.548 | 0.964 | 1e-110 | |
| 356563656 | 360 | PREDICTED: serine/threonine-protein kina | 0.908 | 0.552 | 0.944 | 1e-109 | |
| 224084266 | 362 | predicted protein [Populus trichocarpa] | 0.908 | 0.549 | 0.949 | 1e-109 | |
| 356511732 | 360 | PREDICTED: serine/threonine-protein kina | 0.908 | 0.552 | 0.939 | 1e-109 | |
| 297797685 | 361 | hypothetical protein ARALYDRAFT_920030 [ | 0.904 | 0.548 | 0.939 | 1e-108 | |
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.908 | 0.546 | 0.939 | 1e-108 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.908 | 0.548 | 0.934 | 1e-108 | |
| 312282175 | 361 | unnamed protein product [Thellungiella h | 0.904 | 0.548 | 0.939 | 1e-108 | |
| 225470483 | 361 | PREDICTED: serine/threonine-protein kina | 0.908 | 0.551 | 0.924 | 1e-108 |
| >gi|255562649|ref|XP_002522330.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538408|gb|EEF40014.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1038), Expect = e-110, Method: Compositional matrix adjust.
Identities = 190/199 (95%), Positives = 196/199 (98%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
M+R+++TVGP MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI
Sbjct: 1 MNRSAITVGPGMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICN GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNGGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLLR EYDGK+
Sbjct: 181 TPAYIAPEVLLRQEYDGKI 199
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460610|ref|XP_004148038.1| PREDICTED: serine/threonine-protein kinase SRK2I-like [Cucumis sativus] gi|449502711|ref|XP_004161721.1| PREDICTED: serine/threonine-protein kinase SRK2I-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1033), Expect = e-110, Method: Compositional matrix adjust.
Identities = 192/199 (96%), Positives = 195/199 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA++TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDK TKELVAVKYIERGDKI
Sbjct: 1 MDRATITVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKHTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILT THLAIVMEYASGGELFERI NAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTTTHLAIVMEYASGGELFERISNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLLR EYDGK+
Sbjct: 181 TPAYIAPEVLLRQEYDGKI 199
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563656|ref|XP_003550077.1| PREDICTED: serine/threonine-protein kinase SRK2I-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 401 bits (1030), Expect = e-109, Method: Compositional matrix adjust.
Identities = 188/199 (94%), Positives = 195/199 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHDSDRYD VRDIGSGNFGVARLM+DK TKELVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMQDKQTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICNAGRF+EDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNAGRFTEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLL+ EYDGK+
Sbjct: 181 TPAYIAPEVLLKQEYDGKL 199
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224084266|ref|XP_002307247.1| predicted protein [Populus trichocarpa] gi|222856696|gb|EEE94243.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 400 bits (1027), Expect = e-109, Method: Compositional matrix adjust.
Identities = 189/199 (94%), Positives = 194/199 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR+++TVGP MDMPIMHDSDRYD VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA+GGELFERIC +GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAAGGELFERICKSGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLD SPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDDSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLLR EYDGKV
Sbjct: 181 TPAYIAPEVLLRQEYDGKV 199
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511732|ref|XP_003524577.1| PREDICTED: serine/threonine-protein kinase SAPK10-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1022), Expect = e-109, Method: Compositional matrix adjust.
Identities = 187/199 (93%), Positives = 194/199 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA+LTVGP MDMPIMHDSDRYD VRDIGSGNFGVARLM+DK TKELVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMQDKQTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICNAGRF+EDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNAGRFTEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLL+ EYDGK+
Sbjct: 181 TPAYIAPEVLLKQEYDGKL 199
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297797685|ref|XP_002866727.1| hypothetical protein ARALYDRAFT_920030 [Arabidopsis lyrata subsp. lyrata] gi|297312562|gb|EFH42986.1| hypothetical protein ARALYDRAFT_920030 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1020), Expect = e-108, Method: Compositional matrix adjust.
Identities = 187/199 (93%), Positives = 195/199 (97%), Gaps = 1/199 (0%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP MDMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-MDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRF+EDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFNEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLLR EYDGK+
Sbjct: 180 TPAYIAPEVLLRQEYDGKI 198
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1020), Expect = e-108, Method: Compositional matrix adjust.
Identities = 187/199 (93%), Positives = 195/199 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR+++TVGP MDMPIMHDSDRY+ VRDIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLL+ EYDGK+
Sbjct: 181 TPAYIAPEVLLKKEYDGKI 199
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1020), Expect = e-108, Method: Compositional matrix adjust.
Identities = 186/199 (93%), Positives = 195/199 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR+++TVGPAMD+PIMHDSDRY+ VRDIGSGNFGVARLMRDK T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLL+ EYDGK+
Sbjct: 181 TPAYIAPEVLLKKEYDGKI 199
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312282175|dbj|BAJ33953.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1018), Expect = e-108, Method: Compositional matrix adjust.
Identities = 187/199 (93%), Positives = 195/199 (97%), Gaps = 1/199 (0%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA ++ GP MDMPIMHDSDRYDFV+DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI
Sbjct: 1 MDRAPVSSGP-MDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLLR +YDGK+
Sbjct: 180 TPAYIAPEVLLRQQYDGKI 198
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470483|ref|XP_002264172.1| PREDICTED: serine/threonine-protein kinase SRK2I isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1017), Expect = e-108, Method: Compositional matrix adjust.
Identities = 184/199 (92%), Positives = 194/199 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR++L +GP MD+PIMHDSDRYDFVRDIGSGNFG+ARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRSTLALGPIMDLPIMHDSDRYDFVRDIGSGNFGIARLMRDKLTKELVAVKYIERGDKI 60
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA+GGELFERIC AGRF EDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAAGGELFERICKAGRFIEDEAR 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVL+R EYDGK+
Sbjct: 181 TPAYIAPEVLMRQEYDGKI 199
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 219 | ||||||
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.904 | 0.548 | 0.929 | 3.1e-99 | |
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.899 | 0.544 | 0.914 | 4.2e-95 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.817 | 0.495 | 0.865 | 5e-83 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.812 | 0.494 | 0.859 | 1.2e-81 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.812 | 0.504 | 0.848 | 6.6e-81 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.817 | 0.511 | 0.815 | 2.6e-79 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.817 | 0.521 | 0.815 | 8.7e-79 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.812 | 0.525 | 0.808 | 3.1e-76 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.794 | 0.385 | 0.442 | 1.2e-33 | |
| TAIR|locus:2090537 | 444 | CIPK1 "CBL-interacting protein | 0.776 | 0.382 | 0.438 | 1.2e-33 |
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 985 (351.8 bits), Expect = 3.1e-99, P = 3.1e-99
Identities = 185/199 (92%), Positives = 195/199 (97%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLLR EYDGK+
Sbjct: 180 TPAYIAPEVLLRQEYDGKI 198
|
|
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 946 (338.1 bits), Expect = 4.2e-95, P = 4.2e-95
Identities = 182/199 (91%), Positives = 192/199 (96%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TPAYIAPEVLL+ EYDGKV
Sbjct: 179 TPAYIAPEVLLKKEYDGKV 197
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 5.0e-83, P = 5.0e-83
Identities = 155/179 (86%), Positives = 170/179 (94%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+DIG+GNFGVARLMR K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL R EYDGK+
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 819 (293.4 bits), Expect = 1.2e-81, P = 1.2e-81
Identities = 153/178 (85%), Positives = 167/178 (93%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+Y+ V+D+G+GNFGVARL+R K TKELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCH++Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 812 (290.9 bits), Expect = 6.6e-81, P = 6.6e-81
Identities = 151/178 (84%), Positives = 166/178 (93%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
D+YD V+D+G+GNFGVARL+R K TKELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCH++Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGK 179
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 797 (285.6 bits), Expect = 2.6e-79, P = 2.6e-79
Identities = 146/179 (81%), Positives = 165/179 (92%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RYD +RD+GSGNFGVA+L+R+K E AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCHAMQ+CH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
RDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL R EY+GK+
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKI 180
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 792 (283.9 bits), Expect = 8.7e-79, P = 8.7e-79
Identities = 146/179 (81%), Positives = 167/179 (93%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+RY+ V+DIGSGNFGVA+L+RDK +KEL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCH++Q+CH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL EYDGK+
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 180
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 768 (275.4 bits), Expect = 3.1e-76, P = 3.1e-76
Identities = 144/178 (80%), Positives = 160/178 (89%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
++Y+ V+D+G GNFG+ARLMR+K T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y HA+Q+CH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV R EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGK 179
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 366 (133.9 bits), Expect = 1.2e-33, P = 1.2e-33
Identities = 81/183 (44%), Positives = 111/183 (60%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHP 79
+Y+ R IG G F + R+ T E VA+K +++ K+ E ++REI + ++HP
Sbjct: 23 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKLIKHP 82
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
N+V+ EV+ + T + I++EY +GGELF++I N GR EDEAR +FQQLI V YCH+
Sbjct: 83 NVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYCHSRG 142
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP--KSTVGTPAYIAPEVLLRHE 196
V HRDLK EN LLD LKI DFG S S + ++ GTP Y+APEVL
Sbjct: 143 VYHRDLKPENLLLDSYG--NLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLNDRG 200
Query: 197 YDG 199
YDG
Sbjct: 201 YDG 203
|
|
| TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 366 (133.9 bits), Expect = 1.2e-33, P = 1.2e-33
Identities = 82/187 (43%), Positives = 112/187 (59%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHP 79
+Y+ R +G GNFG + +D V+ AVK I++ D N ++REI + L+HP
Sbjct: 19 KYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKREIRTLKMLKHP 78
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+IVR EV+ + T + +VME +GGELF+RI + G+ +E + R FQQLI G+SYCH+
Sbjct: 79 HIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLIDGISYCHSKG 138
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 192
V HRDLKLEN LLD +KI DFG S +LH+ T G+P Y+APEVL
Sbjct: 139 VFHRDLKLENVLLDAKG--HIKITDFGLSALPQHFRDDGLLHT----TCGSPNYVAPEVL 192
Query: 193 LRHEYDG 199
YDG
Sbjct: 193 ANRGYDG 199
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9296 | 0.9041 | 0.5484 | yes | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9145 | 0.9086 | 0.5497 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_V000200 | hypothetical protein (362 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | gw1.186.8.1 | hypothetical protein (337 aa) | • | 0.455 | |||||||
 | fgenesh4_pg.C_scaffold_7275000001 | hypothetical protein (240 aa) | • | 0.417 | |||||||
 | gw1.57.100.1 | hypothetical protein (187 aa) | • | 0.408 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 219 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-72 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-54 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-39 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-37 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-37 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-34 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-33 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-32 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-32 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-32 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-32 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-31 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-31 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-31 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-31 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-30 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-28 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-28 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-28 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-27 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-27 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-27 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-26 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-26 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-26 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-26 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-26 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-25 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-25 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-25 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-25 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-23 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-23 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-23 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-23 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-21 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-21 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-20 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-20 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-20 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-19 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-18 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-18 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-14 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-12 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.002 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 3e-72
Identities = 77/179 (43%), Positives = 107/179 (59%), Gaps = 4/179 (2%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
Y+ + +G G+FG L RDK T +LVA+K I ++ K E + REI + L+HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
R +V L +VMEY GG+LF+ + GR SEDEARF+ +Q++S + Y H+ + H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL Y V
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 1e-61
Identities = 76/180 (42%), Positives = 103/180 (57%), Gaps = 6/180 (3%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 81
Y+ +R +GSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR + HL +VMEY GG+LF+ + G SEDEA+ Q++ G+ Y H+ +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGK 200
HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL G
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 1e-54
Identities = 76/174 (43%), Positives = 100/174 (57%), Gaps = 5/174 (2%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 88
+G G FG L RDK T + VA+K I++ D E + REI + L HPNIV+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 89 LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
HL +VMEY GG L + + N G+ SEDE Q++ G+ Y H+ + HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 148 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL Y +
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 4e-49
Identities = 63/187 (33%), Positives = 100/187 (53%), Gaps = 14/187 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
+Y+ ++ IG G+FG L+R K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 136
I+++ E L IVMEYA GG+L ++I + F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
+ ++ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176
Query: 194 RHEYDGK 200
Y+ K
Sbjct: 177 NKPYNYK 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-44
Identities = 64/176 (36%), Positives = 92/176 (52%), Gaps = 10/176 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRFK-- 85
+G G+FG L DK T EL+AVK +E +E + +REI SL+HPNIVR+
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
E L I +EY SGG L + G+ E R + +Q++ G++Y H+ + HRD+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127
Query: 146 KLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
K N L+D +K+ DFG +K S GTP ++APEV+ EY
Sbjct: 128 KGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-41
Identities = 61/186 (32%), Positives = 95/186 (51%), Gaps = 8/186 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 83
++ + IG G FG R K T + VA+K I + E + EI + +HPNIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCH 142
+ L L IVME+ SGG L + + + + +E + + ++L+ G+ Y H+ + H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 201 VYFYSI 206
+S+
Sbjct: 178 ADIWSL 183
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-40
Identities = 67/182 (36%), Positives = 100/182 (54%), Gaps = 11/182 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
+G G+FG L+R K T +L A+K +++ I + R+ + HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T L +V+EYA GGELF + GRFSE+ ARF+ +++ + Y H++ + +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 147 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKVYF 203
EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL Y V +
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 204 YS 205
+S
Sbjct: 177 WS 178
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-39
Identities = 64/189 (33%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ Y + IG G G D+ T + VA+K + + E + EI+ + +HPNI
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V + + L L +VMEY GG L + I N R +E + + ++++ G+ Y H+ V
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K +N LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ R +Y
Sbjct: 138 IHRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 198 DGKVYFYSI 206
KV +S+
Sbjct: 194 GPKVDIWSL 202
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-37
Identities = 66/187 (35%), Positives = 98/187 (52%), Gaps = 17/187 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y+ + +G G +GV RDK T E+VA+K I R D +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ 139
IV+ +VI T L +V EY +L + + G S + + QL+ G++YCH+ +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLR- 194
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 195 HEYDGKV 201
Y V
Sbjct: 174 KHYSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-37
Identities = 68/194 (35%), Positives = 114/194 (58%), Gaps = 22/194 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQRE-IINHR----SLR 77
D ++F++ +G+G+FG L+R K + + A+K + + KI + Q E ++N + S+R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59
Query: 78 HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
HP +V F++ ++L +VMEY GGELF + +GRF E ARF+ Q++ +
Sbjct: 60 HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
Y H++ + +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169
Query: 192 LLRHEYDGKVYFYS 205
+L Y V +++
Sbjct: 170 ILSKGYGKAVDWWA 183
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 9e-36
Identities = 59/185 (31%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
RY + IG G G+ +D+ T E VA+K + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
+V+ +V + +VMEY +L E + + R E + + + + L+ GV+Y HA
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-RHE 196
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L +
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 197 YDGKV 201
YD V
Sbjct: 178 YDPGV 182
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-34
Identities = 60/188 (31%), Positives = 95/188 (50%), Gaps = 15/188 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 86
I G +G L + K T ++ A+K I++ D I +N +++ R + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+L +VMEY GG+L + N G ED AR + +++ + Y H+ + HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 147 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+N L+D + LK+ DFG SK + + K VGTP YIAPEV+L +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 198 DGKVYFYS 205
V ++S
Sbjct: 179 SKTVDWWS 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 67/183 (36%), Positives = 95/183 (51%), Gaps = 18/183 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 78
Y ++ +G G FG L R+K T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 136
PNIV+ KEV L V EY G L++ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 194
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LLR
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 195 HEY 197
Sbjct: 173 STS 175
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-33
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 38/199 (19%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 78
+ F + IG G+F L ++K T + A+K + + K+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 79 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
P I++ F++ +L V+EYA GEL + I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 173
H+ + HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 174 HSQPKSTVGTPAYIAPEVL 192
+ S VGT Y++PE+L
Sbjct: 176 RRRFASFVGTAEYVSPELL 194
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-33
Identities = 62/181 (34%), Positives = 94/181 (51%), Gaps = 14/181 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGD-KIDENVQREIINHRSLRHPNIVRFKEV 87
IG G FG + T EL+AVK I + D K + + E+ L+HPN+V++ V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHAMQVCHRDL 145
+ + I MEY SGG L E + GR DE R + QL+ G++Y H+ + HRD+
Sbjct: 68 EVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 146 KLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+ + G
Sbjct: 126 KPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 201 V 201
Sbjct: 184 G 184
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 5e-33
Identities = 60/168 (35%), Positives = 88/168 (52%), Gaps = 10/168 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEV 87
IG G FGV + T + VA+K I +E + +EI ++L+HPNIV++
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
I T L I++EYA G L + I G F E + Q++ G++Y H V HRD+K
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA 127
Query: 148 ENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVL 192
N L DG +K+ DFG + K + + S VGTP ++APEV+
Sbjct: 128 ANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-33
Identities = 63/192 (32%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPN 80
Y+ + IG G+FG R +R K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 81 IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 134
IVR+ + + + L IVMEY GG+L + I E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 135 CH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 188
CH V HRDLK N LD + +K+ DFG +K S T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 189 PEVLLRHEYDGK 200
PE L YD K
Sbjct: 179 PEQLNHMSYDEK 190
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-32
Identities = 58/188 (30%), Positives = 103/188 (54%), Gaps = 8/188 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
D + ++ +G+G FG L+RD++++ A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P I+R L ++MEY GGELF + N+GRFS F+ +++ + Y H+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
++ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ ++
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGHN 176
Query: 199 GKVYFYSI 206
V ++++
Sbjct: 177 KAVDWWAL 184
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-32
Identities = 69/200 (34%), Positives = 100/200 (50%), Gaps = 22/200 (11%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 79
Y +R +G G+FG L RD+ +LVA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 136
NIV+ + L +VMEY GG L + + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 189
+ + HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 190 EVLL---RHEYDGKVYFYSI 206
EVLL +S+
Sbjct: 178 EVLLGLSLAYASSSSDIWSL 197
|
Length = 384 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 66/176 (37%), Positives = 95/176 (53%), Gaps = 15/176 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 82
+G G FG L+R+K T + A+K I + + I + ++ + H ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
K T L VMEYA+GGELF + FSED ARF+ +++S + Y H+ V +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
RDLKLEN +LD +KI DFG K + T GTP Y+APEVL ++Y
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 5e-32
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
+ + + IG G+FG DK T ++VA+K I E D+I++ +Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
I ++ L + L I+MEY GG + + G+ E F ++++ G+ Y H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ +
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 197 YDGKVYFYS--ITQMSLQSTSP 216
YD K +S IT + L P
Sbjct: 175 YDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-32
Identities = 63/180 (35%), Positives = 96/180 (53%), Gaps = 15/180 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKY---IERGDKIDENVQREIINHRSLRHP 79
++Y+ + +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV KE L +V EY EL E + G D R + QL+ ++YCH+
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 193
+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-32
Identities = 66/177 (37%), Positives = 94/177 (53%), Gaps = 8/177 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 85
+G G+FG L K T EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKV 201
KL+N LLD +KI DFG K +L ST GTP YIAPE+L Y V
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-31
Identities = 54/186 (29%), Positives = 99/186 (53%), Gaps = 6/186 (3%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPN 80
++ +R IG G FG +++ + TK++ A+KY+ + +++ R ++N R L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V ++ +V++ GG+L + +FSE++ +F+ +++ + Y H+ +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
HRD+K +N LLD + I DF + + ST GTP Y+APEVL R Y
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVA 179
Query: 201 VYFYSI 206
V ++S+
Sbjct: 180 VDWWSL 185
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 63/177 (35%), Positives = 93/177 (52%), Gaps = 8/177 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 85
IG G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKV 201
K EN LLD L DFG K + HS+ ST GTP Y+APEVL + YD V
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTV 177
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 61/186 (32%), Positives = 94/186 (50%), Gaps = 8/186 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPN 80
+ + +G G +G L + K T E+VA+K +++ N R ++ R + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V+ +L + MEY GG+ + N G SED ARF+ ++ V H +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL YD
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 201 VYFYSI 206
V ++S+
Sbjct: 179 VDYWSL 184
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-31
Identities = 63/190 (33%), Positives = 98/190 (51%), Gaps = 13/190 (6%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 81
Y + IG G +GV RDK+T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
++ +V L +V E+ +L++ I + R E + + QL+ G+++CH+ +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLR-HE 196
HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 197 YDGKVYFYSI 206
Y V +S+
Sbjct: 176 YSTPVDIWSV 185
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-31
Identities = 69/182 (37%), Positives = 94/182 (51%), Gaps = 6/182 (3%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 80
+Y+ +R +G G FG+ L R K ++LV +K I E+ K + Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM 138
I+ + E L L IVMEYA GG L E I ED FF Q++ + + H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 199 GK 200
K
Sbjct: 180 QK 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-31
Identities = 70/190 (36%), Positives = 101/190 (53%), Gaps = 18/190 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+ Y+ ++ IGSG +G RD T ELVA+K I E GD + +Q+EI + RHPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQ 139
IV + L L IVMEY GG L + G SE + + ++ + G++Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 192
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175
Query: 193 -LRHEYDGKV 201
+ YDGK
Sbjct: 176 ERKGGYDGKC 185
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-30
Identities = 55/180 (30%), Positives = 92/180 (51%), Gaps = 6/180 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
+G G FG L++ K A+K +++ ++ Q I + + HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
++ ++MEY GGEL+ + + G F E ARF+ ++ Y H + +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
EN LLD + +K+ DFG++K + + GTP Y+APE++L YD V ++S+
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSL 178
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-28
Identities = 62/177 (35%), Positives = 90/177 (50%), Gaps = 8/177 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 85
IG G+FG L + K AVK +++ + + Q I+ R +L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKV 201
K EN LLD + + DFG K V + ST GTP Y+APEVL + YD V
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 38/205 (18%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
+ ++ +G G+ G L+R K T +L A+K +++ + I N ++EI+ +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 134
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 135 CHAMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 177
H + + +RDLK EN LL S P P K G +SSV
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 178 -----------KSTVGTPAYIAPEV 191
S VGT YIAPEV
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEV 203
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-28
Identities = 72/201 (35%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 83
+G G+FG L K T EL A+K +++GD I + V+ + R S RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVY 202
DLKL+N LLD +KI DFG K + ST GTP ++APEVL Y V
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVD 183
Query: 203 FYS----ITQMSL-QSTSPND 218
++ I +M + +S P D
Sbjct: 184 WWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 67/182 (36%), Positives = 100/182 (54%), Gaps = 10/182 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 84
+G G+FG L K T E A+K +++ D + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
T HL VMEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVYF 203
LKL+N LLD +KI DFG K ++ ST GTP YIAPE+L +Y+ V +
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 204 YS 205
+S
Sbjct: 180 WS 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 64/172 (37%), Positives = 93/172 (54%), Gaps = 7/172 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
+G G FG L+R+K T A+K + + I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T L VMEYA+GGELF + F+E+ ARF+ +++S + Y H+ V +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEY 197
LEN +LD +KI DFG K + + K+ GTP Y+APEVL ++Y
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RH 78
D ++ ++ IG G FG L+RDK T ++ A+K + + D I N + R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 79 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
P IV+ F++ HL +VMEY GG+L + F E+ ARF+ +L+ +
Sbjct: 61 PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 169
H + HRD+K +N L+D +K+ DFG K
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 170 -SSVLHSQPK----STVGTPAYIAPEVLLRHEYDGKVYFYS 205
H Q + STVGTP YIAPEVL Y + ++S
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-28
Identities = 66/185 (35%), Positives = 102/185 (55%), Gaps = 11/185 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 83
IG G FG +R K T+ + A+K + + + + + +R I+ L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
K T + L +V +Y SGGELF + GRFSED A+F+ +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE-YDGKV 201
DLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL + Y V
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 202 YFYSI 206
F+S+
Sbjct: 179 DFWSL 183
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-28
Identities = 61/181 (33%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 80
Y+ + IG G +G R+K T ELVA+K I R + E REI + LRHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 81 IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
IVR KE++ + +I V EY +G L + +F+E + + + +QL+ G+ Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
H+ + HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 193 L 193
L
Sbjct: 174 L 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-27
Identities = 53/197 (26%), Positives = 81/197 (41%), Gaps = 22/197 (11%)
Query: 27 FVRDIGSGNFGVARL----MRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
+ +G G FG + + VAVK + + D ++ ++ RE R L HP
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV+ V L IVMEY GG+L + R S + F Q+ G+ Y +
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 192
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 122 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESL 176
Query: 193 LRHEYDGK--VYFYSIT 207
++ K V+ + +
Sbjct: 177 KEGKFTSKSDVWSFGVL 193
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 64/193 (33%), Positives = 97/193 (50%), Gaps = 19/193 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 80
IGSG+FG L + + EL+AVK +E R + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV++ L HL I +EY GG + + N G F E R F +Q++ G++Y H +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 193
HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 194 RHEYDGKVYFYSI 206
+ Y K +S+
Sbjct: 186 QTSYTRKADIWSL 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-27
Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 7/182 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ +D + +G G++G K T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
V++ T L IVMEY G + + +I N +E+E Q + G+ Y H+ +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 199 GK 200
K
Sbjct: 178 NK 179
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-27
Identities = 60/186 (32%), Positives = 104/186 (55%), Gaps = 14/186 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
+Y V+ IG G+FG A L++ K + +K I + K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA 137
IV+++E +L IVM+Y GG+L+++I NA R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLR 194
++ HRD+K +N L +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 195 HEYDGK 200
Y+ K
Sbjct: 176 RPYNNK 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-27
Identities = 51/184 (27%), Positives = 77/184 (41%), Gaps = 19/184 (10%)
Query: 27 FVRDIGSGNFGVARL----MRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
+ +G G FG + K VAVK + + D ++ ++ RE R L HP
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
N+V+ V L IVMEY GG+L + N + S + F Q+ G+ Y +
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 122 NFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESLK 176
Query: 194 RHEY 197
++
Sbjct: 177 EGKF 180
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-27
Identities = 64/181 (35%), Positives = 98/181 (54%), Gaps = 7/181 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
+G G FG L+R+K + + A+K +++ I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T L VMEY +GGELF + FSED RF+ +++S + Y H+ ++ +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKVYFYS 205
LEN +LD +KI DFG K + + K+ GTP Y+APEVL ++Y V ++
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 180
Query: 206 I 206
+
Sbjct: 181 L 181
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-27
Identities = 61/186 (32%), Positives = 94/186 (50%), Gaps = 14/186 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHP 79
Y +R +G G FG A L R LV K + + E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHA 137
NI+ + + L I MEYA+GG L+++I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLR 194
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175
Query: 195 HEYDGK 200
+Y+ K
Sbjct: 176 VKYNFK 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-27
Identities = 70/201 (34%), Positives = 100/201 (49%), Gaps = 29/201 (14%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ-------REIINHRS 75
D Y+ + I G +GV RDK T E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 76 LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 128
L+HPNIV KEV++ + +VMEY E L E + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 186
+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 187 IAPEVLL-RHEYDGKVYFYSI 206
APE+LL EY + +S+
Sbjct: 173 RAPELLLGAKEYSTAIDMWSV 193
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 62/183 (33%), Positives = 96/183 (52%), Gaps = 10/183 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 84
+G G+FG L K T E+ A+K +++ D I D++V + R L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
T L VMEY +GG+L +I + +F E +RF+ ++ + + H V +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVYF 203
LKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L EY V +
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 204 YSI 206
+++
Sbjct: 180 WAL 182
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 10/188 (5%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RH 78
++F+ +G G+FG L K T EL A+K I + D I D++V+ ++ R L +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + + T L VMEY +GG+L I G+F E A F+ ++ G+ + H+
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
+ +RDLKL+N +LD +KI DFG K ++ + T GTP YIAPE++ Y
Sbjct: 121 GIIYRDLKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 198 DGKVYFYS 205
V +++
Sbjct: 179 GKSVDWWA 186
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 64/197 (32%), Positives = 91/197 (46%), Gaps = 34/197 (17%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 80
RY+ ++ IGSG +GV DK T VA+K I D ID + + REI R LRH N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 81 IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 126
I+ +++ P+ + IV E S L ++D ++F
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 182
Q++ G+ Y H+ V HRDLK N L++ + LKICDFG ++ K V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 183 TPAYIAPEVLLR-HEYD 198
T Y APE+LL Y
Sbjct: 169 TRWYRAPELLLSSSRYT 185
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-26
Identities = 64/192 (33%), Positives = 94/192 (48%), Gaps = 18/192 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 79
IG G +G L + T E++AVK +E I ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV++ T +L+I +EY GG + + GRF E RFF +Q++ G++Y H+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLR 194
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 195 HEYDGKVYFYSI 206
Y KV +S+
Sbjct: 187 QGYSAKVDIWSL 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 61/182 (33%), Positives = 99/182 (54%), Gaps = 8/182 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 85
IG G+FG L R K ++ AVK +++ + + ++ I++ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V++Y +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVYFY 204
K EN LLD + + DFG K ++ H+ ST GTP Y+APEVL + YD V ++
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180
Query: 205 SI 206
+
Sbjct: 181 CL 182
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-26
Identities = 65/191 (34%), Positives = 104/191 (54%), Gaps = 13/191 (6%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
+Y+ +R +G G+FG A L++ + + A+K I + E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
V FKE HL IVMEY GG+L ++I G+ F ED +F Q+ GV + H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLRH 195
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 196 EYDGKVYFYSI 206
Y+ K +S+
Sbjct: 176 PYNNKSDIWSL 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-26
Identities = 66/182 (36%), Positives = 99/182 (54%), Gaps = 8/182 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
+G G FG L+++K T A+K +++ + + V + +R L RHP + K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDL 145
T L VMEYA+GGELF + FSED ARF+ +++S + Y H+ V +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKVYFY 204
KLEN +LD +KI DFG K + + K+ GTP Y+APEVL ++Y V ++
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 180
Query: 205 SI 206
+
Sbjct: 181 GL 182
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 54/166 (32%), Positives = 89/166 (53%), Gaps = 8/166 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
+G+G+FG R+ + K T E A+K +++ + + + + +S L HP IV
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+ ++E+ GGELF + AGRF D A+F+ +L+ Y H+ + +RDLK
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLK 145
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
EN LLD +K+ DFG++K + + + GTP Y+APEV+
Sbjct: 146 PENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVI 187
|
Length = 329 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-26
Identities = 57/183 (31%), Positives = 89/183 (48%), Gaps = 9/183 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 84
+GSG+FG + + AVK + G E V+ +EI L+HPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
+L I +E GG L + + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYF 203
+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ + Y
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 204 YSI 206
+S+
Sbjct: 186 WSL 188
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-26
Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 15/184 (8%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 85
V+ +G G+ GV +R K T ++ A+K I + Q RE+ RS P +V+
Sbjct: 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRD 144
++IV+EY GG L + + G+ E + +Q++ G+ Y H + HRD
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRD 125
Query: 145 LKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKV 201
+K N L+ G KI DFG SK +T VGT Y++PE + G+
Sbjct: 126 IKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERI-----QGES 176
Query: 202 YFYS 205
Y Y+
Sbjct: 177 YSYA 180
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-25
Identities = 66/173 (38%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRHPNIVRFKE 86
IG G +G+ RD + E+VA+K + ER D I + REI +LRHPNIV KE
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKE 73
Query: 87 VILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ HL +VMEY L + + FSE + + QL+ G+ Y H +
Sbjct: 74 VV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFII 130
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL 193
HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL
Sbjct: 131 HRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 62/181 (34%), Positives = 95/181 (52%), Gaps = 8/181 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 85
+G G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T HL VME+ +GG+L I + GRF A F+ +++ G+ + H+ + +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVYFY 204
KL+N +LD +KI DFG K +V ST GTP YIAPE+L +Y V ++
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWW 180
Query: 205 S 205
S
Sbjct: 181 S 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 64/176 (36%), Positives = 93/176 (52%), Gaps = 10/176 (5%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 82
R +G G+FG L R K + L AVK +++ D I D++V+ + R L HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ TP L VME+ +GG+L I + RF E ARF+ ++ S + + H + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L Y
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-25
Identities = 63/179 (35%), Positives = 93/179 (51%), Gaps = 15/179 (8%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVR 83
V IG G +GV R+K+T E+VA+K I R D E V REI + L HPNIV+
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 84 FKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+VI T L +V E+ + F + + QL+ G+++CH+ +V H
Sbjct: 64 LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLRHEY 197
RDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL +Y
Sbjct: 124 RDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGCKY 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 3e-25
Identities = 66/194 (34%), Positives = 101/194 (52%), Gaps = 17/194 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
RY+ ++ IG G+FG L + K E +K I + K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA 137
IV F L IVMEY GG+L +RI N R FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 192
++ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174
Query: 193 LRHEYDGKVYFYSI 206
Y+ K +S+
Sbjct: 175 QNRPYNNKTDIWSL 188
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-25
Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 13 AMDMPIMHDSDRYDFVR--DIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQRE 69
A+ + + R IG G+ G+ + DK T VAVK ++ R + E + E
Sbjct: 7 ALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE 66
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
++ R +HPNIV L L +VME+ GG L + I R +E++ ++
Sbjct: 67 VVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVL 125
Query: 130 SGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAY 186
+S+ HA V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP +
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 187 IAPEVLLRHEYDGKVYFYSITQMSLQ 212
+APEV+ R Y +V +S+ M ++
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-25
Identities = 61/181 (33%), Positives = 97/181 (53%), Gaps = 8/181 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 85
+G G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T +L VMEY +GG+L I + +F A F+ ++I G+ + H+ + +RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVYFY 204
KL+N LLD +KI DFG K ++L T GTP YIAPE+LL +Y+ V ++
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180
Query: 205 S 205
S
Sbjct: 181 S 181
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 6e-25
Identities = 57/186 (30%), Positives = 91/186 (48%), Gaps = 12/186 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 84
+G G FG L D T +AVK + + ++ EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
+ L+I MEY GG + +++ G +E R + +Q++ GV Y H+ + HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGK 200
+K N L D A +K+ DFG SK + S KS GTP +++PEV+ Y K
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187
Query: 201 VYFYSI 206
+S+
Sbjct: 188 ADVWSV 193
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-25
Identities = 67/195 (34%), Positives = 109/195 (55%), Gaps = 17/195 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
D+Y+ V IG G +GV RD+VT E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 136
NIVR ++V+ + L +V EY +L + + ++ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 192
+ +V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175
Query: 193 L-RHEYDGKVYFYSI 206
L Y V +S+
Sbjct: 176 LGSRHYSTPVDIWSV 190
|
Length = 294 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-25
Identities = 58/182 (31%), Positives = 96/182 (52%), Gaps = 8/182 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 85
IG G+FG L + K+ + AVK +++ ++ Q+ I+ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
T L V+++ +GGELF + F E ARF+ ++ S + Y H++ + +RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVYFY 204
K EN LLD + + DFG K + S +T GTP Y+APEV+ + YD V ++
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180
Query: 205 SI 206
+
Sbjct: 181 CL 182
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-25
Identities = 61/187 (32%), Positives = 100/187 (53%), Gaps = 8/187 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
++F+ +G G+FG L K T EL A+K +++ I D++V+ ++ R L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + T L VMEY +GG+L +I GRF E A F+ ++ G+ + H+
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYD 198
+ +RDLKL+N +LD +KI DFG K ++ K+ GTP YIAPE++ Y
Sbjct: 122 IIYRDLKLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179
Query: 199 GKVYFYS 205
V +++
Sbjct: 180 KSVDWWA 186
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-24
Identities = 59/181 (32%), Positives = 93/181 (51%), Gaps = 7/181 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 86
IG G+FG +R + T+ + A+K I + + + + R++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+P L +V+ + +GGELF + GRF ARF+ +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVYFYS 205
EN LLD + +CDFG K ++ +T GTP Y+APE+LL H Y V +++
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178
Query: 206 I 206
+
Sbjct: 179 L 179
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-24
Identities = 60/187 (32%), Positives = 98/187 (52%), Gaps = 8/187 (4%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
++F+ +G G+FG L K T EL A+K +++ I D++V+ ++ R L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + T L VMEY +GG+L I G+F E +A F+ ++ G+ + H
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
+ +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ Y
Sbjct: 122 IIYRDLKLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179
Query: 199 GKVYFYS 205
V +++
Sbjct: 180 KSVDWWA 186
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 3e-24
Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 19/182 (10%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLR 77
RY+ + +G G + V RDK T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 135
HPNI+ +V +++ +V E+ +L E++ + + + + + G+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 191
H+ + HRDLK N L+ LK+ DFG ++S P V T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173
Query: 192 LL 193
L
Sbjct: 174 LF 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-24
Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRH---PNIVRFK 85
IG G +G + T +VA+K I D+ ++QRE+ LR PNI ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
L L I+MEYA GG + + AG +E ++++ + Y H + V HRD+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDI 127
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR-HEYDGKVYF 203
K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ YD K
Sbjct: 128 KAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADI 185
Query: 204 YS--ITQMSLQSTSP 216
+S IT + + +P
Sbjct: 186 WSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-23
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHP 79
+ +R+IG G+FG RD T E+VA+K + K ++II + LRHP
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 80 NIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
N + +K L +VMEY S ++ E + E E + G++Y H+
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---R 194
+ HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+L
Sbjct: 134 HERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 195 HEYDGKVYFYS--ITQMSLQSTSP 216
+YDGKV +S IT + L P
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-23
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 16/197 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHP 79
RY + +IGSG +GV D + + VA+K I + +R E+ R +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 80 NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
NI+ ++++ P + +VM+ +L I + +E+ R+F QL+ G+ Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 190
H+ V HRDLK N L++ L+I DFG S S H V T Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 191 VLLR-HEYDGKVYFYSI 206
+LL EY + +S+
Sbjct: 182 LLLSLPEYTTAIDMWSV 198
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-23
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
+ ++ ++ I +G +G L+R K T++ A+K I + + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
+P +V T HL +VMEY GG+ + N G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 180
+ HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 181 VGTPAYIAPEVLLRHEYDGKVYFYSI 206
GTP YIAPEV+LR Y V ++++
Sbjct: 177 CGTPEYIAPEVILRQGYGKPVDWWAM 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-23
Identities = 63/191 (32%), Positives = 97/191 (50%), Gaps = 11/191 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
++++ + +G G +GV R K TKE+VA+K E +++ E RE+ R+L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV KE L +V EY EL E + N ++ R + QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRH 195
+ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 196 EYDGKVYFYSI 206
Y V +S+
Sbjct: 177 PYGKAVDMWSV 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-23
Identities = 59/188 (31%), Positives = 97/188 (51%), Gaps = 17/188 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRS 75
++ +D ++ IG G FG +L+R K +K++ A+K + + + I + +R+I+ H +
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
IV+ +L +VMEY GG+L + N E ARF+ +++ +
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 191
H+M HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214
Query: 192 LLRHEYDG 199
L DG
Sbjct: 215 LKSQGGDG 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-23
Identities = 55/173 (31%), Positives = 90/173 (52%), Gaps = 15/173 (8%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 80
+++ ++G+GN GV + + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH-A 137
IV F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSR--GQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 6e-23
Identities = 62/193 (32%), Positives = 97/193 (50%), Gaps = 9/193 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA+K + + E + EI+ R +HPNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + L L +VMEY +GG L + + E + ++ + + + H+ QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 200 KVYFYSITQMSLQ 212
KV +S+ M+++
Sbjct: 195 KVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 8e-23
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
D Y+ + IG G V E VA+K I+ +K +V +E+ HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 136
N+V++ + L +VM Y SGG L + G E ++++ G+ Y H
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 137 AMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 189
+ HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 190 EVL-LRHEYDGKVYFYS--ITQMSL 211
EV+ H YD K +S IT + L
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 9e-23
Identities = 67/179 (37%), Positives = 96/179 (53%), Gaps = 17/179 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y V IG G +GV RDK+T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAM 138
IVR +V+ + L +V E+ +L + + ++ D + QL+ G++YCH+
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 193
+V HRDLK +N L+D A LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILL 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-23
Identities = 59/190 (31%), Positives = 99/190 (52%), Gaps = 16/190 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHP 79
+Y+ + IG G +G +++ T E+VA+K + R D DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHA 137
NIVR +V+ + L +V EY + ++ ++ G + + F QL+ G+++CH+
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
V HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF--- 172
Query: 197 YDGKVYFYSI 206
K+Y SI
Sbjct: 173 -GAKLYSTSI 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-22
Identities = 60/189 (31%), Positives = 87/189 (46%), Gaps = 22/189 (11%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 77
Y+ + +IG G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 78 -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 130
HPNIVR +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 131 GVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
GV + H+ ++ HRDLK +N L+ DG ++KI DFG ++ S V T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 189 PEVLLRHEY 197
PEVLL+ Y
Sbjct: 175 PEVLLQSSY 183
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-22
Identities = 50/187 (26%), Positives = 75/187 (40%), Gaps = 19/187 (10%)
Query: 31 IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 85
+G G FG +L VAVK ++ +E +E + L HPN+VR
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 86 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 136
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 193
+ + HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 194 RHEYDGK 200
+ K
Sbjct: 181 DGIFTSK 187
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-22
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 36/204 (17%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---- 77
+ ++ V IG G +G R K T +LVA+K ++ + +E ++ E LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61
Query: 78 HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 127
HPNI F + L +VME GG +L + + G R E+ + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 128 LISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 180
+ G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171
Query: 181 --VGTPAYIAPEVLLRHEYDGKVY 202
+GTP ++APEV+ E Y
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASY 195
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-22
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
D ++ + ++G G FG + K T A K I+ + D V+ +I++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM 138
NIV E L I++E+ GG L + R +E + R+ +Q++ +++ H+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 193
+V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 194 ---RHEYDGKVYFYS--ITQMSLQSTSP 216
+ YD K +S IT + L P
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-22
Identities = 59/180 (32%), Positives = 93/180 (51%), Gaps = 6/180 (3%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIIN 72
D+ + + ++ ++ IGSG +G R+ T EL A+K I E G+ VQ+EII
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ +H NIV + L L I ME+ GG L + G SE + + ++ + G+
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 191
Y H+ HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-22
Identities = 57/187 (30%), Positives = 97/187 (51%), Gaps = 13/187 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV------QREIINHRSL 76
+D +G G+FG +++R+K T ++ A+K +++ + + +R+I++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 135
P I + + +L +VMEY GG+L + +F ED A+F+ +L+ +
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 193
H M HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 194 RHEYDGK 200
DGK
Sbjct: 177 TMNGDGK 183
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-22
Identities = 53/174 (30%), Positives = 88/174 (50%), Gaps = 16/174 (9%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR--------HP 79
++ I G FG L + + T + A+K +++ D I +N ++ N ++ R P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN---QVTNVKAERAIMMIQGESP 57
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + + +L +VMEY +GG+ I G ED A+ + +++ GV H
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
+ HRD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L
Sbjct: 118 IIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETIL 166
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-22
Identities = 57/185 (30%), Positives = 101/185 (54%), Gaps = 15/185 (8%)
Query: 31 IGSGNFGVARLMRDKVTKE----LVAVKYIERG-----DKIDENVQREIINHRSLRHPNI 81
+G G+FG L+R K+T L A+K +++ D++ ++R+I+ + HP I
Sbjct: 4 LGQGSFGKVFLVR-KITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFI 60
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ T L +++++ GG+LF R+ F+E++ +F+ +L + + H++ +
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGK 200
+RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ R +
Sbjct: 121 YRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 201 VYFYS 205
++S
Sbjct: 179 ADWWS 183
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-22
Identities = 63/184 (34%), Positives = 89/184 (48%), Gaps = 12/184 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEV 87
+G G++G ++ + A+K ++ G K E+ EI S+ HPNI+ +KE
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHR 143
L L IVMEYA G+L + I + E E F QL+ G+ H ++ HR
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKVY 202
DLK N LL +KI D G SK VL K+ +GTP Y+APEV Y K
Sbjct: 128 DLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSD 183
Query: 203 FYSI 206
+S+
Sbjct: 184 IWSL 187
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-21
Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 17/181 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 83
+G+G F RD T L+AVK + +++ E +++EI L HP+I+R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+H + +E+ +GG + + G F E + +QL+ G+SY H Q+ HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLRHE 196
D+K N L+D S RL+I DFG ++ L ++ +GT A++APEVL +
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 197 Y 197
Y
Sbjct: 185 Y 185
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-21
Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 10/192 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
IG G+FG D T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L T L I+MEY GG + + AG F E + ++++ G+ Y H+ + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKVYFYS- 205
N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD K +S
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 187
Query: 206 -ITQMSLQSTSP 216
IT + L P
Sbjct: 188 GITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-21
Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 20/196 (10%)
Query: 27 FVRDIGSGNFGV---ARL-MRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPN 80
+ +G G FG L + T+ VAVK ++ G ++ E E + L HPN
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
IVR V L IV EY GG+L F R + + + + Q+ G+ Y +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 193
HRDL N L+ + +KI DFG S+ ++ + APE L
Sbjct: 122 NFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 194 RHEYDGK--VYFYSIT 207
++ K V+ + +
Sbjct: 178 DGKFTSKSDVWSFGVL 193
|
Length = 258 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-21
Identities = 57/176 (32%), Positives = 93/176 (52%), Gaps = 13/176 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKIDEN------VQREIINHRSLR 77
++F+R +G+G+FG L K VA+K E+ I + +R+I+N+ +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HP V ++L +V+E+ GGE F + RF D F+ Q++ Y +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILL 201
|
Length = 340 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-21
Identities = 66/195 (33%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA+K I + E + EI+ + L++PNIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQV 140
F + L L +VMEY +GG L + + DEA+ ++ + + + HA QV
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 198 DGKVYFYSITQMSLQ 212
KV +S+ M+++
Sbjct: 193 GPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-21
Identities = 55/177 (31%), Positives = 82/177 (46%), Gaps = 14/177 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 81
Y + IG G F + + T + A+K + +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 82 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM 138
+R EV+ LA+V E L+E I R E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 193
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLL 171
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-21
Identities = 55/170 (32%), Positives = 85/170 (50%), Gaps = 11/170 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRHPNIVRFKE 86
+G G + R++ T E+VA+K I E G REI + L+H NIVR +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHENIVRLHD 65
Query: 87 VILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
VI T L +V EY + + G + + F QL+ G+++CH +V HRD
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL 193
LK +N L++ LK+ DFG +++ + + + V T Y AP+VLL
Sbjct: 126 LKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-21
Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 12/184 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 84
+G G FG + K T ++ A K ++ R + +++I+ S R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
T L +VM +GG+L I N G F E A F+ Q+I G+ + H ++ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVY 202
RDLK EN LLD R I D G + + K GTP Y+APEVL YD V
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 203 FYSI 206
++++
Sbjct: 177 WFAL 180
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-21
Identities = 57/185 (30%), Positives = 92/185 (49%), Gaps = 14/185 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPN 80
++ + IG G+FGV + K K + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R+ E L L IVMEYA G+L + + ED+ FF Q++ G+++ H+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRH 195
++ HRD+K N LD +KI D G +K +L + VGTP Y++PE+
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 196 EYDGK 200
Y+ K
Sbjct: 177 PYNEK 181
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-21
Identities = 59/170 (34%), Positives = 91/170 (53%), Gaps = 6/170 (3%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
Y+ ++ +GSG +G R+ T EL AVK I E GD +Q+EI + +H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ L+ L I MEY GG L + G SE + + ++ + G++Y H+ H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEV 191
RD+K N LL + +K+ DFG +K + ++ KS +GTP ++APEV
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-20
Identities = 59/186 (31%), Positives = 103/186 (55%), Gaps = 9/186 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
IG G+ G+ + R+K + VAVK ++ R + E + E++ R +H N+V + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
L ++ME+ GG L + I + R +E++ + ++ + Y H+ V HRD+K ++
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 150 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ R Y +V +S+
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSL 203
Query: 207 TQMSLQ 212
M ++
Sbjct: 204 GIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-20
Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 18/200 (9%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
+R+IG G+FG RD E+VA+K + K ++II + LRHPN ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 84 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
++ L +VMEY S +L E + E E + G++Y H+ +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 199 GKVYFYS--ITQMSLQSTSP 216
GKV +S IT + L P
Sbjct: 193 GKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-20
Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 6/167 (3%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G +G+ RD T+ +A+K I ER + + + EI H L+H NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 90 TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 147 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVL 192
+N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI 181
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-20
Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 8/184 (4%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 83
R IG G++ L+ K T+ + A+K I++ D+ VQ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVY 202
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +Y V
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 203 FYSI 206
++++
Sbjct: 179 WWAL 182
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 1e-20
Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
+R+IG G+FG RD T E+VA+K + K ++II + ++HPN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 84 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+K L +VMEY S +L E + E E + G++Y H+ +
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 199 GKVYFYS--ITQMSLQSTSP 216
GKV +S IT + L P
Sbjct: 203 GKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 2e-20
Identities = 61/193 (31%), Positives = 97/193 (50%), Gaps = 9/193 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA+K + + E + EI+ R ++PNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + L L +VMEY +GG L + + E + ++ + + + H+ QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 200 KVYFYSITQMSLQ 212
KV +S+ M+++
Sbjct: 195 KVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-20
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------ 67
+ P + +Y+ + IG G FG R K TK++VA+K + + EN +
Sbjct: 3 YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPIT 57
Query: 68 --REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG-RF 116
REI + L+H N+V E+ T +V E+ +L + N +F
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF 116
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLH 174
+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++ L
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLS 172
Query: 175 SQPKST-----VGTPAYIAPEVLL 193
K V T Y PE+LL
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-20
Identities = 64/191 (33%), Positives = 95/191 (49%), Gaps = 8/191 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
IG G+FG D TKE+VA+K I+ + DE ++Q+EI P I R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L T L I+MEY GG + + G E ++++ G+ Y H+ + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVYFYS-- 205
N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K +S
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG 188
Query: 206 ITQMSLQSTSP 216
IT + L P
Sbjct: 189 ITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-20
Identities = 56/176 (31%), Positives = 89/176 (50%), Gaps = 10/176 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDK--IDENVQREIINHRSLRHP 79
++Y+ + IG G++GV R++ T ++VA+K ++E D I + REI + L+HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
N+V EV L +V EY L E N E + Q + V++CH
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVL 192
HRD+K EN L+ + ++K+CDFG+++ +L V T Y APE+L
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-20
Identities = 63/194 (32%), Positives = 91/194 (46%), Gaps = 14/194 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGD-KIDENVQREIINH--RSLR 77
RY + +G G+FG L++DK L +K I G+ +E VQ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 133
HP IV+F L I+ EY G +L ++ SE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 193 LRHEYDGKVYFYSI 206
YD K +S+
Sbjct: 178 KHQGYDSKSDIWSL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-20
Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 55/221 (24%)
Query: 26 DF--VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLR----- 77
DF ++ IG G FG RL++ K T + A+K + + + + ++E + H R+ R
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILAE 57
Query: 78 --HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
+P +V+ +L ++MEY GG++ + F+E+E RF+ + I +
Sbjct: 58 ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVLH 174
H + HRD+K +N LLD +K+ DFG
Sbjct: 118 HKLGYIHRDIKPDNLLLDAK--GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 175 SQPK------------------STVGTPAYIAPEVLLRHEY 197
S+P STVGTP YIAPEV L+ Y
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-20
Identities = 61/192 (31%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
IG G+FG D T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L T L I+MEY GG + + G E + ++++ G+ Y H+ + HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKVYFYS- 205
N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD K +S
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187
Query: 206 -ITQMSLQSTSP 216
IT + L P
Sbjct: 188 GITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-20
Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 11/189 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRH 78
++RY ++ +G G FG+ RD++T + VA+K I + + + RE+ + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 79 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
NI+ ++ ++P + V E G R+ + + ++F Q++ G+ Y H+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HE 196
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L +
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 197 YDGKVYFYS 205
YD +V +S
Sbjct: 183 YDVEVDIWS 191
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-20
Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 19/197 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGD-----KIDENV--QREIINH 73
++ +R +G+G +G L+R KV +L A+K +++ K E+ +R+++
Sbjct: 2 FELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
R P +V T T L ++++Y +GGELF + F+E E R + +++ +
Sbjct: 61 VR-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
+ H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV
Sbjct: 120 HLHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 192 LLRHE--YDGKVYFYSI 206
+ +D V ++S+
Sbjct: 178 IRGGSGGHDKAVDWWSL 194
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-20
Identities = 60/179 (33%), Positives = 90/179 (50%), Gaps = 13/179 (7%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVRFK 85
V IGSG G + + T L A+K Y D + + REI R + HPN+V+
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
++ + +++E+ GG L +F D AR Q++SG++Y H + HRD+
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHRDI 194
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVL---LRH-EYDG 199
K N L++ A +KI DFG S+ P S+VGT AY++PE + L H YDG
Sbjct: 195 KPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-20
Identities = 59/193 (30%), Positives = 100/193 (51%), Gaps = 9/193 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
+Y IG G G D T + VA++ + + E + EI+ R ++PNIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ + L L +VMEY +GG L + + E + ++ + + + H+ QV H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
RD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ R Y
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 200 KVYFYSITQMSLQ 212
KV +S+ M+++
Sbjct: 196 KVDIWSLGIMAIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-20
Identities = 66/200 (33%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 83
+ +IG G+FG + T E+VAVK + G + +E Q +E+ + L+HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 84 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+K L +VMEY S +L E + E E + G++Y H+ +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 199 GKVYFYS--ITQMSLQSTSP 216
GKV +S IT + L P
Sbjct: 199 GKVDVWSLGITCIELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 9e-20
Identities = 68/194 (35%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
D++D + IG G +G RDK T ELVA+K + R D E REI R L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65
Query: 79 PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 124
NIV KE I+T A +V EY G L + + FSED + F
Sbjct: 66 RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 182
+QL+ G++YCH HRD+K N LL+ ++K+ DFG ++ T V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 183 TPAYIAPEVLLRHE 196
T Y PE+LL E
Sbjct: 180 TLWYRPPELLLGEE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-19
Identities = 75/224 (33%), Positives = 105/224 (46%), Gaps = 40/224 (17%)
Query: 16 MPIMHDS-----DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQR- 68
MP +D + Y+ ++ IG+G FG L++ K T+E K I RG K E Q
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 69 -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 121
E+ R L+H NIVR+ + L + L I+ME+ G+L I G+ E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 122 RFFFQQLISGVSYCHAMQ-------VCHRDLKLENTLLDG---------------SPAPR 159
+QL+ ++YCH ++ V HRDLK +N L + P
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGK 200
KI DFG SK+ + S S VGTP Y +PE+LL HE YD K
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL-HETKSYDDK 223
|
Length = 1021 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-19
Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 13/172 (7%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFK 85
+ +G G G R K T + A+K I + + + RE+ ++S + P IV++
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 86 EVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCHAM 138
L + + I MEY GG L + I GR E + ++ G+SY H+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
++ HRD+K N LL +K+CDFG S V S + GT Y+APE
Sbjct: 125 KIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-19
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 20/181 (11%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y + IG G +GV R+K T ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
IV ++V++ + L ++ E+ S + + + + + + Q++ G+ +CH+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVL 192
+V HRDLK +N L+D +K+ DFG +++ H V T Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE-----VVTLWYRAPEVL 173
Query: 193 L 193
L
Sbjct: 174 L 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 5e-19
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 83
R IG G++ L+R K T+ + A+K +++ + ID + + ++ HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H + +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVY 202
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +Y V
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVD 178
Query: 203 FYSITQMSLQ---STSPNDL 219
++++ + + SP D+
Sbjct: 179 WWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 6e-19
Identities = 62/180 (34%), Positives = 94/180 (52%), Gaps = 14/180 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 80
+Y ++ IG G +G+ ++ T E VA+K I ++ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 81 IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++ K+ I+ P H + IV E +L + I ++ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 193
H+ V HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-19
Identities = 56/186 (30%), Positives = 94/186 (50%), Gaps = 13/186 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
++ YD V+ IG G FG +L+R K ++++ A+K + + + I + R +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P +V+ +L +VMEY GG+L + N E A+F+ +++ + H+
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
M + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216
Query: 194 RHEYDG 199
DG
Sbjct: 217 SQGGDG 222
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 9e-19
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 11/152 (7%)
Query: 27 FVRDIGSGNFGVARLMR----DKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPN 80
F++ +G G+FG L R T E VAVK + ++ + +REI R+L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K V P L ++MEY G L + + + + + F Q+ G+ Y +
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ HRDL N L++ +KI DFG +K
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-18
Identities = 58/190 (30%), Positives = 90/190 (47%), Gaps = 17/190 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 83
+G G +G +L+AVK +E +K E +Q E+ +SL+H NIV+
Sbjct: 8 LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+ L ++I ME+ GG + + G E + +Q++ GV+Y H V HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLRHE 196
D+K N +L P +K+ DFG ++ HS KS GTP ++APEV+
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 197 YDGKVYFYSI 206
Y K +SI
Sbjct: 185 YGRKSDIWSI 194
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 60/183 (32%), Positives = 87/183 (47%), Gaps = 21/183 (11%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------REIINHRSLR 77
RY IG G++GV D T E VA+K I + + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 78 HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
HP+IV K ++L P+ + +V E +L + I + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 188
Y H V HRDLK +N L + +LKICDFG ++ + + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 189 PEV 191
PE+
Sbjct: 175 PEL 177
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-18
Identities = 53/184 (28%), Positives = 95/184 (51%), Gaps = 8/184 (4%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 83
R IG G++ L+R K ++ A+K +++ + ID + + ++ +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKVY 202
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L EY V
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 203 FYSI 206
++++
Sbjct: 179 WWAL 182
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-18
Identities = 61/186 (32%), Positives = 99/186 (53%), Gaps = 9/186 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
IG G+ G+ + +K T + VAVK ++ R + E + E++ R H N+V L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
L +VME+ GG L + I R +E++ ++ +SY H V HRD+K ++
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 150 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ R Y +V +S+
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 204
Query: 207 TQMSLQ 212
M ++
Sbjct: 205 GIMVIE 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-18
Identities = 49/141 (34%), Positives = 75/141 (53%), Gaps = 5/141 (3%)
Query: 67 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 126
+R I+ +++HP IV T L +++EY SGGELF + G F ED A F+
Sbjct: 50 ERNIL--EAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 185
++ + + H + +RDLK EN LLD +K+ DFG K S+ T GT
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIE 165
Query: 186 YIAPEVLLRHEYDGKVYFYSI 206
Y+APE+L+R + V ++S+
Sbjct: 166 YMAPEILMRSGHGKAVDWWSL 186
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-18
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 81
+ ++ + ++G G FG ++K T L A K I+ + ++ E+ EI S HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
V+ + +L I++E+ +GG + + R +E + R +Q + ++Y H ++
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 141 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 193
HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 194 ---RHEYDGKVYFYSITQMSLQSTSP 216
++Y V+ IT + + P
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 4e-18
Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 32/194 (16%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-D--ENVQ------REI 70
H +Y+ ++ +G G +G+ D+ TKE+VA+K KI D N REI
Sbjct: 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREI 57
Query: 71 INHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFF 125
+ + L HPNIV+ VI I + + E E + A + R+
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIM 113
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----- 180
QL+ + Y H+ V HRDLK N LL+ R+K+ DFG ++S +
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 181 -VGTPAYIAPEVLL 193
V T Y APE+LL
Sbjct: 172 YVATRWYRAPEILL 185
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-18
Identities = 60/186 (32%), Positives = 100/186 (53%), Gaps = 9/186 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
IG G+ G+ + K + +LVAVK ++ R + E + E++ R +H N+V L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
L +VME+ GG L + I R +E++ ++ +S HA V HRD+K ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 150 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ R Y +V +S+
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL 202
Query: 207 TQMSLQ 212
M ++
Sbjct: 203 GIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-18
Identities = 60/188 (31%), Positives = 96/188 (51%), Gaps = 14/188 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 84
+G G FG L D T +AVK + + K ++ EI ++LRH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 85 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ P L+I +EY GG + +++ G +E+ R + +Q++ GVSY H+ + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYD 198
RD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYG 187
Query: 199 GKVYFYSI 206
K +S+
Sbjct: 188 RKADVWSV 195
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 8e-18
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 24/194 (12%)
Query: 24 RYDFVRDIGSGNFGVARLMRDK--VTKELVAVKYIE----RGDKIDENVQREIINHRSLR 77
+Y+ IG G +G + K + A+K + + I ++ REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 78 HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 131
H N+V EV L ++ + +YA F R + Q+++G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 132 VSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 183
V Y H+ V HRDLK N L+ +G +KI D G ++ + ++ K V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178
Query: 184 PAYIAPEVLL--RH 195
Y APE+LL RH
Sbjct: 179 IWYRAPELLLGARH 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 9e-18
Identities = 37/121 (30%), Positives = 61/121 (50%), Gaps = 4/121 (3%)
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + H Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 198 D 198
D
Sbjct: 184 D 184
|
Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 9e-18
Identities = 54/182 (29%), Positives = 79/182 (43%), Gaps = 13/182 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHP 79
RY + IG G +G+ K T VA+K I + + REI R +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 135
NI+ + I+ P + EL E ++ S D ++F Q++ G+ Y
Sbjct: 64 NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 191
H+ V HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 192 LL 193
+L
Sbjct: 181 ML 182
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 9e-18
Identities = 57/190 (30%), Positives = 99/190 (52%), Gaps = 17/190 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERG-----DKIDENV--QREIINH 73
++ ++ +G+G +G L+R KVT +L A+K +++ K E+ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVR-KVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ P +V T L ++++Y SGGE+F + FSEDE RF+ ++I +
Sbjct: 61 VR-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
+ H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APE+
Sbjct: 120 HLHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 192 LLRHEYDGKV 201
+ GK
Sbjct: 178 IRGKGGHGKA 187
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-17
Identities = 59/186 (31%), Positives = 94/186 (50%), Gaps = 13/186 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
++ Y+ V+ IG G FG +L+R K T+++ A+K + + + I + R +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P +V+ +L +VMEY GG+L + N E ARF+ +++ + H+
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
M HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL
Sbjct: 161 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216
Query: 194 RHEYDG 199
DG
Sbjct: 217 SQGGDG 222
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-17
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
++ ++ + ++G G FG ++K T L A K IE + + E+ EI + HP
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
IV+ L I++E+ GG + + R +E + + +Q++ + Y H+M+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 193
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 194 ----RHEYDGKVYFYSITQMSLQSTSP 216
++Y ++ IT + + P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 62/220 (28%), Positives = 90/220 (40%), Gaps = 54/220 (24%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
++ IG G FG L+R T L A+K + + D + N +R+I+ + +
Sbjct: 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--NEWV 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ +L VM+Y GG++ + G F ED ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 142 HRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------SSVL 173
HRD+K +N L+D +K+ DFG Y K S +
Sbjct: 124 HRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 174 HSQPK----------------STVGTPAYIAPEVLLRHEY 197
+ K S VGTP YIAPEVLLR Y
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-17
Identities = 50/191 (26%), Positives = 90/191 (47%), Gaps = 19/191 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
+ + IG G F V + +VA+K ++ + +D ++ +EI + L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 134
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 189
H+ ++ HRD+K N + + +K+ D G SK++ HS VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175
Query: 190 EVLLRHEYDGK 200
E + + Y+ K
Sbjct: 176 ERIHENGYNFK 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-17
Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 20/200 (10%)
Query: 25 YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI------------ERGDKIDENVQREII 71
Y + +GSG FG V ++ + + L+A+K I ER I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 127
LRHPNIVR+ + L L IVM+ G L E + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 128 LISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 187 IAPEVLLRHEYDGKVYFYSI 206
PE++ Y K ++
Sbjct: 180 SCPEIVKNEPYGEKADVWAF 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 3e-17
Identities = 56/180 (31%), Positives = 96/180 (53%), Gaps = 16/180 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDKIDENVQ----REIINHRSLR 77
++Y+ + +G G++G+ + K T ++VA+K ++E D D+ V+ REI + LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 135
H N+V EV L +V E+ L E+ N E R + Q++ G+ +C
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 193
H+ + HRD+K EN L+ S + +K+CDFG+++ ++ T V T Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-17
Identities = 56/167 (33%), Positives = 88/167 (52%), Gaps = 7/167 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G + R K+T+ LVA+K I E + RE+ ++L+H NIV ++I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
T L +V EY +L + + N G S + F QL+ G+SYCH ++ HRDLK
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-17
Identities = 57/188 (30%), Positives = 94/188 (50%), Gaps = 14/188 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 84
+G G FG L D T +AVK ++ + E + EI ++L H IV++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 85 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ P L+I ME+ GG + +++ + G +E+ R + +Q++ GVSY H+ + H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
RD+K N L D +K+ DFG SK + + KS GTP +++PEV+ Y
Sbjct: 130 RDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYG 187
Query: 199 GKVYFYSI 206
K +S+
Sbjct: 188 RKADIWSV 195
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-17
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 21/199 (10%)
Query: 26 DFVRDIGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPN 80
+ + IG + L + K T LVAVK I E++ Q+EII R L+HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 81 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
I+ + + + L +V M Y S +L + G E F + +++ + Y H+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 189
HR +K + LL G ++ + YS + V+H PKS+V +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 190 EVLLR--HEYDGKVYFYSI 206
EVL + Y+ K YS+
Sbjct: 178 EVLQQNLQGYNEKSDIYSV 196
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-17
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN 80
SD ++ + IG G +G + +K AVK ++ IDE ++ E ++L HPN
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 81 IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 131
+V+F K+ + L +V+E +GG +L + G R E + + + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 189
+ + H + HRD+K N LL + +K+ DFG S +S + ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193
Query: 190 EVL-----LRHEYDGKVYFYS--ITQMSLQSTSP 216
EV+ L YD + +S IT + L P
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-17
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPN 80
+D ++ + IG G +G + +K L AVK ++ +DE ++ E +SL HPN
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 81 IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 131
+V+F + L +V+E +GG EL + + G R E + + G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 190
+ + H ++ HRD+K N LL +K+ DFG S + + ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 191 VL-----LRHEYDGK--VYFYSITQMSLQSTSP 216
V+ + YD + V+ IT + L P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-16
Identities = 48/181 (26%), Positives = 95/181 (52%), Gaps = 17/181 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDKIDE-------NVQREIINH 73
++ ++ +G+G +G L+R KV + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVR-KVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ P +V T T L ++++Y +GGELF + RF E E + + +++ +
Sbjct: 61 IR-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
+ H + + +RD+KLEN LLD + + + DFG SK + S GT Y+AP++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 192 L 192
+
Sbjct: 178 V 178
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-16
Identities = 56/177 (31%), Positives = 84/177 (47%), Gaps = 9/177 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLR 77
+D Y+ + +G G++ + KV +LVA+K I E G RE + L+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
H NIV ++I T L +V EY + G + + F QL+ G+SY H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-16
Identities = 60/177 (33%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
+ Y + +G G++ R K+T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 137
NIV ++I T L +V EY +L + + + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
+V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-16
Identities = 58/191 (30%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 83
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
TP L +++ +GG+L + G FSE E RF+ ++I G+ + H V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 144 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYD 198
DLK N LLD R+ CDF K P ++VGT Y+APEVL + YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174
Query: 199 GKVYFYSITQM 209
++S+ M
Sbjct: 175 SSADWFSLGCM 185
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-16
Identities = 57/185 (30%), Positives = 90/185 (48%), Gaps = 11/185 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 86
+G G FG + + T +L A K + + K + + ++ R L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCH 142
T T L +VM +GG+L I N F E A F+ Q+ISG+ + H ++ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
RDLK EN LLD ++I D G + + S+ K GTP ++APE+L EYD V
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 202 YFYSI 206
++++
Sbjct: 179 DYFAL 183
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-16
Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 6/146 (4%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
V+ I G FG L R K +L AVK +++ D I++N+ ++ R + P IV
Sbjct: 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVH 68
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+ + ++ +VMEY GG++ + G F E+ A + ++ + Y H + HR
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHR 128
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK 169
DLK +N L+ S +K+ DFG SK
Sbjct: 129 DLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-16
Identities = 55/181 (30%), Positives = 93/181 (51%), Gaps = 8/181 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G + R K+T+ LVA+K I E + RE+ + L+H NIV +++
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 89 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
T L +V EY +L + + + G S + F Q++ G++YCH +V HRDLK
Sbjct: 74 HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKP 132
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKVYFYS 205
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY ++ +
Sbjct: 133 QNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG 190
Query: 206 I 206
+
Sbjct: 191 V 191
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-15
Identities = 61/191 (31%), Positives = 83/191 (43%), Gaps = 22/191 (11%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
RY +R +G G+ G+ D + VAVK I D ++ REI R L H N
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 81 IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 126
IV+ EV+ T L IV EY + G SE+ AR F
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 182
QL+ G+ Y H+ V HRDLK N ++ + LKI DFG ++ H K +
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 183 TPAYIAPEVLL 193
T Y +P +LL
Sbjct: 181 TKWYRSPRLLL 191
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-15
Identities = 58/191 (30%), Positives = 89/191 (46%), Gaps = 19/191 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 83
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 144 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYD 198
DLK N LLD R+ CDF K P ++VGT Y+APEVL + YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174
Query: 199 GKVYFYSITQM 209
++S+ M
Sbjct: 175 SSADWFSLGCM 185
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 53/167 (31%), Positives = 86/167 (51%), Gaps = 7/167 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G + R K+T LVA+K I E + RE+ + L+H NIV ++I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 89 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
T L +V EY +L + + + G + + F QL+ G++YCH +V HRDLK
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
+N L++ LK+ DFG +++ + ++ S V T Y P++LL
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL 177
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-15
Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 14/188 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 84
+G G FG L D T +A K ++ + E + EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 85 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ L I MEY GG + +++ G +E R + +Q++ G+SY H+ + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYD 198
RD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187
Query: 199 GKVYFYSI 206
K +S+
Sbjct: 188 RKADVWSL 195
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-15
Identities = 54/173 (31%), Positives = 81/173 (46%), Gaps = 10/173 (5%)
Query: 42 MRDKVTKELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100
R KE V K++ D+ R E+ + H IV+ + + L ++MEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 101 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156
SGG+L ++I + F E E F Q++ + H+ ++ HRDLK N L P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204
Query: 157 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
+K+ DFG+SK SV S GTP Y+APE+ R Y K +S+
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257
|
Length = 478 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-14
Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 20/184 (10%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
F++++G+G FGV + + + + VA+K I+ G ++ E L H +V+
Sbjct: 8 FLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
V + IV EY S G C E RF QL+ G++Y + Q
Sbjct: 67 VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 197 YDGK 200
+ K
Sbjct: 178 FSSK 181
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-14
Identities = 53/188 (28%), Positives = 81/188 (43%), Gaps = 31/188 (16%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR----- 77
DRY + +GSG +G D T VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 78 ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
H N++ +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 185
++ G+ Y H+ + HRDLK N ++ LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180
Query: 186 YIAPEVLL 193
Y APE++L
Sbjct: 181 YRAPEIML 188
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-14
Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 42/224 (18%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 80
D ++ ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 178
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 121 GFIHRDIKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 179 ----------------STVGTPAYIAPEVLLRHEYDGKVYFYSI 206
STVGTP YIAPEV ++ Y+ ++S+
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-14
Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 9/174 (5%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
Y + +G G++ ++ +LVA+K I K +E V RE + L+H N
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISM--KTEEGVPFTAIREASLLKGLKHAN 64
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV ++I T L V EY I + G R F QL+ G++Y H +
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
HRDLK +N L+ S LK+ DFG +++ + SQ S+ V T Y P+VLL
Sbjct: 125 LHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-14
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREIINHRSLR--- 77
+Y+ V +IG G +G RD + VA+K + D + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 78 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 130
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
G+ + HA + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 191 VLLRHEYDGKVYFYSI 206
VLL+ Y V +S+
Sbjct: 178 VLLQSTYATPVDMWSV 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-14
Identities = 56/185 (30%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDKIDEN--VQREIINHRSLRHPNI 81
Y FVR +G G++G L+R + K+ V K R E ++E L+HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 82 VRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHAM 138
V ++E L IVM + GG+L+ ++ G+ E++ +F Q+ + Y H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRH 195
+ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 196 EYDGK 200
Y+ K
Sbjct: 178 PYNYK 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-14
Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 10/151 (6%)
Query: 27 FVRDIGSGNFGVARLMR-DKV---TKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 81
F++ +G GNFG L R D + T E+VAVK ++ + +REI +SL+H NI
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 82 VRFKEVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHAM 138
V++K V + +L +VMEY G L + + R + + Q+ G+ Y +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ HRDL N L++ R+KI DFG +K
Sbjct: 128 RYVHRDLATRNILVESE--NRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-14
Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 28 VRDIGSGNFGVARLMR----DKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
+R +G G+FG L + T E+VAVK ++R G + ++EI ++L H NI
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 82 VRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
V++K L ++MEY G L + + + + + F QQ+ G++Y H+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
HRDL N LLD +KI DFG +K+
Sbjct: 128 YIHRDLAARNVLLDNDRL--VKIGDFGLAKA 156
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-14
Identities = 65/202 (32%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
D Y+ + IG G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 79 -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 127
IVR +V L +V EY +L + + + GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 186
L+ GV++CH V HRDLK +N L+D LKI D G ++ S+ + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 187 IAPEVLL--RHEYDGKVYFYSI 206
APEVLL H Y V +S+
Sbjct: 178 RAPEVLLGSTH-YSTPVDIWSV 198
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-14
Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 83
++ V +G+G +G R T +L A+K ++ + +E ++ EI + + H NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 84 FKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 135
+ + P H L +VME+ G + + + N ED + ++++ G+++
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
HA +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 138 HAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 195 HEYDGKVYFYSITQMSLQSTS 215
E Y Y SL T+
Sbjct: 196 DENPDATYDYRSDIWSLGITA 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-14
Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 14/185 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 83
+G G FG ++ K T ++ A K +++ G+K+ +++EI+ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHAMQVC 141
+ THL +VM +GG+L I N G + R + Q+ G+ + H+M +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
+RD+K EN LLD RL D G + GT Y+APE+L Y V
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 202 YFYSI 206
++++
Sbjct: 176 DWFAM 180
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-14
Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 19/191 (9%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRF 84
+ IG G F + ++ VA+K ++ + +D +++ + + L HPN++++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQV 140
+ + L IV+E A G+L + I + E +F QL S V + H+ +V
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
HRD+K N + + +K+ D G SK++ H S VGTP Y++PE + +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181
Query: 196 EYDGKVYFYSI 206
Y+ K +S+
Sbjct: 182 GYNFKSDIWSL 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-14
Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 80
++ ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V+ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 178
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 123 IHRDIKPDNLLLDSK--GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 179 --------------STVGTPAYIAPEVLLRHEYDGKVYFYSI 206
STVGTP YIAPEV ++ Y+ ++S+
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-14
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 58/229 (25%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDE----NVQREIINHRSL 76
+ + V+ IG G FG RL++ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
P +V +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 169
+ HRD+K +N L+D +K+ DFG Y K
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 170 --------SSVLHSQPK-------------STVGTPAYIAPEVLLRHEY 197
+ + S+ + STVGTP YIAPE+ L+ Y
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 38/195 (19%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTK--ELVAVKYIERGDKIDENVQREIINHRSLR---- 77
RY+ ++++G G +G+ R+ T E VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 78 ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 125
H NI ++ I+ P + + Y EL E +I +G ++ + F
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 180
Q++ G+ Y H+ V HRDLK N L D LKICDFG ++ S + T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167
Query: 181 --VGTPAYIAPEVLL 193
V T Y APE++L
Sbjct: 168 EYVATRWYRAPEIML 182
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-13
Identities = 40/120 (33%), Positives = 67/120 (55%), Gaps = 9/120 (7%)
Query: 94 LAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
+A+V++YA+ G+L + I + + F E EA F Q++ V + H+ + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 150 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ R Y K +S+
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231
|
Length = 496 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 24/191 (12%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIINHRSL 76
D ++ ++ IG G FG +++ K T+ + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 135
+ I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
H + HRD+K +N LLD + R LK+ G +SSV VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171
Query: 189 PEVLLRHEYDG 199
PE+L E DG
Sbjct: 172 PEILQAME-DG 181
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 22/191 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK------YIERGDKIDENVQREIINHRSL 76
D ++ ++ IG G FG +++ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 135
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 189
H + HRD+K +N LLD + RL DFG S L T VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 190 EVLLRHEYDGK 200
E+L E DGK
Sbjct: 173 EILQAME-DGK 182
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 60/222 (27%), Positives = 86/222 (38%), Gaps = 54/222 (24%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
++ +G G FG L R TK L A+K + + D + N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--NEWV 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123
Query: 142 HRDLKLENTLLD--------------------------GSPAPRLKICDFGYS------- 168
HRD+K +N L+D R DF
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 169 -----------KSSVLHSQ--PKSTVGTPAYIAPEVLLRHEY 197
+++ H + S VGTP YIAPEVLLR Y
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-13
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 10/180 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
D ++ + ++G+GN GV ++ K + ++A K I +I ++ +II + H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
P IV F + ++I ME+ GG L + + A R E+ ++ G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-13
Identities = 54/184 (29%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 28 VRDIGSGNFGVARLMR-----DKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+RD+G G+FG L R D T E VAVK + E G ++++EI R+L H N
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 81 IVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K + + ++ME+ G L E + N + + + + Q+ G+ Y +
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLL 193
Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L+
Sbjct: 128 RQYVHRDLAARNVLVESE--HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 194 RHEY 197
+ ++
Sbjct: 186 QSKF 189
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-13
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 83
++ V +G+G +G R T +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 84 FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 135
+ + L +VME+ G + + I N E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 195 HE-----YDGKVYFYS--ITQMSLQSTSP 216
E YD K +S IT + + +P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-13
Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRF 84
+ IG G F + VA+K ++ D +D + + I + L HPN++++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQV 140
+ L IV+E A G+L I + + E +F QL S + + H+ +V
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
HRD+K N + + +K+ D G SK++ H S VGTP Y++PE + +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181
Query: 196 EYDGKVYFYSI 206
Y+ K +S+
Sbjct: 182 GYNFKSDIWSL 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-13
Identities = 53/180 (29%), Positives = 89/180 (49%), Gaps = 10/180 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
D ++ + ++G+GN GV + K + ++A K I +I ++ +II + H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 8e-13
Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
DRY ++ +GSG +G D+ T VA+K + R + + RE+ + ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 80 NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
N++ +V L +VM + G ++ + SED +F Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y HA + HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-13
Identities = 46/178 (25%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 83
+ D+G+GN G ++ T ++A K + G K +V+++I+ + H P IV
Sbjct: 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVS 67
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCH 142
F L ++ + ME+ G L G + ++ G++Y + ++ H
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
RD+K N L++ ++K+CDFG S +++S + VGT Y++PE + +Y K
Sbjct: 128 RDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYTVK 182
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-12
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYI-----ERGDKIDENVQREIINH-RSL 76
+Y+ V +IG G +G RD K VA+K + E G + + ++ H +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 77 RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 129
HPN+VR +V T L +V E+ +++ G +E FQ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 190 EVLLRHEYDGKVYFYSI 206
EVLL+ Y V +S+
Sbjct: 179 EVLLQSSYATPVDLWSV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-12
Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 13/176 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
D + + ++G GN+G + + T +A+K I ++DE+ +II + H
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 135
P IV F + + MEY G +L+ ED R ++ G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 136 -HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGN--GQVKLCDFGVS-GNLVASLAKTNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-12
Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 8/184 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
V++IGSG FG+ L + K VA+K I G +E+ E L HP
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPK 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+V+ V + + +V E+ G L + + G+FS++ + G++Y +
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV +
Sbjct: 121 VIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 197 YDGK 200
Y K
Sbjct: 178 YSSK 181
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-12
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 8/178 (4%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
F++++GSG FGV L + + + VA+K I G +E+ E L HP +V+
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 87 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V L IV E+ G L + G+ S+D Q + G+ Y HRDL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
N L+ S +K+ DFG ++ VL + S+ G + PEV +Y K
Sbjct: 127 AARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 60/226 (26%), Positives = 88/226 (38%), Gaps = 62/226 (27%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
++ +G G FG L T L A+K + + D ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V+ +L VM+Y GG++ + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 142 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 178
HRD+K +N L LDG +K+ DFG Y K S + +P
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 179 ---------------------------STVGTPAYIAPEVLLRHEY 197
S VGTP YIAPEVLLR Y
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY 225
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-12
Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 8/178 (4%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
F++++GSG FGV L + + K VA+K I G +++ E L HPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 87 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V + IV EY + G L + G+ + + + Y + HRDL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGK 200
N L+ +K+ DFG ++ VL Q S+ GT + PEV + K
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-12
Identities = 42/143 (29%), Positives = 63/143 (44%), Gaps = 6/143 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
IG G FG +M + VAVK ++ + E +LRHPN+V+ V+L
Sbjct: 14 IGKGEFG--DVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 91 PTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L IV EY + G L + + + GR + + F + G+ Y HRDL
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131
Query: 149 NTLLDGSPAPRLKICDFGYSKSS 171
N L+ K+ DFG +K +
Sbjct: 132 NVLVSEDLVA--KVSDFGLAKEA 152
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-12
Identities = 50/185 (27%), Positives = 90/185 (48%), Gaps = 14/185 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIINHRSLRH 78
++ ++ IG G FG +++ K ++ A+K + + + + +R+++ + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA 137
I +L +VM+Y GG+L + R ED ARF+ +++ + H
Sbjct: 63 --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRH 195
+ HRD+K +N L+D + RL DFG + +S+ VGTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 196 EYDGK 200
E DGK
Sbjct: 179 E-DGK 182
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-12
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 17/193 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPN 80
RY ++ +GSG +G DK T E VA+K + R + + RE+ + ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 81 IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++ +V + +VM Y ++I SED+ ++ Q++ G+ Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
H+ + HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188
Query: 195 -HEYDGKVYFYSI 206
Y+ V +S+
Sbjct: 189 WMHYNQTVDIWSV 201
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-12
Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 30 DIGSGNFGVARLMRDKVTKEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
+G G+FGV R R + + VAVK + DK+ + + +E SL H N+
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHAMQ 139
+R V+LT L +V E A G L +R+ +A G F + Q+ +G+ Y + +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
HRDL N LL + ++KI DFG ++
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRA 146
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-12
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
Y+ + +G G FG R T +VA+K I E+ D REI + L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 79 PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 124
PN+V ++ + + +V Y SG L E + + +E + + +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
QL+ G++Y H + HRD+K N L+D LKI DFG
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFG 160
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-12
Identities = 49/175 (28%), Positives = 87/175 (49%), Gaps = 21/175 (12%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 86
+G GN G +T+ ++AVK I I +Q++I++ + + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 87 VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCH 142
++I E+ GG L + +I GR + ++ G++Y ++++ H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
RD+K N L++ ++K+CDFG S V +S K+ VGT AY+APE + +Y
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY 170
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-12
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 12/149 (8%)
Query: 29 RDIGSGNFGVAR--LMRDKVTKEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 81
+++G GNFG + K KE+ VAVK +++ + I ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR V L +VME A G L + + + + Q+ G++Y +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKS 170
HRDL N LL + KI DFG S++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRA 144
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-12
Identities = 47/161 (29%), Positives = 64/161 (39%), Gaps = 16/161 (9%)
Query: 47 TKELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 100
T VA+K + R D +E +RE L HPNIV P L V EY
Sbjct: 2 TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APR 159
G L E + G E Q++ ++ H + HRDLK +N ++ + P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 160 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 192
K+ DFG + T +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-12
Identities = 54/195 (27%), Positives = 86/195 (44%), Gaps = 20/195 (10%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
RY ++ IGSG G+ D V VAVK + R + + +R E++ + + H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 81 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 131
I+ V TP + +VME +C D R + Q++ G
Sbjct: 82 IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ + H+ + HRDLK N ++ LKI DFG ++++ + V T Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 192 LLRHEYDGKVYFYSI 206
+L Y V +S+
Sbjct: 194 ILGMGYKENVDIWSV 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 22/193 (11%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNIV 82
R IG G FGV + D + VA+K + + +N V RE+ +H N++
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 83 RFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSYCHA 137
+ IL P H+ E EL + I + S D + F Q++ G+ Y H+
Sbjct: 63 SALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL-- 193
+ HRD+K N L++ + LKICDFG ++ T V T Y APE+L+
Sbjct: 122 AGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 194 RHEYDGKVYFYSI 206
RH Y V +S+
Sbjct: 180 RH-YTSAVDIWSV 191
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-11
Identities = 53/195 (27%), Positives = 87/195 (44%), Gaps = 20/195 (10%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
RY ++ IGSG G+ D + + VA+K + R + + +R E++ + + H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 131
I+ V TP + IVME +C + D R + Q++ G
Sbjct: 85 IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ + H+ + HRDLK N ++ LKI DFG ++++ V T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKVYFYSI 206
+L Y V +S+
Sbjct: 197 ILGMGYKENVDIWSV 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 35/133 (26%), Positives = 70/133 (52%), Gaps = 4/133 (3%)
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGV 132
+++ HP+++R K+ +++ +V+ + S +L+ + + D+A +Q++ G+
Sbjct: 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGL 170
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
Y HA ++ HRD+K EN ++ ++ I D G ++ V+ GT APEVL
Sbjct: 171 RYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL 228
Query: 193 LRHEYDGKVYFYS 205
R +Y+ K +S
Sbjct: 229 ARDKYNSKADIWS 241
|
Length = 357 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 44/203 (21%), Positives = 82/203 (40%), Gaps = 34/203 (16%)
Query: 22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDE-----N 65
S+RY +G G +G D +T ++VA+K + + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 66 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 125
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 174
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 175 SQPK----STVGTPAYIAPEVLL 193
Q + S V T Y APE+L+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLM 206
|
Length = 335 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 26/198 (13%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------REIINHRSLR 77
RY ++ IGSG G+ D VT + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 78 HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 128
H NI+ V TP + +VME A+ ++ + + R S + Q+
Sbjct: 74 HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
+ G+ + H+ + HRDLK N ++ LKI DFG ++++ V T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 189 PEVLLRHEYDGKVYFYSI 206
PEV+L Y V +S+
Sbjct: 186 PEVILGMGYKENVDIWSV 203
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-11
Identities = 43/148 (29%), Positives = 62/148 (41%), Gaps = 19/148 (12%)
Query: 28 VRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
R +G+G FG V + TK VAVK ++ G E +E + LRH +V+
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHAM 138
V + IV EY S G L + + E + QL+ G++Y +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFG 166
HRDL N L+ + KI DFG
Sbjct: 123 NYIHRDLAARNILVGENLV--CKIADFG 148
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 25/179 (13%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
IG+G+FGV T E VA+K + + + RE++ ++L H NI+ K+ T
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINIIFLKDYYYT 130
Query: 91 PT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
L +VME+ + + R N + + QL ++Y H+
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 138 MQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
+CHRDLK +N L+D P LK+CDFG +K+ + + S + + Y APE++L
Sbjct: 189 KFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML 243
|
Length = 440 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 3e-11
Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 8/189 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
RY ++ IGSG G+ D V VA+K + R + + +R E++ + + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
I+ V L + EL + +C + D R + Q++ G+ + H+
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 198 DGKVYFYSI 206
V +S+
Sbjct: 196 KENVDIWSV 204
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-11
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFK 85
++G+GN GV + + + ++A K I +I ++ +II + H P IV F
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRD 144
+ ++I ME+ GG L + + AGR E+ ++ G++Y ++ HRD
Sbjct: 66 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRD 125
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+K N L++ +K+CDFG S ++ S S VGT +Y++PE L
Sbjct: 126 VKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL 170
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-11
Identities = 59/180 (32%), Positives = 87/180 (48%), Gaps = 18/180 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR--SLRH 78
D + + + +IGSG G MR K T ++AVK + R +EN +R +++ H
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71
Query: 79 --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 134
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129
Query: 135 C---HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPE 190
H V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDAS--GNVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-11
Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 14/193 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
+RY + +GSG +G D ++ VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 80 NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
N++ +V T + E G +L I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
H+ + HRDLK N ++ L+I DFG ++ + + V T Y APE++L
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189
Query: 195 -HEYDGKVYFYSI 206
Y+ V +S+
Sbjct: 190 WMHYNQTVDIWSV 202
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 81
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ 139
V T L +V+ +GG+L I N G F E+ A F+ +++ G+ H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+RDLK EN LLD ++I D G + + VGT Y+APEVL Y
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-10
Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
+RY + +GSG +G D T VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 80 NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
N++ +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
H+ + HRDLK N ++ LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 193 LR-HEYDGKVYFYSI 206
L Y+ V +S+
Sbjct: 190 LNWMHYNQTVDIWSV 204
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-10
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 79
R +G G FG + + T ++ A K +E+ G+ + N +R E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
+V T L +V+ +GG+L I N G F E A F+ +L G+
Sbjct: 62 -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
++ +RDLK EN LLD ++I D G + + VGT Y+APEV+ +Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-10
Identities = 59/189 (31%), Positives = 88/189 (46%), Gaps = 29/189 (15%)
Query: 31 IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
+G G +G A+ K KE A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEY-ALKQIE-GTGISMSACREIALLRELKHPNVIALQKV 66
Query: 88 ILTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHA 137
L+ + + ++ +YA F R A + + Q++ G+ Y HA
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIA 188
V HRDLK N L+ +G R+KI D G+++ L + P V T Y A
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRA 183
Query: 189 PEVLL--RH 195
PE+LL RH
Sbjct: 184 PELLLGARH 192
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-10
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 81
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ 139
V T L +V+ +GG+L I + G F E A F+ ++ G+ H +
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ Y
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-10
Identities = 49/173 (28%), Positives = 70/173 (40%), Gaps = 31/173 (17%)
Query: 27 FVRDIGSGNFGVARL-----MRDKVTKE-----------LVAVKYIERG--DKIDENVQR 68
FV +G G FG L ++D K LVAVK + D E+ +
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 69 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRFS 117
E+ L PNI R V L ++MEY G+L F + CN+ S
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
+ Q+ SG+ Y ++ HRDL N L+ +KI DFG S++
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-10
Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 20/181 (11%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 79
R +G G FG + + T ++ A K +E+ G+ + N ++ E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF---- 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
+V T L +V+ +GG+L I N G F E+ A F+ ++ G+ H
Sbjct: 62 -VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHE 196
++ +RDLK EN LLD ++I D G + + + + VGT Y+APEV+
Sbjct: 121 ERIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNER 177
Query: 197 Y 197
Y
Sbjct: 178 Y 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-09
Identities = 57/188 (30%), Positives = 86/188 (45%), Gaps = 27/188 (14%)
Query: 31 IGSGNFGVARLMRDKVTKEL--VAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
+G G +G + K K+ A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 89 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHAM 138
L+ + ++ +YA F R A + + Q++ G+ Y HA
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 189
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 190 EVLL--RH 195
E+LL RH
Sbjct: 185 ELLLGARH 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 43/176 (24%), Positives = 79/176 (44%), Gaps = 17/176 (9%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
R + S N G + + L+A K ++ G + ++ EI+ L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232
Query: 89 LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHAMQVCHR 143
+ + ++ + +L+ + + +D + R +QL+ V Y H ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEY 197
D+KLEN L+ L DFG + + VGT A +PE+L Y
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345
|
Length = 501 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 35/179 (19%)
Query: 23 DRYDFVRDIGSGNFGVARL-----MRDKVTKE-----------LVAVKYIERGDKIDENV 66
R F +G G FG L M + K+ LVAVK + R D ++N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62
Query: 67 Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 111
+ +EI L+ PNI+R V +T L ++ EY G+L + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 112 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
+ S F Q+ SG+ Y ++ HRDL N L+ + +KI DFG S++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN 179
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-09
Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 26/185 (14%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 86
IG G FG M K + ++AVK I R ++ +R +++ RS P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 87 VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 135
+ I ME S + ++ + + ++++ ++
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181
Query: 195 HEYDG 199
DG
Sbjct: 182 SARDG 186
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-09
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 31 IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
IG+G FG RL + VA+K ++ G E +R+ ++ S+ HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 84 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+ V+ + I+ E+ G L F R N G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N L++ + K+ DFG S+
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-09
Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 22/187 (11%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR 77
D+ + IG+G FG R K+ +E+ VA+K ++ G E +R+ ++ S+
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59
Query: 78 ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 131
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 185
+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174
Query: 186 YIAPEVL 192
+ APE +
Sbjct: 175 WTAPEAI 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-09
Identities = 46/153 (30%), Positives = 66/153 (43%), Gaps = 24/153 (15%)
Query: 31 IGSGNFG---VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
IG G FG RL + VA+K ++ G DK + E HPNI+R +
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 86 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCH 136
V+ + I+ EY G L F R E++ +F QL+ SG+ Y
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
M HRDL N L++ + K+ DFG S+
Sbjct: 124 EMNYVHRDLAARNILVNSN--LVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-09
Identities = 58/212 (27%), Positives = 82/212 (38%), Gaps = 46/212 (21%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR------ 77
RYD +R IG G G L D V VA+K I R D + ++ R LR
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57
Query: 78 ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 124
HP IV + + M Y G L + + S++ A F
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 125 -FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 167
F ++ + + Y H+ V HRDLK +N LL + I D+G
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 168 SKSSVLHSQ---PKSTVGTPAYIAPEVLLRHE 196
+ ++ +S P VGTP Y+APE LL
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVP 207
|
Length = 932 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-09
Identities = 56/184 (30%), Positives = 79/184 (42%), Gaps = 20/184 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
IG G FG +++ + T + VAVK I K D Q E L H N+VR V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHRDL 145
IL L IVME S G L + GR + F + G+ Y + ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGK--VY 202
N L+ S K+ DFG ++ + S P + APE L ++ K V+
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 203 FYSI 206
Y +
Sbjct: 182 SYGV 185
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-08
Identities = 53/176 (30%), Positives = 76/176 (43%), Gaps = 11/176 (6%)
Query: 23 DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKY--IERGDKIDENVQREIINHRSLR 77
+ R IG G FG M + K VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 136
HP+IV+ VI T + IVME A GEL + N + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPE 190
+ + HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-08
Identities = 43/151 (28%), Positives = 62/151 (41%), Gaps = 20/151 (13%)
Query: 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFK 85
IG GNFG K VAVK R + ++ + L HPNIV+
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAM 138
V + + IVME GG L + + + R ++L+ +G+ Y +
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N L+ + LKI DFG S+
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 43/164 (26%), Positives = 68/164 (41%), Gaps = 23/164 (14%)
Query: 27 FVRDIGSGNFGVARL-----MRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
R++G G FG L + + KELVAVK ++ + ++ +RE + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 125
NIV+F V +V EY G+L + + G + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
Q+ SG+ Y + HRDL N L+ +KI DFG S+
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-08
Identities = 42/144 (29%), Positives = 60/144 (41%), Gaps = 9/144 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 86
IG GNFG R + VAVK + + +++ + + + HPNIVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 87 VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V + IVME GG+ + G R E + +G+ Y + HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 146 KLENTLLDGSPAPRLKICDFGYSK 169
N L+ LKI DFG S+
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 27/197 (13%)
Query: 31 IGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRFK 85
IG G + L R K T E V V+ I +E V Q E+ + HPNIV ++
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65
Query: 86 EVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
+ L +V + + G + IC SE + Q ++ + Y H M HR
Sbjct: 66 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHR 125
Query: 144 DLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAYIAPEV 191
+K + L +DG K+ G + V+H PK +V +++PEV
Sbjct: 126 SVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEV 179
Query: 192 LLRH--EYDGKVYFYSI 206
L ++ YD K YS+
Sbjct: 180 LQQNLQGYDAKSDIYSV 196
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-08
Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 30 DIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
++GSGNFG + + + K +++ VAVK I + D D ++ E++ + L +P IVR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
I +VME A G L + + +E Q+ G+ Y HR
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLRHEYDG 199
DL N LL KI DFG SK + + + K+ P + APE + +++
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 200 K 200
K
Sbjct: 178 K 178
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 5e-08
Identities = 39/160 (24%), Positives = 66/160 (41%), Gaps = 29/160 (18%)
Query: 29 RDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHP 79
R++G G+FG +A+ + + VA+K + + E E +N S
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCH 69
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF--------FFQ--- 126
++VR V+ T +VME + G+L + R R + F Q
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQKFIQMAA 126
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
++ G++Y A + HRDL N ++ +KI DFG
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFG 164
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-08
Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLR 77
D + + ++G G +GV MR T ++AVK I E Q+ + I+ RS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58
Query: 78 HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 133
P V F + + I ME S + ++++ + G ++ + ++ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV-SIVKALE 117
Query: 134 YCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 190
Y H+ + V HRD+K N L++ ++K+CDFG S V S K+ G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-08
Identities = 47/179 (26%), Positives = 73/179 (40%), Gaps = 31/179 (17%)
Query: 20 HDSDRYDFVRDIGSGNFGV---ARLMRDKVTKE--LVAVKYIERG--DKIDENVQREIIN 72
+ + ++VRDIG G FG AR + +VAVK ++ + + QRE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 112
HPNIV+ V + ++ EY + G+L E R C
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 113 AGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-08
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 31 IGSGNFG-VAR-LMRDKVTKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
IG+G FG V R +++ KE+ VA+K ++ G E +++ ++ S+ H NI+R
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 84 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
+ V+ I+ EY G L + + + G FS + + + +G+ Y M H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVL 192
RDL N L++ + K+ DFG S+ VL P+ T T + APE +
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAI 182
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-08
Identities = 56/182 (30%), Positives = 78/182 (42%), Gaps = 14/182 (7%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
IG G FG L + K VAVK I + D + E LRH N+V+ VI+
Sbjct: 14 IGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 91 P-THLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
L IV EY + G L + + + GR D F + + Y A HRDL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGK--VYFY 204
N L+ S K+ DFG +K + S + T P + APE L ++ K V+ +
Sbjct: 131 RNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 205 SI 206
I
Sbjct: 186 GI 187
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 22/159 (13%)
Query: 31 IGSGNFG------VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPN 80
+GSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 133
IV+ V L I+ME GG+L + +A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK 169
Y M HRDL N L+ G A R +KI DFG ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-07
Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 18/191 (9%)
Query: 30 DIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 83
++GSGNFG + K+ K+ VA+K ++ + +++V+ E++ + H P IVR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 84 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V L +VME ASGG L + + + Q+ G+ Y H
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLRHEYD 198
RDL N LL KI DFG SK+ + + +S P + APE + ++
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 199 GK--VYFYSIT 207
+ V+ Y IT
Sbjct: 177 SRSDVWSYGIT 187
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-07
Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 7/150 (4%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ V+ +G+G FG V + TK VAVK ++ G + E ++L+H +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
VR V+ + I+ EY + G L F + G+ + F Q+ G++Y
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL+ N L+ S + KI DFG ++
Sbjct: 124 YIHRDLRAANVLV--SESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 20/137 (14%)
Query: 50 LVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105
LVAVK + R D + + + +EI L++PNI+R V ++ L ++ EY G+
Sbjct: 46 LVAVKML-RAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 106 L------------FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153
L F N S + Q+ SG+ Y ++ HRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 154 GSPAPRLKICDFGYSKS 170
+KI DFG S++
Sbjct: 164 NHYT--IKIADFGMSRN 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-07
Identities = 37/143 (25%), Positives = 62/143 (43%), Gaps = 10/143 (6%)
Query: 29 RDIGSGNFG-VAR-LMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 85
R +GSG FG V L +++V VA+K ++ D + ++ Q+E+ + LRH +++
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVR---VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLF 68
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHR 143
V + I+ E G L + + A Q+ G++Y HR
Sbjct: 69 AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 144 DLKLENTLLDGSPAPRLKICDFG 166
DL N L+ K+ DFG
Sbjct: 129 DLAARNILVGEDLV--CKVADFG 149
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-07
Identities = 30/121 (24%), Positives = 51/121 (42%), Gaps = 4/121 (3%)
Query: 51 VAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 110
VAVK ++ E +E + ++HPN+V+ V I+ E+ + G L + +
Sbjct: 34 VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 93
Query: 111 CNAGRFSEDEARFFFQ--QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168
R + + Q+ S + Y HRDL N L+ +K+ DFG S
Sbjct: 94 RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLS 151
Query: 169 K 169
+
Sbjct: 152 R 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-07
Identities = 59/198 (29%), Positives = 85/198 (42%), Gaps = 40/198 (20%)
Query: 31 IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 85
+G GNFG ++DK VAVK + D E + + R L+ HPNIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAM 138
V + IVME GG+ + R +DE + +QL+ +G++Y +
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 190
HRDL N L+ + LKI DFG S+ SS L P + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164
Query: 191 VLL--RHEYDGKVYFYSI 206
L R+ + V+ Y I
Sbjct: 165 ALNYGRYSSESDVWSYGI 182
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 42/157 (26%), Positives = 64/157 (40%), Gaps = 17/157 (10%)
Query: 21 DSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP 79
D +R +G+G FG V + + T VAVK ++ G ++ E + LRHP
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
+++ V + IV E G L E + QLI SG+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+Y A HRDL N L+ + K+ DFG ++
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 43/159 (27%), Positives = 64/159 (40%), Gaps = 19/159 (11%)
Query: 28 VRDIGSGNFG-----VARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
+R +G G FG + R + VAVK + D+ D ++ I++ H
Sbjct: 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS--KFNH 68
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQQLISG 131
NIVR V I++E +GG+L F R R S + F + + G
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSK 169
Y HRD+ N LL R+ KI DFG ++
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-06
Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 6/144 (4%)
Query: 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
V+ +G+G FG + + VA+K +++G E E + L+HP +VR V
Sbjct: 11 VKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 88 ILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
+ T + I+ EY G L F + + + ++ Q+ G+++ HRDL
Sbjct: 70 V-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 146 KLENTLLDGSPAPRLKICDFGYSK 169
+ N L+ S KI DFG ++
Sbjct: 129 RAANILV--SETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 29/170 (17%)
Query: 24 RYDFV--RDIGSGNFGVARLM--------RDKVTKELVAVKYI-ERGDKIDENVQREIIN 72
R++ V R++G G FG L +DK+ LVAVK + + D ++ RE
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKI---LVAVKTLKDASDNARKDFHREAEL 60
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSED 119
+L+H +IV+F V + L +V EY G+L + + G ++
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ QQ+ +G+ Y + HRDL N L+ + +KI DFG S+
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-06
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 21/199 (10%)
Query: 24 RYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----R 74
+ ++ +GSG FG V +KV K VA+K + ++ +EI++
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKV-KIPVAIKVLR--EETSPKANKEILDEAYVMA 64
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 133
S+ HP++VR + L+ ++ + G L + + + + Q+ G+S
Sbjct: 65 SVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPE 190
Y ++ HRDL N L+ +P +KI DFG +K V + + G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 191 VLLRHEYDGK--VYFYSIT 207
+L Y K V+ Y +T
Sbjct: 182 SILHRIYTHKSDVWSYGVT 200
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-06
Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 17/193 (8%)
Query: 30 DIGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRF 84
+IG G N L R T LV V+ + + +E++ Q E++ RHPNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 85 KEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V T + L ++ M Y S L + G SE + G++Y H
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYI 123
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLLR- 194
HR++K + L+ G L YS K+ V++ P+ + +++PE+L +
Sbjct: 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183
Query: 195 -HEYDGKVYFYSI 206
+ Y+ K YS+
Sbjct: 184 LYGYNVKSDIYSV 196
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-06
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 29 RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
+ +G+G FG V +K TK VAVK ++ G E E ++L+H +V+ V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 88 ILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
+ T + I+ E+ + G L F + + + F Q+ G+++ HRDL
Sbjct: 70 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128
Query: 146 KLENTLLDGSPAPRLKICDFGYSK 169
+ N L+ S + KI DFG ++
Sbjct: 129 RAANILV--SASLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-06
Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 12/144 (8%)
Query: 31 IGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G FG V + T+ VA+K ++ G E +E + LRH +V+ V+
Sbjct: 14 LGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 70
Query: 90 TPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGVSYCHAMQVCHRDL 145
+ + IV EY S G L + + G + + Q+ SG++Y M HRDL
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 146 KLENTLLDGSPAPRLKICDFGYSK 169
+ N L+ + K+ DFG ++
Sbjct: 129 RAANILVGENLV--CKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-06
Identities = 39/151 (25%), Positives = 61/151 (40%), Gaps = 19/151 (12%)
Query: 29 RDIGSGNFG------VARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+IG+G FG R M V KEL A + + VQ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQ----PYRELNHPN 56
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 135
+++ + +V+E+ G+L R A +D + ++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
H H DL L N L + +KI D+G
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYG 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-06
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 16/154 (10%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ ++ +G+G FG V + TK VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 135
V+ V+ + + IV EY S G L + + + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
M HRDL+ N L+ KI DFG ++
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-05
Identities = 46/193 (23%), Positives = 82/193 (42%), Gaps = 28/193 (14%)
Query: 27 FVRDIGSGNFG-VAR----LMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHP 79
F+ ++G G FG V + ++++ VA+K ++ K+ + ++E L+HP
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFFQ 126
NIV V ++ EY + G+L E + G S D + F
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 127 ---QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
Q+ +G+ Y + HRDL N L+ +KI DFG S+ S+ + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 181 VGTPAYIAPEVLL 193
+ ++ PE +L
Sbjct: 187 LLPVRWMPPEAIL 199
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-05
Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 25/162 (15%)
Query: 30 DIGSGNFG------VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIV 82
++G G FG L+ ++ K LVAVK + E + ++ QRE L+H +IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQ-DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70
Query: 83 RFKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQ 127
RF V L +V EY G+L F R G+ + + Q
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ SG+ Y ++ HRDL N L+ +KI DFG S+
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-05
Identities = 47/175 (26%), Positives = 72/175 (41%), Gaps = 29/175 (16%)
Query: 31 IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 83
IG GNFG + +++ K A+K ++ + EN R+ + HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 129
+L I +EYA G L + + + D A QQL+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 130 --SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
+G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMG 178
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-05
Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 10/149 (6%)
Query: 28 VRDIGSGNFGVAR----LMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
V+ +GSG FG + + K VA+K + G K + E + S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
VR V L+PT + +V + G L + + + + Q+ G+ Y ++
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N L+ SP +KI DFG ++
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-05
Identities = 41/175 (23%), Positives = 68/175 (38%), Gaps = 29/175 (16%)
Query: 31 IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 83
IG GNFG + ++ + A+K ++ + ++ R+ + HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 84 FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 127
+L + +EYA G L + R+ A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMG 171
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-05
Identities = 49/170 (28%), Positives = 70/170 (41%), Gaps = 26/170 (15%)
Query: 24 RYDFV--RDIGSGNFGVARL-----MRDKVTKELVAVKYIERGD-KIDENVQREIINHRS 75
R D V R++G G FG L + K LVAVK ++ ++ QRE +
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSED 119
L+H +IV+F V L +V EY G+L F R G
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ Q+ SG+ Y + HRDL N L+ + +KI DFG S+
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-05
Identities = 50/207 (24%), Positives = 83/207 (40%), Gaps = 42/207 (20%)
Query: 31 IGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 83
+G G FG A ++ + VAVK ++ E ++ E + + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 84 FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 126
L +++EYA G L F R ++ + DE
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 127 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 173
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ S V
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGK 200
S+ + V ++A E L H Y +
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ 209
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-05
Identities = 51/181 (28%), Positives = 75/181 (41%), Gaps = 18/181 (9%)
Query: 29 RDIGSGNFG-VAR-LMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPNIVR 83
R +G+G FG + R ++ +EL VA+ + G DK E + H NIVR
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 84 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
+ VI + IV EY S G L F R + G+ + L SG+ Y M
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129
Query: 142 HRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIAPEVLLRHE 196
H+ L L++ KI F KS +++ KS V + APE + H
Sbjct: 130 HKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAAPEAIQYHH 184
Query: 197 Y 197
+
Sbjct: 185 F 185
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 1e-04
Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 41 LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100
L+ D T++ +K + + + + II H PN+V + I++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160
A GG+L+ I E+ + + +++ + H + RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+S+ S + Y APEV
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEV 153
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 56/195 (28%), Positives = 84/195 (43%), Gaps = 27/195 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ R+ + +G G FG D+ KE AVK + K + + EI +R +
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 82 V-RFKEVILT------PTHLAIVMEYASGGELFERICNAGRFSEDE-ARFFFQQLISGVS 133
RF + + H+ IVM G L + I G FS A+ FQ ++ +
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMP-KYGPCLLDWIMKHGPFSHRHLAQIIFQTGVA-LD 245
Query: 134 YCHA-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHSQPK 178
Y H + + H DLK EN L++ S P P R++ICD G HS+
Sbjct: 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR-T 303
Query: 179 STVGTPAYIAPEVLL 193
+ V T Y +PEV+L
Sbjct: 304 AIVSTRHYRSPEVVL 318
|
Length = 467 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 32/88 (36%), Positives = 41/88 (46%), Gaps = 15/88 (17%)
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 177
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYS 205
TV T APEVL Y V +S
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSVDIWS 347
|
Length = 461 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 49/189 (25%), Positives = 77/189 (40%), Gaps = 30/189 (15%)
Query: 17 PIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVK----YIERGDKIDENVQRE 69
P++ +D F IG GNFG AR+ +D + + A+K Y + D D + E
Sbjct: 2 PVLEWND-IKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELE 59
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNA 113
++ + HPNI+ +L + +EYA G L + + A
Sbjct: 60 VLC-KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
S + F + G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEV 176
Query: 174 HSQPKSTVG 182
+ K T+G
Sbjct: 177 YV--KKTMG 183
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 38/166 (22%), Positives = 64/166 (38%), Gaps = 34/166 (20%)
Query: 29 RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREI-------INHRSLRH 78
+ +G G FG +L +D ++ VAVK + K+D + EI + H
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI--- 129
PN+++ V + L +++ + G+L + R + Q L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFM 119
Query: 130 ----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK 169
G+ Y HRDL N +L + +C DFG SK
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 11/149 (7%)
Query: 29 RDIGSGNFGVARL--MRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 84
++IG+G FG L + T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHAMQ 139
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYS 168
H DL L N LL +KI D+G S
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 29/158 (18%), Positives = 59/158 (37%), Gaps = 18/158 (11%)
Query: 43 RDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102
+ V +K + + L H ++V+ V + ++ +V EY
Sbjct: 25 VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83
Query: 103 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----- 152
G L E+ + + D A +QL S + Y ++ H ++ +N L+
Sbjct: 84 FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 153 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ P +K+ D G + + + + +IAPE
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPE 174
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 42/212 (19%)
Query: 24 RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
R++F RD +G G FG + +DK KE V V D E ++
Sbjct: 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 67
Query: 71 INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDE 120
++ + +H NI+ L +++EYAS G L E + A R +S D
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDI 126
Query: 121 AR-----FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168
AR F+ L+S G+ Y + + HRDL N L+ + +KI DFG +
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLA 184
Query: 169 K--SSVLHSQPKSTVGTPA-YIAPEVLLRHEY 197
+ +++ + + + P ++APE L Y
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY 216
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 6e-04
Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 9/148 (6%)
Query: 29 RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 83
R IG G+FG L+ K AVK + R ++E Q +E I + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 84 FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVC 141
+ L +V+ Y G+L I + + + F Q+ G+ Y + +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N +LD S +K+ DFG ++
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.001
Identities = 31/124 (25%), Positives = 55/124 (44%), Gaps = 22/124 (17%)
Query: 49 ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104
+ VA+K ++ DK + E + E + L+HPNIV V+ L+++ Y S
Sbjct: 36 QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 105 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHAMQVCHRDLKLE 148
+L E + + G +D+ A F Q+ +G+ + + V H+DL
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 149 NTLL 152
N L+
Sbjct: 154 NVLV 157
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 42/202 (20%), Positives = 78/202 (38%), Gaps = 32/202 (15%)
Query: 31 IGSGNFG---VARL--MRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 81
+G G FG +A+ + ++ + LV VK +++ DEN+Q RE+ R L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 132
VR + +++EY G+L F R + +Q ++ G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 133 SYCHAMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 187
+ + HRDL N L+ L Y+ + ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185
Query: 188 APEVLLRHEYDGK--VYFYSIT 207
APE + ++ K V+ + +
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVL 207
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.002
Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 31 IGSGNFGVAR----LMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNIV 82
+GSG FG + K VA+K I+ D+ +EI +H SL H IV
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
R + + L +V + + G L + + + + Q+ G+ Y ++
Sbjct: 73 RLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV 131
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTP-AYIAPEVLL--R 194
HR+L N LL S + ++I DFG + +L+ K S TP ++A E +L R
Sbjct: 132 HRNLAARNILLK-SDS-IVQIADFGV--ADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 195 HEYDGKVYFYSITQMSLQS 213
+ + V+ Y +T + S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 38/142 (26%), Positives = 63/142 (44%), Gaps = 8/142 (5%)
Query: 31 IGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G FG + + TK VA+K ++ G + E +E + LRH +V V+
Sbjct: 14 LGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV- 70
Query: 90 TPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
+ + IV E+ G L F + + + Q+ G++Y M HRDL+
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130
Query: 148 ENTLLDGSPAPRLKICDFGYSK 169
N L+ + KI DFG ++
Sbjct: 131 ANILVGDNLV--CKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.003
Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 29/145 (20%)
Query: 50 LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105
LVAVK I R D ++N + + + L+ PNI+R V + L ++ EY G+
Sbjct: 48 LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 106 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHAMQVCHRDL 145
L + ++ + E Q+ SG+ Y ++ HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 146 KLENTLLDGSPAPRLKICDFGYSKS 170
N L+ + +KI DFG S++
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN 187
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.004
Identities = 38/154 (24%), Positives = 61/154 (39%), Gaps = 26/154 (16%)
Query: 29 RDIGSGNFG------------VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL 76
++IG+G FG VAR+ V KEL A K ++ +R L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARV----VVKELKA----NASSKEQNEFLQQGDPYRIL 52
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QLISGV 132
+HPNI++ + +V EY G+L + + Q ++ +GV
Sbjct: 53 QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
++ H H DL L N L +K+ D+G
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLT--VKVGDYG 144
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 219 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.88 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.62 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.57 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.53 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.43 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.41 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.3 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.14 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.99 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.98 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.96 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.88 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.81 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.8 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.73 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.72 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.69 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.65 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.51 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.49 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.43 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.41 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.41 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.27 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.23 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.17 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 98.13 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.07 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.05 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.83 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.82 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.78 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.74 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.73 | |
| PLN02236 | 344 | choline kinase | 97.73 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.65 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.5 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.36 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.31 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.27 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.25 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.25 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.25 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.21 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.05 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 97.04 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.54 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.53 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.89 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.36 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=304.29 Aligned_cols=199 Identities=37% Similarity=0.593 Sum_probs=184.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
...++|.+.+.||+|+|++||++++..++..||+|.+.... +..+.+..|+.+++.++||||+.++++....+..++
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 45679999999999999999999999999999999997653 234567899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-CC---CcEEEeecccccccc
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSV 172 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~-~~---~~v~l~dfg~a~~~~ 172 (219)
|||||.||+|.+++...+.+++.+++.++.|++.||++||+++|+|+||||.|||++.. .. ..+||+|||+|+...
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999865 22 359999999999888
Q ss_pred cCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+.....+.+|++.|||||++....|+.|+|+||+|+++|+|++|..
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~ 212 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKP 212 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCC
Confidence 8888888899999999999999999999999999999999999975
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=297.46 Aligned_cols=198 Identities=32% Similarity=0.546 Sum_probs=182.5
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
....++|++++.||+|+||+|+.++.+.+++.||+|++++..- ..+...+|..++..++||.|++++-.|+++..+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 4568899999999999999999999999999999999876432 235678999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc-cc
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~-~~ 173 (219)
|+|+||+.||.|...+++.+.|++..++.++.+|+.||.+||++||+||||||+|||++.+|. ++|+|||+++.. ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccC
Confidence 999999999999999999999999999999999999999999999999999999999999998 999999999843 33
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..+.+.+||+.|+|||.+.+..++..+|+||||+++|||++|..
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~p 223 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKP 223 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCC
Confidence 455666799999999999999999999999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=293.69 Aligned_cols=203 Identities=37% Similarity=0.561 Sum_probs=181.6
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--------CHHHHHHHHHHHhCCCCcEeEEEEE
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--------DENVQREIINHRSLRHPNIVRFKEV 87 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (219)
.++....+.|-+.+.||+|+||.|.+|....+++.||+|+++..... ...+++|++++++++||+|++++++
T Consensus 165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 34455788999999999999999999999999999999999754211 1346799999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-CCCcEEEeecc
Q 027738 88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFG 166 (219)
Q Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~-~~~~v~l~dfg 166 (219)
|+..+..|+|+||++||+|.+++...+.+.+..-+.++.|++.|+.|||++||+||||||+|||++.+ ....+||+|||
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999866 33459999999
Q ss_pred cccccccCCCCCCCCCCCCCCCchhhccccc---cceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY---DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+|+.........+.+||+.|.|||++.+... ..++|+|||||++|-++||-.
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence 9998888888889999999999999986543 347899999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=303.72 Aligned_cols=196 Identities=36% Similarity=0.527 Sum_probs=183.6
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEecc----CcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
...+|...+.||+|+|+.||.+++..+|+.||+|++.+ .+..++.+.+|++++++++||||++++++|++.++.|+
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 34679999999999999999999988999999999976 45566889999999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-C
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 175 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~ 175 (219)
+.|+|+.++|...++...++++.+++.+++||+.||.|||+++|+|||||..|+|++++-+ |||+|||+|...... .
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccc
Confidence 9999999999999998889999999999999999999999999999999999999998887 999999999876644 6
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+.+|||.|.|||++.....+..+||||+||+||.||.|++
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~P 216 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRP 216 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCC
Confidence 7778899999999999999999999999999999999999986
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=286.68 Aligned_cols=197 Identities=29% Similarity=0.409 Sum_probs=180.2
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEec--cCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe-E
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-L 94 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~ 94 (219)
.....++.+.++.||+|..|+||++.++.+++.+|+|.+. ..+...+++.+|+++++.++||+|+.+++.|..++. .
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 3345568888999999999999999999999999999994 345556888999999999999999999999999995 9
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++||||++|+|...+...+.+++..+..++.+++++|.|||+ .+|+||||||+|||++..+. |||||||.+.....
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhh
Confidence 9999999999999999988889999999999999999999995 89999999999999998887 99999999875543
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
. ...+.+||..|||||.+.+..|+.++||||||+.++|+++|+
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~Gr 274 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGR 274 (364)
T ss_pred h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCC
Confidence 3 667789999999999999999999999999999999999996
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=274.35 Aligned_cols=195 Identities=30% Similarity=0.568 Sum_probs=181.4
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++++.||.|+||+|.+++.+.++..+|+|+++..... .+...+|..+++.++||.++++++.+.+.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 5678999999999999999999999999999999998765432 255678999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+||||.+||.|.+++.+.+.|++...+.++.|++.||+|||+++|++||+||+||+++.+|. ++|+|||+|+... .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~--~ 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVS--G 196 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEec--C
Confidence 99999999999999999999999999999999999999999999999999999999999988 9999999998654 3
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+.+|||.|+|||.+..+.+..++|+||||+++|||+.|..
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~p 239 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYP 239 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 3667799999999999999999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=273.26 Aligned_cols=195 Identities=26% Similarity=0.463 Sum_probs=173.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
+++|+.+.++|+|++|.||+++++.+|+.||+|++..++.. .+-..+|++++++++|+|++.++++|......++|+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 47899999999999999999999999999999999765432 244579999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc-cCCC
Q 027738 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~-~~~~ 176 (219)
|||+. ++.+-+... ...+.+.+..+++|++.++.|+|+++++|+||||+||+++.++. +||||||+|+-.. ++..
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcch
Confidence 99987 555555544 45899999999999999999999999999999999999998887 9999999998655 5555
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
....+.|--|+|||.+.+ ..|+..+||||+||++.||++|++|
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL 201 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPL 201 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcC
Confidence 566677888999999987 7899999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=282.53 Aligned_cols=198 Identities=30% Similarity=0.459 Sum_probs=176.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (219)
.....+|.+.+.||.|+|++|++|+...+++.||+|++.+.--. .+-+..|-..+.++ .||+|++++-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34567899999999999999999999999999999988654222 23456778888888 79999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+|+|+||+++|+|.+.+.+.+.|++...+.++.+|+.+|+|||++|||||||||+|||+++++. ++|+|||.|+...+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCCh
Confidence 9999999999999999999999999999999999999999999999999999999999998887 99999999974433
Q ss_pred CCCC--------------CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQP--------------KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.... .+++||..|.+||++.+...++.+|+|+|||++|+|+.|..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~P 285 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQP 285 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCC
Confidence 2222 34679999999999999999999999999999999999965
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=279.71 Aligned_cols=196 Identities=30% Similarity=0.490 Sum_probs=175.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++++.||+|+||.||+|+.+.+|..+|+|++.+++... +.+..|-.+|....++.+++++-.|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 46789999999999999999999999999999999998765432 45678888888889999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc--
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 173 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~-- 173 (219)
|||||++||++...+.+.+.++++.++.++.+++.|++.+|+.|++|+||||+|+||+..|+ +||+|||++....-
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999988 99999999741100
Q ss_pred ---------------------CCC-----C--------------------CCCCCCCCCCCchhhccccccceeeEEEEE
Q 027738 174 ---------------------HSQ-----P--------------------KSTVGTPAYIAPEVLLRHEYDGKVYFYSIT 207 (219)
Q Consensus 174 ---------------------~~~-----~--------------------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg 207 (219)
... . .+.+|||.|+|||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 000 0 023589999999999999999999999999
Q ss_pred EEEeecCCCC
Q 027738 208 QMSLQSTSPN 217 (219)
Q Consensus 208 ~~~~~~~~g~ 217 (219)
||+||||.|=
T Consensus 376 ~ImyEmLvGy 385 (550)
T KOG0605|consen 376 CIMYEMLVGY 385 (550)
T ss_pred HHHHHHHhCC
Confidence 9999999983
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=272.30 Aligned_cols=198 Identities=29% Similarity=0.446 Sum_probs=172.0
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEE-EEEcCC-
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKE-VILTPT- 92 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~- 92 (219)
.......|++.++||.|.||.||++.+..+|+.+|.|.++-.. ..++....|+.++++++||||+++++ .|.+++
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 5667889999999999999999999999999999999987533 33466789999999999999999999 344444
Q ss_pred eEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCCEEecCCCCCcEEEee
Q 027738 93 HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHA--MQ--VCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~--~~--ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
.++++||+|++|+|...++. .+.+++.+++.++.|+|.||..+|+ .+ ++|+||||.|||++.++. +||+|
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGD 171 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGD 171 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeecc
Confidence 48999999999999888864 3459999999999999999999999 56 999999999999998887 99999
Q ss_pred cccccccccCCC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 165 FGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 165 fg~a~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
||+++....... ..+.+|||.||+||.+.+..|++++|||||||++|||+.-.
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~ 225 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQ 225 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcC
Confidence 999986543322 24568999999999999999999999999999999998643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=276.25 Aligned_cols=197 Identities=47% Similarity=0.732 Sum_probs=179.3
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----c--ccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcC
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----D--KIDENVQREIINHRSLR-HPNIVRFKEVILTP 91 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 91 (219)
....++|.+.+.||+|.||+|+.+.+..++..||+|++... . ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35677999999999999999999999999999999987653 1 23456778999999999 99999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-CCCcEEEeecccccc
Q 027738 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKS 170 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~-~~~~v~l~dfg~a~~ 170 (219)
..+++||||+.||+|.+.+...+.+.+.+.+.+++|++.|++|+|++||+||||||+||+++.+ ++ +||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccc
Confidence 9999999999999999999998899999999999999999999999999999999999999988 55 99999999987
Q ss_pred c-ccCCCCCCCCCCCCCCCchhhcccc-cc-ceeeEEEEEEEEeecCCCC
Q 027738 171 S-VLHSQPKSTVGTPAYIAPEVLLRHE-YD-GKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 171 ~-~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Dv~slg~~~~~~~~g~ 217 (219)
. .........+|++.|+|||++.+.. |+ .++||||+|+++|-|++|.
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~ 220 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR 220 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC
Confidence 6 4556677889999999999999877 85 6799999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=262.70 Aligned_cols=195 Identities=32% Similarity=0.470 Sum_probs=169.4
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC--eEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 98 (219)
..+|...+.||+|+||.||++.+..++...|+|.+...... .+.+.+|+.++++++||+|+++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 66799999999999999999999988999999988654211 456899999999999999999999755444 699999
Q ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC-CCCCcEEEeeccccccccc---
Q 027738 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL--- 173 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~-~~~~~v~l~dfg~a~~~~~--- 173 (219)
||+++|+|.+.+.+.+ .+++..+..+..|++++|.|||++|++||||||+|||++. ++. +||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccc
Confidence 9999999999999887 7999999999999999999999999999999999999998 455 99999999876553
Q ss_pred -CCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 -HSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........|++.|+|||++.+ ....+++|+|||||+++||+||..
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 222345679999999999995 334468999999999999999964
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=273.25 Aligned_cols=198 Identities=29% Similarity=0.480 Sum_probs=174.8
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--Ce
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 93 (219)
....+.|+.+++||+|.||.||++++..+|+.||+|++..+. .......+|+.+|+++.||||+++.+...+. +.
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 345788999999999999999999999999999999987543 2335568999999999999999999999887 68
Q ss_pred EEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
+|+|+||++. +|.-++... -.|++.++.-++.|++.+|+|+|++|++|+|||.+|||++.++. +||+|||+|+.+.
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYT 269 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeecc
Confidence 9999999976 777666653 46999999999999999999999999999999999999999888 9999999999766
Q ss_pred cCC--CCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 173 LHS--QPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 173 ~~~--~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
... .....+.|.=|+|||.+++ ..|+..+|+||.|||+.||++|..+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI 319 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPI 319 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCC
Confidence 554 3455677888999999997 6899999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=282.38 Aligned_cols=194 Identities=34% Similarity=0.578 Sum_probs=178.4
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC---HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
+++|.+.+.||+|.||.||+++.+.+.+.||+|.+.+..+.. +.+.+|+++++.++||||+.++++|+....+|+|.
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 468999999999999999999999999999999998766555 44679999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC-
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~- 177 (219)
||+.| +|...+...+.++++.+..++.++..||.|||+.+|+|+|+||.||++..++. +|+||||+|+........
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceee
Confidence 99988 99999999999999999999999999999999999999999999999998887 999999999865544333
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...-|+|.|+|||...+..|+..+|+|||||++||+.+|.+
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 33469999999999999999999999999999999999975
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=270.39 Aligned_cols=199 Identities=32% Similarity=0.408 Sum_probs=173.9
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcE-EEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL-VAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~-v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
....+.+...+.+.+|+|+||+||++... |+. ||+|++...+.. .+.+.+|+.++.+++||||++++|++..+.
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 34455667777888999999999999987 555 999999765433 358999999999999999999999999988
Q ss_pred -eEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 93 -HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 93 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~-ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
.+.+|+||+++|+|..++.. .+.++...+..++.+++.||+|||+++ |+|+||||+|||++.+. .++||+|||++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGls 191 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLS 191 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccc
Confidence 79999999999999999988 577999999999999999999999999 99999999999999886 13999999999
Q ss_pred cccccC-CCCCCCCCCCCCCCchhhc--cccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLH-SQPKSTVGTPAYIAPEVLL--RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..... .......||+.|+|||++. ...++.++||||||++++||+||+.
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 765543 2333367899999999999 5689999999999999999999974
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=269.26 Aligned_cols=194 Identities=30% Similarity=0.466 Sum_probs=170.2
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++++.||+|++|.||++.+..+++.||+|++.... .....+.+|+.+++.++|++|+++++.+..++.++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 22355778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC----
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 174 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~---- 174 (219)
||+++++|.+.+.+.+.+++..+..++.|++.+|++||+++|+|+||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 999999987421100
Q ss_pred ----------------------------------------CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecC
Q 027738 175 ----------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQST 214 (219)
Q Consensus 175 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~ 214 (219)
.......|++.|+|||.+.+..++.++|+|||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0011235888999999999988999999999999999999
Q ss_pred CCCC
Q 027738 215 SPND 218 (219)
Q Consensus 215 ~g~~ 218 (219)
+|..
T Consensus 239 ~G~~ 242 (376)
T cd05598 239 VGQP 242 (376)
T ss_pred hCCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=270.81 Aligned_cols=194 Identities=28% Similarity=0.465 Sum_probs=169.8
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++..+...++|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999999999999999998864321 2245678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC---
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~--- 175 (219)
||+++++|.+.+.....+++..++.++.|++.+|++||+.|++|+||||+||+++.++. ++|+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999985221100
Q ss_pred ---------------------------------------------CCCCCCCCCCCCCchhhccccccceeeEEEEEEEE
Q 027738 176 ---------------------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMS 210 (219)
Q Consensus 176 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~ 210 (219)
......+++.|+|||.+.+..++.++|+|||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00123578899999999988899999999999999
Q ss_pred eecCCCCC
Q 027738 211 LQSTSPND 218 (219)
Q Consensus 211 ~~~~~g~~ 218 (219)
|||++|..
T Consensus 239 ~elltG~~ 246 (377)
T cd05629 239 FECLIGWP 246 (377)
T ss_pred hhhhcCCC
Confidence 99999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=274.58 Aligned_cols=193 Identities=32% Similarity=0.430 Sum_probs=173.6
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-C-----CcEeEEEEEEEcCCeEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~~~lv 97 (219)
+|.+++.||+|.||.|.++++..+++.||+|++++..........|+.+|..++ | -|+++++++|...+..++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 788999999999999999999999999999999888777777788999999886 2 4899999999999999999
Q ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 98 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+|.++ .+|.++++.. ..++...++.++.||+.+|.+||+.+||||||||+|||+.+-...+||++|||.++......
T Consensus 267 fELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v 345 (586)
T KOG0667|consen 267 FELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV 345 (586)
T ss_pred ehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence 99985 4999999865 46899999999999999999999999999999999999988888889999999987543222
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
. ....+..|+|||++.+.+|+.+.|+||||||+.||.+|-+|
T Consensus 346 y--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 346 Y--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred e--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence 2 45567789999999999999999999999999999999876
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=273.12 Aligned_cols=194 Identities=25% Similarity=0.439 Sum_probs=171.4
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|+||++.+..+++.||+|++.... .....+.+|..++..++|++++++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999986532 12245678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-- 176 (219)
||+++++|.+.+.+.+.+++.++..++.|++.||++||++|++|+||||+||+++.++. ++|+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 99999999864321100
Q ss_pred ----------------------------------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 ----------------------------------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....|++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 112468899999999999899999999999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=266.26 Aligned_cols=194 Identities=26% Similarity=0.447 Sum_probs=171.0
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.||+|++.... .....+.+|..++..++|++++++++.+..++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 22345678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-- 176 (219)
||+++++|.+.+.+.+.+++..+..++.|++.+|++||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 99999999764321100
Q ss_pred ----------------------------------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 ----------------------------------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 112358899999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=270.29 Aligned_cols=194 Identities=29% Similarity=0.496 Sum_probs=171.2
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.||+|++.... .....+.+|+.++..++||||+++++++..+..+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999986532 12245678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-- 176 (219)
||+++++|.+.+.....+++.++..++.|++.+|++||+++++|+||||+||+++.++. ++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988888999999999999999999999999999999999999988877 99999999864321110
Q ss_pred -------------------------------------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 -------------------------------------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....|++.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 012358899999999999899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=265.66 Aligned_cols=192 Identities=32% Similarity=0.471 Sum_probs=172.8
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.++..++||||+++++++..++..++++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 12345778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
||+++++|.+.+.....+++.++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988888999999999999999999999999999999999999988776 99999999875432 334
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 196 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCC
Confidence 4568899999999998899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=267.42 Aligned_cols=195 Identities=29% Similarity=0.502 Sum_probs=174.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+.+++.++||||+++++++..++..+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34689999999999999999999999999999999986532 22356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++||+.+++|.+.+.....+++..+..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--
Confidence 99999999999999988888999999999999999999999999999999999999988876 99999999875432
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 213 (329)
T PTZ00263 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213 (329)
T ss_pred CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCC
Confidence 2234568899999999999889999999999999999999964
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=269.52 Aligned_cols=194 Identities=28% Similarity=0.407 Sum_probs=170.0
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..|++++.||+|++|+||++.+..+++.||+|++..... ..+.+.+|+.+++.++|++|+++++.+.+++.+++++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 368999999999999999999999999999999865322 2245788999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC---
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~--- 175 (219)
||+++++|.+.+.....+++..+..++.|++.+|.+||+.+|+|+||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999874221000
Q ss_pred ---------------------------------------------CCCCCCCCCCCCCchhhccccccceeeEEEEEEEE
Q 027738 176 ---------------------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMS 210 (219)
Q Consensus 176 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~ 210 (219)
......+++.|+|||.+.+..++.++|+|||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 01123588999999999988899999999999999
Q ss_pred eecCCCCC
Q 027738 211 LQSTSPND 218 (219)
Q Consensus 211 ~~~~~g~~ 218 (219)
|||++|..
T Consensus 239 ~elltG~~ 246 (381)
T cd05626 239 FEMLVGQP 246 (381)
T ss_pred HHHHhCCC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=247.78 Aligned_cols=194 Identities=29% Similarity=0.458 Sum_probs=173.3
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++|...+.+|+|.+|.||++++..+++.||+|++...... .....+|+..++.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 6899999999999999999999999999999999876443 4667899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
|++. +|...+... ..++..++..++.+++++++|+|++.|+|+||||.|+++++++. +||+|||+|+.........
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 9976 888888654 45999999999999999999999999999999999999998888 9999999998776555544
Q ss_pred CC-CCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 179 ST-VGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 179 ~~-~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
.. +.+-=|+|||.+.+ ..|+..+|+||.||++.||+-|.++
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~ 201 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF 201 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC
Confidence 43 56777999999886 6789999999999999999988764
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=268.95 Aligned_cols=194 Identities=31% Similarity=0.458 Sum_probs=169.7
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.+|++++.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++|++|+++++.+..++..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 368999999999999999999999999999999865322 2346788999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC----
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 174 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~---- 174 (219)
||+++++|.+.+...+.+++..+..++.|++.+|.+||+++|+|+||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988876 999999987421100
Q ss_pred --------------------------------------------CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEE
Q 027738 175 --------------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMS 210 (219)
Q Consensus 175 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~ 210 (219)
.......+++.|+|||.+.+..++.++|+|||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001123578899999999998999999999999999
Q ss_pred eecCCCCC
Q 027738 211 LQSTSPND 218 (219)
Q Consensus 211 ~~~~~g~~ 218 (219)
|||++|..
T Consensus 239 ~elltG~~ 246 (382)
T cd05625 239 YEMLVGQP 246 (382)
T ss_pred HHHHhCCC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=262.48 Aligned_cols=188 Identities=35% Similarity=0.538 Sum_probs=166.1
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
+.||+|++|.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++.+..++..++++||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999986532 12245678999999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCCC
Q 027738 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 183 (219)
Q Consensus 105 ~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~~ 183 (219)
+|...+...+.+++.++..++.|++.+|++||+.|++|+||||+||+++.++. ++|+|||+++..... .......++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988888999999999999999999999999999999999999988776 999999998643222 223345689
Q ss_pred CCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 184 PAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 193 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCC
Confidence 99999999999899999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=265.43 Aligned_cols=194 Identities=32% Similarity=0.509 Sum_probs=173.4
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.||+|++.... .....+.+|+.++..++|++++++++++..++..++|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999986532 22356788999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC---
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~--- 175 (219)
||+++++|.+.+.....++..++..++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988888999999999999999999999999999999999999988877 9999999987544332
Q ss_pred ---------------------------CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 ---------------------------QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 1223458899999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=271.27 Aligned_cols=199 Identities=34% Similarity=0.480 Sum_probs=176.2
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHH--HHHHHHHHHhCC-CCcEeEEEEEEEcCC-e
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREIINHRSLR-HPNIVRFKEVILTPT-H 93 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~--~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~ 93 (219)
....+++|+++++||.|.||.||+|+..+++..||+|.++..-...++ -.+|+..++++. ||||+++.+++.+++ .
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 345678999999999999999999999999999999998765433333 368999999998 999999999999988 8
Q ss_pred EEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
+++|||+++. +|...++.+ +.|++..++.|+.||+++|+++|++|+.|||+||+|||+..... +||+|||+|+...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~ 161 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVR 161 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccc
Confidence 9999999965 888888654 46999999999999999999999999999999999999986555 9999999999888
Q ss_pred cCCCCCCCCCCCCCCCchhhc-cccccceeeEEEEEEEEeecCCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLL-RHEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
........+.|-=|+|||+++ ..-|+.+.|+|++||+++|+.+-++|
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPL 209 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPL 209 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhccc
Confidence 777777788888899999987 57789999999999999999887765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=264.80 Aligned_cols=192 Identities=29% Similarity=0.526 Sum_probs=172.1
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+....++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999999999999999865321 2355788999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
||+++++|.+++...+.+++..+..++.|++.+|++||++|++|+||+|+||++++++. ++|+|||++..... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--Ccc
Confidence 99999999999988888999999999999999999999999999999999999987776 99999999875432 223
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~ 196 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 3468899999999998889999999999999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=254.16 Aligned_cols=195 Identities=31% Similarity=0.430 Sum_probs=172.5
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCc-EeEEEEEEEcCC-----
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT----- 92 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~----- 92 (219)
...|+.+++||.|.+|+||+|+...+|+.||+|++..... ......+|+.+++.++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 6789999999999999999999999999999999976543 3466789999999999999 999999998877
Q ss_pred -eEEEEEeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 93 -HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 93 -~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
.+++++|+++. +|..++.... .++...++.+++|++.||+|+|+++|+|+||||.||++++++. +||+|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--Eeeeccch
Confidence 78999999965 8888887654 4788899999999999999999999999999999999999877 99999999
Q ss_pred ccccc-cCCCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCCC
Q 027738 168 SKSSV-LHSQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 168 a~~~~-~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
|+... +.......+.+.-|+|||++.+. .|+...|+||+||++.||+++.+|
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 98655 33335566778889999999975 789999999999999999998875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=264.06 Aligned_cols=200 Identities=26% Similarity=0.335 Sum_probs=176.0
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
..+.-.+.+.+++.+.||+|-||.|+.+..+. ...|++|.+.......+++.+|++++++++|++|+++++++..++.+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 56666778888999999999999999999983 33689999988777778999999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 95 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
++|+||++.|+|.+++.. ...+...+...++.|||+|++||+++++|||||..+||||+++.. +||+|||+|+...
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIG 354 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccC
Confidence 999999999999999987 456899999999999999999999999999999999999998886 9999999998433
Q ss_pred cCCCCCC--CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 173 LHSQPKS--TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 173 ~~~~~~~--~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
....... .--+..|.|||.+....++.++||||||++|+|++|-+
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence 2222222 22356899999999999999999999999999999853
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=263.18 Aligned_cols=196 Identities=28% Similarity=0.442 Sum_probs=172.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCC-cEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
....++|++.+.||+|++|.||+|.+..++ ..|++|.+.... ...+.+.+|+.+++.++||||+++++++..++.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 346789999999999999999999876544 689999886432 223557789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++++||+.+++|.+.+.....+++..+..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~- 182 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVD- 182 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecC-
Confidence 9999999999999999988888999999999999999999999999999999999999988776 9999999987543
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.......+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~ 226 (340)
T PTZ00426 183 -TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226 (340)
T ss_pred -CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCC
Confidence 22334568899999999998888999999999999999999974
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=255.35 Aligned_cols=206 Identities=27% Similarity=0.417 Sum_probs=181.3
Q ss_pred CCCCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEE
Q 027738 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVI 88 (219)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (219)
.......+....+.|++...||.|..++||+++...++..||+|+++..... -+.+.+|+..++.+.||||++++..|
T Consensus 14 ~~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 14 ASSSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred cccccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 4456677888899999999999999999999999999999999999765433 36789999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
.....+|+||+++.+|++.+.+...- .+.+..+..+++++++||.|||++|.+|||+|+.|||++++|. |+|+|||
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFg 171 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFG 171 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCce
Confidence 99999999999999999999997543 4899999999999999999999999999999999999999998 9999999
Q ss_pred cccccccCCC-C----CCCCCCCCCCCchhhc--cccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHSQ-P----KSTVGTPAYIAPEVLL--RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~~-~----~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+........ . +..++++.|+|||+++ -..|+.|+|||||||+..|+.+|..
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~a 230 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHA 230 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCC
Confidence 8653322211 1 3457999999999966 4789999999999999999999964
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=262.87 Aligned_cols=196 Identities=28% Similarity=0.428 Sum_probs=170.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.+|+|++.... ...+.+.+|+.+++.++|||++++++.+..+...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 35689999999999999999999999999999999986422 12345678999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+|+||+++++|.+.+... .+++.++..++.|++.+|++||+++++|+||||+||+++.++. ++|+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCC
Confidence 999999999999988654 5899999999999999999999999999999999999988776 9999999987543222
Q ss_pred C--CCCCCCCCCCCCchhhccc----cccceeeEEEEEEEEeecCCCCC
Q 027738 176 Q--PKSTVGTPAYIAPEVLLRH----EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~--~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~ 245 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCC
Confidence 2 2345689999999999754 37789999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=264.34 Aligned_cols=195 Identities=32% Similarity=0.504 Sum_probs=178.6
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe-EEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l 96 (219)
.+++|..++++|+|+||.++.+.++..++.+++|.+.... ..++...+|+.++++++||||+.+.+.|..++. +++
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4679999999999999999999999999999999997543 344577899999999999999999999999988 899
Q ss_pred EEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 97 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+|+||+||++...+...+ .|+++.+..++.|++.++.|||+++|+|+|||+.|||.+.++. |+|.|||+|+...+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPE 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCc
Confidence 999999999999997655 5999999999999999999999999999999999999998887 999999999977776
Q ss_pred C-CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 175 S-QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 175 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
. ...+..|++.|++||.+.+..|..|+|+|||||++|||++-.
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk 203 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLK 203 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcc
Confidence 6 566678999999999999999999999999999999998754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=261.93 Aligned_cols=194 Identities=26% Similarity=0.338 Sum_probs=172.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-eEEEEEe
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME 99 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e 99 (219)
.++|.-...||+|+||.||++... ++..||+|++...... ..+|.+|+.++.+++|||+++++|+|.+.+ ..++|+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 467777789999999999999987 4488999988775554 567999999999999999999999999999 4999999
Q ss_pred ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCEEecCCCCCcEEEeeccccccccc-
Q 027738 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~- 173 (219)
|+++|+|.+++.... ++++..+.+|+.+++.||+|||+.- |+|+||||+|||+|++.. .||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEG 230 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCcc
Confidence 999999999998765 7899999999999999999999863 999999999999998888 89999999976554
Q ss_pred CCCCCCC-CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKST-VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....... .++..|+|||....+..+.++||||+|++++|++||+.
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~ 276 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRK 276 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCc
Confidence 3333333 78999999999999999999999999999999999984
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=255.63 Aligned_cols=188 Identities=34% Similarity=0.525 Sum_probs=164.6
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
+.||+|++|.||++.+..+++.|++|++..... ....+..|+.++..++||||+++.+++..++..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999865321 1244567888999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCC
Q 027738 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (219)
Q Consensus 105 ~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~ 182 (219)
+|...+.....+++.++..++.|++.+|.+||+ .+++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999999888889999999999999999999997 79999999999999988876 999999998643222 22233468
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~ 194 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 194 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCC
Confidence 899999999998889999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=257.03 Aligned_cols=194 Identities=28% Similarity=0.470 Sum_probs=169.3
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.||+|.+..... ..+.+.+|+.+++.++|++++++++.+......++|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999875422 2355778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+++++|.+++... ..+++..+..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999999876 57999999999999999999999999999999999999988776 999999998754322221
Q ss_pred --CCCCCCCCCCCchhhc------cccccceeeEEEEEEEEeecCCCCC
Q 027738 178 --KSTVGTPAYIAPEVLL------RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+. +..++.++|+||||+++|+|++|..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence 2235788999999987 4567789999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=254.78 Aligned_cols=193 Identities=24% Similarity=0.330 Sum_probs=169.2
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.|+..+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+.+++.++|++++++.+.+..++..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999999999999999998864321 22456789999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+++++|...+... ..++...+..++.|++.+|++||+.+++|+||||+||++++++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 99999998777543 35899999999999999999999999999999999999987776 999999998765433334
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 199 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCC
Confidence 45578999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=264.76 Aligned_cols=195 Identities=31% Similarity=0.514 Sum_probs=178.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC-HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
....|+..++||+|+.|.||.+....+++.||+|.+....... +-+.+|+.+++..+|+||+.+++.|...+.+|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4678999999999999999999999999999999998765554 456899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~ 178 (219)
|++||+|.+.+.... +++.++..++++++.||.+||.+||+|+|||.+||++..++. +||+|||++....... ...
T Consensus 351 ym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred ecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccc
Confidence 999999999887664 899999999999999999999999999999999999999988 9999999987666555 344
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+-+|++.|+|||+.....|++++||||||++++||+-|+.
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCC
Confidence 5589999999999999999999999999999999999875
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=256.23 Aligned_cols=186 Identities=31% Similarity=0.526 Sum_probs=164.6
Q ss_pred ccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 31 l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
||+|++|.||++.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++..++..++++||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999999999999999986432 2224567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCCCCC
Q 027738 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 185 (219)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~~~~ 185 (219)
...+.....++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||+++..... .......+++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988888999999999999999999999999999999999999988776 999999998743222 22233468899
Q ss_pred CCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 186 YIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 186 ~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~ 191 (312)
T cd05585 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLP 191 (312)
T ss_pred cCCHHHHcCCCCCCccceechhHHHHHHHhCCC
Confidence 999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=269.51 Aligned_cols=197 Identities=31% Similarity=0.508 Sum_probs=176.7
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (219)
....++|++++.||+|.||+|+++..+.+++.||+|.+++..-. -+....|.+++... +||.++.++..|+.+.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 56688999999999999999999999999999999999876432 24566777777766 59999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc-
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~- 172 (219)
+++||||+.||++. .+...+.|++..++.++++++.||.|||++||+++|||.+|||++.+|. +||+|||+++...
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCC
Confidence 99999999999943 3445567999999999999999999999999999999999999999988 9999999998665
Q ss_pred cCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+..+.+.+||+.|+|||.+.+..|+..+|+||||++||||+.|..
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~ 566 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGES 566 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCC
Confidence 5566778899999999999999999999999999999999999964
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=255.70 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=173.3
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
.....+++++++.||.|.-|+||++....++..+|+|++.+.... ..+.+.|.++|+.++||.++.+|..|+....
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 344578899999999999999999999999999999999775433 2456788899999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.+++||||+||+|...++++. .|++..++.++.+++-||+|||-+|||++||||+||||.++|+ +.|+||+++...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~ 229 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRC 229 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccC
Confidence 999999999999999888765 4999999999999999999999999999999999999999998 999999986311
Q ss_pred cc---------------------------------C------------------------CCCCCCCCCCCCCCchhhcc
Q 027738 172 VL---------------------------------H------------------------SQPKSTVGTPAYIAPEVLLR 194 (219)
Q Consensus 172 ~~---------------------------------~------------------------~~~~~~~~~~~~~aPE~~~~ 194 (219)
.. . ....+.+||-+|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 0 00122357889999999999
Q ss_pred ccccceeeEEEEEEEEeecCCCCC
Q 027738 195 HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 195 ~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+.++|+|.||+.+|||+-|..
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~T 333 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTT 333 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999998864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=253.08 Aligned_cols=192 Identities=34% Similarity=0.504 Sum_probs=168.7
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----eEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIV 97 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv 97 (219)
=+|.-.+.+|+|+||.||.+...++++.||+|++-++.+. -..|+++++.++||||+++.-+|.... +..+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3688899999999999999999999999999988655432 346899999999999999998887532 45799
Q ss_pred EeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 98 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+||++. +|...+.. .+.++...++.+.+|++.||+|||+.||+|+||||.|+|++.+.. .+||||||.|+....
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLVK 178 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC-eEEeccCCcceeecc
Confidence 999966 88777764 467899999999999999999999999999999999999987744 499999999998888
Q ss_pred CCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
+....+...+-.|+|||.+.+ ..|+.+.|+||.||++.||+-|..|
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~pl 225 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPL 225 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcc
Confidence 888888888999999999987 6789999999999999999999875
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=255.19 Aligned_cols=194 Identities=25% Similarity=0.423 Sum_probs=168.1
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.||+|.+.... .....+.+|..++..++|++|+++++.+..++..++++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999886422 12234678888999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+++++|..++.. ...+++..+..++.|++.+|++||+++++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 457899999999999999999999999999999999999987776 999999998654332221
Q ss_pred --CCCCCCCCCCCchhhcc-----ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 --KSTVGTPAYIAPEVLLR-----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~ 206 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCC
Confidence 23468999999999875 457889999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=257.39 Aligned_cols=188 Identities=32% Similarity=0.531 Sum_probs=165.6
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
+.||+|++|.||++.+..+++.||+|++.... .....+.+|+.+++.++|||++++.+++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999986532 12245678899999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCCC
Q 027738 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 183 (219)
Q Consensus 105 ~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~~ 183 (219)
+|...+.....+++.++..++.|++.||++||+++++|+||||+||+++.++. ++|+|||+++..... .......++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99999988888999999999999999999999999999999999999988776 999999998643222 222334688
Q ss_pred CCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 184 PAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 193 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCC
Confidence 99999999998889999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=259.17 Aligned_cols=188 Identities=33% Similarity=0.528 Sum_probs=165.2
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
+.||+|++|.||++.+..+++.||+|.+.... .....+.+|+.+++.++|||++++++.+..++..++|+||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999986532 12234567899999999999999999999999999999999999
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCCCCCC
Q 027738 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGT 183 (219)
Q Consensus 105 ~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~~~ 183 (219)
+|...+.....+++..++.++.|++.||.+||++|++|+||||+||+++.++. ++|+|||++....... ......++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99999888888999999999999999999999999999999999999988776 9999999886432222 22334688
Q ss_pred CCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 184 PAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~ 193 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCC
Confidence 99999999998889999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=267.41 Aligned_cols=197 Identities=34% Similarity=0.615 Sum_probs=183.9
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
....+-|++.+.||.|..|.|.+|.+..||+..|+|++... +.....+++|+-+++.+.|||++.++++|+.+..+
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 34566799999999999999999999999999999998654 33346789999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
|+|.||.++|.|++++...+++++.+..+++.||+.++.|+|..+|+|+|+||+|++++..++ +||+|||+|....++
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPG 165 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCC
Confidence 999999999999999999999999999999999999999999999999999999999999888 999999999988888
Q ss_pred CCCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCC
Q 027738 175 SQPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~ 217 (219)
..-.+-+|++.|.|||.+.+..| +.++||||.|+|+|.+|||.
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~ 209 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGK 209 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCC
Confidence 88888999999999999999988 46899999999999999996
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=260.09 Aligned_cols=197 Identities=29% Similarity=0.432 Sum_probs=169.8
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
....++|++.+.||+|++|.||++.+..+++.+|+|++.... ...+.+.+|..+++.++|||++++++.+..+...
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 345689999999999999999999999999999999986422 1224467889999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++||+++++|.+++... .+++..+..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcC
Confidence 9999999999999888654 5899999999999999999999999999999999999988776 999999998754322
Q ss_pred C--CCCCCCCCCCCCCchhhccc----cccceeeEEEEEEEEeecCCCCC
Q 027738 175 S--QPKSTVGTPAYIAPEVLLRH----EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~--~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ......+++.|+|||.+.+. .++.++|+||||+++|||++|..
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 245 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCC
Confidence 2 12345689999999998753 37889999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=246.87 Aligned_cols=201 Identities=31% Similarity=0.416 Sum_probs=175.6
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC---HHHHHHHHHHHhCCCCcEeEEEEEEEcC-
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTP- 91 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 91 (219)
+--+...+.|+.+..|++|.||.||++.++++++.||+|+++...... =.-.+|+.++.+++||||+.+-.+....
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 445677889999999999999999999999999999999997654221 2357999999999999999999988754
Q ss_pred -CeEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 92 -THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 92 -~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+..|+|||||+. +|...+..-+ +|...++.-++.|+++|++|||.+.|+|+||||+|+|++..|. +|++|||+|+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR 225 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAR 225 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhh
Confidence 569999999966 8988887654 7999999999999999999999999999999999999998888 9999999998
Q ss_pred ccccCCCC-CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 170 SSVLHSQP-KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 170 ~~~~~~~~-~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
.+...... ...+.|.=|+|||.+.+ ..|+...|+||+|||+.||+++.+|
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence 77655443 34467888999999987 6789999999999999999998875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=254.05 Aligned_cols=188 Identities=29% Similarity=0.502 Sum_probs=161.8
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHH-HHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.+++|++..... ....+..|.. +++.++||||+++++++...+..++++||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999999999999999864321 1233444443 46778999999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~ 182 (219)
++|...+.+...+++.++..++.|++.+|.+||+.|++|+||||+||++++++. ++|+|||++...... .......+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999998876 999999998643222 22234468
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~ 194 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLP 194 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCC
Confidence 899999999999889999999999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=255.22 Aligned_cols=194 Identities=25% Similarity=0.435 Sum_probs=167.7
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|..++..++|++|+++++++..++.+++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999986422 12345778889999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+++++|.+++.+ ...+++.++..++.|++.+|++||+++++|+||||+||+++.++. ++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999876 456899999999999999999999999999999999999988776 999999998654332222
Q ss_pred --CCCCCCCCCCCchhhcc-----ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 --KSTVGTPAYIAPEVLLR-----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.. ..++.++|+||||+++|+|++|..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 206 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCC
Confidence 22358899999999863 456789999999999999999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=251.49 Aligned_cols=189 Identities=28% Similarity=0.460 Sum_probs=164.5
Q ss_pred eccccCcCceEEEEEEEC---CCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 28 VRDIGSGNFGVARLMRDK---VTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
++.||+|++|.||++.+. .+++.+++|++..... ....+..|+.++++++||||+++++++..++..++|+||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999998763 5788999999865321 2345678999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCC
Q 027738 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 180 (219)
Q Consensus 102 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~ 180 (219)
.+++|.+.+.+...+++.++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++...... ......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence 99999999988888999999999999999999999999999999999999988776 999999998754333 222334
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 196 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCC
Confidence 68889999999998888999999999999999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=255.60 Aligned_cols=193 Identities=29% Similarity=0.488 Sum_probs=167.7
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCC-CcEeEEEEEEEcCCeEEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 98 (219)
+|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+..|..++..++| ++++.+++++...+..++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999986532 223456678888888876 56888999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc-CCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~-~~~~ 177 (219)
||+++++|...+.....+++..+..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999988776 99999999864322 1222
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 33468899999999999889999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=259.11 Aligned_cols=196 Identities=29% Similarity=0.438 Sum_probs=169.4
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++|||++++++++..+...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45679999999999999999999999999999999986432 12244678999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+|+||+++++|.+.+... .+++..+..++.|++.||++||+.+++|+||||+||+++.++. ++|+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCC
Confidence 999999999999887654 5889999999999999999999999999999999999988877 9999999987543222
Q ss_pred --CCCCCCCCCCCCCchhhccc----cccceeeEEEEEEEEeecCCCCC
Q 027738 176 --QPKSTVGTPAYIAPEVLLRH----EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+. .++.++|+|||||++|||++|..
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~ 245 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCC
Confidence 12345689999999998753 37889999999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=253.71 Aligned_cols=193 Identities=28% Similarity=0.492 Sum_probs=166.3
Q ss_pred cceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHL 94 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 94 (219)
+|++.+.||+|++|.||++.+. .+++.|++|++.... ...+.+..|+.+++.++ |++++++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998874 468899999986432 12245678899999984 89999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++||+++++|.+.+.....+++.++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999988876 999999998754322
Q ss_pred CC--CCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ--PKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....+++.|+|||.+.+. .++.++|+||||+++|||++|..
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~ 205 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCC
Confidence 22 2234689999999999865 47889999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=256.11 Aligned_cols=188 Identities=28% Similarity=0.468 Sum_probs=164.7
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.||+|++..... ..+.+..|..++..+ +||||+++++++.....+++++||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 468999999999999999999999999875321 224467888888888 699999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc-cCCCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~-~~~~~~~~~~ 182 (219)
++|...+...+.+++..+..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||+++... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999998888888999999999999999999999999999999999999988776 9999999986422 2222334568
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~ 194 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCC
Confidence 899999999999899999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=254.43 Aligned_cols=193 Identities=30% Similarity=0.489 Sum_probs=167.1
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
+|++.+.||+|++|.||++.+..+++.||+|.+..... ..+....|...+..+ .|++++++++++...+..++|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999875321 113345566666666 5789999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~ 177 (219)
||+++++|...+.....+++.++..++.|++.+|.+||+.+++|+||||+||++++++. ++|+|||+++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999998876 999999998643322 222
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 199 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCC
Confidence 34568899999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=254.71 Aligned_cols=188 Identities=29% Similarity=0.474 Sum_probs=163.9
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.+++|++..... ..+.+..|..++..+ +||||+++++++..++..++++||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 468999999999999999999999999875321 224466777777666 799999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc-CCCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~ 182 (219)
++|...+.....+++..+..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||+++.... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999998888888999999999999999999999999999999999999988877 99999999864322 222334568
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 194 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCC
Confidence 899999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=253.58 Aligned_cols=188 Identities=30% Similarity=0.521 Sum_probs=161.2
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHH-HHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|+||++.+..+++.|++|++..... ....+..|.. +++.++||||+++++.+..++..++++||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 468999999999999999999999999865321 1123334433 55778999999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~ 182 (219)
++|...+.....+++..+..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999988876 999999998643222 22233468
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 194 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLP 194 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCC
Confidence 899999999999889999999999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=253.93 Aligned_cols=188 Identities=31% Similarity=0.538 Sum_probs=161.3
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHH-HHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.|++|++..... ....+..|. .+++.++|+||+++++++...+..++++||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 468999999999999999999999999864321 112333333 356778999999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~ 182 (219)
++|...+.....+++..+..++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999988776 999999998643222 22334568
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 194 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCC
Confidence 999999999999899999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=261.40 Aligned_cols=196 Identities=30% Similarity=0.459 Sum_probs=179.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
....|+..+.||+|.||.||++.+..+++.||+|+++..... .+++++|+.++.+++++||.++|+.+..+..++++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 445788889999999999999999999999999999876443 368899999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
|||.||++.+.+.....+.+.++..++++++.+|.|||..+.+|+|||+.||++..++. ++|+|||.+........ .
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhcc
Confidence 99999999999988887899999999999999999999999999999999999998877 99999999865443333 3
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+.+|++.|||||++....|+.++|+||||++++||++|.+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GeP 209 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEP 209 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCC
Confidence 67789999999999998899999999999999999999985
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=252.66 Aligned_cols=188 Identities=31% Similarity=0.512 Sum_probs=161.4
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHH-HHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++++..+++.|++|++..... ....+..|. .+++.++|||++++++.+...+..++++||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999864321 123344444 456788999999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc-CCCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~ 182 (219)
++|...+.....+++.++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999988888788999999999999999999999999999999999999988876 99999999864322 222233468
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCC
Confidence 899999999998889999999999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=249.36 Aligned_cols=196 Identities=31% Similarity=0.452 Sum_probs=168.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEc-----CC
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT-----PT 92 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~ 92 (219)
...+|..++.||.|++|.|..+.+..+++.||+|++..... ..++..+|+.+++.++|+||+.+.+++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 45566778999999999999999999999999999974322 23677899999999999999999999976 24
Q ss_pred eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
..|+|+|++ +.+|...+..++.+++..+..+++|++.||.|+|+.+++|+|+||+|++++.+.. +|++|||+|+...
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeecc
Confidence 589999999 5588888888888999999999999999999999999999999999999987765 9999999998654
Q ss_pred cC---CCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 173 LH---SQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 173 ~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
.. ......+.|.-|+|||.+.+ ..|+...|+||+||++.||++|+.|
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkpl 227 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPL 227 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCC
Confidence 32 11123356777999999875 7899999999999999999999876
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=251.87 Aligned_cols=194 Identities=29% Similarity=0.476 Sum_probs=168.8
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++|++.+.||+|++|.||++++..+++.+++|++.... ...+.+.+|+.+++.++|||++++++++...+..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999987542 234567889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--C
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~--~ 177 (219)
|++++.+.........++...++.++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9998776655555556899999999999999999999999999999999999988776 99999999875432222 2
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 199 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence 23457889999999998889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=252.35 Aligned_cols=189 Identities=29% Similarity=0.460 Sum_probs=164.2
Q ss_pred eccccCcCceEEEEEEEC---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 28 VRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++.||+|+||.||++++. .+++.||+|.+.... .....+.+|+.+++.++||||+++++++..++..++++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 467889999886432 222456789999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~ 178 (219)
|+++++|.+.+.....+++..+..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||+++...... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888999999999999999999999999999999999999988776 9999999986433222 223
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 198 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCC
Confidence 3468899999999998888999999999999999999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=251.91 Aligned_cols=194 Identities=23% Similarity=0.436 Sum_probs=167.2
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.+++|++.... .....+.+|..++..++|++++++++.+..+..+++|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999885421 12234678888899999999999999999999999999
Q ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-
Q 027738 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~- 176 (219)
||+++++|.+++.+ ...+++..+..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 456899999999999999999999999999999999999987776 99999999864432222
Q ss_pred -CCCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 177 -PKSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+. ...++.++|+||||+++|||++|..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~ 206 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCC
Confidence 22346899999999986 3457889999999999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=251.57 Aligned_cols=188 Identities=30% Similarity=0.473 Sum_probs=162.9
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.||+|++.... ...+.+..|..++..+ +||+|+++++++..++..++|+||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999999899999999986532 1223456677777755 799999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~~ 182 (219)
++|...+...+.+++..+..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++....... ......+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999988876 9999999986432222 2233458
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~ 194 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQP 194 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCC
Confidence 899999999998889999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=254.64 Aligned_cols=199 Identities=38% Similarity=0.578 Sum_probs=180.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 93 (219)
....+.|++.+.||.|.||.||.++.+.+|+.+|+|++..... ..+.+.+|+.+++.++ |||++.+.++|+....
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3456789999999999999999999999999999999976543 2367899999999998 9999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC--CcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~--~~v~l~dfg~a~~~ 171 (219)
+++|||+|.||.|.+.+... .+++.....++.|++.++.++|+.|++|+|+||+|+++..... .+++++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999877 5999999999999999999999999999999999999975543 35999999999887
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.........+|++.|+|||++....++..+|+||+|+++|.|++|..
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence 76556677789999999999999999999999999999999999854
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=250.53 Aligned_cols=195 Identities=29% Similarity=0.482 Sum_probs=168.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||.|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++|||++++++++......++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 5678999999999999999999999999999999886542 22356778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-C
Q 027738 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~ 176 (219)
||+++ +|.+.+.... .++...+..++.|++.||++||+++++|+||||+||+++.++. ++|+|||++....... .
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 99976 8888776544 4789999999999999999999999999999999999988776 9999999986433222 2
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 202 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 233457889999999875 567899999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=252.42 Aligned_cols=188 Identities=28% Similarity=0.462 Sum_probs=164.8
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|..++.++ +||+++.+++++...+.+++|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999875321 224467888888777 699999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc-CCCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~-~~~~~~~~~ 182 (219)
++|...+.....+++.++..++.|++.+|++||+++++|+||||+||+++.++. ++|+|||+++.... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999998888888999999999999999999999999999999999999988877 99999999864322 222334568
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~ 194 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 194 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCC
Confidence 899999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=252.57 Aligned_cols=195 Identities=28% Similarity=0.463 Sum_probs=166.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||.|++|.||++.+..+++.||+|++..... ....+.+|+..++.++|||++++++++..+...++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999999865432 2345678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-C
Q 027738 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~ 176 (219)
||+++ ++.+.+... ..+++.++..++.|++.||++||+.+++|+||||+||++++++. ++|+|||++....... .
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCcc
Confidence 99965 677666553 46899999999999999999999999999999999999988776 9999999986432221 2
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 202 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 233457889999999875 457889999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=252.27 Aligned_cols=188 Identities=31% Similarity=0.483 Sum_probs=163.2
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.||+|++.... ...+.+..|...+... +|||++++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999986432 2224456677777665 699999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~ 182 (219)
++|...+.....+++..+..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999999988888999999999999999999999999999999999999988876 999999998643222 22234468
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 194 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHA 194 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCC
Confidence 999999999998889999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=251.52 Aligned_cols=188 Identities=33% Similarity=0.508 Sum_probs=161.2
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHh-CCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.||+|.+.... ...+....|...+.. .+||||+++++++..+...++++||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999986532 112334455555554 4799999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~ 182 (219)
++|...+.....++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999988776 999999998643322 22334468
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~ 194 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCC
Confidence 999999999998889999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=252.66 Aligned_cols=194 Identities=38% Similarity=0.612 Sum_probs=179.3
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
...+|++.+.||+|.+|+|.++.....|+.||+|.+..+.-.+ -.+.+|+++++.+.||||+.++++|+..+..++
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3578999999999999999999999999999999997654332 346799999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
||||..+|.|.+++...+.+++.+.+.+++||..++.|.|+++++|+|||.+|||++.+++ ++|+|||++..+.....
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKF 208 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccH
Confidence 9999999999999999999999999999999999999999999999999999999999998 99999999988877777
Q ss_pred CCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g 216 (219)
-++++|++.|.+||...+..| ++.+|.||||+++|.+.-|
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 788999999999999999888 5789999999999987654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=252.42 Aligned_cols=200 Identities=32% Similarity=0.493 Sum_probs=167.3
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---------------cCHHHHHHHHHHHhCCCCc
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------IDENVQREIINHRSLRHPN 80 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------------~~~~~~~e~~~l~~l~~~~ 80 (219)
..-....++|++.+.||+|.+|.|.++++..+++.||+|++.+.+. ..+.+.+|+.+++++.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 3344557899999999999999999999999999999999864211 1157889999999999999
Q ss_pred EeEEEEEEEcC--CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 81 IVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 81 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
|++++++..+. +.+|+|+|||..|.+.+.-.....+++.+.+.++..+..+|+|||.+||+||||||+|+|+++++.
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~- 248 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT- 248 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc-
Confidence 99999999875 469999999998887654444444899999999999999999999999999999999999998877
Q ss_pred cEEEeecccccccccCCC------CCCCCCCCCCCCchhhcc---ccc-cceeeEEEEEEEEeecCCCC
Q 027738 159 RLKICDFGYSKSSVLHSQ------PKSTVGTPAYIAPEVLLR---HEY-DGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 159 ~v~l~dfg~a~~~~~~~~------~~~~~~~~~~~aPE~~~~---~~~-~~~~Dv~slg~~~~~~~~g~ 217 (219)
+||+|||.+.....+.. -...+|||.|+|||...+ ..+ +++.||||+|+++|+|+-|.
T Consensus 249 -VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 249 -VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred -EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99999998764422211 133579999999999986 233 56789999999999999886
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=258.77 Aligned_cols=190 Identities=21% Similarity=0.275 Sum_probs=167.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
...+|++.+.||.|++|.||++.+..+++.||+|... .+.+.+|+.+++.++||||+++++++..+...++++|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4578999999999999999999999999999999643 34568899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC--CCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPK 178 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~--~~~~ 178 (219)
+. ++|...+.....++..+++.++.|++.||.|||+.+|+|+||||+||+++.++. ++|+|||++...... ....
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccc
Confidence 85 588888887778999999999999999999999999999999999999988776 999999998643221 1223
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+++.|+|||.+.+..+++++|+||||+++|||++|..
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 4568999999999998889999999999999999999863
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=246.51 Aligned_cols=193 Identities=24% Similarity=0.337 Sum_probs=169.0
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.|++.+.||+|++|.||++.+..+++.||+|.+..... ....+.+|+.+++.++|++++++++.+..+...++++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999998999999998865321 12446789999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+.+++|...+... ..++..++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999998877543 35899999999999999999999999999999999999988776 999999998765433333
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~ 199 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCC
Confidence 44578899999999998889999999999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=253.45 Aligned_cols=195 Identities=27% Similarity=0.396 Sum_probs=174.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|++.++.++|||++++++++...+..++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 4679999999999999999999999999999999886532 22356889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+++++|.+++.....+++..+..++.+++.+|.+||+. +++|+||||+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-ccc
Confidence 9999999999998888899999999999999999999986 6999999999999988876 99999999864432 233
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+..++.++|+||||+++|||++|+.
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 200 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRY 200 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 44568899999999998889999999999999999999974
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=247.19 Aligned_cols=186 Identities=34% Similarity=0.541 Sum_probs=156.9
Q ss_pred ccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhC---CCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 31 l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
||+|++|+||++.+..+++.||+|++...... ......|..++... .||+++++++++.....+++++||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999999999999999999999998643211 12233444555444 699999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~ 182 (219)
++|...+.....+++..+..++.|++.+|+|||+++++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988888999999999999999999999999999999999999988876 999999998643222 22334568
Q ss_pred CCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..|+|||.+.+. .++.++|+||||+++|+|++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~ 195 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWS 195 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCC
Confidence 8999999998754 57899999999999999999964
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=250.95 Aligned_cols=193 Identities=29% Similarity=0.483 Sum_probs=166.7
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 98 (219)
+|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+..|..++..+. |++++++.+++...+.+++|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999986532 11234566777777775 577888999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~ 177 (219)
||+++++|.+.+.....+++.++..++.|++.||.+||+++++|+||||+||+++.++. ++|+|||++....... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988888999999999999999999999999999999999999998876 9999999986432222 22
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCC
Confidence 33458899999999998889999999999999999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=250.54 Aligned_cols=188 Identities=30% Similarity=0.457 Sum_probs=162.3
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHh-CCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.||+|.+.... ...+....|...+.. .+||+++++++++..++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46899999999999999999999999986532 122345566666654 4899999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~ 182 (219)
++|...+.....++..++..++.|++.+|++||++|++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999988888999999999999999999999999999999999999988776 999999998643222 22234568
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 194 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 899999999999899999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=251.31 Aligned_cols=191 Identities=34% Similarity=0.524 Sum_probs=163.6
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHH---HhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|...+ +.++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999986532 1224455665554 456799999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~ 176 (219)
+||+++++|...+.. ..+++.++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++...... ..
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999877754 46899999999999999999999999999999999999998876 999999988643222 22
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~ 199 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCC
Confidence 234568899999999999889999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=254.09 Aligned_cols=192 Identities=32% Similarity=0.482 Sum_probs=164.7
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----eEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 95 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 95 (219)
+|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999886432 12245788999999999999999999886532 479
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++||++ ++|.+.+.....+++..+..++.|++.||.+||+++++|+||||+||+++.++. ++|+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999996 589888888888999999999999999999999999999999999999988876 9999999987443222
Q ss_pred CC----CCCCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QP----KSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~----~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. ....+++.|+|||.+.+ ..++.++|+||||+++|||++|..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~ 206 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence 11 23468889999999875 678899999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=249.47 Aligned_cols=188 Identities=31% Similarity=0.479 Sum_probs=162.2
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHh-CCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..+++.||+|.+.... ...+....|...+.. .+||+++++++++..++.+++++||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999986532 122345566667765 4899999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~ 182 (219)
++|...+.....++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999988778999999999999999999999999999999999999988776 999999998643222 22233468
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~ 194 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 899999999998889999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=248.82 Aligned_cols=188 Identities=33% Similarity=0.526 Sum_probs=163.3
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|+||++.+..+++.||+|++.... .....+..|..++..+ +|||++++++++...+.+++++||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 1224456777777777 699999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~~ 182 (219)
++|...+.....+++.++..++.|++.+|.+||+++++|+||+|+||++++++. ++|+|||++....... ......+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999988888999999999999999999999999999999999999988876 9999999986432222 2233457
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~ 194 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCC
Confidence 889999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=249.79 Aligned_cols=195 Identities=27% Similarity=0.400 Sum_probs=172.4
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|++.++.++|+||+++++++..++..++++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4579999999999999999999999999999999886532 22356889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+++++|.+++.....++...+..++.+++.+|.+||+. +++|+||||+||++++++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hcc
Confidence 9999999999998888899999999999999999999985 7999999999999988776 99999999864422 223
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 200 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY 200 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 34467889999999998889999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=258.90 Aligned_cols=196 Identities=27% Similarity=0.374 Sum_probs=168.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCC-CcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
....|.+.+.||.|++|.||.+....+ +..+++|.+...... ...+..|+.+++.++||||+++++++..++..++||
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 455699999999999999999998877 778888876543322 245678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 99 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
||+++++|.+.+.. ..++++.++..++.|++.+|.++|+.+++|+||||+||+++.++. ++|+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCc
Confidence 99999999887643 346899999999999999999999999999999999999998776 999999998754332
Q ss_pred CC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....+++.|+|||.+.+..++.++|+|||||++++|++|..
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~ 269 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 21 233468999999999998889999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=251.65 Aligned_cols=197 Identities=21% Similarity=0.326 Sum_probs=161.9
Q ss_pred ccCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCccc--CHHHHHHHHHHHhC-CCCcEeEEEEEEEc
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILT 90 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (219)
....++|++.+.||+|+||.||++.+. .++..||+|++...... .+.+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 345689999999999999999999752 34567999988653222 24678899999999 89999999998876
Q ss_pred CC-eEEEEEeccCCCcHHHHHHhc--------------------------------------------------------
Q 027738 91 PT-HLAIVMEYASGGELFERICNA-------------------------------------------------------- 113 (219)
Q Consensus 91 ~~-~~~lv~e~~~~~~L~~~~~~~-------------------------------------------------------- 113 (219)
.+ .+++++||+++++|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 44 589999999999999888642
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC---CCCCCCCC
Q 027738 114 ------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP 184 (219)
Q Consensus 114 ------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~ 184 (219)
.+++..++..++.|++.||+|||+.+++|+||||+||+++.++. ++|+|||+++....... .....++.
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCc
Confidence 23677888999999999999999999999999999999988776 99999999875432211 11223457
Q ss_pred CCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 185 AYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 185 ~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.|+|||.+.+..++.++|+||||+++|||++ |.
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~ 274 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 274 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCC
Confidence 8999999998889999999999999999987 53
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=251.21 Aligned_cols=194 Identities=26% Similarity=0.367 Sum_probs=166.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC----
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 92 (219)
...++|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34689999999999999999999999999999999986532 22356778999999999999999999987543
Q ss_pred --eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 93 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 93 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
..++++||+++ ++...+.. .++...+..++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||++..
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccc
Confidence 47999999976 55555533 4789999999999999999999999999999999999988876 99999999875
Q ss_pred cccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 220 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 444334445567889999999999899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=258.96 Aligned_cols=196 Identities=30% Similarity=0.379 Sum_probs=172.6
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC--cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC------e
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT------H 93 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~ 93 (219)
..-|...+.||+|+||.||+++++.+|+.||+|.++.. ....+..-.|+++++++.|+||++.+++=++.. .
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 35567789999999999999999999999999988763 233466778999999999999999999866543 4
Q ss_pred EEEEEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC--cEEEeecccc
Q 027738 94 LAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--RLKICDFGYS 168 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~--~v~l~dfg~a 168 (219)
.+++||||+||+|...+.... .+++.+++.++..+..||.+||++||+||||||.||++..+..+ --||+|||+|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 689999999999999997654 49999999999999999999999999999999999988654433 3799999999
Q ss_pred cccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCC
Q 027738 169 KSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
+....+..-.+.+||..|.+||.+.+ +.|+..+|.||+|+++|+++||.
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~ 221 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGE 221 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccC
Confidence 98888887788899999999999995 88899999999999999999996
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=242.90 Aligned_cols=193 Identities=29% Similarity=0.426 Sum_probs=160.8
Q ss_pred ccceeeccccCcCceEEEEEEECC-CCcEEEEEEeccCcc---cCHHHHHHHHHHHhC---CCCcEeEEEEEEEc-----
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILT----- 90 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~----- 90 (219)
++|++.+.||+|++|.||++.+.. +++.+|+|.+..... ....+.+|+..++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 467899998865322 223455677666655 69999999999863
Q ss_pred CCeEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 91 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
...+++++|++++ +|.+.+... ..++..++..++.|++.||.+||+++++|+||||+||+++.++. ++|+|||++
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 4568999999975 888888653 34899999999999999999999999999999999999988776 999999998
Q ss_pred cccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.............+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCC
Confidence 75544434445568899999999998889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=241.20 Aligned_cols=192 Identities=34% Similarity=0.600 Sum_probs=171.9
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|++.++.++|||++++++++......++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999899999999886532 22356788999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
||+++++|.+.+.....++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988888999999999999999999999999999999999999988776 999999998754332 33
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 196 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 3467889999999988888999999999999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=240.51 Aligned_cols=192 Identities=28% Similarity=0.423 Sum_probs=161.4
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhC---CCCcEeEEEEEEEc-----CC
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILT-----PT 92 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~ 92 (219)
+|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+..++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58999999999999999999999999999998865322 223456677766655 69999999998865 24
Q ss_pred eEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
..++++|++++ +|.+++... ..++..++..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 57999999975 788877653 34899999999999999999999999999999999999988876 99999999875
Q ss_pred cccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 205 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCc
Confidence 543333344567889999999998889999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=238.65 Aligned_cols=186 Identities=25% Similarity=0.360 Sum_probs=161.2
Q ss_pred ccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 31 l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
||+|++|.||++.+..+++.|++|.+..... ....+..|+++++.++|||++++.+.+..+...++++||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6899999999999999999999998864321 123455689999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCCC
Q 027738 107 FERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184 (219)
Q Consensus 107 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~ 184 (219)
...+.... .++...+..++.|++.+|++||+.+++|+||+|+||++++++. ++|+|||++.............++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 88775443 4888899999999999999999999999999999999988776 9999999987554333333456888
Q ss_pred CCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 185 AYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 185 ~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~ 192 (277)
T cd05607 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRT 192 (277)
T ss_pred CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCC
Confidence 9999999998889999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=240.83 Aligned_cols=186 Identities=30% Similarity=0.406 Sum_probs=160.5
Q ss_pred ccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 31 l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
||+|++|+||++.+..+++.+++|.+...... .+.+..|+.+++.++|++++++.+++..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999999999999999999999998653221 24567799999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-CCCCC
Q 027738 107 FERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV 181 (219)
Q Consensus 107 ~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~~~~~ 181 (219)
...+.. ...+++.++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 877642 345899999999999999999999999999999999999987776 99999999865433222 22346
Q ss_pred CCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 182 GTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~ 195 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARG 195 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 7889999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=253.72 Aligned_cols=193 Identities=25% Similarity=0.362 Sum_probs=165.3
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
....+...+.+.||+|.||+||++.+. | .||||.++..... -+.|++|+.++++-+|.||+-++|++..+.. .
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 344667788899999999999999986 3 4899999765443 3678999999999999999999999998877 9
Q ss_pred EEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc---
Q 027738 96 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS--- 171 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~--- 171 (219)
+|+.||.|.+|..+++-.. .|...+.+.|++|++.|+.|||.++|+|+|||..|||+.++.. |+|+|||++.-.
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRW 541 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeee
Confidence 9999999999999997654 4899999999999999999999999999999999999998866 999999998522
Q ss_pred ccCCCCCCCCCCCCCCCchhhcc---ccccceeeEEEEEEEEeecCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLR---HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
..........+...|+|||+++. ..|++++||||+|+++|||++|.
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~ 590 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE 590 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence 22222233457889999999983 57899999999999999999985
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=238.83 Aligned_cols=193 Identities=24% Similarity=0.338 Sum_probs=167.9
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.|+..+.||+|++|.||++.+..+++.+++|.+...... ...+.+|+.+++.++|++++++.+.+...+..++++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999999999999999988653222 2346789999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+++++|.+.+... ..+++.++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 99999998887543 35899999999999999999999999999999999999988776 999999998654333333
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 199 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 34568899999999998889999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=243.73 Aligned_cols=194 Identities=23% Similarity=0.317 Sum_probs=162.4
Q ss_pred CCccceeeccccCcCceEEEEEEECC----------------CCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKV----------------TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 82 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~----------------~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~ 82 (219)
..++|++.+.||+|+||.||++.+.. ++..|++|.+..... ...++.+|+.++..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence 46789999999999999999998642 334699998865422 235678999999999999999
Q ss_pred EEEEEEEcCCeEEEEEeccCCCcHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 027738 83 RFKEVILTPTHLAIVMEYASGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHAMQVCHR 143 (219)
Q Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~ 143 (219)
++++++...+..++++||+.+++|.+++.... .++..++..++.|++.||.+||+.+++|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999999999998886432 25677899999999999999999999999
Q ss_pred cCCCCCEEecCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 144 dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
||||+||++++++. ++|+|||++........ .....++..|+|||.+.+..++.++|+||||++++||+++
T Consensus 163 dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 163 DLATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred CcchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 99999999988776 99999999865432211 1223456789999999888899999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=266.23 Aligned_cols=195 Identities=29% Similarity=0.359 Sum_probs=167.5
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
.++|++.+.||+|++|.||++.+..+++.||+|++..... ..+++.+|+.+++.++|||++++++++..++..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 3689999999999999999999999999999999865322 235678899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 98 MEYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
|||++|++|.+.+... ...+...+..++.|++.+|++||++|++|+||||+||+++.++. ++|+|||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFG 158 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWG 158 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecC
Confidence 9999999999888642 22456678899999999999999999999999999999988877 9999999
Q ss_pred cccccccCC-------------------CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHS-------------------QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~-------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+++...... ......|++.|+|||.+.+..++.++|+||||++++||+||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 987541110 0112358899999999999889999999999999999999964
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=231.98 Aligned_cols=198 Identities=31% Similarity=0.527 Sum_probs=179.1
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
-....++|++.+.||.|.||.||.++.+.++-.||+|++.++. .....+.+|+++.+.++||||++++++|.+...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 3456789999999999999999999999999999999986543 234667899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.|+++||.+.|++...+. ...++++.....++.|++.||.|+|..+++|+||||+|+|++..+. ++++|||.+...
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHA 174 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeec
Confidence 999999999999999998 5556999999999999999999999999999999999999988887 999999998744
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+ .....+.+|+..|.+||...+...+..+|+|++|++.||++.|..
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~p 220 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLP 220 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCC
Confidence 3 555666789999999999999999999999999999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=254.95 Aligned_cols=193 Identities=27% Similarity=0.416 Sum_probs=162.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--------C
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------T 92 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~ 92 (219)
...+|++.+.||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|||++++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 3568999999999999999999999899999999885432 3446799999999999999999887532 2
Q ss_pred eEEEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 93 HLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
.++++|||+++ ++...+. ....++...++.++.|++.||.|||+.+|+|+||||+||+++.++. .++|+|||++
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla 218 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSA 218 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccc
Confidence 46799999976 6655554 3456899999999999999999999999999999999999986543 3999999999
Q ss_pred cccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+............+++.|+|||.+.+ ..++.++|+|||||++|||++|..
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~ 269 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 86654444455678899999999876 468999999999999999999964
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=243.13 Aligned_cols=192 Identities=35% Similarity=0.522 Sum_probs=170.2
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHH---HHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~---~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
|++.+.||+|++|+||++.+..+++.+++|++......... ...|+..++.++||||+++++++......++++|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 88999999999999999999999999999999876544333 245889999999999999999999999999999999
Q ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc-ccCCCCCCC
Q 027738 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST 180 (219)
Q Consensus 102 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~-~~~~~~~~~ 180 (219)
++++|.+++.....++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999998888999999999999999999999999999999999999997776 999999998653 222333445
Q ss_pred CCCCCCCCchhhc-cccccceeeEEEEEEEEeecCCCCC
Q 027738 181 VGTPAYIAPEVLL-RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 181 ~~~~~~~aPE~~~-~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.++..|.|||... +..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 197 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKL 197 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSS
T ss_pred ccccccccccccccccccccccccccccccccccccccc
Confidence 6788999999998 7888999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=238.54 Aligned_cols=193 Identities=24% Similarity=0.340 Sum_probs=168.2
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.|+..+.||.|++|+||.+.+..+++.+|+|.+..... ....+.+|+.+++.++|++++++.+.+..++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999998865321 12346789999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+.+++|...+... ..++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence 99999998777543 35899999999999999999999999999999999999987776 999999988654333333
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 199 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCC
Confidence 44568899999999998889999999999999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=237.58 Aligned_cols=198 Identities=29% Similarity=0.440 Sum_probs=171.7
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
....++|++.+.||+|++|.||++.+..+++.+++|.+...... ...+.+|+..++.++|||++++++.+...+..+++
T Consensus 5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 34567999999999999999999999989999999988654322 24567899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-C
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~ 176 (219)
+||+++++|.+.+...+.+++.++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccc
Confidence 999999999999988888999999999999999999999999999999999999987776 9999999976443221 1
Q ss_pred CCCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+. +..++.++|+||||+++|+|++|..
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~ 207 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCC
Confidence 23346788999999974 4557889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=236.20 Aligned_cols=194 Identities=28% Similarity=0.421 Sum_probs=170.4
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc------CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
++|++.+.||.|++|.||.+.+..+++.+++|.+...... .+.+.+|+..++.++|||++++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999989999999988643221 2457789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
++|++++++|.+.+.....++...+..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence 9999999999999988888999999999999999999999999999999999999987776 99999999865433222
Q ss_pred C----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 P----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ....++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 205 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 1 22346778999999998889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=247.87 Aligned_cols=195 Identities=26% Similarity=0.368 Sum_probs=167.0
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC----
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP---- 91 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 91 (219)
....++|++.+.||+|++|.||.+.+..+++.|++|++.... .....+.+|+..++.++|||++++++++...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 345789999999999999999999999999999999986532 2235677899999999999999999988653
Q ss_pred --CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 92 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 92 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
...++|+||+++ ++...+.. .++...+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||+++
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~ 174 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLAR 174 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCcc
Confidence 357999999976 66666643 4788999999999999999999999999999999999988776 9999999997
Q ss_pred ccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
............++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 223 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCC
Confidence 6544444445578899999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=248.57 Aligned_cols=195 Identities=26% Similarity=0.341 Sum_probs=163.9
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
.....++|+..+.||.|++|.||++.+..+++.|++|++.... ...+.+.+|+++++.++|+||+++++++..++.++
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 3344678999999999999999999999899999999985432 22356789999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++||+.+++|... ....+..+..++.|++.+|.+||+++++|+||||+||++++++. ++|+|||++.......
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTM 222 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceeccccc
Confidence 99999999988542 23567788899999999999999999999999999999988776 9999999987543221
Q ss_pred -CCCCCCCCCCCCCchhhcc-----ccccceeeEEEEEEEEeecCCCCC
Q 027738 176 -QPKSTVGTPAYIAPEVLLR-----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......++..|+|||.+.. ...+.++||||||+++|||++|..
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~ 271 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC
Confidence 1234568899999998753 233568999999999999999864
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=242.57 Aligned_cols=196 Identities=28% Similarity=0.483 Sum_probs=167.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
...++|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..++.++|+|++++++++..++..+++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 356889999999999999999999998999999998865422 234577899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
+||+++ ++...+.... .++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++........
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCcc
Confidence 999976 7777776543 4789999999999999999999999999999999999988776 99999999864332222
Q ss_pred -CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 -PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 223456889999999865 567889999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=248.63 Aligned_cols=194 Identities=26% Similarity=0.368 Sum_probs=166.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC----
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT---- 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 92 (219)
...++|++.+.||+|++|.||.+.+..+++.+++|.+...... ...+.+|+..++.++|||++++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3468999999999999999999999989999999988654322 245678999999999999999999987543
Q ss_pred --eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 93 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 93 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
..++++||+++ ++...+.. .++...+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||+++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCccccc
Confidence 47999999976 56655543 4789999999999999999999999999999999999988776 99999999876
Q ss_pred cccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 216 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 544444455578899999999999889999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=229.67 Aligned_cols=193 Identities=32% Similarity=0.493 Sum_probs=168.0
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++|+|++++.+.+..++.+++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5899999999999999999999999999999886432 23356788999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCC
Q 027738 102 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (219)
Q Consensus 102 ~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~ 178 (219)
+++++.+.+... ..++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++++|||.+....... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 999998887643 35899999999999999999999999999999999999988776 9999999986443222 122
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 198 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKH 198 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccC
Confidence 3457888999999998889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=254.19 Aligned_cols=199 Identities=27% Similarity=0.398 Sum_probs=169.2
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC--
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT-- 92 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 92 (219)
.....++|++.+.||+|+||+||++.+..+++.||+|.+...... ...+.+|+..+..++|++++++.+.+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344568999999999999999999999999999999998654322 245678899999999999999988775432
Q ss_pred ------eEEEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEE
Q 027738 93 ------HLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (219)
Q Consensus 93 ------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l 162 (219)
.+++++||+++++|.+.+... ..+++.++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL 184 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKL 184 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEE
Confidence 368999999999999888642 45899999999999999999999999999999999999988776 999
Q ss_pred eecccccccccC---CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 163 CDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 163 ~dfg~a~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+|||+++..... .......+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~ 243 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999998654322 12234568899999999999889999999999999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=264.62 Aligned_cols=203 Identities=33% Similarity=0.504 Sum_probs=170.3
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEc--
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT-- 90 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 90 (219)
.+.....++|++.+.||.|+||+||++.+..+++.+++|.+..... ....+..|+.+++.++||||++++++|..
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 3344566799999999999999999999999999999998865322 23567889999999999999999999865
Q ss_pred CCeEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCCEEecCC----
Q 027738 91 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-------QVCHRDLKLENTLLDGS---- 155 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-------~ivh~dl~p~nili~~~---- 155 (219)
...+++||||+++++|...+.. ...+++..++.++.||+.+|.|||+. +|+|+||||+|||++.+
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4568999999999999988865 24699999999999999999999985 49999999999999643
Q ss_pred -----------CCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 156 -----------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 156 -----------~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+...++|+|||++.............+++.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 222389999999876544444445578999999999864 457889999999999999999874
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=249.33 Aligned_cols=192 Identities=27% Similarity=0.395 Sum_probs=164.7
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----eEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 95 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 95 (219)
+|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999899999999886432 12356788999999999999999999998776 789
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++||+.+ +|...+.....++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 99999964 78888877778999999999999999999999999999999999999988776 9999999987543222
Q ss_pred C--CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 176 Q--PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~--~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .....++..|+|||.+.+ ..++.++|+|||||+++||++|..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 203 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCC
Confidence 2 122356788999999986 457889999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=238.51 Aligned_cols=195 Identities=24% Similarity=0.285 Sum_probs=162.7
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcE--EEEEEeccCc--ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~--v~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (219)
....++|++.+.||.|++|.||++.+..++.. +++|...... ...+.+.+|+..+.++ +|+|++++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45677999999999999999999998777654 5666654322 1234677899999999 89999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC
Q 027738 94 LAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~ 157 (219)
+++++||+++++|.+++.... .++..++..++.|++.+|++||++|++|+||+|+||++++++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999886542 4788999999999999999999999999999999999987776
Q ss_pred CcEEEeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 158 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 158 ~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
++|+|||++..............+..|+|||.+.+..++.++|+||||+++++|+|
T Consensus 163 --~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 218 (303)
T cd05088 163 --AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218 (303)
T ss_pred --EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence 99999999863322222222234567999999988888999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=234.46 Aligned_cols=198 Identities=32% Similarity=0.485 Sum_probs=175.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC---cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..+.|++.+.||+|+|+.|+++.+..+|+.+++|+++.. ....+++++|+++.+.++||||+++.+.+.+....++|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 357899999999999999999999999999999988643 22447889999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~dfg~a~~~~~~~~ 176 (219)
+|.+.|++|..-+-..--+++..+..+++|++++|.|.|.++|||+|+||+|+++-+... .-+||+|||+|.....+..
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 999999999777766656899999999999999999999999999999999999853332 2399999999987775555
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
-..+.|+|.|+|||+++..+++..+|+|+-|+++|-++.|..
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~ 210 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 210 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCC
Confidence 566789999999999999999999999999999999998853
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=238.38 Aligned_cols=191 Identities=35% Similarity=0.576 Sum_probs=169.7
Q ss_pred cee--eccccCcCceEEEEEEECCCCcEEEEEEecc---CcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 25 YDF--VRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 25 y~~--~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
|++ .+.||+|-||+||-+.+..+|+.||+|++.+ +......+.+|+.++..++||+|+.+.-.|+..+..++|||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 554 4889999999999999999999999999975 33445778899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-CCCcEEEeecccccccccCCC
Q 027738 100 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 100 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~-~~~~v~l~dfg~a~~~~~~~~ 176 (219)
-+.| ++.+.+.. .+.+++..-..++.||+.||.|||-++|+|+||||+||++.+. +-+++||||||+|+...+...
T Consensus 644 Kl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 9966 66666643 3568999999999999999999999999999999999999533 334699999999998887777
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
..+.+|++.|.|||+++++.|.+.-|.||.|+++|--++|
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSG 762 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG 762 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecc
Confidence 7888999999999999999999999999999999998887
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=236.01 Aligned_cols=193 Identities=28% Similarity=0.495 Sum_probs=172.9
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|++.+++++|||++++++.+..+...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999899999999986533 223567889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~ 179 (219)
|+.+++|...+....++++.++..++.+++.+|.+||+++++|+||+|+||++++++. ++|+|||.+...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999988778999999999999999999999999999999999999988776 99999999876544433444
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|.|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 197 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCC
Confidence 567889999999998889999999999999999999874
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=234.78 Aligned_cols=197 Identities=28% Similarity=0.432 Sum_probs=170.7
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
...++|++.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+.+++.++|||++++++++..+...++++
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 346689999999999999999999998999999998865432 2345778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~ 177 (219)
||+++++|.+.+.....++..++..++.|++.+|.+||+.+++|+|++|+||++++++. ++|+|||++....... ..
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKR 163 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeeccccccc
Confidence 99999999999887778999999999999999999999999999999999999987776 9999999987543222 12
Q ss_pred CCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+. ...++.++|+||+|+++++|++|..
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~ 207 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP 207 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 3345778999999984 3457789999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=239.53 Aligned_cols=193 Identities=27% Similarity=0.407 Sum_probs=170.4
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
++|++.+.||+|++|.||++.+..++..+++|.+..... ....+.+|++.++.++|||++++++.+..++.+++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 479999999999999999999999999999998865322 234577899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~ 179 (219)
+++++|.+++.+...++...+..++.|++++|.|||+ .+++|+||+|+||++++++. ++|+|||++..... .....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-ccccc
Confidence 9999999999888889999999999999999999997 59999999999999988776 99999998764422 22334
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|+|||.+.+..++.++|+||||+++++|++|+.
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 196 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRY 196 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 567889999999988888999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=246.37 Aligned_cols=196 Identities=23% Similarity=0.294 Sum_probs=163.0
Q ss_pred ccCCccceeeccccCcCceEEEEEEE-----CCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEEEc
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 90 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (219)
....++|++.+.||+|+||.||++.+ ..++..||+|++..... ..+.+.+|+.++..+ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34466899999999999999999974 34566899998865432 235678899999999 89999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcC--------------------------------------------------------
Q 027738 91 PTHLAIVMEYASGGELFERICNAG-------------------------------------------------------- 114 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~-------------------------------------------------------- 114 (219)
++..+++|||+++++|.+++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999988885421
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 115 -------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 115 -------------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
.++..++..++.|++.+|.+||+.+++|+||||+||++++++. ++|+|||++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDS 268 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCcc
Confidence 3677889999999999999999999999999999999987765 9999999987543222
Q ss_pred CC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 176 QP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 176 ~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
.. ....++..|+|||.+.+..++.++|+||||++++||+++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~ 312 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 312 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhc
Confidence 11 112245579999999998999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=247.25 Aligned_cols=196 Identities=22% Similarity=0.306 Sum_probs=163.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECC-----CCcEEEEEEeccCccc--CHHHHHHHHHHHhC-CCCcEeEEEEEEEcC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTP 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (219)
...++|++.+.||+|+||.||++++.. +++.|++|.+...... .+.+.+|+.+++.+ +|+||+++++.+...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 456789999999999999999998643 3357999988654322 34578899999999 899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhc----------------------------------------------------------
Q 027738 92 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 113 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------- 113 (219)
+..++++||+++++|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999887532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC---C
Q 027738 114 ------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---K 178 (219)
Q Consensus 114 ------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~---~ 178 (219)
.+++..++..++.|++.+|.+||+++++|+||||+||++++++. ++|+|||+++........ .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeecc
Confidence 13677889999999999999999999999999999999987766 999999998654322211 1
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
...++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~ 312 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 1224567999999998889999999999999999997 64
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=232.48 Aligned_cols=196 Identities=22% Similarity=0.302 Sum_probs=168.1
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
....++|++.++||+|++|.||++... ++..+++|.+.......+.+.+|+.+++.++|+|++++++.+......++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 356789999999999999999999876 5567999988765555577889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 99 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
|++++++|.+++... ..++..++..++.+++.+|++||+.+++|+||+|+||++++++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEY 158 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCce
Confidence 999999999988653 45788999999999999999999999999999999999988776 99999999875432211
Q ss_pred C--CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 177 P--KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 177 ~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
. ....++..|+|||.+.+..++.++|+||||+++|+|+| |.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~ 202 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK 202 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCC
Confidence 1 12234567999999988888999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=232.57 Aligned_cols=194 Identities=29% Similarity=0.430 Sum_probs=167.1
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc------CHHHHHHHHHHHhCCCCcEeEEEEEEEcC--CeE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 94 (219)
.+|++.+.||+|++|.||.+.+..+++.|++|.+...... .+.+.+|+..++.++|+|++++++.+.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5899999999999999999999999999999987543211 24577899999999999999999998764 467
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++||+++++|.+.+.....++...+..++.+++.+|++||+.+++|+||+|+||++++++. ++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence 899999999999999988778899999999999999999999999999999999999987776 999999988643321
Q ss_pred C----CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 S----QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 207 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKP 207 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCC
Confidence 1 1222357788999999988888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=226.90 Aligned_cols=201 Identities=24% Similarity=0.332 Sum_probs=171.1
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc-ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT- 92 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 92 (219)
.--++.+..+|++.+.||.|+|+.|+++.+-.+++.||+|++.... ...+...+|++..++++|||+++++++...+.
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 3446778899999999999999999999999999999999987655 44567889999999999999999988765433
Q ss_pred ----eEEEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEecCCCCCcEEE
Q 027738 93 ----HLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKI 162 (219)
Q Consensus 93 ----~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~--ivh~dl~p~nili~~~~~~~v~l 162 (219)
..|++++|...|+|++.+... ..+++.++..++.++++||.+||+.. +.|+||||.||++++++. +++
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl 170 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVL 170 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEE
Confidence 489999999999998888642 35899999999999999999999998 999999999999998777 899
Q ss_pred eecccccccccCCCCCC----------CCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCC
Q 027738 163 CDFGYSKSSVLHSQPKS----------TVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 163 ~dfg~a~~~~~~~~~~~----------~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.|||.+.........+. ...+..|+|||.+. +...+.++|||||||++|+|.-|+
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~ 238 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGE 238 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcC
Confidence 99999875544333322 23688999999997 456789999999999999998765
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=236.84 Aligned_cols=196 Identities=35% Similarity=0.572 Sum_probs=177.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
..+++|.+++.||+|.||+|.+++.+.+++.||+|++++.--.. .....|-++++..+||.+..+.-.|+.++.++
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 36889999999999999999999999999999999987643222 23456778899999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc-cC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~-~~ 174 (219)
+||||..||.|...+...+.|++...+.+..+|..||.|||+++||++|+|.+|.+++.++. +||+|||+++... .+
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhccccc
Confidence 99999999999999999999999999999999999999999999999999999999999998 9999999987433 33
Q ss_pred CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 175 SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
....+.+|+|.|.|||++.+..|++.+|+|++|++||||..|+
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGR 365 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGR 365 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhcc
Confidence 4556779999999999999999999999999999999999986
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=231.73 Aligned_cols=195 Identities=34% Similarity=0.501 Sum_probs=171.3
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.++|++.+.||.|++|.+|++.+..+++.+++|.+..... ..+.+.+|+..++.++|||++++++.+.....+++++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4789999999999999999999998899999998875433 346788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCC
Q 027738 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (219)
Q Consensus 101 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~ 178 (219)
+++++|.+.+... ..+++.++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||.+....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence 9999999988776 67999999999999999999999999999999999999998776 9999999886543322 223
Q ss_pred CCCCCCCCCCchhhccc---cccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRH---EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~---~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~ 202 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCC
Confidence 34567789999999766 78899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=240.80 Aligned_cols=203 Identities=25% Similarity=0.315 Sum_probs=172.4
Q ss_pred CCCCCCCcccCCccceeeccccCcCceEEEEEEECCCCc---E-EEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEe
Q 027738 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---L-VAVKYIERGD----KIDENVQREIINHRSLRHPNIV 82 (219)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~-v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~ 82 (219)
.|...-++....++-.+.++||+|+||.||++.....+. . ||+|...... ....++.+|+++++.++||||+
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 445555566677788888999999999999998874322 3 8999876422 2236678999999999999999
Q ss_pred EEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEE
Q 027738 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~ 161 (219)
+++|+......+++|+|+|+||+|.+++.+.+. ++..+...++.+.+.||+|||+++++|+||-.+|.|++.++. +|
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vK 302 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VK 302 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EE
Confidence 999999999999999999999999999998874 999999999999999999999999999999999999988776 89
Q ss_pred EeecccccccccCCCCC-CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 162 ICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 162 l~dfg~a~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
|+|||+++....-.... ....+.+|+|||.+....+++++||||+|++++|..+
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~ 357 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFE 357 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeec
Confidence 99999987543111111 2235679999999999999999999999999999988
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=246.30 Aligned_cols=188 Identities=22% Similarity=0.354 Sum_probs=163.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
..+|++.+.||.|++|.||++.+..+++.|++|+... .....|+.+++.++|+||+++++++......++++|++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 4579999999999999999999998899999996532 23356889999999999999999999999999999999
Q ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCC
Q 027738 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (219)
Q Consensus 102 ~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~ 180 (219)
.+ +|..++.. ...++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++............
T Consensus 140 ~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 140 SS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred CC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccc
Confidence 65 77777654 456899999999999999999999999999999999999988776 999999998644333333445
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.++..|+|||.+.+..++.++|+||||+++|||+++.
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~ 253 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcC
Confidence 6889999999999988999999999999999998753
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=234.35 Aligned_cols=194 Identities=29% Similarity=0.449 Sum_probs=168.3
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++|+|++++++.+......++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999999999889999999886432 223567889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~ 178 (219)
|++++++.........++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence 9999888877766667999999999999999999999999999999999999987776 9999999987544332 222
Q ss_pred CCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~ 199 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCC
Confidence 3456778999999876 557889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=249.12 Aligned_cols=189 Identities=21% Similarity=0.241 Sum_probs=163.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
...+|.+.+.||+|++|.||++.+..+++.|++|... ...+.+|+.++++++|+||+++++++..++..++++++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3558999999999999999999999999999999532 23467899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC--
Q 027738 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~-- 177 (219)
+. ++|...+... ..++..++..++.|++.+|.+||++||+|+||||+||+++.++. ++|+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccccc
Confidence 96 5777777653 46999999999999999999999999999999999999987776 999999998754322221
Q ss_pred -CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 178 -KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 178 -~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
....++..|+|||.+.+..++.++||||||+++|||++|.
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~ 359 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT 359 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcC
Confidence 2345899999999999988999999999999999998764
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=235.40 Aligned_cols=189 Identities=24% Similarity=0.364 Sum_probs=165.2
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
++|++.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+.++++++|||++++++.+...+..++++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 468899999999999999999999999999998865422 235678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~ 180 (219)
+++++|... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++..... ......
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~-~~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVN-SIAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceeccc-ccccCC
Confidence 999988543 34788899999999999999999999999999999999988876 99999999865432 223345
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 191 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 67889999999998889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=230.34 Aligned_cols=193 Identities=28% Similarity=0.450 Sum_probs=169.2
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||+|++|.+|++.+..+++.|++|.+.... ...+.+.+|+++++.++|||++++++.+...+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4888999999999999999999999999999886432 2346678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
+++++|.+++... ..++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++........ .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999988764 46899999999999999999999999999999999999998776 99999998875443222 2
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 199 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKH 199 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCC
Confidence 23357788999999998889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=233.85 Aligned_cols=193 Identities=30% Similarity=0.487 Sum_probs=170.9
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
++|++.+.||.|++|.||++.+..+++.+++|.+..... ....+.+|+.+++.++|+|++++++.+..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 479999999999999999999998999999998865432 224678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~ 179 (219)
+++++|.+.+... +++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++++|||++...... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999988765 7899999999999999999999999999999999999998877 999999998765433 22233
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~ 196 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 457788999999998889999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=232.15 Aligned_cols=194 Identities=25% Similarity=0.386 Sum_probs=166.3
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+.++|++.+.||+|++|.||++... .+..+++|.+.......+.+.+|+.+++.++|||++++++++......++++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 4568999999999999999999876 456799998876555567888999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC--
Q 027738 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~-- 177 (219)
+++++|.+.+... ..++...+..++.+++.+|++||+.+++|+||+|+||++++++. ++++|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceecc
Confidence 9999999988653 45899999999999999999999999999999999999987776 999999988643221111
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~ 199 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence 12234567999999998889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=246.98 Aligned_cols=184 Identities=31% Similarity=0.418 Sum_probs=166.6
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
...-++=||+|++|.||+++.. ++.||||+++ +-.+.++.-|++++|+||+.+.|+|....++++|||||..
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred HhhhhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 3344678999999999999987 7789999764 2335578889999999999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~ 183 (219)
|.|...+...+.++...+..+..+|+.++.|||...|+|+|||.-||||.-+.. |||+|||-++........-.+.|+
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGT 274 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGT 274 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999987777 999999988766555555667899
Q ss_pred CCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 184 PAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
..|||||++++...+.|+||||||++|+|||||+
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~E 308 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGE 308 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcC
Confidence 9999999999999999999999999999999996
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=230.70 Aligned_cols=193 Identities=31% Similarity=0.478 Sum_probs=169.9
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|+..+.||.|++|.+|.+.+..+++.+++|.+.... ....++.+|+.++++++|+|++++++++.++...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6999999999999999999999999999999876532 2335678999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CC
Q 027738 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~ 177 (219)
+++++|.+.+... ..++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++++|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999988765 45899999999999999999999999999999999999988776 9999999987543333 22
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|.|||...+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 199 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCC
Confidence 33467889999999998888999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=231.92 Aligned_cols=194 Identities=25% Similarity=0.388 Sum_probs=166.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+.++|++.+.||+|++|.||.+... .+..+++|.+.......+.+.+|+..++.++|||++++++++......++++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 4578999999999999999999876 345699998876555567789999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC--
Q 027738 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~-- 177 (219)
+.+++|.+.+... ..+++.++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||.++........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeec
Confidence 9999999988764 36899999999999999999999999999999999999987776 999999988644322211
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~ 199 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence 11234567999999988888999999999999999998 53
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=232.54 Aligned_cols=192 Identities=23% Similarity=0.287 Sum_probs=166.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
..++|++.+.||.|++|.||++.+. +++.|++|.+.......+.+.+|+..+++++|+|++++++++...+..++++|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4578999999999999999999876 456799999876655567788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 101 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
+.+++|.+++.... .++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++..........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccc
Confidence 99999999987644 6899999999999999999999999999999999999998876 9999999987554222111
Q ss_pred C--CCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 179 S--TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 179 ~--~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
. ...+..|+|||.+.+..++.++|+||||+++++|+|
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 199 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHh
Confidence 1 122357999999998889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=266.51 Aligned_cols=197 Identities=28% Similarity=0.437 Sum_probs=173.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|.+++.||+|+||.|..++++.+++.||+|++++-+ ....-|.+|-.++-....+=|+.+.-.|.++.++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 35789999999999999999999999999999999987632 22244667777877777788889999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+||||++||+|...+.+...+++..++.++.++..||..||+.|+||+||||+|||++..|+ ++|+|||.+-......
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADG 229 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999988 9999999775544333
Q ss_pred C--CCCCCCCCCCCCchhhc----c-ccccceeeEEEEEEEEeecCCCCC
Q 027738 176 Q--PKSTVGTPAYIAPEVLL----R-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~--~~~~~~~~~~~aPE~~~----~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ....+|||.|.|||++. + +.|++.+|+||+|+++|||+-|..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T 279 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET 279 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence 3 34568999999999996 3 568999999999999999999864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=232.55 Aligned_cols=193 Identities=20% Similarity=0.273 Sum_probs=168.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
...+|++.+.||.|++|.||++.+..+++.+++|.+.......+.+.+|++.++.++|++++++++++.....+++++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 45679999999999999999999998899999999876554456788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 101 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
+++++|.+.+... ..++...+..++.|++.+|.+||+++++|+||+|+||++++++. ++|+|||++..........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeec
Confidence 9999999988653 35889999999999999999999999999999999999987776 9999999987543322211
Q ss_pred --CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 179 --STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 179 --~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
....+..|+|||.+.+..++.++|+||||+++|||++
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 200 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence 1223557999999998889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=250.87 Aligned_cols=195 Identities=26% Similarity=0.370 Sum_probs=163.6
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCC------CcEeEEEEEEEcC-CeE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-THL 94 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~-~~~ 94 (219)
.++|++.+.||+|+||+||++.+..+++.||+|++............|+.+++.++| .+++.+++++... ..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 578999999999999999999999899999999986544444556667777776654 4588999998765 468
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCC--------------Cc
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPA--------------PR 159 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~--------------~~ 159 (219)
+++++++ +++|.+++.+.+.++..++..++.|++.+|.|||+ .||+|+||||+||+++.++. ..
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 8999988 56888888888889999999999999999999998 59999999999999976542 24
Q ss_pred EEEeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCCC
Q 027738 160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 160 v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
++|+|||.+... ........+++.|+|||.+.+..++.++|||||||++|||++|..+
T Consensus 287 vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 287 VRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred EEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 899999987532 2233445789999999999999999999999999999999999753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=229.43 Aligned_cols=195 Identities=30% Similarity=0.445 Sum_probs=175.6
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc------c---cCHHHHHHHHHHHhC-CCCcEeEEEEEEEcC
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------K---IDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~------~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (219)
-.+|.-.+.||.|..+.|-++.++.+++.+++|++.... . ..+...+|+.+++++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356788899999999999999999999999999986421 1 124456889999888 599999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
...++|+|.++.|.|.+++...-.+++.+.++++.|+++++.|||.++|||+||||+||+++++.+ ++|+|||+++..
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeecc
Confidence 999999999999999999999989999999999999999999999999999999999999998887 999999999998
Q ss_pred ccCCCCCCCCCCCCCCCchhhc------cccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLL------RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.++..-...+|+|.|.|||.+. ...|+..+|.|++|++||.++.|-+
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 8888888889999999999986 2467888999999999999998864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=231.37 Aligned_cols=193 Identities=33% Similarity=0.477 Sum_probs=168.2
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----------CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
+|.+.+.||.|++|.||++.+..+++.+++|.+...... .+.+.+|+.+++.++|||++++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578889999999999999999888999999988654322 1457789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++++||+++++|.+++.....++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988888999999999999999999999999999999999999987776 99999999865432
Q ss_pred CCC-------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQ-------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .....++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~ 210 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCC
Confidence 111 112246788999999998888999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=233.58 Aligned_cols=196 Identities=22% Similarity=0.277 Sum_probs=164.6
Q ss_pred cCCccceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
.+..+|++.+.||+|+||.||+++.. ..+..+++|.+..... ....+.+|+..++.++|||++++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 35678999999999999999999765 3456899998875432 234678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++|||+++++|.+++... ..++..+++.++.|++.||++||+.+++|+||+|+||+++.++. ++++|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccc
Confidence 9999999999999988764 46899999999999999999999999999999999999988776 89999998654322
Q ss_pred CCCCC--CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 174 HSQPK--STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 174 ~~~~~--~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
..... ...++..|+|||.+.+..++.++|+||||++++|+++ |.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~ 206 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE 206 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCC
Confidence 21111 1234568999999998899999999999999999765 54
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=230.58 Aligned_cols=196 Identities=30% Similarity=0.399 Sum_probs=170.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC--CC----cEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR--HP----NIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~--~~----~i~~~~~~~~~~~~~ 94 (219)
...+|.++.++|+|.||.|-.+++..++..||+|+++.-.+.++...-|++++.++. .| -++.+.+||...+..
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 378999999999999999999999999999999999888888888888999999883 23 367888999999999
Q ss_pred EEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC----------------
Q 027738 95 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---------------- 156 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~---------------- 156 (219)
++|+|.+ |.++.+++..+ .+++..+++.+++|+++++++||+++++|.||||+||++.++.
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 9999998 55899999764 4699999999999999999999999999999999999984321
Q ss_pred --CCcEEEeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCCC
Q 027738 157 --APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 157 --~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
...|+++|||.|..... .....+.|-.|+|||++++-.|+..+||||+|||++|+.||..|
T Consensus 246 ~ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred CCCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 11389999999876543 33556788899999999999999999999999999999999765
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=233.62 Aligned_cols=197 Identities=27% Similarity=0.399 Sum_probs=168.4
Q ss_pred CCccceee-ccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEE
Q 027738 21 DSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 21 ~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 97 (219)
..+-|++. +.||+|+++.|..+++..++..||+|++.+.+.. +.++.+|++++.+++ |+||++++++|++...+|+|
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 34556664 7899999999999999999999999999876543 577899999999986 99999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-CCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~-~~~~v~l~dfg~a~~~~~~~~ 176 (219)
||-+.||+|...+++...|++.+..++...++.+|.+||.+||.|+|+||+|||..+- .-.-||||||++.........
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 9999999999999999999999999999999999999999999999999999998533 333489999999753222111
Q ss_pred --------CCCCCCCCCCCCchhhc---c--ccccceeeEEEEEEEEeecCCCC
Q 027738 177 --------PKSTVGTPAYIAPEVLL---R--HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 177 --------~~~~~~~~~~~aPE~~~---~--~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
-.+.+|+..|||||+.. + .-|+.+.|.||||+++|-|++|=
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence 12346888999999975 2 45789999999999999999984
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=235.37 Aligned_cols=195 Identities=21% Similarity=0.323 Sum_probs=165.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCC-----cEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK-----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..++|++.+.||.|++|.||++.....+ +.+++|.+..... ..+.+.+|+..++.++|||++++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 4568999999999999999999876544 6799998864332 23567899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC
Q 027738 94 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~ 157 (219)
.++++||+++++|.+++... ..++..++..++.|++.+|.+||+.+++|+||+|+||++++++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 99999999999999998764 34788899999999999999999999999999999999988776
Q ss_pred CcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 158 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 158 ~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
++|+|||++........ .....+++.|+|||.+.+..++.++|+||||++++||++ |.
T Consensus 163 --~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~ 224 (283)
T cd05048 163 --VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGL 224 (283)
T ss_pred --EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCC
Confidence 99999999865432221 223345678999999998889999999999999999997 54
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=234.44 Aligned_cols=199 Identities=28% Similarity=0.452 Sum_probs=172.8
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
.......+|++.+.||+|++|.||++.+..+++.+++|.+...... .+.+.+|+.+++.++|+|++++++.+..+...+
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence 3444567999999999999999999999989999999988654332 356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+|+||+++++|..++.. ..++..++..++.|++.+|++||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQ 170 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccc
Confidence 99999999999998865 35799999999999999999999999999999999999988776 9999999886543322
Q ss_pred C-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 Q-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~ 214 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 2 223467889999999998888999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=236.22 Aligned_cols=195 Identities=27% Similarity=0.477 Sum_probs=166.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||.|++|.||++.+..+++.|++|.+..... ....+.+|+..++.++|+||+++++++..+...++++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 56789999999999999999999998999999998864322 2346778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-
Q 027738 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~- 176 (219)
||+++ +|...+... ..++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++........
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 99975 787777653 45899999999999999999999999999999999999988776 99999999865432222
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 203 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence 223356788999999875 457889999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=231.62 Aligned_cols=194 Identities=25% Similarity=0.399 Sum_probs=167.6
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||.|++|.||++++..+++.|++|.+..... ....+.+|+.+++.++|||++++++.+...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 689999999999999999999999999999998754322 2245778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 99 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
||+++++|.+++.. ...++..++..++.+++.+|++||+++++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999887753 334789999999999999999999999999999999999988776 999999987654322
Q ss_pred CC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....+++.|+|||.+.+..++.++|+||+|+++++|++|+.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 204 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCC
Confidence 21 123457788999999998888999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=239.21 Aligned_cols=197 Identities=38% Similarity=0.600 Sum_probs=182.2
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
......|.+.++||+|.|+.|.++++.-++..||+|++.+.... .+.+.+|+.+++.+.||||++++.+.+....+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34467899999999999999999999999999999999875432 345789999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+|+||+.++.+.+++.+.+...+.+.+.++.|+..+++|+|+++|+|+|||++||+++.+.+ ++|+|||++.......
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccc
Confidence 99999999999999999998888999999999999999999999999999999999998888 9999999999888888
Q ss_pred CCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~ 217 (219)
..+++++++.|.|||++.+..+ ++++|+||||+++|.+..|.
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~Gs 252 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGS 252 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecc
Confidence 8999999999999999998777 57899999999999998874
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=230.93 Aligned_cols=194 Identities=24% Similarity=0.369 Sum_probs=165.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+..+|++.+.||+|++|.||++.+. ++..+++|.+.......+.+.+|+.+++.++|+|++++++++...+..++++|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3457999999999999999999886 466799998876555556788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC--
Q 027738 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~-- 177 (219)
+++++|.+++... ..++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceeccccccccc
Confidence 9999999988653 46899999999999999999999999999999999999998776 999999988654322111
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.....+..|+|||.+.+..++.++|+||||++++++++++
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g 198 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEG 198 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccC
Confidence 1112345799999999888999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=244.02 Aligned_cols=190 Identities=22% Similarity=0.307 Sum_probs=164.7
Q ss_pred CccceeeccccCcCceEEEEEEEC--CCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
..+|++.+.||.|++|.||++... .+++.|++|.+... ....+|+.+++.++||||+++++++......++++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 457999999999999999999764 34677999977542 345689999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC--
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~-- 177 (219)
++. ++|..++.....++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++.........
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence 986 478888877778999999999999999999999999999999999999988776 999999998654333222
Q ss_pred -CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 -KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 -~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++|||++|+.
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~ 285 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 23468999999999998889999999999999999999864
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=229.49 Aligned_cols=194 Identities=25% Similarity=0.351 Sum_probs=163.7
Q ss_pred CccceeeccccCcCceEEEEEEE----CCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--Ce
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~----~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 93 (219)
..-|++++.||+|++|.||.+.. ..++..|++|.+..... ..+.+.+|+..++.++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34579999999999999999974 35678899998864422 235688999999999999999999998875 56
Q ss_pred EEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
.++++||+++++|.+++.... .++..++..++.+++.+|++||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccc
Confidence 899999999999999986643 5899999999999999999999999999999999999988776 9999999987543
Q ss_pred cCCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 173 LHSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 173 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
..... ....++..|+|||.+.+..++.++|+||||+++++++++.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~ 209 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCC
Confidence 32211 1234566799999998888999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=241.77 Aligned_cols=192 Identities=25% Similarity=0.419 Sum_probs=163.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC------
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------ 91 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 91 (219)
-.++|++.+.||+|++|.||++.+..+++.||+|.+..... ..+.+.+|+..++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45799999999999999999999999999999998865422 224567899999999999999999988643
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
...+++++++ +++|...+. ...++..++..++.|++.+|.+||+.+++|+||||+||++++++. ++|+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceec
Confidence 3468999987 668877664 456999999999999999999999999999999999999988876 999999998754
Q ss_pred ccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (343)
T cd07878 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214 (343)
T ss_pred CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCC
Confidence 32 2334567889999999976 567899999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=233.50 Aligned_cols=194 Identities=31% Similarity=0.521 Sum_probs=169.4
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++|++.+.||+|++|.+|++.+..+++.|++|.+.... ...+.+.+|+++++.++|+|++++++.+..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999999899999999886532 234678899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC--CC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~--~~ 177 (219)
|++++.+.....+...++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9998777666666667999999999999999999999999999999999999998776 9999999987554433 22
Q ss_pred CCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 200 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 234567889999999887 78999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=227.78 Aligned_cols=193 Identities=25% Similarity=0.461 Sum_probs=165.6
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC-CeEEEEEe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVME 99 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e 99 (219)
+|++.+.||.|++|.||.+.+..+++.+++|.+..... ..+.+.+|++.++.++|++++++.+.+... ..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 58999999999999999999998899999999865432 234578899999999999999999988754 46799999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-C
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~ 176 (219)
++++++|.+.+... ..+++.++..++.+++.++.+||+.+++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 99999999888653 45899999999999999999999999999999999999988776 9999999986443221 2
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKH 200 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 223457889999999999889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=240.30 Aligned_cols=198 Identities=27% Similarity=0.397 Sum_probs=179.2
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
..+.+.|+.-+.||+|+||.|+-++...+|+.||+|.+.+.. ....-..+|-.++.++..+.|+.+--.|+..+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 345667888899999999999999999999999999885421 2223356888999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 95 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
++|+..+.||+|.-.+.+.+ .|++..+..++.+|+-+|++||+.+||++|+||+|||+|+.|+ ++|+|+|+|....
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~ 338 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIP 338 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecC
Confidence 99999999999988887665 6999999999999999999999999999999999999999998 9999999999988
Q ss_pred cCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+.....++||.+|||||++.+..|+...|+|||||++|||+-|..
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~s 384 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHS 384 (591)
T ss_pred CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccC
Confidence 8888888899999999999999999999999999999999999864
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=232.31 Aligned_cols=196 Identities=28% Similarity=0.440 Sum_probs=167.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
..+.|++.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++|+|++++++.+..++..++++|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 34789999999999999999999998999999999865432 23567789999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CC
Q 027738 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~ 177 (219)
|+++++|...+.. ...++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceecccccccc
Confidence 9999999877654 456899999999999999999999999999999999999987766 9999999876432221 12
Q ss_pred CCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+. +..++.++|+||||+++|+|++|..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 213 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCC
Confidence 2345778899999985 3456788999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=233.81 Aligned_cols=198 Identities=28% Similarity=0.455 Sum_probs=172.4
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
......+|++.+.||+|++|.||++.+..+++.|++|.+...... .+.+.+|+..++.++|+|++++++.+..+...++
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 344568999999999999999999999889999999988654332 3567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
++||+++++|.+++.+ ..++..++..++.+++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 170 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCcc
Confidence 9999999999998865 45789999999999999999999999999999999999988776 99999999865433322
Q ss_pred C-CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 P-KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ....+++.|+|||.+.+..++.++|+||||++++++++|..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~ 213 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 2 23457788999999998888999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=232.68 Aligned_cols=195 Identities=30% Similarity=0.482 Sum_probs=170.6
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...+|++.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++|+|++++++.+......++++|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 45689999999999999999999998999999998865432 23567889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-CC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~~ 178 (219)
|+++++|...+... .++..++..++.+++.+|++||+.+++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 97 YLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred ecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCC
Confidence 99999999887654 5899999999999999999999999999999999999988776 99999998765433322 22
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+..++.++|+||||+++|++++|..
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~ 213 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 3457788999999998888999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=230.41 Aligned_cols=194 Identities=23% Similarity=0.293 Sum_probs=164.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...++|++.++||.|++|.||++.+..+ ..+++|++.......+.+.+|+.+++.++|+|++++++.+.. ...++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e 80 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 80 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence 3467899999999999999999988755 459999987655555678899999999999999999998754 56789999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+++++|.+.+... ..++...+..++.+++.+|++||+.+++|+||+|+||++++++. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 158 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccccc
Confidence 99999999998753 34788999999999999999999999999999999999988776 999999998654332221
Q ss_pred --CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 178 --KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
....++..|+|||...+..++.++|+||||++++++++++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g 200 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 200 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 1223556799999998888999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=235.41 Aligned_cols=192 Identities=28% Similarity=0.493 Sum_probs=164.0
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5899999999999999999999999999999886432 2235677899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-CC
Q 027738 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (219)
Q Consensus 101 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~~ 178 (219)
+++ +|...+.. ...++...++.++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 975 67776654 456899999999999999999999999999999999999988776 99999999875432222 22
Q ss_pred CCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+. .++.++|+||||+++++|+||+.
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~ 198 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCC
Confidence 34567889999998764 46889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=229.62 Aligned_cols=194 Identities=27% Similarity=0.437 Sum_probs=166.2
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc-ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
+-|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++++.+..+...++++||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 45789999999999999999999999999999886543 22356778999999999999999999999999999999999
Q ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCC
Q 027738 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (219)
Q Consensus 102 ~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~ 179 (219)
++++|...+.. ..++++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++++|||++...... .....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccccccc
Confidence 99999887754 456899999999999999999999999999999999999987776 999999998643222 12233
Q ss_pred CCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|+|||.+. +..++.++|+||+|+++++|++|..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~ 206 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCC
Confidence 45788999999984 3457789999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=231.39 Aligned_cols=192 Identities=28% Similarity=0.381 Sum_probs=161.1
Q ss_pred ccc-eeeccccCcCceEEEEEE----ECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--Ce
Q 027738 23 DRY-DFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (219)
Q Consensus 23 ~~y-~~~~~l~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 93 (219)
++| ++.+.||.|++|+||.+. ...+++.+++|.+..... ....+.+|+..++.++|||++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 466 999999999999998765 334677899998865432 345678899999999999999999988753 45
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++++|++++++|.+++... .++..+++.++.|++.+|.+||+++++|+||||+||++++++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence 89999999999999988764 5899999999999999999999999999999999999988766 99999999875443
Q ss_pred CCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 174 HSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 174 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.... ....++..|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 2221 1123456799999998888899999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=228.92 Aligned_cols=194 Identities=26% Similarity=0.433 Sum_probs=171.9
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
.++|++.+.|++|++|.+|++.+..+++.+++|.+..... .+.+.+|++.++.++|+|++++++.+......++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 4689999999999999999999998889999998865533 567899999999999999999999999999999999999
Q ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCC
Q 027738 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (219)
Q Consensus 102 ~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~ 179 (219)
++++|.+.+.. ...++...+..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999998865 446899999999999999999999999999999999999998776 9999999987554333 2233
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~ 197 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCC
Confidence 457789999999988889999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=235.36 Aligned_cols=194 Identities=30% Similarity=0.449 Sum_probs=168.4
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.+++|.+...... .+.+.+|++.++.++|++++++++.+......++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4799999999999999999999988999999998765322 245778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 99 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
|++.+++|.+.+... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999988754 45899999999999999999999999999999999999988776 99999998764322211
Q ss_pred ------------------------------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 ------------------------------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence 112246778999999998888999999999999999999874
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=242.06 Aligned_cols=195 Identities=24% Similarity=0.291 Sum_probs=162.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCC-----CcEEEEEEeccCccc--CHHHHHHHHHHHhCC-CCcEeEEEEEEEc
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVILT 90 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 90 (219)
....++|++.+.||+|+||.||++.+... ...||+|++...... .+.+.+|+.+++.+. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 34577899999999999999999987432 346999988654322 356789999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhc---------------------------------------------------------
Q 027738 91 PTHLAIVMEYASGGELFERICNA--------------------------------------------------------- 113 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~--------------------------------------------------------- 113 (219)
....++++||+++++|.+++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 99999999999999998887542
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC
Q 027738 114 ---------------------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (219)
Q Consensus 114 ---------------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~ 154 (219)
..++..++..++.|++.+|.+||+.+++|+||||+||++++
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 13677788899999999999999999999999999999988
Q ss_pred CCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 155 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 155 ~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
++. ++|+|||+++....... .....++..|+|||.+.+..++.++|+||||+++++|++
T Consensus 273 ~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 334 (400)
T cd05105 273 GKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334 (400)
T ss_pred CCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 766 99999999875432222 122345678999999998889999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=232.84 Aligned_cols=196 Identities=28% Similarity=0.428 Sum_probs=168.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
..++|++.+.||.|++|.||++.+..+++.+++|.+...... .+.+.+|+.+++.++|+|++++++.+..+...++++|
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 457899999999999999999999888999999998654322 3567789999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CC
Q 027738 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~ 177 (219)
|+++++|.+++... ..++..++..++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhccccccc
Confidence 99999999988764 46899999999999999999999999999999999999988776 9999999876433222 22
Q ss_pred CCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+. +..++.++|+||||+++|+|++|..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~ 206 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 2345788899999975 3456788999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=227.93 Aligned_cols=186 Identities=30% Similarity=0.489 Sum_probs=165.6
Q ss_pred ccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 31 l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+.+++.++|||++++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999998899999999865432 235688899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCCCCC
Q 027738 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186 (219)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~ 186 (219)
.+.+.+...++..++..++.|++.+|++||+.+++|+||+|+||+++.++. ++|+|||++.............++..|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988888999999999999999999999999999999999999988776 999999998765443333445678899
Q ss_pred CCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 187 IAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 187 ~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++||.+.+..++.++|+||||+++|++++|..
T Consensus 159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~ 190 (262)
T cd05572 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRP 190 (262)
T ss_pred cChhHhcCCCCCChhhhhhhHHHHHHHHhCCC
Confidence 99999988888999999999999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=229.30 Aligned_cols=193 Identities=30% Similarity=0.444 Sum_probs=170.2
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
+|+..+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++|++++++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57888999999999999999998899999998865431 225678899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
+||+++++|.+.+.+..+++...+..++.+++.+|++||+.+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988878999999999999999999999999999999999999988776 999999988654433333
Q ss_pred CCCCCCCCCCCchhhcccc-ccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHE-YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+.. ++.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~ 200 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 4456788899999998766 8899999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=244.00 Aligned_cols=189 Identities=31% Similarity=0.504 Sum_probs=167.0
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..|.=++.||.|+||.||.+++..+.+.||+|+++.+.... +++..|+.+++++.|||.+.+.++|....-.|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34666899999999999999999999999999997654432 67899999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|||-| +..+.+.-. .++.+.++..+..+.+.+|+|||+.+.+|+|||..|||+++.+. |||+|||.|.. ....
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi---~~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASI---MAPA 179 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhh---cCch
Confidence 99976 666666533 46899999999999999999999999999999999999998887 99999998753 3566
Q ss_pred CCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCC
Q 027738 178 KSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
++++|||.|+|||++. .+.|+.++||||||++.+|+.-..
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERk 222 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 222 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcC
Confidence 7889999999999986 578999999999999999987554
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=227.42 Aligned_cols=194 Identities=27% Similarity=0.403 Sum_probs=167.0
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--CeE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 94 (219)
.+|+..+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+.+++.++|||++++++.+... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999998999999998864321 124577899999999999999999998763 568
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++|++++++|.+.+.....++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence 899999999999999988778999999999999999999999999999999999999987766 999999998644321
Q ss_pred C----CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 S----QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ......++..|+|||.+.+..++.++|+||+|++++|+++|..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~ 207 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCC
Confidence 1 1122347788999999998889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=227.45 Aligned_cols=194 Identities=35% Similarity=0.515 Sum_probs=169.9
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||.|++|.+|++.+..+++.+++|.+.... ...+.+.+|++.++.++|||++++++.+...+..++++|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6899999999999999999999899999999986542 2235678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 101 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
+++++|.+++... ..+++..+..++.+++.+|++||+++++|+||+|+||++++++. .++++|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999998764 34899999999999999999999999999999999999976543 37999999987655444444
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 199 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199 (256)
T ss_pred ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCC
Confidence 4567889999999988888999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=239.97 Aligned_cols=196 Identities=35% Similarity=0.563 Sum_probs=178.4
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..+=|.+.+.||+|.|..|.++++..+|..||||++.+.. .....+.+|++.++.++||||+++|++...+..+|+|
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4567999999999999999999999999999999997643 3346688999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC-CCCCcEEEeecccccccccCC
Q 027738 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~-~~~~~v~l~dfg~a~~~~~~~ 175 (219)
.|.-++|+|.+++-++. .++++....+++||+.++.|.|+..+||+||||+|+++-+ -+. |||+|||++....++.
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGl--VKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGL--VKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCc--eEeeeccccccCCCcc
Confidence 99999999999997765 4899999999999999999999999999999999997643 344 9999999999999999
Q ss_pred CCCCCCCCCCCCCchhhcccccc-ceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYD-GKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slg~~~~~~~~g~~ 218 (219)
.-.+.+|+..|.|||.+.+..|+ +++||||||+++|.+..|..
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~ 217 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQP 217 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCC
Confidence 99999999999999999999886 67899999999999988864
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=232.99 Aligned_cols=194 Identities=30% Similarity=0.467 Sum_probs=168.5
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.|+.|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++|||++++++.+..++..++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 479999999999999999999999999999998875432 2245678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-- 176 (219)
|++++++|.+++...+.+++..+..++.+++.+|.+||+.+++|+||+|+||+++.++. ++++|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988888999999999999999999999999999999999999988776 99999998753211110
Q ss_pred --------------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 --------------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 --------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 011245678999999988888999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=231.96 Aligned_cols=192 Identities=30% Similarity=0.490 Sum_probs=163.6
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++|||++++++++..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999998999999998865322 235678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-
Q 027738 101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (219)
Q Consensus 101 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~- 176 (219)
+++ +|...+... ..++..++..++.|++.+|++||+.+++|+||+|+||++++++. ++|+|||++........
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 974 787777543 45899999999999999999999999999999999999988877 99999999864432221
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+ ..++.++|+||||+++++|+||+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 200 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP 200 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence 122356788999999875 456889999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=232.30 Aligned_cols=194 Identities=24% Similarity=0.364 Sum_probs=164.7
Q ss_pred CCccceeeccccCcCceEEEEEEE-----CCCCcEEEEEEeccCc-ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
+.++|.+.+.||.|++|.||++.. ..++..+++|.+.... ...+.+.+|+..++.++||+++++++++...+..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 567899999999999999999985 2345668999876533 2245688999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEE
Q 027738 95 AIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~ 161 (219)
++++||+++++|.+++.... .+++.++..++.|++.+|++||+.+++|+||+|+||++++++. ++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~k 160 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VK 160 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EE
Confidence 99999999999999887543 3899999999999999999999999999999999999988776 99
Q ss_pred EeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 162 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 162 l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
|+|||++........ .....++..|+|||.+.+..++.++|+||||+++++|+++
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~ 218 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999875432211 1222346689999999988899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=233.80 Aligned_cols=193 Identities=24% Similarity=0.286 Sum_probs=160.7
Q ss_pred ccceeeccccCcCceEEEEEEECCCCc--EEEEEEeccCc--ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKE--LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~--~v~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 97 (219)
++|++.+.||.|++|.||+++...++. .+++|.+.... ...+.+.+|+..+.++ +|||++++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999876654 46777765321 2235678899999888 799999999999999999999
Q ss_pred EeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEE
Q 027738 98 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~ 161 (219)
+||+++++|.+++.+.. .++..++..++.|++.+|++||+.+++|+||||+||++++++. ++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence 99999999999986542 3788899999999999999999999999999999999987766 99
Q ss_pred EeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 162 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 162 l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
|+|||++..............+..|+|||.+.+..++.++|+||||++++||++ |.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~ 216 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGG 216 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999764322212222233457999999988889999999999999999997 54
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=230.86 Aligned_cols=195 Identities=30% Similarity=0.485 Sum_probs=166.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||.|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.++|+|++++++++..+...++|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 45789999999999999999999998999999999865432 2345678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-
Q 027738 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~- 176 (219)
||+++ +|.+.+... ..++...+..++.|+++||.+||+.+++|+||+|+||++++++. ++|+|||++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCcc
Confidence 99986 888877654 45899999999999999999999999999999999999988876 99999998864322211
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+.+ ..++.++|+||+|+++++|++|..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~ 202 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRP 202 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 122345778999999875 457889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=231.29 Aligned_cols=195 Identities=27% Similarity=0.425 Sum_probs=164.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..++.++|+|++++++++..+...++++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 34789999999999999999999998999999999865432 2346678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-C
Q 027738 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~ 176 (219)
||+.+ ++...+.. ...++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||+++...... .
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQT 159 (291)
T ss_pred ecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCC
Confidence 99964 66665544 345788899999999999999999999999999999999988776 9999999886432221 2
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 233356788999999875 457888999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=228.61 Aligned_cols=194 Identities=27% Similarity=0.426 Sum_probs=173.5
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
++|++.+.||.|++|.+|++.+..+++.+++|++..... ..+.+.+|+..+..++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 478999999999999999999999999999999876543 346788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC-
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 178 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~- 178 (219)
+++++|.+.+.....+++..+..++.|++.++.+||+ .+++|+||+|+||++++++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999887889999999999999999999999 99999999999999988776 9999999887554333332
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|.|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~ 198 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKF 198 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 3457789999999998888999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=229.84 Aligned_cols=196 Identities=26% Similarity=0.436 Sum_probs=167.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcC------Ce
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------TH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~~ 93 (219)
..+.|++.+.||+|++|.||++.+..+++.+++|.+.........+.+|+..++.+ +|+|++++++.+... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 45689999999999999999999998999999999876655567788999999888 699999999998753 45
Q ss_pred EEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.++++||+++++|.+.+... ..+++..+..++.|++.+|++||+.+++|+||+|+||++++++. ++|+|||++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~ 161 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 161 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceec
Confidence 89999999999999988764 35899999999999999999999999999999999999998876 999999998654
Q ss_pred ccCC-CCCCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHS-QPKSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.... ......++..|+|||.+. +..++.++|+||+|++++||++|..
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 3221 223345788899999986 3457889999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=229.30 Aligned_cols=197 Identities=26% Similarity=0.459 Sum_probs=166.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEE-----cCCe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTH 93 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~ 93 (219)
...++|++.+.||+|++|.||++.+..+++.+++|++.......+.+.+|+..++.+ +|+|++++++++. .+..
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 367899999999999999999999999999999998866544456788899999888 6999999999884 3456
Q ss_pred EEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 94 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
.++++||+++++|.+.+.. ...+++..+..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~ 172 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSA 172 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCcee
Confidence 8999999999999887652 345888999999999999999999999999999999999988776 9999999986
Q ss_pred ccccCC-CCCCCCCCCCCCCchhhcc-----ccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHS-QPKSTVGTPAYIAPEVLLR-----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...... ......++..|+|||.+.. ..++.++|+||||+++++|++|..
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~ 227 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence 543222 2233457889999999853 447889999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=228.10 Aligned_cols=194 Identities=30% Similarity=0.452 Sum_probs=167.1
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc------ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--CeE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 94 (219)
.+|++.+.||+|++|.+|++.+..+++.+++|.+.... .....+++|+..++.++|+|++++++.+... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875321 1124678899999999999999999998764 458
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++|++++++|.+.+.....++...+..++.+++.+|.+||+++++|+||+|+||++++++. ++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence 899999999999999987777899999999999999999999999999999999999987776 999999998654321
Q ss_pred C----CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 S----QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ......++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 207 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 1 1123457788999999998888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=228.62 Aligned_cols=196 Identities=21% Similarity=0.300 Sum_probs=164.1
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCC-----CcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 89 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (219)
.....++|++.+.||+|++|.||++..... ...+++|.+..... ....+.+|+.+++.+ +|+|++++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 345678999999999999999999987633 36789998865322 224577899999999 7999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec
Q 027738 90 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~ 153 (219)
.++.+++++||+++++|..++... ..++...+..++.|++.+|.+||+.+++|+||+|+||+++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999999999988642 3588999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 154 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 154 ~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
+++. ++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++||+++
T Consensus 167 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (293)
T cd05053 167 EDHV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229 (293)
T ss_pred CCCe--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhc
Confidence 8776 99999999875433221 111234567999999988889999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=230.14 Aligned_cols=194 Identities=28% Similarity=0.455 Sum_probs=168.8
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
+|+..+.||+|++|.+|.+.+..+++.+++|.+..... ..+.+.+|+..++.++|+|++++++++..++.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48888999999999999999999999999998864321 23567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
++||+.+++|.+.+...+++++..+..++.|++.||.+||+++++|+||+|+||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988888999999999999999999999999999999999999976543 389999999865433211
Q ss_pred -----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 -----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 206 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCC
Confidence 122356788999999988888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=232.56 Aligned_cols=195 Identities=25% Similarity=0.329 Sum_probs=166.1
Q ss_pred CCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..++|.+.+.||+|++|.||++.+. .+++.+++|.+...... .+.+.+|+++++.++|+|++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 3568999999999999999999874 33578999988654333 3678899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCc
Q 027738 94 LAIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~ 159 (219)
.++++||+++++|.+++...+ .++..++..++.+++.++.+||+++++|+||+|+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-- 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV-- 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--
Confidence 999999999999999987542 3788899999999999999999999999999999999988876
Q ss_pred EEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 160 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 160 v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
++|+|||++........ ......++.|+|||.+.+..+++++|+||||++++||++ |.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~ 222 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCC
Confidence 99999999864322211 122335678999999999999999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=230.75 Aligned_cols=184 Identities=18% Similarity=0.133 Sum_probs=159.7
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEc----CCeEEEEEec
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEY 100 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~ 100 (219)
..+++|+++.||++.. +++.|++|.+....... +.+.+|+..+++++||||+++++++.+ ....++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999988 48899999987654433 456799999999999999999999877 3468999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~ 179 (219)
+++++|.+.+.+.+.++......++.+++.+|.+||+. +++|+||+|+||++++++. ++++|||++..... ....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~--~~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSS--PPFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhcc--cccc
Confidence 99999999998888899999999999999999999984 9999999999999998876 99999999864322 2234
Q ss_pred CCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|+|||.+.+ ..++.++|+||||+++|||++|..
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~ 220 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC
Confidence 467889999999976 678999999999999999999864
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=228.72 Aligned_cols=186 Identities=27% Similarity=0.344 Sum_probs=158.4
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+++++.++|||++++++++......++++||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999999899999999875432 2235688999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC---CCCC
Q 027738 107 FERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 182 (219)
Q Consensus 107 ~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~---~~~~ 182 (219)
.+++.... .++..++..++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||.+.......... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 99886544 5899999999999999999999999999999999999987776 9999999986433221111 1122
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
+..|+|||.+.+..++.++|+||||+++|+|+++
T Consensus 159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~ 192 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSL 192 (252)
T ss_pred ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 4569999999888899999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=227.74 Aligned_cols=186 Identities=25% Similarity=0.361 Sum_probs=164.5
Q ss_pred ccccCcCceEEEEEEECCC---CcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+... +..+++|.+...... .+.+.+|+..++.++|++++++++++......++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4789999999999999865 888999998765443 46788999999999999999999999999999999999999
Q ss_pred CcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 104 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 104 ~~L~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++|.+++... ..+++.++..++.|++.+|.+||+++++|+||+|+||++++++. ++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence 9999999875 67999999999999999999999999999999999999998876 999999998755433
Q ss_pred C---CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 175 S---QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 175 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
. ......++..|+|||.+.+..++.++|+||||+++++|+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 203 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhc
Confidence 2 22334567889999999988899999999999999999985
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=232.45 Aligned_cols=195 Identities=24% Similarity=0.385 Sum_probs=172.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||+|++|+||++.+..+++.+++|++.... ...+.+.+|+++++.++|||++++++.+.....+++++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4578999999999999999999999899999999876542 23467889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+++++|...+.+.+.++...+..++.+++.+|.+||+ .+++|+||+|+||++++++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~-~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELIN-SIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhh-hcc
Confidence 999999999998887889999999999999999999997 58999999999999987776 99999998754322 223
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~ 200 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF 200 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCC
Confidence 34567889999999988889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=226.75 Aligned_cols=193 Identities=28% Similarity=0.503 Sum_probs=168.2
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||+|++|.+|.+.+..+++.+++|.+.... ...+++.+|+..++.++|||++++.+++...+..++++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6899999999999999999999999999999886432 2235688999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC-
Q 027738 101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~- 177 (219)
+.+++|.+.+.... .++..++..++.|++.+|.+||+++++|+||+|+||+++.++. ++++|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999999887543 4789999999999999999999999999999999999987776 999999988644322211
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|.|||.+.+..++.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 199 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCC
Confidence 22356788999999988888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=227.44 Aligned_cols=194 Identities=25% Similarity=0.404 Sum_probs=168.6
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|++.++.++|++++++++.+...+..++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999899999999886422 22456889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 99 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
||+++++|...+.. ...++..++..++.+++.+|.+||+.|++|+||+|+||+++.++. ++++|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999888754 234899999999999999999999999999999999999988776 999999987643322
Q ss_pred CC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....+++.|.|||.+.+..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~ 204 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCC
Confidence 21 223457788999999998889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=228.48 Aligned_cols=196 Identities=27% Similarity=0.478 Sum_probs=166.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcC-----CeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----THL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~~~ 94 (219)
..++|++.+.||+|++|.||++.+..+++.+++|.+.......+.+.+|+..+..+ +|||++++++++... ...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 46789999999999999999999999999999999876544456778899999888 799999999998754 358
Q ss_pred EEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 95 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
++++||+++++|.+.+.. ...+++..++.++.|++.+|++||+.+++|+||+|+||++++++. ++|+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchh
Confidence 999999999999887753 346899999999999999999999999999999999999988776 99999999865
Q ss_pred cccCC-CCCCCCCCCCCCCchhhccc-----cccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHS-QPKSTVGTPAYIAPEVLLRH-----EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..... ......++..|+|||.+... .++.++|+||||+++++|++|..
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCC
Confidence 43322 22334577889999998643 36789999999999999999974
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=231.94 Aligned_cols=196 Identities=23% Similarity=0.407 Sum_probs=174.3
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
+..+-|.++++||.|++|.||++.++.+|+.+|+|.+... ...+++..|+.++.+++.|+++++|+.+..+..+|+|||
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3456688999999999999999999999999999987543 345778899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc-ccCCCC
Q 027738 100 YASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~-~~~~~~ 177 (219)
||..|++.+.+. +..++++.++..++...+++|+|||..+-+|+|||..|||++-++. .+|+|||.|-.. ...-..
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhh
Confidence 999999998885 5567999999999999999999999999999999999999988887 899999987432 222334
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++..|++-|+|||++..-.|+.++|+||||++..||.-|++
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCC
Confidence 55679999999999999899999999999999999999975
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=230.44 Aligned_cols=196 Identities=18% Similarity=0.238 Sum_probs=162.6
Q ss_pred cCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
...++|++.+.||+|++|.||.+.+. .++..+++|.+..... ....+.+|+..++.++|+|++++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999864 2356799998754322 2345778999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEE
Q 027738 93 HLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l 162 (219)
..++++||+++++|.+++.... .++...+..++.+++.+|.+||+.+++|+||||+||++++++. ++|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l 160 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKI 160 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEE
Confidence 9999999999999999886532 2467788999999999999999999999999999999998776 999
Q ss_pred eecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 163 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 163 ~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
+|||++........ .....++..|+|||.+.+..++.++|+||||++++||++++
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 218 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 218 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCC
Confidence 99999864322211 11223466899999999888999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=234.58 Aligned_cols=194 Identities=20% Similarity=0.273 Sum_probs=161.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCc----EEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
...+|++.+.||+|++|.||++.+..+++ .|++|.+.... ...+++.+|+..++.++||||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 35679999999999999999998765554 38999886432 2235678899999999999999999998765 56
Q ss_pred EEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++++++++++|.+.+.... .++...+..++.|++.+|+|||+++++|+||||+||++++++. ++|+|||+++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccC
Confidence 78999999999999887643 5889999999999999999999999999999999999988776 99999999875543
Q ss_pred CCCCC---CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 174 HSQPK---STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 174 ~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
..... ....+..|+|||.+.+..++.++|+||||+++||+++ |.
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~ 209 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 209 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 22211 1223567999999999899999999999999999887 53
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=230.00 Aligned_cols=193 Identities=20% Similarity=0.286 Sum_probs=162.4
Q ss_pred CCccceeeccccCcCceEEEEEEE----CCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~----~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
+.++|++.+.||+|++|.||++.. ..+++.+++|.+...... ...+.+|+..++.++|||++++++++..+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 457899999999999999999985 345678999988643222 24678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC
Q 027738 95 AIVMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~ 157 (219)
++++||+++++|.+++... ..++..++..++.+++.+|.+||+++++|+||+|+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999999999888532 23678889999999999999999999999999999999988776
Q ss_pred CcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 158 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 158 ~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
++|+|||+++....... .....++..|+|||.+.+..++.++|+||||++++||++
T Consensus 163 --~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 221 (283)
T cd05090 163 --VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221 (283)
T ss_pred --EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 99999999865432221 122234567999999988888999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=227.92 Aligned_cols=196 Identities=19% Similarity=0.274 Sum_probs=165.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCC-----CcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
...++|++.+.||+|++|.||++.+... +..+++|.+...... ...+.+|+..++.++|+|++++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 4578999999999999999999987643 378999988654322 245778999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEE
Q 027738 93 HLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l 162 (219)
..++++||+++++|.+++.... .++...+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEE
Confidence 9999999999999999886432 3577889999999999999999999999999999999998877 999
Q ss_pred eecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 163 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 163 ~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+|||+++....... .....++..|+|||.+.+..++.++|+||||++++|++| |.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 219 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCC
Confidence 99999865432221 122345678999999988889999999999999999998 44
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=229.48 Aligned_cols=195 Identities=27% Similarity=0.413 Sum_probs=162.8
Q ss_pred CCccceeeccccCcCceEEEEEEE----CCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcC--Ce
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTP--TH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~----~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 93 (219)
+..+|++.+.||+|++|.||.+.. ..+++.|++|.+...... .+.+.+|+..++.++|||++++++++... ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 346899999999999999999973 456888999988654322 35678999999999999999999987543 46
Q ss_pred EEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
+++++||+++++|.+++... ..++...+..++.|++.+|++||+.|++|+||+|+||++++++. ++|+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~ 159 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLP 159 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCccccccc
Confidence 89999999999999998764 35899999999999999999999999999999999999988776 9999999987543
Q ss_pred cCCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 173 LHSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 173 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
..... ....++..|+|||.+.+..++.++|+||||++++||++|.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 208 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS 208 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcC
Confidence 32221 1112344699999998888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=227.71 Aligned_cols=195 Identities=22% Similarity=0.273 Sum_probs=169.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...++|++.+.||+|++|.||++.+. +++.+++|.+.......+++.+|+..++.++|++++++++++......++++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 46789999999999999999999976 45779999988766666789999999999999999999999999899999999
Q ss_pred ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
++++++|.+.+.... .++..++..++.+++.++.+||+++++|+||+|+||++++++. ++++|||++.........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYT 159 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhh
Confidence 999999999987643 5899999999999999999999999999999999999988876 999999998654322111
Q ss_pred --CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 178 --KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.....+..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~ 202 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence 12234567999999998888999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=227.11 Aligned_cols=193 Identities=23% Similarity=0.312 Sum_probs=164.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...++|++.+.||+|++|.||++.+. ++..+++|.+.......+.+.+|+.+++.++|++++++++++. ....++++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 45679999999999999999999876 5566999988776555678899999999999999999999875 456789999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+++++|.+.+... ..++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYT 158 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccc
Confidence 99999999988753 35899999999999999999999999999999999999988766 999999998654322211
Q ss_pred --CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 178 --KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
....++..|+|||.+.+..++.++|+||||+++++|+++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~ 199 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence 112345679999999888889999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=224.25 Aligned_cols=194 Identities=33% Similarity=0.458 Sum_probs=167.7
Q ss_pred cCCccceee-ccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEc----CCe
Q 027738 20 HDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT----PTH 93 (219)
Q Consensus 20 ~~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~ 93 (219)
.-.++|++. +.||.|-.|.|..+.++++++.+|+|++..+ +...+|+++.=.. .||||+.++++|+. ..+
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 356788876 7899999999999999999999999988544 3445666665444 69999999999875 357
Q ss_pred EEEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeecccccc
Q 027738 94 LAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 170 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~ 170 (219)
+.+|||.+.||.|++.++.++. |++.++..++.||+.|+.|||+.+|.|+||||+|+|..... +..+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 8999999999999999988775 99999999999999999999999999999999999996443 33599999999987
Q ss_pred cccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
......-.+.+-++.|.|||++....|+...|.||+|+++|-|+.|=
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGy 260 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCC
Confidence 66555666778899999999999889999999999999999999873
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=227.81 Aligned_cols=195 Identities=23% Similarity=0.331 Sum_probs=163.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCc---EEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
+...|++.+.||+|++|.||++....+++ .|++|.+.... ...+.+..|+..++.++|||++++.+++..+...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35679999999999999999999876654 59999886532 22357888999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+++||+++++|.+++.. ...++..++..++.|++.+|++||+++++|+||+|+||++++++. ++++|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~ 159 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccC
Confidence 99999999999988875 345899999999999999999999999999999999999987765 999999987644332
Q ss_pred CCCCCC---C---CCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 SQPKST---V---GTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~~~~~~---~---~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
...... . .+..|+|||.+.+..++.++|+||||++++|+++ |.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~ 209 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 209 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCC
Confidence 221111 1 1347999999998889999999999999999876 54
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=228.44 Aligned_cols=186 Identities=30% Similarity=0.412 Sum_probs=162.4
Q ss_pred ccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 31 l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
||.|++|+||++.+..+++.+++|.+.... .....+..|+.+++.++||+++++++.+...+..++++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999999999999886432 1234456899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCCC
Q 027738 107 FERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184 (219)
Q Consensus 107 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~ 184 (219)
.+.+.+.. .++..++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||.+.............++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99887655 6899999999999999999999999999999999999988776 9999999886544333334446778
Q ss_pred CCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 185 AYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 185 ~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~ 192 (277)
T cd05577 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192 (277)
T ss_pred CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCC
Confidence 8999999988889999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=226.59 Aligned_cols=193 Identities=31% Similarity=0.461 Sum_probs=170.1
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||+|++|.+|++.+..+++.+++|.+..... ..+.+.+|+..++.++|+|++++++.+.....+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 68999999999999999999988899999999876544 346788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC--
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 178 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~-- 178 (219)
+++++|.+.+.....++...+..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence 999999999988777899999999999999999999999999999999999998776 9999999986543332221
Q ss_pred ---CCCCCCCCCCchhhcccc---ccceeeEEEEEEEEeecCCCCC
Q 027738 179 ---STVGTPAYIAPEVLLRHE---YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ---~~~~~~~~~aPE~~~~~~---~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+.. ++.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~ 204 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCC
Confidence 234678999999998665 7899999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=227.74 Aligned_cols=193 Identities=33% Similarity=0.472 Sum_probs=166.4
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-----------CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-----------DENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
+|.+.+.||.|++|.||++.+..+++.+++|.+...... .+.+.+|+..++.++|+|++++++++..+.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 688899999999999999999888999999987542110 135678999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
..++++||+++++|.+.+.....++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++++|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999987776 9999999986432
Q ss_pred cCCC---CCCCCCCCCCCCchhhcccc--ccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQ---PKSTVGTPAYIAPEVLLRHE--YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~---~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.... .....++..|+|||.+.+.. ++.++|+||||++++++++|..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 210 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCC
Confidence 2111 12235678899999987654 7899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=226.62 Aligned_cols=195 Identities=24% Similarity=0.346 Sum_probs=165.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCC---CcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
+.++|++.+.||+|++|.||++.+..+ ...+++|.+..... ....+.+|+..++.++|||++++++++..++..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 457899999999999999999988643 45789998765322 2356778999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+++|++++++|.+++... ..++..++..++.+++.+|.+||+++++|+||+|+||++++++. ++|+|||++......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccc
Confidence 999999999999998764 36899999999999999999999999999999999999988776 999999998765311
Q ss_pred CCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 SQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
... .....+..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~ 206 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE 206 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCC
Confidence 111 11234568999999998889999999999999999987 54
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=229.80 Aligned_cols=194 Identities=24% Similarity=0.344 Sum_probs=165.3
Q ss_pred CCccceeeccccCcCceEEEEEEECCCC----------------cEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK----------------ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 82 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~----------------~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~ 82 (219)
..++|++.+.||+|++|.||++.+...+ ..+++|.+..... ..+.+.+|+..++.++|||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4578999999999999999999876533 4579998865432 235678899999999999999
Q ss_pred EEEEEEEcCCeEEEEEeccCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 027738 83 RFKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (219)
Q Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nil 151 (219)
++++++..+...++++|++++++|..++.... .++...++.++.|++.+|.+||+.+++|+||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999987665 6899999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 152 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 152 i~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
+++++. ++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++||++++
T Consensus 163 i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 163 VGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred ecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence 988866 99999999864432221 1223456789999999888899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=244.36 Aligned_cols=198 Identities=27% Similarity=0.420 Sum_probs=169.0
Q ss_pred CcccCCccc-eeeccccCcCceEEEEEEECCCCcEEE---EEE--eccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 17 PIMHDSDRY-DFVRDIGSGNFGVARLMRDKVTKELVA---VKY--IERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 17 ~~~~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~---~K~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
.-....++| ++...||+|++-+||+|.+..+|-.|| +|+ +.+.+...+++..|+.+|+.++||||++++++|.+
T Consensus 33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 334456677 778999999999999999998887765 221 12333444889999999999999999999999997
Q ss_pred CCe--EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 91 PTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 91 ~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
... ..+|+|.+..|+|..++++.+......+..|++||+++|.|||++ .|+|+|||-+||||+.+. +.|||+|+|
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDLG 191 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDLG 191 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc-Cceeecchh
Confidence 654 899999999999999999999999999999999999999999999 599999999999997554 459999999
Q ss_pred cccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 167 ~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
+|........ ....|||.|||||.+. ..|+..+|||||||+|+||.|++
T Consensus 192 LAtl~r~s~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~e 240 (632)
T KOG0584|consen 192 LATLLRKSHA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSE 240 (632)
T ss_pred HHHHhhcccc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhcc
Confidence 9986543333 3368999999999997 78899999999999999999985
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=236.38 Aligned_cols=193 Identities=26% Similarity=0.371 Sum_probs=166.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 92 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 92 (219)
..++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.++|+|++++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 46789999999999999999999999999999998864321 2245678999999999999999999986543
Q ss_pred -eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 93 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
..++++||+.+ +|...+... ++...+..++.|++.+|++||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeC
Confidence 47999999965 777776554 899999999999999999999999999999999999988876 999999998765
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCC
Confidence 44433344567889999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=236.89 Aligned_cols=196 Identities=21% Similarity=0.324 Sum_probs=161.5
Q ss_pred cCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCccc--CHHHHHHHHHHHhC-CCCcEeEEEEEEEcC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTP 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (219)
...++|++.+.||.|+||.||+++.. .+++.|++|++...... .+.+.+|+..+..+ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 45679999999999999999999743 34578999988643222 24567899999999 799999999988754
Q ss_pred -CeEEEEEeccCCCcHHHHHHhc---------------------------------------------------------
Q 027738 92 -THLAIVMEYASGGELFERICNA--------------------------------------------------------- 113 (219)
Q Consensus 92 -~~~~lv~e~~~~~~L~~~~~~~--------------------------------------------------------- 113 (219)
..+++++||+++++|.+.+...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5688999999999998887532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC---CCCCCCCCC
Q 027738 114 ----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY 186 (219)
Q Consensus 114 ----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~ 186 (219)
.+++...+..++.|++.+|++||+++++|+||||+||++++++. ++|+|||++......... ....++..|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccc
Confidence 25788899999999999999999999999999999999997766 999999998754322221 223446689
Q ss_pred CCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 187 IAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 187 ~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+|||.+.+..++.++|+|||||+++||++ |.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~ 273 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA 273 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=228.95 Aligned_cols=193 Identities=25% Similarity=0.381 Sum_probs=167.3
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++|++.+.||+|++|.||++.+..+++.+++|.+..... ..+++.+|+.+++.++|+|++++++.+..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 589999999999999999999988999999998764322 2356778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 99 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
|++++++|.+.+.. ...+++.+++.++.+++++|.+||+++++|+||+|+||+++.++. ++++|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence 99999999888763 345899999999999999999999999999999999999987776 999999987644322
Q ss_pred CC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 175 SQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 175 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.. .....++..|+|||.+.+..++.++|+||||+++++|++|.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~ 203 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCC
Confidence 21 22345788999999999888899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=227.11 Aligned_cols=192 Identities=28% Similarity=0.413 Sum_probs=166.1
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-------CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
+|++.+.||.|++|.||++.+. +++.+++|.+...... .+.+.+|++.++.++|+|++++.+++.+....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999875 7788999988643211 1457789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC--
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 174 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-- 174 (219)
++||+++++|.+++....+++...+..++.|++.+|++||+.+++|+||+|+||++++++. ++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999988778999999999999999999999999999999999999987776 999999987643211
Q ss_pred -----CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 -----SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.......++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 206 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP 206 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 11123357788999999998888999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=229.15 Aligned_cols=196 Identities=22% Similarity=0.278 Sum_probs=164.4
Q ss_pred CCccceeeccccCcCceEEEEEEECC-----CCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..++|++.+.||+|++|.||++.+.. ++..+++|.+..... ....+.+|+..++.++|+|++++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45789999999999999999999976 677899998754322 23457889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeec
Q 027738 94 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDF 165 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~df 165 (219)
.++++|++.+++|.+++...+ .++..++..++.|++.+|++||+++++|+||+|+||++++++. ..++|+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999999987653 4788999999999999999999999999999999999986542 24899999
Q ss_pred ccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 166 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 166 g~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
|+++....... ......+..|+|||.+.+..++.++|+||||++++||+++
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~ 217 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcC
Confidence 99875422111 1122334679999999988899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=227.86 Aligned_cols=197 Identities=27% Similarity=0.477 Sum_probs=168.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCC------
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------ 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~------ 92 (219)
...++|++.+.||+|++|.+|++.+..+++.+++|++.......+.+.+|+.+++++ .|+|++++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 356899999999999999999999988899999999877665567788999999998 6999999999997654
Q ss_pred eEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 93 HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
.+++++||+++++|.+.+.. ...++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccc
Confidence 48999999999999888764 346899999999999999999999999999999999999988776 999999988
Q ss_pred cccccCC-CCCCCCCCCCCCCchhhcc-----ccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHS-QPKSTVGTPAYIAPEVLLR-----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~-~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....... ......++..|+|||.+.. ..++.++|+||||+++++|++|..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~ 216 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCC
Confidence 6433222 2233457888999998753 346788999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=230.77 Aligned_cols=193 Identities=28% Similarity=0.454 Sum_probs=170.4
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
++|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|++.++.++|||++++++.+......++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 47889999999999999999999999999999886643 2335678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 101 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
+++++|.+.+... ..++...+..++.+++.+|++||+ .+++|+||+|+||++++++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-K 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-h
Confidence 9999999999876 679999999999999999999999 99999999999999998776 99999998764432222 2
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 197 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRF 197 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 2567788999999998889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=224.14 Aligned_cols=194 Identities=29% Similarity=0.448 Sum_probs=168.9
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
++|++.+.||.|++|+||++....++..+++|++..... ..+.+.+|+..++.++|++++++++.+......++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 479999999999999999999988899999998865432 336688999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
+++++|.+.+... ..+++..+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999998764 35899999999999999999999999999999999999998776 999999998654433222
Q ss_pred -----CCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 178 -----KSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 -----~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+... .++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~ 205 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA 205 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCC
Confidence 223577889999998766 78899999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=225.44 Aligned_cols=194 Identities=21% Similarity=0.307 Sum_probs=165.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...++|++.+.||+|++|.||++... +++.+++|.+.......+.+.+|+.+++.++|+|++++++++. .+..++++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 45678999999999999999999875 5678999998776655678899999999999999999999864 456899999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
++.+++|.+.+... ..++..++..++.+++.+|++||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcc
Confidence 99999999888653 35889999999999999999999999999999999999998776 999999998654322111
Q ss_pred --CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 178 --KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
....++..|+|||.+....+++++|+||||++++|+++ |.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~ 201 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCC
Confidence 12234568999999988888999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=232.40 Aligned_cols=189 Identities=28% Similarity=0.404 Sum_probs=153.7
Q ss_pred eccccCcCceEEEEEEEC--CCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEc--CCeEEEEEeccCC
Q 027738 28 VRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 103 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 103 (219)
.++||+|++|.||++.+. .+++.+++|.+.... ....+.+|+.+++.++|||++++++++.. ....++++||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999965 467889999886543 34567889999999999999999999865 4568999999865
Q ss_pred CcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC--CCCcEEEeecccccccc
Q 027738 104 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 172 (219)
Q Consensus 104 ~~L~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~--~~~~v~l~dfg~a~~~~ 172 (219)
+|...+... ..++...+..++.|++.||.+||+++++|+||||+||++..+ ....++|+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 777776532 248999999999999999999999999999999999999532 22349999999987543
Q ss_pred cCCC----CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQ----PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.... .....+++.|+|||.+.+ ..++.++|+||+|+++++|++|..
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 2211 223457889999999986 457899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=230.57 Aligned_cols=193 Identities=24% Similarity=0.363 Sum_probs=165.0
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..+++++|+|++++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47999999999999999999999899999999886432 2235678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 101 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
+++++|..++... ..++...+..++.+++.+|.+||+ .+++|+||+|+||+++.++. ++|+|||++..... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA-SL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccC-Cc
Confidence 9999998887663 368999999999999999999997 59999999999999988766 99999998864422 22
Q ss_pred CCCCCCCCCCCCchhhccc------cccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRH------EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 205 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC
Confidence 2334567789999998643 34789999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=228.41 Aligned_cols=193 Identities=28% Similarity=0.468 Sum_probs=167.9
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
..|+..+.||+|++|.+|.+.+..++..+++|.+.... .....+.+|+.+++.+.|++++++++.+..+...++++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46888999999999999999999889999999886543 2235678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-CCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~~~ 179 (219)
+++++|.+.+.. .+++..++..++.+++.+|+++|+.+++|+||+|+||+++.++. ++++|||++........ ...
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence 999999988764 46899999999999999999999999999999999999988776 99999999865433221 222
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|.|||.+.+..++.++|+||||++++||++|..
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCC
Confidence 356778999999988888999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=230.69 Aligned_cols=194 Identities=19% Similarity=0.288 Sum_probs=163.2
Q ss_pred CCccceeeccccCcCceEEEEEEECC-----CCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
+.++|++.+.||.|++|.||++.+.. .++.+++|.+...... .+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 45689999999999999999998753 3577999998754322 3567889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC
Q 027738 94 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~ 157 (219)
.++++||+.+++|..++... ..++...+..++.|++.+|.++|+.+++|+||||+||++++++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 99999999999999888532 23788889999999999999999999999999999999987776
Q ss_pred CcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 158 PRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 158 ~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
++|+|||+++........ ....+++.|+|||.+.+..++.++|+||||++++||+++
T Consensus 163 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 222 (283)
T cd05091 163 --VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY 222 (283)
T ss_pred --eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcC
Confidence 999999997654322211 223356789999999888899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=222.62 Aligned_cols=193 Identities=31% Similarity=0.501 Sum_probs=172.5
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
.|++.+.||+|++|.+|++.+..+++.+++|++..... ..+.+.+|+..++.++|++++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 48889999999999999999998899999999876544 44678899999999999999999999999999999999999
Q ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCC
Q 027738 103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181 (219)
Q Consensus 103 ~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~ 181 (219)
+++|.+.+... ..++...+..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence 99999998776 57899999999999999999999999999999999999998776 9999999987655443334456
Q ss_pred CCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 182 GTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 195 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKP 195 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 7889999999988888999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=228.85 Aligned_cols=195 Identities=33% Similarity=0.451 Sum_probs=166.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcC--CeEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLA 95 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 95 (219)
..++|++.+.||.|++|.||++.+..+++.+++|.+...... ...+.+|+..+.+++|||++++++++... ...+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 356899999999999999999999989999999998654322 23567899999999999999999999877 8899
Q ss_pred EEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+++||+++ +|.+.+.... .++..++..++.|++.+|++||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSP 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCC
Confidence 99999975 8888876544 4899999999999999999999999999999999999998876 999999988755433
Q ss_pred C-CCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 175 S-QPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ......+++.|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 205 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCC
Confidence 2 22234567889999998754 46889999999999999999964
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=231.71 Aligned_cols=191 Identities=28% Similarity=0.423 Sum_probs=165.3
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc------CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
+|++.+.||.|++|.||++.+..+++.|++|.+...... ...+..|+..++.++|+|++++++++..+...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999988999999998754322 34567899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-
Q 027738 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~- 175 (219)
+||+ +++|.+.+.... .++..++..++.|++++|.+||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999987765 7999999999999999999999999999999999999998776 9999999987544332
Q ss_pred CCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.......+..|.|||.+.+ ..++.++|+||||+++++|++|.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 2222345678999999864 45688999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=231.17 Aligned_cols=194 Identities=26% Similarity=0.475 Sum_probs=167.1
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++|++.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|++.++.++|||++++++++..+...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 479999999999999999999988899999998765332 23567889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-CC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~~ 178 (219)
|++++++.........++..++..++.|++.+|.+||+.+++|+|++|+||++++++. ++|+|||++........ ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9999888877766666899999999999999999999999999999999999988776 99999999865433222 12
Q ss_pred CCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~ 199 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCC
Confidence 3356788999999875 456788999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=225.47 Aligned_cols=190 Identities=26% Similarity=0.362 Sum_probs=167.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...++|++.+.||.|++|.||++... ++.+++|.+.......+++.+|+.+++.++|+|++++++++......++++|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 35679999999999999999999875 7889999987665445678899999999999999999999999899999999
Q ss_pred ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
++++++|.+++.... .++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||.+...... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~--~ 156 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQG--Q 156 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccc--c
Confidence 999999999987665 6899999999999999999999999999999999999988776 999999998755322 1
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
.....+..|+|||.+.+..++.++|+||||++++++++
T Consensus 157 ~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~ 194 (256)
T cd05039 157 DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHh
Confidence 23334567999999988888999999999999999987
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=248.99 Aligned_cols=196 Identities=27% Similarity=0.427 Sum_probs=171.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC-cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
..+.|.+++.||.|+||.||++.++.++-..|.|.+... ....+++.-|++++..++||+|+++++.|...+.+|++.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 357899999999999999999999988877788887643 3344778889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc-cccCCCC
Q 027738 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~-~~~~~~~ 177 (219)
+|+||-....+.. .+.+++.++..+++++|++|.|||+++|+|+|||..|||+..+|. ++|+|||.+.. .......
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhh
Confidence 9999998887765 456999999999999999999999999999999999999999988 99999997643 2223334
Q ss_pred CCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
-++.|+|.|+|||+.. +.+|+.++||||||++++||.-+.+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 4568999999999975 5789999999999999999988764
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=231.57 Aligned_cols=195 Identities=22% Similarity=0.280 Sum_probs=162.3
Q ss_pred cCCccceeeccccCcCceEEEEEEECC-------CCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 89 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (219)
...++|.+.+.||+|++|.||.+.+.. +...+++|.+..... ....+.+|+.+++.+ +|+|++++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 345899999999999999999998643 234699998875422 224577899999988 7999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec
Q 027738 90 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~ 153 (219)
..+..++++||+++++|.+++.... .++..++..++.|++.+|++||+.|++|+||+|+||+++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 9999999999999999999997542 378889999999999999999999999999999999998
Q ss_pred CCCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 154 GSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 154 ~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
+++. ++|+|||++......... .....+..|+|||.+.+..++.++|+||||+++|+|+++
T Consensus 175 ~~~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 175 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred CCCc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence 8776 999999998654322111 112234689999999988899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=228.05 Aligned_cols=192 Identities=29% Similarity=0.454 Sum_probs=166.6
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.++|||++++++++..+...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999999899999999987543 2246788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--C
Q 027738 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 177 (219)
Q Consensus 101 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~--~ 177 (219)
+ +++|.+.+.. ...++..+++.++.|++.+|++||+.+++|+||+|+||++++++. ++++|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence 9 8899988864 356899999999999999999999999999999999999988766 99999998865433321 2
Q ss_pred CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 199 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSP 199 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCc
Confidence 33457889999999875 446889999999999999999854
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=230.71 Aligned_cols=190 Identities=31% Similarity=0.432 Sum_probs=159.3
Q ss_pred eeeccccCcCceEEEEEEEC----CCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 26 DFVRDIGSGNFGVARLMRDK----VTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 26 ~~~~~l~~g~~~~v~~~~~~----~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++.+.||.|.||.||+|... ..+..|++|.+...... .+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999987 34567999999653322 4678899999999999999999999998888999999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~- 176 (219)
|+++++|.+++... ..++..++..++.|++.||.|||+++++|+||+++||++++++. +||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 99999999999886 67999999999999999999999999999999999999998776 99999999875522111
Q ss_pred --CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 177 --PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 177 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.........|.|||.+.+..++.++||||||++++|+++++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~ 202 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLG 202 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc
Confidence 12234567899999999888999999999999999999953
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=226.22 Aligned_cols=195 Identities=24% Similarity=0.334 Sum_probs=164.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCc---EEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
+.++|++.+.||+|++|.||++.+..++. .+++|.+..... ..+.+.+|+..++.++|||++++++++..++..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45789999999999999999998864443 689998865332 2356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+++|++++++|.+++... ..++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++++|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccc
Confidence 999999999999998764 45899999999999999999999999999999999999987766 999999998754332
Q ss_pred CCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 SQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
... .....+..|+|||.+.+..++.++|+||||++++|+++ |.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCC
Confidence 211 11122457999999998889999999999999999876 64
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=227.94 Aligned_cols=194 Identities=25% Similarity=0.342 Sum_probs=163.2
Q ss_pred CCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCc-ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
...+|++.++||+|++|.||++... .++..+++|.+.... ...+.+.+|++.++.++|+|++++++++..+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 4678999999999999999999743 346678888775432 2235688999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCc
Q 027738 95 AIVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~ 159 (219)
++++||+++++|.+++.... .++...+..++.|++.++.+||+.+++|+||+|+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~-- 160 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-- 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--
Confidence 99999999999999887643 3788999999999999999999999999999999999987766
Q ss_pred EEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 160 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 160 v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++++|+++
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 220 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 99999999864432221 1122346789999999988899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=224.70 Aligned_cols=193 Identities=22% Similarity=0.283 Sum_probs=162.9
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...++|++.+.||.|++|.||++.+..+ ..+++|.+.......+.+.+|+.+++.++|++++++++++.. +..++++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTE 80 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEE
Confidence 3457899999999999999999988754 458999887655555778899999999999999999998754 56789999
Q ss_pred ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+.+++|.+++.... .++...+..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCccc
Confidence 999999999887543 4788999999999999999999999999999999999988776 999999998654322211
Q ss_pred --CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 178 --KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
....++..|+|||...+..++.++|+||||+++|+|+++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~ 199 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhC
Confidence 122345679999999888889999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=233.13 Aligned_cols=191 Identities=25% Similarity=0.396 Sum_probs=159.5
Q ss_pred eeeccccCc--CceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 26 DFVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 26 ~~~~~l~~g--~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
++++.||+| ++++||++.+..+++.||+|.+..... ..+.+++|+.+++.++||||+++++++..++..++|+||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 678999999999999999999865422 235677899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--
Q 027738 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (219)
Q Consensus 101 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-- 176 (219)
+++++|.+++... ..++...+..++.|++.+|.+||+.+++|+||||+||+++.++. +++.||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccc
Confidence 9999999988653 45899999999999999999999999999999999999988776 89999986432211110
Q ss_pred ------CCCCCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 ------PKSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ------~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+.+ ..++.++|+||||++++||++|..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~ 208 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 208 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 111235667999999975 458899999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=227.81 Aligned_cols=192 Identities=20% Similarity=0.256 Sum_probs=166.7
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
..+|++.+.||.|++|.||++.+.. +..+++|.+..... ..+.+..|+..++.++|+|++++++++......++++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4579999999999999999999986 78899999876554 356788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC-
Q 027738 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~- 177 (219)
+++++|.+.+... ..++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLS 161 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCccccc
Confidence 9999999998753 35899999999999999999999999999999999999988776 999999998654322211
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
....++..|+|||.+.+..++.++|+||||+++++|+++
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~ 200 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 122345679999999888899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=228.42 Aligned_cols=195 Identities=25% Similarity=0.330 Sum_probs=164.6
Q ss_pred CCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
...+|.+.+.||.|++|.||++.+. .++..+++|.+...... .+.+.+|+..++.++|+|++++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 3567999999999999999999853 24556888887654332 35688999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 95 AIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
++++||+++++|.+++.... .++...+..++.+++.+|++||+++++|+||+|+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 161 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL- 161 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-
Confidence 99999999999999986542 3788999999999999999999999999999999999988776
Q ss_pred cEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 159 ~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 162 -~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 223 (291)
T cd05094 162 -VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223 (291)
T ss_pred -EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999864432221 122345678999999998889999999999999999998 53
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=228.06 Aligned_cols=196 Identities=20% Similarity=0.276 Sum_probs=162.2
Q ss_pred cCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
...++|++.+.||+|++|.||++... ..+..|++|.+...... ...+.+|+..++.++|+|++++++++..+.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45789999999999999999998754 23457999987654322 235678899999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEE
Q 027738 93 HLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l 162 (219)
..++++||+++++|.+++.... ..+...+..++.|++.+|.+||+++++|+||+|+||++++++. ++|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L 160 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKI 160 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEE
Confidence 9999999999999999986532 2466788999999999999999999999999999999988776 999
Q ss_pred eecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 163 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 163 ~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
+|||+++....... .....++..|+|||.+.+..++.++|+||||++++||++++
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~ 218 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 218 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCC
Confidence 99999864332211 11223466799999999888999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=222.69 Aligned_cols=194 Identities=20% Similarity=0.300 Sum_probs=164.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...++|++.+.||+|++|.||++... .+..+++|.+.......+.+.+|+.+++.++|++++++.+.+.. ...++++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 46789999999999999999999865 45568999887655445678899999999999999999999887 77899999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+++++|.+++.+. ..++..++..++.+++.+|.+||+.+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT 158 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcc
Confidence 99999999998763 34788889999999999999999999999999999999988776 999999988643322111
Q ss_pred --CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 178 --KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
....++..|+|||.+....++.++|+||||++++++++ |.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~ 201 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCC
Confidence 12234567999999988888999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=226.54 Aligned_cols=197 Identities=30% Similarity=0.516 Sum_probs=173.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...+.|+..+.|++|++|.+|++.+..+++.+++|.+.......+.+.+|++.++.++|+|++++++.+......++++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45678999999999999999999999889999999997655445678899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
|+++++|.+++.... .++..++..++.+++.+|++||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhh
Confidence 999999999998876 7999999999999999999999999999999999999987776 99999998754332211 1
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~ 214 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 23346778999999988888999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=230.43 Aligned_cols=193 Identities=23% Similarity=0.339 Sum_probs=161.5
Q ss_pred CccceeeccccCcCceEEEEEEECCC--------------CcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVT--------------KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFK 85 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~--------------~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~ 85 (219)
.++|++.+.||+|++|.||++++..+ ...|++|.+..... ..+.+.+|++.++.++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46899999999999999999987543 23589998865322 235678899999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec
Q 027738 86 EVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153 (219)
Q Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~ 153 (219)
+++......++++||+++++|.+++.... .++..++..++.+++.+|.+||+.+++|+||+|+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999886432 367888999999999999999999999999999999998
Q ss_pred CCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 154 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 154 ~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
+++. ++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++++|+++
T Consensus 164 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred CCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 7766 99999999864432221 1122346689999999988899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=223.27 Aligned_cols=192 Identities=26% Similarity=0.343 Sum_probs=162.8
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEE-cCCeEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIV 97 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv 97 (219)
..+.++|++.+.||+|++|.||++... +..+++|.+.... ..+.+.+|+..++.++|++++++++++. .+...+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 346779999999999999999999775 7789999886433 3456889999999999999999999765 45678999
Q ss_pred EeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+||+++++|.+++.... .++...+..++.+++.+|++||++|++|+||+|+||++++++. ++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~- 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceecccc-
Confidence 99999999999887644 3788999999999999999999999999999999999988776 999999988643322
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~ 197 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197 (256)
T ss_pred -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 222334567999999998889999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=228.69 Aligned_cols=202 Identities=26% Similarity=0.437 Sum_probs=167.4
Q ss_pred CCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
.++++....++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+..++.++|||++++++++..
T Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 3 YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred ccCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 356777888999999999999999999999999999999998864322 22355689999999999999999999876
Q ss_pred CC--------eEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEE
Q 027738 91 PT--------HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 91 ~~--------~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~ 161 (219)
.. ..++++||+.+ ++...+.... .++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~k 159 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LK 159 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EE
Confidence 43 45999999975 7777665543 6899999999999999999999999999999999999988776 99
Q ss_pred EeecccccccccCCCC-----CCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 162 ICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 162 l~dfg~a~~~~~~~~~-----~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+|||++......... ....++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~ 222 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCC
Confidence 9999998654332221 123467789999998654 46889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=223.98 Aligned_cols=195 Identities=27% Similarity=0.397 Sum_probs=166.4
Q ss_pred CccceeeccccCcCceEEEEEEEC----CCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEc--CCe
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDK----VTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT--PTH 93 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~----~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 93 (219)
.+.|++.+.||+|++|.||++... .+++.+++|.+...... .+.+.+|++.++.++|+|++++++++.. +..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 467899999999999999999864 34788999998765543 5678999999999999999999999987 557
Q ss_pred EEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
.++++||+++++|.+++.... .++..++..++.+++.+|.+||+++++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccc
Confidence 899999999999999997655 5899999999999999999999999999999999999988766 9999999987554
Q ss_pred cCCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..... .....+..|.|||.+.+..++.++|+||||++++||++|..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~ 210 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence 22111 12234557999999988889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=229.16 Aligned_cols=196 Identities=22% Similarity=0.272 Sum_probs=162.5
Q ss_pred ccCCccceeeccccCcCceEEEEEEEC-------CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 88 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (219)
....++|++.+.||+|++|.||++.+. .....+++|.+..... ....+.+|+..++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 445689999999999999999999763 2345689998764322 224577899999988 699999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili 152 (219)
.....+++++||+++++|.+++.... .++..++..++.|++.+|.+||+.|++|+||+|+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 99999999999999999999986532 37888899999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 153 DGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 153 ~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
++++. ++|+|||+++........ ....++..|+|||.+.+..++.++|+||||+++++++++
T Consensus 168 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~ 232 (314)
T cd05099 168 TEDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232 (314)
T ss_pred cCCCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhC
Confidence 88776 999999998754322111 112234579999999988899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=226.06 Aligned_cols=197 Identities=25% Similarity=0.440 Sum_probs=167.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEc------CC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PT 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~~ 92 (219)
...+.|++.+.||+|++|.||++.+..+++.+++|.+.........+..|+..++.+ +|+|++++++++.. ..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 355899999999999999999999998999999999876655556788888888888 69999999999853 45
Q ss_pred eEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
..++++||+++++|.+.+... ..+++..+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++..
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~ 170 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhh
Confidence 689999999999999888653 34788889999999999999999999999999999999998776 99999998764
Q ss_pred cccC-CCCCCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLH-SQPKSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.... .......++..|+|||.+. +..++.++|+||||+++++|++|..
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~ 224 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCC
Confidence 4322 2223345788999999986 3457889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=230.01 Aligned_cols=194 Identities=29% Similarity=0.457 Sum_probs=168.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.+.|+..+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++|||++++++.+..+...++++|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 356888999999999999999999889999999886433 223568899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-CC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~~ 178 (219)
|+++++|.+.+.. ..+++..+..++.+++.++.+||+++++|+||+|+||++++++. ++++|||++........ ..
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhh
Confidence 9999999887754 46899999999999999999999999999999999999988776 99999999865432221 12
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+..++.++|+||||++++||++|..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP 199 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCC
Confidence 2356788999999998888999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=225.55 Aligned_cols=185 Identities=18% Similarity=0.144 Sum_probs=157.7
Q ss_pred ccccCcCceEEEEEEECCCC----------cEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 29 RDIGSGNFGVARLMRDKVTK----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~----------~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
+.||+|++|.||++.+..++ ..+++|.+.........+.+|+.+++.++|||++++++++.. ...++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998665 347788776554435778899999999999999999999988 7789999
Q ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC-----cEEEeecccccccc
Q 027738 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 172 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~-----~v~l~dfg~a~~~~ 172 (219)
||+++++|.+++.... .++...+..++.|++.+|.+||+++++|+||||+||+++.++.. .++++|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999998766 68999999999999999999999999999999999999877622 49999999987543
Q ss_pred cCCCCCCCCCCCCCCCchhhccc--cccceeeEEEEEEEEeecCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRH--EYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
. .....+...|+|||.+.+. .++.++|+||||++++++++|+
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence 2 2334566789999999876 7889999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=226.85 Aligned_cols=192 Identities=20% Similarity=0.295 Sum_probs=160.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCc----EEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
..++|++.+.||+|++|+||++.+..+++ .|++|.+..... ..+.+.+|+..+..+.|+|++++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 45789999999999999999998766665 478998764322 235677899999999999999999998754 46
Q ss_pred EEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++++++++++|.+.+... ..++..++..++.|++.+|.+||+++++|+||||+||++++++. ++|+|||+++....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~ 161 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDI 161 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeeccc
Confidence 7899999999999998764 46899999999999999999999999999999999999987766 99999999875533
Q ss_pred CCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 174 HSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 174 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
.... .....+..|+|||...+..++.++|+||||+++||+++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t 206 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHc
Confidence 2221 11234567999999988889999999999999999988
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=229.18 Aligned_cols=199 Identities=22% Similarity=0.297 Sum_probs=166.8
Q ss_pred CcccCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 88 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (219)
......++|.+.+.||+|++|.||++.+. .++..+++|.+..... ..+.+.+|+.+++++ +|+|++++++.+
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 45566789999999999999999999752 3456799998865432 235678899999999 799999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
...+..++++||+.+++|.+++..... ++..++..++.+++.+|.+||+++++|+||+|+||++++++. ++++|||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg 186 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFG 186 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCc
Confidence 999999999999999999998875432 899999999999999999999999999999999999987765 9999999
Q ss_pred cccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 167 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 167 ~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
++........ .....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 9864432211 112234678999999998889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=223.70 Aligned_cols=191 Identities=19% Similarity=0.257 Sum_probs=158.2
Q ss_pred ceeeccccCcCceEEEEEEECCC---CcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe-----
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH----- 93 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 93 (219)
|++.+.||+|++|.||.+....+ +..+++|.+...... .+.+.+|+..++.++|+|++++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987643 477999988754322 2457889999999999999999998876554
Q ss_pred -EEEEEeccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 94 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 94 -~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
.++++||+++++|...+... ..++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence 79999999999998887543 24899999999999999999999999999999999999988766 9999999
Q ss_pred cccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 167 YSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 167 ~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
+++........ .....+..|+|||.+.+..++.++|+||||++++||++++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g 212 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 212 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCC
Confidence 98754332221 1123456799999998888999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=222.48 Aligned_cols=192 Identities=26% Similarity=0.378 Sum_probs=165.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+..+|++.+.||+|++|.||++.+. ++..+++|.+.........+.+|++.++.++||+++++++++......++++||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 4568999999999999999999886 467899998876655567889999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC--
Q 027738 101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~-- 177 (219)
+.+++|.+.+... ..++...+..++.+++.++++||+.+++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCccccc
Confidence 9999999888654 45899999999999999999999999999999999999987766 999999988644322111
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
.....+..|+|||.+.+..++.++|+||||++++||++
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~ 196 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHc
Confidence 12234568999999988889999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=223.79 Aligned_cols=193 Identities=25% Similarity=0.345 Sum_probs=159.5
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHH-HHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++|++.+.||.|++|.||++.+..+++.||+|.+...... ...+..|... ++..+|||++++++++..++..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4799999999999999999999999999999988654322 2344445554 566789999999999999999999999
Q ss_pred ccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 100 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 100 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
|+++ +|...+.. ...+++.++..++.|++.+|.+||++ +++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 9974 77666543 24589999999999999999999997 9999999999999988776 999999998754333
Q ss_pred CCCCCCCCCCCCCCchhhcc----ccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQPKSTVGTPAYIAPEVLLR----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.......++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 205 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRF 205 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCC
Confidence 23333457788999999864 456889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=228.68 Aligned_cols=193 Identities=24% Similarity=0.373 Sum_probs=160.9
Q ss_pred CccceeeccccCcCceEEEEEEECC----------------CCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKV----------------TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR 83 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~----------------~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~ 83 (219)
.++|++.+.||.|++|.||++.+.. ++..+++|.+..... ..+.+.+|+..++.++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4679999999999999999986432 344689998865422 2356889999999999999999
Q ss_pred EEEEEEcCCeEEEEEeccCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe
Q 027738 84 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (219)
Q Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili 152 (219)
+++++..++..++++||+++++|.+++.... .++..++..++.+++.+|++||+.+++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999887543 25677899999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 153 ~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
++++. ++|+|||++........ ......+..|++||...+..++.++|+||||+++|||+++
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 164 GKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred cCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence 87766 99999999875432221 1112345689999998888899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=226.69 Aligned_cols=198 Identities=29% Similarity=0.463 Sum_probs=170.6
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc-ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
+....++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++|||++++++.+......++
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 3445689999999999999999999998889999999886432 233567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
++||+++++|.+++.+. .++..++..++.+++.+|.+||+++++|+||+|+||+++.++. ++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 170 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccc
Confidence 99999999999888654 4789999999999999999999999999999999999988776 99999998764433222
Q ss_pred C-CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 P-KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ....+++.|+|||.+.+..++.++|+||||++++++++|..
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~ 213 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 2 22357778999999988888999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=221.68 Aligned_cols=193 Identities=33% Similarity=0.478 Sum_probs=172.6
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--CeEEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 98 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 98 (219)
+|+..+.|++|++|.+|++.+..+++.+++|.+..... ..+.+.+|+..+++++|+|++++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58889999999999999999998999999998866542 346788999999999999999999999988 8899999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-- 176 (219)
|++++++|.+.+.....++..++..++.+++.+|.+||+.+++|+|++|+||++++++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence 99999999999988878999999999999999999999999999999999999998766 99999999876554443
Q ss_pred -CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 -PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|.|||.+.+...+.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 201 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 344567889999999988888999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=224.82 Aligned_cols=194 Identities=31% Similarity=0.505 Sum_probs=162.7
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++|++.+.||.|.+|.+|++.+..+++.|++|.+..... ..+.+.+|+..++.++|+|++++++++......++++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 689999999999999999999998999999998865432 23567889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-
Q 027738 100 YASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~- 176 (219)
|+++ ++...+..... ++...+..++.|++.||++||+++++|+||+|+||+++.++. .++++|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9965 77777655433 578888999999999999999999999999999999985443 389999999865433222
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+ ..++.++|+||||+++++|+||..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~ 202 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP 202 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 123356788999999876 457889999999999999999964
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=246.08 Aligned_cols=199 Identities=27% Similarity=0.414 Sum_probs=182.7
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
......+.+++..||-|+||.|-++..+.....+|+|++++. ....+.+..|-.++..++.|.|+++|..|.+..+
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 345567888999999999999999988755555889988653 2334667788899999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.|++||-|-||.+|..+...+.|.+.+.+.++..+++|++|||++||+++||||+|.+++.++- +||.|||+|+....
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhcc
Confidence 9999999999999999999999999999999999999999999999999999999999998888 99999999999999
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..+.+++||+.|.|||.+.++..+.++|.||||+++||+++|++
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~p 617 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSP 617 (732)
T ss_pred CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999999999999999999999986
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=223.77 Aligned_cols=187 Identities=24% Similarity=0.282 Sum_probs=155.1
Q ss_pred ccccCcCceEEEEEEECCCCc--EEEEEEeccC--cccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~--~v~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+..++. .+++|..... ....+.+.+|+..+..+ +|||++++++++...+..++++||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987765 4677877532 22235678899999999 799999999999999999999999999
Q ss_pred CcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 104 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 104 ~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
++|.+++.... .++..++..++.+++.+|++||+.+++|+||+|+||++++++. ++++|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence 99999986543 3788999999999999999999999999999999999988776 99999998
Q ss_pred ccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 168 a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+..............+..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~ 209 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 753322212222233567999999988889999999999999999997 53
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=224.83 Aligned_cols=193 Identities=27% Similarity=0.410 Sum_probs=165.4
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--CeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 98 (219)
++|+..+.||.|++|.||++.+..+++.+++|.+..... ....+.+|++.++.++||||+++++++... +.+++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 478999999999999999999998999999998875433 335688999999999999999999998653 4689999
Q ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 99 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
||+++++|.+.+.. ...++...+..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999877643 345899999999999999999999999999999999999988776 999999997644322
Q ss_pred CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 201 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRF 201 (287)
T ss_pred c-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 1 123356778999999998889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=224.71 Aligned_cols=195 Identities=23% Similarity=0.303 Sum_probs=164.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCc---EEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
..++|+..+.||+|++|.||++....+++ .+++|.+.... ...+.+.+|++.++.++|+|++++.+++...+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 45689999999999999999999875554 68999886542 22356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+++|++++++|..++... +.++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++++|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~ 160 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccc
Confidence 999999999999988653 56899999999999999999999999999999999999987766 999999998644322
Q ss_pred CCCC----CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 SQPK----STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~~~~----~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.... ....+..|+|||.+.+..++.++|+||||+++||+++ |.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~ 208 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCC
Confidence 2111 1123457999999988888999999999999999887 64
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=222.16 Aligned_cols=186 Identities=26% Similarity=0.333 Sum_probs=156.1
Q ss_pred ccccCcCceEEEEEEE--CCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRD--KVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~--~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.. ..+++.+++|++..... ..+.+.+|+.+++.++|+|++++++++. ....++++|++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 3689999999999964 35678899998865432 2356788999999999999999999875 4567899999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC----CC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KS 179 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~----~~ 179 (219)
++|.+++.....++...+..++.|++.+|++||+++++|+||+|.||++++++. ++|+|||++......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCC
Confidence 999999988788999999999999999999999999999999999999988766 999999998654322211 11
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
..++..|+|||.+.+..++.++|+||||+++|||++ |.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~ 196 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQ 196 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence 223578999999988888999999999999999998 64
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=224.49 Aligned_cols=194 Identities=20% Similarity=0.262 Sum_probs=159.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCc----EEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
..++|++.+.||.|++|.||++.+..+++ .+++|.+..... ...++..|+..+..++|||++++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 45789999999999999999999876665 477777653321 12456677778889999999999998754 457
Q ss_pred EEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
++++|++++++|.+.+... ..+++..+..++.|++.+|.+||+.+++|+||||+||++++++. ++|+|||+++....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccC
Confidence 7899999999999999754 46899999999999999999999999999999999999987766 99999999875433
Q ss_pred CCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 174 HSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 174 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.... ....++..|+|||.+.+..++.++|+||||+++||+++ |.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~ 209 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGA 209 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCC
Confidence 2221 12235668999999998889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=246.90 Aligned_cols=193 Identities=23% Similarity=0.358 Sum_probs=153.8
Q ss_pred CccceeeccccCcCceEEEEEEECCCC-cEEE------------------EEEeccCcccCHHHHHHHHHHHhCCCCcEe
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTK-ELVA------------------VKYIERGDKIDENVQREIINHRSLRHPNIV 82 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~------------------~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (219)
.++|++.+.||+|+||+||++...... ...+ .|...........+.+|+.+++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998754322 1111 122222222335578999999999999999
Q ss_pred EEEEEEEcCCeEEEEEeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC
Q 027738 83 RFKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (219)
Q Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~ 157 (219)
++++++...+..+++++++.+ ++..++... ......++..++.|++.+|.|||+++|+|+||||+||+++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999865 666665432 12346678889999999999999999999999999999988776
Q ss_pred CcEEEeecccccccccCCC--CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 158 PRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 158 ~~v~l~dfg~a~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|||++|+
T Consensus 306 --vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~ 365 (501)
T PHA03210 306 --IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365 (501)
T ss_pred --EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999875433222 22356899999999999989999999999999999999875
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=221.18 Aligned_cols=186 Identities=26% Similarity=0.292 Sum_probs=157.5
Q ss_pred ccccCcCceEEEEEEECCCC---cEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTK---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~---~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.....+ ..+++|.+..... ..+.+.+|+..++.+.|+|++++++++. ....++++||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999765444 7899998876544 3456788999999999999999999876 4568999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC----C
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----S 179 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~----~ 179 (219)
++|.+++.+...+++..+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988878999999999999999999999999999999999999988776 9999999987543322211 1
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
..++..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~ 196 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGA 196 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCC
Confidence 122457999999998889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=245.02 Aligned_cols=195 Identities=26% Similarity=0.393 Sum_probs=161.9
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC-cccCHHHHHHHHHHHhCC-CCcEeEEEEEEEc------
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREIINHRSLR-HPNIVRFKEVILT------ 90 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~------ 90 (219)
.....++++.+.|.+|+|+.||.|.+...+..||+|+.-.. +...+.+.+|++++++++ |+||+.+++....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34466788999999999999999999977788999987544 334577899999999997 9999999994321
Q ss_pred -CCeEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEecCCCCCcEEEeec
Q 027738 91 -PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 91 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
...+.++||||.|+.|.+++... ..|++.++++|++++|+|+.+||.+. |+|||||-+|||++.++. .|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcc
Confidence 13478999999999999999843 34999999999999999999999997 999999999999998887 999999
Q ss_pred ccccccccCCCCC----------CCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCC
Q 027738 166 GYSKSSVLHSQPK----------STVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 166 g~a~~~~~~~~~~----------~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
|.|.-........ ....|+.|+|||.+. +...+.|+|||+|||+||-++-
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy 253 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY 253 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH
Confidence 9986333222111 124688999999985 6788999999999999987653
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=244.22 Aligned_cols=195 Identities=26% Similarity=0.354 Sum_probs=169.7
Q ss_pred CCccceeeccccCcCceEEEEEEECC-----CCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
...+-++.+.||+|+||+||+++... ...-||||.++.... .+++|++|++++..++||||++++|++.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 35566788999999999999998652 345699998876543 35789999999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhc----------C----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCc
Q 027738 94 LAIVMEYASGGELFERICNA----------G----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~----------~----~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~ 159 (219)
+++|+||+..|+|..++... . +++..+.+.++.||+.+|.||-++.+||+||-.+|.||.++-.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~-- 641 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV-- 641 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--
Confidence 99999999999999999632 1 2788999999999999999999999999999999999988877
Q ss_pred EEEeecccccccccCCCCCCC---CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 160 LKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 160 v~l~dfg~a~~~~~~~~~~~~---~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
|||+|||+++........... .-+.+|||||.+....+|.++||||+|++|+|.+|=+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccc
Confidence 999999999866555444433 3567999999999999999999999999999998854
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=222.14 Aligned_cols=190 Identities=28% Similarity=0.344 Sum_probs=164.9
Q ss_pred ceeeccccCcCceEEEEEEECCCC----cEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~----~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
+++.+.||.|++|.||++.+...+ ..+++|.+..... ..+.+.+|+..++.++|+|++++++++...+..++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 357789999999999999998765 8899999866543 3467889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 99 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
|++++++|.+.+..... ++..++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence 99999999999876554 899999999999999999999999999999999999988876 99999999875543322
Q ss_pred CCC--CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 177 PKS--TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 177 ~~~--~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
... ..++..|+|||.+.+..++.++|+||||+++++|+++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 221 2356789999999888889999999999999999984
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=223.56 Aligned_cols=186 Identities=30% Similarity=0.454 Sum_probs=155.5
Q ss_pred cccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHH---hCCCCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHR---SLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 30 ~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
.||+|++|.||++.+..+++.+++|.+...... .....++..+++ ...||+++.+++.+..++..++++||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999989999999988653221 122334443333 3468999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCC
Q 027738 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (219)
Q Consensus 103 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~ 182 (219)
+++|.+.+.....++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++...... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999999988888999999999999999999999999999999999999987776 999999998643322 2223467
Q ss_pred CCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..|+|||.+.+ ..++.++|+||+|+++++|++|..
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 194 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHS 194 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 889999999874 567899999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=234.58 Aligned_cols=199 Identities=24% Similarity=0.309 Sum_probs=164.9
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCccc--CHHHHHHHHHHHhCC-CCcEeEEEE
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKE 86 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~ 86 (219)
+.......++|.+.+.||+|+||.||++++. .+++.||+|++...... .+.+.+|+.++..+. ||||+++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3345566778999999999999999999864 34568999999754322 246788999999997 999999999
Q ss_pred EEEcCCeEEEEEeccCCCcHHHHHHhcC----------------------------------------------------
Q 027738 87 VILTPTHLAIVMEYASGGELFERICNAG---------------------------------------------------- 114 (219)
Q Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------------------------------------------- 114 (219)
.+..++..++++||+++++|.+++...+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999998886431
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 027738 115 ----------------------------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148 (219)
Q Consensus 115 ----------------------------------------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~ 148 (219)
.++...+..++.|++.+|.+||+.+++|+||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2456678889999999999999999999999999
Q ss_pred CEEecCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 149 nili~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
||++++++. ++|+|||+++....... .....++..|+|||.+.+..++.++|+||||++++||++
T Consensus 269 NiLl~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~ 336 (401)
T cd05107 269 NVLICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336 (401)
T ss_pred eEEEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 999987665 99999999875432211 122345678999999998888999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=221.20 Aligned_cols=193 Identities=32% Similarity=0.527 Sum_probs=170.1
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||.|++|.+|++.+..+++.+++|.+..... ..+.+.+|++.++.++|+|++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58999999999999999999998999999999876432 335678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-
Q 027738 101 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 101 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~- 175 (219)
+++++|...+... ..++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999988764 56999999999999999999999999999999999999988776 9999999986543332
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||...+..++.++|+||+|+++++|++|..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 201 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH 201 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCC
Confidence 2233457888999999988888999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=219.72 Aligned_cols=193 Identities=31% Similarity=0.434 Sum_probs=171.4
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||+|++|.+|++.+..+++.+++|.+..... ..+.+.+|++.++.++|++++++++++......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58899999999999999999998899999999876543 335688999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC-CC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~-~~ 179 (219)
+++++|.+.+.....++...+..++.+++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+......... ..
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence 999999999988888999999999999999999999999999999999999988665 999999998755433332 23
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|+|||...+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~ 197 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP 197 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 457888999999988778899999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=230.80 Aligned_cols=199 Identities=28% Similarity=0.433 Sum_probs=170.0
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
+.....+.|.....||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++|+|++++++.+..++..+
T Consensus 16 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 16 SPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred ccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 344455677878899999999999999998899999998865332 2356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++||+++++|.+++.. ..++..++..++.|++.+|++||+.+++|+||+|+||++++++. ++|+|||++.......
T Consensus 96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhccccc
Confidence 99999999999887754 46899999999999999999999999999999999999988776 9999999886433222
Q ss_pred C-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 Q-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .....++..|+|||.+.+..++.++|+||||++++||++|..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~ 216 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 2 223457889999999988888999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=225.05 Aligned_cols=195 Identities=20% Similarity=0.304 Sum_probs=165.2
Q ss_pred CCccceeeccccCcCceEEEEEEECC-----CCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..++|++.+.||.|++|.||++.... +.+.+++|.+...... .+.+.+|+.++++++|+|++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 35789999999999999999999753 3467899987654332 3578899999999999999999999999899
Q ss_pred EEEEEeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 94 LAIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
.++++||+++++|.+++.... .++...+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++++|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcc
Confidence 999999999999999997665 6899999999999999999999999999999999999988776 89999
Q ss_pred cccccccccCC--CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 165 FGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 165 fg~a~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
||++....... ......++..|+|||.+.+..++.++|+||||++++++++++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99875332111 112234566799999998888889999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=222.15 Aligned_cols=193 Identities=34% Similarity=0.521 Sum_probs=166.3
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEc--CCeEEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM 98 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 98 (219)
+|++.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++|+|++++++.+.. +...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999998865432 23457789999999999999999998764 45689999
Q ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 99 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh-----~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
||+++++|.+.+.. ...++..+++.++.+++.+|.+|| +.+++|+||+|+||++++++. ++++|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence 99999999988865 356899999999999999999999 899999999999999998776 9999999987
Q ss_pred ccccCCC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....... .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 5543332 233467889999999998888999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=227.95 Aligned_cols=197 Identities=21% Similarity=0.288 Sum_probs=164.1
Q ss_pred cccCCccceeeccccCcCceEEEEEEEC-------CCCcEEEEEEeccCc--ccCHHHHHHHHHHHhC-CCCcEeEEEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEV 87 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 87 (219)
+....++|++.+.||+|++|.||.+... ..+..+++|...... ...+++.+|+..++.+ +|||++++++.
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3466889999999999999999999742 234578999876432 2235688999999999 79999999999
Q ss_pred EEcCCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 027738 88 ILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (219)
Q Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nil 151 (219)
+......++++||+++++|.+++.... .++..++..++.|++.+|.+||++|++|+||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 999999999999999999999987532 3677889999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 152 LDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 152 i~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
+++++. ++|+|||+++........ ....++..|+|||.+.+..++.++|+||||+++++++++
T Consensus 170 i~~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 170 VTENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred EcCCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 987776 999999998754332211 122345679999999888899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=230.66 Aligned_cols=194 Identities=31% Similarity=0.485 Sum_probs=165.3
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC-----Ce
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 93 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 93 (219)
..+|++.+.||+|++|+||++.+..+++.|++|.+.... .....+.+|+.+++.++|+|++++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 468999999999999999999999999999999886532 2234567899999999999999999988754 34
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++++||++ ++|...+.....++...+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCC
Confidence 799999996 588888888788999999999999999999999999999999999999988776 99999999875533
Q ss_pred C-CCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 H-SQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .......++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 207 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence 2 12223456788999999875 568899999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=222.29 Aligned_cols=195 Identities=21% Similarity=0.292 Sum_probs=163.9
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCc----EEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
...++|++.+.||+|++|.||++.+..+++ .+++|....... ....+.+|+..++.++|+|++++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 356789999999999999999999875554 588887765432 23567889999999999999999999887 78
Q ss_pred EEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
.++++|++++++|.+.+... ..+++..+..++.|++.+|++||+.+++|+||+|+||++++++. ++|+|||+++...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~ 160 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLD 160 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCccccccc
Confidence 89999999999999988764 45899999999999999999999999999999999999987776 9999999987554
Q ss_pred cCCCCCC---CCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 173 LHSQPKS---TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 173 ~~~~~~~---~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
....... ...+..|+|||.+.+..++.++|+||||++++|+++ |.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~ 209 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGA 209 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCC
Confidence 3222111 123467999999988888999999999999999998 64
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=226.91 Aligned_cols=196 Identities=31% Similarity=0.487 Sum_probs=164.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcC--CeE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--THL 94 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 94 (219)
...++|++.+.||.|++|.||++.+..+++.|++|.+...... ...+.+|+.+++.++|+|++++++++... +..
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3678999999999999999999999999999999988644322 23456799999999999999999998765 468
Q ss_pred EEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
++++||+++ +|.+.+.. ...++..++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~ 160 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGL 160 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCC
Confidence 999999975 77777765 356899999999999999999999999999999999999988776 99999999875443
Q ss_pred CC-CCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HS-QPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .......+..|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 207 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence 22 1222345678999999875 557889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=221.88 Aligned_cols=189 Identities=25% Similarity=0.479 Sum_probs=160.0
Q ss_pred Cccceeeccc--cCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDI--GSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l--~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.++|++.+.+ |.|++|.||++.+..++..+++|.+........ |......+ +|+|++++++.+..++..++++
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~ 88 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM 88 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence 4577777776 999999999999999999999998865432211 22222222 6999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
||+++++|.+.+.....+++.++..++.|++++|.+||+.+++|+||+|+||+++.++. .++++|||++.... ...
T Consensus 89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~---~~~ 164 (267)
T PHA03390 89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIG---TPS 164 (267)
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecC---CCc
Confidence 99999999999988778999999999999999999999999999999999999988772 39999999876432 223
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 204 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKH 204 (267)
T ss_pred cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 3457889999999998889999999999999999999874
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=228.78 Aligned_cols=196 Identities=27% Similarity=0.446 Sum_probs=168.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.....|.....||.|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++|||++++++.+..++..++++
T Consensus 18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 344566777899999999999999998899999999865332 3456788999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
||+++++|...+.. ..++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccc
Confidence 99999999886644 46899999999999999999999999999999999999988876 99999998864332221 2
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+..++.++|+||||++++||++|..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 215 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 23457889999999998888999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=223.97 Aligned_cols=192 Identities=31% Similarity=0.491 Sum_probs=163.4
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
...+|+..+.||+|++|.||++.+..+++.|++|.+...... .+.+.+|+.+++.++|||++++.+++......++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 346799999999999999999999988999999988643222 2457789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 97 VMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 97 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
++||+.+ ++.+.+. ....++..++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++....
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~--- 166 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVS--- 166 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecC---
Confidence 9999975 5655554 3456899999999999999999999999999999999999988876 9999999876432
Q ss_pred CCCCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......++..|+|||.+. ...++.++|+||||+++++|++|..
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~ 212 (307)
T cd06607 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212 (307)
T ss_pred CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCC
Confidence 223345778899999874 3567889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=227.55 Aligned_cols=188 Identities=28% Similarity=0.412 Sum_probs=152.0
Q ss_pred ccccCcCceEEEEEEECC--CCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEc--CCeEEEEEeccCCC
Q 027738 29 RDIGSGNFGVARLMRDKV--TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG 104 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~--~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 104 (219)
.+||+|++|.||++.... ++..+++|.+.... ....+.+|+.+++.++|||++++++++.. +...++++||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 579999999999999653 56789999886543 34567889999999999999999999854 4578999999875
Q ss_pred cHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC--CCcEEEeeccccccccc
Q 027738 105 ELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL 173 (219)
Q Consensus 105 ~L~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~--~~~v~l~dfg~a~~~~~ 173 (219)
+|.+.+... ..++...+..++.|++.||.+||+.+++|+||||+||++..++ ..+++|+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 676666421 2478899999999999999999999999999999999994322 23499999999875433
Q ss_pred CCC----CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQ----PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .....+++.|+|||.+.+ ..++.++|+||||++++||+||..
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~ 214 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCC
Confidence 221 123356888999999976 457899999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=223.43 Aligned_cols=192 Identities=30% Similarity=0.466 Sum_probs=165.6
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCC---CCcEeEEEEEEEcCCeEEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.|++.+.||+|++|.+|++.+..+++.+++|.+.... ...+.+.+|+.+++.++ ||+++++++.+..+...++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5888999999999999999999899999999886542 22356788999988886 999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
||+++++|.+.+.. ..++...+..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCcccc
Confidence 99999999988765 47899999999999999999999999999999999999998766 99999999875543332 2
Q ss_pred CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 200 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCC
Confidence 23357788999999875 456889999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=220.60 Aligned_cols=185 Identities=30% Similarity=0.442 Sum_probs=157.3
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHH-HHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||.|++|.||++.+..+++.|++|.+....... ..+..|... ....+|+|++++++.+..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999999899999999886543211 223334333 3455899999999999999999999999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~ 183 (219)
++|...+.....++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++..... .....++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence 999999988888999999999999999999999999999999999999988766 99999998764322 3334577
Q ss_pred CCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 184 PAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~ 191 (260)
T cd05611 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191 (260)
T ss_pred cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCC
Confidence 88999999988878999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=220.90 Aligned_cols=186 Identities=30% Similarity=0.450 Sum_probs=155.6
Q ss_pred cccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHH---HHhCCCCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIIN---HRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 30 ~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~---l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
.||+|++|.||++.+..+++.|++|.+...... .....+|... ++...||+++.+.+.+..++..++++||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999989999999988654221 1123333333 344578999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCC
Q 027738 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (219)
Q Consensus 103 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~ 182 (219)
+++|...+.....+++.++..++.|++.+|++||+.+++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence 9999998888788999999999999999999999999999999999999988776 999999998644322 2233467
Q ss_pred CCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..|+|||.+.+ ..++.++|+||+|+++++|++|..
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~ 194 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 194 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCC
Confidence 889999999975 468899999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=218.78 Aligned_cols=185 Identities=26% Similarity=0.342 Sum_probs=152.8
Q ss_pred cccCcCceEEEEEEEC--CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCc
Q 027738 30 DIGSGNFGVARLMRDK--VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105 (219)
Q Consensus 30 ~l~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (219)
.||+|++|.||++... ..+..+++|.+..... ..+.+.+|+.+++.++|+|++++++++. ....++++||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999765 3455689998865432 2356789999999999999999999875 457899999999999
Q ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC----CCC
Q 027738 106 LFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 180 (219)
Q Consensus 106 L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~----~~~ 180 (219)
|.+.+.. ...+++.++..++.+++.+|.+||+++++|+||+|+||+++.++. ++|+|||++......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998874 446899999999999999999999999999999999999987776 999999998644322211 111
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.++..|+|||.+.+..++.++|+||||++++++++ |.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 196 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQ 196 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCC
Confidence 23468999999988888999999999999999986 54
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=222.30 Aligned_cols=193 Identities=27% Similarity=0.463 Sum_probs=166.5
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+-|+..+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+..++.++|||++++++.+..+...++++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 357888999999999999999988899999998764432 225678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-CCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~~~ 179 (219)
+++++|...+.. ..++...+..++.+++.++.+||+.+++|+||+|+||+++.++. ++++|||++........ ...
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence 999999888764 45899999999999999999999999999999999999987776 99999998764432221 223
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 356778999999988888999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=230.58 Aligned_cols=193 Identities=31% Similarity=0.476 Sum_probs=161.5
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----eE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HL 94 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 94 (219)
.++|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++|+|++++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999999999999999886432 22355778999999999999999999876543 47
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++|++++ ++...+. ...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence 999999975 7766664 456899999999999999999999999999999999999988776 999999998654322
Q ss_pred CCC----CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQP----KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~----~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... ....++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~ 208 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 211 12356788999998764 567899999999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=228.35 Aligned_cols=194 Identities=22% Similarity=0.287 Sum_probs=160.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCC-------CcEEEEEEeccCc--ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEc
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVT-------KELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-------~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (219)
...+|++.+.||+|++|.||.+.+... +..+++|.+.... ...+.+.+|+.+++++ +|+||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 446899999999999999999986422 2368999776432 2235678899999999 79999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC
Q 027738 91 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~ 154 (219)
.+..++++||+++++|.+++.... .++..++..++.|++.+|.+||+++++|+||+|+||++++
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 999999999999999999886532 3677888999999999999999999999999999999987
Q ss_pred CCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 155 SPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 155 ~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
++. ++|+|||+++........ ....++..|+|||.+.+..++.++|+||||++++||+++
T Consensus 170 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 170 DNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred CCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhc
Confidence 776 999999998754332211 112234579999999988899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=223.46 Aligned_cols=193 Identities=26% Similarity=0.457 Sum_probs=165.0
Q ss_pred cceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (219)
+|++.+.||.|++|.||.+.+. .+++.|++|.+.... ...+.+.+|+.+++.+ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 468899999886432 2235677899999999 589999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++||+++++|.+.+.....++...+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence 999999999999999988888999999999999999999999999999999999999988776 999999998654332
Q ss_pred CCC--CCCCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQP--KSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~--~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... ....++..|+|||.+.+ ..++.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 206 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCC
Confidence 211 23457888999999875 346788999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=224.56 Aligned_cols=192 Identities=21% Similarity=0.294 Sum_probs=159.8
Q ss_pred cceeeccccCcCceEEEEEEECC-----CCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
+|++.+.||+|++|.||++.+.. ....+++|.+...... .+.+.+|+..++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 2246888877643322 2467889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe
Q 027738 97 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili 152 (219)
++||+++++|.+++... ..++..++..++.|++.+|.+||+.+++|+||+|+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999887642 237788999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 153 ~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
++++. ++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~ 227 (290)
T cd05045 161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227 (290)
T ss_pred cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCC
Confidence 88776 99999999864322211 122234668999999988889999999999999999998 53
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=222.35 Aligned_cols=192 Identities=29% Similarity=0.478 Sum_probs=163.9
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
+|++.+.||.|++|.+|++.+..+++.|++|.+..... ..+.+.+|+..++.++|+|++++++.+...+..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58999999999999999999999999999998875432 2356778999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 102 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 102 ~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
++ +|.+++... ..+++.++..++.|++.+|.+||+.+++|+||+|+||++++++. ++++|||++........ .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 86 787777643 35899999999999999999999999999999999999988776 99999999864332211 2
Q ss_pred CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|++||.+.+ ..++.++|+||||++++++++|..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP 199 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 23346778999999865 456889999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=221.92 Aligned_cols=190 Identities=29% Similarity=0.413 Sum_probs=158.8
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCC-CCcEeEEEEEEEcC--CeEEEEEe
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME 99 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~e 99 (219)
|++.+.||.|++|.||++.+..+++.+++|.+...... .....+|+..+.++. |+|++++++++.++ +..++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 78899999999999999999989999999988654222 223456788888775 99999999999987 88999999
Q ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
|+++ ++.+.+.. ...+++.++..++.|++.+|.+||+.+++|+||+|+||++++ +. ++|+|||++..........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC--eEEEecccccccccCCCcC
Confidence 9975 77777765 346899999999999999999999999999999999999988 44 9999999987554333333
Q ss_pred CCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.. ..++.++|+||||++++||++|..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence 4457889999998754 556889999999999999999853
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=226.67 Aligned_cols=192 Identities=27% Similarity=0.378 Sum_probs=161.1
Q ss_pred cceeeccccCcCceEEEEEEECC--CCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--CeEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKV--TKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 95 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 95 (219)
+|++.++||+|++|.||++.+.. +++.|++|.+.... ...+.+.+|+.+++.++|||++++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999987 78999999987632 2346678899999999999999999999988 7899
Q ss_pred EEEeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC----CCCCcEEEeecc
Q 027738 96 IVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG----SPAPRLKICDFG 166 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~----~~~~~v~l~dfg 166 (219)
+|+|++++ ++...+... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++. ++. ++|+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCc
Confidence 99999976 566555422 25899999999999999999999999999999999999987 444 9999999
Q ss_pred cccccccCCC----CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++........ .....++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 214 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEP 214 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCC
Confidence 9875433222 122346778999999876 457889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=219.14 Aligned_cols=197 Identities=28% Similarity=0.418 Sum_probs=163.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
+.+.......||+|++|.||++.+..++..+++|.+..... ..+.+.+|+.+++.++|+|++++++++..++..++++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 34445556789999999999999988899999998865432 23568899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 100 YASGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 100 ~~~~~~L~~~~~~~-~~~--~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
++++++|.+++... ..+ +...+..++.|++.+|++||+.+++|+||+|+||+++.+.. .++|+|||.+........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGINP 164 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC-eEEEecchhheecccCCC
Confidence 99999999988754 445 78889999999999999999999999999999999975332 499999998864432222
Q ss_pred -CCCCCCCCCCCCchhhccc--cccceeeEEEEEEEEeecCCCCC
Q 027738 177 -PKSTVGTPAYIAPEVLLRH--EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+. .++.++|+||||++++++++|..
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~ 209 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCC
Confidence 2233578899999998653 37889999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=221.86 Aligned_cols=196 Identities=20% Similarity=0.195 Sum_probs=164.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECC----CCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEc-CC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT-PT 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~----~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 92 (219)
.+.++|++.+.||+|++|.||++.+.. ++..+++|.+..... ..+.+.+|+..++.++|+|++++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 467899999999999999999999875 257789998764322 23557789999999999999999998776 46
Q ss_pred eEEEEEeccCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 93 HLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
..+++++++++++|..++... ..++..++..++.+++.+|++||+.+++|+||+|+||++++++. ++++|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECC
Confidence 789999999999999988653 34889999999999999999999999999999999999987766 99999
Q ss_pred cccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 165 FGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 165 fg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
||+++........ ....++..|+|||.+.+..++.++|+||||++++|+++ |+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 9998754332211 12234567999999998889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=222.47 Aligned_cols=193 Identities=31% Similarity=0.411 Sum_probs=160.5
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCe-----
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTH----- 93 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~----- 93 (219)
++|++.+.||.|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.+. |+|++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999998765432 2356788999999995 6999999999987665
Q ss_pred EEEEEeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC-CCCCcEEEeeccc
Q 027738 94 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGY 167 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~-~~~~~v~l~dfg~ 167 (219)
.++++||+++ ++...+... ..+++.++..++.|++.+|.+||+.+++|+||+|+||+++. ++. ++|+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence 8999999986 787776542 34799999999999999999999999999999999999987 444 99999999
Q ss_pred ccccccC-CCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 168 SKSSVLH-SQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 168 a~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+...... .......+++.|.|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 210 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCC
Confidence 8644322 12223346778999998865 557889999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=235.28 Aligned_cols=189 Identities=30% Similarity=0.465 Sum_probs=165.5
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCc-ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcHH
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 107 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (219)
-.||+|.+|+||-+++..++..+|+|.+...+ ...+-+.+|+.+.+.++|+||++++|.+.+++.+-+.||-.+||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 46899999999999999999999999885433 33456889999999999999999999999999999999999999999
Q ss_pred HHHH-hcCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc-cccCCCCCCCCCC
Q 027738 108 ERIC-NAGRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT 183 (219)
Q Consensus 108 ~~~~-~~~~~--~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~-~~~~~~~~~~~~~ 183 (219)
+.+. +.+++ .+.++..+..||+++|.|||++.|||+|||-+|++|+--. +-+||.|||-+++ ......+.++.|+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTyS-GvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYS-GVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeecc-ceEEecccccchhhccCCccccccccc
Confidence 8885 45676 7888999999999999999999999999999999997443 2489999998764 4445667778899
Q ss_pred CCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 184 PAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 184 ~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..|+|||++.. ..|+..+|+|||||++.||.||++
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrP 776 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRP 776 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCC
Confidence 99999999985 467889999999999999999986
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=218.39 Aligned_cols=186 Identities=26% Similarity=0.294 Sum_probs=158.6
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
+.||.|++|.||++.+.. ++.|++|.+..... ....+.+|+++++.++|++++++++++......++++|++.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 478999999999999886 89999998875433 235678999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC---CCCCC
Q 027738 107 FERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 182 (219)
Q Consensus 107 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~ 182 (219)
.+++... ..++...+..++.+++.+|.+||+++++|+||+|+||+++.++. ++|+|||.+......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 9988653 45889999999999999999999999999999999999987776 999999998644321111 11223
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
+..|+|||.+.+..++.++|+||||+++++|+|++
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~ 192 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLG 192 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhcc
Confidence 45799999998888999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=251.66 Aligned_cols=195 Identities=31% Similarity=0.434 Sum_probs=172.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC---HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.-+|+...+||.|.||.||.+.+..+|.-.|+|-+..++... +.+.+|..++..+.|||+++++|+=.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 447888899999999999999999999999999886554333 55789999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC-
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~- 177 (219)
|||.+|+|.+.+...+..++.....+..|++.++++||+.||||+||||.||+++.++. +|++|||.|+........
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcC
Confidence 99999999999998888888888999999999999999999999999999999999987 999999999866544222
Q ss_pred ----CCCCCCCCCCCchhhcc---ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 ----KSTVGTPAYIAPEVLLR---HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ----~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+...||+-|||||++.+ +.-..++|||||||+.+||.||+-
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence 23469999999999975 345678999999999999999974
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=220.10 Aligned_cols=192 Identities=32% Similarity=0.481 Sum_probs=168.4
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.|+.|++|.+|++.+..+++.+++|.+.... ....++.+|+..++.++|+|++++.+++......++++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999899999999886533 2234567899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 101 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 101 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
+++++|..++.. ...++...+..++.+++.+|++||+.|++|+||+|+||++++++. ++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence 999999888865 345899999999999999999999999999999999999998766 999999998755433 3
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|.|||...+..+++++|+||||++++++++|..
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~ 199 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP 199 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 334557889999999998888999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=221.73 Aligned_cols=186 Identities=32% Similarity=0.497 Sum_probs=163.2
Q ss_pred ccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 31 l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
||.|++|.||++++..+++.+++|.+..... ..+.+.+|+..++.++|+|++++++.+..+...++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6889999999999998899999998865432 235678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC---------CC
Q 027738 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QP 177 (219)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~---------~~ 177 (219)
.+.+.+.+.+++.++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999988778999999999999999999999999999999999999998876 9999999886443321 11
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||...+...+.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 199 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 22356778999999988888999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=222.60 Aligned_cols=191 Identities=21% Similarity=0.288 Sum_probs=156.5
Q ss_pred ceeeccccCcCceEEEEEEECCCCc--EEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC------Ce
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKE--LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 93 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~--~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 93 (219)
+.+.+.||+|++|.||++.+..++. .+++|.+.... ...+.+.+|...++.++|+|++++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999876665 58999876542 2235677899999999999999999987532 24
Q ss_pred EEEEEeccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 94 LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
.++++||+.+++|..++... ..++...+..++.|++.+|++||+.+++|+||||+||++++++. ++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 68999999999998877432 23789999999999999999999999999999999999987776 99999999
Q ss_pred ccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 168 SKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 168 a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
++....... ......++.|+|||...+..++.++|+||||+++|||++++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence 875432221 12234567899999999888999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=228.66 Aligned_cols=198 Identities=24% Similarity=0.316 Sum_probs=163.3
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcC
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTP 91 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 91 (219)
.-+......|+++++||+|+.+.||++... +.+.|++|++.... .....+.+|+..|.+++ |..|++++++-..+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 445566789999999999999999999886 44556777665432 22356789999999995 89999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 92 THLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
+.+|+|||+- ..+|..++.+... .+...++.+..|++.++.++|+.||||.||||.|+++..+ ++||+|||+|..
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG---~LKLIDFGIA~a 508 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG---RLKLIDFGIANA 508 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee---eEEeeeechhcc
Confidence 9999999974 5589888876554 5557999999999999999999999999999999999644 389999999986
Q ss_pred cccCCCC---CCCCCCCCCCCchhhccc-----------cccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQP---KSTVGTPAYIAPEVLLRH-----------EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~---~~~~~~~~~~aPE~~~~~-----------~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+... .+.+||..|++||.+... ..++++|||||||++|+|+=|+.
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgkt 570 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKT 570 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCC
Confidence 6655443 456899999999998632 15688999999999999998864
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=230.29 Aligned_cols=194 Identities=22% Similarity=0.331 Sum_probs=158.8
Q ss_pred cCCccceeeccccCcCceEEEEEEE-----CCCCcEEEEEEeccCccc--CHHHHHHHHHHHhC-CCCcEeEEEEEEEcC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTP 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (219)
...++|++.+.||.|+||.||++.+ ..+++.||+|.+...... ...+.+|+..+..+ +|+|++++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 4567999999999999999999984 345788999998653322 24577899999999 689999999988654
Q ss_pred -CeEEEEEeccCCCcHHHHHHhcC--------------------------------------------------------
Q 027738 92 -THLAIVMEYASGGELFERICNAG-------------------------------------------------------- 114 (219)
Q Consensus 92 -~~~~lv~e~~~~~~L~~~~~~~~-------------------------------------------------------- 114 (219)
...++++||+++++|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 46789999999999998886421
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC---CCC
Q 027738 115 -----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KST 180 (219)
Q Consensus 115 -----------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~---~~~ 180 (219)
.++...+..++.|++.+|++||+++++|+||||+||++++++. ++|+|||++......... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCC
Confidence 2567788899999999999999999999999999999987776 999999998654222111 112
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
.++..|+|||.+.+..++.++|+||||++++++++
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 276 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 34567999999998889999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=225.04 Aligned_cols=194 Identities=30% Similarity=0.458 Sum_probs=170.2
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 97 (219)
++|++.+.||+|++|.||++.+..+++.+++|++.... ...+.+.+|..++++++ |+|++++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999886532 22356778899999998 99999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~- 176 (219)
+|++.+++|.+.+...+.++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999998888999999999999999999999999999999999999988776 99999999864433221
Q ss_pred --------------------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 --------------------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 --------------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||...+..++.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~ 220 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCC
Confidence 112246788999999988888999999999999999999864
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=219.73 Aligned_cols=191 Identities=30% Similarity=0.432 Sum_probs=161.4
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhC---CCCcEeEEEEEEEcCCe-----
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSL---RHPNIVRFKEVILTPTH----- 93 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~----- 93 (219)
|++.+.||+|++|.||++.+..+++.+++|.+...... ...+.+|+.+++.+ .|+|++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78899999999999999999988999999998754322 23456677766655 59999999999998776
Q ss_pred EEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.++++|++++ +|.+++.... .+++..+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence 8999999975 7888776543 4899999999999999999999999999999999999998866 999999998765
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~ 204 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRP 204 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCC
Confidence 43333334456788999999998889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=221.62 Aligned_cols=193 Identities=31% Similarity=0.477 Sum_probs=166.9
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
..|...+.||.|++|.+|++.+..+++.+++|.+...... .+.+.+|+..++.+.|+|++++++++..++..++++|++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 3566678999999999999999888999999988644322 355788999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCCC
Q 027738 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 180 (219)
Q Consensus 102 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~~ 180 (219)
++++|.+.+.. ..++..++..++.+++.+|++||+.+++|+||+|+||+++.++. ++|+|||.+....... .....
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccc
Confidence 99999998877 56899999999999999999999999999999999999988776 9999999876433221 12234
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~ 213 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 57889999999988888999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=222.61 Aligned_cols=191 Identities=31% Similarity=0.487 Sum_probs=164.4
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--CeEEEEEe
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME 99 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 99 (219)
|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+|+..++.++|+|++++++++... +..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999999889999999997653 2235678899999999999999999999988 78999999
Q ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--
Q 027738 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 176 (219)
Q Consensus 100 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-- 176 (219)
|+++ +|...+... ..++..+++.++.+++++|++||+.+++|+||+|+||++++++. ++|+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9975 788877665 57899999999999999999999999999999999999998876 99999999875543321
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~ 200 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP 200 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCC
Confidence 223345778999998764 457889999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=224.04 Aligned_cols=192 Identities=31% Similarity=0.487 Sum_probs=163.2
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|+..+.||.|++|.||++.+..+++.+++|.+..... ....+.+|++.++.++|||++++++++..++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48899999999999999999998999999998864322 235688999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC-
Q 027738 101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~- 177 (219)
+. ++|...+... ..++..++..++.+++.+|++||+.+++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 96 4788777543 45899999999999999999999999999999999999998876 999999998644322221
Q ss_pred CCCCCCCCCCCchhhcccc-ccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHE-YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|.|||.+.+.. ++.++|+||||+++|+|+||..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~ 199 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 2234577899999887644 5888999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=225.76 Aligned_cols=198 Identities=26% Similarity=0.397 Sum_probs=162.4
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC---
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--- 91 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 91 (219)
-+...++|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+++++.++|+|++++++.+...
T Consensus 3 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (311)
T cd07866 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDK 82 (311)
T ss_pred CCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence 34557899999999999999999999999999999998864322 234567899999999999999999987543
Q ss_pred -----CeEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeec
Q 027738 92 -----THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 92 -----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
..++++++|+.+ ++...+.. ...++..++..++.|++++|.+||+.+++|+||+|+||++++++. ++|+||
T Consensus 83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~df 159 (311)
T cd07866 83 SKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADF 159 (311)
T ss_pred ccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcC
Confidence 346999999875 56665554 446999999999999999999999999999999999999998877 999999
Q ss_pred ccccccccCCCCC------------CCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLHSQPK------------STVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~~~~~------------~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|++.......... ...+++.|+|||.+.+ ..++.++|+||||++++||++|..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 9986443222111 1234677999998865 457889999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=220.75 Aligned_cols=187 Identities=21% Similarity=0.282 Sum_probs=150.8
Q ss_pred ccccCcCceEEEEEEECC--CCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 29 RDIGSGNFGVARLMRDKV--TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~--~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
+.||+|+||.||++.... ....+++|.+...... ...+.+|+..++.++|+||+++++.+......++++||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 468999999999996542 3456888876543221 245678999999999999999999999999999999999999
Q ss_pred cHHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC---
Q 027738 105 ELFERICNAGR-----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 176 (219)
Q Consensus 105 ~L~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~--- 176 (219)
+|.+++..... .+...+..++.|++.+|++||+++++|+||||+||++++++. ++++|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence 99999876432 467788899999999999999999999999999999988776 99999998864322211
Q ss_pred CCCCCCCCCCCCchhhcc-------ccccceeeEEEEEEEEeecCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-------HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.....++..|+|||.+.. ..++.++|+||||++++||++++
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA 206 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCC
Confidence 122345667999999752 35678999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=228.29 Aligned_cols=194 Identities=28% Similarity=0.465 Sum_probs=165.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEc----CCeE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 94 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 94 (219)
.++|++.+.||.|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++|||++++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 378999999999999999999999999999999986542 223567789999999999999999998763 3468
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++||+. ++|...+.....++..++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeeccc
Confidence 99999996 489888877777999999999999999999999999999999999999998876 999999998644322
Q ss_pred CCC-----CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQP-----KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~-----~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... ....++..|.|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~ 210 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCC
Confidence 211 22357788999999865 557899999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=223.08 Aligned_cols=193 Identities=25% Similarity=0.378 Sum_probs=162.7
Q ss_pred CCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
+.++|++.+.||.|++|.||++.+. .++..+++|.+..... ..+.+.+|+..++.++|||++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4578999999999999999999874 3577899998865432 23567889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 027738 94 LAIVMEYASGGELFERICNA----------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nil 151 (219)
.++++||+++++|.+++... ..++..++..++.+++.+|.+||+++++|+||+|+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 99999999999999988643 23678889999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 152 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 152 i~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
+++++. ++|+|||++........ ......+..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 163 ~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 163 VGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred ecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence 988776 99999998764332211 112234567999999988889999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=222.11 Aligned_cols=194 Identities=23% Similarity=0.285 Sum_probs=162.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.++|+..+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..+.++. |+|++++++++..+...++++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4578888999999999999999999999999998865432 2356778898888886 999999999999999999999
Q ss_pred eccCCCcHHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 99 EYASGGELFERI---C--NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 99 e~~~~~~L~~~~---~--~~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
|++.. ++.+.. . ....+++..+..++.+++.+|++||+. +++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhc
Confidence 99864 444332 1 235689999999999999999999975 9999999999999987776 9999999986544
Q ss_pred cCCCCCCCCCCCCCCCchhhccc---cccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRH---EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.........++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 208 (288)
T cd06616 160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208 (288)
T ss_pred cCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCC
Confidence 33333444678889999999765 68899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=222.05 Aligned_cols=191 Identities=34% Similarity=0.513 Sum_probs=163.5
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
|++.+.||.|++|.||++.+..+++.|++|++..... ..+.+.+|+..++.++|++++++++++..++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 6788999999999999999998999999998865432 2356788999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-CC
Q 027738 102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 178 (219)
Q Consensus 102 ~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~~ 178 (219)
+ ++|.+++.... .+++.++..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||++........ ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence 5 58988887765 6899999999999999999999999999999999999998766 99999999864432221 12
Q ss_pred CCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 198 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 23457789999988654 56889999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=222.31 Aligned_cols=200 Identities=28% Similarity=0.397 Sum_probs=166.2
Q ss_pred ccCCccceeeccccCcCceEEEEEEECC-CC---cEEEEEEeccC---cccCHHHHHHHHHHHhCCCCcEeEEEEEEEc-
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-TK---ELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT- 90 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~-~~---~~v~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 90 (219)
......|+..+.||+|.+|.||++.... ++ +.+|+|.++.. .....+.-+|+.+++.++|||++.+..+|..
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 3456789999999999999999995543 32 25899988654 2345778899999999999999999999988
Q ss_pred CCeEEEEEeccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC--CcEEEe
Q 027738 91 PTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKIC 163 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~--~~v~l~ 163 (219)
...+++++||.+. +|++.+.-+ ..++...+..++.|++.++.|||++=++|+||||.||++..++. ++|||+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 7789999999865 899888643 35899999999999999999999999999999999999976632 359999
Q ss_pred ecccccccccCCCC----CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 164 DFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 164 dfg~a~~~~~~~~~----~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
|+|+++........ ...+.|.-|+|||.+.+ ..|+++.|+|+.||++.||+|-.+|
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~Pl 239 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPL 239 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcc
Confidence 99999865443332 22345677999999997 6789999999999999999997764
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=217.59 Aligned_cols=189 Identities=26% Similarity=0.330 Sum_probs=160.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
..++|++.+.||+|++|.||.+.. +++.+++|.+.... ..+.+.+|+..++.++|||++++++++..+ ..++++||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 457899999999999999998864 57889999886532 346788999999999999999999998765 47899999
Q ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 101 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
+++++|.+++.... .++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VD 155 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CC
Confidence 99999999987643 4789999999999999999999999999999999999988776 999999998643221 12
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
....+..|.|||.+.+..++.++|+||||+++++|++ |.
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 195 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195 (254)
T ss_pred CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCC
Confidence 2234567999999988889999999999999999997 54
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=218.25 Aligned_cols=186 Identities=26% Similarity=0.351 Sum_probs=158.3
Q ss_pred ccccCcCceEEEEEEECC-CCc--EEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDKV-TKE--LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~-~~~--~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|++|.||++.+.. +++ .+++|.+..... ..+.+.+|+..+++++|+|++++++.+.. ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998864 333 589998876544 24578899999999999999999999988 889999999999
Q ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC----C
Q 027738 104 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P 177 (219)
Q Consensus 104 ~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~----~ 177 (219)
++|.+.+.... .++...+..++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999987654 5899999999999999999999999999999999999998866 99999999875433211 1
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~ 198 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGE 198 (257)
T ss_pred cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCC
Confidence 12345678999999998889999999999999999998 54
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=219.72 Aligned_cols=194 Identities=23% Similarity=0.252 Sum_probs=161.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCC---CcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
..++|++.+.||.|++|.||++.+... ...+++|...... ...+.+.+|+..++.++|||++++++++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 456799999999999999999987543 3468999876543 233568899999999999999999999876 4567
Q ss_pred EEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+++|++++++|.+++.... .++..++..++.+++.+|.+||+.+++|+||+|+||+++.++. ++++|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 160 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccc
Confidence 9999999999999997644 5899999999999999999999999999999999999988776 999999998654332
Q ss_pred CCC--CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 SQP--KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
... .....+..|+|||.+....++.++|+||||++++|+++ |.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 206 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGV 206 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCC
Confidence 211 11223467999999988888999999999999999886 54
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=215.92 Aligned_cols=184 Identities=26% Similarity=0.303 Sum_probs=155.6
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
+.||+|++|.||++... +++.+++|.+..... ....+.+|+..++.++|||++++++++......++++||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 678899998765432 234678899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC--CCCCC
Q 027738 107 FERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGT 183 (219)
Q Consensus 107 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~--~~~~~ 183 (219)
.+.+... ..++..++..++.+++.+|.++|+.+++|+||+|+||++++++. ++++|||++.......... ....+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9888653 45789999999999999999999999999999999999987776 9999999886432221111 12335
Q ss_pred CCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 184 PAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 184 ~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
..|+|||.+.+..++.++|+||||++++++++
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 67999999988888999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=222.29 Aligned_cols=195 Identities=31% Similarity=0.482 Sum_probs=163.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 92 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 92 (219)
..++|++.+.||.|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.++|||++++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 35789999999999999999999998899999999865432 2356778999999999999999999987654
Q ss_pred -----eEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 93 -----HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 93 -----~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
.+++++||+++ ++...+... ..++..++..++.|++.+|++||+.+++|+||+|+||++++++. ++|+|||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCccc
Confidence 78999999987 666666543 46899999999999999999999999999999999999988776 9999999
Q ss_pred cccccccCCC--CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHSQ--PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++........ ......+..|+|||.+.+ ..++.++|+||||++++++++|..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~ 216 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 9875433221 122345678999998865 456889999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=227.64 Aligned_cols=192 Identities=32% Similarity=0.492 Sum_probs=167.4
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----eEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 95 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 95 (219)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++|+|++++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999999889999999887543 23467889999999999999999999998775 789
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
++++|+++ +|...+.....+++..+..++.+++.+|++||+.|++|+||+|.||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence 99999975 78888887778999999999999999999999999999999999999998866 9999999987654432
Q ss_pred C----CCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 176 Q----PKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~----~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .....++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~ 205 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCC
Confidence 1 2234567889999999877 78999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=227.09 Aligned_cols=199 Identities=28% Similarity=0.427 Sum_probs=167.1
Q ss_pred CCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
+...++...++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 6 VNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhhhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 344566678899999999999999999999999999999998864322 23467789999999999999999999876
Q ss_pred CC------eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 91 PT------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 91 ~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
.. .++++++++ +++|...+.. ..++...+..++.|++.+|.+||+.|++|+||+|+||++++++. ++++|
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~d 161 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILD 161 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEee
Confidence 53 358999998 6688777654 56899999999999999999999999999999999999987776 99999
Q ss_pred cccccccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||++..... ......+++.|+|||.+.+ ..++.++|+||||++++++++|..
T Consensus 162 fg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~ 214 (343)
T cd07880 162 FGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214 (343)
T ss_pred ccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999865432 2233456788999999876 457889999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=223.14 Aligned_cols=192 Identities=20% Similarity=0.278 Sum_probs=159.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCc----EEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
..++|+..+.||+|++|.||++.+..++. .+++|.+...... ...+.+|+..++.++|||++++++++... ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 45788999999999999999999876665 4688877643321 23577899999999999999999998764 46
Q ss_pred EEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++++++++++|.+.+.... .++...+..++.|++.+|.+||+++++|+||+|+||++++++. ++|+|||++.....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccC
Confidence 78999999999999887644 5889999999999999999999999999999999999987766 99999999875432
Q ss_pred CCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 174 HSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 174 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
.... ....++..|+|||.+.+..++.++|+||||+++||+++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 2221 12234568999999998889999999999999999987
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=220.55 Aligned_cols=191 Identities=33% Similarity=0.501 Sum_probs=163.8
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEecc
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
|++.+.||+|++|.||++....+++.+++|.+...... .....+|+..++.++ |+|++++++.+..++..++++||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 78899999999999999999888999999988654322 223456888899998 999999999999999999999999
Q ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCC
Q 027738 102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (219)
Q Consensus 102 ~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~ 179 (219)
++++.+.+.... .++..++..++.|++.+|.+||+++++|+||+|+||++++++. ++|+|||++...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 668888887654 6899999999999999999999999999999999999998776 99999999875544333344
Q ss_pred CCCCCCCCCchhhc-cccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLL-RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~-~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|+|||.+. +..++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~ 197 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCC
Confidence 56778899999885 4557899999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=222.40 Aligned_cols=191 Identities=32% Similarity=0.482 Sum_probs=165.0
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
|++.+.||+|++|.+|++.+..+++.+++|.+...... ...+.+|+..++.++|++++++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999989999999988654322 356788999999999999999999999999999999999
Q ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCC
Q 027738 102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (219)
Q Consensus 102 ~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~ 179 (219)
++ ++...+.. ...++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++++|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 76 77777765 457899999999999999999999999999999999999987776 9999999986554433 2223
Q ss_pred CCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|.|||.+.+. .++.++|+||||++++++++|..
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 197 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 4567789999999876 78899999999999999999964
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=217.03 Aligned_cols=187 Identities=22% Similarity=0.262 Sum_probs=152.0
Q ss_pred ccccCcCceEEEEEEEC--CCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 29 RDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
+.||+|++|.||++... .++..+++|.+...... ...+.+|+..++.++|||++++++.+.+....++++||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999764 34567899988654322 246778999999999999999999999999999999999999
Q ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC---
Q 027738 105 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 176 (219)
Q Consensus 105 ~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~--- 176 (219)
+|.+++.... ..+...+..++.|++.+|++||+.+++|+||||+||+++.++. ++|+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence 9999886432 3466778889999999999999999999999999999988766 99999999864322211
Q ss_pred CCCCCCCCCCCCchhhccc-------cccceeeEEEEEEEEeecCC-CC
Q 027738 177 PKSTVGTPAYIAPEVLLRH-------EYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~-------~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.....++..|+|||.+.+. .++.++|+||||++++||++ |.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~ 207 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGS 207 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCC
Confidence 1223456789999998642 35789999999999999986 65
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=218.08 Aligned_cols=194 Identities=31% Similarity=0.510 Sum_probs=167.4
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999999999999999986542 2345678999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC-
Q 027738 101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~- 177 (219)
+++++|.+.+.... .+++..+..++.+++.+|.+||+.+++|+||+|+||++++++. .++++|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999887643 4789999999999999999999999999999999999987654 3799999988654322211
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~ 200 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKH 200 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 22357888999999988888999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=218.85 Aligned_cols=193 Identities=30% Similarity=0.473 Sum_probs=162.3
Q ss_pred cceeeccccCcCceEEEEEEECC-CCcEEEEEEeccCcc-----------cCHHHHHHHHHHH-hCCCCcEeEEEEEEEc
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDK-----------IDENVQREIINHR-SLRHPNIVRFKEVILT 90 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~~K~~~~~~~-----------~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~ 90 (219)
.|++.+.||+|++|.||++.+.. +++.+++|.+..... ...++.+|+.++. .++|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 678899998753211 1133556777775 4789999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeec
Q 027738 91 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
++..++++||+++++|.+.+.. ...++...++.++.+++.+|.+||+ .+++|+||+|+||++++++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 9999999999999999887643 3458999999999999999999996 68999999999999988776 999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|.+.............++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~ 211 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCC
Confidence 99875443333344567889999999998888999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=224.95 Aligned_cols=195 Identities=24% Similarity=0.346 Sum_probs=164.0
Q ss_pred CCcccee-eccccCcCceEEEEEEECCCCcEEEEEEeccCcccC---------------HHHHHHHHHHHhCCCCcEeEE
Q 027738 21 DSDRYDF-VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRF 84 (219)
Q Consensus 21 ~~~~y~~-~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---------------~~~~~e~~~l~~l~~~~i~~~ 84 (219)
..++|.. .+.||.|++|.||++.+..+++.|++|.+....... ..+.+|+++++.++|+|++++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3567764 577999999999999999899999999886543221 246789999999999999999
Q ss_pred EEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
++++..+...++++|++++ +|.+.+.....++...+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~d 162 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIAD 162 (335)
T ss_pred eEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECC
Confidence 9999999999999999975 89888887778999999999999999999999999999999999999988776 99999
Q ss_pred cccccccccC---------------CCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLH---------------SQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||++...... .......++..|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9988644311 111122356789999998764 46889999999999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=224.75 Aligned_cols=194 Identities=25% Similarity=0.414 Sum_probs=162.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC----
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP---- 91 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 91 (219)
+...++|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+..+++++|+||+++++++...
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 4456899999999999999999999988999999998865322 234567899999999999999999988643
Q ss_pred --CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 92 --THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 92 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
...+++++++ +++|.+.+.. ..++...+..++.|++.||.+||+.+++|+||+|+||++++++. ++|+|||++.
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~ 168 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR 168 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccc
Confidence 3467888876 6688776654 35899999999999999999999999999999999999998876 9999999986
Q ss_pred ccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .......++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 216 (345)
T cd07877 169 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216 (345)
T ss_pred ccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCC
Confidence 532 22233467788999999876 567889999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=220.75 Aligned_cols=187 Identities=16% Similarity=0.142 Sum_probs=155.4
Q ss_pred ccccCcCceEEEEEEECCCCc-------EEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 29 RDIGSGNFGVARLMRDKVTKE-------LVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~-------~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+.||.|+||.||++.+...+. .+++|....... ..+.+.+|+.+++.++|||++++++++..+...++++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998865443 377787654332 235678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC------cEEEeeccccccccc
Q 027738 101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL 173 (219)
Q Consensus 101 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~------~v~l~dfg~a~~~~~ 173 (219)
+++++|..++...+ .++...+..++.|++.+|++||+++++|+||||+||+++.++.. .++++|||++....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~- 159 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL- 159 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC-
Confidence 99999999987654 58999999999999999999999999999999999999876542 26899999875432
Q ss_pred CCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 203 (258)
T cd05078 160 --PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGD 203 (258)
T ss_pred --CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 2223456778999999986 457889999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=243.86 Aligned_cols=200 Identities=24% Similarity=0.308 Sum_probs=171.5
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCc-----EEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL 89 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (219)
.+.....+.++.+.||+|+||.||.+....... .|++|.+.+.. ....+|.+|..+++.+.||||++++|++.
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 344667888999999999999999998764332 38999887653 33467899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEE
Q 027738 90 TPTHLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l 162 (219)
.....++++|||.+|+|..++.+.+ .++..++..++.++++++.||+++++||+||..+|.|++.... |||
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKI 843 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKI 843 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEE
Confidence 9999999999999999999998763 4899999999999999999999999999999999999988855 999
Q ss_pred eecccccccccCCCCCC---CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 163 CDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 163 ~dfg~a~~~~~~~~~~~---~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+|||+|+.......... ..-...|+|||.+.+..++.|+||||||++++|++|.+.
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~ 902 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGA 902 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCC
Confidence 99999984433333222 234568999999999999999999999999999998764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=220.09 Aligned_cols=196 Identities=16% Similarity=0.150 Sum_probs=150.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCC---CcEEEEEEeccCcccC--H----------HHHHHHHHHHhCCCCcEeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKID--E----------NVQREIINHRSLRHPNIVRF 84 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~~--~----------~~~~e~~~l~~l~~~~i~~~ 84 (219)
....+|++.+.||+|+||.||++.+..+ +..+++|......... + ....+...+..++|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3457999999999999999999998766 5667777543222110 1 11122233456689999999
Q ss_pred EEEEEcCC----eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcE
Q 027738 85 KEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (219)
Q Consensus 85 ~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v 160 (219)
++.+.... ..+++++++.. ++.+.+......+...+..++.|++.+|.+||+.+++|+||||+||++++++. +
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--G 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--E
Confidence 98776543 34677777644 66666666555788899999999999999999999999999999999987766 9
Q ss_pred EEeecccccccccCC--------CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 161 KICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 161 ~l~dfg~a~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+|+|||+++...... ......+++.|+|||...+..++.++|+||||++++||++|..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~ 231 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999987543221 1122358899999999999999999999999999999999863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=218.73 Aligned_cols=202 Identities=27% Similarity=0.458 Sum_probs=181.5
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEecc----CcccCHHHHHHHHHHHhC-CCCcEeEEEEEEE
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER----GDKIDENVQREIINHRSL-RHPNIVRFKEVIL 89 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~----~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (219)
........++|++++.||+|++.+|..++.+.+.+.||+|++++ .+...++++.|-.+..+. .||.++-+...|.
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 34455668899999999999999999999999999999999865 344457778888887766 5899999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
.+..+++|.||.+||+|.-.++.++.++++..+.+..+|+.+|.+||++||+++|||.+|++++.++. +||+|+|.++
T Consensus 322 tesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmck 399 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCK 399 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhh
Confidence 99999999999999999888999999999999999999999999999999999999999999999988 9999999987
Q ss_pred cc-ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SS-VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .++..+++.+|++.|.|||.+++..|.+++|+|+||++|+||..|+.
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrs 449 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 449 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCC
Confidence 43 44556677899999999999999999999999999999999998874
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=215.56 Aligned_cols=185 Identities=17% Similarity=0.122 Sum_probs=151.6
Q ss_pred ccccCcCceEEEEEEECC------------CCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 29 RDIGSGNFGVARLMRDKV------------TKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~------------~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
+.||+|++|.||++.... ....+++|.+...... ...+.+|+..++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 1235888877654322 346778889999999999999999999998999
Q ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC-----cEEEeeccccc
Q 027738 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSK 169 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~-----~v~l~dfg~a~ 169 (219)
+++||+++++|..++... ..++..++..++.|++.+|.+||+++++|+||+|+||+++.++.. .++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 999999999998887653 468999999999999999999999999999999999999765431 28999999875
Q ss_pred ccccCCCCCCCCCCCCCCCchhhc-cccccceeeEEEEEEEEeecCCC
Q 027738 170 SSVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
... ......++..|+|||.+. +..++.++|+||||+++|+|+++
T Consensus 161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 161 TVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred ccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 432 223345677899999987 46688899999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=219.15 Aligned_cols=190 Identities=30% Similarity=0.488 Sum_probs=162.1
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..|+..+.||+|++|.+|++.+..++..+++|.+...... ...+.+|+..++.++|+|++++++++......++++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4488899999999999999999988999999988654222 245778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+.+ ++.+.+.. ..+++..++..++.+++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++.... ..
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PA 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---Cc
Confidence 99976 66666643 456899999999999999999999999999999999999988776 9999999876432 22
Q ss_pred CCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+. +..++.++|+||||+++++|++|..
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~ 222 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 3345778899999974 3567889999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=214.67 Aligned_cols=186 Identities=36% Similarity=0.594 Sum_probs=164.1
Q ss_pred ccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 31 l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
||.|++|.+|.+.+..+++.+++|.+...... .+.+..|+..++.++|++++++++.+..+...++++|++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999988999999988654322 24678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCCCCCCCC
Q 027738 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 185 (219)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~~~~~~~ 185 (219)
.+.+.....++..++..++.|++.+|.++|+.+++|+||+|+||+++.++. ++|+|||.+...... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988878999999999999999999999999999999999999988776 999999998755433 12334457788
Q ss_pred CCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 186 YIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 186 ~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|.|||...+..++.++|+||||++++++++|..
T Consensus 159 ~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~ 191 (250)
T cd05123 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191 (250)
T ss_pred ccChHHhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999988888999999999999999999864
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=201.65 Aligned_cols=198 Identities=23% Similarity=0.302 Sum_probs=162.4
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC--cccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (219)
+....+...-...||+|++|.+-+.++..+|...|+|.+... ....+++..|+.+..+. ..|..+.++|.....+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344556666688999999999999999999999999998643 23335566677666544 589999999999999999
Q ss_pred EEEEeccCCCcHHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 95 AIVMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~----~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
++.||.++. +|..+ +.+.+..++.-+.+++..+..||++||++ .++|+|+||+|||++.++. ||+||||++-
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccce
Confidence 999999865 55433 34566799999999999999999999977 8999999999999998887 9999999976
Q ss_pred ccccCCCCCCCCCCCCCCCchhhc----cccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHSQPKSTVGTPAYIAPEVLL----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+-......|-..|+|||.+. ...|+-++||||||++++||.+++.
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~ 250 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF 250 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc
Confidence 544444444467788999999986 3478999999999999999999874
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=219.82 Aligned_cols=193 Identities=28% Similarity=0.439 Sum_probs=164.6
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
..|+....||.|++|.||++....+++.+++|.+..... ....+.+|+..++.++|+|++++++.+..++..++++||+
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 344555789999999999999998999999998754332 2356788999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCCC
Q 027738 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 180 (219)
Q Consensus 102 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~~ 180 (219)
++++|.+.+.. ..++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceeccccccccccc
Confidence 99999887644 46899999999999999999999999999999999999988776 9999999876443222 12234
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.++..|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~ 214 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 56788999999988888999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=218.86 Aligned_cols=191 Identities=33% Similarity=0.517 Sum_probs=165.7
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccC---cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
|++.+.||+|.+|.+|++.+..+++.+++|.+... ....+.+..|+..++.++|++++++.+++......++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999998764 223466788999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCC
Q 027738 102 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (219)
Q Consensus 102 ~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~ 179 (219)
++ +|.+.+... ..++..++..++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||++....... ....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 75 899988876 57999999999999999999999999999999999999998776 9999999986543322 2223
Q ss_pred CCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+..|+|||.+.+. .++.++|+||||++++|+++|..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 197 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCC
Confidence 3456789999998765 78899999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=214.46 Aligned_cols=177 Identities=19% Similarity=0.249 Sum_probs=152.0
Q ss_pred cCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhc
Q 027738 34 GNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 113 (219)
Q Consensus 34 g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 113 (219)
|.++.||++.+..+++.|++|.+.... ....|...+....|||++++++++..+...++++||+++++|.+.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999999999999999986543 2233444445567999999999999999999999999999999999887
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhc
Q 027738 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193 (219)
Q Consensus 114 ~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~ 193 (219)
..++..++..++.|++.+|.++|+++++|+||+|+||+++.++. ++++|||.+..... .......+..|+|||...
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~--~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVED--SCDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhcccc--ccccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999988776 99999997654332 222334566799999998
Q ss_pred cccccceeeEEEEEEEEeecCCCCC
Q 027738 194 RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 194 ~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..+++++|+||+|+++|||++|..
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~ 180 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKT 180 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcc
Confidence 8888999999999999999999864
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=215.57 Aligned_cols=188 Identities=23% Similarity=0.284 Sum_probs=152.4
Q ss_pred ccccCcCceEEEEEEECC---CCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEE-cCCeEEEEEeccC
Q 027738 29 RDIGSGNFGVARLMRDKV---TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYAS 102 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~ 102 (219)
+.||+|++|.||++.+.. .+..+++|.+..... ..+.+.+|+.+++.++|||++++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 345799998754221 2356678999999999999999999775 4556889999999
Q ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-----C
Q 027738 103 GGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q 176 (219)
Q Consensus 103 ~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-----~ 176 (219)
+++|..++.+.. ..+...+..++.+++++|.+||+.+++|+||+|+||++++++. ++|+|||++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 999999987543 4677888999999999999999999999999999999988776 9999999986433211 1
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+.+..++.++|+||||++++||++|+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 200 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 200 (262)
T ss_pred cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCC
Confidence 112234668999999988889999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=217.77 Aligned_cols=189 Identities=24% Similarity=0.316 Sum_probs=156.1
Q ss_pred ccccCcCceEEEEEEECCCC------cEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 29 RDIGSGNFGVARLMRDKVTK------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~------~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+.||+|++|.||++...... +.+++|.+.... .....+.+|+..++.++||||+++++++......++++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999876433 678999876543 2345678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC---CCcEEEeecccccc
Q 027738 101 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 170 (219)
Q Consensus 101 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~---~~~v~l~dfg~a~~ 170 (219)
+++++|.+++... ..++..++..++.+++.+|.+||+.+++|+||+|+||++++++ ...++++|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999988642 2367889999999999999999999999999999999998766 11399999999864
Q ss_pred cccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 171 SVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 171 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
...... ......+..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~ 211 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ 211 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCC
Confidence 432211 112234678999999998889999999999999999998 54
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=221.08 Aligned_cols=193 Identities=28% Similarity=0.468 Sum_probs=163.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEc-CCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 95 (219)
...++|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+.+++.++|||++++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35678999999999999999999999999999999875432 234667889999999999999999999876 45789
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++|+++ ++|...+.. ..++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+|||.+.... .
T Consensus 87 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~--~ 160 (328)
T cd07856 87 FVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQD--P 160 (328)
T ss_pred EEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccC--C
Confidence 9999984 578776654 45788899999999999999999999999999999999987776 9999999886432 2
Q ss_pred CCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......++..|+|||.+.+ ..+++++|+||||+++++|++|..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 204 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence 2233456778999999865 567899999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=198.21 Aligned_cols=190 Identities=29% Similarity=0.499 Sum_probs=165.5
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++|.-.++||+|.+|+||++++..+.+.|++|.+..++.. ..+..+|+-+++.++|+||++++++....+.+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 5788899999999999999999999999999998765432 3678899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCC
Q 027738 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~ 177 (219)
+|+- +|..+... .+.+....++.++.|++.+|.+.|+.+++|+|+||.|.+|+.++. +++.|||+++..... ...
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 9965 66655543 456899999999999999999999999999999999999998888 999999999754333 345
Q ss_pred CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCC
Q 027738 178 KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~ 215 (219)
+..+.+.-|++|+++.+ +-|+.+.|.||.||++.|+.+
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelan 197 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhh
Confidence 55677888999999987 557889999999999998865
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=208.08 Aligned_cols=195 Identities=26% Similarity=0.338 Sum_probs=163.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (219)
.+.++.++++.||.|.+|.|+++....++..+|||........ .+++...+.+.... +.|+|++++|+|..+...++
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 3455667789999999999999999999999999988765432 24566666666554 47999999999999999999
Q ss_pred EEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 97 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
.||.+.. .....+.. ..++++.-+..+...+.+||.||-++ +++|+|+||+|||+++.++ +|+||||++-+...+
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecc
Confidence 9998743 44444433 34689988999999999999999866 8999999999999999998 999999999877767
Q ss_pred CCCCCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCC
Q 027738 175 SQPKSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.......|-+.|+|||.+. +..|+..+||||||++++|+.||.
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~ 291 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQ 291 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhccc
Confidence 6777778899999999997 457888999999999999999985
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=217.57 Aligned_cols=190 Identities=30% Similarity=0.480 Sum_probs=161.5
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
+.|...+.||.|++|.||++.+..+++.+++|.+...... .+.+.+|+..++.++|||++++++++......++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 4477778899999999999999989999999988653222 245778999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+.+ ++.+.+.. ..+++..++..++.|++.+|.+||+.|++|+||+|+||++++++. ++|+|||++.... ..
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PA 174 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CC
Confidence 99975 66666654 456899999999999999999999999999999999999988776 9999999875432 22
Q ss_pred CCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+. +..++.++|+||||+++++|++|..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~ 218 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 3456788899999984 4567889999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=218.60 Aligned_cols=199 Identities=27% Similarity=0.334 Sum_probs=163.5
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCe
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (219)
....+.++|++.+.||+|++|.||++.+..+++.+++|.+...... ...+..|+..+... .|+|++++++++.....
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3455778999999999999999999999988999999998754322 23455666666555 49999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.++++|++++ ++.+.... ...++...+..++.+++.+|.+||+ .+++|+||+|+||++++++. ++|+|||++...
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~ 165 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRL 165 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhc
Confidence 9999999855 66666654 4468999999999999999999997 59999999999999987776 999999998654
Q ss_pred ccCCCCCCCCCCCCCCCchhhcccc----ccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHE----YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........++..|+|||.+.+.. ++.++|+||||+++++|++|..
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 3333333445678899999987543 7889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=222.67 Aligned_cols=194 Identities=30% Similarity=0.443 Sum_probs=162.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC---cccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcC--CeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~ 94 (219)
..++|++.+.||+|++|.+|++.+..+++.+++|.+... ......+.+|+..++++ +|+|++++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 357899999999999999999999888999999987542 22234567899999999 999999999998754 368
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++|++++ +|...+... .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSEL 160 (337)
T ss_pred EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccc
Confidence 999999975 888887665 6888999999999999999999999999999999999998877 999999998654332
Q ss_pred CCC------CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQP------KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~------~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... ....++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~ 211 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCC
Confidence 211 12346778999998764 557889999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=217.39 Aligned_cols=193 Identities=28% Similarity=0.500 Sum_probs=163.4
Q ss_pred cceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (219)
+|++.+.||.|++|.||++.+. .+++.+++|.+.... ...+.+.+|+.+++.+ +|++++++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 457889999886432 2234577899999999 589999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++||+++++|...+.....++...+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++++|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence 999999999999999887778999999999999999999999999999999999999988776 999999987643322
Q ss_pred CC--CCCCCCCCCCCCchhhcccc--ccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ--PKSTVGTPAYIAPEVLLRHE--YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....++..|+|||.+.+.. .+.++|+||||+++++|++|..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~ 206 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCC
Confidence 21 12235788999999987654 6889999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=216.79 Aligned_cols=185 Identities=19% Similarity=0.182 Sum_probs=150.3
Q ss_pred cccCcCceEEEEEEECCC------------------------CcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEE
Q 027738 30 DIGSGNFGVARLMRDKVT------------------------KELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRF 84 (219)
Q Consensus 30 ~l~~g~~~~v~~~~~~~~------------------------~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~ 84 (219)
.||+|+||.||++....+ ...+++|.+...... ...+.+|+.+++.++|||++++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 689999999999874321 235888887653322 3467788889999999999999
Q ss_pred EEEEEcCCeEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-----C
Q 027738 85 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-----P 158 (219)
Q Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-----~ 158 (219)
++++..+...++|+||+++++|..++.. .+.++..++..++.|++.+|++||+++++|+||||+||+++..+. .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999888865 456899999999999999999999999999999999999975432 2
Q ss_pred cEEEeecccccccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecC-CCC
Q 027738 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQST-SPN 217 (219)
Q Consensus 159 ~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~-~g~ 217 (219)
.++++|||.+.... ......++..|+|||.+.+ ..++.++|+||||++++|++ +|.
T Consensus 162 ~~kl~d~g~~~~~~---~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~ 219 (274)
T cd05076 162 FIKLSDPGVSFTAL---SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219 (274)
T ss_pred eeeecCCccccccc---cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 37999999875332 1223356778999999875 56789999999999999985 443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=217.81 Aligned_cols=192 Identities=29% Similarity=0.476 Sum_probs=162.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
....|+..+.||.|++|.||++.+..+++.+++|.+..... ..+++.+|+++++.++|+|++++.+++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34568889999999999999999998999999998864321 12456789999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 97 VMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 97 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
++||+.+ ++.+.+. ...+++..++..++.+++.+|.+||+.+++|+||+|+||+++.++. ++++|||++.....
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~-- 167 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC--
Confidence 9999975 6766654 3456899999999999999999999999999999999999988766 99999998764432
Q ss_pred CCCCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++..|+|||.+. ...++.++|+||||+++++|++|..
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 212 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCC
Confidence 23345778899999985 3457889999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=222.42 Aligned_cols=194 Identities=31% Similarity=0.414 Sum_probs=160.3
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcC---------
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTP--------- 91 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 91 (219)
.++|++.+.||.|++|.||++.+..+++.|++|.+...... .+.+.+|++.++.++|||++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57999999999999999999999999999999988654432 35678899999999999999999776653
Q ss_pred -----CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 92 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 92 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
...++++||+++ +|...+.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. .++++|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcc
Confidence 357899999975 78777653 46899999999999999999999999999999999999975443 38999999
Q ss_pred cccccccCCCC----CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHSQP----KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~~~----~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++......... ....++..|+|||.+.+ ..++.++|+||||+++++|++|+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 217 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCC
Confidence 98643221111 22346778999998754 567889999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=220.09 Aligned_cols=189 Identities=22% Similarity=0.284 Sum_probs=155.9
Q ss_pred eccccCc--CceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 28 VRDIGSG--NFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 28 ~~~l~~g--~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
...||.| ++++||.+.+..+++.|++|+....... .+.+.+|+.+++.++||||+++++++..++..++++|++.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 8899999999999999999998654322 2567888999899999999999999999999999999999
Q ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC---
Q 027738 103 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--- 177 (219)
Q Consensus 103 ~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~--- 177 (219)
++++.+.+... ..+++..+..++.|++.+|++||+++++|+||||+||+++.++. ++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCccccc
Confidence 99999888764 34899999999999999999999999999999999999987776 999999864322111111
Q ss_pred -----CCCCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 -----KSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 -----~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++..|+|||.+.+ ..++.++|+||||++++||++|..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 208 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 11124557999999976 457889999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=213.28 Aligned_cols=187 Identities=20% Similarity=0.243 Sum_probs=149.7
Q ss_pred ccccCcCceEEEEEEECCC--CcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 29 RDIGSGNFGVARLMRDKVT--KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~--~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
+.||+|++|.||++....+ ...+++|.+.... ...+.+.+|+..++.++|||++++++.+......++++||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975432 3346677665432 22356788999999999999999999999999999999999999
Q ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC---CCC
Q 027738 105 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 177 (219)
Q Consensus 105 ~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~---~~~ 177 (219)
+|.+++... ...+...+..++.|++.||.+||+.+++|+||||+||+++.++. ++|+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999988753 23567778899999999999999999999999999999988776 999999987532111 112
Q ss_pred CCCCCCCCCCCchhhcc-------ccccceeeEEEEEEEEeecCCCC
Q 027738 178 KSTVGTPAYIAPEVLLR-------HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
....++..|+|||.+.. ..++.++|+||||++++||++++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 23456788999999753 23577899999999999998754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=220.06 Aligned_cols=192 Identities=27% Similarity=0.436 Sum_probs=159.6
Q ss_pred cceeeccccCcCceEEEEEEECCC--CcEEEEEEeccCcc---cCHHHHHHHHHHHhC-CCCcEeEEEEEEEcC----Ce
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVT--KELVAVKYIERGDK---IDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 93 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~--~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----~~ 93 (219)
+|++.+.||+|++|.||++.+..+ ++.+++|.+..... ..+.+.+|+..++.+ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 588999999999999999999877 88999998864321 234567899999888 599999999875432 35
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++++++++ ++|...+.....++..++..++.|++.+|.+||+.|++|+||+|+||++++++. ++|+|||++.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 788888886 589888888788999999999999999999999999999999999999988776 99999999875432
Q ss_pred CCC-----CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQ-----PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .....++..|+|||.+.+ ..++.++|+||||++++++++|..
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~ 208 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCc
Confidence 221 122357888999998865 567899999999999999998864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=213.97 Aligned_cols=190 Identities=21% Similarity=0.281 Sum_probs=154.9
Q ss_pred ceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC------
Q 027738 25 YDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------ 92 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 92 (219)
|++.+.||+|++|.||++... .+++.+++|.+..... ..+.+.+|+..++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677899999999999999864 3578899998865322 2345778999999999999999999886532
Q ss_pred eEEEEEeccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 93 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
..+++++|+.+++|..++... ..++...+..++.|++.+|++||+.+++|+||+|+||++++++. ++++|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 247888999999998776432 24788999999999999999999999999999999999987766 9999999
Q ss_pred cccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 167 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 167 ~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
++........ .....+++.|++||.+.+..++.++|+||||+++++|+++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhC
Confidence 9875432221 1122345689999999888889999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=221.46 Aligned_cols=192 Identities=28% Similarity=0.439 Sum_probs=160.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC----
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 92 (219)
...++|.+.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++|+|++++++++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 34579999999999999999999998889999999886532 22355788999999999999999999987543
Q ss_pred --eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 93 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 93 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
.+++++|++.. ++.... ...++...+..++.|++.+|++||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~ 166 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARH 166 (342)
T ss_pred CceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcC
Confidence 46899999864 665544 235899999999999999999999999999999999999988776 99999999865
Q ss_pred cccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... ......++..|+|||.+.+ ..++.++|+||||++++||++|..
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~ 213 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCC
Confidence 422 2233456778999999876 457889999999999999999874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=223.57 Aligned_cols=199 Identities=25% Similarity=0.474 Sum_probs=175.0
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEc-----C
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----P 91 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-----~ 91 (219)
.....+.|.+.+.+|.|.+|.||++.+..+++..|+|+.......+++++.|.++++.. .|||++.++++|.- +
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 34457789999999999999999999999999999999988888889999999999877 48999999999974 4
Q ss_pred CeEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 92 THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+.+|+|||+|.+|+..+.+++. ..+.+..+..|++.++.+|.+||++.++|+|+|-.||+++.++. |||+|||.+.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSa 171 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSA 171 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeee
Confidence 5799999999999999999764 45889999999999999999999999999999999999999888 9999999864
Q ss_pred c-cccCCCCCCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 170 S-SVLHSQPKSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~-~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .......++..|++.|+|||++. ...|+..+|+||||++.+||.-|..
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 3 23334456678999999999986 3457788999999999999998864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=221.40 Aligned_cols=192 Identities=26% Similarity=0.376 Sum_probs=166.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---------ccCHHHHHHHHHHHhCC---CCcEeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---------KIDENVQREIINHRSLR---HPNIVRFKEV 87 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---------~~~~~~~~e~~~l~~l~---~~~i~~~~~~ 87 (219)
....+|..++.+|.|+||.|+.++++.+...|++|.+.+.. +....+..|++++..+. |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34567999999999999999999999999999999987542 11234568999998886 9999999999
Q ss_pred EEcCCeEEEEEec-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 88 ILTPTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 88 ~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
|++++++|+++|- =+|.+|++++...+.+++.+...++.|+..++++||++||+|||||-+|+.++.+|- ++|+|||
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfg 715 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFG 715 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeecc
Confidence 9999999999985 456699999999999999999999999999999999999999999999999998887 9999999
Q ss_pred cccccccCCCCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecC
Q 027738 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQST 214 (219)
Q Consensus 167 ~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~ 214 (219)
.|.... ....-..+|+..|.|||++.+..| +..-|+|+||+++|...
T Consensus 716 saa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv 763 (772)
T KOG1152|consen 716 SAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV 763 (772)
T ss_pred chhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE
Confidence 886433 223345679999999999999887 44579999999999764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=228.28 Aligned_cols=192 Identities=31% Similarity=0.465 Sum_probs=164.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
...+.|.+...+|.|+++.|-.+.+..+++..++|++... ..+..+|+..+... +|+|+++..+++..+...++|+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4588999999999999999999999999999999999765 23334555444433 6999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec-CCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~-~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|.+.++.+.+.+-..+.++ .++..|+++|+.++.+||++|++||||||+|||++ +.++ ++|+|||.++..... .
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--C 470 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--h
Confidence 9999999888887776666 78888999999999999999999999999999995 4444 999999998755433 2
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
-+..-+..|.|||+.....+++++|+||||+++|+|++|..+
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp 512 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTL 512 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCc
Confidence 233457789999999999999999999999999999999764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=224.55 Aligned_cols=195 Identities=30% Similarity=0.459 Sum_probs=169.9
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..-|..++.||-|+||.|.++....+...||+|.+.+.+... ..++.|..+|...+.+-+++++-.|.+.+++|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 445777899999999999999998888999999887654322 3467888899888999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc--------
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------- 169 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~-------- 169 (219)
|+|++||++-..+.+-+-|.++..+.++.++.-+++..|..|++|+||||+||||+.+|. +||+|||++.
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceecccc
Confidence 999999999999999999999999999999999999999999999999999999999998 9999999974
Q ss_pred -ccccCCCC----------------------------------CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecC
Q 027738 170 -SSVLHSQP----------------------------------KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQST 214 (219)
Q Consensus 170 -~~~~~~~~----------------------------------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~ 214 (219)
.+..+... ...+|++.|+|||++....++..+|+||.|++||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 11111000 1124889999999999999999999999999999999
Q ss_pred CCCC
Q 027738 215 SPND 218 (219)
Q Consensus 215 ~g~~ 218 (219)
.|..
T Consensus 866 ~g~~ 869 (1034)
T KOG0608|consen 866 VGQP 869 (1034)
T ss_pred hCCC
Confidence 9974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=206.78 Aligned_cols=196 Identities=21% Similarity=0.425 Sum_probs=172.2
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCC--e
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--H 93 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~ 93 (219)
..+...++|++.+++|+|.++.||.+.+..+++.+++|++++- ..+.+.+|+.++..++ +|||++++++..++. -
T Consensus 32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3455789999999999999999999999999999999998753 3477899999999997 999999999998765 4
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
..+++|+..+.+... -.+.++..+++.++.++++||.|+|++||.|+|+||.|++|+.... .++|+|||+|.++-+
T Consensus 110 paLiFE~v~n~Dfk~---ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQ---LYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHP 185 (338)
T ss_pred chhHhhhhccccHHH---HhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCC
Confidence 789999998755433 3345899999999999999999999999999999999999987766 499999999999999
Q ss_pred CCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+...+.++.+..|.-||.+.+ ..|+.+-|+|||||++..|+...+
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrke 231 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 231 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccC
Confidence 999999999999999999986 567899999999999998876543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=221.31 Aligned_cols=198 Identities=30% Similarity=0.504 Sum_probs=171.0
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC-HHH---HHHHHHHHhC-CCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENV---QREIINHRSL-RHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~-~~~---~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (219)
.....+|.++..||.|+||.|.++..+.+.+.||+|+++.+--.. +++ ..|-++|... +-|.++++...|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 566788999999999999999999999999999999887643221 111 2344444433 45788888999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+|+||||+.||+|-..++.-+.|-+.....++.+|+-+|-+||++||+++|||.+||+++.++. ++|+|||+++....
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeeccccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999888 99999999875544
Q ss_pred CCC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+.. +.+.+|++.|+|||.+...+|+.++|+||+|+++|||+.|..
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQp 548 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 548 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCC
Confidence 433 455689999999999999999999999999999999999865
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=222.45 Aligned_cols=196 Identities=26% Similarity=0.400 Sum_probs=164.8
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..+...++|++.+.||+|++|.+|++.+..+++.|++|.+.... ...+.+.+|+.+++.++|+|++++.+++.....
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 34456789999999999999999999999999999999886432 122456789999999999999999988876554
Q ss_pred ------EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 94 ------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 94 ------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
.++++|++ +++|.+.+.. ..++..++..++.|++.+|++||+.|++|+||+|+||++++++. ++|+|||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~ 164 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGL 164 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccc
Confidence 89999998 5588887765 46899999999999999999999999999999999999998776 99999999
Q ss_pred ccccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 168 SKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 168 a~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..... ......++..|+|||.+.+ ..++.++|+||||++++++++|..
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~ 214 (343)
T cd07851 165 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214 (343)
T ss_pred cccccc--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 875432 2233456778999999865 467889999999999999999974
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=213.58 Aligned_cols=192 Identities=30% Similarity=0.470 Sum_probs=160.5
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc------ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
+|.+.+.||+|++|.||++.+...+..+++|...... .....+..|+.+++.++|||++++++.+......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6899999999999999999998777666666654321 1223456788899999999999999999999999999
Q ss_pred EeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 98 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+||+++++|.+.+.. ...+++.++..++.|++.+|.+||+.+++|+||+|+||+++++ .++++|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence 999999999887753 3458999999999999999999999999999999999999743 389999998865433
Q ss_pred CCC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~ 203 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAH 203 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 222 223457788999999988888899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=215.77 Aligned_cols=182 Identities=26% Similarity=0.417 Sum_probs=151.8
Q ss_pred CceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHH
Q 027738 35 NFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 111 (219)
Q Consensus 35 ~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 111 (219)
+.+.+|.+.+..+++.||+|++.... ...+.+.+|+..++.++|+|++++++++......++++||+++++|.+.+.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44566777777789999999987542 223578899999999999999999999999999999999999999999887
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC--------CCCCC
Q 027738 112 NA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTV 181 (219)
Q Consensus 112 ~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~--------~~~~~ 181 (219)
.. ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++. ++++||+.+........ .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence 53 35889999999999999999999999999999999999998776 99999998764432211 12234
Q ss_pred CCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 182 GTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 182 ~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++..|+|||.+.. ..++.++|+||+|++++||++|..
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~ 208 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHV 208 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 5668999999875 457889999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=207.67 Aligned_cols=195 Identities=26% Similarity=0.348 Sum_probs=159.7
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC--cccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (219)
.+.++.+=++.||.|+||+|.+..++.+|+..|+|++... +....++..|.+...+- ..|+|++++|....++..|+
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 3455666688999999999999999999999999998653 23445666777666544 57999999999999999999
Q ss_pred EEeccCCCcHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 97 VMEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 97 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
.||.++- ++..+-. ....++++-+..+.-....||.||-.. .|+|+|+||+|||++..|. +||||||++-.
T Consensus 141 CMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGq 217 (361)
T KOG1006|consen 141 CMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQ 217 (361)
T ss_pred eHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHh
Confidence 9999864 5533322 334588988888988999999999755 8999999999999998887 99999999765
Q ss_pred cccCCCCCCCCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
...+.......|-..|+|||.+.. ..|+-++||||||++|||..||+
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~ 266 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGN 266 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCC
Confidence 554545555677888999999973 46899999999999999999997
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=238.94 Aligned_cols=192 Identities=31% Similarity=0.465 Sum_probs=156.5
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC--cccCHHHHHHHHHHHhCCCCcEeEEEEEEEc---------
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT--------- 90 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 90 (219)
..+|+.++.||+|+||.||+++++-+|..||+|++... ......+.+|+.++.++.|||+++++..|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 45677899999999999999999999999999999765 3334668899999999999999998765510
Q ss_pred --------------------------------------------------------------------------------
Q 027738 91 -------------------------------------------------------------------------------- 90 (219)
Q Consensus 91 -------------------------------------------------------------------------------- 90 (219)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CeEEEEEeccCCCcHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCC
Q 027738 91 ----------------------P--------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139 (219)
Q Consensus 91 ----------------------~--------~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~l~~~l~~lh~~~ 139 (219)
+ ..+|+.||||+..++.+.+...-.. .....++++++|++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 1258889999886666666544322 48889999999999999999999
Q ss_pred ceeccCCCCCEEecCCCCCcEEEeecccccccc-------------------cCCCCCCCCCCCCCCCchhhccc---cc
Q 027738 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLRH---EY 197 (219)
Q Consensus 140 ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~---~~ 197 (219)
++||||||.|||+++.+. |||+|||+|+... ........+||..|+|||++.+. .|
T Consensus 718 iIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred eeeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999997776 9999999997511 00112335689999999999864 49
Q ss_pred cceeeEEEEEEEEeecCC
Q 027738 198 DGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 198 ~~~~Dv~slg~~~~~~~~ 215 (219)
+.|+|+||||++++||+-
T Consensus 796 n~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cchhhhHHHHHHHHHHhc
Confidence 999999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=215.30 Aligned_cols=191 Identities=28% Similarity=0.423 Sum_probs=160.3
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----eEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 95 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 95 (219)
+.+-.+.||.|+||.||.+++.++++.|++|++..-. ...+.+.+|..+++.++|.|++..++...... ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455688999999999999999999999999875422 23477889999999999999999888877653 357
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++|.++. +|...+-..+.++.+.+.-+++||+.+|.|||+.+|+|+||||.|.+++++-- +||||||+|+-.....
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhh
Confidence 88888855 78888888888999999999999999999999999999999999999976654 9999999997554443
Q ss_pred CCCC--CCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCC
Q 027738 176 QPKS--TVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 176 ~~~~--~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.... .+.+..|+|||.+++ ..|+...||||.||++.|++..+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRr 255 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRK 255 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhh
Confidence 3322 356788999999997 67899999999999999988654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=221.77 Aligned_cols=192 Identities=25% Similarity=0.351 Sum_probs=167.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++..+.++||+|-||.|.+++-. .+..||+|.++..... +.+|.+|++.+.+++||||+.++++|..++.+++++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4566788999999999999999876 3688999999775433 468999999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 99 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
||++.|+|..++..+. ........+++.||+.+|+||.+.++||+|+.+.|+|++.+.+ +||+|||.++....+..
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCc
Confidence 9999999999998773 3455667779999999999999999999999999999998887 99999999985554444
Q ss_pred CCC---CCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 177 PKS---TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 177 ~~~---~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
... .+-+.+|+|+|.+..+.++.++|+|++|+++||+++
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~ 734 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFM 734 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHH
Confidence 432 356789999999999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=217.03 Aligned_cols=195 Identities=25% Similarity=0.324 Sum_probs=169.4
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC------CCcEeEEEEEEEcCCeEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR------HPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 95 (219)
..+|.+....|+|-|++|..|.+..-++.||+|+|...+.-.+.=+.|+++|+++. .-|+++++..|...+.++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 46888999999999999999999988999999999888777777789999999984 248899999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 96 IVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
+|||-+. -+|.+.+.+.+. +....++.++.|++.||..|-+.|++|+||||+||||+++.+ .++|||||.|-...
T Consensus 511 lVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 511 LVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS 588 (752)
T ss_pred EEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc
Confidence 9999884 489999988764 788899999999999999999999999999999999998877 49999999886543
Q ss_pred cCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
.. .-.....+--|.|||.+.+..|+...|+||+||++||+.||.-|
T Consensus 589 en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 589 EN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred cc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 22 22223455679999999999999999999999999999999643
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=220.68 Aligned_cols=205 Identities=22% Similarity=0.329 Sum_probs=172.9
Q ss_pred CCCCCCCcccCCccceeeccccCcCceEEEEEEECC-CCc--EEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEE
Q 027738 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKV-TKE--LVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFK 85 (219)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~-~~~--~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~ 85 (219)
.+....--.+..++.++.++||+|.||.|+++.+.. +|+ .||||++...... -.+|.+|+..+.+++|+|++++|
T Consensus 98 ~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 98 NPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred CcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEe
Confidence 344555555667788899999999999999998763 344 4899988765433 47899999999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEe
Q 027738 86 EVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (219)
Q Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~ 163 (219)
|+..+ ....+|+|.++.|+|.+.+.+ ...|....+..++.||+.+|.||.++++||+||-.+|+++-.... |||+
T Consensus 178 GvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~ 254 (1039)
T KOG0199|consen 178 GVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKIC 254 (1039)
T ss_pred eeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeee
Confidence 99887 678899999999999999977 345899999999999999999999999999999999999976544 9999
Q ss_pred ecccccccccCCCCC----CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 164 DFGYSKSSVLHSQPK----STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 164 dfg~a~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|||+++........- .......|.|||.++...++-++|||++|++++||+|+++
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGE 313 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGE 313 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCC
Confidence 999998654443332 1234567999999999999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=221.54 Aligned_cols=203 Identities=23% Similarity=0.335 Sum_probs=173.8
Q ss_pred CCCCcccCCccceeeccccCcCceEEEEEEECCCCc---EEEEEEeccC--cccCHHHHHHHHHHHhCCCCcEeEEEEEE
Q 027738 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVI 88 (219)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (219)
-.+..-.+....++.+.||.|.||.|+++..+..++ .||+|.++.. ++.+.+|..|+.++-+++||||+++.|+.
T Consensus 620 reFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 620 REFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred HHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 344455667778899999999999999999886654 5999988764 45567899999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 89 LTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
.......+++||+++|+|..++..+ ++|+..++..+++.|+.++.||-+.++||+||-.+|||++.+=- +|++|||+
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGL 777 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGL 777 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccc
Confidence 9999999999999999999999754 56999999999999999999999999999999999999987766 89999999
Q ss_pred ccccccCCCC--CCCC--CCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 168 SKSSVLHSQP--KSTV--GTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 168 a~~~~~~~~~--~~~~--~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++....+... .+.. -+.+|.|||.+.-..++.++||||+|++|+|..+=++
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence 9855444311 1111 2568999999999999999999999999999887543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-35 Score=209.26 Aligned_cols=205 Identities=26% Similarity=0.392 Sum_probs=171.9
Q ss_pred CCCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEecc---CcccCHHHHHHHHHHHhCCCCcEeEEEEEE
Q 027738 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVI 88 (219)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (219)
..+..|++.+.+.|..+.++|+|.||.||+++...+++.|++|++-- .+.......+|+.++..++|+|++.+++.+
T Consensus 6 ~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 6 DSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred hcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 35678899999999999999999999999999999999999987632 222345678999999999999999988877
Q ss_pred EcC--------CeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCc
Q 027738 89 LTP--------THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (219)
Q Consensus 89 ~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~ 159 (219)
... ..+++|+++|.. +|.-.+.+. ..++..++..++.+++.+|.|+|+..|+|+|+||.|++|+.++.
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi-- 162 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI-- 162 (376)
T ss_pred hhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--
Confidence 542 348999999966 777777655 56999999999999999999999999999999999999998887
Q ss_pred EEEeecccccccccCCC-----CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 160 LKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 160 v~l~dfg~a~~~~~~~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
++|+|||+++....... ...++.+.-|++||.+.+ ..++++.|+|+.||++.||.|+.++
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspi 228 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPI 228 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcc
Confidence 99999999953332222 223355788999999986 6789999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=197.14 Aligned_cols=212 Identities=24% Similarity=0.349 Sum_probs=172.2
Q ss_pred cccCccCCCCCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEe
Q 027738 4 DRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIV 82 (219)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~ 82 (219)
++..+..-+-.+++.....+.|.+.+.||+|.||.+-+++++.++..+++|.+..+.....+|.+|...--.+ .|.||+
T Consensus 5 ~~g~ih~I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi 84 (378)
T KOG1345|consen 5 DGGQIHLIPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHII 84 (378)
T ss_pred CCCcccccccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhh
Confidence 3445556667788888899999999999999999999999999999999998887777778888888765555 478888
Q ss_pred EEEEE-EEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEE
Q 027738 83 RFKEV-ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 83 ~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~ 161 (219)
.-|++ |+..+.+++++|+++.|+|.+-+... .+.+..-..++.|+++|+.++|++++||+|||.+||||-+.+..+||
T Consensus 85 ~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 85 DTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred HHHHHHhhcCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEE
Confidence 76654 56677899999999999998877654 36788889999999999999999999999999999999665555899
Q ss_pred EeecccccccccCCCCCCCCCCCCCCCchhhcc-----ccccceeeEEEEEEEEeecCCCCC
Q 027738 162 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 162 l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|||||....... .....--...|.+||.... ....+.+|+|+||++++.++||+-
T Consensus 164 lcDFG~t~k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~ 223 (378)
T KOG1345|consen 164 LCDFGLTRKVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKF 223 (378)
T ss_pred eeecccccccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCC
Confidence 999998764321 1111223456889998762 234688999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=197.96 Aligned_cols=192 Identities=38% Similarity=0.612 Sum_probs=168.7
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
|.+.+.|++|+++.+|++....+++.+++|.+..... ..+.+.+|++.+..++|++++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6778999999999999999998889999999876543 35678899999999999999999999999999999999999
Q ss_pred CCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC--CCCC
Q 027738 103 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 179 (219)
Q Consensus 103 ~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~--~~~~ 179 (219)
+++|.+.+..... ++...+..++.+++.++.+||+.+++|+|++|.||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence 9999999988766 899999999999999999999999999999999999988765 9999999887554432 2234
Q ss_pred CCCCCCCCCchhh-ccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVL-LRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~-~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..+...|++||.+ ....++.++|+|+||++++++++|..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~ 198 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPE 198 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 4577789999998 56677789999999999999999874
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=234.97 Aligned_cols=184 Identities=19% Similarity=0.227 Sum_probs=154.3
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
..++....||+|++|.||++.+..++..||+|.+..... ...+|++.+++++||||+++++++......++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 345667789999999999999988999999998864332 22346888899999999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCC
Q 027738 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (219)
Q Consensus 103 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~ 179 (219)
+++|.+++.. ++..++..++.+++.||+||| +.+++|+|+||+||+++.+.. .++. ++.+... .....
T Consensus 767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~---~~~~~ 837 (968)
T PLN00113 767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLL---CTDTK 837 (968)
T ss_pred CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-ecccccc---ccCCC
Confidence 9999998854 788999999999999999999 679999999999999987776 3443 4443221 11223
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..++..|+|||.+.+..++.++||||+|+++|||+||..
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~ 876 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCC
Confidence 367789999999999899999999999999999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=206.83 Aligned_cols=198 Identities=28% Similarity=0.367 Sum_probs=166.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCH--------HHHHHHHHHHhCCCCcEeEEEEEEEcC-
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--------NVQREIINHRSLRHPNIVRFKEVILTP- 91 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~--------~~~~e~~~l~~l~~~~i~~~~~~~~~~- 91 (219)
..++|-++.+||.|+|+.||++.+-.-+++||+|+-.....+++ ..-+|..+.+.++||.|+++|++|...
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 46799999999999999999999998889999998655443332 234788889999999999999999754
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCCEEecCCCCC-cEEEeecccc
Q 027738 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAP-RLKICDFGYS 168 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~ivh~dl~p~nili~~~~~~-~v~l~dfg~a 168 (219)
+.++-|.|||+|-+|.-+++..+.+++.+.+.|+.|+..+|.||.+. .|+|-||||.|||+.++..+ .++|+|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 56889999999999999999999999999999999999999999977 59999999999998655443 4999999998
Q ss_pred cccccCCCC--------CCCCCCCCCCCchhhcc----ccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQP--------KSTVGTPAYIAPEVLLR----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~~--------~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+........ ....|+.-|.+||.|.- ...+.++||||+|+++|+++-|+.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrK 682 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRK 682 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCC
Confidence 754433322 22347778999999863 346889999999999999998864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=213.93 Aligned_cols=187 Identities=26% Similarity=0.354 Sum_probs=158.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++.+.||+|+||.||++.+..+++.||+|++...... ...+..|+..+..++|++|+++++++......++
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 467999999999999999999999999999999998654322 2567788999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
||||+.+++|..++.....++...++.++.|++.+|.|||+.+|+|+||||+||+++.++. ++|+|||+++.......
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~~~~~~~~ 159 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSKVTLNREL 159 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCccccCCcc
Confidence 9999999999999988888999999999999999999999999999999999999987776 99999999875433222
Q ss_pred -CCCCCCCCCCCCchhhcccc-ccceeeEEEEEEE
Q 027738 177 -PKSTVGTPAYIAPEVLLRHE-YDGKVYFYSITQM 209 (219)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slg~~ 209 (219)
.....+++.|.+||...... -...+++|++|.-
T Consensus 160 ~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~ 194 (669)
T cd05610 160 NMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFN 194 (669)
T ss_pred cccccccCccccCccccccCCCCceeeeeeecCcC
Confidence 22346788899998765432 2345788888853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=198.59 Aligned_cols=196 Identities=25% Similarity=0.339 Sum_probs=169.4
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT- 92 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 92 (219)
.......+|.-+..++.|+. .|..+.+.-.+++|++|....+. ...++..+|..++..+.|+|+++++.+|....
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 44556779999999999999 78888888899999999876542 22366788999999999999999999998654
Q ss_pred -----eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 93 -----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 93 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
..|+|+|+++. +|...+.. .++-..+..+..|++-|+.+||+.||+|+||||+||++..+.. +|+.|||+
T Consensus 90 l~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ 164 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGL 164 (369)
T ss_pred HHHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchh
Confidence 47999999965 88888874 3678889999999999999999999999999999999987766 99999999
Q ss_pred ccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 168 a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+...........+.+-.|.|||++.+..+...+|+||+||++.||++|.-
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~V 215 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTV 215 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceE
Confidence 987777666666778889999999999889999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=195.58 Aligned_cols=182 Identities=41% Similarity=0.633 Sum_probs=161.8
Q ss_pred CceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHh
Q 027738 35 NFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 112 (219)
Q Consensus 35 ~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 112 (219)
++|.+|++....+++.+++|++...... .+.+.+|++.+++++|++++++++.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 4789999999988999999998765433 47788999999999999999999999999999999999999999999887
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCCCCCCCchhh
Q 027738 113 AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192 (219)
Q Consensus 113 ~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~ 192 (219)
...++...+..++.+++.++.+||+.+++|+||+|+||++++++. ++++|||.+.............++..|++||..
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 766899999999999999999999999999999999999988866 999999998766554444556678899999999
Q ss_pred ccccccceeeEEEEEEEEeecCCCCC
Q 027738 193 LRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 193 ~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+..++.++|+||||++++++++|..
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~ 184 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKP 184 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 88888999999999999999999853
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=215.32 Aligned_cols=196 Identities=18% Similarity=0.222 Sum_probs=138.5
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCC----CcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEE------
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------ 87 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~----~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------ 87 (219)
.....++|++.+.||+|+||.||++++..+ +..|++|.+............. +....+.++..+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~---l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER---VRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH---HHhhchhhHHHHHHhhhcccc
Confidence 344678999999999999999999999888 8899999875432211111111 111111111111111
Q ss_pred EEcCCeEEEEEeccCCCcHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 027738 88 ILTPTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147 (219)
Q Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p 147 (219)
.......++++||+++++|.+++..... .....+..++.|++.+|.|||+.+|+|+||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 2345678999999999999888864321 12334667999999999999999999999999
Q ss_pred CCEEecCCCCCcEEEeecccccccccCC--CCCCCCCCCCCCCchhhcccc----------------------ccceeeE
Q 027738 148 ENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHE----------------------YDGKVYF 203 (219)
Q Consensus 148 ~nili~~~~~~~v~l~dfg~a~~~~~~~--~~~~~~~~~~~~aPE~~~~~~----------------------~~~~~Dv 203 (219)
+||+++++.. .++|+|||+++...... ......+++.|+|||.+.... ++.++||
T Consensus 284 ~NILl~~~~~-~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSG-SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCC-cEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985422 39999999997543222 223456788999999764221 2345699
Q ss_pred EEEEEEEeecCCCC
Q 027738 204 YSITQMSLQSTSPN 217 (219)
Q Consensus 204 ~slg~~~~~~~~g~ 217 (219)
|||||++|||++|.
T Consensus 363 wSlGviL~el~~~~ 376 (566)
T PLN03225 363 YSAGLIFLQMAFPN 376 (566)
T ss_pred HHHHHHHHHHHhCc
Confidence 99999999999763
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=207.48 Aligned_cols=197 Identities=20% Similarity=0.262 Sum_probs=145.9
Q ss_pred ccCCccceeeccccCcCceEEEEEEEC----------------CCCcEEEEEEeccCccc-C--------------HHHH
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDK----------------VTKELVAVKYIERGDKI-D--------------ENVQ 67 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~----------------~~~~~v~~K~~~~~~~~-~--------------~~~~ 67 (219)
....++|++.++||+|+||.||++... ..++.|++|.+...... . +...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 346889999999999999999998642 24567999998643211 1 1223
Q ss_pred HHHHHHHhCCCCcE-----eEEEEEEEc--------CCeEEEEEeccCCCcHHHHHHhcC--------------------
Q 027738 68 REIINHRSLRHPNI-----VRFKEVILT--------PTHLAIVMEYASGGELFERICNAG-------------------- 114 (219)
Q Consensus 68 ~e~~~l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~-------------------- 114 (219)
.|+.++.+++|.++ +++++++.. .+..++|+||+++++|.+.+....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 45666666765543 566666653 346899999999999998886421
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCC--CCCCCCCC
Q 027738 115 ----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 188 (219)
Q Consensus 115 ----~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~--~~~~~~~a 188 (219)
.++...+..++.|++.+|.++|+.+++|+||||+||+++.++. ++|+|||++............ ..++.|+|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1345678889999999999999999999999999999988776 999999998654332222222 34789999
Q ss_pred chhhcccc--------------------c--cceeeEEEEEEEEeecCCCC
Q 027738 189 PEVLLRHE--------------------Y--DGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 189 PE~~~~~~--------------------~--~~~~Dv~slg~~~~~~~~g~ 217 (219)
||.+.... + ..+.|+||+|+++++|++|.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~ 429 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPE 429 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCC
Confidence 99986322 1 12469999999999999874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=210.01 Aligned_cols=191 Identities=23% Similarity=0.259 Sum_probs=160.4
Q ss_pred cceeeccccCcCceEEEEEEECCC--C--cEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVT--K--ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~--~--~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..++.++||.|-||.||.++...- | -.||+|..+.+. ...+.|.+|+.+++.++||||++++|++.+. ..|+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 344568899999999999986522 2 248999886632 2347789999999999999999999998864 68999
Q ss_pred EeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
||.++-|.|.++++... .++...+..++.|++.+|.|||+.++||+||-.+||++....- |||+|||+++.......
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAY 546 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccch
Confidence 99999999999998765 4889999999999999999999999999999999999986665 99999999986655444
Q ss_pred CCCC--CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 177 PKST--VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 177 ~~~~--~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.... .-+.-|+|||.+.-..++.++|||.||++++|.++-+
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lG 589 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLG 589 (974)
T ss_pred hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhc
Confidence 3332 2356799999999889999999999999999988754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=200.17 Aligned_cols=131 Identities=27% Similarity=0.402 Sum_probs=114.7
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-----C---CcEeEEEEEEEc---
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----H---PNIVRFKEVILT--- 90 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-----~---~~i~~~~~~~~~--- 90 (219)
..+|.+.++||.|-|++||++++.++.+.||+|+.+...-..+....|+.++++++ + ..|+++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 48999999999999999999999999999999988766555677889999999884 2 469999999986
Q ss_pred -CCeEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEec
Q 027738 91 -PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLD 153 (219)
Q Consensus 91 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~ 153 (219)
+..+++|+|++ |.+|..++... +.++...++.|++|++.+|.|||+. ||+|.||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 34689999999 55888888654 4599999999999999999999965 999999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=200.89 Aligned_cols=186 Identities=26% Similarity=0.354 Sum_probs=155.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHH--hCCCCcEeEEEEEEEcCC----eEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVILTPT----HLA 95 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~----~~~ 95 (219)
..+.++.+.||+|.||.||++.+. |+.||||++...+ +++..+|.++++ -++|+||+.+++.-.... .+|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 677899999999999999999997 9999999986433 355666777765 459999999988765432 589
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
+|++|-+.|+|.+++.. ..++.+...+++..++.+|++||.. .|.|+|||..||+|..++. ..|+|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGL 362 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 362 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeecee
Confidence 99999999999999988 4689999999999999999999943 4999999999999998888 89999999
Q ss_pred ccccccC-----CCCCCCCCCCCCCCchhhccc----cc-c-ceeeEEEEEEEEeecC
Q 027738 168 SKSSVLH-----SQPKSTVGTPAYIAPEVLLRH----EY-D-GKVYFYSITQMSLQST 214 (219)
Q Consensus 168 a~~~~~~-----~~~~~~~~~~~~~aPE~~~~~----~~-~-~~~Dv~slg~~~~~~~ 214 (219)
|...... ...+.++||.+|+|||++... .+ + ..+||||||.+++|.+
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 9766544 334667899999999999742 22 2 3489999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=203.96 Aligned_cols=190 Identities=25% Similarity=0.320 Sum_probs=158.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHH--hCCCCcEeEEEEEEEcCC----e
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVILTPT----H 93 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~----~ 93 (219)
.+....++.+.+|+|.||.||++... ++.||||++...+ .+.++.|-.+.+ .++|+||+++++.-.... .
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 34677788999999999999999886 6899999986533 456777777665 458999999999877665 7
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEecCCCCCcEEEee
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---------QVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---------~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
+++|+++-+.|+|.+++..+ ..+.....+++..++.+|+|||+- .|+|||||..|||+..+.+ ..|+|
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaD 359 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIAD 359 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeec
Confidence 99999999999999999876 479999999999999999999954 5999999999999998888 89999
Q ss_pred cccccccccCCCC---CCCCCCCCCCCchhhccccc------cceeeEEEEEEEEeecCCC
Q 027738 165 FGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEY------DGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 165 fg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~------~~~~Dv~slg~~~~~~~~g 216 (219)
||+|....++... ...+||.+|||||++.+..- -.+.||||+|.+++|+++.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 9999765544332 34689999999999975321 1358999999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=181.49 Aligned_cols=181 Identities=41% Similarity=0.619 Sum_probs=157.4
Q ss_pred ccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcHHH
Q 027738 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 108 (219)
Q Consensus 31 l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (219)
||+|.+|.+|++....+++.+++|++...... .+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68899999999999888999999998765442 4678999999999999999999999999999999999999899999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC-CCCCcEEEeecccccccccCC-CCCCCCCCCC
Q 027738 109 RICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 185 (219)
Q Consensus 109 ~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~-~~~~~v~l~dfg~a~~~~~~~-~~~~~~~~~~ 185 (219)
++... ..++...+..++.+++.++.+||+.+++|+||+|.||+++. ++. ++++||+.+....... ..........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence 98776 46899999999999999999999999999999999999987 555 9999999986543322 1233457788
Q ss_pred CCCchhhccc-cccceeeEEEEEEEEeec
Q 027738 186 YIAPEVLLRH-EYDGKVYFYSITQMSLQS 213 (219)
Q Consensus 186 ~~aPE~~~~~-~~~~~~Dv~slg~~~~~~ 213 (219)
|.+||..... ..+.++|+|++|++++++
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 9999999876 788899999999998875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=210.07 Aligned_cols=200 Identities=22% Similarity=0.318 Sum_probs=167.6
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECC-------CCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKE 86 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~ 86 (219)
.+..+.++.++.+.||.|+||.|+++.... ....||+|....... ..+.+..|+.+++.+ +|+|++.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 444555666777899999999999997541 145689998865433 346788999999988 5999999999
Q ss_pred EEEcCCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 027738 87 VILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (219)
Q Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~ni 150 (219)
.+...+..+++.||+..|+|.+++...+ .++..++..++.|++.+++||++.+++||||-.+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999998766 388899999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeecccccccccCCCCCCC--C--CCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 151 LLDGSPAPRLKICDFGYSKSSVLHSQPKST--V--GTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 151 li~~~~~~~v~l~dfg~a~~~~~~~~~~~~--~--~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++..+.. ++++|||+|+........... . -+..|+|||.+....++.++||||+|++++|++|.+.
T Consensus 450 Li~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 450 LITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred EecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence 9988866 999999999854443333211 1 3557999999999999999999999999999998764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-31 Score=207.63 Aligned_cols=191 Identities=20% Similarity=0.268 Sum_probs=168.5
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
.+.....+||.|-+|.||.++++.-.-.||||.++.+....++|..|+.+++.++|||+++++++|..+..+|+|+||+.
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 33455689999999999999999888889999998887778999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCC
Q 027738 103 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (219)
Q Consensus 103 ~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~ 180 (219)
.|+|.+++... ..++..-+..++.||..+++||..++++|+||-.+|-||.++.- ||++|||+++....+......
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceeccc
Confidence 99999999753 34777788899999999999999999999999999999988876 999999999876554443322
Q ss_pred --CCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 181 --VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 181 --~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
-=..-|.|||.+....++.++|||+||++++|+.|
T Consensus 425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIAT 461 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 461 (1157)
T ss_pred CccCcccccCcccccccccccchhhHHHHHHHHHHHh
Confidence 12457999999999999999999999999999876
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=204.91 Aligned_cols=188 Identities=27% Similarity=0.275 Sum_probs=155.2
Q ss_pred eeeccccCcCce-EEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 26 DFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 26 ~~~~~l~~g~~~-~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
.-.+.+|.|+.| .||++... ++.||||++.... ....++|+..++.. +||||+++++.-.+....|+..|.|.
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 335677888887 68888876 8899999875432 34568899999887 59999999999999999999999995
Q ss_pred CcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC---CCCCcEEEeecccccccccCCC
Q 027738 104 GELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 104 ~~L~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~---~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
.+|.+++..... ......+..+.|+++||++||+.+|||+||||.||||+. ++.-+++|+|||+++....+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 499999987421 222456788999999999999999999999999999986 4555699999999987766655
Q ss_pred CCC----CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKS----TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~----~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... ..|+-+|.|||.+....-+.++|++||||++|+.+||+.
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~ 712 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGS 712 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCc
Confidence 433 358889999999998887889999999999999999963
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-31 Score=209.78 Aligned_cols=192 Identities=32% Similarity=0.484 Sum_probs=171.3
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
..++|.++..+|+|.+|.||++++..+++..++|+++..... -.-+++|+-+++.++||||+.+++.+.....+|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 567999999999999999999999999999999999865443 3567889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~ 178 (219)
||++++|.+.-+-.+++++.++....++.+.+|+|||++|-+|+|||-.||++++.+. +++.|||.+..+... ....
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRK 170 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999998888 999999987543322 2334
Q ss_pred CCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecC
Q 027738 179 STVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQST 214 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~ 214 (219)
.+.|++.|+|||+-. ...|...+|+|++|++..|+.
T Consensus 171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~ 209 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELG 209 (829)
T ss_pred cccCCccccchhHHHHHhcccccccccccccccchhhhh
Confidence 567999999999974 577889999999999988764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=209.23 Aligned_cols=191 Identities=23% Similarity=0.272 Sum_probs=162.6
Q ss_pred cceeeccccCcCceEEEEEEECCCCc----EEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..+..++||+|+||+||++.+...++ +|++|++.... +...++.+|+..+.+++|||++++++++.... +-+|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34457899999999999998864444 57888775543 33578899999999999999999999998766 7889
Q ss_pred EeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
++|++.|+|.+++..++ ++.....+.|..||+++|.|||.++++||||-.+|+||..-.. +++.|||+++...++..
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccc
Confidence 99999999999997654 6889999999999999999999999999999999999987766 99999999986665544
Q ss_pred CCCCC---CCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 177 PKSTV---GTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 177 ~~~~~---~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.-... -.+-|+|-|.++...++.++||||+|++.+|++|-+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFG 897 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFG 897 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcC
Confidence 43322 356799999999999999999999999999999865
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=173.56 Aligned_cols=200 Identities=23% Similarity=0.253 Sum_probs=168.4
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCC-CcEeEEEEEEEcCCeE
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHL 94 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~ 94 (219)
.+...-.++|+++++||+|+||.+|.+....+|..||+|.- ........+.-|..+.+.+++ .+|+.+..++.+...-
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~E-s~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLE-SSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEee-cccCCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 34455678999999999999999999999999999999954 444456778889999999986 7899999999999999
Q ss_pred EEEEeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC-cEEEeecccccccc
Q 027738 95 AIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSV 172 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~-~v~l~dfg~a~~~~ 172 (219)
++||+.+ |.+|.+... -.+.|+..+++-++.|++.-++++|..+++|+||||+|++..-+..+ ++.++|||+|+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 568888776 34569999999999999999999999999999999999998655543 49999999998654
Q ss_pred cCCCC--------CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 173 LHSQP--------KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 173 ~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
..... ....||.+|.+-....+..-++.+|..|+|.+++++.-|.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~ 218 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGS 218 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCC
Confidence 43322 2345889999988888877789999999999999987764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=181.63 Aligned_cols=163 Identities=17% Similarity=0.101 Sum_probs=125.4
Q ss_pred cccCCccceeeccccCcCceEEEEEEECC-CCcEEEEEEeccC------cccCHHHHHHHHHHHhCCCCcEeE-EEEEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR-FKEVIL 89 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~~K~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~ 89 (219)
.....++|++.+.||+|+||+||++.+.. +++.+++|+.... ....+.+.+|+++++.++|+++++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34567889999999999999999999876 6777899986532 112356889999999999999874 4442
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEecCCCCCcEEEeecccc
Q 027738 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl-~p~nili~~~~~~~v~l~dfg~a 168 (219)
+..+++|||++|++|.. ... .. ...++.+++.+|.++|+.|++|+|| ||+||+++.++. ++|+|||+|
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA 159 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLA 159 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccc
Confidence 45799999999998863 211 11 1467889999999999999999999 999999976665 999999999
Q ss_pred cccccCCCCC---------CCCCCCCCCCchhhc
Q 027738 169 KSSVLHSQPK---------STVGTPAYIAPEVLL 193 (219)
Q Consensus 169 ~~~~~~~~~~---------~~~~~~~~~aPE~~~ 193 (219)
+......... ...++..|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 7554332111 223566788999876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=182.72 Aligned_cols=196 Identities=25% Similarity=0.342 Sum_probs=161.9
Q ss_pred cccCCccceeeccccCcCceEEEEEEECC---CCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCe
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTH 93 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 93 (219)
+......|....+||.|.|++||++.+.. .+..|++|.+.... ...++..|++++..+. +.|++++.+.+..++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 34456789999999999999999999886 67889999886543 3467899999999885 8999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
..+|+||++.....++... ++..++..+++.++.+|.++|.+||+|+|+||+|++++.... +-.|+|||+|.....
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDG 185 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHh
Confidence 9999999988777766654 679999999999999999999999999999999999986655 479999999851100
Q ss_pred CC--------------C-------------------------------CCCCCCCCCCCCchhhcc-ccccceeeEEEEE
Q 027738 174 HS--------------Q-------------------------------PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSIT 207 (219)
Q Consensus 174 ~~--------------~-------------------------------~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg 207 (219)
.. . .....|+++|+|||++.. ..-+.++|+||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 001237899999999986 4457889999999
Q ss_pred EEEeecCCCCC
Q 027738 208 QMSLQSTSPND 218 (219)
Q Consensus 208 ~~~~~~~~g~~ 218 (219)
++++.++++..
T Consensus 266 VI~Lslls~~~ 276 (418)
T KOG1167|consen 266 VILLSLLSRRY 276 (418)
T ss_pred ceeehhhcccc
Confidence 99999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=182.87 Aligned_cols=193 Identities=26% Similarity=0.257 Sum_probs=159.3
Q ss_pred cceeeccccCcCceEEEEEEECCCC-cEEEEEEeccCccc-CHHHHHHHHHHHhCC----CCcEeEEEEEE-EcCCeEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKI-DENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI 96 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~l 96 (219)
+|++.+.||+|+||.||.+.+...+ ..+|+|........ ...+..|..++..+. .++++.+++.+ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998664 57888876554322 236788888888876 36999999999 57778899
Q ss_pred EEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-C--CcEEEeeccccc--
Q 027738 97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK-- 169 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~--~~v~l~dfg~a~-- 169 (219)
||+.+ |.+|.+..... +.++..++..++.|++.+|.++|+.|++|+||||.|+.+.... . ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99988 66999888544 4699999999999999999999999999999999999997654 1 349999999998
Q ss_pred ccccCC--------C-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 170 SSVLHS--------Q-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 170 ~~~~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
...... . .....||.+|.++....+...++++|+|||+.++.++..|.
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 321111 1 12334899999999999999999999999999999999884
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=174.05 Aligned_cols=194 Identities=22% Similarity=0.268 Sum_probs=168.5
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.-.|++.++||.|.||.++.+.+--++++||+| +.+.......+..|.+..+.+. .++|+.++-+..++..-.+|+|.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIK-fEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIK-FEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEE-eccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 458999999999999999999999999999999 5555555678899999999885 69999999999999899999999
Q ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCc---EEEeecccccccccCCC
Q 027738 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 101 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~---v~l~dfg~a~~~~~~~~ 176 (219)
+ |.+|.+...- .+.|+..++.-+|.|++.-++++|++.+|++||||+|+||..-+..+ +.++|||+|+.+.....
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 8 6689888875 45699999999999999999999999999999999999996544432 89999999987665544
Q ss_pred CC--------CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 177 PK--------STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 177 ~~--------~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.+ +..||.+||+-....+..-++.+|+.|||-+++++|-|.
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGs 233 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 233 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCC
Confidence 33 335899999999999998899999999999999999885
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=163.97 Aligned_cols=168 Identities=15% Similarity=0.134 Sum_probs=129.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHH----------HHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~----------~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
.++|+..+.++.|++|.||.+.. ++..+++|.+.+.....+. +++|+..+.++.|++++.+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 67999999999999999999766 3667999998754433332 57888899999999999999887643
Q ss_pred --------CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEe
Q 027738 92 --------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (219)
Q Consensus 92 --------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~ 163 (219)
+..+++|||++|.+|.+... ++. ....+++.++..+|+.|++|||++|+||++++++ ++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~li 176 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRII 176 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEE
Confidence 35789999999999977632 233 2456899999999999999999999999998665 8999
Q ss_pred ecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeec
Q 027738 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQS 213 (219)
Q Consensus 164 dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~ 213 (219)
|||......... ..........+..++|+||||+++..+
T Consensus 177 Dfg~~~~~~e~~-----------a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 177 DLSGKRCTAQRK-----------AKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred ECCCcccccchh-----------hHHHHHHHhHhcccccccceeEeehHH
Confidence 999765331110 001133455667789999999998653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=158.25 Aligned_cols=137 Identities=20% Similarity=0.198 Sum_probs=107.5
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCccc----------C-----------------HHHHHHHHHHHhCCCCc
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------D-----------------ENVQREIINHRSLRHPN 80 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----------~-----------------~~~~~e~~~l~~l~~~~ 80 (219)
.+.||+|++|.||.+.+. +|+.||+|++...... . .....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999997 8999999998654211 0 12235888888887776
Q ss_pred EeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCEEecCCCCCc
Q 027738 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPR 159 (219)
Q Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~ivh~dl~p~nili~~~~~~~ 159 (219)
+......... ..+++|||++++++.........++..++..++.|++.+|.++ |+.|++|+||||+||++++ + +
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--K 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--c
Confidence 5333222222 2389999999877765545556789999999999999999999 7999999999999999973 3 4
Q ss_pred EEEeecccccc
Q 027738 160 LKICDFGYSKS 170 (219)
Q Consensus 160 v~l~dfg~a~~ 170 (219)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-24 Score=154.11 Aligned_cols=139 Identities=18% Similarity=0.139 Sum_probs=109.3
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---------------------------CHHHHHHHHHHHhCCCC
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHP 79 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------------------------~~~~~~e~~~l~~l~~~ 79 (219)
+.+.||+|++|.||++.+. +|+.||+|++...... ...+..|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998764211 11235788888889888
Q ss_pred cEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCC
Q 027738 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~ 158 (219)
++.....+.... .+++|||++|+++.........++..+...++.+++.++.++|+ .|++|+||||+||+++ ++.
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~- 155 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK- 155 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC-
Confidence 774443333332 47999999987554443344567888999999999999999999 9999999999999998 444
Q ss_pred cEEEeeccccccc
Q 027738 159 RLKICDFGYSKSS 171 (219)
Q Consensus 159 ~v~l~dfg~a~~~ 171 (219)
++|+|||++...
T Consensus 156 -~~liDFG~a~~~ 167 (190)
T cd05145 156 -PYIIDVSQAVEL 167 (190)
T ss_pred -EEEEEcccceec
Confidence 999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-26 Score=193.93 Aligned_cols=139 Identities=13% Similarity=0.123 Sum_probs=105.8
Q ss_pred CcEeEEEEEE-------EcCCeEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 027738 79 PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (219)
Q Consensus 79 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~ni 150 (219)
+||..++++| .....++.++|++ +++|.+++.. .+.++..++..++.|++.||.|||++||+|+||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 3555566665 2234577888887 5599999965 34599999999999999999999999999999999999
Q ss_pred EecCCC-----------------CCcEEEeecccccccccCC-----------------CCCCCCCCCCCCCchhhcccc
Q 027738 151 LLDGSP-----------------APRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEVLLRHE 196 (219)
Q Consensus 151 li~~~~-----------------~~~v~l~dfg~a~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~~ 196 (219)
|++..+ ...++++|||+++...... ......+++.|+|||.+.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 996422 2236777777765321100 001124677899999999989
Q ss_pred ccceeeEEEEEEEEeecCCCCC
Q 027738 197 YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 197 ~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.++|||||||++|||++|..
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~ 213 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVS 213 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCC
Confidence 9999999999999999998753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=181.87 Aligned_cols=196 Identities=20% Similarity=0.266 Sum_probs=158.5
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC---CCcEeEEEEEEEcCCeEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~ 95 (219)
....+.|.+.+.+|.|++|+||.|.... ++.||+|+-.++..++=-+- .+++.+++ -+.|..+...+.-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~--~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC--LQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh--HHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3457899999999999999999999985 99999998776655431111 12222232 355666666777778889
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-----CCCcEEEeecccccc
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKS 170 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~-----~~~~v~l~dfg~a~~ 170 (219)
++++|.+.|+|.+.++..+.+++..+..+..|++..++.||..+||||||||+|.++... +...++|+|||.+..
T Consensus 771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 999999999999999988889999999999999999999999999999999999998522 222499999999875
Q ss_pred cccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 171 SVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 171 ~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
...-... ...+.+-.|-.+|...|..|++++|.|+|+.+++-|+.|.
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 5444333 2335788899999999999999999999999999998875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=157.25 Aligned_cols=190 Identities=36% Similarity=0.545 Sum_probs=161.4
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCC-cEeEEEEEEEcCCeEEEEEe
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 99 (219)
|.+.+.||.|.++.||.+.+. ..+++|.+...... ...+.+|...+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 77888988665432 45688899999999988 79999999988777899999
Q ss_pred ccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-
Q 027738 100 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~- 175 (219)
++.++++.+.+.... .++......++.|++.++.++|+.+++|+|+||+||+++..+. .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence 999999997776664 6899999999999999999999999999999999999987762 28999999986443332
Q ss_pred ------CCCCCCCCCCCCCchhhcc---ccccceeeEEEEEEEEeecCCCCC
Q 027738 176 ------QPKSTVGTPAYIAPEVLLR---HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ------~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......++..|.+||...+ ...+...|+||+|++++++++|..
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~ 209 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 2345578999999999987 577889999999999888887763
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=144.76 Aligned_cols=178 Identities=16% Similarity=0.157 Sum_probs=132.5
Q ss_pred eeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCH-----HHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEe
Q 027738 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 26 ~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~-----~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.....|++|.||+|+.+.. .+..++.+.+...+...+ .+.+|+++++++. ++++++++++ +..+++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3568899999999997765 577788777766554333 4789999999996 4889999886 44689999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCCEEecCCCCCcEEEeecccccccccCCCC-
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl-~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~- 177 (219)
|+.|.+|...... ....++.+++.+|.++|++|++|+|| +|.||+++.++. ++|+|||+|........-
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchHH
Confidence 9999888643311 12357789999999999999999999 799999987766 999999999744322210
Q ss_pred -------------CCCCCCCCCCCchhhccc-ccc-ceeeEEEEEEEEeecCCCCC
Q 027738 178 -------------KSTVGTPAYIAPEVLLRH-EYD-GKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 -------------~~~~~~~~~~aPE~~~~~-~~~-~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....++.+++|+...-- ..+ ...++++.|+-+|.+.|++-
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~ 205 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRV 205 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccC
Confidence 001146677777775422 223 45688999999999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-22 Score=146.17 Aligned_cols=142 Identities=17% Similarity=0.068 Sum_probs=112.3
Q ss_pred ccceeeccccCcCceEEEEEE-ECCCCcEEEEEEeccCccc-------------------------CHHHHHHHHHHHhC
Q 027738 23 DRYDFVRDIGSGNFGVARLMR-DKVTKELVAVKYIERGDKI-------------------------DENVQREIINHRSL 76 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~-~~~~~~~v~~K~~~~~~~~-------------------------~~~~~~e~~~l~~l 76 (219)
.-|++.+.||+|++|.||+|. +..+|+.|++|++...... ...+..|+..+..+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 368899999999999999999 6678999999998653210 02346789999888
Q ss_pred CC--CcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCCEEec
Q 027738 77 RH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLD 153 (219)
Q Consensus 77 ~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~-ivh~dl~p~nili~ 153 (219)
.+ ..+++++++ ...++|+||+++.++.............+...++.|++.++.+||+.| ++|+||+|+||+++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 65 335555553 235899999999887665544455677778899999999999999999 99999999999998
Q ss_pred CCCCCcEEEeeccccccc
Q 027738 154 GSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 154 ~~~~~~v~l~dfg~a~~~ 171 (219)
++. ++++|||.+...
T Consensus 184 -~~~--i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGK--VVIIDVSQSVEL 198 (237)
T ss_pred -CCC--EEEEEChhhhcc
Confidence 444 999999988643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-23 Score=156.83 Aligned_cols=196 Identities=15% Similarity=0.133 Sum_probs=155.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCC-----CcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcC-C
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTP-T 92 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~ 92 (219)
...++++.-.+.+|.||.+|.+.+..- .+.+.+|.++..... -..+.+|.-++.-+.|||+..+.++..+. .
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 456788888899999999999966522 234566655443222 24567788788888999999999988764 4
Q ss_pred eEEEEEeccCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 93 HLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
..++++.+...++|..++.. .+..+..++..++.|+..++++||+.+++|.||-.+|-+|++.-. ++|+|
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--VkltD 439 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLTD 439 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEecc
Confidence 67888899999999999871 234788889999999999999999999999999999999987754 99999
Q ss_pred cccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
=.+++..-++... -..-.+..|++||.+.+..|+..+|+||||++++||.|-+.
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~ 496 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGK 496 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCC
Confidence 8888754333222 22234668999999999999999999999999999988654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-20 Score=136.04 Aligned_cols=137 Identities=18% Similarity=0.205 Sum_probs=106.0
Q ss_pred eeeccccCcCceEEEEEEECCCCcEEEEEEeccCc-ccCHHHHHHHHHHHhC-----CCCcEeEEEEEEEcCC---e-EE
Q 027738 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---H-LA 95 (219)
Q Consensus 26 ~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~-~~ 95 (219)
.-.+.||+|+++.||. +..+... ++|++.... ...+.+.+|+..++.+ .||||++++++++++. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3467899999999995 6656555 688876542 2346789999999999 5799999999999874 3 33
Q ss_pred EEEec--cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCCEEecCCC--CCcEEEeecccc
Q 027738 96 IVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYS 168 (219)
Q Consensus 96 lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l-~~lh~~~ivh~dl~p~nili~~~~--~~~v~l~dfg~a 168 (219)
+|+|| +.+++|.+.+... .+++. ..++.+++.++ +|||+++|+|+||||+||+++..+ ..+++|+|++-+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 4478999999764 45555 35677888777 899999999999999999997532 335999994433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.4e-22 Score=163.28 Aligned_cols=193 Identities=32% Similarity=0.479 Sum_probs=151.4
Q ss_pred ccc-eeeccccCcCceEEEEEEECCCCcEEEEEEec----cCcccC---HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 23 DRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE----RGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 23 ~~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~----~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
+.| .....+|.|++|.++.+......+.+..|.+. ...... ..+..|..+-..+.|++++.....+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 446 45688899999977877776555555555433 111111 1244555666678899998877777776666
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
...||||++ +|..++.....+...++.-++.|++.+++|+|+.|+.|+|+||+|+++..++. ++++|||.+.....+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccC
Confidence 666999999 99999988777999999999999999999999999999999999999998887 999999987533333
Q ss_pred CC-----CCCCCCCCCCCCchhhccccccce-eeEEEEEEEEeecCCCCC
Q 027738 175 SQ-----PKSTVGTPAYIAPEVLLRHEYDGK-VYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....|+..|+|||++.+..|++. .|+||.|++++.|.+|+-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 22 234568999999999999988764 799999999999999964
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-20 Score=135.09 Aligned_cols=134 Identities=22% Similarity=0.209 Sum_probs=110.1
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCccc---------CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
++.||+|++|.||++.. ++..+++|........ ...+.+|+..+..+.+++++....++......++++
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36789999999999987 4677889976532211 134667889999999888877777777777889999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
||++|.+|.+.+..... +...++.+++.+|.++|+.+++|+|++|.||+++ ++. ++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 99999999988865432 8888999999999999999999999999999998 443 89999998864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.1e-22 Score=140.97 Aligned_cols=101 Identities=21% Similarity=0.185 Sum_probs=87.0
Q ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCC
Q 027738 104 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (219)
Q Consensus 104 ~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~ 182 (219)
|+|.+.+.. ..++++.+++.++.|++.||.|||+.+ ||+||+++.++. +++ ||++...... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 578888876 446999999999999999999999998 999999988776 777 9988654322 2257
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.|+|||.+.+..++.++||||||+++|||++|..
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 102 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYEL 102 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 899999999999999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-19 Score=130.30 Aligned_cols=130 Identities=22% Similarity=0.181 Sum_probs=102.1
Q ss_pred cccCcCceEEEEEEECCCCcEEEEEEeccCccc---------CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 30 ~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.||+|++|.||++.. ++..+++|........ ..++.+|++.++.++++++.....++......++++|+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 479999999999985 4678899975432111 14456899999999887655544455556667899999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
++|++|.+.+..... .++.+++.+|.++|+.+++|+|++|.||+++ ++. ++++|||++...
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~--~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK--LYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc--EEEEECCCCcCC
Confidence 999999887754321 7889999999999999999999999999998 443 999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-22 Score=158.42 Aligned_cols=182 Identities=25% Similarity=0.402 Sum_probs=152.2
Q ss_pred cccCcCceEEEEEEEC---CCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 30 DIGSGNFGVARLMRDK---VTKELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 30 ~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
.+|+|++|.++.+... ..+..+++|..+.... .+.....|..++..++ ||.++++.-.++.....+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3688999998887543 3466688887754321 1123445666777776 8999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCC
Q 027738 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182 (219)
Q Consensus 103 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~ 182 (219)
++.+...+.+...+.+.....+..+++-+++.+|+.+++++|+|++||+++.+|. +++.|||+.+........ +|
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence 9999999999999999999999999999999999999999999999999999988 999999998755433333 89
Q ss_pred CCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 183 TPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 183 ~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..|+|||.++ .....+|+||+|++++||+||..
T Consensus 156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~ 189 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTL 189 (612)
T ss_pred chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCC
Confidence 99999999998 44667899999999999999863
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-19 Score=129.55 Aligned_cols=134 Identities=22% Similarity=0.253 Sum_probs=104.0
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-----------------------cCHHHHHHHHHHHhCCCC-
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHP- 79 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~- 79 (219)
.|.+.+.|++|++|.||++... +++.+++|++..+.. .......|...+..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888899999999999999885 789999998754321 011246677778777666
Q ss_pred -cEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 80 -NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 80 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
.++..++. ...++++||++|.+|..... ......++.+++.++.++|+.+++|+||+|+||++++++.
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 44555442 34589999999988865432 1345678899999999999999999999999999987665
Q ss_pred cEEEeecccccc
Q 027738 159 RLKICDFGYSKS 170 (219)
Q Consensus 159 ~v~l~dfg~a~~ 170 (219)
++|+|||.+..
T Consensus 164 -~~liDfg~~~~ 174 (198)
T cd05144 164 -IYIIDWPQMVS 174 (198)
T ss_pred -EEEEECCcccc
Confidence 99999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.3e-19 Score=144.50 Aligned_cols=136 Identities=21% Similarity=0.120 Sum_probs=107.5
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccC-c--------ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-D--------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~-~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
.|...+.||+|++|.||++..... .+++|+.... . ...+++.+|++.++.++|++++....+.......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345678999999999999887533 3344432111 0 1124577899999999999998877777777778
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
++++||+++++|.+.+. ....++.+++.+|.+||+.+++|+|+||+||+++ ++. ++++|||+++...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~--~~liDFGla~~~~ 478 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKYSD 478 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc--EEEEeCcccccCC
Confidence 99999999999988775 3567899999999999999999999999999993 443 9999999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-20 Score=137.58 Aligned_cols=189 Identities=19% Similarity=0.128 Sum_probs=120.6
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-c---CHHHHHHHHHHHhCCC----------CcEeEEEEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-I---DENVQREIINHRSLRH----------PNIVRFKEVIL 89 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~---~~~~~~e~~~l~~l~~----------~~i~~~~~~~~ 89 (219)
.....+.||.|+++.||.+++..+++.+++|++..... . .+.+++|......+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45677899999999999999999999999998754321 1 2445555544443321 12333333332
Q ss_pred c---------C---C-----eEEEEEeccCCCcHHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 027738 90 T---------P---T-----HLAIVMEYASGGELFERIC---NAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDL 145 (219)
Q Consensus 90 ~---------~---~-----~~~lv~e~~~~~~L~~~~~---~~~~----~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl 145 (219)
. . . ..+++++...+ +|...+. .... ........+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 24678887754 7766653 2222 223334455689999999999999999999
Q ss_pred CCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhcc--------ccccceeeEEEEEEEEeecCCCC
Q 027738 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--------HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 146 ~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
+|+|++++.+|. +.|+||+........... ...+..|.+||.... ..++.+.|.|+||+++|.+-+++
T Consensus 172 ~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999887 999999987644332221 333467889998743 24678899999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.4e-21 Score=159.49 Aligned_cols=188 Identities=23% Similarity=0.361 Sum_probs=147.5
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHH--HHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIIN--HRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~--l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.+...+.||++.|=++.++.+. .| .|++|++-+.... .+.+.++++- ....++||++++..+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 7899999999999999999886 33 4889988654422 2444443333 345689999999999888888899999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~ 179 (219)
|.-. +|.+.+..++-+..-+.+.++.|++.||...|..||.|||||.+||||..=+. +.|+||...+..........
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcc
Confidence 8854 89999987776788889999999999999999999999999999999986665 89999998764443333222
Q ss_pred C--------CCCCCCCCchhhcccc-----------ccceeeEEEEEEEEeecCCC
Q 027738 180 T--------VGTPAYIAPEVLLRHE-----------YDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 180 ~--------~~~~~~~aPE~~~~~~-----------~~~~~Dv~slg~~~~~~~~g 216 (219)
. ..-.+|.|||.+.... .+++-|+||+||++.|+++-
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~E 234 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLE 234 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhc
Confidence 1 1334799999987421 56788999999999998764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.4e-18 Score=120.57 Aligned_cols=135 Identities=21% Similarity=0.228 Sum_probs=94.6
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHH-------------------------HHHHHHHHHhCCCC--c
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-------------------------VQREIINHRSLRHP--N 80 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~-------------------------~~~e~~~l~~l~~~--~ 80 (219)
.+.||+|++|+||.+.+. +++.|++|++......... ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 8889999988653221111 12445555554333 2
Q ss_pred EeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCc
Q 027738 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPR 159 (219)
Q Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~ 159 (219)
+++.++. ...++++||++++.+.......... ..+...++.+++.++.++|+ .+++|+||+|+||+++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~-- 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK-- 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc--
Confidence 4444443 2358999999984332111111011 16678899999999999999 9999999999999998 444
Q ss_pred EEEeeccccccc
Q 027738 160 LKICDFGYSKSS 171 (219)
Q Consensus 160 v~l~dfg~a~~~ 171 (219)
++++|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-17 Score=114.68 Aligned_cols=132 Identities=23% Similarity=0.266 Sum_probs=110.3
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCC--CcEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
+.+.|+.|.++.+|++... ++.+++|....... ...+.+|...++.+++ ..+++++.+....+..++++||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 4578999999999999986 36789998865443 5678899999999976 58999999988888899999999887
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 105 ~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
++... +......++.+++.+++.+|.. +++|+|++|.||++++.+. ++++||+.+..
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAGY 138 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEecccccC
Confidence 66543 5566777889999999999985 6999999999999987544 99999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-17 Score=121.12 Aligned_cols=144 Identities=19% Similarity=0.236 Sum_probs=105.5
Q ss_pred ccCCccceee-cccc-CcCceEEEEEEECCCCcEEEEEEeccCc--------------ccCHHHHHHHHHHHhCCCCcE-
Q 027738 19 MHDSDRYDFV-RDIG-SGNFGVARLMRDKVTKELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI- 81 (219)
Q Consensus 19 ~~~~~~y~~~-~~l~-~g~~~~v~~~~~~~~~~~v~~K~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i- 81 (219)
+.+.+.+... ..|| .|+-|++|.+... +..+++|.+.... .....+.+|+.++..++++++
T Consensus 26 ~~~~~~~~~~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~ 103 (239)
T PRK01723 26 LFDPDFWQQQARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLP 103 (239)
T ss_pred hcCHHHHhhcCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCC
Confidence 3344455433 3465 7888888888775 6778999885321 122457889999999988775
Q ss_pred -eEEEEEEEcCC----eEEEEEeccCC-CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC
Q 027738 82 -VRFKEVILTPT----HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155 (219)
Q Consensus 82 -~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~ 155 (219)
+..+++..... ..++++|+++| .+|.+.+.. .+++... +.+++.++.++|+.|++|+||+|.||+++.+
T Consensus 104 vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 104 VPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPD 178 (239)
T ss_pred CceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCC
Confidence 66776644322 23599999997 688877754 3455543 5688999999999999999999999999876
Q ss_pred CCCcEEEeeccccccc
Q 027738 156 PAPRLKICDFGYSKSS 171 (219)
Q Consensus 156 ~~~~v~l~dfg~a~~~ 171 (219)
+. ++|+|||.+...
T Consensus 179 ~~--v~LIDfg~~~~~ 192 (239)
T PRK01723 179 GK--FWLIDFDRGELR 192 (239)
T ss_pred CC--EEEEECCCcccC
Confidence 65 999999988654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-19 Score=149.57 Aligned_cols=164 Identities=29% Similarity=0.467 Sum_probs=120.4
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
...+..++|+.++.+..|++|.||.++++.+.+++++| ++++.. +.+. ++.-...|.++
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn--ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN--ILTFAGNPFVV-------------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc--cccccCCccee--------------
Confidence 44556778999999999999999999999999999995 543321 1111 11111222222
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
|+=...++..++++... +.+++|+|+.+|+|+|+||+|.+|..-+. ++++|||+++.......
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhcc
Confidence 23344455545555443 77899999999999999999999988887 99999999752211111
Q ss_pred ----------------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 ----------------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ----------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++++.|.|||++..+.|...+|+|++|+++|+++-|-.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcv 256 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 256 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeee
Confidence 112368999999999999999999999999999999997753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-19 Score=132.25 Aligned_cols=191 Identities=18% Similarity=0.307 Sum_probs=152.3
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC---cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
.+..+..+..+|.....|..|+++++ |..++.|+++.. ....++|.+|+-.++.+.||||+++++.+..+..+.+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 44556677888999999999999987 455677877654 3445789999999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC-cee-ccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 97 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ-VCH-RDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~-ivh-~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
+..|++.++|...++.... .+..+..+++..++.+++|||+.. ++- --++...++|+++-+.++.+.|--++
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs---- 340 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---- 340 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee----
Confidence 9999999999999987655 577788999999999999999984 333 37889999999887755655554432
Q ss_pred cCCCCCCCCCCCCCCCchhhcccccc---ceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYD---GKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+.-++.|++||.+..++-+ +.+|.|||+++++|+.|.+.
T Consensus 341 --fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trev 387 (448)
T KOG0195|consen 341 --FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREV 387 (448)
T ss_pred --eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccc
Confidence 122233446789999999765432 56899999999999988753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-17 Score=127.57 Aligned_cols=138 Identities=28% Similarity=0.388 Sum_probs=104.0
Q ss_pred CCCcEeEEEEEEEc---------------------------CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHH
Q 027738 77 RHPNIVRFKEVILT---------------------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129 (219)
Q Consensus 77 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~ 129 (219)
+||||+++.+.|.+ +..+|+||..++. +|..++-.. ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999888853 2347899987754 788777554 357888888999999
Q ss_pred HHHHHHHHCCceeccCCCCCEEec--CCCCCcEEEeeccccccccc-------CCCCCCCCCCCCCCCchhhcccc----
Q 027738 130 SGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVL-------HSQPKSTVGTPAYIAPEVLLRHE---- 196 (219)
Q Consensus 130 ~~l~~lh~~~ivh~dl~p~nili~--~~~~~~v~l~dfg~a~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~---- 196 (219)
+++.+||+.|+.|+|+|.+||++. ++.-+.+++.|||++-.... ........|+...+|||......
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999984 55555689999998632111 11112234667789999986311
Q ss_pred -c-cceeeEEEEEEEEeecCCC
Q 027738 197 -Y-DGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 197 -~-~~~~Dv~slg~~~~~~~~g 216 (219)
. -.++|.|+.|.+.||.++.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~ 453 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGR 453 (598)
T ss_pred eeccchhhhhhhhhhHHHHhcc
Confidence 1 2578999999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.5e-18 Score=138.75 Aligned_cols=196 Identities=31% Similarity=0.439 Sum_probs=159.3
Q ss_pred CCccceeeccccCcCceEEEEEEECCC-CcEEEEEEeccCcccC---HHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYIERGDKID---ENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~~K~~~~~~~~~---~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 95 (219)
....|.+.+.||+|+++.+-...+..+ ...++.|.+....... ..+..|....+.+. |+|++.+++........+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 577899999999999999888877543 4456777666554222 34445777777776 999999999999999999
Q ss_pred EEEeccCCCcHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 96 IVMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 96 lv~e~~~~~~L~~~~-~~~~-~~~~~~~~~~~~~l~~~l~~lh-~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
+..++..++++...+ .... ..+....-.++.|+..++.|+| ..++.|+|++|+|.+++..+. .+++.|||+|....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYR 176 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccc
Confidence 999999999999888 5554 5788888999999999999999 999999999999999998882 28999999997554
Q ss_pred c-CCCC---CCCCC-CCCCCCchhhcccc-ccceeeEEEEEEEEeecCCCC
Q 027738 173 L-HSQP---KSTVG-TPAYIAPEVLLRHE-YDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 173 ~-~~~~---~~~~~-~~~~~aPE~~~~~~-~~~~~Dv~slg~~~~~~~~g~ 217 (219)
. .... ....+ ++.|.|||...+.. ..+..|+||.|+++..+++|+
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~ 227 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGE 227 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCC
Confidence 4 2121 23467 99999999998854 467799999999999999986
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-15 Score=106.98 Aligned_cols=137 Identities=14% Similarity=0.148 Sum_probs=100.5
Q ss_pred eccccCcCceEEEEEEECC------CCcEEEEEEeccC--------------cc---------cC----HHHHHHHHHHH
Q 027738 28 VRDIGSGNFGVARLMRDKV------TKELVAVKYIERG--------------DK---------ID----ENVQREIINHR 74 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~------~~~~v~~K~~~~~--------------~~---------~~----~~~~~e~~~l~ 74 (219)
...|++|..+.||.+.... .+..+|+|++..+ +. .. .+.++|+..++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4689999999999998653 3578999987421 11 01 12348999998
Q ss_pred hCCC--CcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCEE
Q 027738 75 SLRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTL 151 (219)
Q Consensus 75 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~ivh~dl~p~nil 151 (219)
++.. -.+|.++++ ..-+++||++.+..+.....+...++..+...+..+++.+|..+ |+.|++||||+|.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8864 456777765 45789999997654422222333456667778889999999988 8999999999999999
Q ss_pred ecCCCCCcEEEeeccccccc
Q 027738 152 LDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 152 i~~~~~~~v~l~dfg~a~~~ 171 (219)
+.++ ++.++|||.+...
T Consensus 158 ~~~~---~v~iIDF~qav~~ 174 (197)
T cd05146 158 WHDG---KVWFIDVSQSVEP 174 (197)
T ss_pred EECC---cEEEEECCCceeC
Confidence 9743 3899999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-17 Score=130.63 Aligned_cols=119 Identities=27% Similarity=0.335 Sum_probs=102.5
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 92 THLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
.++++.|++|.-.+|.+++...+. -+......++.|+..++.| ++.+|+|++|.||+...+.. ++|.|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhe
Confidence 357899999999999999975543 5677788899999999999 99999999999999987775 999999998
Q ss_pred cccccCC-------CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC
Q 027738 169 KSSVLHS-------QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 169 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~ 215 (219)
....... ......++..|++||.+.+..|+.++|+||||++++|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 6554444 3445679999999999999999999999999999999875
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.4e-15 Score=104.50 Aligned_cols=128 Identities=17% Similarity=0.195 Sum_probs=95.4
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc-EeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
++.++.|..+.+|++... ++.+++|...........+..|+..++.+.+.+ +++++.... ...++++||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 467788999999999875 778999987654433345678888888875433 455665543 235799999999877
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i-----vh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
... .......+.++..+|+.||+.++ +|||++|.||+++ ++. ++++||+.+..
T Consensus 79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~--~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR--LWLIDWEYAGM 136 (170)
T ss_pred ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe--EEEEecccccC
Confidence 543 11123456789999999999985 9999999999998 333 89999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-13 Score=95.97 Aligned_cols=129 Identities=22% Similarity=0.209 Sum_probs=97.5
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc-----c-----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----I-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-----~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..+.+|+-+.++.+... +..+++|. ..+.. . .++..+|+.++.+++.-+++...-+..+.....++|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 45788999999988654 54566663 22111 1 144578999998887767766666667777888999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
||++|..|.+.+... . ..++..+-..+.-||..||+||||+++||+++.++ +.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCcccc
Confidence 999999888888765 1 34556666667889999999999999999997554 89999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-15 Score=121.49 Aligned_cols=143 Identities=23% Similarity=0.316 Sum_probs=117.9
Q ss_pred HhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCCCEE
Q 027738 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQV-CHRDLKLENTL 151 (219)
Q Consensus 74 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i-vh~dl~p~nil 151 (219)
+.++|.|+.++++.+.++...+.+.++|+.|+|.+.+.. ...++......+++.++++|+|+|+..+ .||.++..|-+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl 81 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL 81 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence 567899999999999999999999999999999999987 4457888888899999999999998876 99999999999
Q ss_pred ecCCCCCcEEEeecccccccccC---CCCCCCCCCCCCCCchhhccc---c----ccceeeEEEEEEEEeecCCCCC
Q 027738 152 LDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRH---E----YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 152 i~~~~~~~v~l~dfg~a~~~~~~---~~~~~~~~~~~~~aPE~~~~~---~----~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.... +|++|||+....... ...........|.|||.+++. . .+.+.|+||+|++++|+++..+
T Consensus 82 vd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 82 VDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred eeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 988777 999999987544321 111111235579999999853 1 4677999999999999988654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=7e-14 Score=112.43 Aligned_cols=135 Identities=17% Similarity=0.185 Sum_probs=92.9
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCccc--------------------------C---------------HHHH
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--------------------------D---------------ENVQ 67 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--------------------------~---------------~~~~ 67 (219)
+.|++|+.|.||+|+.. +|+.||+|+..+.-.. . -++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999986 7899999987543100 0 0133
Q ss_pred HHHHHHHhC----CC-CcE--eEEEEEEEcCCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHC
Q 027738 68 REIINHRSL----RH-PNI--VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHAM 138 (219)
Q Consensus 68 ~e~~~l~~l----~~-~~i--~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~-~l~~lh~~ 138 (219)
.|+..+.++ ++ +++ ++++ .......+++|||++|.++.+..... ... ....++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~--~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVY--WDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEe--hhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 445444444 22 332 2333 22344579999999999997766432 122 23345555555 46789999
Q ss_pred CceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 139 ~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
|++|+|++|.||++++++. ++++|||++...
T Consensus 277 g~~H~D~hPgNilv~~~g~--i~liDfG~~~~l 307 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGK--IIALDFGIVGRL 307 (437)
T ss_pred CceeCCCCcccEEECCCCc--EEEEeCCCeeEC
Confidence 9999999999999987766 999999998644
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.4e-14 Score=116.01 Aligned_cols=166 Identities=16% Similarity=0.198 Sum_probs=128.1
Q ss_pred EEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHH
Q 027738 42 MRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 120 (219)
Q Consensus 42 ~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 120 (219)
+..+.++.++.+..++..... .+...+.++.++.++||+|+++++.++..+..|+|+|.+. .|...++.. +...
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~ 105 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEE 105 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHH
Confidence 445567888888888765542 2446788899999999999999999999999999999875 466666664 4778
Q ss_pred HHHHHHHHHHHHHHHH-HCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-CCCCCCCCCCCCchhhcccccc
Q 027738 121 ARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYD 198 (219)
Q Consensus 121 ~~~~~~~l~~~l~~lh-~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~ 198 (219)
+..-++||+.||.+|| +.+++|+|++...|+|+..|. .+|.+|.++........ .......-.|..|+.+....+
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~- 182 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW- 182 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc-
Confidence 8889999999999997 668999999999999999988 99999998754332222 111223334666766543332
Q ss_pred ceeeEEEEEEEEeecCCC
Q 027738 199 GKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 199 ~~~Dv~slg~~~~~~~~g 216 (219)
..|.|.||++.+++.+|
T Consensus 183 -s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 -SIDSWGLGCLIEELFNG 199 (690)
T ss_pred -chhhhhHHHHHHHHhCc
Confidence 36999999999999988
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.4e-13 Score=92.91 Aligned_cols=141 Identities=16% Similarity=0.102 Sum_probs=106.4
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEe-c----cC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYI-E----RG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~-~----~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
.+..+.+|+.+.|+.+... |+.+++|.= . .+ .....+..+|++.+.++.--+|.-..-+|.+...-.+.
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5788899999999988775 777777731 1 11 11235668899999888766776666667777777899
Q ss_pred EeccCC-CcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCc-EEEeeccccc
Q 027738 98 MEYASG-GELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR-LKICDFGYSK 169 (219)
Q Consensus 98 ~e~~~~-~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~-v~l~dfg~a~ 169 (219)
|||++| .++.+++..... ..+.-...++..+-..+.-||.++++||||+.+||++.+++... +.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999987 466777765432 33333478888999999999999999999999999998777642 5899999875
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.2e-14 Score=115.96 Aligned_cols=142 Identities=24% Similarity=0.315 Sum_probs=92.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-----------------------------------cCH--
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------------------------------IDE-- 64 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-----------------------------------~~~-- 64 (219)
...|+. +.|++|+.|.|+.|+...+|+.||+|+..+.-. ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999987799999999864310 001
Q ss_pred ----HHHHHHHHHHhCC----CCcEeEEEEEEE-cCCeEEEEEeccCCCcHHHHH--HhcC----CCCHHHHHHHHHHHH
Q 027738 65 ----NVQREIINHRSLR----HPNIVRFKEVIL-TPTHLAIVMEYASGGELFERI--CNAG----RFSEDEARFFFQQLI 129 (219)
Q Consensus 65 ----~~~~e~~~l~~l~----~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~--~~~~----~~~~~~~~~~~~~l~ 129 (219)
++.+|+..+.+++ +...+.+-.++. .....+++|||++|+++.+.. ...+ .+....+..++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~---- 273 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF---- 273 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH----
Confidence 1234444444442 333233333332 245678999999999997643 2221 12222233333
Q ss_pred HHHHHHHHCCceeccCCCCCEEecCCC--CCcEEEeeccccccc
Q 027738 130 SGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 171 (219)
Q Consensus 130 ~~l~~lh~~~ivh~dl~p~nili~~~~--~~~v~l~dfg~a~~~ 171 (219)
..+...|++|+|++|.||+++.++ .++++++|||++...
T Consensus 274 ---~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 274 ---TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ---HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 345579999999999999998776 224999999997643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.4e-14 Score=113.02 Aligned_cols=195 Identities=20% Similarity=0.157 Sum_probs=153.5
Q ss_pred CCccceeeccccC--cCceEEEEEEE--CCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCC
Q 027738 21 DSDRYDFVRDIGS--GNFGVARLMRD--KVTKELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (219)
Q Consensus 21 ~~~~y~~~~~l~~--g~~~~v~~~~~--~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 92 (219)
....+.+.+.+|. |.+|.+|.+.. ..++..+++|.-..+. ....+-.+|+.....+ .|++.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3556778899999 99999999998 8888899999744332 2233445667666666 4899999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 93 HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~----~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
..++-+|.|. .++......... ++...++....+... ||.++|+.+++|.|++|.||+...+.. ..+++|||+
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~-s~~~~df~~ 269 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT-SCKLTDFGL 269 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc-eeecCCcce
Confidence 9999999996 466666655444 888999999999999 999999999999999999999987732 379999999
Q ss_pred ccccccCCCCCC------CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 168 SKSSVLHSQPKS------TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 168 a~~~~~~~~~~~------~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
............ ..+...|++||... ..++..+|+++||.+.++...+-+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~ 325 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSH 325 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcc
Confidence 876555443322 15777899999885 445778999999999988776654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.8e-12 Score=94.45 Aligned_cols=140 Identities=19% Similarity=0.263 Sum_probs=101.5
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCC--cEeEEEEEEEcCC---eEEEEEecc
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHP--NIVRFKEVILTPT---HLAIVMEYA 101 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~---~~~lv~e~~ 101 (219)
+.|+.|..+.+|++... +|+.+++|....... ....+..|...++.+.+. .+++++.+..... ..++++|++
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 56889999999999875 357899998765443 356788999999988753 4577777766543 568999999
Q ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 027738 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-------------------------------------------- 137 (219)
Q Consensus 102 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-------------------------------------------- 137 (219)
+|.++...+.. ..++..+...++.+++++|..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99877664431 235555666666666666666653
Q ss_pred ------------CCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 138 ------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 138 ------------~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
..++|+|+.|.||+++++....+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 346899999999999874222378999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-11 Score=92.26 Aligned_cols=131 Identities=14% Similarity=0.036 Sum_probs=94.2
Q ss_pred eEEEEEEECCCCcEEEEEEeccCcc------------cCHHHHHHHHHHHhCCCCcEe--EEEEEEEc-----CCeEEEE
Q 027738 37 GVARLMRDKVTKELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIV--RFKEVILT-----PTHLAIV 97 (219)
Q Consensus 37 ~~v~~~~~~~~~~~v~~K~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~--~~~~~~~~-----~~~~~lv 97 (219)
..|+++.. .|+.|.+|....... ......+|...+..+...+|+ ..+.+++. ....++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34556554 477888997643221 111367888888888554443 44555543 2347899
Q ss_pred EeccCCC-cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC-----CCCCcEEEeeccccc
Q 027738 98 MEYASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 169 (219)
Q Consensus 98 ~e~~~~~-~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~-----~~~~~v~l~dfg~a~ 169 (219)
+|++++. +|.+++.. ..+.+......++.++...+..||+.|++|+|++++||+++. ++..++.++||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999886 78887753 234567778899999999999999999999999999999975 233459999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.1e-12 Score=90.01 Aligned_cols=124 Identities=26% Similarity=0.284 Sum_probs=81.3
Q ss_pred EEEEEEECCCCcEEEEEEeccC--------------cc--------c-----CHHHHHHHHHHHhCCCC--cEeEEEEEE
Q 027738 38 VARLMRDKVTKELVAVKYIERG--------------DK--------I-----DENVQREIINHRSLRHP--NIVRFKEVI 88 (219)
Q Consensus 38 ~v~~~~~~~~~~~v~~K~~~~~--------------~~--------~-----~~~~~~e~~~l~~l~~~--~i~~~~~~~ 88 (219)
.||.|... ++..+|+|+.... .. . ..+.++|.+.|.++... ++|+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888875 6778999987421 00 1 13467899999999765 567777552
Q ss_pred EcCCeEEEEEeccC--CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCceeccCCCCCEEecCCCCCcEEEeec
Q 027738 89 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVS-YCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 89 ~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~-~lh~~~ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
.-++||||++ |..+....... ++..+...++.+++..+. .+|+.|++|||+++.||+++++ . +.++||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEec
Confidence 3479999998 65554433322 124455667777777444 4689999999999999999877 3 999999
Q ss_pred cccccc
Q 027738 166 GYSKSS 171 (219)
Q Consensus 166 g~a~~~ 171 (219)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.5e-13 Score=106.06 Aligned_cols=197 Identities=18% Similarity=0.144 Sum_probs=145.1
Q ss_pred cCCccceeeccccCcCceEEEEEEEC-CCCcEEEEEEeccCcccC-HHH--HHHHHHHHhC-CCCcEeEEEEEEEcCCeE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGDKID-ENV--QREIINHRSL-RHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~~K~~~~~~~~~-~~~--~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (219)
....++..+..|+.+.++.++.+.-+ .++..|++|...+.-... .++ ..|+.+...+ .|.+.+..+..|......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567889999999999999988755 677888888765432211 111 2344444333 477777777777777777
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++--|+|.+++......-...+.+..++++..|++.++.++|+..++|.|++|+||++..++ .-.++.||++++.. .
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~--~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRL--A 418 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccc--c
Confidence 78899999988877776556688999999999999999999999999999999999998753 22688999988641 1
Q ss_pred CCCCCCCCCCCCC--CchhhccccccceeeEEEEEEEEeecCCCCCC
Q 027738 175 SQPKSTVGTPAYI--APEVLLRHEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 175 ~~~~~~~~~~~~~--aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
..........++. ++.......+-.++|++|||.-+.+.+++..|
T Consensus 419 ~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 419 FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred eecccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 2222222233333 55555677888899999999999998888654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.5e-11 Score=89.39 Aligned_cols=133 Identities=20% Similarity=0.223 Sum_probs=103.1
Q ss_pred eeeccccCcCceEEEEEEECCCCcEEEEEEeccC-----------------------cccCHHHHHHHHHHHhCCCC--c
Q 027738 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----------------------DKIDENVQREIINHRSLRHP--N 80 (219)
Q Consensus 26 ~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~-----------------------~~~~~~~~~e~~~l~~l~~~--~ 80 (219)
.+..+||-|.-+.||.+.+. .+.++++|+-... ...+...++|.+.|..+... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45688999999999999987 7788999964211 11123457899999988755 6
Q ss_pred EeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcE
Q 027738 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (219)
Q Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v 160 (219)
+++.+++ +.-+++||+++|..|...- +.......++..++..+..+-..|++|||+++=||++++++. +
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~ 241 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--I 241 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--E
Confidence 7777776 6678999999987664322 235566667777888888777999999999999999998877 9
Q ss_pred EEeecccccc
Q 027738 161 KICDFGYSKS 170 (219)
Q Consensus 161 ~l~dfg~a~~ 170 (219)
.++||..+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999997754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.7e-12 Score=95.62 Aligned_cols=141 Identities=20% Similarity=0.302 Sum_probs=105.8
Q ss_pred HHHHhCCCCcEeEEEEEEEcCC-----eEEEEEeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC--C
Q 027738 71 INHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAM--Q 139 (219)
Q Consensus 71 ~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~--~ 139 (219)
..+.++.|.|++++..+|.+.+ ...++.||+..+++..++.+.. .+......+|+.|++.+|.|||+. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3444556899999999987654 4789999999999999987543 477888899999999999999998 4
Q ss_pred ceeccCCCCCEEecCCCCCcEEEeecccccccccC--------CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEe
Q 027738 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--------SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSL 211 (219)
Q Consensus 140 ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~ 211 (219)
++|+++..+.|++..++. +++. +....... .......+.+.|.+||.=.....+..+|+|++|++.+
T Consensus 199 iihgnlTc~tifiq~ngL--Ikig---~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGL--IKIG---SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred cccCCcchhheeecCCce--EEec---ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 999999999999997765 4442 22111000 0111223567899998876666677899999999988
Q ss_pred ecCCC
Q 027738 212 QSTSP 216 (219)
Q Consensus 212 ~~~~g 216 (219)
+|.-+
T Consensus 274 email 278 (458)
T KOG1266|consen 274 EMAIL 278 (458)
T ss_pred HHHHh
Confidence 87644
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.2e-10 Score=81.98 Aligned_cols=108 Identities=18% Similarity=0.186 Sum_probs=85.1
Q ss_pred CHHHHHHHHHHHhCCCCc--EeEEEEEEEcCC----eEEEEEeccCCC-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027738 63 DENVQREIINHRSLRHPN--IVRFKEVILTPT----HLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYC 135 (219)
Q Consensus 63 ~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 135 (219)
.....+|...+..+...+ .++.+.+.+... ..++++|++++. +|.+++......+......++.++...++.|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 356778888887775443 445666665532 358999999874 7888887755577788889999999999999
Q ss_pred HHCCceeccCCCCCEEecCCC-CCcEEEeecccccc
Q 027738 136 HAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 170 (219)
Q Consensus 136 h~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~ 170 (219)
|+.|++|+|++|.|||++.++ ..++.++||+.+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999998776 33599999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.1e-09 Score=76.40 Aligned_cols=135 Identities=10% Similarity=0.093 Sum_probs=97.8
Q ss_pred cCcCceEEEEEEECCCCcEEEEEEecc----C---cccCHHHHHHHHHHHhCCCCc--EeEEEEEEE---cC--CeEEEE
Q 027738 32 GSGNFGVARLMRDKVTKELVAVKYIER----G---DKIDENVQREIINHRSLRHPN--IVRFKEVIL---TP--THLAIV 97 (219)
Q Consensus 32 ~~g~~~~v~~~~~~~~~~~v~~K~~~~----~---~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~---~~--~~~~lv 97 (219)
+.|+-+.|+..... |+.+-+|.-.. + +.....+.+|+..+..+..-+ ++++. ++. .+ ...++|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 34777888887765 44677786541 1 335688999999999885433 44444 222 11 236889
Q ss_pred EeccCC-CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 98 MEYASG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 98 ~e~~~~-~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+|-+++ .+|.+++... .+.+..+...++.++..+++.||+.|+.|+|+.+.||+++.++...+.++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997654 5787776553 24577778899999999999999999999999999999986554459999998654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.1e-09 Score=85.68 Aligned_cols=133 Identities=20% Similarity=0.269 Sum_probs=103.8
Q ss_pred CceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEc----CCeEEEEEeccCC-CcHHH
Q 027738 35 NFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASG-GELFE 108 (219)
Q Consensus 35 ~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~ 108 (219)
-..+.|++....+|..|++|+++-.... ....-.-++.++++.|+|++++.++|.. ...+++|++|.++ .+|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3468999999999999999999432211 1233456788999999999999999974 3468999999875 35544
Q ss_pred HHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 109 RICN---------------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 109 ~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
.--. ....++..+|.++.|+..+|.++|+.|+..+-|.|.+|++..+. |++|...|...
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~D 441 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMD 441 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEeccccee
Confidence 3321 12367899999999999999999999999999999999997665 48888777654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.4e-10 Score=89.04 Aligned_cols=184 Identities=12% Similarity=0.065 Sum_probs=125.8
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHH-hCCCCcEeEEEEEEE------c-CCeEEEEE
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-SLRHPNIVRFKEVIL------T-PTHLAIVM 98 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~------~-~~~~~lv~ 98 (219)
..+.||+|+.+.+|-.-.- +.. +.|++..++...+.- .+..+- .-.||-+-.=+.|=. . +....++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQAQ--KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh--hch-hheeecCCCchHHHH--HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4678999999998865433 333 448887655433321 222222 224443322111111 1 22367788
Q ss_pred eccCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 99 EYASGGELFERIC-------NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 99 e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
+.+++..--.-+. ...........+.++.++.+.+.||+.|.+-||++++|+++++++. |.|.|-+.....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~ 167 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN 167 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence 8777652222121 2233677788999999999999999999999999999999998887 999987765544
Q ss_pred ccCCCCCCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
..+......++...|.+||... +...+...|.|+||+++++++.|+
T Consensus 168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~gg 218 (637)
T COG4248 168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGG 218 (637)
T ss_pred cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcC
Confidence 4455556678999999999976 455678899999999999999883
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.6e-11 Score=104.22 Aligned_cols=199 Identities=22% Similarity=0.264 Sum_probs=144.2
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
.....+.+.+.+-+.+|.++.++.+.-..++.-...|.....+... +....+-..+....+|.++...-.+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3467788889999999999999988777777444444333222211 122222222222234555544444555667
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.+++++++.++++...+++.+..+.+-.+..+..+..++++||+..+.|+|++|.|+++..++. ..+.+|+.......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGL 956 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCcccccccccc
Confidence 8999999999999999998887888888888899999999999999999999999999988877 68888873221100
Q ss_pred C--------------------------------CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 H--------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~--------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .......+++.|.+||...+......+|+|+.|+++++.++|-.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 0 00112247888999999999888889999999999999999853
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.99 E-value=9.3e-09 Score=74.31 Aligned_cols=135 Identities=17% Similarity=0.223 Sum_probs=84.4
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHH----------HHHHHHHHHhCCCCcEeEE-------
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRF------- 84 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~----------~~~e~~~l~~l~~~~i~~~------- 84 (219)
..+|+..+.+....-..|.+..- +++.+++|.........++ ..+.+.....++..++..+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 45677777777666555554444 4788899976543222111 1223333333332222222
Q ss_pred -EEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEe
Q 027738 85 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (219)
Q Consensus 85 -~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~ 163 (219)
.-.+......++++||++|..|.+... +++ .++..+.+++..+|+.|+.|||..|.|+++++++ ++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEE
Confidence 222222345679999999988765432 222 2445677788999999999999999999998554 8999
Q ss_pred eccccc
Q 027738 164 DFGYSK 169 (219)
Q Consensus 164 dfg~a~ 169 (219)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 999754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.7e-10 Score=90.33 Aligned_cols=89 Identities=15% Similarity=0.253 Sum_probs=72.0
Q ss_pred HHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC----------CCCCCCCCCCchhhccc
Q 027738 127 QLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----------STVGTPAYIAPEVLLRH 195 (219)
Q Consensus 127 ~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~----------~~~~~~~~~aPE~~~~~ 195 (219)
+..+|+.++|+. ++||++|.|++|+++.++. .|++.|+++....++.... .......|.|||.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 444899999966 8999999999999998887 9999999987554422211 11245689999999998
Q ss_pred cccceeeEEEEEEEEeecCCCC
Q 027738 196 EYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 196 ~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
..++++|++|||+++|...+|+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~g 206 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGG 206 (700)
T ss_pred cccccccceeeeeEEEEEecCC
Confidence 8899999999999999988554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.2e-08 Score=74.61 Aligned_cols=138 Identities=17% Similarity=0.115 Sum_probs=95.6
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEeccC--------------------cccC-----HHHHHHHHHHHhCCC--C
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--------------------DKID-----ENVQREIINHRSLRH--P 79 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~--------------------~~~~-----~~~~~e~~~l~~l~~--~ 79 (219)
+...|++|..+.||+|... ++..+|+|++... .... .+...|+..|+++.. -
T Consensus 52 ~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 3568889999999999874 6888999998532 0011 334678888887743 3
Q ss_pred cEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCC
Q 027738 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~ 158 (219)
.+++.+.+. .-.++||+++....-....+.-+....+...+..++++.+.-|-. .++||+||+.=|||+. ++.
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~- 204 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE- 204 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe-
Confidence 445555542 347999998654221111122233444677788889999888776 8999999999999998 444
Q ss_pred cEEEeecccccccc
Q 027738 159 RLKICDFGYSKSSV 172 (219)
Q Consensus 159 ~v~l~dfg~a~~~~ 172 (219)
+.++||+-|....
T Consensus 205 -p~iID~~QaV~~~ 217 (268)
T COG1718 205 -PYIIDVSQAVTID 217 (268)
T ss_pred -EEEEECccccccC
Confidence 8999999886543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.6e-08 Score=71.42 Aligned_cols=72 Identities=15% Similarity=0.144 Sum_probs=54.5
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc--EeEEEEEEEcCCeEEEEEeccCCCc
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE 105 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (219)
..|++|..+.+|+. .+..+++|.... .....++.+|.+.++.+..-+ +++++++....+...++|++++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999973 244578897754 334466889999998886433 5788888888888889999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.8e-08 Score=81.12 Aligned_cols=138 Identities=20% Similarity=0.209 Sum_probs=93.2
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccC-----------------------cc---c---------CHH------HH
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERG-----------------------DK---I---------DEN------VQ 67 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~-----------------------~~---~---------~~~------~~ 67 (219)
+.+++++-|.|+.|+.+ +|+.||||+..+. +. . .+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 66778899999999998 5999999987532 10 0 011 23
Q ss_pred HHHHHHHhCC-----CCcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 027738 68 REIINHRSLR-----HPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVC 141 (219)
Q Consensus 68 ~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~iv 141 (219)
.|+..+.+++ .+.+.-..-+++..+.-+++|||++|..+.+... +...++...+.....+++ +..+-..|+.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 4444444442 3444433444455567899999999999988753 224456555444333332 3455668999
Q ss_pred eccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 142 h~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
|+|..|.||+++.++. +.+.|||+....
T Consensus 288 HaDpHpGNi~v~~~g~--i~~lDfGi~g~l 315 (517)
T COG0661 288 HADPHPGNILVRSDGR--IVLLDFGIVGRL 315 (517)
T ss_pred ccCCCccceEEecCCc--EEEEcCcceecC
Confidence 9999999999998876 999999987543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.6e-07 Score=70.31 Aligned_cols=76 Identities=12% Similarity=0.039 Sum_probs=53.7
Q ss_pred cccCcCc-eEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEeccCCCcHH
Q 027738 30 DIGSGNF-GVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 107 (219)
Q Consensus 30 ~l~~g~~-~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (219)
.|..|.. ..||++... +..+++|+..... ...+.+|+..++.+. +.-+++++.+...++..++++++++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444555 688988764 3578888775433 345677888887773 355778888887777789999999987775
Q ss_pred HH
Q 027738 108 ER 109 (219)
Q Consensus 108 ~~ 109 (219)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 43
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.4e-07 Score=64.87 Aligned_cols=129 Identities=20% Similarity=0.190 Sum_probs=90.2
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCc-----------------ccCHHHHHHHHHHHhCC------CCcEeEE
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRF 84 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-----------------~~~~~~~~e~~~l~~l~------~~~i~~~ 84 (219)
...|++|+...|| .+..+ ...++|+..+.. ....+..+|+.....+. +.+|+++
T Consensus 6 ~~~i~~G~~R~cy--~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCY--QHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEE--ECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4678999999988 44433 335778876544 22355667776666665 7889999
Q ss_pred EEEEEcCCeEEEEEeccCC------CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 85 KEVILTPTHLAIVMEYASG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 85 ~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
+|+.+++....+|+|.+.. .+|.+++... .++. ..... +-+...+|-+.+|+..|++|.||++.....+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999987632 3677777443 3555 33333 3344557889999999999999999755543
Q ss_pred --cEEEee
Q 027738 159 --RLKICD 164 (219)
Q Consensus 159 --~v~l~d 164 (219)
++.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 366666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.9e-07 Score=64.03 Aligned_cols=128 Identities=18% Similarity=0.136 Sum_probs=92.6
Q ss_pred eeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCC-cEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 26 ~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
+..+.|+.|..|.||++... +..+++| +...+..+..++.|++++..+.-. .-++++.+.... +.|||+.|.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~K-vrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALK-VRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEE-EecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCc
Confidence 45689999999999999886 6688988 555666788999999999988754 446677775543 449999998
Q ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCCEEecCCCCCcEEEeeccccc
Q 027738 105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK-LENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 105 ~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~-p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+|....... ...++. .+++.-.-|-..||-|+.|+ |...++..+.. +.|+||..|+
T Consensus 98 ~L~~~~~~~---~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~--~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIGG---DRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLVNDRD--VYIIDFDSAT 154 (201)
T ss_pred chhhhhhcc---cHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEecCCc--EEEEEccchh
Confidence 887665432 333333 34444455888999999986 44444433333 8999999886
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-07 Score=69.60 Aligned_cols=78 Identities=18% Similarity=0.195 Sum_probs=55.4
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCC--cEeEEEEEEEc---CCeEEEEEeccC
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEVILT---PTHLAIVMEYAS 102 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~---~~~~~lv~e~~~ 102 (219)
++.++.|..+.+|.+.... ..+++|..... .....+..|..+++.+... .+++++..... ....++++++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678889999999999874 47899987554 3446777888888777533 35677764433 345799999999
Q ss_pred CCcHHH
Q 027738 103 GGELFE 108 (219)
Q Consensus 103 ~~~L~~ 108 (219)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 987776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.7e-07 Score=79.01 Aligned_cols=78 Identities=19% Similarity=0.208 Sum_probs=56.0
Q ss_pred eccccCcCceEEEEEEECCCC--cEEEEEEeccCcc--cCHHHHHHHHHHHhCC-CCcE--eEEEEEEEcC---CeEEEE
Q 027738 28 VRDIGSGNFGVARLMRDKVTK--ELVAVKYIERGDK--IDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAIV 97 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~--~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~lv 97 (219)
++.++.|.+..+|++.....+ ..+++|+...... ....+.+|..+++.+. |.++ ++++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 677788888899998765332 4678886544321 2356889999999885 5654 7778777654 457899
Q ss_pred EeccCCCc
Q 027738 98 MEYASGGE 105 (219)
Q Consensus 98 ~e~~~~~~ 105 (219)
||+++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.6e-09 Score=92.27 Aligned_cols=75 Identities=17% Similarity=0.182 Sum_probs=55.8
Q ss_pred eccCCCC-CEEecCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 142 HRDLKLE-NTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 142 h~dl~p~-nili~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
+++..|. |+++...+. .++.+|+.++....+.. .....+++.|+|||++.+..++.++|||||||++|||++|.
T Consensus 500 ~~~~~p~~~~~~~p~~~--~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~ 577 (669)
T cd05610 500 TQKPRPHGNLYQTPKQV--KIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGI 577 (669)
T ss_pred CCCCCCCCceeECCccc--cccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 3455555 455554443 67889998765433322 23346899999999999988999999999999999999986
Q ss_pred C
Q 027738 218 D 218 (219)
Q Consensus 218 ~ 218 (219)
.
T Consensus 578 ~ 578 (669)
T cd05610 578 P 578 (669)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.2e-06 Score=71.64 Aligned_cols=138 Identities=18% Similarity=0.177 Sum_probs=88.7
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccC--------------------------------cccCH------HHHHH
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERG--------------------------------DKIDE------NVQRE 69 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~--------------------------------~~~~~------~~~~e 69 (219)
-+.|++.+.+.|++++.+ +|+.||+|+-++. +...+ ++.+|
T Consensus 166 ~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 367888899999999998 5999999975421 00001 12334
Q ss_pred HHHHHhC----CCCc------EeEEEEEEEcCCeEEEEEeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 027738 70 IINHRSL----RHPN------IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAM 138 (219)
Q Consensus 70 ~~~l~~l----~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~ 138 (219)
++...++ .|-+ |++++-. .....+++|||++|..+.+.-. ....++...+..-+.+.. ++.+-..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 4333332 3333 4443332 2346799999999987765543 222366665554443332 2345567
Q ss_pred CceeccCCCCCEEecCC--CCCcEEEeecccccc
Q 027738 139 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSKS 170 (219)
Q Consensus 139 ~ivh~dl~p~nili~~~--~~~~v~l~dfg~a~~ 170 (219)
|++|+|-.|.||+++.+ +..++.+.|||+...
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 89999999999999864 345699999998753
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.3e-06 Score=65.11 Aligned_cols=72 Identities=11% Similarity=-0.011 Sum_probs=45.4
Q ss_pred ccccCcCce-EEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCC---cEeEEEEEEEcC---CeEEEEEecc
Q 027738 29 RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEYA 101 (219)
Q Consensus 29 ~~l~~g~~~-~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~e~~ 101 (219)
+.++.|+.. .||.+. ..+++|+... ......+..|.+.+..+... -+++++...... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456666665 588652 2477786543 22345788999999877532 345555544432 2358899999
Q ss_pred CCCcH
Q 027738 102 SGGEL 106 (219)
Q Consensus 102 ~~~~L 106 (219)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 88665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.7e-06 Score=67.11 Aligned_cols=139 Identities=19% Similarity=0.209 Sum_probs=99.7
Q ss_pred eeeccccCcCceEEEEEEECCCCcEEEEEEeccC---------------------------cccCHHHHHHHHHHHhCCC
Q 027738 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---------------------------DKIDENVQREIINHRSLRH 78 (219)
Q Consensus 26 ~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~---------------------------~~~~~~~~~e~~~l~~l~~ 78 (219)
.+.++|.+|.-+.||.+... +|..+|+|+++.+ ....-+.+.|++.|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 56789999999999999875 7888999987521 0011356789999998876
Q ss_pred CcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCCEEecCCCC
Q 027738 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPA 157 (219)
Q Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-h~~~ivh~dl~p~nili~~~~~ 157 (219)
.+|+..--... ..-+|||+++..-.-.....+..+++...+..+-.+++.-+.-| +..++||.||+-=|+|+-++.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~- 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGK- 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCE-
Confidence 66543222222 23579999986433333333445678888888888888888865 566999999999999996543
Q ss_pred CcEEEeecccccc
Q 027738 158 PRLKICDFGYSKS 170 (219)
Q Consensus 158 ~~v~l~dfg~a~~ 170 (219)
+.++|.+-+..
T Consensus 303 --lyiIDVSQSVE 313 (520)
T KOG2270|consen 303 --LYIIDVSQSVE 313 (520)
T ss_pred --EEEEEcccccc
Confidence 89999887653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.6e-08 Score=80.09 Aligned_cols=178 Identities=21% Similarity=0.245 Sum_probs=126.8
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc-EeEEEEEEEcCCeEEEEEeccC
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
-|...+.+++++++++++.+....... ..+++... ....-++++|.+++||| .+..++-+..+...++.+++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL-~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLL-QHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhe-eceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 346678888899999998887644443 35655443 34455788999999999 5666666666778899999998
Q ss_pred CC-cHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCC
Q 027738 103 GG-ELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (219)
Q Consensus 103 ~~-~L~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~ 180 (219)
++ +-.... ...-.+...+.....+.-.+.++++|+..-+|+| ||+-.++. .+..+|+.+..........+.
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccccC
Confidence 76 111111 1111244455566667777889999998777887 77776543 688999987665555556677
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeec
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQS 213 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~ 213 (219)
.+++.++|||+.....+....|.|++|.-..++
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ 423 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQM 423 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhc
Confidence 899999999999999999999999999744333
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.4e-06 Score=60.62 Aligned_cols=75 Identities=16% Similarity=0.227 Sum_probs=48.4
Q ss_pred eccccCcCceEEEEEEECC-CCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEeccCCCc
Q 027738 28 VRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGE 105 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~-~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (219)
++.|..|-...+|++.... .++.|++|+........-+.++|+..++.+. +.-.++++..+. + .+++||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence 3566778888999887653 3567889977543322234457888888774 333455555433 2 37999998866
Q ss_pred H
Q 027738 106 L 106 (219)
Q Consensus 106 L 106 (219)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.3e-05 Score=55.49 Aligned_cols=125 Identities=19% Similarity=0.301 Sum_probs=89.5
Q ss_pred CccceeeccccCcCc-eEEEEEEECCCCcEEEEEEec---cC------------c-------ccCHHHHHHHHHHHhCCC
Q 027738 22 SDRYDFVRDIGSGNF-GVARLMRDKVTKELVAVKYIE---RG------------D-------KIDENVQREIINHRSLRH 78 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~-~~v~~~~~~~~~~~v~~K~~~---~~------------~-------~~~~~~~~e~~~l~~l~~ 78 (219)
.++++.++.||.|.. |.||++.-. |+.||+|++. .. + .....|..|++...+++.
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 478999999999999 999999886 8899999832 11 0 011346788888877753
Q ss_pred ---CcE--eEEEEEEEcCC------------------eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 027738 79 ---PNI--VRFKEVILTPT------------------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135 (219)
Q Consensus 79 ---~~i--~~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 135 (219)
.++ ++++||..... ...+|.||.+... .++... +.++..-+..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHH
Confidence 344 89999985331 2467777765533 223333 45666777889
Q ss_pred HHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 136 h~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
|+.||+-+|+++.|.. + -+|+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~--G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----G--GKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----C--CEEEecccC
Confidence 9999999999999974 1 389999854
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.27 E-value=5.3e-06 Score=59.45 Aligned_cols=97 Identities=14% Similarity=0.072 Sum_probs=76.4
Q ss_pred HHHHHHHHhCCC-CcEeEEEEEEEcCCeEEEEEeccCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 027738 67 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHA---MQ 139 (219)
Q Consensus 67 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~ 139 (219)
.+|..+++.+++ +++++++|++ ..+++.|+.+.++++.. +......+...+..++.++++.+..++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457788888876 6999999997 33678888876555321 2222235899999999999999999998 45
Q ss_pred ceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 140 ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+..+|++|+|+.+++++. ++++|.+.+.
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 888999999999997776 9999999764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.6e-05 Score=60.04 Aligned_cols=132 Identities=14% Similarity=0.087 Sum_probs=76.2
Q ss_pred cccCcCceEEEEEEECCCCcEEEEEEeccCcccC-HHHHHHHHHHHhCCCCc-EeEEEEEEEcCCeEEEEEeccCCCcHH
Q 027738 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELF 107 (219)
Q Consensus 30 ~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~-~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (219)
.+..|-...+|++.. +++.+++|........- -+..+|...++.+...+ .++++.... -++|++|++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 355677788898874 46678889765432221 24577888888875432 345554432 36899999886653
Q ss_pred HH----------H-------HhcC----CCCHH-HHHHHHHHH---------HHHHHHHHH--------CCceeccCCCC
Q 027738 108 ER----------I-------CNAG----RFSED-EARFFFQQL---------ISGVSYCHA--------MQVCHRDLKLE 148 (219)
Q Consensus 108 ~~----------~-------~~~~----~~~~~-~~~~~~~~l---------~~~l~~lh~--------~~ivh~dl~p~ 148 (219)
.. + +... +++.. .+..+..++ ...+..+.. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1 1111 11211 111221111 111222222 24899999999
Q ss_pred CEEecCCCCCcEEEeecccccc
Q 027738 149 NTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 149 nili~~~~~~~v~l~dfg~a~~ 170 (219)
||++++++ +.++||..+..
T Consensus 157 Nil~~~~~---~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG---LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC---CEEEeccccCc
Confidence 99998654 68999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.18 E-value=0.00023 Score=56.85 Aligned_cols=76 Identities=18% Similarity=0.079 Sum_probs=52.8
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccC--------cccCHHHHHHHHHHHhCC---CCcEeEEEEEEEcCCeEEE
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERG--------DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~--------~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 96 (219)
.+.|+.|....||++.....++.+++|.-.+. +...++...|.+.++.+. ...+|+++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 46789999999999998744458999974321 112355666777777652 34677887773 355789
Q ss_pred EEeccCCCc
Q 027738 97 VMEYASGGE 105 (219)
Q Consensus 97 v~e~~~~~~ 105 (219)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997644
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.2e-05 Score=59.61 Aligned_cols=136 Identities=19% Similarity=0.143 Sum_probs=79.7
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc--EeEEEEE------EEcCCeEEEEEe
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVME 99 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv~e 99 (219)
.+.+..|....+|++... +..+++|+... ...+.+..|+.++..+...+ +++++.. ...++..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 566777877889988654 44688898754 23456777888777774332 4444332 233456789999
Q ss_pred ccCCCcHHH-------HH-------Hhc-CCCC--------HHHHHH------------HHHHHHHHHHHHHH-------
Q 027738 100 YASGGELFE-------RI-------CNA-GRFS--------EDEARF------------FFQQLISGVSYCHA------- 137 (219)
Q Consensus 100 ~~~~~~L~~-------~~-------~~~-~~~~--------~~~~~~------------~~~~l~~~l~~lh~------- 137 (219)
+++|..+.. .+ +.. ..+. ...... ....+..++..+.+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865421 00 000 0000 000000 11112223334432
Q ss_pred CCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 138 ~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
.+++|||+.|.|+++++++. +.++||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 36999999999999987543 5799999865
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.4e-05 Score=59.04 Aligned_cols=74 Identities=11% Similarity=0.079 Sum_probs=47.4
Q ss_pred ccccCcCceEEEEEEECC------CCcEEEEEEeccCcccCHHHHHHHHHHHhCCC-CcEeEEEEEEEcCCeEEEEEecc
Q 027738 29 RDIGSGNFGVARLMRDKV------TKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~------~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
+.+..|-...+|++.... .++.+++|+.........+..+|...+..+.. .-.++++..+.. ..|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 445556667888887643 25789999876544333456778888877753 234556665542 2578888
Q ss_pred CCCcH
Q 027738 102 SGGEL 106 (219)
Q Consensus 102 ~~~~L 106 (219)
+|.++
T Consensus 80 ~G~~l 84 (302)
T cd05156 80 PSRTL 84 (302)
T ss_pred CCCcC
Confidence 77655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.07 E-value=6.1e-05 Score=58.44 Aligned_cols=140 Identities=18% Similarity=0.149 Sum_probs=79.1
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc--EeEEEEEE------EcCCeEEE
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVI------LTPTHLAI 96 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~------~~~~~~~l 96 (219)
....+.++.|....+|.+... ++ .+++|+.... ...+.+..|.+++..+...+ +++++... ...+..++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ceeccccCCccccceEEEEeC-CC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 444667777777889988754 33 5788976542 22345566777776664322 34443321 12456789
Q ss_pred EEeccCCCcHH-----------HHH---Hhc-CCC----------CHH-H-HH-----------HHHHHHHHHHHHHH--
Q 027738 97 VMEYASGGELF-----------ERI---CNA-GRF----------SED-E-AR-----------FFFQQLISGVSYCH-- 136 (219)
Q Consensus 97 v~e~~~~~~L~-----------~~~---~~~-~~~----------~~~-~-~~-----------~~~~~l~~~l~~lh-- 136 (219)
+++|++|..+. ..+ +.. ..+ +.. . .. .....+...++++.
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999875421 101 100 001 000 0 00 00111222344443
Q ss_pred -----HCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 137 -----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 137 -----~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
..+++|+|+.+.|+++++++. +.++||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 258999999999999987653 5899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00018 Score=56.12 Aligned_cols=74 Identities=11% Similarity=0.047 Sum_probs=44.2
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc--EeEEEE------EEEcCCeEEEEEe
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME 99 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~------~~~~~~~~~lv~e 99 (219)
.+.+..|....+|.+... +..+++|++.. ...+.+..+...+..+...+ +++++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 455667777788988764 33688898752 22344455555555553222 334432 1223556789999
Q ss_pred ccCCCc
Q 027738 100 YASGGE 105 (219)
Q Consensus 100 ~~~~~~ 105 (219)
|++|..
T Consensus 103 ~l~G~~ 108 (319)
T PRK05231 103 FLEGKW 108 (319)
T ss_pred ecCCCC
Confidence 998864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=1.5e-05 Score=61.06 Aligned_cols=133 Identities=14% Similarity=0.149 Sum_probs=91.1
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccC-------------------ccc----CHHHHHHHHHHHhCCCCc
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-------------------DKI----DENVQREIINHRSLRHPN 80 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~-------------------~~~----~~~~~~e~~~l~~l~~~~ 80 (219)
-+.+..+||-|.-+.+|.+-+. .|.+.++|+-... ..+ +-...+|+..++.+....
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4566789999999999999876 6777888853211 000 112357888888775433
Q ss_pred --EeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 81 --i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
+++.+++ +.-++|||++.|-+|...-+-. ...+ +...+...+.-|...|++|||.+-=||++.+++.
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~---d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~- 240 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE---DPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK- 240 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeecC---ChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence 3444444 5568899999888775543221 2222 3334444456788999999999999999997766
Q ss_pred cEEEeeccccc
Q 027738 159 RLKICDFGYSK 169 (219)
Q Consensus 159 ~v~l~dfg~a~ 169 (219)
++++||.-+.
T Consensus 241 -i~vIDFPQmv 250 (465)
T KOG2268|consen 241 -IVVIDFPQMV 250 (465)
T ss_pred -EEEeechHhh
Confidence 9999999654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.82 E-value=1.7e-05 Score=69.57 Aligned_cols=151 Identities=21% Similarity=0.232 Sum_probs=112.5
Q ss_pred HHHHHHHHHhCCCCcEeEEEEEEEcCCeE----EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 027738 66 VQREIINHRSLRHPNIVRFKEVILTPTHL----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141 (219)
Q Consensus 66 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~iv 141 (219)
.+-|...+.+++|+|+..++.|....... .+..++|..-++...+..-...+.++.+.+..+..++|.++|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 35577778888999999999998775443 34557888888888888888899999999999999999999999766
Q ss_pred eccCCCC---CEEecCCCCCcEEEe--ecccccccccCCCCCCCCCCCCCCCchhhcccccc--ceeeEEEEEEEEeecC
Q 027738 142 HRDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GKVYFYSITQMSLQST 214 (219)
Q Consensus 142 h~dl~p~---nili~~~~~~~v~l~--dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~Dv~slg~~~~~~~ 214 (219)
|.-+..+ +--++..+. +... ||+..+.............+..+.++|.......+ ...|+|.+|.....+.
T Consensus 309 ~v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eeEEecccccccccCccce--eecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 6655555 223333333 4444 88877766655555666667788888888765544 4479999999888887
Q ss_pred CCCC
Q 027738 215 SPND 218 (219)
Q Consensus 215 ~g~~ 218 (219)
.|.+
T Consensus 387 ~~~~ 390 (1351)
T KOG1035|consen 387 QGED 390 (1351)
T ss_pred hcCc
Confidence 7754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00021 Score=54.48 Aligned_cols=32 Identities=22% Similarity=0.298 Sum_probs=25.0
Q ss_pred CceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 139 ~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.++|||++|.||++++++. -.-++||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcccC
Confidence 4899999999999986433 1469999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00045 Score=53.35 Aligned_cols=106 Identities=12% Similarity=0.064 Sum_probs=71.9
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCC---CcEeEEEEEEEc---CCeEEEEE
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILT---PTHLAIVM 98 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~~lv~ 98 (219)
-.-.+.|+.|..+.+|..... ++ .+++|... .......+..|...++.+.. ..++++++++.. .+..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS-QG-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcC-CC-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344678999999999998754 23 46667643 22234678999999988853 368888888754 36689999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 138 (219)
|++++.++.+. ..+......+..++.++|+.||+.
T Consensus 93 E~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 93 ERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99998776541 123334445556666667777753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0013 Score=51.69 Aligned_cols=73 Identities=19% Similarity=0.136 Sum_probs=46.4
Q ss_pred cccCcCceEEEEEEECCCCcEEEEEEecc-----C---cccCHHHHHHHHHHHhCC--CC-cEeEEEEEEEcCCeEEEEE
Q 027738 30 DIGSGNFGVARLMRDKVTKELVAVKYIER-----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 30 ~l~~g~~~~v~~~~~~~~~~~v~~K~~~~-----~---~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~ 98 (219)
.+|.|....||++.+...++.+++|.-.+ + +...++..-|.+.++... -| .+|+++.+ ++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57889999999999864446899997431 1 222345556666665542 23 45555544 445567899
Q ss_pred eccCCC
Q 027738 99 EYASGG 104 (219)
Q Consensus 99 e~~~~~ 104 (219)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 988553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00046 Score=53.37 Aligned_cols=144 Identities=13% Similarity=0.059 Sum_probs=80.5
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEec--cCcccCHHHHHHHHHHHhCCC--CcEeEEEEEEEcCC--eEEEEE
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPT--HLAIVM 98 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~--~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~~lv~ 98 (219)
..+++....|-.-.+|..... ++.++++.-. ..-....+..+|...++.+.. .-++..++.+.++. ..+.+|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 344455544544455655554 7778888221 111222456778888876643 23344455554444 569999
Q ss_pred eccCCCcH---------H-HHHH--------h--------c------CCCCHHHHHHHHHHH--------------HHHH
Q 027738 99 EYASGGEL---------F-ERIC--------N--------A------GRFSEDEARFFFQQL--------------ISGV 132 (219)
Q Consensus 99 e~~~~~~L---------~-~~~~--------~--------~------~~~~~~~~~~~~~~l--------------~~~l 132 (219)
+|+.|... . .+.. . . ..+...++..+..+. ....
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 99987322 1 1111 0 0 001222333333332 1223
Q ss_pred HHHHHC--------CceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 133 SYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 133 ~~lh~~--------~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
.+++.. .++|||+++.|+++++++. +-+.||+.+....
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGD 230 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGD 230 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCC
Confidence 345533 4899999999999998877 8999999986443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00068 Score=53.46 Aligned_cols=138 Identities=16% Similarity=0.179 Sum_probs=78.3
Q ss_pred eccccCcCceEEEEEEECC----CCcEEEEEEeccCcccCHHHHHHHHHHHhCCC-CcEeEEEEEEEcCCeEEEEEeccC
Q 027738 28 VRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~----~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
+..+..|-.-.+|++.... .++.+++|+........-+..+|..+++.+.. .--+++++.+..+ .+.+|++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 4455557778899987432 24678999876543222223678888887754 3345666665432 4788887
Q ss_pred CCcHHHH----------H-------HhcC------CCCHHHHHHHHHHH-----------------HHHHHHH----H--
Q 027738 103 GGELFER----------I-------CNAG------RFSEDEARFFFQQL-----------------ISGVSYC----H-- 136 (219)
Q Consensus 103 ~~~L~~~----------~-------~~~~------~~~~~~~~~~~~~l-----------------~~~l~~l----h-- 136 (219)
+.++... + +... .....++..+..++ ...+..| .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7655311 1 0000 01112222222111 1111111 1
Q ss_pred --HCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 137 --AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 137 --~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
...++|+|+++.||+++++.. .+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~-~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETR-AITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCC-cEEEEeehhccc
Confidence 225899999999999975432 399999998853
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00074 Score=52.96 Aligned_cols=78 Identities=14% Similarity=0.174 Sum_probs=46.4
Q ss_pred cceeeccccCcCceEEEEEEECCC---CcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcE-eEEEEEEEcCCeEEEEEe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVME 99 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e 99 (219)
..+ ++.|..|-.-.+|++..... +..|++|+.......--+..+|..+++.+...++ +++++++. ++ ++.+
T Consensus 16 ~i~-i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 16 DFS-VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred ceE-EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 444 34444477778888865422 3478999876543222233677888877754443 56666653 32 4788
Q ss_pred ccCCCcH
Q 027738 100 YASGGEL 106 (219)
Q Consensus 100 ~~~~~~L 106 (219)
|+++.++
T Consensus 91 fi~g~~l 97 (330)
T PLN02421 91 FINARTL 97 (330)
T ss_pred hhcCCCC
Confidence 8877654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0022 Score=51.16 Aligned_cols=78 Identities=18% Similarity=0.126 Sum_probs=49.9
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEecc----C---cccCHHHHHHHHHHHhCC--CC-cEeEEEEEEEcCC
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPT 92 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~----~---~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~ 92 (219)
+.++ .+.||.|....||++.+...++.++||.-.+ . +...++..-|.+.|+... .| .+|+++.+ ++.
T Consensus 30 ~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e 106 (409)
T PRK12396 30 KGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSV 106 (409)
T ss_pred ccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcH
Confidence 3444 6788999999999999854456789886432 1 222355566677776543 23 56666655 334
Q ss_pred eEEEEEeccCC
Q 027738 93 HLAIVMEYASG 103 (219)
Q Consensus 93 ~~~lv~e~~~~ 103 (219)
...++||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 55678887754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.017 Score=44.85 Aligned_cols=29 Identities=31% Similarity=0.615 Sum_probs=24.5
Q ss_pred CCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 138 ~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
.+++|||+.+.||+++. +. +.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 47899999999999986 33 8999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0067 Score=47.52 Aligned_cols=70 Identities=13% Similarity=0.048 Sum_probs=42.3
Q ss_pred CceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEe--E---EEE--EEEcCCeEEEEEeccCCCc
Q 027738 35 NFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV--R---FKE--VILTPTHLAIVMEYASGGE 105 (219)
Q Consensus 35 ~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~--~---~~~--~~~~~~~~~lv~e~~~~~~ 105 (219)
....||.+... ++..+++|+..+.......+..|...+..+....++ . .-+ ....++..+.++++.+|..
T Consensus 37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34567888764 566789998765444456677788877766322221 1 111 1223456788999987753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0029 Score=48.51 Aligned_cols=75 Identities=11% Similarity=0.069 Sum_probs=49.3
Q ss_pred eeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC---CCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 26 ~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
+-.+.++.|....+|++. .+++.+.+|.-. ......+..|..-|+.+. --.+++++.+....+..++++||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445677888889999887 467889999665 334567888888888773 4568899999988888899999987
Q ss_pred CC
Q 027738 103 GG 104 (219)
Q Consensus 103 ~~ 104 (219)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 65
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0018 Score=50.83 Aligned_cols=102 Identities=21% Similarity=0.234 Sum_probs=69.2
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+.+.|+++++- |+++...-. ....++..++.+++..+.-+... ..-|+|+...||+|+ +|+ |.|+||.+++
T Consensus 298 ~~y~yl~~kdh-gt~is~ik~----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISIIKA----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeeeeec----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeeeee
Confidence 34567777763 545532221 35678888999999988888765 789999999999999 666 9999999987
Q ss_pred ccccCCCCCCCCCCCCCCCchhhccccccceeeEEE
Q 027738 170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYS 205 (219)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 205 (219)
.. ..+......++-.|..+.|.. +.+-|||-
T Consensus 370 l~----~~q~~isy~rldhp~lF~G~d-d~QFeIYr 400 (488)
T COG5072 370 LS----YSQGIISYNRLDHPDLFNGVD-DYQFEIYR 400 (488)
T ss_pred cc----cCCceeeccccCchhhhcCcc-ceeeeHHH
Confidence 32 223333344556676676443 44445543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0088 Score=47.88 Aligned_cols=75 Identities=8% Similarity=-0.002 Sum_probs=44.7
Q ss_pred eccccCcCceEEEEEEECCCC-c-----EEEEEEeccCcccCHHHHHHHHHHHhCCC-CcEeEEEEEEEcCCeEEEEEec
Q 027738 28 VRDIGSGNFGVARLMRDKVTK-E-----LVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~-~-----~v~~K~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.+.+..|-...+|++...... . .|.++........--+..+|..+++.+.. ..-+++++.+.. +++.||
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 445555778889998754221 1 24555432221111223667888888864 455667777653 588899
Q ss_pred cCCCcH
Q 027738 101 ASGGEL 106 (219)
Q Consensus 101 ~~~~~L 106 (219)
++|.++
T Consensus 131 IeGr~l 136 (383)
T PTZ00384 131 VEGNTM 136 (383)
T ss_pred eccccC
Confidence 988765
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0011 Score=51.68 Aligned_cols=131 Identities=17% Similarity=0.177 Sum_probs=75.1
Q ss_pred CceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcE------eEEEEEE--EcCC--eEEEEEeccCCC
Q 027738 35 NFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI------VRFKEVI--LTPT--HLAIVMEYASGG 104 (219)
Q Consensus 35 ~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i------~~~~~~~--~~~~--~~~lv~e~~~~~ 104 (219)
....+|++... +|+ +++|+..+. ....++..|...+..+...++ +..-|-. .-.. ..+-+++|++|.
T Consensus 37 ~eN~~f~~~~~-~g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTE-DGR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEec-CCC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 34567887765 344 489988776 667788888888877642222 2221111 1123 778899999887
Q ss_pred cHHH-----H-------H---Hh-cCCC-----------CHH----H---------HHHHHHHHHHHHHHHH--------
Q 027738 105 ELFE-----R-------I---CN-AGRF-----------SED----E---------ARFFFQQLISGVSYCH-------- 136 (219)
Q Consensus 105 ~L~~-----~-------~---~~-~~~~-----------~~~----~---------~~~~~~~l~~~l~~lh-------- 136 (219)
.+.. . + +. .+.+ ... . -.....++...+..+.
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 6652 0 0 00 0001 000 0 0001222233333333
Q ss_pred HCC--ceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 137 AMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 137 ~~~--ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+.+ ++|+|+.|.||++++++. -+.++||+.+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 224 999999999999987764 26889999875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0056 Score=49.10 Aligned_cols=73 Identities=16% Similarity=0.187 Sum_probs=48.8
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEecc-----Ccc---cCHHHHHHHHHHHhCC---CCcEeEEEEEEEcCCeEE
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDK---IDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~-----~~~---~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~ 95 (219)
..+.+|.|....||++.+. ++.+++|.-.+ +.. ..++-..|.+.|+... ...+++++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678899999999999874 45688997541 211 2233344566665543 247888888877 3457
Q ss_pred EEEeccCC
Q 027738 96 IVMEYASG 103 (219)
Q Consensus 96 lv~e~~~~ 103 (219)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999966
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.011 Score=45.92 Aligned_cols=30 Identities=20% Similarity=0.226 Sum_probs=26.3
Q ss_pred CceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 139 ~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
+++|||+.++|+++++++. +.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhccc
Confidence 6999999999999987766 89999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0014 Score=47.86 Aligned_cols=55 Identities=16% Similarity=0.024 Sum_probs=32.1
Q ss_pred CcEEEEEEeccCcccCHHHHHHHHHHHhCCC-CcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 48 KELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 48 ~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
++.|++|+.......--....|...++.+.. ..-+++++.+..+ .+.+|+++.+|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence 4568889886664444556778888887754 4446666665432 45588766543
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.016 Score=52.36 Aligned_cols=32 Identities=34% Similarity=0.484 Sum_probs=25.8
Q ss_pred CCceeccCCCCCEEecCCCCCcEE-Eeeccccc
Q 027738 138 MQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK 169 (219)
Q Consensus 138 ~~ivh~dl~p~nili~~~~~~~v~-l~dfg~a~ 169 (219)
.+++|+|+++.||+++.++..++. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 469999999999999877532354 99999875
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.058 Score=44.13 Aligned_cols=76 Identities=16% Similarity=0.033 Sum_probs=44.9
Q ss_pred eeccccCcCceEEEEEEECC--------CCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcE-eEEEEEEEcCCeEEEE
Q 027738 27 FVRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIV 97 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~--------~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv 97 (219)
-++.|..|-.-.+|++.... .++.|++|+.-.....--...+|..+++.+...++ +++++.+. + +.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence 35556556667788886542 14678999875543222234567777776654333 45666543 2 356
Q ss_pred EeccCCCcH
Q 027738 98 MEYASGGEL 106 (219)
Q Consensus 98 ~e~~~~~~L 106 (219)
.+|++|.++
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 888877533
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.026 Score=41.52 Aligned_cols=86 Identities=16% Similarity=0.124 Sum_probs=56.3
Q ss_pred HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--Cce
Q 027738 64 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--QVC 141 (219)
Q Consensus 64 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~iv 141 (219)
.-+..+.+++.++ .+|+++..- .+..+.++.|.|-.... ....++-.=++.|.-+|+. +.+
T Consensus 103 ~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI-------------NFSNFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc-------------chhHHHHHhHHHHHHhhccCCCee
Confidence 3455666666544 467776632 44467889998843211 0111122225667888843 799
Q ss_pred eccCCCCCEEecCCCCCcEEEeecccc
Q 027738 142 HRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 142 h~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
|||.+|+||+.+..|. +||.|=++.
T Consensus 166 HGD~np~NiM~D~~G~--lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGY--LKLVDPVCL 190 (308)
T ss_pred cCCCChhheeecCCCC--EEecChhhh
Confidence 9999999999999998 999998753
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.076 Score=39.31 Aligned_cols=78 Identities=21% Similarity=0.191 Sum_probs=54.6
Q ss_pred eeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC---CCCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 26 ~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
+-.+.+..|..-..|.+.+. ..++.+|+-.. ....-+..|+.-|+.+ +.-.+++++.+....+..|+|+||++
T Consensus 19 ~er~~v~gG~inea~~v~dg--~~~~FvK~n~~--~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDG--TDPFFVKCNQR--EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred hcccccCCccccceeEeecC--CcceEEEecch--hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 33556666777788888765 55678884322 1224566677666655 34678999999999999999999998
Q ss_pred CCcHH
Q 027738 103 GGELF 107 (219)
Q Consensus 103 ~~~L~ 107 (219)
.+.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 75553
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.036 Score=42.22 Aligned_cols=44 Identities=25% Similarity=0.356 Sum_probs=32.3
Q ss_pred HHHHHHHHHHHHHHC--CceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 124 FFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 124 ~~~~l~~~l~~lh~~--~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
.+..+-..+..++.. -++|+|+.|.|++.++.+. +.|+||..|.
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~--l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGG--LFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCc--EEEEecccCC
Confidence 444444444444433 5889999999999988565 9999999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 219 | ||||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-109 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-105 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-104 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-104 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-104 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-101 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-33 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-33 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-33 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-33 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-33 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-33 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-33 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-33 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-33 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-32 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-32 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-32 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-31 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-31 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-29 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-29 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-29 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-29 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-29 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-28 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-28 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-28 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-28 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-28 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-28 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-28 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-28 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-28 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-28 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-28 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-28 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-28 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-28 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-28 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-28 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-28 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-28 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-28 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-28 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-28 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-28 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-27 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-27 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-27 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-27 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-27 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-26 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-26 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-26 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-26 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-26 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-26 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-26 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-26 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-26 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-26 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-26 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-26 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-26 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-26 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-26 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-26 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-26 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-26 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-26 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-26 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-26 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-26 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-26 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-26 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-25 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-25 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-25 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-25 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-25 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-25 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-25 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-24 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-24 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-24 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-24 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-24 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-24 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-24 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-24 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-24 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-24 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-23 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-23 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-23 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-23 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-23 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-23 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-23 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-23 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-23 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-23 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-23 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-23 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-23 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-23 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-23 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-23 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-23 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-23 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-23 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-22 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-22 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-22 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-22 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-22 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-22 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-22 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-22 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-22 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-22 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-22 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-22 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-22 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-22 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-22 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-22 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-22 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-22 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-22 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-22 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-22 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-22 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-22 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-22 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-22 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-22 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-22 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-22 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-22 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-22 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-22 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-22 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-22 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-22 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-22 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-22 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-22 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-22 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-22 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-21 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-21 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-21 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-21 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-21 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-21 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-21 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-21 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-21 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-21 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-20 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-20 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-20 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-20 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-19 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-18 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-18 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-18 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-18 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-18 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-18 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-18 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-18 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-18 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-18 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-17 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-17 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-17 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-17 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-17 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-17 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-17 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-17 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-17 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-17 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-17 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-17 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-17 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-17 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-17 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-17 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-17 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-10 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-08 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-08 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-08 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-08 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-08 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-08 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-08 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-08 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-08 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 4e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 6e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 7e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 7e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-04 |
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 354 bits (911), Expect = e-124
Identities = 183/198 (92%), Positives = 192/198 (96%), Gaps = 1/198 (0%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERG I
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGK 200
TPAYIAPEVLLR EYDGK
Sbjct: 180 TPAYIAPEVLLRQEYDGK 197
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 1e-99
Identities = 69/192 (35%), Positives = 108/192 (56%), Gaps = 10/192 (5%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
M +P + + +D V+ +G G +G +L ++VT+E VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 188
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGK 200
PE+L R E+ +
Sbjct: 176 PELLKRREFHAE 187
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 7e-99
Identities = 69/192 (35%), Positives = 108/192 (56%), Gaps = 10/192 (5%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
M +P + + +D V+ +G G +G +L ++VT+E VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 188
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGK 200
PE+L R E+ +
Sbjct: 176 PELLKRREFHAE 187
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 6e-74
Identities = 78/181 (43%), Positives = 100/181 (55%), Gaps = 8/181 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
Y +G G FG ++ ++T VAVK + R KI ++REI N + RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR FQQ++S V YCH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ Y
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 199 G 199
G
Sbjct: 189 G 189
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 9e-74
Identities = 60/184 (32%), Positives = 86/184 (46%), Gaps = 7/184 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
RY R +G G F + D TKE+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEY 197
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL + +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 198 DGKV 201
+V
Sbjct: 193 SFEV 196
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-72
Identities = 60/184 (32%), Positives = 86/184 (46%), Gaps = 7/184 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
RY R +G G F + D TKE+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEY 197
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL + +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 198 DGKV 201
+V
Sbjct: 219 SFEV 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-72
Identities = 73/181 (40%), Positives = 105/181 (58%), Gaps = 7/181 (3%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
Y ++ IG GNF +L R +T VA+K I++ +++ + + RE+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV+ EVI T L ++MEYASGGE+F+ + GR E EAR F+Q++S V YCH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ +YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 200 K 200
Sbjct: 193 P 193
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-71
Identities = 77/181 (42%), Positives = 103/181 (56%), Gaps = 8/181 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
Y +G G FG ++ + ++T VAVK + R KI ++REI N + RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R FQQ++SGV YCH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ Y
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 199 G 199
G
Sbjct: 194 G 194
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-70
Identities = 75/181 (41%), Positives = 105/181 (58%), Gaps = 9/181 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
Y +G G+FG +L T++ VA+K+I R + V+REI + LRH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R FFQQ+I + YCH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
++ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ Y
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 199 G 199
G
Sbjct: 186 G 186
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-69
Identities = 55/185 (29%), Positives = 90/185 (48%), Gaps = 8/185 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
+ + +G G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA 137
P+I+ ++ +V+E GE+ + N FSE+EAR F Q+I+G+ Y H+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHE 196
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ R
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 197 YDGKV 201
+ +
Sbjct: 189 HGLES 193
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-68
Identities = 60/183 (32%), Positives = 97/183 (53%), Gaps = 7/183 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH 78
D +D R +G G FG L R+K K ++A+K + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI+R + +++E+A GEL++ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 199 GKV 201
KV
Sbjct: 191 EKV 193
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 3e-68
Identities = 56/187 (29%), Positives = 84/187 (44%), Gaps = 12/187 (6%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIINHR 74
+Y + +GSG FG DK + V VK+I++ D V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 75 SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ H NI++ ++ +VME + SG +LF I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y + HRD+K EN ++ +K+ DFG + + GT Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 194 RHEYDGK 200
+ Y G
Sbjct: 203 GNPYRGP 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 5e-68
Identities = 63/183 (34%), Positives = 101/183 (55%), Gaps = 5/183 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 80
+ F+ +GSG F L++ ++T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV +++ + TH +VM+ SGGELF+RI G ++E +A QQ++S V Y H +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 141 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYD 198
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL + Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 199 GKV 201
V
Sbjct: 186 KAV 188
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 6e-68
Identities = 57/183 (31%), Positives = 96/183 (52%), Gaps = 7/183 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH 78
+ ++ R +G G FG L R+K +K ++A+K + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI+R T + +++EYA G ++ + +F E + +L + +SYCH+
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 199 GKV 201
KV
Sbjct: 186 EKV 188
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-67
Identities = 63/184 (34%), Positives = 91/184 (49%), Gaps = 4/184 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
SD YD ++G G F V R K T A K I + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCH+
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 198 DGKV 201
V
Sbjct: 185 SKPV 188
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-67
Identities = 54/192 (28%), Positives = 85/192 (44%), Gaps = 20/192 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--------VQREIINHR 74
+Y +GSG FG VA+K++E+ D+I + V E++ +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101
Query: 75 SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 131
+ ++R + P +++E +LF+ I G E+ AR FF Q++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 188
V +CH V HRD+K EN L+D + LK+ DFG K +V GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216
Query: 189 PEVLLRHEYDGK 200
PE + H Y G+
Sbjct: 217 PEWIRYHRYHGR 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-67
Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 18/190 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------DENVQREIINHRSLR 77
+Y +G G++G + + D T AVK +++ K+ + NV++EI R LR
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64
Query: 78 HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 133
H N+++ +V+ + +VMEY G E+ + + RF +A +F QLI G+
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 190
Y H+ + H+D+K N LL LKI G +++ + +++ G+PA+ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 191 VLL-RHEYDG 199
+ + G
Sbjct: 182 IANGLDTFSG 191
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 4e-67
Identities = 64/183 (34%), Positives = 97/183 (53%), Gaps = 5/183 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHP 79
+ Y IG G++G ++ K T+ A K I + ++ + ++EI +SL HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NI+R E T + +VME +GGELFER+ + F E +A + ++S V+YCH +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 140 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
V HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+VL Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YG 185
Query: 199 GKV 201
+
Sbjct: 186 PEC 188
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 6e-67
Identities = 49/194 (25%), Positives = 76/194 (39%), Gaps = 22/194 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--------NVQREIINHR 74
Y +G G FG + VA+K I R +++ E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89
Query: 75 SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 129
+ HP ++R + T +V+E +LF+ I G E +R FF Q++
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 186
+ + +CH+ V HRD+K EN L+D K+ DFG GT Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204
Query: 187 IAPEVLLRHEYDGK 200
PE + RH+Y
Sbjct: 205 SPPEWISRHQYHAL 218
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 216 bits (550), Expect = 1e-66
Identities = 59/191 (30%), Positives = 83/191 (43%), Gaps = 12/191 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPN 80
++ +G+G FG + T E VA+K + K E EI + L HPN
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 81 IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 131
+V +EV LA + MEY GG+L + + N E R + S
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 132 VSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ Y H ++ HRDLK EN +L G KI D GY+K VGT Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 191 VLLRHEYDGKV 201
+L + +Y V
Sbjct: 194 LLEQKKYTVTV 204
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-66
Identities = 65/184 (35%), Positives = 87/184 (47%), Gaps = 7/184 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
+D Y+ DIG G++ V + K T AVK I DK + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
I+ K+V ++ +V E GGEL ++I FSE EA + V Y HA V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 141 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
HRDLK N L ++ICDFG++K + T T ++APEVL R Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 198 DGKV 201
D
Sbjct: 198 DAAC 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-66
Identities = 63/188 (33%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIIN 72
D Y + +GSG G +L ++ T + VA+K I + NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 133 SYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 192 LLRHEYDG 199
L+ G
Sbjct: 188 LVSVGTAG 195
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-65
Identities = 62/189 (32%), Positives = 100/189 (52%), Gaps = 9/189 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D Y+ ++GSG F + R R K T + A K+I R E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+RHPNI+ ++ T + +++E SGGELF+ + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H+ ++ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 193 LRHEYDGKV 201
+
Sbjct: 184 NYEPLGLEA 192
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 2e-65
Identities = 43/197 (21%), Positives = 76/197 (38%), Gaps = 17/197 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+ + +G G R K T +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 80 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 134
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 193 LR--------HEYDGKV 201
R +Y V
Sbjct: 188 ERAVLRKDHQKKYGATV 204
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-65
Identities = 69/184 (37%), Positives = 103/184 (55%), Gaps = 5/184 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
++RY+ V +G G+FG +D++T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 198 DGKV 201
D K
Sbjct: 200 DEKC 203
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 6e-65
Identities = 62/188 (32%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIIN 72
D Y + +GSG G +L ++ T + VA++ I + NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 133 SYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 192 LLRHEYDG 199
L+ G
Sbjct: 313 LVSVGTAG 320
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 6e-65
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 43/213 (20%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------------------------- 58
+Y +IG G++GV +L ++ A+K + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 59 --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 114
E V +EI + L HPN+V+ EV+ P HL +V E + G + E +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 169
SED+ARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190
Query: 170 SSVLHSQPKSTVGTPAYIAPEVL--LRHEYDGK 200
++L +TVGTPA++APE L R + GK
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGK 219
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 7e-65
Identities = 66/181 (36%), Positives = 100/181 (55%), Gaps = 2/181 (1%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
SD ++ ++G G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
++ KE+ TPT +++V+E +GGELF+RI G +SE +A +Q++ V+Y H +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 142 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y +
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230
Query: 201 V 201
V
Sbjct: 231 V 231
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-64
Identities = 41/188 (21%), Positives = 73/188 (38%), Gaps = 9/188 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+ + +G G R K T +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 80 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 134
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 193 LRHEYDGK 200
R
Sbjct: 188 ERAVLRKD 195
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-64
Identities = 64/184 (34%), Positives = 92/184 (50%), Gaps = 4/184 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKID-ENVQREIINHRSLRH 78
SD YD ++G G F V R K T A K I + D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCH+
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL + Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 198 DGKV 201
V
Sbjct: 208 SKPV 211
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-64
Identities = 61/187 (32%), Positives = 92/187 (49%), Gaps = 8/187 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 79
D + F R +GSG FG L+ ++ + +K I ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 135
NI++ EV ++ IVME GGEL ERI SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 136 HAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
H+ V H+DLK EN L SP +KI DFG ++ + GT Y+APEV +
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199
Query: 195 HEYDGKV 201
+ K
Sbjct: 200 RDVTFKC 206
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-64
Identities = 70/186 (37%), Positives = 100/186 (53%), Gaps = 8/186 (4%)
Query: 22 SDRYDF---VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLR 77
YD + +G G+F + R K + + AVK I + +++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HPNIV+ EV H +VME +GGELFERI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 138 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRH 195
+ V HRDLK EN L D + +KI DFG+++ +QP K+ T Y APE+L ++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 196 EYDGKV 201
YD
Sbjct: 185 GYDESC 190
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 9e-64
Identities = 62/189 (32%), Positives = 103/189 (54%), Gaps = 9/189 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 135 CHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H++Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 193 LRHEYDGKV 201
+
Sbjct: 190 NYEPLGLEA 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-63
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 13/190 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREI- 70
+ Y+ +G G V R K T + AVK I E ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 71 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130
I + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 191 VLLRHEYDGK 200
++ D
Sbjct: 194 IIECSMNDNH 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-63
Identities = 55/189 (29%), Positives = 87/189 (46%), Gaps = 12/189 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREI-I 71
+YD IG G V R + T AVK +E +++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
+ HP+I+ + + + + +V + GELF+ + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
VS+ HA + HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 192 LLRHEYDGK 200
L +
Sbjct: 271 LKCSMDETH 279
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-63
Identities = 59/189 (31%), Positives = 96/189 (50%), Gaps = 9/189 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ H N++ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 193 LRHEYDGKV 201
+
Sbjct: 191 NYEPLGLEA 199
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-63
Identities = 61/189 (32%), Positives = 97/189 (51%), Gaps = 9/189 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ HPNI+ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 193 LRHEYDGKV 201
+
Sbjct: 191 NYEPLGLEA 199
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 5e-63
Identities = 42/181 (23%), Positives = 78/181 (43%), Gaps = 1/181 (0%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
++Y D+G G FG+ + +K+ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQV 140
+ E + L ++ E+ SG ++FERI + +E E + Q+ + + H+ +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 201 V 201
Sbjct: 184 T 184
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 8e-63
Identities = 62/188 (32%), Positives = 90/188 (47%), Gaps = 11/188 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
++ Y ++G G F V R + + A I D + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNIVR + I H ++ + +GGELFE I +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 139 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 193
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 194 RHEYDGKV 201
+ Y V
Sbjct: 187 KDPYGKPV 194
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-62
Identities = 69/184 (37%), Positives = 103/184 (55%), Gaps = 5/184 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
++RY+ V +G G+FG +D++T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEVL Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 198 DGKV 201
D K
Sbjct: 200 DEKC 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 9e-62
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 2/182 (1%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
D YD + ++GSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQ 139
++ + + +++E+ SGGELF+RI + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ H D+K EN + + A +KI DFG + K T T + APE++ R
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 200 KV 201
Sbjct: 230 YT 231
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-61
Identities = 74/185 (40%), Positives = 104/185 (56%), Gaps = 6/185 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKID-ENVQREIINHRSLR 77
SDRY R +G G+FG L +DK+T + AVK I + K D E++ RE+ + L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HPNI++ E + +V E +GGELF+ I + RFSE +A +Q++SG++Y H
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ HRDLK EN LL+ S ++I DFG S + K +GT YIAPEVL
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 203
Query: 197 YDGKV 201
YD K
Sbjct: 204 YDEKC 208
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-61
Identities = 68/184 (36%), Positives = 97/184 (52%), Gaps = 5/184 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
S+ Y V+ +GSG +G L RDKVT A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI++ + + +VME GGELF+ I + +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ HRDLK EN LL +KI DFG S + K +GT YIAPEVL + Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-Y 214
Query: 198 DGKV 201
D K
Sbjct: 215 DEKC 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 4e-61
Identities = 52/194 (26%), Positives = 82/194 (42%), Gaps = 14/194 (7%)
Query: 22 SDRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREI-INHRSLRH 78
D Y D +G G + + +T + AVK IE + I V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
N++ E +V E GG + I F+E EA Q + S + + H
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 139 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 188
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 189 PEVLLRHEYDGKVY 202
PEV+ + +Y
Sbjct: 190 PEVVEAFSEEASIY 203
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-60
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 32/210 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ ++ + +G G FG R+ + A+K I ++ + E++ SL H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 82 VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 127
VR+ L + L I MEY G L++ I + DE F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 172
++ +SY H+ + HRDLK N +D S +KI DFG +K+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 173 LHSQPKSTVGTPAYIAPEVLL-RHEYDGKV 201
S +GT Y+A EVL Y+ K+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-60
Identities = 66/195 (33%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--------------GDKIDENVQ 67
+ Y VR +GSG +G L ++K A+K I++ +K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 68 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 128 LISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 187 IAPEVLLRHEYDGKV 201
IAPEVL + Y+ K
Sbjct: 215 IAPEVLKKK-YNEKC 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-60
Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 8/188 (4%)
Query: 22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREI-INHRSL 76
++ Y +++G G F V R K T + A K+++ RG + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 134
P ++ EV + + +++EYA+GGE+F A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 135 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
H + H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 194 RHEYDGKV 201
Sbjct: 207 YDPITTAT 214
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 5e-60
Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 14/211 (6%)
Query: 5 RASLTVGPAMDMPIMHDS--DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE----- 57
S G +DM D Y+ IG G F V R ++ T + AVK ++
Sbjct: 4 GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63
Query: 58 -RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR- 115
E+++RE L+HP+IV E + L +V E+ G +L I
Sbjct: 64 SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA 123
Query: 116 ---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 171
+SE A + +Q++ + YCH + HRD+K LL + +K+ FG +
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 172 VLHSQP-KSTVGTPAYIAPEVLLRHEYDGKV 201
VGTP ++APEV+ R Y V
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPV 214
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 6e-60
Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 2/182 (1%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
D YD ++G+G FGV + ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ 139
+V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 200 KV 201
Sbjct: 336 YT 337
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 8e-60
Identities = 57/184 (30%), Positives = 88/184 (47%), Gaps = 4/184 (2%)
Query: 22 SDRYDFVR--DIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRH 78
+ Y + +G G FG + T +A K I+ RG K E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHA 137
N+++ + + + +VMEY GGELF+RI + +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
M + H DLK EN L A ++KI DFG ++ + K GTP ++APEV+
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 198 DGKV 201
Sbjct: 266 SFPT 269
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-59
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 5 RASLTVGPAMDMPIMHDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
V + + D Y + +G G G + +K T+E A+K ++
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98
Query: 64 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 116
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 175
+E EA + + + Y H++ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 176 QPKSTVGTPAYIAPEVLLRHEYDGKV 201
+ TP Y+APEVL +YD
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSC 244
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 6e-59
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 53/233 (22%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKID-ENVQREIINHRS 75
+Y IG G++GV R+ + T+ + A+K + + + D E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 115
L HPNI R EV ++ +VME GG L +++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 116 --------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155
E +Q+ S + Y H +CHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 156 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVL--LRHEYDGKV 201
+ +K+ DFG SK + + GTP ++APEVL Y K
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 6e-59
Identities = 36/209 (17%), Positives = 73/209 (34%), Gaps = 39/209 (18%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------------------GDKIDE 64
+ Y +R + G F L + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 65 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 116
+ + E+ +++ + + +I + I+ EY + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 117 SEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
+ + +++ SY H +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHE-YDGK 200
+ + GT ++ PE Y+G
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGA 231
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 7e-59
Identities = 40/183 (21%), Positives = 76/183 (41%), Gaps = 13/183 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
Y ++ IGSG + ++ K++ A+KY+ + + ++ + EI L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRH 195
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 196 EYD 198
Sbjct: 204 SSS 206
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-58
Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 23/197 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
+ + IGSG FG + ++ + +K + +E +RE+ L H NIV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67
Query: 83 RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 124
+ + L I ME+ G L + I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
F+Q+ GV Y H+ ++ +RDLK N L + ++KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 185 AYIAPEVLLRHEYDGKV 201
Y++PE + +Y +V
Sbjct: 186 RYMSPEQISSQDYGKEV 202
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 6e-58
Identities = 40/183 (21%), Positives = 76/183 (41%), Gaps = 13/183 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
Y ++ IGSG + ++ K++ A+KY+ + + ++ + EI L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRH 195
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 196 EYD 198
Sbjct: 185 SSS 187
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-58
Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 16/190 (8%)
Query: 22 SDRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHP 79
+D Y + +G G G + T + A+K + ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82
Query: 80 NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 133
+IV +V H I+ME GGELF RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 134 YCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 191
+ H+ + HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 192 LLRHEYDGKV 201
L +YD
Sbjct: 201 LGPEKYDKSC 210
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-57
Identities = 39/183 (21%), Positives = 76/183 (41%), Gaps = 13/183 (7%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
Y ++ IGSG + ++ K++ A+KY+ + + ++ + EI L+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRH 195
+ H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 196 EYD 198
Sbjct: 232 SSS 234
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 7e-57
Identities = 53/184 (28%), Positives = 94/184 (51%), Gaps = 8/184 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHP 79
++Y ++ IG G+FG A L++ +K I E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHA 137
NIV+++E L IVM+Y GG+LF+RI F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 197 YDGK 200
Y+ K
Sbjct: 202 YNNK 205
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-55
Identities = 61/194 (31%), Positives = 96/194 (49%), Gaps = 17/194 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHP 79
+ Y+ + IG+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 80 NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
NIVR+ + I+ T L IVMEY GG+L I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 134 YCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 187
CH V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 188 APEVLLRHEYDGKV 201
+PE + R Y+ K
Sbjct: 184 SPEQMNRMSYNEKS 197
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-54
Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQ 67
P M + + + IG G F + VA+K ++ D +D +
Sbjct: 24 PDMGYNTL---ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80
Query: 68 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARF 123
+EI + L HPN++++ + L IV+E A G+L I + + E
Sbjct: 81 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 182
+F QL S + + H+ +V HRD+K N + + +K+ D G + S + S VG
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 183 TPAYIAPEVLLRHEYDGKV 201
TP Y++PE + + Y+ K
Sbjct: 199 TPYYMSPERIHENGYNFKS 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-54
Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 9/184 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSL-RH 78
+ + +G G++G +R K L AVK RG K E+ +H + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHA 137
P VR ++ L + E G L + G E + + + + +++ H+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
+ H D+K N L P R K+ DFG + G P Y+APE+ L+ Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232
Query: 198 DGKV 201
Sbjct: 233 GTAA 236
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 9e-52
Identities = 47/197 (23%), Positives = 74/197 (37%), Gaps = 21/197 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHP 79
D+ Y F++ +G G F L+ A+K I ++ D E QRE HR HP
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 80 NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 131
NI+R L +++ + G L+ I +ED+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 181
+ HA HRDLK N LL + + D G + +H +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 182 GTPAYIAPEVLLRHEYD 198
T +Y APE+ +
Sbjct: 205 CTISYRAPELFSVQSHC 221
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-51
Identities = 49/209 (23%), Positives = 77/209 (36%), Gaps = 32/209 (15%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
++ ++ +G G FGV ++KV A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 81 IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 125
IVR+ L +L I M+ L + + C F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 172
Q+ V + H+ + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
+++ VGT Y++PE + + Y KV
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKV 211
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-51
Identities = 53/188 (28%), Positives = 80/188 (42%), Gaps = 33/188 (17%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
D + +G G G + +K T+E A+K ++ +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72
Query: 81 IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 134
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 135 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
H++ + HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171
Query: 194 RHEYDGKV 201
+YD
Sbjct: 172 GEKYDKSC 179
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-50
Identities = 32/211 (15%), Positives = 70/211 (33%), Gaps = 27/211 (12%)
Query: 21 DSDRYDFVRDIGSGNFGVARL-----MRDKVTKELVAVKYIERGDKIDENVQREIIN-HR 74
S +G G F + D K+ +K + + + + +++ +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 129
++F L +V E S G L I + F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 180
+ H ++ H D+K +N +L + L + D G S + PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240
Query: 181 V-----GTPAYIAPEVLLRHEYDGKVYFYSI 206
+ T + E+L ++ ++ ++ +
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-48
Identities = 46/207 (22%), Positives = 78/207 (37%), Gaps = 28/207 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 81
+ + +G G+ G + VAVK + + EI + S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 134
+R+ T L I +E L + + + E+ +Q+ SGV++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 135 CHAMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 178
H++++ HRDLK +N L+ S R+ I DFG K S +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 179 STVGTPAYIAPEVLLRHEYDGKVYFYS 205
+ GT + APE+L +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLT 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-47
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 29/206 (14%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREIINHRSL-R 77
+ + + IGSG FG ++ + A+K + G ++N RE+ H L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
H ++VR+ H+ I EY +GG L + I R F E E + Q+ G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 134 YCHAMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 176
Y H+M + H D+K N + S KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 177 PKSTVGTPAYIAPEVLL-RHEYDGKV 201
P+ G ++A EVL + + K
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKA 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-46
Identities = 49/205 (23%), Positives = 78/205 (38%), Gaps = 31/205 (15%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 81
R R + G F +D + A+K + ++ + +E+ + L HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 82 VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 131
V+F KE T +++ G+L E + G S D F Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 132 VSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 180
V + H + + HRDLK+EN LL +K+CDFG + + + +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQ--GTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 181 ----VGTPAYIAPEV--LLRHEYDG 199
TP Y PE+ L + G
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIG 231
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-45
Identities = 48/195 (24%), Positives = 71/195 (36%), Gaps = 16/195 (8%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 82
+ +G G G R VAVK I + RE+ + S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVC 141
R+ I +E L E + E QQ SG+++ H++ +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 142 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLR 194
HRDLK N L+ + + I DFG K S+ GT +IAPE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 195 HE---YDGKVYFYSI 206
V +S
Sbjct: 201 DCKENPTYTVDIFSA 215
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-45
Identities = 51/177 (28%), Positives = 77/177 (43%), Gaps = 11/177 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
+G G+FG M+DK T AVK + ++ E++ L P IV +
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150
+ I ME GG L + I G ED A ++ Q + G+ Y H ++ H D+K +N
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 151 LLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
LL R +CDFG++ GT ++APEV++ D KV
Sbjct: 182 LLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-45
Identities = 53/183 (28%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 78
+ F + +G G+F L R+ T A+K +I + +K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRH 195
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 196 EYD 198
Sbjct: 208 SAC 210
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-42
Identities = 51/193 (26%), Positives = 99/193 (51%), Gaps = 15/193 (7%)
Query: 23 DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----S 75
+++ ++ +G G+FG + + + ++L A+K + + + + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 136 HAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 192
H++ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 193 LRHEYDGKVYFYS 205
R + ++S
Sbjct: 199 NRRGHTQSADWWS 211
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-41
Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 19/190 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------R 74
+ +D+++ +G G FG L+R+K T A+K + R + I + ++ + H +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 191
H+ V +RD+KLEN +LD G +KI DFG K + T GTP Y+APEV
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 192 LLRHEYDGKV 201
L ++Y V
Sbjct: 177 LEDNDYGRAV 186
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-41
Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 20/195 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+ F++ IG G+FG L R K + AVK + + I ++++ H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
Y H++ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 191 VLLRHEYDGKVYFYS 205
VL + YD V ++
Sbjct: 210 VLHKQPYDRTVDWWC 224
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-41
Identities = 64/186 (34%), Positives = 95/186 (51%), Gaps = 16/186 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
D ++F+R +G G+FG L R K T +L AVK + + D I +Q + +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 193 LRHEYD 198
Y
Sbjct: 197 QEMLYG 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-41
Identities = 57/191 (29%), Positives = 93/191 (48%), Gaps = 20/191 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+D +R IG G++ L+R K T + A+K + + + + E I+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 191 VLLRHEYDGKV 201
+L +Y V
Sbjct: 181 ILRGEDYGFSV 191
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 4e-41
Identities = 59/191 (30%), Positives = 93/191 (48%), Gaps = 20/191 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+ + + +G G+FG L K T + A+K + K D + + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
+ H+ + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 191 VLLRHEYDGKV 201
+LL +Y+ V
Sbjct: 189 ILLGQKYNHSV 199
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-41
Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 20/184 (10%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
+ +R +G+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 137 AMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
+ + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 195 HEYD 198
Y+
Sbjct: 178 KPYN 181
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-41
Identities = 55/185 (29%), Positives = 103/185 (55%), Gaps = 12/185 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
D++D ++ +G+G+FG L++ K + A+K +++ + +N + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
+ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 197 YDGKV 201
Y+ V
Sbjct: 215 YNKAV 219
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-40
Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 23 DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQRE-IINHR---- 74
+ ++ +R +G G +G R + T ++ A+K +++ + R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 191
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 192 LLRHEYDGKV 201
L+R ++ V
Sbjct: 193 LMRSGHNRAV 202
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 10/180 (5%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 81
+ +R IG G+FG +++ TK++ A+KY+ + ++ N R + L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
V + +V++ GG+L + F E+ + F +L+ + Y ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 142 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
HRD+K +N LLD G + I DF + +Q + GT Y+APE+ + G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-40
Identities = 60/191 (31%), Positives = 89/191 (46%), Gaps = 20/191 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
++F+ +G G+FG L K T EL AVK + K D +Q + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLA 75
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
+ + + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 191 VLLRHEYDGKV 201
++ Y V
Sbjct: 192 IIAYQPYGKSV 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 55/188 (29%), Positives = 92/188 (48%), Gaps = 20/188 (10%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
+D +R IG G++ L+R K T + A++ + + + + E I+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 191 VLLRHEYD 198
+L +Y
Sbjct: 224 ILRGEDYG 231
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-40
Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 8/178 (4%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 89
+G G +G+ RD + +A+K I D + + EI H+ L+H NIV++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 90 TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
+ I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 147 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHE--YDGKV 201
+N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ + Y
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-40
Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 9/184 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ +D + +G G++G K T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V++ T L IVMEY G + + I +EDE Q + G+ Y H M+
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 198 DGKV 201
+
Sbjct: 203 NCVA 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 63/185 (34%), Positives = 99/185 (53%), Gaps = 8/185 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
+ +++++ +G G FG L+++K T A+K +++ + ++ + + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + K T L VMEYA+GGELF + FSED ARF+ +++S + Y H+
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 139 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHE 196
+ V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL ++
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 197 YDGKV 201
Y V
Sbjct: 326 YGRAV 330
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-39
Identities = 54/183 (29%), Positives = 90/183 (49%), Gaps = 6/183 (3%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
+ + + IG G+FG D T+++VA+K I E + E++Q+EI P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ ++ L T L I+MEY GG + + G E + ++++ G+ Y H+ +
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
HRD+K N LL +K+ DFG + ++T VGTP ++APEV+ + YD
Sbjct: 140 KIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 199 GKV 201
K
Sbjct: 198 SKA 200
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-39
Identities = 56/185 (30%), Positives = 93/185 (50%), Gaps = 11/185 (5%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
+Y IG G G D T + VA++ + ++ K + + EI+ R ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV + + L L +VMEY +GG L + + E + ++ + + + H+ Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ R
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 197 YDGKV 201
Y KV
Sbjct: 193 YGPKV 197
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-39
Identities = 60/184 (32%), Positives = 98/184 (53%), Gaps = 9/184 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 80
D IG G+ G+ L R+K + VAVK ++ R + E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V + L L ++ME+ GG L + I + R +E++ + ++ ++Y HA V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ R Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 198 DGKV 201
+V
Sbjct: 219 ATEV 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-39
Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 10/186 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
++F+ +G G+FG L K T EL AVK +++ I ++ V++ ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRH 195
+ + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 196 EYDGKV 201
Y V
Sbjct: 518 PYGKSV 523
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 46/193 (23%), Positives = 84/193 (43%), Gaps = 17/193 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------R 74
D ++ ++ IG G F +++ K T ++ A+K + + ++R ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 133
+ I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 191
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 192 LLRHEYDGKVYFY 204
L Y
Sbjct: 235 LQAVGGGPGTGSY 247
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-38
Identities = 57/186 (30%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
Y+ V+ IG G FG +L+R K T+++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 194
+M HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 195 HEYDGK 200
DG
Sbjct: 244 QGGDGY 249
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-38
Identities = 60/194 (30%), Positives = 88/194 (45%), Gaps = 16/194 (8%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D + +G G FGV + + K + VA+K I + + E+ + HPN
Sbjct: 6 DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHA 137
IV+ L P + +VMEYA GG L+ + A A + GV+Y H+
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 138 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
MQ + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 195 HEYDGK--VYFYSI 206
Y K V+ + I
Sbjct: 178 SNYSEKCDVFSWGI 191
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-37
Identities = 50/189 (26%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 26 DFVRDIGSGNFG---VARLMRDKVTKELVAVK-----YIERGDKIDENVQRE-----IIN 72
+ ++ +G+G +G + R + T +L A+K I + K E+ + E I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 133 SYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 188
+ H + + +RD+KLEN LLD G + + DFG SK V ++ GT Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 189 PEVLLRHEY 197
P+++ +
Sbjct: 229 PDIVRGGDS 237
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 46/189 (24%), Positives = 84/189 (44%), Gaps = 17/189 (8%)
Query: 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
++ ++ IG G FG +++ K ++ A+K + E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 135
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 193
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 194 RHEYDGKVY 202
E Y
Sbjct: 250 AMEGGKGRY 258
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 9e-37
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 11/188 (5%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-------SLRH 78
R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ + H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE-Y 197
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL + Y
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 198 DGKVYFYS 205
D ++S
Sbjct: 369 DSSADWFS 376
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-36
Identities = 49/191 (25%), Positives = 94/191 (49%), Gaps = 16/191 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
++ ++ V ++G G FG ++K T L A K I + +++++ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAM 138
IV+ L I++E+ GG + + +E + + +Q++ +++ H+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRH 195
++ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 196 E-----YDGKV 201
YD K
Sbjct: 193 TMKDTPYDYKA 203
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 26/213 (12%), Positives = 53/213 (24%), Gaps = 42/213 (19%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR-- 77
+G + D+ T E V ++ + ++ E++ R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 78 -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 106
++R + L+ Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
Q+I ++ H + H L+ + +LD + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251
Query: 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
V + + + PE+ R
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATIS 281
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 55/190 (28%), Positives = 82/190 (43%), Gaps = 15/190 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
D + R +G G FG + K T +L A K + + + + + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 134
IV T T L +VM +GG++ I N F E A F+ Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 191
H + +RDLK EN LLD G ++I D G + GTP ++APE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 192 LLRHEYDGKV 201
LL EYD V
Sbjct: 361 LLGEEYDFSV 370
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-36
Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 8/184 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREI-INHRSLR 77
D ++ + ++G+GN GV + K + ++A K I K + RE+ + H
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 138 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ HRD+K N L++ +K+CDFG S + S S VGT +Y++PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 197 YDGK 200
Y +
Sbjct: 207 YSVQ 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 8/185 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRH 78
+ + R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 136
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
++ +RDLK EN LLD ++I D G + K VGT Y+APEV+
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 197 YDGKV 201
Y
Sbjct: 362 YTFSP 366
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 3e-36
Identities = 49/206 (23%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 21 DSDRYDFVRDIGSG--NFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRS 75
+ Y+ + IG G + L R K T E V V+ I +++ +Q E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 133
HPNIV ++ + L +V + + G + IC +E + Q ++ +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 185
Y H M HR +K + L+ + + + + V+H PK +V
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 186 YIAPEVLLR--HEYDGKVYFYS--IT 207
+++PEVL + YD K YS IT
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGIT 226
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-36
Identities = 64/189 (33%), Positives = 92/189 (48%), Gaps = 19/189 (10%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
IG+G+FG + R + VAVK + D E V RE+ + LRHPNIV F
Sbjct: 45 IGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 88 ILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAM--QVCH 142
+ P +L+IV EY S G L+ + +G E + G++Y H + H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDG 199
R+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL +
Sbjct: 163 RNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 200 K--VYFYSI 206
K VY + +
Sbjct: 219 KSDVYSFGV 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-36
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRH 78
+ D Y+ IGSG V + KE VA+K I E+ + + +EI H
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 130
PNIV + + L +VM+ SGG + + +G E ++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 131 GVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS------KSSVLHSQPKSTVG 182
G+ Y H HRD+K N LL DGS ++I DFG S + K+ VG
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 183 TPAYIAPEVLLR-HEYDGKVYFYS--IT 207
TP ++APEV+ + YD K +S IT
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGIT 216
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-36
Identities = 45/186 (24%), Positives = 78/186 (41%), Gaps = 6/186 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREI-INHRSLR 77
+ + + + ++GSG G MR + T ++AVK + + ++ + ++ + +S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
P IV+ +T T + I ME + G E ++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 138 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
V HRD+K N LLD ++K+CDFG S V + G AY+APE + +
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 197 YDGKVY 202
Y
Sbjct: 201 PTKPDY 206
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-35
Identities = 58/197 (29%), Positives = 85/197 (43%), Gaps = 20/197 (10%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 80
IG G FG ++ R + VAVK D ENV++E L+HPN
Sbjct: 10 TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-- 138
I+ + V L +L +VME+A GG L + R D + Q+ G++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 139 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ HRDLK N L+ LKI DFG ++ + S G A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185
Query: 192 LLRHEYDGK--VYFYSI 206
+ + V+ Y +
Sbjct: 186 IRASMFSKGSDVWSYGV 202
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 29/217 (13%), Positives = 51/217 (23%), Gaps = 44/217 (20%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
+ V + G+ V L+RD E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 80 NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 107
+ ++ + ++M AS L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 108 ERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167
G QLI + + + H +N + RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239
Query: 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGKV 201
+ P AP L + +
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHAL 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-35
Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 18/190 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSL 76
+ +R+IG G+FG RD E+VA+K + + +K + + +E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
RHPN ++++ L +VMEY G + E E + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 137 AMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 193
+ + HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224
Query: 194 --RHEYDGKV 201
+YDGKV
Sbjct: 225 MDEGQYDGKV 234
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-35
Identities = 62/179 (34%), Positives = 92/179 (51%), Gaps = 10/179 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
DRY + +G G +G D VT E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
NI+ K VI L ++ EYA +L + + S + F QLI+GV++CH+
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 139 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
+ HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-34
Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 21/197 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPN 80
+ ++ V +G+G +G R T +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 81 IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 132
I + K L +VME+ G + + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 133 SYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 189
S+ H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 190 EVLLRHE-----YDGKV 201
EV+ E YD K
Sbjct: 199 EVIACDENPDATYDFKS 215
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-34
Identities = 51/196 (26%), Positives = 80/196 (40%), Gaps = 20/196 (10%)
Query: 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV--------QREIINHRSLR 77
++ + IG G FG+ R K +VA+K + GD E QRE+ +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 136
HPNIV+ ++ P +VME+ G+L+ R+ + + G+ Y
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 137 AM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ HRDL+ N L + K+ DFG S+ +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 192 LL-RHE-YDGKVYFYS 205
+ E Y K YS
Sbjct: 198 IGAEEESYTEKADTYS 213
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-34
Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 5 RASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE 64
S V + ++Y+ + +G G++G+ R+K T +VA+K D+
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65
Query: 65 NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 118
V REI + LRH N+V EV +V E+ + E N
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123
Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178
+ + Q+I+G+ +CH+ + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181
Query: 179 ST-VGTPAYIAPEVLL 193
V T Y APE+L+
Sbjct: 182 DDEVATRWYRAPELLV 197
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-34
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 12/185 (6%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 84
IG G+F D T VA ++ QR E + L+HPNIVRF
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 85 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VC 141
+ + + +V E + G L + R + +Q++ G+ + H +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +YD V
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDESV 210
Query: 202 YFYSI 206
Y+
Sbjct: 211 DVYAF 215
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-34
Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 11/178 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
+ + V IG G +GV R+K+T E+VA+K I R D E V REI + L H
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
PNIV+ +VI T L +V E+ + + + + QL+ G+++CH
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
+ +V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL
Sbjct: 121 SHRVLHRDLKPQNLLINTE--GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 176
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-34
Identities = 45/192 (23%), Positives = 84/192 (43%), Gaps = 15/192 (7%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREI-INHRSLR 77
+D + + ++G G +GV MR + +++AVK I E + ++ I+ R++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 134
P V F + + I ME + ++++ + ED ++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 135 CHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
H+ + V HRD+K N L++ ++K+CDFG S V K G Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 193 L----RHEYDGK 200
+ Y K
Sbjct: 182 NPELNQKGYSVK 193
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-34
Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 24/176 (13%)
Query: 31 IGSGNFGVARLMRDKVTKEL----VAVKYIERGDKIDENVQ---REIINHRSLRHPNIVR 83
IG G FG +V VA++ I+ ++ ++ RE++ +R RH N+V
Sbjct: 41 IGKGRFG-------QVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 84 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCH 142
F ++P HLAI+ G L+ + +A ++ R Q+++ G+ Y HA + H
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 192
+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 154 KDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 16/180 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
++Y+ + IG G++GV R++ T ++VA+K + D ++ REI + L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
PN+V EV L +V EY +R E + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 193
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 17/213 (7%)
Query: 1 MKMDR-ASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--E 57
M ++ L + P ++ + +IG G +G M K + +++AVK I
Sbjct: 1 MSIESSGKLKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 58 RGDKIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA- 113
+K + + ++ + RS P IV+F + I ME S + ++ + +
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 114 -GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171
E+ + +++ +++ HRD+K N LLD S +K+CDFG S
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQL 176
Query: 172 VLHSQPKSTVGTPAYIAPEVL----LRHEYDGK 200
V G Y+APE + R YD +
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 4e-33
Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 10/183 (5%)
Query: 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSL 76
M S ++ + +G+G + +K T VA+K + + + REI + L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 77 RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 131
+H NIVR +VI T L +V E+ + + ++F QL+ G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 190
+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 191 VLL 193
VL+
Sbjct: 179 VLM 181
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-33
Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 12/178 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
+Y+ + IG G +G +++ T E+VA+K + R D DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
NIVR +V+ + L +V E+ + F+ G + + F QL+ G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
+ V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-33
Identities = 26/221 (11%), Positives = 58/221 (26%), Gaps = 41/221 (18%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR-- 77
+G + D+ T E V ++ + ++ E++ R LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 78 --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 106
P + V L + ++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
Q+I ++ H + H L+ + +LD + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256
Query: 167 YSKS--SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYS 205
+ + S P A +L ++ + ++
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-33
Identities = 54/194 (27%), Positives = 86/194 (44%), Gaps = 18/194 (9%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP 79
Y + IG+G+FGV + + ELVA+K + DK +N RE+ R L H
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--RELQIMRKLDHC 107
Query: 80 NIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLIS 130
NIVR + + +L +V++Y + + QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 188
++Y H+ +CHRD+K +N LLD A LK+CDFG +K L + + + Y A
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPNVSYICSRYYRA 224
Query: 189 PEVLLR-HEYDGKV 201
PE++ +Y +
Sbjct: 225 PELIFGATDYTSSI 238
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-32
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 19/192 (9%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------ 67
M + + + RY+ + +G G F RDK T ++VA+K I + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59
Query: 68 -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 124
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 181
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173
Query: 182 GTPAYIAPEVLL 193
T Y APE+L
Sbjct: 174 VTRWYRAPELLF 185
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-32
Identities = 31/190 (16%), Positives = 71/190 (37%), Gaps = 22/190 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEV 87
+ + G L + + + VK ++ D + + E R HPN++
Sbjct: 18 LNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 88 ILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQ--VC 141
+P H ++ + G L+ + F D+++ F + G+++ H ++ +
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK- 200
L + ++D +I S Q + PA++APE L + D
Sbjct: 136 RHALNSRSVMIDED--MTARISMADVKFS----FQSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 201 ----VYFYSI 206
++ +++
Sbjct: 190 RSADMWSFAV 199
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-32
Identities = 58/178 (32%), Positives = 93/178 (52%), Gaps = 13/178 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
++Y + IG G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 79 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
NIV+ +VI T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
+V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 9e-32
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 9/176 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+ Y + +G G + + K+T LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 81 IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
IV ++I T L +V EY + + + + F QL+ G++YCH
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
+V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
M ++ ++Y + +G G +GV +D +VA+K I R D
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58
Query: 63 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 116
DE + REI + L HPNIV +VI + L +V E+ ++ + N
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174
Query: 177 PKST-VGTPAYIAPEVLL 193
+ V T Y AP+VL+
Sbjct: 175 SYTHEVVTLWYRAPDVLM 192
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-31
Identities = 52/185 (28%), Positives = 81/185 (43%), Gaps = 16/185 (8%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
IGSG+FG + + K + VAVK + + +Q E+ R RH NI+ F
Sbjct: 32 IGSGSFG--TVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 88 ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
T LAIV ++ G L+ + + +F + +Q G+ Y HA + HRDLK
Sbjct: 89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 147 LENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGK 200
N L +KI DFG + Q + G+ ++APEV+ + Y +
Sbjct: 148 SNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 201 VYFYS 205
Y+
Sbjct: 206 SDVYA 210
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 22/191 (11%)
Query: 23 DRYDFVRD-IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH 78
D +++ +G G +G A+ +D + A+K IE I + REI R L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77
Query: 79 PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 128
PN++ ++V L+ + + +YA + + + Q+
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 182
+ G+ Y HA V HRDLK N L+ G R +KI D G ++ + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 183 TPAYIAPEVLL 193
T Y APE+LL
Sbjct: 198 TFWYRAPELLL 208
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-31
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 24/201 (11%)
Query: 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----Q 67
+++ P + +Y+ + IG G FG R + T + VA+K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64
Query: 68 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 117
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 173
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 174 HSQP-KSTVGTPAYIAPEVLL 193
+ V T Y PE+LL
Sbjct: 181 QPNRYTNRVVTLWYRPPELLL 201
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-31
Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 19/192 (9%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
+G G FG A + + T E++ +K + R ++ +E+ R L HPN+++F V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 90 TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
L + EY GG L I + + + F + + SG++Y H+M + HRDL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 149 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 193
N L+ + + + DFG ++ + + VG P ++APE++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 194 RHEYDGKVYFYS 205
YD KV +S
Sbjct: 196 GRSYDEKVDVFS 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-31
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 19/192 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
Y + IG+G+FGV + + E VA+K + DK +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94
Query: 82 VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 132
V K + L +V+EY + + QL+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
+Y H++ +CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211
Query: 191 VLLR-HEYDGKV 201
++ Y +
Sbjct: 212 LIFGATNYTTNI 223
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-30
Identities = 46/192 (23%), Positives = 73/192 (38%), Gaps = 23/192 (11%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
+G G +G + R E VAVK D+ + E+ N LRH NI+ F
Sbjct: 16 VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ------- 139
+ T L ++ Y G L++ + + SG+++ H
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 140 -VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 193
+ HRDLK +N L+ + + I D G + ++ L VGT Y+APEV L
Sbjct: 133 AIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV-L 189
Query: 194 RHEYDGKVYFYS 205
+
Sbjct: 190 DETIQVDCFDSY 201
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 32/163 (19%), Positives = 56/163 (34%), Gaps = 18/163 (11%)
Query: 60 DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 116
+ +I N V + +L I M+ L + + C+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176
F Q+ V + H+ + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219
Query: 177 PKST-------------VGTPAYIAPEVLLRHEYDGKVYFYSI 206
++ VGT Y++PE + + Y KV +S+
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 6e-10
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPN 80
++ ++ +G G FGV ++KV A+K I ++ E V RE+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 81 IVRFKE 86
IVR+
Sbjct: 66 IVRYFN 71
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-30
Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ-------REIINHRS 75
RY+ V +IG G +G RD + VA+K + R RE+ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67
Query: 76 LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 125
L HPN+VR +V T + +V E+ ++ + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 182
+Q + G+ + HA + HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181
Query: 183 TPAYIAPEVLLRHEYDGKV 201
T Y APEVLL+ Y V
Sbjct: 182 TLWYRAPEVLLQSTYATPV 200
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 31/225 (13%)
Query: 7 SLTVGPAMDMPIMH---DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
S + G +P++ + + V+ IG G +G + K E VAVK ++
Sbjct: 18 SQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEAS 75
Query: 64 ENVQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSED 119
+ EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAK 134
Query: 120 EARFFFQQLISGVSYCHAMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 169
+SG+ + H + HRDLK +N L+ + I D G +
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKF 192
Query: 170 ---SSVLHSQPKSTVGTPAYIAPEVL-----LRH-EYDGKVYFYS 205
++ + P + VGT Y+ PEVL H + YS
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-29
Identities = 47/190 (24%), Positives = 92/190 (48%), Gaps = 17/190 (8%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN 80
D Y VR +G G + + E V VK ++ K + ++REI +LR PN
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+ +++ P A+V E+ + + + ++ + RF+ +++ + YCH+M
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHE 196
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLV--- 203
Query: 197 YDGKVYFYSI 206
D ++Y YS+
Sbjct: 204 -DYQMYDYSL 212
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-29
Identities = 52/179 (29%), Positives = 75/179 (41%), Gaps = 22/179 (12%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
IG G FG + R K E VAVK ++ + EI LRH NI+ F +
Sbjct: 50 IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------M 138
T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL 192
+ HRDLK +N L+ + I D G + + + P VGT Y+APEVL
Sbjct: 167 AIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-29
Identities = 58/201 (28%), Positives = 86/201 (42%), Gaps = 17/201 (8%)
Query: 7 SLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN- 65
SL A D + DR+ R G G FG +L ++K T VA+K + D N
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNR 65
Query: 66 VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR--- 115
+ + + L HPNIV+ + T L +VMEY L N R
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV 124
Query: 116 -FSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172
+ F QLI + H ++ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLS 183
Query: 173 LHSQPKSTVGTPAYIAPEVLL 193
+ + + Y APE++
Sbjct: 184 PSEPNVAYICSRYYRAPELIF 204
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-28
Identities = 46/195 (23%), Positives = 71/195 (36%), Gaps = 28/195 (14%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D D + IG G +G + + + + VAVK ++ + ++ I + H N
Sbjct: 11 DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 81 IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
I RF + +VMEY G L + + + + + G++Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 136 HAM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 177
H + HRDL N L+ I DFG S +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 178 KSTVGTPAYIAPEVL 192
S VGT Y+APEVL
Sbjct: 186 ISEVGTIRYMAPEVL 200
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 54/198 (27%), Positives = 81/198 (40%), Gaps = 19/198 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
RY ++ +G G G+ D + VA+K I D ++ REI R L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 81 IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 128
IV+ E++ + E E + G E+ AR F QL
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 184
+ G+ Y H+ V HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 185 AYIAPEVLLR-HEYDGKV 201
Y +P +LL + Y +
Sbjct: 189 WYRSPRLLLSPNNYTKAI 206
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-27
Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 23/196 (11%)
Query: 23 DRYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYIERGDKIDENVQ----REI---INHR 74
+Y+ V +IG G +G RD K VA+K + R +E + RE+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 75 SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 127
+ HPN+VR +V T L +V E+ ++ + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 185
L+ G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ Q T V T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 186 YIAPEVLLRHEYDGKV 201
Y APEVLL+ Y V
Sbjct: 185 YRAPEVLLQSSYATPV 200
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 14/189 (7%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
RY ++ IGSG G+ D + + VA+K + R ++ + RE++ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
NI+ V L IVME L ++ + + Q++ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+ H+ + HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 193 LRHEYDGKV 201
L Y V
Sbjct: 199 LGMGYKENV 207
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-25
Identities = 63/191 (32%), Positives = 87/191 (45%), Gaps = 8/191 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLR 77
++RY V +G G L D + VA+K I + E +RE+ N L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
H NIV +V +VMEY G L E I + G S D A F Q++ G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRH 195
M++ HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 196 EYDGKVYFYSI 206
D YSI
Sbjct: 188 ATDECTDIYSI 198
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 52/192 (27%), Positives = 85/192 (44%), Gaps = 20/192 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
+RY + +GSG +G D T VAVK + R I + RE+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
N++ +V L +V G +L I + ++D +F Q++ G+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
Y H+ + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199
Query: 191 VLL-RHEYDGKV 201
++L Y+ V
Sbjct: 200 IMLNWMHYNQTV 211
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 20/192 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
Y ++ +GSG +G D T VA+K + R ++ + RE+ + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
N++ +V L +VM + G +L ++ + ED +F Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
Y HA + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195
Query: 191 VLL-RHEYDGKV 201
V+L Y V
Sbjct: 196 VILNWMRYTQTV 207
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 18/191 (9%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
RY ++ IGSG G+ D V VA+K + R ++ + RE++ + + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
NI+ V L +VME L + I + + Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
+ H+ + HRDLK N ++ LKI DFG +++ + T V T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 191 VLLRHEYDGKV 201
V+L Y V
Sbjct: 234 VILGMGYKENV 244
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 35/207 (16%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQ------REII 71
+ S + +G G +GV K T E+VA+K KI+ + REI
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61
Query: 72 NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 126
+ +H NI+ + + I+ E +L R+ + S+D ++F
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 180
Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 181 -----VGTPAYIAPEVLL-RHEYDGKV 201
V T Y APEV+L +Y +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM 204
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 58/198 (29%), Positives = 85/198 (42%), Gaps = 28/198 (14%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQ------REIINH 73
RY + IG G +G+ D + K VA+K KI E+ REI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79
Query: 74 RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 128
RH NI+ ++I PT + IV + +L ++ S D +F Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 184
+ G+ Y H+ V HRDLK N LL+ + LKICDFG ++ + V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 185 AYIAPEVLL-RHEYDGKV 201
Y APE++L Y +
Sbjct: 196 WYRAPEIMLNSKGYTKSI 213
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 53/192 (27%), Positives = 91/192 (47%), Gaps = 21/192 (10%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
Y +GSG +G DK + E VA+K + R +I + RE++ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 79 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
N++ +V + L +VM + +L + + +FSE++ ++ Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
Y H+ V HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193
Query: 191 VLL-RHEYDGKV 201
V+L Y+ V
Sbjct: 194 VILSWMHYNQTV 205
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 6e-25
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 27/207 (13%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
S + G FG + + ++ E VAVK DK + E+ + ++H N
Sbjct: 22 QSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHEN 79
Query: 81 IVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
I++F K L ++ + G L + + A S +E + + G++Y H
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLH 138
Query: 137 AMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 183
+ HRD+K +N LL + I DFG + T VGT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 184 PAYIAPEVL-----LRHEYDGKVYFYS 205
Y+APEVL + + ++ Y+
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYA 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-24
Identities = 43/213 (20%), Positives = 79/213 (37%), Gaps = 45/213 (21%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
S +Y + +G+G+FG+ + D + + A+K + + D +N RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 114
++ + T N G
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 115 --------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160
+ + QL V + H++ +CHRD+K +N L++ L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181
Query: 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
K+CDFG +K + + + + Y APE++L
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELML 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-24
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSL 76
DRY+ IG+G++G DK+ K +VA+K I R D ID + + REI L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 77 RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
H ++V+ ++++ L +V+E A + + +E + L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
V Y H+ + HRDLK N L++ +K+CDFG
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFG 201
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-24
Identities = 45/201 (22%), Positives = 71/201 (35%), Gaps = 23/201 (11%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------------ 67
Y R I SG++G D VA+K + V
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 68 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 121
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 182 GTPAYIAPEVLL-RHEYDGKV 201
Y APE+++ + V
Sbjct: 195 THRWYRAPELVMQFKGFTKLV 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-23
Identities = 54/207 (26%), Positives = 80/207 (38%), Gaps = 15/207 (7%)
Query: 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV---- 66
G M P DRY+ +G G L RD VAVK + D +
Sbjct: 1 GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 67 QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
+RE N +L HP IV + IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 178
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 179 STVGTPAYIAPEVLLRHEYDGKVYFYS 205
+ +GT Y++PE D + YS
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYS 204
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-23
Identities = 48/188 (25%), Positives = 75/188 (39%), Gaps = 8/188 (4%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLRHP 79
Y R +G G G D V + +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
++V + L + M +G +L + G + A +Q+ S + HA
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 198 DGKVYFYS 205
+ Y+
Sbjct: 213 TYRADIYA 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 20/180 (11%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGDKIDENVQ----REIINHRSL 76
+ +Y+ I G G L D+ V V +K + D Q E +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136
Query: 77 RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
HP+IV+ + IVMEY G L + EA + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+SY H++ + + DLK EN +L +LK+ D G + GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-23
Identities = 53/212 (25%), Positives = 86/212 (40%), Gaps = 35/212 (16%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
D Y IG G++G L DK T++ VA+K + R D ID + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 79 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
I+R ++I+ L IV+E A +L + +E+ + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 185
+ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 186 ---------------YIAPEVLL-RHEYDGKV 201
Y APE++L + Y +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 9e-23
Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLR- 77
+Y+ V+ +G G +G+ D+ T E+VAVK I + D + REI+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 78 HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
H NIV V+ + +V +Y +L + A ++ QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 180
H+ + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 181 -------VGTPAYIAPEVLL-RHEYDGKV 201
V T Y APE+LL +Y +
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI 212
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-21
Identities = 54/192 (28%), Positives = 79/192 (41%), Gaps = 21/192 (10%)
Query: 20 HDSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH 78
H + RY+ ++ IG G+FG V + D + VA+K + + EI R L H
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149
Query: 79 ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 127
N++ E H+ + E S L+E I FS R F
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 186
++ + H ++ H DLK EN LL +K+ DFG SS Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 187 IAPEVLLRHEYD 198
APEV+L Y
Sbjct: 266 RAPEVILGARYG 277
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-21
Identities = 46/201 (22%), Positives = 77/201 (38%), Gaps = 25/201 (12%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHR 74
+ RY VR +G G+F L +D V VA+K + E + EI +N
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 75 SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 122
+I++ + H+ +V E G L + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 123 FFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 177
+QL+ G+ Y H + H D+K EN L++ +P +KI D G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 178 KSTVGTPAYIAPEVLLRHEYD 198
+++ T Y +PEVLL +
Sbjct: 193 TNSIQTREYRSPEVLLGAPWG 213
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-20
Identities = 56/187 (29%), Positives = 80/187 (42%), Gaps = 15/187 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP--- 79
DRY+ IG G+FG D+V +E VA+K I+ Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 80 ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 134
IV K + HL +V E S L++ + N S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 135 CHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 191
+ + H DLK EN LL +KI DFG SS Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 192 LLRHEYD 198
LL YD
Sbjct: 230 LLGMPYD 236
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-19
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 18/181 (9%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
F++ +G GNFG ++D T E+VAVK + ++ + +REI +SL+H N
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K V + L ++MEY G L + + + R + + Q+ G+ Y
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
+ HRDL N L+ + R+KI DFG +K + + V P APE L
Sbjct: 133 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 193 L 193
Sbjct: 190 T 190
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 49/179 (27%), Positives = 63/179 (35%), Gaps = 12/179 (6%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 84
IG GNFG R + LVAVK D + +E + HPNIVR
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 85 KEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
V + IVME GG+ + R +G+ Y + HR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEY 197
DL N L+ LKI DFG S+ + G + APE L Y
Sbjct: 238 DLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-19
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 18/181 (9%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
F++ +G GNFG ++D T E+VAVK + ++ + +REI +SL+H N
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV++K V + L ++MEY G L + + + R + + Q+ G+ Y
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
+ HRDL N L+ + R+KI DFG +K + + V P APE L
Sbjct: 164 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 193 L 193
Sbjct: 221 T 221
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-19
Identities = 47/153 (30%), Positives = 75/153 (49%), Gaps = 13/153 (8%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
+RD+G G+FG D T E VAVK + E G ++++EI R+L H
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 80 NIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 136
NIV++K + + ++ME+ G L E + N + + + + Q+ G+ Y
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ Q HRDL N L+ S ++KI DFG +K
Sbjct: 144 SRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK 174
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-18
Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
++ +G GNFG + D T LVAVK + G + QREI ++L
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDN-TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
IV+++ V P L +VMEY G L + + + R + Q+ G+ Y +
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ HRDL N L+ S A +KI DFG +K
Sbjct: 146 RRCVHRDLAARNILV-ESEA-HVKIADFGLAK 175
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-18
Identities = 42/151 (27%), Positives = 64/151 (42%), Gaps = 11/151 (7%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHP 79
+ +G G+FGV VAVK ++ + I SL H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
N++R V+LTP + +V E A G L +R+ + G F + Q+ G+ Y +
Sbjct: 82 NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ HRDL N LL + +KI DFG +
Sbjct: 141 RFIHRDLAARNLLL-ATRD-LVKIGDFGLMR 169
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 11/151 (7%)
Query: 27 FVRDIGSGNFGVARL----MRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+RD+G G+FG L + T E+VAVK + + G + ++EI R+L H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 81 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+++K L +VMEY G L + + + F QQ+ G++Y HA
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N LL + +KI DFG +K
Sbjct: 154 HYIHRDLAARNVLL-DNDR-LVKIGDFGLAK 182
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 37/208 (17%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSL 76
+ + +R +G G FG V + K+ AVK + K + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 134
+ NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 135 CHAMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 171
M + H DLK EN LLD +K+ DFG +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 172 VLHSQPKST-VGTPAYIAPEVLLRHEYD 198
S + + T Y APEV+L +D
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWD 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-17
Identities = 23/149 (15%), Positives = 42/149 (28%), Gaps = 8/149 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRH 78
RY + G D VA+ +++ + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + R +V+ T +V E+ GG L E S A Q L + H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGY 167
V + S + +
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVVLAYPAT 175
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-17
Identities = 49/203 (24%), Positives = 74/203 (36%), Gaps = 31/203 (15%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP-- 79
+RY+ V ++G G FG V + K VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 80 ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 133
V + H+ I E G FE + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 134 YCHAMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 176
+ H Q+ H DLK EN L S +++ DFG S+ +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 177 PKST-VGTPAYIAPEVLLRHEYD 198
+T V T Y PEV+L +
Sbjct: 195 HHTTIVATRHYRPPEVILELGWA 217
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-17
Identities = 41/184 (22%), Positives = 69/184 (37%), Gaps = 6/184 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G +G K VAVK ++ E +E + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
HR+L N L+ + +K+ DFG S+ + APE L ++
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 197 YDGK 200
+ K
Sbjct: 396 FSIK 399
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-16
Identities = 57/204 (27%), Positives = 82/204 (40%), Gaps = 33/204 (16%)
Query: 23 DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHR-- 74
RY+ V +G G FG V + K VAVK ++ D+ E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 132
+ V+ E H+ IV E G ++ I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 175
++ H+ ++ H DLK EN L S P +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 176 QPKST-VGTPAYIAPEVLLRHEYD 198
+ ST V T Y APEV+L +
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWS 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-16
Identities = 37/145 (25%), Positives = 59/145 (40%), Gaps = 4/145 (2%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
+G G +G K VAVK ++ E +E + ++HPN+V+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 87 VILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
V I+ E+ + G L + R CN S + Q+ S + Y HRD
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136
Query: 145 LKLENTLLDGSPAPRLKICDFGYSK 169
L N L+ + +K+ DFG S+
Sbjct: 137 LAARNCLVGENHL--VKVADFGLSR 159
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-16
Identities = 34/152 (22%), Positives = 68/152 (44%), Gaps = 14/152 (9%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERGDKIDENVQREIINH----RSLRH 78
++ +GSG FG + + ++ VA+K + +EI++ S+ +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDN 76
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 77 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
++ HRDL N L+ +P +KI DFG +K
Sbjct: 136 RRLVHRDLAARNVLV-KTPQ-HVKITDFGLAK 165
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 7e-16
Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 6/151 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL+ N L+ + K+ DFG ++
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLAR 328
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 8e-16
Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 6/151 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL+ N L+ + K+ DFG ++
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLAR 411
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-15
Identities = 48/241 (19%), Positives = 81/241 (33%), Gaps = 65/241 (26%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLR 77
RY +R +G G+F L D K+ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 78 HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 128
PN +V+ FK + TH+ +V E + + N + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155
Query: 129 ISGVSYCHA-MQVCHRDLKLENTLLD---------------------------------- 153
+ G+ Y H ++ H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 154 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
+ ++KI D G + +H + T Y + EVL+ Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 201 V 201
Sbjct: 274 A 274
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-15
Identities = 42/147 (28%), Positives = 66/147 (44%), Gaps = 10/147 (6%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
FV++IGSG FG+ +K VA+K I G +E+ E L HP +V+
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDK---VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V L + +V E+ G L + R G F+ + + G++Y V H
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK 169
RDL N L+ + +K+ DFG ++
Sbjct: 128 RDLAARNCLVGENQV--IKVSDFGMTR 152
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-15
Identities = 36/145 (24%), Positives = 64/145 (44%), Gaps = 6/145 (4%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
+ +G+G FG + + VAVK ++ G E E ++L+H +V+
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 87 VILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
V+ T + I+ E+ + G L F + + + F Q+ G+++ HRD
Sbjct: 251 VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 145 LKLENTLLDGSPAPRLKICDFGYSK 169
L+ N L+ S KI DFG ++
Sbjct: 310 LRAANILVSASLV--CKIADFGLAR 332
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-15
Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 12/148 (8%)
Query: 29 RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNI 81
+++GSGNFG KV K VAVK + + + D ++ E++ + L +P I
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKT-VAVKIL-KNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
VR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 81 VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N LL + KI DFG SK
Sbjct: 140 HRDLAARNVLL-VTQH-YAKISDFGLSK 165
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 5e-15
Identities = 48/180 (26%), Positives = 68/180 (37%), Gaps = 16/180 (8%)
Query: 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
++ IG G FG L + K VAVK I + D + E LRH N+V+
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 87 VILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
VI+ L IV EY + G L + R D F + + Y HR
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGK 200
DL N L+ K+ DFG +K + + + APE L ++ K
Sbjct: 314 DLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK 366
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-15
Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 10/147 (6%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
V +G+G FG VAVK +++G + E + L+H +VR
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V+ T + I+ EY G L F + + + + ++ Q+ G+++ H
Sbjct: 74 YAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK 169
RDL+ N L+ + + KI DFG ++
Sbjct: 133 RDLRAANILVSDTLS--CKIADFGLAR 157
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-15
Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 10/150 (6%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
+ IGSG+ G RL VA+K ++ G ++ + E HPNI
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+R + V+ IV EY G L F R + G+F+ + + + +G+ Y +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N L+D + K+ DFG S+
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSR 199
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-15
Identities = 34/150 (22%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPN 80
++ +GSG FG + + ++ VA+K + K ++ + E S+ +P+
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ R + LT T + ++ + G L + + + + Q+ G++Y +
Sbjct: 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ HRDL N L+ +P +KI DFG +K
Sbjct: 138 LVHRDLAARNVLV-KTPQ-HVKITDFGLAK 165
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-14
Identities = 42/145 (28%), Positives = 58/145 (40%), Gaps = 10/145 (6%)
Query: 31 IGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
+G GNFG K + VA+K +++G E + RE L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 86 EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
V + +VME A GG L + + Q+ G+ Y HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 145 LKLENTLLDGSPAPRLKICDFGYSK 169
L N LL + KI DFG SK
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK 484
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-14
Identities = 38/147 (25%), Positives = 66/147 (44%), Gaps = 10/147 (6%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
F++++G+G FGV + R + VA+K I+ G ++ E +L H +V+
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYD---VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V + I+ EY + G L + R RF + + + + Y + Q H
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK 169
RDL N L++ +K+ DFG S+
Sbjct: 144 RDLAARNCLVNDQGV--VKVSDFGLSR 168
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-14
Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 17/178 (9%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
Y R IG G+FGV + + + VA+K+ E ++ E ++ L I
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 82 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
H +V++ S +L +C +FS +Q+++ V H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 140 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAY 186
+ +RD+K +N L+ + A + + DFG K + H + K+ GT Y
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-14
Identities = 38/149 (25%), Positives = 61/149 (40%), Gaps = 9/149 (6%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
R +G G FG K K VAVK ++ E E + ++L HP+I
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V+ +I I+ME GEL + N + Q+ ++Y ++
Sbjct: 76 VKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRD+ + N L+ +K+ DFG S+
Sbjct: 135 VHRDIAVRNILVASPEC--VKLGDFGLSR 161
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 2e-14
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 15/176 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 81
+++ R IGSG+FG L + T E VA+K E + E +R L+ I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 82 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + + +VM+ S +LF C+ + S Q+I+ V + H+
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 140 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAY 186
HRD+K +N L+ G A ++ I DFG +K S+ H + K+ GT Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-14
Identities = 44/152 (28%), Positives = 60/152 (39%), Gaps = 8/152 (5%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ ++ IG G FG L + K VAVK I + D + E LRH N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75
Query: 81 IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHA 137
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N L+ S K+ DFG +K
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTK 165
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-14
Identities = 44/144 (30%), Positives = 62/144 (43%), Gaps = 8/144 (5%)
Query: 31 IGSGNFG-VAR-LMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKE 86
+G GNFG V + + R + + VA+K +++G E + RE L +P IVR
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 87 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
V + +VME A GG L + + Q+ G+ Y HRDL
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 146 KLENTLLDGSPAPRLKICDFGYSK 169
N LL + KI DFG SK
Sbjct: 137 AARNVLL-VNRH-YAKISDFGLSK 158
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-14
Identities = 36/150 (24%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
++ +GSG FG + + + ++ V +K I + G + + V ++ SL H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
IVR + + L +V +Y G L + + + G + Q+ G+ Y
Sbjct: 77 IVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ HR+L N LL SP+ ++++ DFG +
Sbjct: 136 MVHRNLAARNVLL-KSPS-QVQVADFGVAD 163
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-14
Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 14/174 (8%)
Query: 27 FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
++++GSG FGV + + + VAVK I+ G ++ +E L HP +V+F
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYD---VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68
Query: 85 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
V + IV EY S G L + R + + + G+++ + Q H
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 193
RDL N L+D +K+ DFG ++ VL Q S+VGT + APEV
Sbjct: 128 RDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFH 178
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-14
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 10/150 (6%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
+ +G+G FG RL + VA+K ++ G +K + E HPNI
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+R + V+ + IV EY G L F R + +F+ + + + SG+ Y M
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N L++ + K+ DFG +
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLGR 195
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 5e-14
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 17/177 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 82
+ + IG GNFG RL ++ T E VA+K +E + E ++ L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 83 RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+ + A+V+E S +LF +C+ FS QLIS + Y H+ +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 141 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAY 186
+RD+K EN L+ ++ DF +K + H + KS GT Y
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 6e-14
Identities = 49/176 (27%), Positives = 74/176 (42%), Gaps = 15/176 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
+RY R IGSG+FG L D E VA+K E + E ++ ++ I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 82 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ + +VME S +LF C+ +FS Q+IS + Y H+
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 140 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAY 186
HRD+K +N L+ G + I DFG +K + H + K+ GT Y
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-14
Identities = 26/159 (16%), Positives = 53/159 (33%), Gaps = 17/159 (10%)
Query: 27 FVRDIGSGNFGV-------ARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRH 78
F +G G F ++ + V +K +++ E+ L H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 136
++V V + +V E+ G L + + N + +QL + + +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 137 AMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSK 169
+ H ++ +N LL + K+ D G S
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 7e-14
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 11/150 (7%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
R IG G FG M + VA+K + D + E +E + R HP+I
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 82 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
V+ VI I+ME + GEL F + + QL + ++Y + +
Sbjct: 79 VKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRD+ N L+ + +K+ DFG S+
Sbjct: 137 FVHRDIAARNVLVSSNDC--VKLGDFGLSR 164
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-14
Identities = 44/151 (29%), Positives = 66/151 (43%), Gaps = 11/151 (7%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPN 80
+ IG+G FG L KE+ VA+K ++ G +K + E H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 81 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
I+R + VI + I+ EY G L F R G FS + + + +G+ Y M
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRDL N L++ + K+ DFG S+
Sbjct: 167 NYVHRDLAARNILVNSNLV--CKVSDFGLSR 195
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 9e-14
Identities = 39/149 (26%), Positives = 62/149 (41%), Gaps = 9/149 (6%)
Query: 27 FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
R IG G FG M + VA+K + D + E +E + R HP+I
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
V+ VI I+ME + GEL + + QL + ++Y + +
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSK 169
HRD+ N L+ + +K+ DFG S+
Sbjct: 513 VHRDIAARNVLVSSNDC--VKLGDFGLSR 539
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 26/170 (15%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHR 74
++ R +G G FG A+L ++ + VAVK ++ +++ RE +
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 75 SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
HP++ + +++ + G+L F A R E+ Q
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137
Query: 127 QLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
L+ G+ Y + HRDL N +L + + DFG S+
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR 185
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 44/163 (26%), Positives = 67/163 (41%), Gaps = 11/163 (6%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
+ I S F IG G+FG L+ + K AVK + R I E Q E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 70 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
Q+ G+ Y + + HRDL N +LD +K+ DFG ++
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR 176
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 39/158 (24%), Positives = 57/158 (36%), Gaps = 15/158 (9%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
+R +G G FG M + + VAVK + + + E + H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
NIVR V L I+ME +GG+L + + L+ G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSK 169
Y HRD+ N LL R+ KI DFG ++
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-13
Identities = 38/158 (24%), Positives = 57/158 (36%), Gaps = 15/158 (9%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
+R +G G FG M + + VAVK + + + E + H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
NIVR V L I++E +GG+L + + L+ G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSK 169
Y HRD+ N LL R+ KI DFG ++
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-13
Identities = 49/194 (25%), Positives = 76/194 (39%), Gaps = 31/194 (15%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLRHPN 80
R++G G FG + K LVAVK ++ QRE +L+H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQLI-- 129
IV+F V L +V EY G+L + I G+ + + Q++
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 130 -----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
SG+ Y + HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGH 194
Query: 185 AYI-----APEVLL 193
+ PE ++
Sbjct: 195 TMLPIRWMPPESIM 208
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-13
Identities = 34/169 (20%), Positives = 59/169 (34%), Gaps = 25/169 (14%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHR 74
D + + +G G FG L ++ T VAVK ++ + ++ E +
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 75 SLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQ 127
HPN++R + +++ + G+L + R Q
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQT 148
Query: 128 LI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
L+ G+ Y HRDL N +L + + DFG SK
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK 195
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 43/163 (26%), Positives = 67/163 (41%), Gaps = 11/163 (6%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
+ I S F IG G+FG L+ + K AVK + R I E Q E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 70 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
Q+ G+ + + + HRDL N +LD +K+ DFG ++
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR 240
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 1e-12
Identities = 47/234 (20%), Positives = 69/234 (29%), Gaps = 59/234 (25%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---------VQREIIN 72
+++ IG G FG VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 73 HRSL---------RHPNIVRFKEVIL------------------------------TPTH 93
+ L R + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLL 152
L IV+E+ GG E++ S A+ QL + ++ +++ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 153 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
K+ KSS + + G I L R E DG V F +
Sbjct: 196 K--KTSLKKLHYTLNGKSSTIP-----SCGLQVSIIDYTLSRLERDGIVVFCDV 242
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-12
Identities = 43/161 (26%), Positives = 60/161 (37%), Gaps = 23/161 (14%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLRHPN 80
++G G FG + + K LVAVK ++ + QRE L+H +
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQLI--- 129
IVRF V L +V EY G+L AG QL+
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 130 ----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
+G+ Y + HRDL N L+ +KI DFG
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFG 203
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-12
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 13/164 (7%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
D+ I H+ R IG G+FGV + + A+K + R ++ + RE
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 70 IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 125
+ R L HPN++ ++L +++ Y G+L F R + + F
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
Q+ G+ Y + HRDL N +LD S +K+ DFG ++
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLAR 172
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-12
Identities = 33/160 (20%), Positives = 65/160 (40%), Gaps = 19/160 (11%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
R++G G+FG VA+ + + VA+K + + E + E +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFFQQLI 129
++VR V+ ++ME + G+L + R + ++
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
G++Y +A + HRDL N ++ + +KI DFG ++
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR 186
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-12
Identities = 32/163 (19%), Positives = 60/163 (36%), Gaps = 25/163 (15%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
F+ ++G FG + VA+K ++ + E + E + L+HP
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQLI- 129
N+V V+ L+++ Y S G+L + + ++ +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 130 ------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
+G+ Y + V H+DL N L+ +KI D G
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLG 173
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-12
Identities = 45/178 (25%), Positives = 66/178 (37%), Gaps = 35/178 (19%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQRE 69
D + F IG GNFG AR+ +D + + A+K + + D E V +
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 120
+ HPNI+ +L + +EYA G L E +
Sbjct: 82 L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 121 ARFFFQQLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171
+ QQL+ G+ Y Q HRDL N L+ + KI DFG S+
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQ 192
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-11
Identities = 40/171 (23%), Positives = 58/171 (33%), Gaps = 38/171 (22%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQREIINH 73
F + +G+G FG A + VAVK + ER + E V +
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL--- 83
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSEDEAR 122
H NIV ++ EY G+L + +DE
Sbjct: 84 --GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
+ L+S G+++ + HRDL N LL KICDFG
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFG 190
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-11
Identities = 40/171 (23%), Positives = 63/171 (36%), Gaps = 33/171 (19%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+VRDIG G FG A + +VAVK ++ + + QRE +P
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSEDEAR 122
NIV+ V + ++ EY + G+L + A S
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 123 FFFQQLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
+ + +G++Y + HRDL N L+ +KI DFG
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFG 219
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-10
Identities = 34/171 (19%), Positives = 60/171 (35%), Gaps = 34/171 (19%)
Query: 23 DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVK-------YIERGDKIDE-NVQRE 69
+ F + +G+G FG A + + VAVK E+ + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 122
+ +H NIV + ++ EY G+L + F+ +
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
+ L+ G+++ + HRD+ N LL + KI DFG
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFG 209
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-10
Identities = 37/171 (21%), Positives = 62/171 (36%), Gaps = 33/171 (19%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
+ +G G FG A ++ + VAVK ++ ++ E + + HP
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSEDEAR 122
++++ L +++EYA G L ++ DE
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
LIS G+ Y M++ HRDL N L+ +KI DFG
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFG 195
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-09
Identities = 38/166 (22%), Positives = 65/166 (39%), Gaps = 28/166 (16%)
Query: 27 FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYIERGDKIDENV--QREIINHRSL- 76
+ +G G FG + +DK + + VAVK ++ + E+ + +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 127
+H NI+ L +++EYAS G L + E + F+
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 128 LIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
L+S G+ Y + + HRDL N L+ + +KI DFG
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFG 202
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-09
Identities = 39/174 (22%), Positives = 57/174 (32%), Gaps = 37/174 (21%)
Query: 23 DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQRE 69
DR + +G G FG A + T VAVK + E + E +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 70 IINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL---------FERICNAGRFSED 119
I H N+V P L +++E+ G L
Sbjct: 87 I-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 120 EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
+ + LI G+ + + + HRDL N LL +KICDFG
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFG 193
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-09
Identities = 38/166 (22%), Positives = 65/166 (39%), Gaps = 28/166 (16%)
Query: 27 FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYIERGDKIDENV--QREIINHRSL- 76
+ +G G FG + +DK + + VAVK ++ + E+ + +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 77 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 127
+H NI+ L +++EYAS G L + E + F+
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 128 LIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
L+S G+ Y + + HRDL N L+ + +KI DFG
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFG 248
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-09
Identities = 41/171 (23%), Positives = 64/171 (37%), Gaps = 38/171 (22%)
Query: 27 FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYI-------ERGDKIDE-NVQREII 71
+ +G G FG L +DK + VAVK + + D I E + + I
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 72 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEAR 122
+H NI+ L +++EYAS G L + E +
Sbjct: 133 -----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
+ L+S G+ Y + + HRDL N L+ + +KI DFG
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFG 236
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-09
Identities = 39/176 (22%), Positives = 57/176 (32%), Gaps = 43/176 (24%)
Query: 27 FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQREIINH 73
F + +GSG FG A + VAVK + ER + E + ++
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL--- 105
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNAGRFS 117
H NIV + ++ EY G+L
Sbjct: 106 --GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 118 EDEARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
ED F+ L+ G+ + HRDL N L+ +KICDFG
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 54/187 (28%), Positives = 70/187 (37%), Gaps = 49/187 (26%)
Query: 31 IGSGNFGVARLMRDKVTK------ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 82
IG G FG KV K VA+K I+E + EI RHP++V
Sbjct: 47 IGHGVFG-------KVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLV 98
Query: 83 RF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQ 126
E + ++ +Y G L + + + AR
Sbjct: 99 SLIGFCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR---- 150
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GT 183
G+ Y H + HRD+K N LLD + P KI DFG SK Q STV GT
Sbjct: 151 ----GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGT 204
Query: 184 PAYIAPE 190
YI PE
Sbjct: 205 LGYIDPE 211
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-08
Identities = 29/167 (17%), Positives = 59/167 (35%), Gaps = 24/167 (14%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 83
++ + IGSG FG+ L E A ++ + + + E+ ++ + + ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 84 FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 122
+L I VME ++ N G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-08
Identities = 22/171 (12%), Positives = 55/171 (32%), Gaps = 29/171 (16%)
Query: 24 RYDFVRDIGSGNFGV--------ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS 75
++ N G+ K+ ++K ++ D N Q R+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99
Query: 76 LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 118
+ + ++K++ TP + +V+ S + SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158
Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+L+ + + H + H ++ EN +D ++ + +G++
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-06
Identities = 47/190 (24%), Positives = 65/190 (34%), Gaps = 53/190 (27%)
Query: 31 IGSGNFGVARLMRDKVTK-----ELVAVKYIERGDKI-----DENVQREIINHRSLRHPN 80
+G G FG V K VAVK + I + +EI +H N
Sbjct: 39 MGEGGFG-------VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91
Query: 81 IVRFKEVILTPTHLAIVMEYASGG----ELFER-------------ICNAGRFSEDEARF 123
+V L +V Y G L I + A
Sbjct: 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA------QGAAN- 144
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST-- 180
G+++ H HRD+K N LLD + KI DFG ++ S ++
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRI 195
Query: 181 VGTPAYIAPE 190
VGT AY+APE
Sbjct: 196 VGTTAYMAPE 205
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-06
Identities = 50/192 (26%), Positives = 74/192 (38%), Gaps = 56/192 (29%)
Query: 31 IGSGNFGVARLMRDKVTK------ELVAVKYIERGDKIDENVQRE------IINHRSLRH 78
+G G FG KV K LVAVK ++ + + + +I+ H
Sbjct: 38 LGRGGFG-------KVYKGRLADGTLVAVKRLKEERT--QGGELQFQTEVEMISM--AVH 86
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQ 126
N++R + +TPT +V Y + G L ER + AR
Sbjct: 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR---- 142
Query: 127 QLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 181
G++Y H ++ HRD+K N LLD + DFG +K L + V
Sbjct: 143 ----GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTT 193
Query: 182 ---GTPAYIAPE 190
GT +IAPE
Sbjct: 194 AVRGTIGHIAPE 205
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-06
Identities = 26/169 (15%), Positives = 50/169 (29%), Gaps = 25/169 (14%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKV-----TKELVAVK---------------YIERGDKID 63
+ IG G FG L + VK Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 64 ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 120
+ L P ++ ++M+ + +++E RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153
Query: 121 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 3e-05
Identities = 28/198 (14%), Positives = 73/198 (36%), Gaps = 40/198 (20%)
Query: 25 YDFVRDIGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
FV ++ N+ ++ + ++ ++ YIE+ D++ + Q + S R +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138
Query: 83 RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 133
+ ++ + L P ++ + G + +C + + + + F+ ++ +
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 134 YCH-------AMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
C+ +Q + ++ + D S +L+I +L S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242
Query: 186 YIAPEVL--LRHEYDGKV 201
Y L L + + K
Sbjct: 243 Y--ENCLLVLLNVQNAKA 258
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 219 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.61 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.43 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.12 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 99.03 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.83 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.61 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.42 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.18 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.16 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 98.02 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.94 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.93 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.74 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.58 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.42 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.26 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.66 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.36 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.36 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.33 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-55 Score=332.40 Aligned_cols=197 Identities=28% Similarity=0.430 Sum_probs=179.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|+||+||++++..+++.||+|++... ....+.+.+|+++++.++||||++++++|++++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3457899999999999999999999999999999999643 223467899999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+|||||+||+|.+.+.+.+.+++.+++.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+|+......
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPES 186 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCC
Confidence 99999999999999999889999999999999999999999999999999999999988877 9999999998654322
Q ss_pred ---CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 ---QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+.+||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 232 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 2345689999999999999999999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-55 Score=336.75 Aligned_cols=207 Identities=26% Similarity=0.456 Sum_probs=173.8
Q ss_pred CCCCCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEE
Q 027738 10 VGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKE 86 (219)
Q Consensus 10 ~~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (219)
+.-.........+++|++++.||+|+||+||++++..+++.||+|++..... ..+.+.+|+.+++.++||||+++++
T Consensus 11 vd~gten~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~ 90 (350)
T 4b9d_A 11 VDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90 (350)
T ss_dssp ----CCCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCCcccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEE
Confidence 3333344556678999999999999999999999999999999999976432 2356889999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 87 VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
++.+++.+|+|||||+|++|.+++...+ .+++.+++.++.|++.||.|||++||+||||||+|||++.++. +||+|
T Consensus 91 ~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~D 168 (350)
T 4b9d_A 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGD 168 (350)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECS
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcc
Confidence 9999999999999999999999997543 4799999999999999999999999999999999999998877 99999
Q ss_pred cccccccccCC-CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||+|+...... .....+||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 169 FGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~ 223 (350)
T 4b9d_A 169 FGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223 (350)
T ss_dssp TTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99997543221 1233469999999999999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=323.79 Aligned_cols=197 Identities=38% Similarity=0.591 Sum_probs=161.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
....++|++.+.||+|+||+||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 345679999999999999999999999999999999997542 2235688999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++||||+ +++|.+.+.+.+.+++.++..++.|++.||+|||++||+||||||+||++++++. ++|+|||+|+.....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCC
Confidence 9999999 5699999998889999999999999999999999999999999999999988877 999999999876655
Q ss_pred CCCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 175 SQPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.......||+.|+|||.+.+..+ +.++|+|||||++|+|++|..
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~ 210 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCC
Confidence 55566789999999999998876 579999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=329.31 Aligned_cols=194 Identities=28% Similarity=0.439 Sum_probs=176.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.+.|++.++||+|+||+||+|.+..+++.||+|++..... ..+.+.+|+.+++.++||||++++++|.+++.+|+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3579999999999999999999999999999999965433 346688999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~ 179 (219)
|+|++|.+++.+ ..+++.+++.++.|++.||.|||++||+|+||||+|||++.++. +||+|||+|+..... .....
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCcccc
Confidence 999999998876 46999999999999999999999999999999999999998877 999999999765433 33456
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 689999999999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=330.69 Aligned_cols=194 Identities=28% Similarity=0.439 Sum_probs=176.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.+.|++.++||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.+++.++||||++++++|..++.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4679999999999999999999999999999999976443 346788999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~~ 179 (219)
|+||+|.+++.. ..+++.++..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+..... .....
T Consensus 230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCC
T ss_pred CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCccccc
Confidence 999999998865 46999999999999999999999999999999999999998877 999999999765433 33345
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+||+.|+|||++.+..|+.++|||||||++|||++|..
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 679999999999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=324.41 Aligned_cols=197 Identities=26% Similarity=0.467 Sum_probs=170.3
Q ss_pred cCCccceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
.+.++|++.+.||+|+||+||+|++. .+++.||+|++.... .....+.+|+.++++++||||+++++++.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 34578999999999999999999874 467889999986532 223567889999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++|||||+|++|.+.+.+.+.+++.++..++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESID 178 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC---
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccC
Confidence 9999999999999999999999999999999999999999999999999999999999998887 99999999975433
Q ss_pred -CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........||+.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 224 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC
Confidence 233455689999999999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=322.50 Aligned_cols=194 Identities=28% Similarity=0.396 Sum_probs=172.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...+.|++.++||+|+||.||++++..+++.||+|++..... ..+|+.+++.++||||+++++++.+++.+++|||
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 345678999999999999999999999999999999975432 2468999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC---
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 176 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~--- 176 (219)
||+|++|.+++...+.+++.++..++.|++.||.|||+++|+||||||+|||++.++. ++||+|||+|+.......
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC--------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccc
Confidence 9999999999999889999999999999999999999999999999999999987763 399999999976543322
Q ss_pred ---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 123469999999999999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=312.38 Aligned_cols=192 Identities=27% Similarity=0.408 Sum_probs=168.6
Q ss_pred ccc-eeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEc----CCeE
Q 027738 23 DRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 94 (219)
Q Consensus 23 ~~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 94 (219)
++| ++.++||+|+||+||+|.+..++..||+|.+..... ..+.+.+|+.++++++||||++++++|.. +..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 455 788899999999999999999999999999865432 23568899999999999999999999875 3468
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEecC-CCCCcEEEeeccccccc
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 171 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--ivh~dl~p~nili~~-~~~~~v~l~dfg~a~~~ 171 (219)
++|||||++++|.+++.+.+.+++.++..++.|++.||+|||+++ |+||||||+|||++. ++. +||+|||+|+..
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~ 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGC
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeC
Confidence 999999999999999999889999999999999999999999998 999999999999974 455 999999999743
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ........||+.|+|||.+.+ .++.++|||||||++|||+||..
T Consensus 183 ~-~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~ 227 (290)
T 3fpq_A 183 R-ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred C-CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence 2 333445689999999998865 59999999999999999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=310.33 Aligned_cols=192 Identities=26% Similarity=0.394 Sum_probs=160.0
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC--------
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 92 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 92 (219)
++|++++.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.+++.++||||++++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 579999999999999999999999999999999875432 2356889999999999999999999997543
Q ss_pred ----eEEEEEeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeec
Q 027738 93 ----HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 93 ----~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
.++++||||++++|.+++..... .....++.++.|++.||+|||++||+|+||||+|||++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 37999999999999999987654 455668899999999999999999999999999999998877 999999
Q ss_pred ccccccccCCC-------------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 166 GYSKSSVLHSQ-------------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 166 g~a~~~~~~~~-------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
|+|+....... ....+||+.|+|||.+.+..++.++|||||||++|||+++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~P 226 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHSC
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHccC
Confidence 99975443222 1234699999999999999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=312.48 Aligned_cols=197 Identities=23% Similarity=0.335 Sum_probs=169.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
....++|.+.+.||+|+||+||++++. .++..||+|+++.... ..+++.+|++++++++||||+++++++.+++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 345678999999999999999999864 3578899999975432 3467899999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCc
Q 027738 93 HLAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~ 159 (219)
.+++|||||++|+|.+++... ..+++.++..++.|++.||.|||+++|+||||||+|||+++++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~-- 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-- 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--
Confidence 999999999999999999764 35899999999999999999999999999999999999998877
Q ss_pred EEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 160 LKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 160 v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+||+|||+|+........ ....+++.|+|||.+.+..++.++||||||+++|||+| |+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~ 228 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999754333222 22357899999999999999999999999999999998 55
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=307.70 Aligned_cols=196 Identities=20% Similarity=0.305 Sum_probs=169.8
Q ss_pred cCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
...+++++.++||+|+||+||+|... .+++.||+|.+.... ...+++.+|+.++++++||||+++++++..++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 45678999999999999999999853 457889999986542 23467999999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC
Q 027738 93 HLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~ 156 (219)
.+++|+|||++|+|.+++... ..+++.++..++.|++.||.|||+++++||||||+|||+++++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 999999999999999999653 3489999999999999999999999999999999999999887
Q ss_pred CCcEEEeecccccccccCC---CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 157 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 157 ~~~v~l~dfg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
. +||+|||+|+...... ......+++.|+|||.+.+..++.++||||||+++|||+| |.
T Consensus 183 ~--~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~ 245 (308)
T 4gt4_A 183 N--VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 245 (308)
T ss_dssp C--EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred C--EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCC
Confidence 7 9999999997554332 2234568899999999999999999999999999999998 54
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=308.58 Aligned_cols=196 Identities=24% Similarity=0.324 Sum_probs=164.7
Q ss_pred cCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
...+++.+.++||+|+||+||+++.. .+++.||+|++..... ..+++.+|++++++++||||+++++++.+++.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34578899999999999999999864 3678899999975432 24678999999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 94 LAIVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
+++|||||++|+|.+++... .++++.++..++.|++.||.|||+++|+||||||+|||+++++.
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~- 196 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV- 196 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE-
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc-
Confidence 99999999999999998754 35899999999999999999999999999999999999998876
Q ss_pred cEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 159 ~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||+| |+
T Consensus 197 -~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~ 258 (329)
T 4aoj_A 197 -VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258 (329)
T ss_dssp -EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred -EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCC
Confidence 99999999975433322 233568999999999999999999999999999999998 55
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=301.88 Aligned_cols=194 Identities=26% Similarity=0.341 Sum_probs=163.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
-.+.+++++.++||+|+||+||+++.. ..||+|+++..... .+.+.+|+.++++++||||+++++++.. +.++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 456788999999999999999999865 35899988654322 3568899999999999999999998764 5689
Q ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+|||||++|+|.+++... .++++.++..++.|++.||+|||+++|+||||||+|||+++++. +||+|||+|+.....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRW 185 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC----
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccC
Confidence 999999999999999764 46999999999999999999999999999999999999998876 999999999754322
Q ss_pred C---CCCCCCCCCCCCCchhhcc---ccccceeeEEEEEEEEeecCCCCC
Q 027738 175 S---QPKSTVGTPAYIAPEVLLR---HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~---~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ......||+.|+|||.+.+ ..++.++|||||||++|||+||..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~ 235 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCC
Confidence 2 2234579999999999964 458999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=309.85 Aligned_cols=195 Identities=28% Similarity=0.482 Sum_probs=170.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcC------C
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP------T 92 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 92 (219)
.++|++.+.||+|+||+||+|++..+|+.||+|++...... .+.+.+|+.+++.++||||+++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999999999999999999754332 24577899999999999999999998643 5
Q ss_pred eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
.+|+|||||+ ++|.+.+...+.+++.+++.++.|++.||.|||++||+|+||||+|||++.++. ++|+|||+|+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence 6899999996 589999998889999999999999999999999999999999999999998877 9999999997543
Q ss_pred cC-----CCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCCC
Q 027738 173 LH-----SQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 173 ~~-----~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
.. ......+||+.|+|||++.+. .++.++|+||+||++|||++|..+
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~p 262 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQL 262 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCS
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCC
Confidence 22 223456899999999998875 568999999999999999999753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=320.33 Aligned_cols=198 Identities=28% Similarity=0.431 Sum_probs=174.1
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHH---HHHHHhCCCCcEeEEEEEEEc
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQRE---IINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~ 90 (219)
.....++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+| +.+++.++||||++++++|.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 3556789999999999999999999999999999999986431 112223333 455667789999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
.+.+|+||||++||+|...+.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||+|+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~ 341 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACD 341 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeee
Confidence 9999999999999999999999999999999999999999999999999999999999999998887 99999999975
Q ss_pred cccCCCCCCCCCCCCCCCchhhc-cccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... ....+.+||+.|+|||++. +..|+.++|+|||||++|||++|..
T Consensus 342 ~~~-~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~ 389 (689)
T 3v5w_A 342 FSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389 (689)
T ss_dssp CSS-CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCC-CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 533 3445678999999999997 4678999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=318.96 Aligned_cols=197 Identities=29% Similarity=0.474 Sum_probs=178.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.++|++.+.||+|+||.||++.+..+|+.||+|++...... .+.+.+|+.+++.++||||++++++|.+...++++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 57899999999999999999999999999999998764432 46688999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCC
Q 027738 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~ 179 (219)
|+||+|.+++.. ...+++.++..++.|++.||.|||+++|+|+||||+||+++.+..+.++|+|||+|+..........
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~ 315 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence 999999998864 4569999999999999999999999999999999999999876545599999999987655555555
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~ 354 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred eEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 689999999999999999999999999999999999975
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=297.85 Aligned_cols=190 Identities=26% Similarity=0.308 Sum_probs=158.5
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC----eEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~ 98 (219)
.+|.+.++||+|+||+||++... |+.||+|++..........+.|+..+..++||||+++++++..++ .+++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 57899999999999999999874 889999999754433333445666667889999999999998654 579999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
||+++++|.+++... +++..++..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence 999999999999764 589999999999999999999987 9999999999999998887 99999999975
Q ss_pred cccCCC-----CCCCCCCCCCCCchhhccc------cccceeeEEEEEEEEeecCCCC
Q 027738 171 SVLHSQ-----PKSTVGTPAYIAPEVLLRH------EYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 171 ~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
...... .....||+.|+|||.+.+. .++.++|||||||++|||+||.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~ 215 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTB
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCC
Confidence 543322 2234699999999999754 4678999999999999999984
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=301.18 Aligned_cols=196 Identities=21% Similarity=0.298 Sum_probs=167.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCC-----CcEEEEEEeccCccc--CHHHHHHHHHHHhCCC-CcEeEEEEEEEcC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDKI--DENVQREIINHRSLRH-PNIVRFKEVILTP 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 91 (219)
...++|++.+.||+|+||+||+|.+..+ ++.||+|.+...... .+.+.+|+.++++++| |||+++++++...
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 4568999999999999999999987643 367999998754322 3568899999999976 8999999998764
Q ss_pred -CeEEEEEeccCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC
Q 027738 92 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (219)
Q Consensus 92 -~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~ 154 (219)
+.+++|||||++|+|.+++... ..++..++..++.|++.||.|||+++++||||||+|||+++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5689999999999999999753 23789999999999999999999999999999999999998
Q ss_pred CCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 155 SPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 155 ~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
++. +||+|||+|+........ ....+++.|+|||.+.+..++.++|||||||++|||+| |.
T Consensus 221 ~~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 221 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred CCC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCC
Confidence 877 999999999755333221 23357889999999999999999999999999999998 55
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=297.43 Aligned_cols=193 Identities=22% Similarity=0.305 Sum_probs=164.8
Q ss_pred CCccceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 96 (219)
-.++|++.+.||+|+||+||+|+++ .+++.||+|.+.... ...++.+|+++++.+ .||||++++++|..++.+++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 3578999999999999999999875 357889999886543 345678899999988 59999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~- 175 (219)
||||+++++|.+.+. .+++.+++.++.|++.||+|||++||+||||||+|||++.+.. .++|+|||+|+......
T Consensus 98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~-~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLK-KYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECTTCSC
T ss_pred EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCC-eEEECcCCCCcccCCccc
Confidence 999999999999884 4899999999999999999999999999999999999986632 49999999996433211
Q ss_pred ----------------------------CCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 176 ----------------------------QPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ----------------------------~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+||+.|+|||++.+. .++.++|+||+||++|||++|..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 11234689999999999875 58999999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=295.61 Aligned_cols=215 Identities=86% Similarity=1.316 Sum_probs=178.1
Q ss_pred ccccCccCCCCCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEe
Q 027738 3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82 (219)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (219)
|++++.+..| ..+++....++|++.+.||+|++|.||++.+..+++.||+|++.......+.+.+|+..++.++||||+
T Consensus 1 m~~~~~~~~p-~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCC-CCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence 3444444444 566788899999999999999999999999999999999999988777778899999999999999999
Q ss_pred EEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEE
Q 027738 83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (219)
Q Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l 162 (219)
++++++......++|+||+++++|.+.+...+.++..++..++.|++.+|.+||++|++|+||||+||+++.++..+++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999999999999999998888899999999999999999999999999999999999998777667999
Q ss_pred eecccccccccCCCCCCCCCCCCCCCchhhccccccce-eeEEEEEEEEeecCCCCC
Q 027738 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK-VYFYSITQMSLQSTSPND 218 (219)
Q Consensus 163 ~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slg~~~~~~~~g~~ 218 (219)
+|||+++............+++.|+|||.+.+..++.+ +|+||||+++|+|++|..
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 216 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAY 216 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSC
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCC
Confidence 99999875554555556679999999999988777655 899999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=282.83 Aligned_cols=197 Identities=38% Similarity=0.618 Sum_probs=178.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 456799999999999999999999999999999999865432 23567899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
|+||+++++|.+.+...+.+++.++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++........
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCG
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCc
Confidence 9999999999999988888999999999999999999999999999999999999988877 99999999976655555
Q ss_pred CCCCCCCCCCCCchhhcccccc-ceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYD-GKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++ +++|+||||+++|+|++|..
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 212 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 5566799999999999987764 78999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=282.88 Aligned_cols=196 Identities=32% Similarity=0.539 Sum_probs=176.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++.+.||+|++|+||++.+..+++.||+|++... ....+.+.+|..+++.++||||+++++++...+..++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 467999999999999999999999999999999998653 2233567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc-CC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 175 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~-~~ 175 (219)
||||+++++|...+...+.+++.+++.++.|++.||.+||++|++|+||||+||+++.++. ++|+|||+++.... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCC
Confidence 9999999999999998888999999999999999999999999999999999999988876 99999999875332 22
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 203 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCC
Confidence 3344578999999999999999999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=286.96 Aligned_cols=199 Identities=27% Similarity=0.456 Sum_probs=176.6
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCC
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 92 (219)
.....++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+..|..++.++ +||||+++++++....
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 4456789999999999999999999999999999999987542 2235577888888776 8999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc-
Q 027738 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS- 171 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~- 171 (219)
.+++|+||+++++|...+...+.+++..++.++.|++.||.+||++||+|+||||+||+++.++. ++|+|||+++..
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~ 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecc
Confidence 99999999999999999998889999999999999999999999999999999999999998877 999999999753
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~ 251 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 23334455678999999999999999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=285.76 Aligned_cols=202 Identities=25% Similarity=0.414 Sum_probs=180.6
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
........++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 7 DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD 86 (384)
T ss_dssp -CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3344556789999999999999999999999999999999986432 233667899999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
....++|+||+.+++|...+.....+++..+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||+++.
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~ 164 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAM 164 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeee
Confidence 9999999999999999999998888999999999999999999999999999999999999988877 99999999986
Q ss_pred cccCCCCCCCCCCCCCCCchhhcc---ccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLR---HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~ 215 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCC
Confidence 655555566789999999999974 458899999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=282.72 Aligned_cols=198 Identities=31% Similarity=0.521 Sum_probs=178.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 45789999999999999999999999999999999875432 23678899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC--CcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~--~~v~l~dfg~a~~~ 171 (219)
+++|+||+++++|.+++.....+++.++..++.|++.+|.+||+.|++|+||||+||++++++. ..++|+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999999999988888999999999999999999999999999999999999987662 24999999999876
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~ 216 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 55555556679999999999998899999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=283.96 Aligned_cols=198 Identities=32% Similarity=0.500 Sum_probs=170.9
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (219)
....++|++.+.||+|++|.||++++..+++.||+|++... ....+.+..|..+++.+ +||||+++++++...+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999999999999999998653 22235567888999887 69999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++||||+++++|...+...+.+++.+++.++.|++.||.+||++|++|+||||+||+++.++. ++|+|||+++....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIC 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeeccc
Confidence 9999999999999999998889999999999999999999999999999999999999988877 99999999875332
Q ss_pred -CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 222 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCC
Confidence 223345578999999999999899999999999999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=280.62 Aligned_cols=197 Identities=22% Similarity=0.376 Sum_probs=177.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
.++|++.+.||+|++|.||++.+..+++.+++|.+.......+.+.+|+.+++.++||||+++++++...+..++++||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 57999999999999999999999999999999999766555567889999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCC
Q 027738 102 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (219)
Q Consensus 102 ~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~ 180 (219)
++++|.+.+.... .+++.++..++.|++.+|.+||+.|++|+||||+||+++.+....++|+|||++............
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 9999999997654 699999999999999999999999999999999999998744445999999999765544444445
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 201 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 68999999999998888999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=278.83 Aligned_cols=197 Identities=28% Similarity=0.470 Sum_probs=176.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (219)
...++|++.+.||+|++|.||++++..+++.||+|++...... .+.+.+|..+++.+ +||||+++++++......
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 3567999999999999999999999999999999999764322 24567889999887 899999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc-c
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~-~ 173 (219)
++|+||+++++|...+...+.+++.+++.++.|++.||.+||++|++|+||||+||+++.++. ++|+|||+++... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCC
Confidence 999999999999999998888999999999999999999999999999999999999988876 9999999987532 2
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 208 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCC
Confidence 233445678999999999999999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=276.58 Aligned_cols=195 Identities=28% Similarity=0.502 Sum_probs=176.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|..+++.++||||+++++++.+....+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 35689999999999999999999999999999999986532 23356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++||+++++|.+.+.....+++..+..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||+++... .
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~--~ 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVP--D 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECS--S
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecC--C
Confidence 99999999999999998888999999999999999999999999999999999999988876 9999999987543 2
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 201 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 3345678999999999999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=279.53 Aligned_cols=198 Identities=30% Similarity=0.470 Sum_probs=174.7
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (219)
....++|++.+.||+|++|.||++++..+++.||+|++... ....+.+..|..++..+ +||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999998653 22335567788888766 89999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++||||+++++|.+++.....+++.++..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhccc
Confidence 9999999999999999998888999999999999999999999999999999999999988876 99999999875432
Q ss_pred C-CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 H-SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .......+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 216 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCC
Confidence 2 23345678999999999999999999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=275.99 Aligned_cols=198 Identities=32% Similarity=0.548 Sum_probs=178.4
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45789999999999999999999999999999999875432 23678899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC--CcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~--~~v~l~dfg~a~~~ 171 (219)
.++++||+++++|.+++.....+++.++..++.|++.+|.+||+.+++|+||||+||+++.++. .+++|+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 9999999999999999988888999999999999999999999999999999999999987662 24999999999866
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 215 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 55555556678999999999998889999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=272.65 Aligned_cols=196 Identities=28% Similarity=0.462 Sum_probs=175.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
...++|++.+.||+|++|+||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 4567999999999999999999999999999999998654433 466789999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
||+++++|.+++... .+++.++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++........ .
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCB
T ss_pred ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCccccc
Confidence 999999999988765 5899999999999999999999999999999999999988876 99999999875543333 2
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 214 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 34578999999999999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=272.19 Aligned_cols=196 Identities=31% Similarity=0.425 Sum_probs=171.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++.+.||+|++|.||++.+..+++.|++|.+....... +.+.+|+..++.++||||+++++++..++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 4679999999999999999999999999999999986543332 567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
++||+++++|.+++...++++..++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++........
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccc
Confidence 9999999999999998889999999999999999999999999999999999999988876 99999999875443322
Q ss_pred --CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 --PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 210 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 223468999999999999889999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=278.90 Aligned_cols=198 Identities=32% Similarity=0.482 Sum_probs=177.6
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356899999999999999999999999999999999754322 25678999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~dfg~a~~~~~~~~ 176 (219)
+||+.+++|.+.+.....+++.++..++.|++.+|.+||+++++|+||||+||+++.++. ..++|+|||++........
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 999999999999988888999999999999999999999999999999999999976542 3499999999986654444
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 228 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 455678999999999999899999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=276.47 Aligned_cols=195 Identities=39% Similarity=0.623 Sum_probs=176.6
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++... ......+.+|+.+++.++||||+++++++..+...++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 457999999999999999999999999999999998643 2334678999999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
|+||+ +++|.+.+...+.+++.++..++.|++.+|.+||+.|++|+||||+||++++++. ++|+|||++........
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBT
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcc
Confidence 99999 6789999988888999999999999999999999999999999999999998876 99999999987666555
Q ss_pred CCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..+ ++++|+||||+++|+|++|..
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRL 206 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCC
Confidence 666789999999999988776 689999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=278.15 Aligned_cols=198 Identities=29% Similarity=0.461 Sum_probs=174.9
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (219)
....++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+..|..++..+ +||+|+++++++...+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 346789999999999999999999999899999999986532 2335677888888877 79999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++||||+++++|.+++...+.+++.+++.++.|++.||.+||++|++|+||||+||+++.++. ++|+|||+++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCccccccc
Confidence 9999999999999999998888999999999999999999999999999999999999988876 99999999875332
Q ss_pred -CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 219 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCC
Confidence 223345678999999999999999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=278.91 Aligned_cols=198 Identities=30% Similarity=0.524 Sum_probs=169.7
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHH-HHhCCCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIIN-HRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~ 93 (219)
....++|++.+.||+|++|.||++++..+++.||+|++...... ...+..|... ++.++||||+++++++...+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 45678999999999999999999999999999999998754322 2334555554 466789999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++||||+++++|.+.+.+.+.+++..++.++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCcccccccc
Confidence 9999999999999999998888999999999999999999999999999999999999998876 99999999875332
Q ss_pred -CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~ 237 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCC
Confidence 233445679999999999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=277.26 Aligned_cols=196 Identities=29% Similarity=0.518 Sum_probs=177.2
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
....++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++......
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 456789999999999999999999999999999999986532 2335678899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++||||+++++|.+++...+.+++.+++.++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||+++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC-
Confidence 999999999999999998888999999999999999999999999999999999999988876 99999999875432
Q ss_pred CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 194 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (350)
T 1rdq_E 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCC
Confidence 3344578999999999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=282.61 Aligned_cols=196 Identities=29% Similarity=0.432 Sum_probs=173.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|..+++.++||||+++++++.+...++
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 4568999999999999999999999999999999998642 223456789999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+||||+++++|.+.+.. ..+++..++.++.|++.||.+||++||+|+||||+||+++.++. ++|+|||+++......
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCC
Confidence 99999999999998865 46899999999999999999999999999999999999988877 9999999997544332
Q ss_pred --CCCCCCCCCCCCCchhhcccc----ccceeeEEEEEEEEeecCCCCC
Q 027738 176 --QPKSTVGTPAYIAPEVLLRHE----YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+.. ++.++|+||||+++|||++|..
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence 233567999999999998654 7899999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=271.08 Aligned_cols=198 Identities=26% Similarity=0.436 Sum_probs=174.3
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc-ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
....++|++.+.||+|++|+||++.+..+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 346789999999999999999999999999999999885533 3346788999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
+||+++++|.+++.. ...++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKT 163 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccc
Confidence 999999999999987 456999999999999999999999999999999999999988777 99999999875433222
Q ss_pred C---------------CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 P---------------KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~---------------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ....+++.|+|||.+.+..++.++||||||+++++|++|..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 220 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCC
Confidence 1 13468889999999999999999999999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=267.77 Aligned_cols=195 Identities=26% Similarity=0.444 Sum_probs=169.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC---HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.++|++.+.||+|++|+||++.+..+++.||+|++....... +.+.+|+.+++.++||||+++++++..++..++|+
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 368999999999999999999999999999999997544332 56789999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~ 177 (219)
||+++..+.......+.+++.++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++...... ...
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCC
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCccccc
Confidence 99987544444444677999999999999999999999999999999999999988876 999999998754322 233
Q ss_pred CCCCCCCCCCCchhhcccc-ccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHE-YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+.. ++.++|+||||+++++|++|+.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~ 200 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCC
Confidence 4456789999999998755 7999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=284.24 Aligned_cols=197 Identities=22% Similarity=0.414 Sum_probs=174.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|+||+||++.+..+++.||+|++... ....+.+.+|..++..++||||+++++++.+.+.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 3467999999999999999999999999999999998642 222345788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+||||+++++|.+++.. ...+++..++.++.|++.||.+||+++|+|+||||+||+++.++. ++|+|||+++.....
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMED 228 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccC
Confidence 99999999999999987 467999999999999999999999999999999999999998877 999999998754433
Q ss_pred CC--CCCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ--PKSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....+++.|+|||.+. +..++.++|+||||+++|||++|..
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~ 279 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCC
Confidence 22 23357899999999997 4678999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=272.59 Aligned_cols=200 Identities=28% Similarity=0.450 Sum_probs=168.0
Q ss_pred CcccCCccceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHHhCCCCcEeEEEEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVI 88 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (219)
+.....++|++.+.||+|++|.||++.+. .+++.||+|++.... .....+.+|+.+++.++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 44556789999999999999999999985 578999999987542 2234577899999999999999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
...+..++|+||+++++|.+.+.....+++.++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~ 168 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLC 168 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcc
Confidence 999999999999999999999998888999999999999999999999999999999999999988776 999999998
Q ss_pred cccccC-CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 219 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCC
Confidence 753322 22344578999999999998889999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=279.33 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=176.7
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
...++|++.+.||+|++|.||++.+..+++.+|+|++..... ....+.+|+.+++.++||||+++++++......++|+
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 446789999999999999999999999999999999876432 2356889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+++++|.+.+.... .+++.++..++.|++.+|.+||++|++|+||||+||+++.++...++|+|||++.........
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 9999999999887554 699999999999999999999999999999999999998655556999999999865544444
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 248 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 248 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCC
Confidence 44578999999999999889999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=280.41 Aligned_cols=197 Identities=23% Similarity=0.400 Sum_probs=174.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|..++..++||+|+++++++.+.+.++
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999986432 22345788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+||||+++++|.+++.+.+ .+++..++.++.|++.||.+||+++|+|+||||+||+++.++. ++|+|||+++.....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRAD 215 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCC
Confidence 9999999999999998754 7999999999999999999999999999999999999998877 999999999765433
Q ss_pred CC--CCCCCCCCCCCCchhhc-------cccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ--PKSTVGTPAYIAPEVLL-------RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~--~~~~~~~~~~~aPE~~~-------~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....+++.|+|||.+. +..++.++|+||||+++|||++|..
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~ 268 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSC
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCC
Confidence 32 23457899999999997 3568999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=281.95 Aligned_cols=198 Identities=30% Similarity=0.464 Sum_probs=174.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..++|++.+.||+|+||.||++.+..+++.+|+|++..... ..+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35789999999999999999999999999999999876432 235678999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-CCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~-~~~~v~l~dfg~a~~~~~~~~ 176 (219)
+||+.+++|.+.+.....+++.++..++.|++.+|.+||++|++|+||||+||+++.+ ....++|+|||++........
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999999999998899999999999999999999999999999999999999853 223499999999975543322
Q ss_pred -CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 -PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~ 211 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP 211 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 234578999999999999899999999999999999999865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=274.03 Aligned_cols=197 Identities=35% Similarity=0.527 Sum_probs=172.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
+..++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++..++..+++
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 346799999999999999999999999999999999865432 236688999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC--
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 175 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-- 175 (219)
+||+++++|.+.+.....+++.++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEE
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcc
Confidence 999999999999988878999999999999999999999999999999999999988776 9999999987543222
Q ss_pred -CCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 176 -QPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 206 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 2234578999999999987765 778999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=269.91 Aligned_cols=197 Identities=22% Similarity=0.318 Sum_probs=172.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC--eEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 456899999999999999999999999999999999875432 2366789999999999999999999998765 789
Q ss_pred EEEeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe----cCCCCCcEEEeecccc
Q 027738 96 IVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----DGSPAPRLKICDFGYS 168 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili----~~~~~~~v~l~dfg~a 168 (219)
+|+||+++++|.+++..... ++..++..++.|++.+|.+||+++++|+||||+||++ +.++ .++|+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCc
Confidence 99999999999999976543 8999999999999999999999999999999999998 4333 4999999999
Q ss_pred cccccCCCCCCCCCCCCCCCchhhc--------cccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQPKSTVGTPAYIAPEVLL--------RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+............+++.|+|||.+. +..++.++|+||||+++|||++|..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 221 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 8665555555667899999999986 4678899999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=269.95 Aligned_cols=198 Identities=30% Similarity=0.504 Sum_probs=178.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..++|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 46789999999999999999999999999999999875432 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC--cEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~--~v~l~dfg~a~~~ 171 (219)
.++++||+++++|.+++.....+++.++..++.|++.+|.+||+.|++|+||+|+||+++.++.. +++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999999999988889999999999999999999999999999999999999877631 4999999999766
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 216 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCC
T ss_pred CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCC
Confidence 55544455678999999999998889999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=265.43 Aligned_cols=195 Identities=28% Similarity=0.432 Sum_probs=168.4
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc------ccCHHHHHHHHHHHhCC---CCcEeEEEEEEEcC
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLR---HPNIVRFKEVILTP 91 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~------~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~ 91 (219)
..++|++.+.||+|++|+||++.+..+++.||+|++.... .....+.+|+..++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3679999999999999999999999999999999986422 22356777887777664 99999999999876
Q ss_pred C-----eEEEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 92 T-----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 92 ~-----~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
. ..++++|++++ +|.+++..... +++.++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECS
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEee
Confidence 5 47999999975 99999887654 999999999999999999999999999999999999988876 99999
Q ss_pred cccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||++.............+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 217 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSC
T ss_pred CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCC
Confidence 999976554444455678999999999999899999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=273.93 Aligned_cols=197 Identities=34% Similarity=0.513 Sum_probs=159.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++......++++||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3567999999999999999999999999999999987543 346678899999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC-CCCCcEEEeecccccccccCCCCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~-~~~~~v~l~dfg~a~~~~~~~~~~~ 179 (219)
+++++|.+.+...+.+++.++..++.|++.+|.+||+.+++|+||||+||+++. +....++|+|||+++..........
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence 999999999988888999999999999999999999999999999999999975 2233499999999876554444445
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 248 (349)
T 2w4o_A 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248 (349)
T ss_dssp ---CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCC
Confidence 678999999999999889999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=272.86 Aligned_cols=198 Identities=28% Similarity=0.413 Sum_probs=172.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC------cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357899999999999999999999999999999998532 12346789999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeeccccc
Q 027738 95 AIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSK 169 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~dfg~a~ 169 (219)
++||||+++++|.+.+... ..+++..+..++.|++.+|.+||+++++|+||||+||+++.++. ..++|+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999998777543 24899999999999999999999999999999999999976543 349999999987
Q ss_pred ccccCCC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 231 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCC
Confidence 6543322 334578999999999999889999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=261.59 Aligned_cols=195 Identities=33% Similarity=0.480 Sum_probs=175.3
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
..++|++.+.||+|++|.||++.+..++..+++|++..... ..+.+.+|+.+++.++||||+++++++......++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35689999999999999999999999999999999876433 34678899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe---cCCCCCcEEEeecccccccccCCC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili---~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
|+++++|.+.+...+.+++.++..++.|++.+|.+||+++++|+||+|+||++ +.++. ++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~--~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC--EEECCCTTCEECCTTSC
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc--EEEEecccceeccCccc
Confidence 99999999999888889999999999999999999999999999999999999 44444 99999999987665555
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+. ++.++|+||||+++++|++|..
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~ 205 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYP 205 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSC
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCC
Confidence 5666789999999998755 8899999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=285.57 Aligned_cols=197 Identities=24% Similarity=0.350 Sum_probs=177.3
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++.++||||+++++++...+.++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4578899999999999999999999999999999998643 223356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 96 IVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+||||++|++|.+.+...+. +++..+..++.|++.||.+||++||+|+||||+||+++.++. ++|+|||+++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceeccc
Confidence 99999999999999876543 999999999999999999999999999999999999998876 99999999986654
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~ 383 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSC
T ss_pred CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 444455689999999999999899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=273.87 Aligned_cols=195 Identities=16% Similarity=0.155 Sum_probs=168.3
Q ss_pred cCCccceeeccccCcCceEEEEEE-----ECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC---CCcEeEEEEEEEcC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTP 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~ 91 (219)
...++|++.+.||+|+||.||+++ +..+++.||+|++... ...++..|...++.++ |++++++++++...
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 346789999999999999999994 5678899999998653 3456788888888887 89999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC-----------C
Q 027738 92 THLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-----------S 155 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~-----------~ 155 (219)
+..++||||+++++|.+++.. ...+++.++..++.|++.||.|||+.+|+|+||||+||+++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999999974 456999999999999999999999999999999999999987 4
Q ss_pred CCCcEEEeeccccccccc---CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 156 PAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 156 ~~~~v~l~dfg~a~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+. ++|+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++|..
T Consensus 220 ~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 220 AG--LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp TT--EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred CC--EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 44 99999999964332 222344578999999999999889999999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=268.58 Aligned_cols=195 Identities=25% Similarity=0.364 Sum_probs=167.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-------
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT------- 92 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 92 (219)
.++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4689999999999999999999999999999999875432 3467889999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEeccCCCcHHHHHHhcCC---CCHH
Q 027738 93 --------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSED 119 (219)
Q Consensus 93 --------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~---~~~~ 119 (219)
..++++||+++++|.+++..... .+..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999987643 5666
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-------------CCCCCCCCCCC
Q 027738 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAY 186 (219)
Q Consensus 120 ~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-------------~~~~~~~~~~~ 186 (219)
.+..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||+++...... ......+++.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 78999999999999999999999999999999987776 9999999987554332 22334689999
Q ss_pred CCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 187 IAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 187 ~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+|||.+.+..++.++|+||||+++++|++|..
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~ 274 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999999853
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=272.83 Aligned_cols=204 Identities=23% Similarity=0.362 Sum_probs=177.1
Q ss_pred CCCCCcccCCccceeeccccCc--CceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEE
Q 027738 13 AMDMPIMHDSDRYDFVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEV 87 (219)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g--~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (219)
....++....++|++.+.||+| ++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 15 QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp C--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 4556677889999999999999 9999999999999999999999754322 2567789999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeec
Q 027738 88 ILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
+...+..++|+||+++++|.+++... ..+++.++..++.|++.||.+||+++++|+||||+||+++.++. ++|+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~df 172 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGL 172 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEccc
Confidence 99999999999999999999999875 56999999999999999999999999999999999999987776 999999
Q ss_pred ccccccccC--------CCCCCCCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLH--------SQPKSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~--------~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|.+...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~ 235 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 987533211 11223367888999999987 678999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=262.20 Aligned_cols=198 Identities=32% Similarity=0.482 Sum_probs=177.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..++|++.+.||+|++|.||++.+..+++.|++|++...... .+.+.+|+.+++.++||||+++++++......+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 357999999999999999999999999999999998654322 25678899999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~dfg~a~~~~~~~~ 176 (219)
+||+++++|.+.+.....++..++..++.|++.+|.+||+++++|+||+|+||+++.++. ..++|+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988888999999999999999999999999999999999999976543 3499999999976655555
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 205 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCC
Confidence 555678999999999999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=272.04 Aligned_cols=196 Identities=28% Similarity=0.406 Sum_probs=175.3
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 35789999999999999999999999999999999876432 234567899999999999999999999999
Q ss_pred CeEEEEEeccCCC-cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 92 THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 92 ~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
+..++++|++.++ +|.+++.....+++..+..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++..
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~ 179 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAY 179 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceE
Confidence 9999999998766 99999998888999999999999999999999999999999999999988776 99999999976
Q ss_pred cccCCCCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 228 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence 655444455578999999999988776 788999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=281.61 Aligned_cols=197 Identities=39% Similarity=0.628 Sum_probs=177.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+..++.++||||+++++++...+..+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35679999999999999999999999999999999986532 22356889999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+|+||+++++|.+++...+.+++.++..++.|++.||.+||+.+++|+||||+||+++.++. ++|+|||++.......
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccc
Confidence 99999999999999988888999999999999999999999999999999999999988876 9999999998665544
Q ss_pred CCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~ 214 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTL 214 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCC
Confidence 4556679999999999988765 689999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=270.49 Aligned_cols=197 Identities=26% Similarity=0.374 Sum_probs=167.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEcCCe--
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTH-- 93 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 93 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++....... ..+.+|+..++.++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 45679999999999999999999999999999999997643332 457789999999999999999999886543
Q ss_pred --EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 94 --LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 94 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.++|+||+++++|.+++...+.++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++...
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~ 166 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC---
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccc
Confidence 4999999999999999998888999999999999999999999999999999999999988877 999999998754
Q ss_pred ccCCC----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 217 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 33222 223458999999999999899999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=282.06 Aligned_cols=197 Identities=32% Similarity=0.531 Sum_probs=167.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++.++||||+++++++...+.++
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 3568899999999999999999999999999999998643 222345678889999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeeccccccccc-
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~- 173 (219)
+||||+++++|...+...+.++...+..++.|++.||.|||+ .||+|+||||+||+++.++. ++|+|||+++....
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKD 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC-
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCC
Confidence 999999999999999988899999999999999999999998 99999999999999988876 99999999875332
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 347 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCC
Confidence 223345678999999999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=265.65 Aligned_cols=200 Identities=28% Similarity=0.453 Sum_probs=168.3
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
........++|++.+.||+|++|+||++.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++..+
T Consensus 13 ~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp --CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred ceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 3345566789999999999999999999996 5889999998654322 25678999999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
...++|+||+++ ++.+.+... ..+++.++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||+++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~ 168 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARA 168 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEE
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCcee
Confidence 999999999986 777777654 45999999999999999999999999999999999999988876 99999999875
Q ss_pred cccC-CCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLH-SQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.... .......+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence 5432 22334568999999999976 568999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=281.44 Aligned_cols=197 Identities=29% Similarity=0.387 Sum_probs=175.7
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+..|..+++.++||||+++++++.....++
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999986532 22356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 96 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
+||||++|++|...+... ..+++..+..++.|++.||.+||++||+|+||||+||+++.++. ++|+|||+++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeec
Confidence 999999999999998764 35999999999999999999999999999999999999998877 999999999765
Q ss_pred ccCCCC-CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQP-KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...... ....+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~ 387 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCC
Confidence 443332 33479999999999999999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=280.20 Aligned_cols=197 Identities=34% Similarity=0.520 Sum_probs=174.4
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--------------ccCHHHHHHHHHHHhCCCCcEeEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNIVRFKE 86 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (219)
..++|++.+.||+|++|+||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3688999999999999999999999999999999986542 22356889999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeec
Q 027738 87 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDF 165 (219)
Q Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~df 165 (219)
++.....+++|+||+++++|.+.+.....+++.++..++.|++.+|.+||++|++|+||||+||+++.++. ..++|+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999999999999988888999999999999999999999999999999999999987653 24999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|++.............+++.|+|||.+. ..++.++|+||||+++|+|++|..
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~ 245 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP 245 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCC
Confidence 9998766555556677999999999987 458999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=261.45 Aligned_cols=197 Identities=32% Similarity=0.562 Sum_probs=172.4
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
.++|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3689999999999999999999999999999999865421 246788999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC--CcEEEeecccccccc
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 172 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~--~~v~l~dfg~a~~~~ 172 (219)
++++|++++++|.+++.....++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. .+++|+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 999999999999999988888999999999999999999999999999999999999987652 249999999987655
Q ss_pred cCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.........+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 209 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCC
Confidence 4444455568899999999998889999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=264.91 Aligned_cols=195 Identities=27% Similarity=0.421 Sum_probs=156.4
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 4679999999999999999999999999999999986543 23467889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 99 EYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 99 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
||+++ +|.+++... ..++...+..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++....
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG 159 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence 99985 888888653 35899999999999999999999999999999999999988876 9999999987554
Q ss_pred cCC-CCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHS-QPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 322 2334568999999999976 468999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=270.30 Aligned_cols=196 Identities=31% Similarity=0.464 Sum_probs=171.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
...++|++.+.||+|+||.||++.+..+++.||+|++..... ...+|++.+.++ +||||+++++++.++...++||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 446789999999999999999999999999999999976432 235677777776 7999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC--CcEEEeecccccccccCC-
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~--~~v~l~dfg~a~~~~~~~- 175 (219)
||+++++|.+.+...+.+++.++..++.|++.+|.+||++|++|+||||+||++.++.. ..++|+|||+++......
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99999999999998888999999999999999999999999999999999999854432 249999999987554332
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 218 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCC
Confidence 2334568999999999998889999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=278.99 Aligned_cols=196 Identities=36% Similarity=0.539 Sum_probs=172.3
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.++|++.+.||+|++|+||++.+..++..+|+|++.... .....+.+|+.+++.++||||+++++++.....+++|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 458999999999999999999999999999999987542 33567889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+.+++|.+.+.....+++.++..++.|++.+|.+||++|++|+||||+||+++..+ ...++|+|||++.........
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 9999999999998888899999999999999999999999999999999999997643 234999999999876655555
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+. ..++.++|+||||+++|+|++|..
T Consensus 196 ~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~ 235 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235 (494)
T ss_dssp CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCC
Confidence 6677999999999986 468999999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=268.72 Aligned_cols=196 Identities=24% Similarity=0.385 Sum_probs=172.9
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-----CCcEeEEEEEEEcCCeE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILTPTHL 94 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~ 94 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++.......+....|+.+++.++ ||||+++++++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3468999999999999999999999999999999999765555567788999999886 99999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-----------------
Q 027738 95 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS----------------- 155 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~----------------- 155 (219)
++|+|++ +++|.+++.... .++..++..++.|++.||.+||++|++|+||||+||+++..
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999999 889999998654 48999999999999999999999999999999999999751
Q ss_pred ------CCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 156 ------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 156 ------~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++|+|||++.... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 13349999999987533 23345678999999999999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=259.44 Aligned_cols=197 Identities=26% Similarity=0.383 Sum_probs=173.8
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
+....++|++.+.||+|++|.||++.+. +++.|++|++.......+.+.+|+.++++++||||+++++++......+++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 3456789999999999999999999987 577799999987766678899999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-
Q 027738 98 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~- 175 (219)
+||+++++|.+++... ..++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccc
Confidence 9999999999999654 45899999999999999999999999999999999999987776 9999999987543222
Q ss_pred -CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 176 -QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
......+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~ 205 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCC
Confidence 2233445678999999998889999999999999999999 54
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=266.47 Aligned_cols=196 Identities=24% Similarity=0.235 Sum_probs=172.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+.+|+.+++.+ +||||+++++++......++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3578999999999999999999999999999999886543 345688999999999 89999999999999999999999
Q ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC---cEEEeecccccccccCC
Q 027738 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSVLHS 175 (219)
Q Consensus 100 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~---~v~l~dfg~a~~~~~~~ 175 (219)
++ +++|.+++... ..++..++..++.|++.+|.+||+.+++|+||||+||+++.++.. .++|+|||+++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 88999998863 579999999999999999999999999999999999999866532 29999999997544332
Q ss_pred C--------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 Q--------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .....+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 215 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSL 215 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCC
Confidence 2 234568999999999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=264.37 Aligned_cols=201 Identities=30% Similarity=0.435 Sum_probs=165.2
Q ss_pred CCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC---HHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
.........++|++.+.||+|++|+||++.+. ++.||+|++....... +.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 33444566889999999999999999999874 8889999987654322 457889999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEecCCCCCcEEEeec
Q 027738 91 PTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~--ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
....++++||+++++|.+.+..... ++..++..++.|++.+|.+||+.+ ++|+||||+||+++.++. ++|+||
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Df 183 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDF 183 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCC
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCC
Confidence 9999999999999999999987653 899999999999999999999999 999999999999988776 999999
Q ss_pred ccccccccCCC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+++....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 237 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCC
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99874433222 234568999999999999989999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=264.21 Aligned_cols=195 Identities=28% Similarity=0.423 Sum_probs=167.3
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 46899999999999999999999999999999988654332 245678999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~ 177 (219)
||+++++|...+.....++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCccccc
Confidence 99999999998888888999999999999999999999999999999999999988776 9999999987544222 22
Q ss_pred CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 201 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 34568889999999976 667999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=267.18 Aligned_cols=195 Identities=36% Similarity=0.543 Sum_probs=155.5
Q ss_pred Cccceee---ccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEE
Q 027738 22 SDRYDFV---RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 22 ~~~y~~~---~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 97 (219)
.++|++. +.||+|++|.||++.+..+++.||+|++... ....+.+|+..++.+. ||||+++++++......++|
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 3577775 7899999999999999999999999998643 3466788999999997 99999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~dfg~a~~~~~~~~ 176 (219)
+||+++++|.+.+.....+++.++..++.|++.+|.+||+++++|+||||+||+++.++. ..++|+|||+++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp ECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999999999999999889999999999999999999999999999999999999976542 2499999999875443322
Q ss_pred -CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 -PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 207 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQV 207 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCC
Confidence 234467899999999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=270.95 Aligned_cols=196 Identities=29% Similarity=0.429 Sum_probs=167.3
Q ss_pred cccee--eccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 23 DRYDF--VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 23 ~~y~~--~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
+.|++ .+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34554 5789999999999999999999999999876442 34678899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
|+++++|.+.+... ..+++.++..++.|++.+|.+||+.+++|+||||+||++..+...+++|+|||++..........
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99999998888654 46899999999999999999999999999999999999964444459999999998765555555
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 286 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 5678999999999998889999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=279.13 Aligned_cols=198 Identities=36% Similarity=0.546 Sum_probs=174.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC---cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
...++|++.+.||+|++|+||++.+..+++.||+|++... ......+.+|+.+++.++||||+++++++.....+++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 4578999999999999999999999999999999998542 2334678899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeecccccccccCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~~~~~~ 175 (219)
++||+.+++|.+.+.....+++.++..++.|++.+|.+||++|++|+||||+||+++..+ ...++|+|||++.......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999999999998888899999999999999999999999999999999999996432 2349999999998665555
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+ .++.++|+||||+++|+|++|..
T Consensus 179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 220 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTP 220 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCC
Confidence 5556679999999999876 48899999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=258.97 Aligned_cols=196 Identities=26% Similarity=0.376 Sum_probs=173.0
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
....++|++.+.||+|++|.||++.+. ++..||+|++.......+.+.+|+..++.++||||+++++++......++++
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 346789999999999999999999887 5677999999877666788999999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-
Q 027738 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~- 176 (219)
||+++++|.+++.... .+++.++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhh
Confidence 9999999999997654 4999999999999999999999999999999999999988876 99999999875433221
Q ss_pred -CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 177 -PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 203 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK 203 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTC
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCC
Confidence 122345667999999998889999999999999999998 54
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=287.11 Aligned_cols=197 Identities=30% Similarity=0.479 Sum_probs=175.4
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (219)
...++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+..|..++..+ +||+|+.+++++...+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3567899999999999999999999999999999998643 23346677888888877 689999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc-
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~- 173 (219)
++||||+++++|..++...+.+++.+++.++.|++.||.|||+++|+|+||||+|||++.++. ++|+|||+++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCT
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccC
Confidence 999999999999999998889999999999999999999999999999999999999998887 99999999975332
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~ 540 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCC
Confidence 333445679999999999999999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=268.14 Aligned_cols=205 Identities=32% Similarity=0.444 Sum_probs=165.4
Q ss_pred CCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEE
Q 027738 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVIL 89 (219)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (219)
....+.....++|++.+.||+|++|+||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 24 VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp --------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred eccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 44556677789999999999999999999999999999999998654322 345678999999999999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC---CCcEEEeecc
Q 027738 90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFG 166 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~---~~~v~l~dfg 166 (219)
.+...++|+||+++ +|.+++.....++..++..++.|++.+|.+||+++++|+||||+||+++.++ ...++|+|||
T Consensus 104 ~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 104 HNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp ETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred cCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999999999975 9999999888899999999999999999999999999999999999995433 2249999999
Q ss_pred cccccccC-CCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLH-SQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++...... .......+++.|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 98754322 222334678999999999874 57999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=261.52 Aligned_cols=193 Identities=30% Similarity=0.460 Sum_probs=165.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.++|++.+.||+|++|.||++.+ .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++++
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 36899999999999999999999 578899999986543 23467889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CC
Q 027738 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~ 176 (219)
|++++ +|.+.+... ..++..++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++...... ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRK 156 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC----
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCccccc
Confidence 99986 888888754 56999999999999999999999999999999999999988876 999999998754322 22
Q ss_pred CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 234467899999999976 458999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=260.51 Aligned_cols=199 Identities=22% Similarity=0.348 Sum_probs=172.5
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
.......++|++.+.||+|++|.||++.+. ++..|++|++.......+.+.+|+..++.++||||+++++++......+
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 445567889999999999999999999887 6778999999877666788999999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+++||+++++|.+++.. ...++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEcccccccccccc
Confidence 99999999999999976 456999999999999999999999999999999999999988776 999999998754322
Q ss_pred C--CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 S--QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~ 219 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 1 1223345678999999998889999999999999999998 65
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=279.00 Aligned_cols=195 Identities=26% Similarity=0.371 Sum_probs=164.3
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC-----
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP----- 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 91 (219)
...++|++.+.||+|+||+||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 34689999999999999999999999999999999997542 2235678999999999999999999999765
Q ss_pred -CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 92 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 92 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
...++|+||+++ ++...+.. .++..++..++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||+++.
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~ 213 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART 213 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC--
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeee
Confidence 357999999977 46555543 4899999999999999999999999999999999999998876 99999999987
Q ss_pred cccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
...........+++.|+|||.+.+..++.++|+||||++++||++|..+
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p 262 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 262 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCC
Confidence 6555555667889999999999999999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=258.25 Aligned_cols=197 Identities=31% Similarity=0.425 Sum_probs=175.9
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.+++|++..... ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 456899999999999999999999999999999999865432 2356788999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++||+++++|.+.+.....++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999988776 9999999987544222
Q ss_pred -CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 -QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 213 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 2334568899999999998889999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=267.40 Aligned_cols=196 Identities=21% Similarity=0.299 Sum_probs=168.5
Q ss_pred cCCccceeeccccCcCceEEEEEEEC-------CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 89 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (219)
...++|++.+.||+|+||.||++.+. .++..||+|++..... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 45689999999999999999999874 2456799999875432 235678999999999 8999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec
Q 027738 90 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~ 153 (219)
..+.+++|+||+++++|.+++...+ .++..++..++.|++.||.+||+++++|+||||+||+++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 9999999999999999999997653 378999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 154 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 154 ~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.++. ++|+|||+++....... .....+++.|+|||.+.+..++.++|+||||+++|||++ |.
T Consensus 238 ~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 303 (370)
T 2psq_A 238 ENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303 (370)
T ss_dssp TTCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 8876 99999999875433222 122345678999999999999999999999999999999 54
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=275.06 Aligned_cols=194 Identities=27% Similarity=0.422 Sum_probs=156.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC-----
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP----- 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 91 (219)
...++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 345899999999999999999999999999999999865322 235678999999999999999999999543
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
..+++|+|+++ ++|...+.....+++.++..++.|++.||.|||+.+|+|+||||+||+++.++. ++|+|||+++..
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~ 206 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTV 206 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCT
T ss_pred ceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhc
Confidence 56899999985 589999988888999999999999999999999999999999999999988876 999999999754
Q ss_pred ccCCC----------------------------CCCCCCCCCCCCchhhc-cccccceeeEEEEEEEEeecCCC
Q 027738 172 VLHSQ----------------------------PKSTVGTPAYIAPEVLL-RHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 172 ~~~~~----------------------------~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
..... ....++++.|+|||++. +..++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 32211 12235788999999874 56789999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=263.27 Aligned_cols=196 Identities=32% Similarity=0.426 Sum_probs=175.6
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++.+.||+|++|.||++.+..+++.+++|++..... ..+.+.+|+.+++.++|+||+++++++...+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 46799999999999999999999999999999999865432 23567889999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~- 175 (219)
++||+++++|.+++.....++..++..++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||++.......
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcc
Confidence 9999999999999988888999999999999999999999999999999999999988776 9999999987554222
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 239 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcC
Confidence 2334568899999999998889999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=272.01 Aligned_cols=197 Identities=28% Similarity=0.394 Sum_probs=168.9
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcC--
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP-- 91 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 91 (219)
....-.++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 3444578999999999999999999999999999999999754222 35678999999999999999999999876
Q ss_pred ---CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 92 ---THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 92 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
...++|+|++++ +|.+.+.....+++.++..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 100 ~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla 176 (432)
T 3n9x_A 100 LKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLA 176 (432)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTC
T ss_pred CcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCc
Confidence 568999999865 99999988888999999999999999999999999999999999999988776 999999999
Q ss_pred cccccCCC-----------------------CCCCCCCCCCCCchhhc-cccccceeeEEEEEEEEeecCCC
Q 027738 169 KSSVLHSQ-----------------------PKSTVGTPAYIAPEVLL-RHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 169 ~~~~~~~~-----------------------~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
+....... .....+++.|+|||.+. +..++.++|+|||||+++||++|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 75543221 23456899999999974 56789999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=261.94 Aligned_cols=202 Identities=23% Similarity=0.290 Sum_probs=164.9
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
........++|++.+.||+|++|.||++.+..+++.|++|++...... .+.+.+|+..++.++||||+++++++..
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp --------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 334556678999999999999999999999999999999998754333 2567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
++..++++|++++++|.+++....+++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~ 183 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASA 183 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC---
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcc
Confidence 9999999999999999999998888999999999999999999999999999999999999988776 99999999865
Q ss_pred cccCCC--CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...... .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCC
Confidence 443221 223468889999999999889999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=281.29 Aligned_cols=199 Identities=37% Similarity=0.513 Sum_probs=175.4
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
....++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 344679999999999999999999999999999999986542 2346788999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-CCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~-~~~~v~l~dfg~a~~~~~ 173 (219)
++++|++.+++|.+.+.....+++.++..++.|++.+|.+||++|++|+||||+||+++.. ....++|+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999999988899999999999999999999999999999999999999532 223499999999876554
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........+++.|+|||.+.+ .++.++|+||||+++|+|++|..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 225 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCC
Confidence 444444578999999999876 68999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=258.76 Aligned_cols=196 Identities=30% Similarity=0.533 Sum_probs=172.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 45689999999999999999999999999999999985432 22456889999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++||+++++|.+.+.....++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++..... .
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-S 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC----
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-c
Confidence 99999999999999998888999999999999999999999999999999999999988876 99999998854332 2
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 205 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCC
Confidence 3344568899999999999888999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=259.92 Aligned_cols=201 Identities=25% Similarity=0.367 Sum_probs=171.0
Q ss_pred CCcccCCccceeeccccCcCceEEEEEE----ECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEE
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL 89 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (219)
.+.....++|++.+.||+|++|.||++. +..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3444567789999999999999999998 567899999999875432 2367889999999999999999999998
Q ss_pred cC--CeEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 90 TP--THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 90 ~~--~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
.. ...++++||+++++|.+++.. ...++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg 171 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFG 171 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCT
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECccc
Confidence 77 668999999999999999954 456999999999999999999999999999999999999988776 9999999
Q ss_pred cccccccCCC----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++........ .....++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccC
Confidence 9875543322 233456777999999999999999999999999999999854
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=265.82 Aligned_cols=199 Identities=23% Similarity=0.300 Sum_probs=169.1
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCc---EEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
......++|++.+.||+|++|.||++.+..+++ .||+|++.... ...+.+.+|+.+++.++||||+++++++..+
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 344567899999999999999999999975554 59999987542 2235688999999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
+..++|+||+++++|.+++... ..++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||+++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 200 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRV 200 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccc
Confidence 9999999999999999999654 56999999999999999999999999999999999999988776 99999999875
Q ss_pred cccCCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 171 SVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 171 ~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
....... ....+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 252 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 4432221 12234667999999998899999999999999999998 64
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=260.16 Aligned_cols=197 Identities=30% Similarity=0.447 Sum_probs=167.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||+|++|.||++.+..+++.+++|++..... ..+.+.+|+.+++.++||||+++++++......++++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 46899999999999999999999999999999999876432 2367899999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeeccccccccc
Q 027738 99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL 173 (219)
Q Consensus 99 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~~~~ 173 (219)
||+++++|.+.+.. ...++..++..++.|++.+|.+||+.+++|+||+|+||+++++. ...++|+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999999888854 36799999999999999999999999999999999999996432 23499999999976555
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........+++.|+|||.+. ..++.++|+||||+++++|++|..
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~ 223 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCL 223 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCC
Confidence 55555567899999999986 467899999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=270.78 Aligned_cols=194 Identities=32% Similarity=0.481 Sum_probs=160.6
Q ss_pred CCccceee-ccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHH-HhCCCCcEeEEEEEEEc----CCeE
Q 027738 21 DSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHL 94 (219)
Q Consensus 21 ~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~----~~~~ 94 (219)
..++|.+. +.||.|++|+||++.+..+++.||+|++.. ...+.+|+..+ +..+||||+++++++.. ...+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 35678777 789999999999999999999999999853 35567788776 45589999999999876 5678
Q ss_pred EEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeeccccccc
Q 027738 95 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 171 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~~ 171 (219)
++||||+++++|.+++.... .+++.++..++.|++.+|.|||+.+++|+||||+||+++.++ ...++|+|||+++..
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence 99999999999999998654 499999999999999999999999999999999999998732 234999999999865
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........+++.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 261 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_dssp C-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 54444455678999999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=262.79 Aligned_cols=206 Identities=24% Similarity=0.402 Sum_probs=170.8
Q ss_pred CCCCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEE
Q 027738 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL 89 (219)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (219)
............++|++.+.||+|++|.||++.+..+++.|++|++.......+.+.+|+..++.+ +||||+++++++.
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 334444555678999999999999999999999998999999999987766678899999999998 7999999999998
Q ss_pred c------CCeEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEE
Q 027738 90 T------PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 90 ~------~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~ 161 (219)
. ....++++||+++++|.+++... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~k 169 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VK 169 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EE
Confidence 7 46789999999999999999764 46899999999999999999999999999999999999987776 99
Q ss_pred EeecccccccccCC-CCCCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 162 ICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 162 l~dfg~a~~~~~~~-~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+|||++....... ......+++.|+|||.+. +..++.++|+||||+++|+|++|..
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 232 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232 (326)
T ss_dssp ECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSC
T ss_pred EeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCC
Confidence 99999987543222 223446889999999997 5667899999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=263.27 Aligned_cols=203 Identities=26% Similarity=0.411 Sum_probs=172.2
Q ss_pred CCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
.+.......++|++.+.||+|++|.||++.+..+++.|++|++...... .+.+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 16 TENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp ---CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cchhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 3445566789999999999999999999999999999999998654332 2456789999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
.+..++++||+++++|.........++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~ 173 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFART 173 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC--
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCcee
Confidence 9999999999999999888877778999999999999999999999999999999999999988876 99999999865
Q ss_pred cccC-CCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLH-SQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..
T Consensus 174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (331)
T 4aaa_A 174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCC
Confidence 4332 223445688999999999875 78899999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=262.73 Aligned_cols=196 Identities=31% Similarity=0.476 Sum_probs=165.4
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---------------------------cCHHHHHHHHH
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------------------IDENVQREIIN 72 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------------------------~~~~~~~e~~~ 72 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 456799999999999999999999999999999999865421 12567899999
Q ss_pred HHhCCCCcEeEEEEEEEc--CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 027738 73 HRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (219)
Q Consensus 73 l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~ni 150 (219)
++.++||||+++++++.. ....++++||+++++|.+.. ....+++.++..++.|++.+|.+||+++++|+||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 56789999999999987754 345699999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeecccccccccCCC-CCCCCCCCCCCCchhhcccc---ccceeeEEEEEEEEeecCCCCC
Q 027738 151 LLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHE---YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 151 li~~~~~~~v~l~dfg~a~~~~~~~~-~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+++.++. ++|+|||++........ .....+++.|+|||.+.+.. .+.++|+||||+++|+|++|..
T Consensus 169 l~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 169 LVGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp EECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9988876 99999999875443322 23456899999999998654 3778999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=262.04 Aligned_cols=193 Identities=21% Similarity=0.259 Sum_probs=161.3
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC---HHHHHHHHHHH-hCCCCcEeEEEEEEEcCCeEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
.++|++.++||+|++|+||++.+..+++.||+|++....... .....|+..+. ..+||||+++++++..++..+++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 378999999999999999999999999999999886543222 23334444444 44899999999999999999999
Q ss_pred EeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
+|++ +++|.+.+... ..+++.++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++........
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC----
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCC
Confidence 9999 45787777654 45999999999999999999999999999999999999988876 99999999876655555
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+ .++.++||||||++++||++|..
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~ 253 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNME 253 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCC
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCC
Confidence 556678999999999876 68999999999999999999865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=272.94 Aligned_cols=199 Identities=22% Similarity=0.293 Sum_probs=171.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC--eEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 456799999999999999999999999999999999875432 2366789999999999999999999998765 789
Q ss_pred EEEeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec--CCCCCcEEEeecccccc
Q 027738 96 IVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKS 170 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~--~~~~~~v~l~dfg~a~~ 170 (219)
+|+||+++++|.+++..... ++..+++.++.|++.+|.+||+++++|+||||+||++. +++...++|+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999999876443 89999999999999999999999999999999999982 12222499999999986
Q ss_pred cccCCCCCCCCCCCCCCCchhhcc--------ccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLR--------HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........+++.|+|||.+.+ ..++.++|+||||+++|||++|..
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~ 221 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCC
Confidence 655555556678999999999875 567889999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=264.28 Aligned_cols=201 Identities=25% Similarity=0.409 Sum_probs=171.0
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
..+.+...++|++.+.||+|++|.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 45566678999999999999999999999999999999998865432 235778999999999999999999999873
Q ss_pred --------CeEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEE
Q 027738 92 --------THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (219)
Q Consensus 92 --------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l 162 (219)
+..++|+||+++ ++...+.. ...++..++..++.|++.+|.+||++|++|+||||+||+++.++. ++|
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl 165 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKL 165 (351)
T ss_dssp --------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEE
T ss_pred ccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEE
Confidence 468999999986 66666654 356999999999999999999999999999999999999988876 999
Q ss_pred eecccccccccCC-----CCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 163 CDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 163 ~dfg~a~~~~~~~-----~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+|||++....... ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 227 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 9999987543221 2233457889999999976 557999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=265.94 Aligned_cols=201 Identities=23% Similarity=0.287 Sum_probs=171.7
Q ss_pred CCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
.....+....++|++.+.||+|+||.||++.+. ++.||+|++............|+..++.++||||+++++++....
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 344456678899999999999999999999886 789999999765554556677888899999999999999998754
Q ss_pred ----eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCCEEecCCCCC
Q 027738 93 ----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM----------QVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 93 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----------~ivh~dl~p~nili~~~~~~ 158 (219)
.+++|+||+++++|.+++... .++..++..++.|++.+|.+||+. +++|+||||+||+++.++.
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~- 169 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT- 169 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC-
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe-
Confidence 479999999999999999764 589999999999999999999999 9999999999999988776
Q ss_pred cEEEeecccccccccCCC---CCCCCCCCCCCCchhhcc-----ccccceeeEEEEEEEEeecCCCCC
Q 027738 159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLR-----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 159 ~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++|+|||+++....... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..
T Consensus 170 -~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 236 (322)
T 3soc_A 170 -ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236 (322)
T ss_dssp -EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBT
T ss_pred -EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCC
Confidence 99999999975443322 233468999999999986 456778999999999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=257.78 Aligned_cols=196 Identities=31% Similarity=0.545 Sum_probs=175.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.|++|++... ....+.+.+|+.+++.++|||++++++++...+..+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 4568999999999999999999999999999999998643 223367889999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++||+++++|.+.+...+.++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++..... .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-L 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-S
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-c
Confidence 99999999999999998888999999999999999999999999999999999999988776 99999999864432 2
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCC
Confidence 2344568899999999999889999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=257.40 Aligned_cols=192 Identities=26% Similarity=0.393 Sum_probs=171.8
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEc-----------
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 90 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------- 90 (219)
.++|++.+.||+|++|.||++.+..+++.|++|.+.... +.+.+|+..++.++|||++++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 468999999999999999999999899999999986543 567889999999999999999998864
Q ss_pred -----CCeEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEe
Q 027738 91 -----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (219)
Q Consensus 91 -----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~ 163 (219)
....++++||+++++|.+++... ..++...+..++.|++.+|.+||+.+++|+||+|+||++++++. ++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEEC
Confidence 34589999999999999999754 56999999999999999999999999999999999999988776 9999
Q ss_pred ecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 164 dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|||++.............+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~ 219 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCS
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCC
Confidence 9999876655555555678999999999999889999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=258.98 Aligned_cols=197 Identities=28% Similarity=0.421 Sum_probs=154.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 35678999999999999999999999899999999986432 22367889999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+++||+++++|.+++... .+++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMP 165 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC--
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCC
Confidence 999999999999998865 56999999999999999999999999999999999999988776 999999998754322
Q ss_pred C-CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 S-QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ......+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 210 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRP 210 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 2 2233468899999999998888999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=260.63 Aligned_cols=192 Identities=29% Similarity=0.455 Sum_probs=171.2
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccC
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 102 (219)
.|+..+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+..++.++||||+++++++...+..++++||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 478888999999999999999989999999998765433 3568899999999999999999999999999999999999
Q ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCCCC
Q 027738 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 181 (219)
Q Consensus 103 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~~~ 181 (219)
+++|.+++.. ..+++.++..++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||++....... ......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998764 46899999999999999999999999999999999999988776 9999999987554332 223457
Q ss_pred CCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 182 GTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 239 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 8999999999999889999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=263.42 Aligned_cols=199 Identities=26% Similarity=0.399 Sum_probs=167.2
Q ss_pred CcccCCccceeeccccCcCceEEEEEE----ECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
+.....++|++.+.||+|++|.||++. +..+++.||+|++...... .+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 445678899999999999999999998 5668899999998754332 35688999999999999999999998654
Q ss_pred --CeEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 92 --THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 92 --~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
...++|+||+++++|.+++.... .++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCccc
Confidence 45899999999999999997754 4999999999999999999999999999999999999988776 999999998
Q ss_pred cccccCCC----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 169 KSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 169 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
........ .....++..|+|||.+.+..++.++||||||+++++|++|.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 214 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 214 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcc
Confidence 75433322 12234566799999999989999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=265.99 Aligned_cols=194 Identities=29% Similarity=0.448 Sum_probs=173.4
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---------CHHHHHHHHHHHhC-CCCcEeEEEEEEEcCC
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------DENVQREIINHRSL-RHPNIVRFKEVILTPT 92 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 92 (219)
++|++.+.||+|++|.||++.+..+|+.||+|++...... .+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 6799999999999999999999989999999998754321 24567899999988 7999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
..++++||+++++|.+++.....++...+..++.|++.+|.+||+.|++|+||+|+||++++++. ++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999988888999999999999999999999999999999999999988876 9999999987665
Q ss_pred cCCCCCCCCCCCCCCCchhhcc------ccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLR------HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 5555556678999999999863 357889999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=262.61 Aligned_cols=205 Identities=23% Similarity=0.279 Sum_probs=172.6
Q ss_pred CCCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEE--EEEEeccC--cccCHHHHHHHHHHHhC-CCCcEeEEEE
Q 027738 12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKE 86 (219)
Q Consensus 12 ~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v--~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 86 (219)
+....-+..+.++|++.+.||+|++|.||++.+..++..+ ++|.+... ....+.+.+|+.+++++ +||||+++++
T Consensus 14 ~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 93 (327)
T 1fvr_A 14 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 93 (327)
T ss_dssp --CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred CCCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhce
Confidence 3333444466789999999999999999999998888755 88988643 22346688999999999 8999999999
Q ss_pred EEEcCCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCE
Q 027738 87 VILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150 (219)
Q Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~ni 150 (219)
++...+..++++||+++++|.+++...+ .++..+++.++.|++.+|.+||++|++|+||||+||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 173 (327)
T 1fvr_A 94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 173 (327)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred eeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceE
Confidence 9999999999999999999999997654 689999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CCC
Q 027738 151 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PND 218 (219)
Q Consensus 151 li~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~~ 218 (219)
+++.++. ++|+|||++.............+++.|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus 174 l~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 240 (327)
T 1fvr_A 174 LVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240 (327)
T ss_dssp EECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred EEcCCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCC
Confidence 9987776 99999999875444444444567789999999998889999999999999999998 653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=260.20 Aligned_cols=198 Identities=26% Similarity=0.375 Sum_probs=168.3
Q ss_pred CCccceee-ccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEE
Q 027738 21 DSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 21 ~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 97 (219)
..++|++. +.||+|++|.||++.+..+++.||+|++...... .+.+.+|+..+.++ +||||+++++++..++..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45789986 7899999999999999999999999999765433 46788999999885 799999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeecccccccccCC-
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~dfg~a~~~~~~~- 175 (219)
+||+++++|.+.+.....+++.++..++.|++.+|.+||+++++|+||||+||+++.++. ..++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999999998888999999999999999999999999999999999999986653 348999999986443221
Q ss_pred -------CCCCCCCCCCCCCchhhcc-----ccccceeeEEEEEEEEeecCCCCC
Q 027738 176 -------QPKSTVGTPAYIAPEVLLR-----HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 -------~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~ 224 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCC
Confidence 1123358899999999975 567899999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=267.85 Aligned_cols=194 Identities=28% Similarity=0.402 Sum_probs=157.3
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCC--eEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLA 95 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~ 95 (219)
.++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+..++.+. ||||+++++++...+ .++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 5789999999999999999999999999999999864322 2355678999999997 999999999998654 689
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~- 174 (219)
+|+||+++ +|...+.. ..++...+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||+++.....
T Consensus 88 lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred EEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence 99999975 88887765 46899999999999999999999999999999999999988876 999999998754221
Q ss_pred ---------------------CCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 175 ---------------------SQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 175 ---------------------~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
.......+++.|+|||.+.+ ..++.++|+|||||+++||++|..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 11123468889999999986 6789999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=256.66 Aligned_cols=197 Identities=39% Similarity=0.611 Sum_probs=167.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+..++.++||||+++++++...+..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 35679999999999999999999999999999999986532 22357889999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+++|++++++|.+++.....++..++..++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC--
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCc
Confidence 99999999999999988888999999999999999999999999999999999999988776 9999999987655444
Q ss_pred CCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..+ +.++|+||||+++++|++|..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 209 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTL 209 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSC
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCC
Confidence 4445568899999999987665 689999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=257.64 Aligned_cols=197 Identities=29% Similarity=0.418 Sum_probs=174.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----------cCHHHHHHHHHHHhCC-CCcEeEEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----------IDENVQREIINHRSLR-HPNIVRFKEVI 88 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----------~~~~~~~e~~~l~~l~-~~~i~~~~~~~ 88 (219)
...++|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 456899999999999999999999999999999999865431 1245678999999996 99999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
..+...++++|++++++|.+++.....++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~ 171 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFS 171 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccch
Confidence 999999999999999999999998888999999999999999999999999999999999999988876 999999998
Q ss_pred cccccCCCCCCCCCCCCCCCchhhc------cccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQPKSTVGTPAYIAPEVLL------RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.............+++.|+|||.+. ...++.++|+||||+++++|++|..
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 227 (298)
T 1phk_A 172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227 (298)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCC
Confidence 7665554455567889999999985 3467889999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=258.90 Aligned_cols=199 Identities=20% Similarity=0.252 Sum_probs=175.7
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
......++|++.+.||+|++|.||++.+..+++.|++|.+.......+.+.+|+.+++.++||||+++++++......++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 34457889999999999999999999999899999999998766666788999999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++|++++++|.+++... ..++...+..++.+++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD 164 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCC
Confidence 99999999999999864 34899999999999999999999999999999999999987776 999999998754432
Q ss_pred CCC--CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 SQP--KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
... ....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~ 210 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 210 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 221 12235678999999998889999999999999999999 54
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=256.62 Aligned_cols=205 Identities=27% Similarity=0.438 Sum_probs=178.5
Q ss_pred CCCCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEE
Q 027738 11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 88 (219)
Q Consensus 11 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (219)
.|.+........+.|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+..++.++|||++++++++
T Consensus 10 ~p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 89 (303)
T 3a7i_A 10 LPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89 (303)
T ss_dssp ---CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 444555556677889999999999999999999999999999999876532 236788999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
......++++||+++++|.+++.. .+++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~ 166 (303)
T 3a7i_A 90 LKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVA 166 (303)
T ss_dssp EETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTC
T ss_pred ecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccc
Confidence 999999999999999999998865 56899999999999999999999999999999999999988776 999999998
Q ss_pred cccccCCC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........ .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (303)
T 3a7i_A 167 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217 (303)
T ss_dssp EECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCC
Confidence 75543322 234568889999999999899999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=265.90 Aligned_cols=193 Identities=25% Similarity=0.443 Sum_probs=164.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEc---------
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--------- 90 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 90 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 456799999999999999999999999999999999865432 23479999999999999999999854
Q ss_pred -----------------------------CCeEEEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH
Q 027738 91 -----------------------------PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHA 137 (219)
Q Consensus 91 -----------------------------~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~ 137 (219)
....++||||+++ +|.+.+. ....++...+..++.|++.+|.+||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3348899999986 6655554 45679999999999999999999999
Q ss_pred CCceeccCCCCCEEecC-CCCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCC
Q 027738 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTS 215 (219)
Q Consensus 138 ~~ivh~dl~p~nili~~-~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~ 215 (219)
.|++|+||||+||+++. ++. ++|+|||+++............+++.|+|||.+.+. .++.++|+||||+++++|++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 99999999999999973 444 999999999876656666667789999999998864 58999999999999999999
Q ss_pred CCC
Q 027738 216 PND 218 (219)
Q Consensus 216 g~~ 218 (219)
|..
T Consensus 238 g~~ 240 (383)
T 3eb0_A 238 GKP 240 (383)
T ss_dssp SSC
T ss_pred CCC
Confidence 875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=253.87 Aligned_cols=194 Identities=24% Similarity=0.388 Sum_probs=168.0
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 97 (219)
.++|++.+.||+|++|.||++.+..+++.|++|++..... ....+.+|+..+..+ +||||+++++++...+..+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 5789999999999999999999999999999999875432 235677888888888 899999999999999999999
Q ss_pred EeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-----------------
Q 027738 98 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP----------------- 156 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~----------------- 156 (219)
+||+++++|.+++... ..+++.++..++.|++.+|.+||+++++|+||||+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999765 5689999999999999999999999999999999999998543
Q ss_pred CCcEEEeecccccccccCCCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 157 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 157 ~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...++|+|||++..... .....+++.|+|||.+.+. .+++++|+||||+++++|++|..
T Consensus 170 ~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 229 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229 (289)
T ss_dssp CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCC
T ss_pred ceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCC
Confidence 22499999999875432 2334588999999999865 66789999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=259.89 Aligned_cols=200 Identities=20% Similarity=0.277 Sum_probs=171.5
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEE
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 88 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (219)
.......++|++.+.||+|++|.||++.+. .+++.|++|++..... ..+.+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 344556789999999999999999999883 3458899999865432 235678999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHAMQVCHRD 144 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------~~~~~~~~~~~~l~~~l~~lh~~~ivh~d 144 (219)
...+..++++||+++++|.+++..... ++..++..++.|++.+|.+||+++++|+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999986543 89999999999999999999999999999
Q ss_pred CCCCCEEecCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 145 l~p~nili~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
|||+||+++.++. ++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 176 ikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 176 LAARNILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CSGGGEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cchheEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999997776 99999999875433222 223345678999999999889999999999999999999 64
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=259.81 Aligned_cols=195 Identities=34% Similarity=0.552 Sum_probs=170.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
..++|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+..++.++||||+++++++......++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 45789999999999999999999999999999999976543 34568899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe---cCCCCCcEEEeecccccccccCCC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili---~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
++++++|.+.+.....+++.++..++.|++.+|.+||+.|++|+||+|+||++ +.++. ++|+|||++...... .
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~-~ 163 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK--IMITDFGLSKMEQNG-I 163 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCC--EEBCSCSTTCCCCCB-T
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCC--EEEccCCcceecCCC-c
Confidence 99999999999888889999999999999999999999999999999999999 44444 999999998643221 2
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 205 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP 205 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 222357899999999999889999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=272.44 Aligned_cols=196 Identities=33% Similarity=0.505 Sum_probs=163.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 5789999999999999999999999999999999865321 12357899999999999999999999865 4
Q ss_pred eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeeccccccc
Q 027738 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSS 171 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~dfg~a~~~ 171 (219)
..++|+||+++++|.+.+.....+++.++..++.|++.+|.+||+++++|+||||+||+++.++. ..++|+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 57899999999999999888888999999999999999999999999999999999999975432 34999999999866
Q ss_pred ccCCCCCCCCCCCCCCCchhhcc---ccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLR---HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 55444455678999999999863 667889999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=263.91 Aligned_cols=197 Identities=22% Similarity=0.294 Sum_probs=169.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECC-------CCcEEEEEEeccCccc--CHHHHHHHHHHHhC-CCCcEeEEEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVI 88 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (219)
....++|++.+.||+|++|.||++.+.. .+..||+|++...... .+.+.+|+++++.+ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 4456899999999999999999999753 2357999998754322 25678999999999 899999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili 152 (219)
...+..++|+||+++++|.+++.... .+++.++..++.|++.+|.+||+.+++|+||||+||++
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 99999999999999999999998654 48999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 153 ~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+.++. ++|+|||+++....... .....+++.|+|||.+.+..++.++||||||+++++|++ |.
T Consensus 225 ~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~ 291 (382)
T 3tt0_A 225 TEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291 (382)
T ss_dssp CTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 88876 99999999875443221 223345678999999999999999999999999999999 54
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=264.28 Aligned_cols=193 Identities=26% Similarity=0.369 Sum_probs=160.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT----- 92 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 92 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 467999999999999999999999999999999998754322 255778999999999999999999998765
Q ss_pred -eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 93 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
..++|+||+++ +|.+.+. ..++...+..++.|++.||.+||++|++|+||||+||+++.++. ++|+|||+++..
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC----
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeeccccc
Confidence 68999999976 7777775 35899999999999999999999999999999999999988876 999999999765
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 224 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 54444455678999999999999889999999999999999999974
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=263.89 Aligned_cols=197 Identities=24% Similarity=0.347 Sum_probs=170.0
Q ss_pred ccCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
....++|++.+.||+|++|.||++.+. .+++.|++|++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 445789999999999999999999987 3458899999875432 235688999999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 027738 92 THLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p 147 (219)
+..++++||+++++|.+++... ..++..+++.++.|++.+|.+||+++++|+||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999999999999763 4689999999999999999999999999999999
Q ss_pred CCEEecCCCCCcEEEeecccccccccCC---CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 148 ENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 148 ~nili~~~~~~~v~l~dfg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 203 ~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 203 RNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp GGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999988776 9999999986543222 2233456788999999998889999999999999999999 64
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=255.01 Aligned_cols=197 Identities=20% Similarity=0.221 Sum_probs=172.4
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+.+|+..++.+ +|++++++++++......++++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 34678999999999999999999999999999999886543 446688899999999 7999999999999999999999
Q ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC---CcEEEeecccccccccC
Q 027738 99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLH 174 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~---~~v~l~dfg~a~~~~~~ 174 (219)
|++ +++|.+++.... +++..++..++.|++.+|.+||+++++|+||||+||+++.++. ..++|+|||++......
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999 889999998654 5999999999999999999999999999999999999976543 23999999999755433
Q ss_pred CC--------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ--------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 216 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCC
Confidence 22 234468999999999999889999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=253.63 Aligned_cols=196 Identities=26% Similarity=0.386 Sum_probs=173.3
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..+.++|++.+.||+|++|.||++.+. +++.|++|++.......+.+.+|+..++.++|||++++++++..++..++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 356789999999999999999999987 6778999999877666678999999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC--C
Q 027738 99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 175 (219)
Q Consensus 99 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~--~ 175 (219)
|++++++|.+++... ..++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccc
Confidence 999999999999765 45899999999999999999999999999999999999987776 999999998754322 1
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
......++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 203 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCC
Confidence 2233456678999999998889999999999999999999 54
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=263.39 Aligned_cols=197 Identities=16% Similarity=0.170 Sum_probs=161.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCC-----CcEEEEEEeccCcc------------cCHHHHHHHHHHHhCCCCcEeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVR 83 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~~K~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~ 83 (219)
..++|++.+.||+|+||.||++.+..+ ++.||+|++..... .......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345999999999999999999998754 57899998865431 1122334455566778999999
Q ss_pred EEEEEEcC----CeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 84 FKEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 84 ~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
+++++... ...+++|||+ +++|.+++... ..++..++..++.|++.+|.+||+++++|+||||+||+++.+...
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99999874 4589999999 88999999775 579999999999999999999999999999999999999833334
Q ss_pred cEEEeecccccccccCCCC--------CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 159 RLKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 159 ~v~l~dfg~a~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.++|+|||+++........ ....+++.|+|||.+.+..++.++||||||+++|||++|..
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 4999999999654333221 22348999999999999889999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=266.33 Aligned_cols=196 Identities=27% Similarity=0.395 Sum_probs=174.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
...++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+.+++.++||||+++++++..++..+++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 45679999999999999999999999999999999987542 2235678999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
+||+++++|.+++.....++...+..++.+++.+|.+||+. +++|+||||+||+++.++. ++|+|||++..... ..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 186 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SM 186 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-cc
Confidence 99999999999999888899999999999999999999996 9999999999999988876 99999999864432 23
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 228 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSC
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 344578999999999999999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=266.02 Aligned_cols=199 Identities=29% Similarity=0.437 Sum_probs=168.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC------cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 4468899999999999999999999999999999998643 2234678899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 027738 94 LAIVMEYASGGELFERICNA----------------------------------------GRFSEDEARFFFQQLISGVS 133 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~----------------------------------------~~~~~~~~~~~~~~l~~~l~ 133 (219)
.++|+||+++++|.+.+... ..+++..++.++.|++.+|.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999888421 11367788899999999999
Q ss_pred HHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-----CCCCCCCCCCCCchhhcc--ccccceeeEEEE
Q 027738 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLR--HEYDGKVYFYSI 206 (219)
Q Consensus 134 ~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~sl 206 (219)
+||+++++|+||||+||+++.++..+++|+|||++........ .....+++.|+|||.+.+ ..++.++|+|||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9999999999999999999877754599999999875433221 234568899999999975 678899999999
Q ss_pred EEEEeecCCCCC
Q 027738 207 TQMSLQSTSPND 218 (219)
Q Consensus 207 g~~~~~~~~g~~ 218 (219)
|+++++|++|..
T Consensus 263 G~il~el~~g~~ 274 (345)
T 3hko_A 263 GVLLHLLLMGAV 274 (345)
T ss_dssp HHHHHHHHHSSC
T ss_pred HHHHHHHHHCCC
Confidence 999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=263.89 Aligned_cols=197 Identities=19% Similarity=0.198 Sum_probs=164.3
Q ss_pred CCccceeeccccCcCceEEEEEEECC---CCcEEEEEEeccCcc------------cCHHHHHHHHHHHhCCCCcEeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVRFK 85 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~ 85 (219)
..++|++.+.||+|++|.||++.+.. ++..+++|+...... ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999999986 778899998865432 223456778888899999999999
Q ss_pred EEEEc----CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEE
Q 027738 86 EVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 86 ~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~ 161 (219)
+++.. ....++++|++ +++|.+++...+.++..++..++.|++.+|.+||+.+++|+||||+||+++.++...++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99988 77899999999 88999999877789999999999999999999999999999999999999887744599
Q ss_pred EeecccccccccCCCC--------CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 162 ICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 162 l~dfg~a~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+|||+++........ ....+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 258 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKL 258 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999754332211 33468999999999999889999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=259.86 Aligned_cols=195 Identities=23% Similarity=0.420 Sum_probs=173.0
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEc--CCeE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHL 94 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~ 94 (219)
.....++|++.+.||+|++|.||++.+..+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.. ....
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 344578999999999999999999999999999999998643 3467899999999997 9999999999998 5678
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++|++++++|...+.. ++..++..++.|++.+|.+||++|++|+||||+||+++.++. .++|+|||+++.....
T Consensus 109 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTT
T ss_pred EEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCC
Confidence 999999999999887754 899999999999999999999999999999999999986663 4999999999866655
Q ss_pred CCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.......++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 229 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCC
Confidence 55566778999999999987 678999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=269.49 Aligned_cols=199 Identities=25% Similarity=0.315 Sum_probs=171.1
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
......++|++.+.||+|++|.||++.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 344567899999999999999999999998999999998865422 224577899999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
++|+||+++++|.+++...+ .++..++..++.|++.||++||+++++|+||+|+||+++.++. ++|+|||+++....
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEAD 265 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCC
Confidence 99999999999999987654 5899999999999999999999999999999999999988776 99999999875332
Q ss_pred CCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 174 HSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 174 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.... ....++..|+|||.+.+..++.++||||||++++||+| |.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~ 313 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGA 313 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 2111 11224567999999998889999999999999999998 54
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=267.76 Aligned_cols=200 Identities=25% Similarity=0.340 Sum_probs=174.0
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC------CCCcEeEEEEEEE
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVIL 89 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~ 89 (219)
.+......+|++.+.||+|+||.||++.+..+++.||+|++.......+.+.+|+.+++.+ .|+|++++++++.
T Consensus 90 ~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 90 VPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp CTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 3444557789999999999999999999999999999999976655556677888888776 4679999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 90 TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
.....++++|++++ +|.+.+.... .++...+..++.|++.+|.+||+.+++|+||||+||+++.++...++|+|||+
T Consensus 170 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999999999964 8888887654 48999999999999999999999999999999999999987765699999999
Q ss_pred ccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 168 a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+.... .......+++.|+|||.+.+..++.++|||||||++|||++|..
T Consensus 249 a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~ 297 (429)
T 3kvw_A 249 SCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297 (429)
T ss_dssp CEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCC
Confidence 86432 33345578899999999999999999999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=265.67 Aligned_cols=200 Identities=21% Similarity=0.314 Sum_probs=169.6
Q ss_pred CcccCCccceeeccccCcCceEEEEEE-----ECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhC-CCCcEeEEEEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVI 88 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (219)
......++|++.+.||+|++|.||++. +..+++.||+|++...... .+.+.+|+.++..+ +||||+++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 344567999999999999999999998 5566789999999754322 25688999999999 789999999999
Q ss_pred EcCCe-EEEEEeccCCCcHHHHHHhcCC----------------------------------------------------
Q 027738 89 LTPTH-LAIVMEYASGGELFERICNAGR---------------------------------------------------- 115 (219)
Q Consensus 89 ~~~~~-~~lv~e~~~~~~L~~~~~~~~~---------------------------------------------------- 115 (219)
...+. .++++||+++++|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 88654 8999999999999999976543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC---CC
Q 027738 116 --------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK 178 (219)
Q Consensus 116 --------------~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~---~~ 178 (219)
++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||+++....... ..
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC-
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhcc
Confidence 889999999999999999999999999999999999987776 99999999875433222 12
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~~ 218 (219)
...+++.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 294 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 294 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCC
Confidence 3346778999999999899999999999999999998 653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=255.74 Aligned_cols=196 Identities=35% Similarity=0.532 Sum_probs=173.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+..++.++||||+++++++...+..++++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 45789999999999999999999999999999999865432 2367889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC---
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~--- 175 (219)
|++++++|.+.+.....++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRER 162 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEEC
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchh
Confidence 99999999999887778999999999999999999999999999999999999988776 9999999987543221
Q ss_pred CCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+..+ +.++|+||||+++++|++|..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 206 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 206 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 2234568889999999987665 778999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=263.79 Aligned_cols=197 Identities=27% Similarity=0.400 Sum_probs=164.8
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT- 92 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 92 (219)
....-.++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 19 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp SEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred ceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 3344578999999999999999999999999999999998654322 356789999999999999999999998763
Q ss_pred -----eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 93 -----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 93 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
.+++++|++ +++|.+.+.. ..+++.++..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~ 174 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGL 174 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTT
T ss_pred cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeec
Confidence 469999999 7799888876 56899999999999999999999999999999999999988776 99999999
Q ss_pred ccccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 168 SKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 168 a~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
++... .......++..|+|||.+.+ ..++.++|+|||||+++||++|..+
T Consensus 175 a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 225 (367)
T 1cm8_A 175 ARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225 (367)
T ss_dssp CEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred ccccc--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 87543 23344578899999999987 6789999999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=263.12 Aligned_cols=194 Identities=27% Similarity=0.481 Sum_probs=162.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.++|++.+.||+|++|.||++.+..+++.||+|++...... ...+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 36899999999999999999999999999999998654322 2244578999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
|+++ +|.+.+...+ .++..++..++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC-------
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCcccc
Confidence 9975 8888777654 5899999999999999999999999999999999999988876 99999999875433222 2
Q ss_pred CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 33467889999999976 668999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=273.94 Aligned_cols=198 Identities=19% Similarity=0.248 Sum_probs=174.6
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
.....++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.+++.++||||+++++++......++|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 34457789999999999999999999998899999999987666668899999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 98 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+||+++++|.+++... ..++...+..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||+++......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDT 372 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCc
Confidence 9999999999999764 35899999999999999999999999999999999999987776 9999999987543221
Q ss_pred C--CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 176 Q--PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 176 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
. .....++..|+|||.+.+..++.++||||||++++||++ |.
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~ 417 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 417 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCC
Confidence 1 122345678999999998889999999999999999999 54
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=261.63 Aligned_cols=197 Identities=24% Similarity=0.301 Sum_probs=171.1
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
....++|++.+.||+|++|.||++.+. +++.|++|++..... ..+.+.+|+..++.++||||+++++++...+..+++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 345689999999999999999999975 688999998865433 236788999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 98 MEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+||+++++|.+++.... .++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTE 191 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeeccccccccc
Confidence 99999999998886543 4899999999999999999999999999999999999988776 99999999875432
Q ss_pred CCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~ 239 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCT
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCC
Confidence 222 122347889999999998889999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=263.79 Aligned_cols=200 Identities=27% Similarity=0.408 Sum_probs=163.6
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc------cCHHHHHHHHHHHhCCCCcEeEEEEEEE
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVIL 89 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (219)
..+....++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 3 l~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (346)
T 1ua2_A 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG 82 (346)
T ss_dssp ----------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe
Confidence 3445567899999999999999999999999999999999865321 2356789999999999999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 90 TPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
.....++++||+++ +|...+.... .+++.++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++
T Consensus 83 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a 159 (346)
T 1ua2_A 83 HKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLA 159 (346)
T ss_dssp CTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGG
T ss_pred eCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccc
Confidence 99999999999987 7877776543 5899999999999999999999999999999999999988876 999999998
Q ss_pred cccccCC-CCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHS-QPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 7553322 2334568999999999975 457899999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=265.35 Aligned_cols=198 Identities=20% Similarity=0.249 Sum_probs=166.9
Q ss_pred cCCccceeeccccCcCceEEEEEE-----ECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
...++|++.+.||+|+||.||++. +..+++.||+|++..... ....+.+|+.+++.++||||+++++++....
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 346889999999999999999999 445678899999865322 2346788999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEee
Q 027738 93 HLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICD 164 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~d 164 (219)
..++|+||+++++|.+++...+ .++..++..++.|++.+|.+||++|++|+||||+||+++.++. ..++|+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999999997653 4899999999999999999999999999999999999985442 2499999
Q ss_pred cccccccccCC---CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 165 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 165 fg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
||+++...... ......+++.|+|||.+.+..++.++||||||++++||++ |.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 284 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99987433222 2223456889999999999899999999999999999998 54
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=266.90 Aligned_cols=193 Identities=25% Similarity=0.349 Sum_probs=168.3
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-eEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAI 96 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~l 96 (219)
.....++|++.+.||+|+||.||++... ++.||+|++.... ..+.+.+|+.++++++||||+++++++.... ..++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 3456789999999999999999999886 7799999987654 5678999999999999999999999987765 7999
Q ss_pred EEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 97 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
|+||+++++|.+++...+. ++..++..++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||+++....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~- 341 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS- 341 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCcccccc-
Confidence 9999999999999987654 799999999999999999999999999999999999988776 99999999874332
Q ss_pred CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
......++..|+|||.+.+..++.++||||||++++||+| |.
T Consensus 342 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 384 (450)
T 1k9a_A 342 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred -cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 2223356788999999999999999999999999999998 64
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=260.70 Aligned_cols=191 Identities=30% Similarity=0.486 Sum_probs=167.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
.++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999999999999999998754322 24678999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
+||+.| ++.+.+. ....+++.++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||++.... .
T Consensus 133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~---~ 206 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---P 206 (348)
T ss_dssp EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---S
T ss_pred EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecC---C
Confidence 999975 7777664 4567999999999999999999999999999999999999987776 9999999987543 2
Q ss_pred CCCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+. +..++.++||||||++++||++|..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 251 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 33457899999999985 5678899999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=254.78 Aligned_cols=196 Identities=26% Similarity=0.422 Sum_probs=168.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...++|++.+.||+|++|.||++.+..+++.|++|.+.... ..+.+.+|+..++.++||||+++++++...+..++++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 45678999999999999999999999999999999987643 45778999999999999999999999999999999999
Q ss_pred ccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 100 YASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 100 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
|+++++|.+++. ....++..++..++.+++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCB
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhcccc
Confidence 999999999986 4567999999999999999999999999999999999999988876 99999999865443322 2
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 34468889999999999889999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=261.36 Aligned_cols=210 Identities=28% Similarity=0.423 Sum_probs=172.4
Q ss_pred ccCccCCCCCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEe
Q 027738 5 RASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIV 82 (219)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~ 82 (219)
++.-.......-......++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+
T Consensus 9 ~~~~~~~~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 88 (364)
T 3qyz_A 9 AAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88 (364)
T ss_dssp ------CCBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHhhcceEEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCc
Confidence 3334444444445555678999999999999999999999999999999998753322 25678999999999999999
Q ss_pred EEEEEEEcC-----CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC
Q 027738 83 RFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (219)
Q Consensus 83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~ 157 (219)
++++++... ...++++|++++ +|.+.+.. ..++..++..++.|++.+|.+||++|++|+||||+||+++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~ 166 (364)
T 3qyz_A 89 GINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 166 (364)
T ss_dssp CCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred cceeEEecCCccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC
Confidence 999999765 368999999975 88888765 46899999999999999999999999999999999999988776
Q ss_pred CcEEEeecccccccccCCC----CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 158 PRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 158 ~~v~l~dfg~a~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++|+|||++........ .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 167 --~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 230 (364)
T 3qyz_A 167 --LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230 (364)
T ss_dssp --EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred --EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCC
Confidence 99999999875543322 233468999999998764 558999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=262.28 Aligned_cols=198 Identities=33% Similarity=0.491 Sum_probs=168.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---------cCHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 346799999999999999999999999999999999865321 12457899999999999999999999877
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC-CcEEEeeccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSK 169 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~-~~v~l~dfg~a~ 169 (219)
+. .++++||+++++|.+.+.....++..++..++.|++.+|.+||+++++|+||+|+||+++.++. ..++|+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 65 8999999999999999988888999999999999999999999999999999999999986542 349999999987
Q ss_pred ccccCCCCCCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHSQPKSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
............+++.|+|||.+. +..++.++|+||||+++|+|++|..
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 543222222335789999999974 4667899999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=252.12 Aligned_cols=200 Identities=20% Similarity=0.280 Sum_probs=172.1
Q ss_pred CCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
.........++|++.+.||+|++|.||++.+. ++..|++|.+.......+.+.+|+.+++.++|||++++++++.. +.
T Consensus 4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 33445567789999999999999999999976 56789999998766666788999999999999999999999864 56
Q ss_pred EEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.++++|++++++|.+++.... .++..++..++.|++.+|.+||++|++|+||+|+||++++++. ++|+|||++...
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLI 159 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccc
Confidence 889999999999999987543 6899999999999999999999999999999999999987776 999999998755
Q ss_pred ccCCC--CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 172 VLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 172 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
..... .....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 208 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTC
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCC
Confidence 43221 223345778999999998889999999999999999999 54
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=268.35 Aligned_cols=198 Identities=20% Similarity=0.283 Sum_probs=171.7
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
.......++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.+++.++||||+++++++. ....+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 345567889999999999999999999986 5677999999876666788999999999999999999999986 56789
Q ss_pred EEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 96 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+|+||+.+++|.+++... ..++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||+++....
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIED 336 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCC
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCC
Confidence 999999999999999754 35899999999999999999999999999999999999988776 99999999875432
Q ss_pred CC--CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 174 HS--QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 174 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.. ......++..|+|||.+....++.++||||||++++||+| |.
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~ 383 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCC
Confidence 21 1222345678999999998889999999999999999999 65
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=257.64 Aligned_cols=196 Identities=15% Similarity=0.123 Sum_probs=169.4
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCC-------cEEEEEEeccCc-ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTK-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~-------~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
...++|++.+.||+|++|.||++.+..++ ..|++|.+.... ...+.+.+|+..++.++||||+++++++..+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 45789999999999999999999988766 469999886543 2346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC------cEEEee
Q 027738 92 THLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKICD 164 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~------~v~l~d 164 (219)
+..++++||+++++|.+++..... ++..++..++.|++.+|.+||+++++|+||||+||+++.++.. .++|+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999999987654 9999999999999999999999999999999999999876642 289999
Q ss_pred cccccccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||++..... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|+.
T Consensus 165 fg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 216 (289)
T 4fvq_A 165 PGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216 (289)
T ss_dssp CCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCC
Confidence 998864321 122346778999999987 778999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=263.06 Aligned_cols=197 Identities=26% Similarity=0.472 Sum_probs=169.3
Q ss_pred cCCccceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEc
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILT 90 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (219)
...++|++.+.||+|+||.||++.+. .+++.||+|++.... ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34589999999999999999999984 478999999986432 2335567889999988 69999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
....++|+||+++++|.+++.....++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||+++.
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKE 208 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCee
Confidence 9999999999999999999998888999999999999999999999999999999999999988776 99999999875
Q ss_pred cccCC--CCCCCCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHS--QPKSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~--~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~ 260 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 43222 2233468999999999985 457889999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=264.35 Aligned_cols=199 Identities=27% Similarity=0.409 Sum_probs=160.4
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe---
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH--- 93 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 93 (219)
......++|++.+.||+|++|.||++.+..+++.||+|++...........+++..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 34456789999999999999999999999999999999987766666777888888899999999999999976433
Q ss_pred ----EEEEEeccCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEecC-CCCCcEEE
Q 027738 94 ----LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDG-SPAPRLKI 162 (219)
Q Consensus 94 ----~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~ivh~dl~p~nili~~-~~~~~v~l 162 (219)
.++++||++++ +...+ .....++...+..++.|++.+|.+|| +.|++|+||||+||+++. ++. ++|
T Consensus 97 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKL 173 (360)
T ss_dssp TCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEE
T ss_pred cceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEE
Confidence 78999999874 43333 34556899999999999999999999 999999999999999986 554 999
Q ss_pred eecccccccccCCCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 163 ~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+|||++.............+++.|+|||.+.+. .++.++||||||+++|+|++|..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~ 230 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999876655555666789999999999764 48999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=258.65 Aligned_cols=202 Identities=26% Similarity=0.398 Sum_probs=172.7
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEE----ECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEE
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVIL 89 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (219)
......+.++|++.+.||+|++|.||++. +..+++.|++|++...... .+.+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY 94 (327)
T ss_dssp --CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence 34455678999999999999999999998 5678899999998765332 356889999999999999999999987
Q ss_pred --cCCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 90 --TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 90 --~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
.....++++||+++++|.+++... ..++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg 172 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFG 172 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGG
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccc
Confidence 455689999999999999999763 45999999999999999999999999999999999999988776 9999999
Q ss_pred cccccccCC----CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++....... ......++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~ 228 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 987543322 1223456777999999998889999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=259.48 Aligned_cols=195 Identities=22% Similarity=0.317 Sum_probs=164.5
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCC--CcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRH--PNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~ 93 (219)
....++|++.+.||+|++|.||++.+. +++.||+|++...... .+.+.+|+.+++.++| +||+++++++.....
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 446788999999999999999999985 6888999998754332 2567889999999986 999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.+++|| +.+++|.+++.....+++.++..++.|++.+|.+||+.+++|+||||+||++++ + .++|+|||+++....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC--
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCc
Confidence 999999 557799999999889999999999999999999999999999999999999963 3 399999999975543
Q ss_pred CCC---CCCCCCCCCCCCchhhcc-----------ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQ---PKSTVGTPAYIAPEVLLR-----------HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 218 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 322 234568999999999865 667889999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=260.17 Aligned_cols=198 Identities=23% Similarity=0.300 Sum_probs=168.7
Q ss_pred cccCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCc--ccCHHHHHHHHHHHhC-CCCcEeEEEEEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 89 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (219)
.....++|++.+.||+|++|.||++.+. .++..|++|++.... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445789999999999999999999972 356789999986532 3357789999999999 8999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 027738 90 TPTHLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~ 146 (219)
..+..++++||+++++|.+++.... .++..++..++.|++.+|.+||+.|++|+|||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997653 27899999999999999999999999999999
Q ss_pred CCCEEecCCCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 147 p~nili~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
|+||+++.++. ++|+|||++......... ....+++.|+|||.+.+..++.++|+||||+++++|+| |.
T Consensus 200 p~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 200 ARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp GGGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred hhhEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 99999987776 999999998755433222 12235678999999998889999999999999999998 64
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=254.12 Aligned_cols=197 Identities=36% Similarity=0.546 Sum_probs=173.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+..++.++||||+++++++......+++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3579999999999999999999999899999999986543 2346788999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~~~~~~~ 176 (219)
+|++++++|.+.+.....++..++..++.|++.+|.+||++|++|+||+|+||+++.++ ...++|+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 99999999999998888899999999999999999999999999999999999997654 23599999999876544433
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+. ++.++|+||||+++++|++|..
T Consensus 180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~ 220 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTP 220 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCC
Confidence 3444577889999998764 8899999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=259.95 Aligned_cols=199 Identities=19% Similarity=0.273 Sum_probs=154.5
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCc---EEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
......++|++.+.||+|++|.||++.+..++. .||+|++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 344567899999999999999999999886664 79999987542 223668899999999999999999999988
Q ss_pred CCeE------EEEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 91 PTHL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 91 ~~~~------~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
.... ++++||+.+++|.+++.... .++..++..++.|++.+|.+||++|++|+||||+||++++++.
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~- 175 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT- 175 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC-
Confidence 7654 99999999999999886543 5899999999999999999999999999999999999988776
Q ss_pred cEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 159 RLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 159 ~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
++|+|||+++........ ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 176 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 237 (323)
T 3qup_A 176 -VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237 (323)
T ss_dssp -EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred -EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCC
Confidence 999999998754333222 22345678999999999899999999999999999999 54
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=263.62 Aligned_cols=201 Identities=22% Similarity=0.307 Sum_probs=162.5
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEEC---CCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEE
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL 89 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (219)
.+......++|++.+.||+|++|.||++.+. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++.
T Consensus 37 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp TTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3444556789999999999999999999876 456779999987542 22356889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 90 TPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
.....++|+||+++++|.+++.... .++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a 194 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLG 194 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccc
Confidence 9999999999999999999997654 6999999999999999999999999999999999999988776 999999998
Q ss_pred cccccCCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 169 KSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 169 ~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+........ ....++..|+|||.+.+..++.++||||||++++|+++ |.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~ 248 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCC
Confidence 754432211 11234668999999998899999999999999999987 64
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=259.35 Aligned_cols=198 Identities=26% Similarity=0.438 Sum_probs=168.1
Q ss_pred CCccceee-ccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEE
Q 027738 21 DSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 21 ~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 95 (219)
..++|.+. +.||+|++|.||++.+..+++.||+|++..... ....+.+|+..++.++ ||||+++++++......+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 46678887 899999999999999999999999999875332 2367889999999885 699999999999999999
Q ss_pred EEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeecccccccc
Q 027738 96 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 172 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~~~ 172 (219)
+|+||+.+++|.+.+... ..+++.++..++.|++.+|.+||++|++|+||||+||+++... ...++|+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999999888543 5699999999999999999999999999999999999998621 2249999999998665
Q ss_pred cCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.........+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 186 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 231 (327)
T 3lm5_A 186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231 (327)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 5544555678999999999999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=259.05 Aligned_cols=197 Identities=20% Similarity=0.272 Sum_probs=162.6
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcE----EEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~----v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
-....++|++.+.||+|++|+||++.+..+++. |++|.+.... ...+.+.+|+.+++.++||||+++++++..+
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 345678999999999999999999998877665 4777765432 3346788999999999999999999999876
Q ss_pred CeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
. .+++++++.+++|.+.+... ..++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||+++.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKL 166 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeE
Confidence 5 77889999999999998764 56999999999999999999999999999999999999988776 99999999875
Q ss_pred cccCCCCC---CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 171 SVLHSQPK---STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 171 ~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
........ ...++..|+|||.+.+..++.++||||||+++|||++ |.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 217 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCC
Confidence 43332222 2345678999999999999999999999999999999 65
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=251.23 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=170.9
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEc--
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT-- 90 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 90 (219)
.........|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred hhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 3344566779999999999999999999999999999999865432 23567899999999999999999999875
Q ss_pred --CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEec-CCCCCcEEEeec
Q 027738 91 --PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLD-GSPAPRLKICDF 165 (219)
Q Consensus 91 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--ivh~dl~p~nili~-~~~~~~v~l~df 165 (219)
....++++||+++++|.+++.....++...+..++.|++.+|.+||+.+ ++|+||+|+||+++ +++. ++|+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Df 176 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDL 176 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCT
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeC
Confidence 3568999999999999999998888999999999999999999999999 99999999999997 4554 999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|++..... .......+++.|+|||.+.+ .++.++|+||||+++++|++|..
T Consensus 177 g~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~ 227 (290)
T 1t4h_A 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp TGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccccc-cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCC
Confidence 99864322 22334568899999998864 58899999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=256.87 Aligned_cols=197 Identities=21% Similarity=0.296 Sum_probs=167.9
Q ss_pred ccCCccceeeccccCcCceEEEEEEEC-------CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 88 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (219)
....++|++.+.||+|++|.||++.+. .++..|++|++..... ..+.+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345689999999999999999999975 3567899999875432 235678999999999 899999999999
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili 152 (219)
...+..++|+||+++++|.+++.... .++..++..++.|++.+|.+||+.+++|+||||+||++
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999997654 38999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 153 ~~~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+.++. ++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 191 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 257 (334)
T 2pvf_A 191 TENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257 (334)
T ss_dssp CTTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCC
Confidence 88776 99999999875443221 223345678999999998889999999999999999999 54
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=256.65 Aligned_cols=197 Identities=22% Similarity=0.286 Sum_probs=170.2
Q ss_pred ccCCccceeeccccCcCceEEEEEEE-----CCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEEEc
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 90 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 90 (219)
....++|++.+.||+|++|.||++.+ ..+++.|++|++..... ..+.+.+|+..++.+ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34567999999999999999999985 45678899999875532 236688999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe
Q 027738 91 PTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 152 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili 152 (219)
++..++++||+++++|.+++.... .++..++..++.|++.+|.+||+.+++|+||||+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999997654 38999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 153 DGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 153 ~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+.++. ++|+|||++......... ....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 179 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 179 THGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp ETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 88776 999999998755433221 22335678999999998889999999999999999998 54
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=257.28 Aligned_cols=197 Identities=20% Similarity=0.267 Sum_probs=166.0
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcE----EEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~----v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
....++|++.+.||+|++|.||++.+..+++. +++|.+.... ...+.+.+|+..++.++||||+++++++. ..
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 44678999999999999999999999877765 7777765432 22356678999999999999999999886 45
Q ss_pred eEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
..++++||+.+++|.+.+... ..++...+..++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||+++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCccccc
Confidence 688999999999999998764 46899999999999999999999999999999999999988776 999999999765
Q ss_pred ccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CCC
Q 027738 172 VLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PND 218 (219)
Q Consensus 172 ~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~~ 218 (219)
...... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 216 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCC
Confidence 433222 23356778999999998889999999999999999999 653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=262.38 Aligned_cols=195 Identities=22% Similarity=0.310 Sum_probs=164.8
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCC--CCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLR--HPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 93 (219)
....++|++.+.||+|+||.||++.+.. ++.||+|++...... .+.+.+|+.+++.++ ||||+++++++...+.
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 3445679999999999999999999874 889999998654322 356789999999996 4999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++||| +.+++|.+++.....+++.++..++.|++.+|.+||+.+|+|+||||+||++++ +. ++|+|||+++....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~~--~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM--LKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-SC--EEECCCSSSCCC--
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-Ce--EEEEecCccccccC
Confidence 999999 567899999998888999999999999999999999999999999999999953 43 99999999976543
Q ss_pred CCC---CCCCCCCCCCCCchhhcc-----------ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQ---PKSTVGTPAYIAPEVLLR-----------HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~ 265 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCC
Confidence 322 234568999999999875 367889999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=252.42 Aligned_cols=197 Identities=24% Similarity=0.370 Sum_probs=162.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
...++|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+..++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 356799999999999999999999998999999999875332 2356789999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 96 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
+++|++++++|.+++.. ...++..++..++.+++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFF 186 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeee
Confidence 99999999999988864 456899999999999999999999999999999999999987776 999999998654
Q ss_pred ccCCC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..... .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 234 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 33222 233467889999999999889999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=264.09 Aligned_cols=194 Identities=27% Similarity=0.425 Sum_probs=163.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC------Ce
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 93 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 93 (219)
....+|++.+.||+|+||.||++.+..+++.||+|++.... ....+|+++++.++||||+++++++... ..
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 34557999999999999999999999999999999986543 2334799999999999999999998542 23
Q ss_pred EEEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 94 LAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+++++||+++ ++...+. ....++...+..++.|++.+|.|||++||+|+||||+||+++.++. .++|+|||+++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~ 205 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK 205 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhh
Confidence 6799999986 5555443 3457999999999999999999999999999999999999986543 38999999998
Q ss_pred ccccCCCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
............+++.|+|||.+.+. .++.++|||||||++|||++|..
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~ 255 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence 66555555566789999999999764 78999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=250.81 Aligned_cols=196 Identities=29% Similarity=0.343 Sum_probs=159.2
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-----DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..+.++|++.+.||+|++|.||++.+. ++.+++|++...... .+.+.+|+..++.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 346789999999999999999999985 888999998654322 2568899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCCEEecCCC------CCcEEEee
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSP------APRLKICD 164 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---ivh~dl~p~nili~~~~------~~~v~l~d 164 (219)
.++++||+++++|.+.+. ...+++.++..++.|++.+|.+||+++ ++|+||||+||+++... ...++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999988875 457999999999999999999999999 89999999999998631 23499999
Q ss_pred cccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||++...... ......+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 160 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 212 (271)
T 3dtc_A 160 FGLAREWHRT-TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCC
T ss_pred CCcccccccc-cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9998754332 2234568899999999998889999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=258.81 Aligned_cols=202 Identities=29% Similarity=0.433 Sum_probs=153.2
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
..|.....++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++||||+++++++...+
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 4566778899999999999999999999998889999999886532 23456788999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 93 HLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
..++++||+++++|.+++.. ...++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~d 164 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIAD 164 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEe
Confidence 99999999999999998874 345899999999999999999999999999999999999988776 99999
Q ss_pred cccccccccCC------CCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLHS------QPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~~------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||++....... ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 99986443221 1223468899999999976 568899999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=253.04 Aligned_cols=197 Identities=23% Similarity=0.298 Sum_probs=155.2
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC---HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
....++|++.+.||+|++|.||++.+..+++.||+|++....... +.+.++...++.++|||++++++++..++..+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 346789999999999999999999999999999999986543222 22344555577889999999999999999999
Q ss_pred EEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 96 IVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
+++||+++ +|.+.+. ....+++.++..++.|++.+|.+||++ |++|+||||+||+++.++. ++|+|||++..
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGY 159 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC-----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCccc
Confidence 99999976 7766654 356799999999999999999999998 9999999999999988776 99999999976
Q ss_pred cccCCCCCCCCCCCCCCCchhh----ccccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVL----LRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........+++.|+|||.+ .+..++.++|+||||+++++|++|..
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 211 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSC
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCC
Confidence 6555555556789999999996 45678899999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=260.04 Aligned_cols=197 Identities=24% Similarity=0.290 Sum_probs=171.0
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
....++|++.+.||+|++|.||++.+. +++.||+|++..... ....+.+|+.+++.++||||+++++++......++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 345789999999999999999999865 688899999875432 23468899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 97 VMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
++||+++++|.+.+.... +++...+..++.|++.+|.+||+. +++|+||||+||+++.++. ++|+|||++.
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~ 182 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK 182 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCE
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCcccc
Confidence 999999999999997643 389999999999999999999999 9999999999999988776 9999999987
Q ss_pred ccccCCC--CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....... .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCC
T ss_pred ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCC
Confidence 5433222 233458999999999998889999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=257.62 Aligned_cols=195 Identities=29% Similarity=0.374 Sum_probs=169.5
Q ss_pred CCccceeeccccCcCceEEEEEEE-CCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCC------cEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~ 93 (219)
..++|++.+.||+|++|.||++.+ ..+++.||+|++.......+.+.+|+.+++.++|+ +++++++++...+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 357999999999999999999998 56789999999976655557788899988887654 59999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC---------------
Q 027738 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--------------- 156 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~--------------- 156 (219)
.++++|++ +++|.+.+.... +++..++..++.|++.+|.+||+++++|+||||+||+++.++
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999999 779999887765 589999999999999999999999999999999999998743
Q ss_pred --CCcEEEeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 157 --APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 157 --~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..+++|+|||++.... .......+++.|+|||.+.+..++.++|+||||++++||++|..
T Consensus 171 ~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp ESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 3349999999987533 23345578999999999999899999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=249.42 Aligned_cols=196 Identities=26% Similarity=0.443 Sum_probs=167.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC--------HHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~--------~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
....++|++.+.||+|++|.||++.+..+++.||+|++....... +.+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 355789999999999999999999999999999999986543221 568899999999999999999999876
Q ss_pred CCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEecCCCCC---cEEEee
Q 027738 91 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAP---RLKICD 164 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--ivh~dl~p~nili~~~~~~---~v~l~d 164 (219)
.. ++++||+++++|.+.+... ..++...+..++.|++.+|.+||+.+ ++|+||||+||+++.++.. .++|+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 65 6899999999998887654 46999999999999999999999999 9999999999999765431 389999
Q ss_pred cccccccccCCCCCCCCCCCCCCCchhhc--cccccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLL--RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||+++... .......+++.|+|||.+. ...++.++|+||||+++|+|++|..
T Consensus 173 fg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 226 (287)
T 4f0f_A 173 FGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226 (287)
T ss_dssp CTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCC
Confidence 99987432 2334457899999999984 5667889999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=264.66 Aligned_cols=194 Identities=25% Similarity=0.373 Sum_probs=166.9
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC--------CCcEeEEEEEEE----
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL---- 89 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~---- 89 (219)
.++|++.+.||+|++|+||++.+..+++.||+|++.......+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 57999999999999999999999999999999999766555577889999998885 778999999998
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCC---------
Q 027738 90 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPA--------- 157 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~--------- 157 (219)
.....++|+|++.+ ++.+.+... ..++..+++.++.|++.||.+||++ |++|+||||+||+++.++.
T Consensus 116 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 55678999999955 565555543 4699999999999999999999998 9999999999999986641
Q ss_pred --------------------------------------CcEEEeecccccccccCCCCCCCCCCCCCCCchhhccccccc
Q 027738 158 --------------------------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199 (219)
Q Consensus 158 --------------------------------------~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 199 (219)
.+++|+|||++..... ......+++.|+|||.+.+..++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCc
Confidence 1499999999875432 334457899999999999988999
Q ss_pred eeeEEEEEEEEeecCCCCC
Q 027738 200 KVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 200 ~~Dv~slg~~~~~~~~g~~ 218 (219)
++||||||+++|+|++|..
T Consensus 273 ~~DiwslG~il~elltg~~ 291 (397)
T 1wak_A 273 PADIWSTACMAFELATGDY 291 (397)
T ss_dssp HHHHHHHHHHHHHHHHSSC
T ss_pred HHHHHHHHHHHHHHhhCCC
Confidence 9999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=252.80 Aligned_cols=199 Identities=24% Similarity=0.286 Sum_probs=167.3
Q ss_pred CcccCCccceeec-cccCcCceEEEEEEE--CCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 17 PIMHDSDRYDFVR-DIGSGNFGVARLMRD--KVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 17 ~~~~~~~~y~~~~-~l~~g~~~~v~~~~~--~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
....+.++|++.+ .||+|++|.||++.+ ..+++.|++|++...... .+.+.+|+..++.++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3445678999998 999999999999954 566788999998754322 35688999999999999999999999 5
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
.+..++++|++++++|.+++.....++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKA 166 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCccee
Confidence 6678999999999999999998888999999999999999999999999999999999999988776 99999999875
Q ss_pred cccCCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CCC
Q 027738 171 SVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PND 218 (219)
Q Consensus 171 ~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~~ 218 (219)
....... ....+++.|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 219 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCC
Confidence 4332221 12235678999999998889999999999999999999 653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=261.84 Aligned_cols=195 Identities=26% Similarity=0.416 Sum_probs=152.8
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC---
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--- 91 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 91 (219)
.+.-.++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 44456899999999999999999999999999999999865432 235677999999999999999999999764
Q ss_pred ---CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 92 ---THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 92 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
...+++++++ +++|.+.+.. ..++..++..++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a 179 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLA 179 (367)
T ss_dssp GGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC----
T ss_pred ccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccc
Confidence 4579999998 5689887765 56999999999999999999999999999999999999988776 999999998
Q ss_pred cccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+.... ......++..|+|||.+.+ ..++.++|+|||||++++|++|..
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 228 (367)
T 2fst_X 180 RHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 75432 2334578899999999987 678999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=251.69 Aligned_cols=196 Identities=25% Similarity=0.336 Sum_probs=162.3
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC-Ce
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-TH 93 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 93 (219)
........++|++.+.||+|++|.||++.+. ++.|++|++.... ..+.+.+|+..++.++|||++++++++... +.
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 3344567899999999999999999999885 8899999886543 457789999999999999999999997654 47
Q ss_pred EEEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.++++|++++++|.+++..... ++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~ 167 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEA 167 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC----
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeeccccccc
Confidence 8999999999999999976543 899999999999999999999999999999999999988776 999999998644
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.. ......+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 212 (278)
T 1byg_A 168 SS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cc--cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCC
Confidence 32 2233456788999999998889999999999999999998 64
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=251.85 Aligned_cols=197 Identities=21% Similarity=0.256 Sum_probs=158.2
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCC---CcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
.....++|++.+.||+|++|.||++.+..+ +..|++|.+..... ..+.+.+|+..++.++||||+++++++. .+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 345678999999999999999999998643 45699998865332 2356789999999999999999999984 46
Q ss_pred eEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
..++++||+++++|.+++.... .++..++..++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYM 166 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECcccccccc
Confidence 6889999999999999997654 6899999999999999999999999999999999999987776 999999998755
Q ss_pred ccCCCC--CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 172 VLHSQP--KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 172 ~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
...... ....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~ 215 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 215 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCC
Confidence 433222 22345678999999998889999999999999999997 54
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=268.87 Aligned_cols=193 Identities=12% Similarity=0.040 Sum_probs=160.7
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHH---HHHhCCCCcEeEEE-------
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREII---NHRSLRHPNIVRFK------- 85 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~---~l~~l~~~~i~~~~------- 85 (219)
...++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+. .++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 34688999999999999999999998899999999986432 22366788994 45555799999988
Q ss_pred EEEEcCCe-----------------EEEEEeccCCCcHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCce
Q 027738 86 EVILTPTH-----------------LAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHAMQVC 141 (219)
Q Consensus 86 ~~~~~~~~-----------------~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~~~~l~~~l~~lh~~~iv 141 (219)
+++...+. .+++|||+ +++|.+++...+.+++ ..+..++.|++.||.+||++|++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 77766542 78999999 5699999987554555 78888999999999999999999
Q ss_pred eccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhccc-----------cccceeeEEEEEEEE
Q 027738 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-----------EYDGKVYFYSITQMS 210 (219)
Q Consensus 142 h~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Dv~slg~~~ 210 (219)
|+||||+||+++.++. ++|+|||+++... .......+ +.|+|||.+.+. .++.++||||||+++
T Consensus 229 HrDikp~NIll~~~~~--~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGG--VFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp CSCCCGGGEEECTTCC--EEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCC--EEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999998876 9999999987532 22334456 999999999887 899999999999999
Q ss_pred eecCCCCC
Q 027738 211 LQSTSPND 218 (219)
Q Consensus 211 ~~~~~g~~ 218 (219)
|||++|..
T Consensus 304 ~elltg~~ 311 (377)
T 3byv_A 304 YWIWCADL 311 (377)
T ss_dssp HHHHHSSC
T ss_pred HHHHHCCC
Confidence 99999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=253.23 Aligned_cols=193 Identities=30% Similarity=0.478 Sum_probs=163.5
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEc-----------
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 90 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------- 90 (219)
.++|++.+.||+|++|.||++.+..+++.|++|++.......+.+.+|+.+++.++|||++++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 468999999999999999999999999999999997655455678899999999999999999998865
Q ss_pred --CCeEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 91 --PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 91 --~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
....++++||+++++|.+++.... .++..+++.++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~ 162 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGL 162 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcc
Confidence 356899999999999999998544 5788999999999999999999999999999999999988776 99999999
Q ss_pred ccccccC---------------CCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCC
Q 027738 168 SKSSVLH---------------SQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 168 a~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g 216 (219)
+...... .......+++.|+|||.+.+. .++.++|+||||+++|+|+++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p 227 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSC
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhc
Confidence 8754321 112234578899999999864 689999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=265.31 Aligned_cols=197 Identities=22% Similarity=0.278 Sum_probs=166.7
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
......++|++.+.||+|+||.||++.+.. +..||+|++.......+.+.+|+.+++.++||||+++++++.. +..++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 344567899999999999999999999874 4679999998766556789999999999999999999999876 67899
Q ss_pred EEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 97 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
|+||+++++|.+++.. ...++..++..++.|++.+|.+||+++++|+||+|+||++++++. ++|+|||+++.....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDN 333 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCC
Confidence 9999999999999964 346899999999999999999999999999999999999987776 999999998754332
Q ss_pred CCC--CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 SQP--KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
... ....++..|+|||.+.+..++.++||||||++++||++ |.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 379 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCC
Confidence 211 22345678999999998889999999999999999999 54
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=255.53 Aligned_cols=195 Identities=29% Similarity=0.386 Sum_probs=164.9
Q ss_pred CCccc-eeeccccCcCceEEEEEE----ECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC--
Q 027738 21 DSDRY-DFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-- 91 (219)
Q Consensus 21 ~~~~y-~~~~~l~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 91 (219)
..++| ++.+.||+|++|+||++. +..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34455 999999999999998775 345788999999876432 235688999999999999999999999874
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
..+++++||+++++|.+++... .++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++...
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAV 184 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEEC
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCccccccc
Confidence 5789999999999999988665 4899999999999999999999999999999999999988876 999999998765
Q ss_pred ccCCC----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..... .....++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~ 235 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCD 235 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 43322 223456778999999999889999999999999999999853
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=260.90 Aligned_cols=198 Identities=26% Similarity=0.405 Sum_probs=166.6
Q ss_pred CCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
.....+...++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++..
T Consensus 33 ~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 112 (371)
T 4exu_A 33 VNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 112 (371)
T ss_dssp ETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred eccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheec
Confidence 3334445568999999999999999999999999999999998764322 3567899999999999999999999988
Q ss_pred CCeE------EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 91 PTHL------AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 91 ~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
.+.. ++++|++.+ +|...+. ..+++.++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|
T Consensus 113 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~D 187 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILD 187 (371)
T ss_dssp CSSSTTCCCCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECS
T ss_pred cCCcccceeEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEe
Confidence 7654 999999974 7877663 34899999999999999999999999999999999999988876 99999
Q ss_pred cccccccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 165 fg~a~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||+++... .......+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 188 fg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 240 (371)
T 4exu_A 188 FGLARHAD--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 240 (371)
T ss_dssp TTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cCcccccc--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 99987543 23344567999999999987 678999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=254.06 Aligned_cols=190 Identities=24% Similarity=0.312 Sum_probs=159.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHh--CCCCcEeEEEEEEEc----CCe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILT----PTH 93 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~~~ 93 (219)
...++|++.+.||+|++|.||++.+ +++.||+|++.... ...+..|.+++.. ++||||+++++++.. ...
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 3467999999999999999999988 58899999986543 3445556666655 789999999998754 345
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEecCCCCCcEEEeec
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------~~~ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
.++++||+++++|.+++.. ..++...+..++.|++.+|.+|| +.+++|+||||+||+++.++. ++|+||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Df 157 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADL 157 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCC
T ss_pred eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeC
Confidence 8999999999999999854 46899999999999999999999 999999999999999988776 999999
Q ss_pred ccccccccCCC-----CCCCCCCCCCCCchhhccc------cccceeeEEEEEEEEeecCCC
Q 027738 166 GYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRH------EYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 166 g~a~~~~~~~~-----~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slg~~~~~~~~g 216 (219)
|+++....... .....+++.|+|||.+.+. .+++++||||||+++|||++|
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 99864433222 2334789999999999876 566899999999999999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=254.93 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=169.8
Q ss_pred CcccCCccceeeccccCcCceEEEEEE----ECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
+.....++|++.+.||+|++|.||++. +..+++.|++|++...... .+.+.+|+..++.++||||+++++++...
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 445567889999999999999999998 4568899999998764332 35688999999999999999999998765
Q ss_pred C--eEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 92 T--HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 92 ~--~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
+ ..++++|++++++|.+++.... .++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcch
Confidence 4 6899999999999999998764 5899999999999999999999999999999999999987776 999999998
Q ss_pred cccccCCC----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
........ .....++..|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~ 246 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC
Confidence 75543322 223345667999999998889999999999999999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=252.13 Aligned_cols=197 Identities=25% Similarity=0.422 Sum_probs=166.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
...++|++.+.||+|++|.||++.+..+++.+++|++..... ..+.+.+|+..++.++||||+++++++...+..++++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 356899999999999999999999999999999999865433 3467889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CC
Q 027738 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (219)
Q Consensus 99 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~ 176 (219)
||+++++|.+++.. ...++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccc
Confidence 99999999988865 456999999999999999999999999999999999999987776 999999987532211 22
Q ss_pred CCCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+. +..++.++|+||||+++++|++|..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 220 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCC
Confidence 33456888999999984 5677889999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=259.68 Aligned_cols=195 Identities=24% Similarity=0.334 Sum_probs=158.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc------------CHHHHHHHHHHHhCCCCcEeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFKEV 87 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (219)
...++|++.+.||+|++|.||++.+.. ++.||+|++...... .+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 346899999999999999999999864 889999988543211 1668899999999999999999999
Q ss_pred EEc-----CCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEE
Q 027738 88 ILT-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 88 ~~~-----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~ 161 (219)
+.. ....++++|++++ +|.+.+... ..++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--IT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EE
T ss_pred EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EE
Confidence 854 3368999999985 777777654 36999999999999999999999999999999999999988776 99
Q ss_pred EeecccccccccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 162 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 162 l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+|||++.............+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 999999975555555555678889999999986 678999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=255.54 Aligned_cols=198 Identities=21% Similarity=0.271 Sum_probs=169.6
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCc-----EEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 89 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 89 (219)
.....++|++.+.||+|++|.||++.+..+++ .|++|.+..... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34557899999999999999999999876554 799998865432 235678999999999 8999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC
Q 027738 90 TPTHLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~ 155 (219)
..+..++++||+++++|.+++... ..++..++..++.|++.+|.+||+.+++|+||||+||+++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999999999988653 357999999999999999999999999999999999999877
Q ss_pred CCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 156 PAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 156 ~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+. ++|+|||++......... ....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 201 ~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 264 (333)
T 2i1m_A 201 HV--AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 264 (333)
T ss_dssp GE--EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred Ce--EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCC
Confidence 76 999999998754433221 22345678999999998889999999999999999998 54
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=260.55 Aligned_cols=192 Identities=26% Similarity=0.395 Sum_probs=160.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC------eE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~ 94 (219)
...+|++.+.||+|+||.||++.+..+++ +++|++..... ...+|+.+++.++||||+++++++.... ..
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 45689999999999999999999986666 78787754332 2246899999999999999999996543 37
Q ss_pred EEEEeccCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec-CCCCCcEEEeecccccc
Q 027738 95 AIVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS 170 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~-~~~~~~v~l~dfg~a~~ 170 (219)
++|+||++++.+.... .....++...++.++.|++.||.|||+.|++|+||||+||+++ .++. ++|+|||+++.
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~ 191 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKI 191 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCccc
Confidence 8999999875443322 2355799999999999999999999999999999999999998 4554 99999999987
Q ss_pred cccCCCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........+++.|+|||.+.+. .++.++|+|||||++|||++|..
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 240 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP 240 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 6555556667789999999999764 58999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=259.75 Aligned_cols=193 Identities=12% Similarity=0.097 Sum_probs=165.6
Q ss_pred CCccceeeccccCcCceEEEEEEECC--------CCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeE---------
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR--------- 83 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~--------~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~--------- 83 (219)
..++|++.+.||+|++|.||++.+.. +++.||+|++... +.+.+|+.+++.++|||+++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 46899999999999999999999987 4788999988643 46788999999999988776
Q ss_pred ------EEEEEEc-CCeEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC
Q 027738 84 ------FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (219)
Q Consensus 84 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~ 154 (219)
+++++.. ....++++||+ +++|.+++... ..++..++..++.|++.+|.+||+++++|+||||+||+++.
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 6777776 67889999999 88999999876 67999999999999999999999999999999999999998
Q ss_pred CCCCcEEEeecccccccccCCC--------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 155 SPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 155 ~~~~~v~l~dfg~a~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++..+++|+|||+++....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 7633499999999975443322 123468899999999999899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=253.71 Aligned_cols=197 Identities=31% Similarity=0.505 Sum_probs=167.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEc--CCeE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHL 94 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 94 (219)
...++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++||||+++++++.. +...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 457899999999999999999999999999999999875432 23567899999999999999999998854 5679
Q ss_pred EEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEecCCCCCcEEEeec
Q 027738 95 AIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~-----ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
++++||+++++|.+++... ..++..+++.++.|++.+|.+||+.+ ++|+||+|+||+++.++. ++|+||
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~df 160 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDF 160 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecC
Confidence 9999999999999998753 24899999999999999999999999 999999999999988776 999999
Q ss_pred ccccccccCCC-CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|++........ .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 214 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99865432211 112357889999999998889999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=253.63 Aligned_cols=202 Identities=21% Similarity=0.269 Sum_probs=164.7
Q ss_pred CCCCcccCCccceeeccccCcCceEEEEEEECCCC----cEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEE
Q 027738 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEV 87 (219)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~----~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~ 87 (219)
..+......++|++.+.||+|++|.||++.+..++ ..|++|.+..... ....+.+|+.+++.++||||++++++
T Consensus 35 ~~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 114 (333)
T 1mqb_A 35 LKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114 (333)
T ss_dssp ---CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 34445667889999999999999999999886543 3599999875432 23467899999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 88 ILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
+...+..++++|++++++|.+++... ..++..++..++.|++.+|.+||+.|++|+||||+||+++.++. ++|+|||
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg 192 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFG 192 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCC
Confidence 99999999999999999999998764 56999999999999999999999999999999999999988776 9999999
Q ss_pred cccccccCCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 167 YSKSSVLHSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 167 ~a~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
++......... ....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 248 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 248 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 98754432211 12234668999999998889999999999999999998 65
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=255.20 Aligned_cols=199 Identities=24% Similarity=0.362 Sum_probs=166.9
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEc----CC
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILT----PT 92 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 92 (219)
+....++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 34567899999999999999999999999999999998865432 34668899999999999999999999873 34
Q ss_pred eEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 93 HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
..++++||+.+++|.+.+.. ...+++.+++.++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~ 181 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSM 181 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSC
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcc
Confidence 78999999999999998875 456999999999999999999999999999999999999988776 999999987
Q ss_pred cccccCCCC----------CCCCCCCCCCCchhhccc---cccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQP----------KSTVGTPAYIAPEVLLRH---EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~~----------~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......... ....+++.|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 244 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSC
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 643221111 112358899999998754 36889999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=246.99 Aligned_cols=194 Identities=24% Similarity=0.227 Sum_probs=165.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEe-EEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e 99 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+.+|+.+++.++|++++ .+..++......++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4679999999999999999999999999999999886543 346788999999999887644 45445567778899999
Q ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec---CCCCCcEEEeecccccccccCC
Q 027738 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 100 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~---~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
|+ +++|.+.+.. ...++..++..++.|++.+|.+||+++++|+||||+||+++ +++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCcccccccc
Confidence 99 8899999874 45699999999999999999999999999999999999994 4554 9999999987554432
Q ss_pred C--------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 Q--------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .....+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 213 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 2 234468999999999999889999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=248.37 Aligned_cols=199 Identities=25% Similarity=0.337 Sum_probs=168.1
Q ss_pred CcccCCccceeec-cccCcCceEEEEEEEC--CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 17 PIMHDSDRYDFVR-DIGSGNFGVARLMRDK--VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 17 ~~~~~~~~y~~~~-~l~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
.+....++|.+.+ .||+|++|.||++.+. .++..|++|++..... ..+.+.+|+..++.++||||+++++++ ..
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 3456678898887 9999999999999864 4677899999876432 236688999999999999999999999 45
Q ss_pred CeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
+..++++|++++++|.+++... ..++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~ 159 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKA 159 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceee
Confidence 6689999999999999998654 45999999999999999999999999999999999999987776 99999999875
Q ss_pred cccCCC----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CCC
Q 027738 171 SVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PND 218 (219)
Q Consensus 171 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~~ 218 (219)
...... .....+++.|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 212 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 533222 122345778999999998889999999999999999998 653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=252.31 Aligned_cols=196 Identities=29% Similarity=0.420 Sum_probs=167.6
Q ss_pred cCCccceeeccccCcCceEEEEEEEC-CCCcEEEEEEeccCc---ccCHHHHHHHHHHHhC---CCCcEeEEEEEEE---
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL--- 89 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~--- 89 (219)
...++|++.+.||+|++|.||++.+. .+++.||+|++.... .....+.+|+..++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34589999999999999999999995 678899999886432 2234566777777655 8999999999987
Q ss_pred --cCCeEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeec
Q 027738 90 --TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 90 --~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
.....++++|++++ +|.+++.... .++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSC
T ss_pred cCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecC
Confidence 45678999999974 9999887654 3899999999999999999999999999999999999988776 999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|++.............+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 99876554444455678999999999998889999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=247.67 Aligned_cols=194 Identities=17% Similarity=0.258 Sum_probs=167.8
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcC--
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP-- 91 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 91 (219)
......++|++.+.||+|++|.||++.+. ++.+++|++...... .+.+.+|+..++.++||||+++++++...
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 34567889999999999999999999986 888999998764322 35678999999999999999999999887
Q ss_pred CeEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 92 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
...++++||+++++|.+++.... .++..++..++.|++.+|.+||+.+ ++|+||+|+||+++.++. ++++|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~ 159 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADV 159 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGS
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccc
Confidence 77899999999999999998765 4899999999999999999999999 999999999999998877 88888887
Q ss_pred ccccccCCCCCCCCCCCCCCCchhhccccccc---eeeEEEEEEEEeecCCCCC
Q 027738 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG---KVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 168 a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Dv~slg~~~~~~~~g~~ 218 (219)
+.. .......+++.|+|||.+.+..++. ++|+||||+++++|++|..
T Consensus 160 ~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 209 (271)
T 3kmu_A 160 KFS----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209 (271)
T ss_dssp CCT----TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred eee----ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 643 2233456788999999998765544 7999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=253.46 Aligned_cols=203 Identities=22% Similarity=0.243 Sum_probs=167.4
Q ss_pred CCCCcccCCccceeeccccCcCceEEEEEEECCC---CcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEE
Q 027738 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 88 (219)
Q Consensus 14 ~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (219)
....+.....+|++.+.||+|++|.||++.+..+ ...+++|.+..... ..+.+.+|+..+++++||||+++++++
T Consensus 16 ~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred hheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 3444566778899999999999999999987533 34589998865332 235678999999999999999999986
Q ss_pred E-cCCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 89 L-TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
. .++..++++||+++++|.+++... ..++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||
T Consensus 96 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg 173 (298)
T 3f66_A 96 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFG 173 (298)
T ss_dssp CCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCG
T ss_pred EcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECccc
Confidence 5 456789999999999999999753 45899999999999999999999999999999999999987776 9999999
Q ss_pred cccccccCCC-----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++........ .....+++.|+|||.+.+..+++++|+||||+++++|++|+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~ 230 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 9875433221 222345678999999998899999999999999999999653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=253.56 Aligned_cols=198 Identities=20% Similarity=0.266 Sum_probs=162.7
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEE----EEEEeccC--cccCHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v----~~K~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
.-....++|++.+.||+|++|.||++.+..+++.+ ++|.+... ....+.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 34456789999999999999999999998777654 66666433 2334678899999999999999999999987
Q ss_pred CCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+. .+++++++.+++|.+++... ..++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||+++
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~ 165 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAK 165 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC--
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCccee
Confidence 65 78889999999999998764 46999999999999999999999999999999999999988776 9999999987
Q ss_pred ccccCCCCC---CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 170 SSVLHSQPK---STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 170 ~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
......... ...+++.|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 217 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 217 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCC
Confidence 543332222 2245668999999999999999999999999999999 65
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=254.37 Aligned_cols=198 Identities=18% Similarity=0.241 Sum_probs=169.5
Q ss_pred CcccCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVIL 89 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (219)
......++|++.+.||+|++|.||++.+. .+++.|++|.+...... ...+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 44556789999999999999999999876 35778999998754322 245789999999999999999999999
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCc
Q 027738 90 TPTHLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR 159 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~ 159 (219)
.+...++++|++++++|.+++... ..++..++..++.|++.+|.+||++|++|+||||+||+++.++.
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~-- 176 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-- 176 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--
Confidence 999999999999999999988753 35689999999999999999999999999999999999988776
Q ss_pred EEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 160 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 160 v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++++|++|
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 236 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhc
Confidence 99999999875433222 1223457789999999988899999999999999999984
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=252.05 Aligned_cols=199 Identities=20% Similarity=0.257 Sum_probs=159.9
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECC---CCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEE
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVIL 89 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (219)
-.+....++|++.+.||+|++|.||++.+.. +++.|++|++...... .+.+.+|+..++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 4455678899999999999999999998764 4568999998754322 255788999999999999999999998
Q ss_pred cCC-----eEEEEEeccCCCcHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 90 TPT-----HLAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 90 ~~~-----~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
... ..++++||+++++|.+++.. ...++..+++.++.|++.+|.+||+++++|+||||+||+++.++.
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~- 185 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT- 185 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC-
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc-
Confidence 765 35999999999999999843 345999999999999999999999999999999999999988776
Q ss_pred cEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 159 ~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++++|+++
T Consensus 186 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 245 (313)
T 3brb_A 186 -VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245 (313)
T ss_dssp -EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred -EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhc
Confidence 99999999875433321 2223467789999999999999999999999999999993
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=253.49 Aligned_cols=197 Identities=25% Similarity=0.360 Sum_probs=170.5
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-------cCHHHHHHHHHHHhCC--CCcEeEEEEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVIL 89 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~ 89 (219)
....++|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+.+++.++ |+|++++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3457889999999999999999999999999999999875432 2245678999999886 599999999999
Q ss_pred cCCeEEEEEeccCC-CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec-CCCCCcEEEeeccc
Q 027738 90 TPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGY 167 (219)
Q Consensus 90 ~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~-~~~~~~v~l~dfg~ 167 (219)
.++..++++|++.+ ++|.+++.....++..++..++.|++.+|.+||+.+++|+||||+||+++ +++. ++|+|||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~ 196 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGS 196 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCcc
Confidence 99999999999975 89999998888899999999999999999999999999999999999998 4444 99999999
Q ss_pred ccccccCCCCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 168 a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+..... .......+++.|+|||.+.+..+ +.++|+||||++++||++|..
T Consensus 197 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 247 (320)
T 3a99_A 197 GALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247 (320)
T ss_dssp CEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence 875442 22334568899999999987665 688999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=266.35 Aligned_cols=197 Identities=22% Similarity=0.278 Sum_probs=170.4
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
......++|++.+.||+|+||.||++.+.. +..||+|++.......+.+.+|+.+++.++|+||+++++++.. ...++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 345667899999999999999999999874 4679999998766566789999999999999999999999876 67899
Q ss_pred EEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
|+||+.+++|.+++... ..++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||+++.....
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDN 416 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCC
Confidence 99999999999999643 45899999999999999999999999999999999999987776 999999998754322
Q ss_pred C--CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 175 S--QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 175 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
. ......++..|+|||.+.+..++.++||||||++++||++ |.
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~ 462 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTC
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 1 1223345678999999998889999999999999999999 54
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=257.86 Aligned_cols=194 Identities=29% Similarity=0.384 Sum_probs=168.4
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CC-----cEeEEEEEEEcCCeEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHLA 95 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~~~~ 95 (219)
.++|++.+.||+|++|+||++.+..+++.||+|++.......+.+..|+.+++.++ |+ +++++++++...+..+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 68999999999999999999999999999999999765544566778888887775 44 4999999999999999
Q ss_pred EEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 96 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
+|+|++++ +|.+.+... ..++...+..++.|++.+|.+|| +.||+|+||||+||+++.+....++|+|||+++..
T Consensus 133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 99999975 898888765 45899999999999999999999 57999999999999997544445999999998754
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .......+++.|+|||.+.+..++.++||||||++++||++|..
T Consensus 212 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 256 (382)
T 2vx3_A 212 G--QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256 (382)
T ss_dssp T--CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred c--cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 3 23345578899999999999899999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=248.44 Aligned_cols=194 Identities=24% Similarity=0.227 Sum_probs=161.3
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeE-EEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~lv~e 99 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++.... ..+.+.+|+.+++.++|++++. +..++......++++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 4578999999999999999999999999999999865543 3456788999999998766554 4445567788899999
Q ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe---cCCCCCcEEEeecccccccccCC
Q 027738 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 100 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili---~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
++ +++|.+.+.. ...++..++..++.|++.+|.+||+.+++|+||||+||++ +.++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcc
Confidence 99 8899999874 4569999999999999999999999999999999999999 55555 9999999987554332
Q ss_pred C--------CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 Q--------PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 213 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 213 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCC
Confidence 2 224468899999999999899999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=246.92 Aligned_cols=197 Identities=27% Similarity=0.415 Sum_probs=166.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
...++|.....||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++||||+++++++...+..++++
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 344455556699999999999999999999999999876543 3467889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC-CCCCcEEEeecccccccccC
Q 027738 99 EYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~-~~~~~v~l~dfg~a~~~~~~ 174 (219)
|++++++|.+++.... .++...+..++.|++.+|.+||+.+++|+||+|+||+++. ++. ++|+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGI 176 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC-
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCC
Confidence 9999999999987652 4678899999999999999999999999999999999986 554 999999998754332
Q ss_pred C-CCCCCCCCCCCCCchhhccc--cccceeeEEEEEEEEeecCCCCC
Q 027738 175 S-QPKSTVGTPAYIAPEVLLRH--EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~-~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ......+++.|+|||.+.+. .++.++|+||||+++++|++|..
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSC
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 2 23345688899999999764 37889999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=247.59 Aligned_cols=197 Identities=20% Similarity=0.220 Sum_probs=164.6
Q ss_pred ccCCccceeeccccCcCceEEEEEEECC---CCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
....++|++.+.||+|++|.||++.+.. ++..|++|.+..... ..+.+.+|+..++.++||||+++++++..+ .
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence 4467899999999999999999998653 344699998875432 236688999999999999999999998654 5
Q ss_pred EEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
.++++|++++++|.+.+.... .++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIE 164 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC-
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccc
Confidence 689999999999999997654 5999999999999999999999999999999999999988776 9999999987544
Q ss_pred cCCC--CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CCC
Q 027738 173 LHSQ--PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PND 218 (219)
Q Consensus 173 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~~ 218 (219)
.... .....+++.|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~ 213 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCC
Confidence 3322 123345678999999998889999999999999999998 653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=254.34 Aligned_cols=199 Identities=21% Similarity=0.310 Sum_probs=168.6
Q ss_pred CcccCCccceeeccccCcCceEEEEEEE-----CCCCcEEEEEEeccCccc--CHHHHHHHHHHHhC-CCCcEeEEEEEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVI 88 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (219)
......++|++.+.||+|++|.||++.+ ..+++.|++|++...... .+.+.+|+..++.+ +||||+++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 3445678999999999999999999985 356788999998764322 34678999999999 689999999998
Q ss_pred EcCC-eEEEEEeccCCCcHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 027738 89 LTPT-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (219)
Q Consensus 89 ~~~~-~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nil 151 (219)
...+ ..++++||+++++|.+++..... ++..++..++.|++.+|.+||+.+++|+||||+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 8755 58999999999999999987654 789999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 152 LDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 152 i~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
++.++. ++|+|||++......... ....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 181 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 181 LSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp ECGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ECCCCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 987776 999999998754332221 12345778999999999889999999999999999998 54
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=259.67 Aligned_cols=194 Identities=23% Similarity=0.240 Sum_probs=167.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCC-CcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 99 (219)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+..|+.+++.++| ++++.+..++......++++|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 3579999999999999999999999999999999876543 34568889999999986 667777777788889999999
Q ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEe---cCCCCCcEEEeecccccccccCC
Q 027738 100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 100 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili---~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
|+ +++|.+++.. ...++..+++.++.|++.+|.|||+++|+|+||||+|||+ +.++. ++|+|||+++......
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCc
Confidence 99 8899999975 4579999999999999999999999999999999999999 45554 9999999997654433
Q ss_pred CC--------CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 QP--------KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~--------~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. ....+++.|+|||.+.+..++.++||||||+++|||++|..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~ 211 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSL 211 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 22 24568999999999999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=256.61 Aligned_cols=193 Identities=25% Similarity=0.279 Sum_probs=157.2
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHH--HHhCCCCcEeEEEEEEEc-----
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIIN--HRSLRHPNIVRFKEVILT----- 90 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~----- 90 (219)
.....++|++.+.||+|++|.||++.. +++.||+|++..... ..+..|.++ +..++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 345678999999999999999999977 588999999865432 333334444 445799999999986543
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCCEEecCCCCCcEE
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---------QVCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---------~ivh~dl~p~nili~~~~~~~v~ 161 (219)
...+++|+||+++++|.+++.... .+...+..++.|++.+|.+||+. +++|+||||+||+++.++. ++
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~k 160 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CV 160 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EE
T ss_pred CceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EE
Confidence 235789999999999999997654 48899999999999999999999 9999999999999988776 99
Q ss_pred EeecccccccccCC---------CCCCCCCCCCCCCchhhcc-------ccccceeeEEEEEEEEeecCCCC
Q 027738 162 ICDFGYSKSSVLHS---------QPKSTVGTPAYIAPEVLLR-------HEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 162 l~dfg~a~~~~~~~---------~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
|+|||+++...... ......+++.|+|||.+.+ ..++.++||||||+++|||++|.
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 99999997543221 1223468899999999986 46678899999999999999984
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=253.92 Aligned_cols=200 Identities=21% Similarity=0.242 Sum_probs=164.7
Q ss_pred cccCCccceeeccccCcCceEEEEEE-----ECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEc
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 90 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (219)
.....++|++.+.||+|++|.||++. +..+++.|++|.+.... .....+.+|+..++.++||||+++++++..
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 34567899999999999999999998 55678899999986432 223567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEE
Q 027738 91 PTHLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKI 162 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l 162 (219)
....++++||+++++|.+++.... .++..++..++.|++.+|.+||+.+++|+||+|+||+++.++ ...++|
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999998653 389999999999999999999999999999999999998443 234999
Q ss_pred eecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 163 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 163 ~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+|||++........ .....+++.|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 243 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 243 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 99999864432221 223356788999999998889999999999999999998 53
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=250.38 Aligned_cols=200 Identities=28% Similarity=0.372 Sum_probs=160.6
Q ss_pred CCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEE-----
Q 027738 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVIL----- 89 (219)
Q Consensus 16 ~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 89 (219)
.+-....++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|+..++.++|||++++++++.
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 4 IHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp --CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 3444567899999999999999999999999999999998875432 2366789999999999999999999884
Q ss_pred ---------cCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcE
Q 027738 90 ---------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160 (219)
Q Consensus 90 ---------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v 160 (219)
.....++++||+++ +|.+.+.. .+++..++..++.|++.+|.+||++|++|+||||+||+++.++. .+
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~ 160 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL-VL 160 (320)
T ss_dssp CCC----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTT-EE
T ss_pred cccccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC-eE
Confidence 34678999999974 89888854 56899999999999999999999999999999999999974432 39
Q ss_pred EEeecccccccccCCC----CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 161 KICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 161 ~l~dfg~a~~~~~~~~----~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 223 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCC
Confidence 9999999875433211 122346888999999875 678999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=248.24 Aligned_cols=200 Identities=25% Similarity=0.317 Sum_probs=157.7
Q ss_pred CCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEE
Q 027738 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVIL 89 (219)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (219)
....+.....++|++.+.||+|++|.||++.+. ..+++|++...... .+.+.+|+..++.++|||+++++++.
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 344455667889999999999999999999875 34999988654332 25678999999999999999999964
Q ss_pred cCCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 90 TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 90 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
.....++++||+++++|.+.+... ..++..++..++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~ 167 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLA 167 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC--
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceec
Confidence 556789999999999999988543 45899999999999999999999999999999999999988776 999999998
Q ss_pred cccccC---CCCCCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLH---SQPKSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~---~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...... .......+++.|+|||.+. +..++.++|+||||+++++|++|..
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 223 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL 223 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCC
Confidence 644321 1223346899999999997 5667889999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=252.67 Aligned_cols=199 Identities=23% Similarity=0.327 Sum_probs=155.0
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCC-CCcEeEEEEEEE-----
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVIL----- 89 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----- 89 (219)
.+.....+|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+..++.+. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 344556799999999999999999999999999999998855432 2356788999999996 999999999994
Q ss_pred ---cCCeEEEEEeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEecCCCCCcEE
Q 027738 90 ---TPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLK 161 (219)
Q Consensus 90 ---~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~--ivh~dl~p~nili~~~~~~~v~ 161 (219)
....+++++||+. ++|.+++.. ...++..++..++.|++.+|.+||+.+ ++|+||||+||+++.++. ++
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~k 178 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IK 178 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EE
Confidence 3345899999996 588887754 456999999999999999999999999 999999999999988776 99
Q ss_pred EeecccccccccCCCC-------------CCCCCCCCCCCchhh---ccccccceeeEEEEEEEEeecCCCCC
Q 027738 162 ICDFGYSKSSVLHSQP-------------KSTVGTPAYIAPEVL---LRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 162 l~dfg~a~~~~~~~~~-------------~~~~~~~~~~aPE~~---~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+|||++......... ....+++.|+|||.+ .+..++.++||||||+++|+|++|..
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 9999998754332221 134578899999998 46678899999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=248.35 Aligned_cols=200 Identities=25% Similarity=0.312 Sum_probs=167.5
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCc---EEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
.+....-.|++.+.||+|++|.||++.+..+++ .+++|.+..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred EccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 344455577788999999999999998754443 799998875432 235678999999999999999999999876
Q ss_pred CeE-EEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 92 THL-AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 92 ~~~-~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+.. ++++|++.+++|.+.+.. ...++..++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++.
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~ 172 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLAR 172 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSC
T ss_pred CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcc
Confidence 655 999999999999999976 456899999999999999999999999999999999999988776 9999999986
Q ss_pred ccccC-----CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLH-----SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..... .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 226 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCC
Confidence 44322 12233456788999999999999999999999999999999653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=253.14 Aligned_cols=194 Identities=28% Similarity=0.383 Sum_probs=165.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcC-----Ce
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 93 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 46799999999999999999999999999999999865332 234567899999999999999999988764 67
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++++|++++ +|.+.+.. +.++..++..++.|++.+|.+||++|++|+||||+||+++.++. ++|+|||++.....
T Consensus 89 ~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred EEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccc
Confidence 8999999975 88888766 46899999999999999999999999999999999999988776 99999999875432
Q ss_pred CCC-----------CCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQ-----------PKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~-----------~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 221 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCC
Confidence 211 122357889999998864 678999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=257.58 Aligned_cols=194 Identities=21% Similarity=0.345 Sum_probs=170.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC------------------HHHHHHHHHHHhCCCCcE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID------------------ENVQREIINHRSLRHPNI 81 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~------------------~~~~~e~~~l~~l~~~~i 81 (219)
...++|++.+.||+|++|.||++.+ +++.||+|.+....... +.+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999999999 79999999986532211 778999999999999999
Q ss_pred eEEEEEEEcCCeEEEEEeccCCCcHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEe
Q 027738 82 VRFKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLL 152 (219)
Q Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~--~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili 152 (219)
+++++++...+..++|+||+++++|.++ +.. ...++...+..++.|++.+|.+||+ .|++|+||+|+||++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999887 555 5679999999999999999999999 999999999999999
Q ss_pred cCCCCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhccc-cccc-eeeEEEEEEEEeecCCCCC
Q 027738 153 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDG-KVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 153 ~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Dv~slg~~~~~~~~g~~ 218 (219)
+.++. ++|+|||++...... ......++..|+|||.+.+. .++. ++|+||||+++++|++|..
T Consensus 186 ~~~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 250 (348)
T 2pml_X 186 DKNGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250 (348)
T ss_dssp CTTSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 88876 999999998754332 33445688899999999876 6665 8999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=252.68 Aligned_cols=195 Identities=24% Similarity=0.333 Sum_probs=166.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCC-cEEEEEEeccCcccCHHHHHHHHHHHhCCCCc------EeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~~~ 93 (219)
..++|++.+.||+|++|.||++.+..++ +.||+|++.......+.+.+|+.+++.++|++ ++.+.+++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4689999999999999999999998776 68999999765555677888999998887654 8999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC----------------
Q 027738 94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS---------------- 155 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~---------------- 155 (219)
.++++|+++ +++.+.+... ..++..++..++.|++.+|.+||+++++|+||||+||++..+
T Consensus 97 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 97 MCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 999999995 4666666554 369999999999999999999999999999999999999432
Q ss_pred -CCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 156 -PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 156 -~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....++|+|||++.... .......+++.|+|||.+.+..++.++|+||||+++|||++|..
T Consensus 176 ~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp ESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 12349999999987533 23344578999999999999899999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=252.04 Aligned_cols=188 Identities=24% Similarity=0.369 Sum_probs=157.3
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHh--CCCCcEeEEEEEEEcC----CeEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLA 95 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~----~~~~ 95 (219)
.++|++.+.||+|++|.||++.+. ++.||+|++..... .....|.+++.. ++||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 579999999999999999999886 88999999865432 333445555544 4899999999999887 6799
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
+++||+++++|.+++... .++..++..++.|++.+|.+||+. +++|+||||+||+++.++. ++|+|||+
T Consensus 112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~ 188 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 188 (337)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCC
Confidence 999999999999999654 689999999999999999999999 9999999999999988776 99999999
Q ss_pred ccccccCCCC-----CCCCCCCCCCCchhhccccccce------eeEEEEEEEEeecCCC
Q 027738 168 SKSSVLHSQP-----KSTVGTPAYIAPEVLLRHEYDGK------VYFYSITQMSLQSTSP 216 (219)
Q Consensus 168 a~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~------~Dv~slg~~~~~~~~g 216 (219)
+......... ....+++.|+|||.+.+...+.. +|+||||+++|||++|
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 8654332222 24468899999999987665554 8999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=250.63 Aligned_cols=198 Identities=23% Similarity=0.287 Sum_probs=148.9
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc--CHHHHHHHH-HHHhCCCCcEeEEEEEEEcCCeE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREII-NHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
.....++|++.+.||+|++|.||++.+..+++.||+|++...... ...+..|.. .++.++||||+++++++...+..
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 345678999999999999999999999999999999998754322 233445554 66778999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 95 AIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
++++||+++ +|.+.+.. ...++...+..++.+++.+|.+||+. |++|+||+|+||+++.++. ++|+|||++
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~ 173 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGIS 173 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCc
Confidence 999999986 77776653 56789999999999999999999999 9999999999999987776 999999998
Q ss_pred cccccCCCCCCCCCCCCCCCchhh----ccccccceeeEEEEEEEEeecCCCCC
Q 027738 169 KSSVLHSQPKSTVGTPAYIAPEVL----LRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.............+++.|+|||.+ .+..++.++|+||||+++++|++|..
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 765544444445788999999998 45668899999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=248.67 Aligned_cols=194 Identities=28% Similarity=0.398 Sum_probs=162.7
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC-----cccCHHHHHHHHHHHhCCCCcEeEEEEEEE--cCCeE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHL 94 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~ 94 (219)
.++|++.+.||+|++|.||++.+..+++.+++|++... ....+.+.+|+..++.++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 57999999999999999999999999999999998643 223467889999999999999999999984 45578
Q ss_pred EEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 95 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
++++||++++ +.+.+.. ...++..++..++.|++.+|.+||+++++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence 9999999876 6666654 346899999999999999999999999999999999999988776 9999999987543
Q ss_pred cCC---CCCCCCCCCCCCCchhhcccc--ccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHS---QPKSTVGTPAYIAPEVLLRHE--YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~---~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... ......+++.|+|||.+.+.. ++.++|+||||+++++|++|..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 211 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY 211 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCC
Confidence 221 123346889999999997643 4778999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=258.29 Aligned_cols=195 Identities=27% Similarity=0.424 Sum_probs=150.6
Q ss_pred Cccceee-ccccCcCceEEEEEEEC--CCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEc--CCeEEE
Q 027738 22 SDRYDFV-RDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 96 (219)
Q Consensus 22 ~~~y~~~-~~l~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 96 (219)
.+.|++. ++||+|+||.||++.+. .+++.||+|++... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 3567774 47999999999999965 56888999998654 345678899999999999999999999954 668999
Q ss_pred EEeccCCCcHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC--CCCcEEEeec
Q 027738 97 VMEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDF 165 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~--~~~~v~l~df 165 (219)
|+||+.+ +|.+.+... ..+++.+++.++.|++.||.+||+++|+|+||||+||++..+ ....++|+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9999975 777776532 248999999999999999999999999999999999999422 2224999999
Q ss_pred ccccccccC----CCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLH----SQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~----~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+++..... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 234 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCC
Confidence 999754332 12233568999999999987 458999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=248.31 Aligned_cols=192 Identities=30% Similarity=0.442 Sum_probs=160.9
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..+.++|++.+.||+|++|.||++.+. ++.|++|.+... ...+.+.+|+..++.++||||+++++++.+ ..++++
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 356789999999999999999999885 788999988643 344678899999999999999999998774 478999
Q ss_pred eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 99 EYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
||+++++|.+++.... .++...+..++.|++.+|.+||+ ++++|+||||+||+++.++. .++|+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQ 157 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC-----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccc
Confidence 9999999999998655 37899999999999999999999 89999999999999987664 37999999986443
Q ss_pred cCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ......+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 201 (307)
T 2eva_A 158 T--HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred c--ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 2 2233468899999999999899999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=251.14 Aligned_cols=196 Identities=28% Similarity=0.390 Sum_probs=148.0
Q ss_pred ccCCccceeec-cccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEc----CCe
Q 027738 19 MHDSDRYDFVR-DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----PTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~-~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 93 (219)
....++|++.+ .||+|++|.||++.+..+++.||+|++.... ....+....++.++|||++++++++.. +..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 34578999965 5999999999999999999999999986533 222333344567799999999999976 455
Q ss_pred EEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeecccccc
Q 027738 94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 170 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~ 170 (219)
.++|+||+++++|.+++.... .+++.+++.++.|++.+|.+||++|++|+||||+||+++.++ ...++|+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 899999999999999998764 599999999999999999999999999999999999997643 23499999999875
Q ss_pred cccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .......+++.|+|||.+.+..++.++|+||||+++++|++|..
T Consensus 181 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 181 TTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp C-----------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred ccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 432 23344567899999999988889999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=259.64 Aligned_cols=193 Identities=15% Similarity=0.105 Sum_probs=148.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc----cCHHHHHHHHHHHhC--CCCcEeEEE-------EE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL--RHPNIVRFK-------EV 87 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~----~~~~~~~e~~~l~~l--~~~~i~~~~-------~~ 87 (219)
...+|++.+.||+|++|.||++.+..+++.||+|++..... ..+.+.+|+..++.+ +|||+++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 34569999999999999999999999999999999987543 224566775444444 699988755 55
Q ss_pred EEcC-----------------CeEEEEEeccCCCcHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCceec
Q 027738 88 ILTP-----------------THLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHAMQVCHR 143 (219)
Q Consensus 88 ~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~------~~~~~~l~~~l~~lh~~~ivh~ 143 (219)
+... ...++||||++ ++|.+++... ..++...+ ..++.|++.||++||+++++|+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 5433 33799999998 7999999763 23455555 6777999999999999999999
Q ss_pred cCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCCCCCCCchhhcc--ccccceeeEEEEEEEEeecCCCCC
Q 027738 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 144 dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
||||+||+++.++. ++|+|||+++.... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 219 Dikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 219 HFTPDNLFIMPDGR--LMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp TCSGGGEEECTTSC--EEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCHHHEEECCCCC--EEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999998876 99999999875432 1213455689999999987 778999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=255.75 Aligned_cols=195 Identities=24% Similarity=0.321 Sum_probs=168.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-----------CCcEeEEEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL 89 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~ 89 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++.......+.+.+|+..++.++ |+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 467999999999999999999999999999999999765555577888999888776 789999999998
Q ss_pred cCC----eEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCC----CC
Q 027738 90 TPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSP----AP 158 (219)
Q Consensus 90 ~~~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~----~~ 158 (219)
..+ ..++++|++ +++|.+.+... ..++..++..++.|++.+|.+||++ |++|+||||+||+++.++ ..
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 654 789999999 77999988764 4599999999999999999999998 999999999999996433 22
Q ss_pred cEEEeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 159 ~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.++|+|||++..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 233 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233 (373)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 499999999875432 3344578899999999999889999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=247.04 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=159.6
Q ss_pred CCCCCcccCCccceeeccccCcCceEEEEEEECC-CCc--EEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEE
Q 027738 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKV-TKE--LVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFK 85 (219)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~-~~~--~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (219)
..........++|++.+.||+|++|.||++.+.. +++ .|++|++.... ...+.+.+|+..++.++||||++++
T Consensus 8 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (291)
T 1u46_A 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 87 (291)
T ss_dssp ---CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 3344456678899999999999999999998643 333 58999886542 2235678999999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEee
Q 027738 86 EVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD 164 (219)
Q Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~d 164 (219)
+++..+. .++++|++++++|.+.+... ..++..++..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|
T Consensus 88 ~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~D 164 (291)
T 1u46_A 88 GVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGD 164 (291)
T ss_dssp EEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECC
T ss_pred EEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEcc
Confidence 9998765 88999999999999988764 46899999999999999999999999999999999999987776 99999
Q ss_pred cccccccccCCC----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 165 FGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 165 fg~a~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
||++........ .....++..|+|||.+.+..++.++|+||||+++++|++ |.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 222 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999875543322 122345668999999998889999999999999999999 65
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=254.81 Aligned_cols=197 Identities=22% Similarity=0.237 Sum_probs=157.0
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCC---CcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEc-CC
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT-PT 92 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 92 (219)
......|++.+.||+|+||.||++....+ +..+++|.+..... ..+.+.+|+.+++.++||||+++++++.. ++
T Consensus 85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 34556788999999999999999987533 24589998865322 23567899999999999999999998754 45
Q ss_pred eEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
..++++||+++++|.+++.... .++..++..++.|++.+|.+||+++++|+||||+||+++.++. ++|+|||+++..
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~ 242 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDM 242 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC------
T ss_pred CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeeccccccc
Confidence 7899999999999999997654 5889999999999999999999999999999999999988776 999999998754
Q ss_pred ccCCCC-----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 172 VLHSQP-----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 172 ~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
...... ....+++.|+|||.+.+..++.++|+||||+++|||++|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~ 293 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 293 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCc
Confidence 322211 2234567899999999999999999999999999999964
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=244.43 Aligned_cols=191 Identities=28% Similarity=0.329 Sum_probs=163.1
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc-----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (219)
..|...+.||+|++|.||++.+ +++.|++|++.... ...+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 3455568999999999999987 47889999886532 2235688999999999999999999999999999999
Q ss_pred EeccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 98 MEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+||+++++|.+.+.. ..+++...+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKF 186 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSC
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccc
Confidence 999999999998873 345899999999999999999999999999999999999987776 999999998754332
Q ss_pred CC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....+++.|+|||.+.+ .++.++|+||||+++++|++|..
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~ 232 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP 232 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCC
T ss_pred cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCC
Confidence 22 233468899999998865 47889999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=251.60 Aligned_cols=191 Identities=27% Similarity=0.415 Sum_probs=162.4
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe----
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH---- 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 93 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 357899999999999999999999999999999998654322 3567889999999999999999999987654
Q ss_pred --EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 94 --LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 94 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
+++++|++++ +|.+.+.. .++..++..++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC-
T ss_pred eeEEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCC
Confidence 4999999975 78766643 4899999999999999999999999999999999999988776 999999998754
Q ss_pred ccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 177 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 222 (353)
T 3coi_A 177 DA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCC
Confidence 32 2334567889999999986 678899999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=249.61 Aligned_cols=196 Identities=26% Similarity=0.366 Sum_probs=161.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-------cCHHHHHHHHHHHhC----CCCcEeEEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSL----RHPNIVRFKEVI 88 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~l~~l----~~~~i~~~~~~~ 88 (219)
...++|++.+.||+|++|.||++.+..+++.|++|++..... ....+.+|+..++++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 346789999999999999999999999999999999865432 123345788888888 899999999999
Q ss_pred EcCCeEEEEEec-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec-CCCCCcEEEeecc
Q 027738 89 LTPTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFG 166 (219)
Q Consensus 89 ~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~-~~~~~~v~l~dfg 166 (219)
...+..++++|+ +.+++|.+++.....++..++..++.|++.+|.+||+.+++|+||+|+||+++ .++. ++|+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEcc
Confidence 999999999999 78899999999888899999999999999999999999999999999999998 5554 9999999
Q ss_pred cccccccCCCCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++...... ......++..|+|||.+.+..+ +.++|+||||+++++|++|..
T Consensus 186 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 237 (312)
T 2iwi_A 186 SGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237 (312)
T ss_dssp SCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred hhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence 98754432 3344568899999999987665 458999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=245.93 Aligned_cols=201 Identities=24% Similarity=0.312 Sum_probs=152.5
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC---HHHHHHHHHHHhCCCCcEeEEEEEEEcC
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTP 91 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 91 (219)
........++|++.+.||+|++|.||++.+..+++.|++|++....... +.+.++..+++.++||||+++++++..+
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred chhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 3445667889999999999999999999999999999999987653322 2234455567788999999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 92 THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
+..++++||+ +..+...... ...+++..+..++.|++.+|.+||++ |++|+||+|+||+++.++. ++|+|||++.
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~ 173 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISG 173 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC-
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCch
Confidence 9999999999 4455555543 46799999999999999999999996 9999999999999988776 9999999987
Q ss_pred ccccCCCCCCCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHSQPKSTVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
............+++.|+|||.+. +..++.++|+||||+++++|++|..
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred hccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 655444444557899999999995 4567889999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=247.98 Aligned_cols=188 Identities=26% Similarity=0.317 Sum_probs=163.0
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHh--CCCCcEeEEEEEEEcCC----eEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLA 95 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~----~~~ 95 (219)
.++|++.+.||+|++|.||++.+. ++.||+|++... ..+.+.+|.+++.. ++||||+++++++.... ..+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 579999999999999999999984 889999998643 23566778888877 78999999999999876 789
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCCEEecCCCCCcEEEeeccc
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--------~~~ivh~dl~p~nili~~~~~~~v~l~dfg~ 167 (219)
+++||+++++|.+++... .++..++..++.|++.+|.+|| +.+++|+||||+||+++.++. ++|+|||+
T Consensus 117 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~ 193 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 193 (342)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTT
T ss_pred EEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCC
Confidence 999999999999999764 6899999999999999999999 899999999999999988876 99999999
Q ss_pred ccccccCC-----CCCCCCCCCCCCCchhhccc------cccceeeEEEEEEEEeecCCC
Q 027738 168 SKSSVLHS-----QPKSTVGTPAYIAPEVLLRH------EYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 168 a~~~~~~~-----~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slg~~~~~~~~g 216 (219)
+....... ......+++.|+|||.+.+. .++.++|+||||+++|||++|
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 87554333 23445689999999999865 345789999999999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=264.83 Aligned_cols=186 Identities=25% Similarity=0.312 Sum_probs=158.2
Q ss_pred ccccCcCceEEEEEEE--CCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRD--KVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~--~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
+.||+|+||.||++.+ ..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 45678899999875432 23678999999999999999999999875 458899999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC----CC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KS 179 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~----~~ 179 (219)
++|.+++.....+++.++..++.|++.+|.|||+++|+|+||||+||+++.++. ++|+|||+++........ ..
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccC
Confidence 999999998888999999999999999999999999999999999999998776 999999998754333221 12
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
..+++.|+|||.+.+..++.++||||||+++|||++ |.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 235678999999999899999999999999999998 65
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=268.88 Aligned_cols=200 Identities=29% Similarity=0.397 Sum_probs=171.0
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEc------
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT------ 90 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 90 (219)
....++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 334589999999999999999999999899999999886532 223567889999999999999999999765
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC-cEEEeecc
Q 027738 91 PTHLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFG 166 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~-~v~l~dfg 166 (219)
++..++|+||+++++|.+++.... .+++..++.++.+++.+|.+||+.|++|+||+|+||+++.++.. .++|+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 667899999999999999998654 58999999999999999999999999999999999999866542 38999999
Q ss_pred cccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.............+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~ 221 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCC
Confidence 9987665555566678999999999999999999999999999999999964
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=262.89 Aligned_cols=195 Identities=25% Similarity=0.328 Sum_probs=161.2
Q ss_pred CCccceeec-cccCcCceEEEEEEEC--CCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 21 DSDRYDFVR-DIGSGNFGVARLMRDK--VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 21 ~~~~y~~~~-~l~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
..+++.+.+ .||+|+||.||++.+. .++..||+|++.... ...+.+.+|+.+++.++||||+++++++.. +..+
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 345556565 8999999999999875 345679999987643 234678999999999999999999999976 5689
Q ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+|+||+.+++|.+++... ..++..++..++.|++.||.+||+++++|+||||+||+++.++. ++|+|||+++.....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGAD 489 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC--
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCC
Confidence 999999999999998654 45999999999999999999999999999999999999988776 999999999754332
Q ss_pred CCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CCC
Q 027738 175 SQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PND 218 (219)
Q Consensus 175 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~~ 218 (219)
... ....+++.|+|||.+.+..++.++||||||++++||++ |..
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 538 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 221 11234578999999998899999999999999999998 653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=245.02 Aligned_cols=197 Identities=22% Similarity=0.316 Sum_probs=163.9
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCC--CCcEeEEEEEEEcC
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLR--HPNIVRFKEVILTP 91 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 91 (219)
......++|++.+.||+|++|.||++.+. +++.||+|++...... .+.+.+|+..++.++ |+|++++++++...
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 34455778999999999999999999986 5888999998654322 356788999999997 59999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
...++++| +.+++|.+++.....++..++..++.|++.+|.+||+++++|+||+|+||++++ + .++|+|||++...
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQM 176 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC-
T ss_pred CEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccc
Confidence 99999999 557799999998888999999999999999999999999999999999999964 3 4999999998755
Q ss_pred ccCCC---CCCCCCCCCCCCchhhcc-----------ccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQ---PKSTVGTPAYIAPEVLLR-----------HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCC
Confidence 43322 223468899999999875 467889999999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=267.75 Aligned_cols=188 Identities=23% Similarity=0.289 Sum_probs=160.7
Q ss_pred CccceeeccccCcCceEEEEEEECC-CCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe-----
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 93 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 93 (219)
.++|++.+.||+|++|.||++.+.. +++.|++|++..... ..+.+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4899999999999999999999975 789999998865322 23467889999999999999999999987665
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
.++||||+++++|.+.+.. .++..++..++.|++.+|.+||++||+|+||||+||+++.+ .++|+|||+++....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhccc
Confidence 7999999999999887655 68999999999999999999999999999999999999864 399999999875432
Q ss_pred CCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+.. +.++||||||+++++|++|..
T Consensus 234 ---~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~ 274 (681)
T 2pzi_A 234 ---FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLP 274 (681)
T ss_dssp ---CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCC
T ss_pred ---CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCC
Confidence 24557899999999987654 889999999999999998853
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=260.45 Aligned_cols=195 Identities=21% Similarity=0.265 Sum_probs=163.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCC---CcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
...++|++.+.||+|+||.||++.+..+ +..+++|.+..... ..+.+.+|+..++.++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3467899999999999999999998643 45699998765332 2366889999999999999999999985 4568
Q ss_pred EEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
++|+||+++++|.+++.... .++...+..++.|++.||.+||+.+++|+||||+||+++.++. ++|+|||+++....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED 543 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCC
Confidence 99999999999999997654 6899999999999999999999999999999999999998776 99999999875533
Q ss_pred CCCC--CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 174 HSQP--KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 174 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.... ....+++.|+|||.+.+..++.++|+||||++++||++ |.
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~ 590 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 590 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCC
Confidence 3222 12345678999999998889999999999999999997 54
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=246.21 Aligned_cols=196 Identities=23% Similarity=0.353 Sum_probs=162.7
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
......++|++.+.||+|++|.||++.+.. .+++|.+.... ...+.+.+|+..++.++||||+++++++.....
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 344567899999999999999999998863 48999886532 223567789999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
.++++||+++++|.+++...+ .++..++..++.|++.+|.+||+.+++|+||+|+||+++ ++. ++|+|||++....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~--~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK--VVITDFGLFSISG 180 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C--CEECCCSCCC---
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC--EEEeecCCccccc
Confidence 999999999999999997655 689999999999999999999999999999999999997 333 8999999876432
Q ss_pred cC------CCCCCCCCCCCCCCchhhcc---------ccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LH------SQPKSTVGTPAYIAPEVLLR---------HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~------~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .......+++.|+|||.+.+ ..++.++|+||||+++++|++|..
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 241 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 11 11223357788999999974 346889999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=249.82 Aligned_cols=196 Identities=24% Similarity=0.256 Sum_probs=156.4
Q ss_pred CcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEE
Q 027738 17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 17 ~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 95 (219)
.+.....+|++.+.||+|++|+|+. ....+++.||+|++.... ...+.+|+.+++.+ +||||+++++++......+
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 3445566899999999999999764 344578899999986533 23457899999998 7999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC---CCCCcEEEeeccccccc
Q 027738 96 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSS 171 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~---~~~~~v~l~dfg~a~~~ 171 (219)
+++|++++ +|.+.+.... ..+..++..++.|++.||.+||+++++|+||||+||+++. ++..+++|+|||+++..
T Consensus 95 lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 95 IAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred EEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 99999975 8988887654 3566677899999999999999999999999999999953 33335889999998765
Q ss_pred ccCC----CCCCCCCCCCCCCchhhc---cccccceeeEEEEEEEEeecCCC
Q 027738 172 VLHS----QPKSTVGTPAYIAPEVLL---RHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 172 ~~~~----~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
.... ......+++.|+|||.+. ...++.++|||||||+++||+++
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~ 225 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcC
Confidence 4332 223356899999999997 45677899999999999999993
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=233.65 Aligned_cols=168 Identities=14% Similarity=0.064 Sum_probs=148.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccC----HHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++.+.||+|++|.||++.+..+++.||+|++....... +.+.+|+..+..++||||+++++++..++..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 3478999999999999999999999999999999997654433 668899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
||||+++++|.+++... ....++..++.|++.+|.+||++|++|+||||+||++++++. ++|++++.
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~~--------- 175 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPAT--------- 175 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCCC---------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEeccc---------
Confidence 99999999999998543 467788999999999999999999999999999999998877 88874432
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++ .++.++|+||||+++|+|++|..
T Consensus 176 ----------~~-------~~~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 176 ----------MP-------DANPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp ----------CT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred ----------cC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence 22 25788999999999999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=250.67 Aligned_cols=190 Identities=21% Similarity=0.246 Sum_probs=156.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---------cCHHHHHHHHHHHhCC---------CCcE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNI 81 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---------~~~~~~~e~~~l~~l~---------~~~i 81 (219)
...++|++.+.||+|++|.||++++ +++.||+|++..... ..+.+.+|+.+++.++ |||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4568999999999999999999998 589999999975432 1267889999988775 8888
Q ss_pred eEEEEEEE------------------------------cCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHH
Q 027738 82 VRFKEVIL------------------------------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131 (219)
Q Consensus 82 ~~~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (219)
+++.+++. .....++||||++++++.+.+.+ ..+++.+++.++.|++.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 88877753 26789999999999876666644 568999999999999999
Q ss_pred HHHHH-HCCceeccCCCCCEEecCCCC------------------CcEEEeecccccccccCCCCCCCCCCCCCCCchhh
Q 027738 132 VSYCH-AMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192 (219)
Q Consensus 132 l~~lh-~~~ivh~dl~p~nili~~~~~------------------~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~ 192 (219)
|.+|| +++|+|+||||+||+++.++. ..++|+|||+|+.... ....+++.|+|||.+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhh
Confidence 99999 999999999999999987761 1499999999975542 234789999999999
Q ss_pred ccccccceeeEEEEEEE-EeecCCCC
Q 027738 193 LRHEYDGKVYFYSITQM-SLQSTSPN 217 (219)
Q Consensus 193 ~~~~~~~~~Dv~slg~~-~~~~~~g~ 217 (219)
.+.. +.++|||||+++ .+++.+|.
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~ 274 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEY 274 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSC
T ss_pred cCCC-ccceehhhhhCCCCccccccc
Confidence 8766 889999998766 56666654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=244.98 Aligned_cols=192 Identities=24% Similarity=0.261 Sum_probs=151.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.+.|...+.||+|++|+||.+. ..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++..+...++++|+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4556677899999999998754 4578999999886532 35567899999865 899999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-----------CCcEEE
Q 027738 101 ASGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-----------APRLKI 162 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~-------~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-----------~~~v~l 162 (219)
++ ++|.+++...... +...+..++.|++.||.+||+++++|+||||+||+++.++ ...++|
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 5999999765432 2234577999999999999999999999999999997542 335999
Q ss_pred eecccccccccCCCC-----CCCCCCCCCCCchhhcc-------ccccceeeEEEEEEEEeecCC-CC
Q 027738 163 CDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLR-------HEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 163 ~dfg~a~~~~~~~~~-----~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
+|||+++........ ....+++.|+|||.+.+ ..++.++||||||++++||++ |.
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~ 237 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence 999999765433221 23468999999999975 568899999999999999999 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=230.52 Aligned_cols=181 Identities=30% Similarity=0.451 Sum_probs=154.6
Q ss_pred CCCCCcccCCccceee-ccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHH-HhCCCCcEeEEEEEEEc
Q 027738 13 AMDMPIMHDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT 90 (219)
Q Consensus 13 ~~~~~~~~~~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~ 90 (219)
...+......++|.+. +.||+|++|.||++.+..+++.||+|++.. .....+|+..+ +..+||||+++++++..
T Consensus 7 ~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3444555667889988 779999999999999999999999999853 35667788877 66689999999999987
Q ss_pred ----CCeEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEe
Q 027738 91 ----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKIC 163 (219)
Q Consensus 91 ----~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~ 163 (219)
....++++||+++++|.+++.... .++..++..++.|++.+|.+||+++++|+||||+||+++.++ ...++|+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 677899999999999999998754 599999999999999999999999999999999999998732 2349999
Q ss_pred ecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 164 dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|||++.... +..++.++|+||||+++|+|++|..
T Consensus 163 Dfg~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~ 196 (299)
T 3m2w_A 163 DFGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYP 196 (299)
T ss_dssp CCTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCC
Confidence 999875321 3457788999999999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=239.11 Aligned_cols=192 Identities=13% Similarity=0.011 Sum_probs=148.5
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHHHHHHHHhCCC-C----------------
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH-P---------------- 79 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~-~---------------- 79 (219)
....|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+..++.++| +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456888999999999999999999999999999987322 224678899999988876 2
Q ss_pred -----cEeEEEEEEEc-----CCeEEEEEeccCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 027738 80 -----NIVRFKEVILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHAMQVCH 142 (219)
Q Consensus 80 -----~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh 142 (219)
+...+...+.. ...++++++.+ +++|.+++.. ...++...+..++.|++.+|+|||+++|+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 11112222222 22467777766 5688888741 223677889999999999999999999999
Q ss_pred ccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCCCCCCCCCchhh----------ccccccceeeEEEEEEEEee
Q 027738 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----------LRHEYDGKVYFYSITQMSLQ 212 (219)
Q Consensus 143 ~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Dv~slg~~~~~ 212 (219)
+||||+||+++.++. ++|+|||+++..... .....+ +.|+|||.+ .+..++.++||||||+++||
T Consensus 235 rDiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999998887 999999998754333 344456 999999999 55668889999999999999
Q ss_pred cCCCCC
Q 027738 213 STSPND 218 (219)
Q Consensus 213 ~~~g~~ 218 (219)
|++|..
T Consensus 310 lltg~~ 315 (413)
T 3dzo_A 310 IWCADL 315 (413)
T ss_dssp HHHSSC
T ss_pred HHHCCC
Confidence 999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=240.77 Aligned_cols=181 Identities=13% Similarity=0.082 Sum_probs=129.7
Q ss_pred cccCcCceEEEEEEECCCCcEEEEEEeccCc-----------ccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCeEEEE
Q 027738 30 DIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 97 (219)
Q Consensus 30 ~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-----------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 97 (219)
.++.|+.+....++....|+.+++|++.... ...+++.+|+++++++ .|+||+++++++++++..|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4455666655565666678889999986542 1225688999999999 699999999999999999999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-C
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~ 176 (219)
|||++|++|.+.+...++++.. .++.|++.||+|+|++||+||||||+|||+++++. +||+|||+|+...... .
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence 9999999999999998888775 47899999999999999999999999999998876 9999999987543322 2
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
....++|+.|+|||++.+. +..++|+||+|++++++.++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred ccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 2234689999999999764 56779999999999998876
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-29 Score=205.80 Aligned_cols=167 Identities=21% Similarity=0.116 Sum_probs=128.2
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCccc---------CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.+.||+|+||.||++.. .++.+++|........ .+++.+|++++++++||||+++..++......+++|
T Consensus 341 ~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 56899999999999944 4778888876432211 234689999999999999995555555667779999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC-
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~- 177 (219)
||+++++|.+++.. +..++.|++.+|.+||+++|+|+||||+||++++ . ++|+|||+++........
T Consensus 419 E~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~--~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 419 SYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D--LYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp ECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S--EEECCCTTCEECCCHHHHH
T ss_pred ECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e--EEEEECccCEECCCccccc
Confidence 99999999998866 5689999999999999999999999999999987 3 999999999865432211
Q ss_pred -------CCCCCCCCCCCchhhcc--ccccceeeEEEEEE
Q 027738 178 -------KSTVGTPAYIAPEVLLR--HEYDGKVYFYSITQ 208 (219)
Q Consensus 178 -------~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slg~ 208 (219)
....+++.|+|||.+.. ..|+...|+||..+
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl 526 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL 526 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence 23468999999999986 66777788887543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=175.38 Aligned_cols=140 Identities=19% Similarity=0.166 Sum_probs=111.4
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcc-------------------cCHHHHHHHHHHHhCCCCcEeEEEEEE
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFKEVI 88 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (219)
.+.||+|++|.||++.+ .+++.||+|++..... ....+.+|+.+++.++| +++.+++
T Consensus 95 ~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~ 170 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVY 170 (282)
T ss_dssp EEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEE
T ss_pred cCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEE
Confidence 39999999999999999 7899999999864321 13457899999999984 4555544
Q ss_pred EcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccc
Q 027738 89 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168 (219)
Q Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a 168 (219)
.. +..++||||+++++|.+ +. ..+...++.|++.+|.+||+.|++|+||||+||+++ ++. ++|+|||+|
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~DFG~a 239 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIIDFPQS 239 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECCCTTC
T ss_pred ec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEECCCC
Confidence 33 45699999999999987 31 123557999999999999999999999999999999 554 999999998
Q ss_pred cccccCCCCCCCCCCCCCCCchhhcc
Q 027738 169 KSSVLHSQPKSTVGTPAYIAPEVLLR 194 (219)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~aPE~~~~ 194 (219)
+.. ..+.|||.+..
T Consensus 240 ~~~------------~~~~a~e~l~r 253 (282)
T 1zar_A 240 VEV------------GEEGWREILER 253 (282)
T ss_dssp EET------------TSTTHHHHHHH
T ss_pred eEC------------CCCCHHHHHHH
Confidence 632 24678888753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.8e-23 Score=153.11 Aligned_cols=137 Identities=15% Similarity=0.094 Sum_probs=106.4
Q ss_pred cceeeccccCcCceEEEEEEECCCCcE--EEEEEeccCccc-------------------------CHHHHHHHHHHHhC
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKI-------------------------DENVQREIINHRSL 76 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~--v~~K~~~~~~~~-------------------------~~~~~~e~~~l~~l 76 (219)
-|++.+.||+|++|.||++.+..+|+. ||+|++...... ...+.+|+..++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999999667888 999987543111 12578899999988
Q ss_pred CCCc--EeEEEEEEEcCCeEEEEEeccCC-C----cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCC
Q 027738 77 RHPN--IVRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLE 148 (219)
Q Consensus 77 ~~~~--i~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~ivh~dl~p~ 148 (219)
.|++ ++.+++. ...++||||+++ + +|.+.... .++.++..++.|++.+|.+|| +.|++|+||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 7765 3444443 356899999942 3 66554332 235567889999999999999 999999999999
Q ss_pred CEEecCCCCCcEEEeeccccccc
Q 027738 149 NTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 149 nili~~~~~~~v~l~dfg~a~~~ 171 (219)
||++++ . ++|+|||+|...
T Consensus 201 NILl~~--~--~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--K--VYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--S--EEECCCTTCEET
T ss_pred HEEEcC--c--EEEEECcccccC
Confidence 999986 3 999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=5.8e-20 Score=143.34 Aligned_cols=136 Identities=16% Similarity=0.112 Sum_probs=100.1
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---------------C--------HHHHHHHHHHHhCCCCc
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------------D--------ENVQREIINHRSLRHPN 80 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---------------~--------~~~~~e~~~l~~l~~~~ 80 (219)
-|++.++||+|++|.||+|.+. +|+.||+|++...... . -+...|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3889999999999999999986 7899999987532100 0 01235677777775544
Q ss_pred E--eEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC
Q 027738 81 I--VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP 158 (219)
Q Consensus 81 i--~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~ 158 (219)
+ +..++. ...++||||++|.+|.... .......++.|++.+|.++|+.|++||||||.|||+++++..
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 3 333332 1237999999998875432 122456788999999999999999999999999999877632
Q ss_pred --------cEEEeecccccc
Q 027738 159 --------RLKICDFGYSKS 170 (219)
Q Consensus 159 --------~v~l~dfg~a~~ 170 (219)
.+.++||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 278999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1e-14 Score=109.21 Aligned_cols=139 Identities=16% Similarity=0.120 Sum_probs=110.0
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc-ccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEe
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.+.|++...++.|+.+.||++... ++.+++|...... .....+.+|+..++.+. +..++++++++...+..+++||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 457999999998888999999764 6789999876422 22356889999998884 5678899999998889999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA------------------------------------------ 137 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~------------------------------------------ 137 (219)
+++|.++...+. +......++.++..+|..||+
T Consensus 91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999876531 122334678889999999998
Q ss_pred -----------------CCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 138 -----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 138 -----------------~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
..++|||++|.||+++++.. +.++||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE--EEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE--EEEEEchhcc
Confidence 44899999999999975432 5699999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.6e-13 Score=101.18 Aligned_cols=137 Identities=14% Similarity=0.112 Sum_probs=99.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc--EeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~ 98 (219)
....|.+....+.|..+.||++.. .++..+++|+.... ....+..|+..++.+.+.+ +++++.+...++..++++
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 345677655555666789999965 35677999987543 2356788898888875433 677899888888899999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--------------------------------------- 139 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--------------------------------------- 139 (219)
|+++|.++. .. .... ..++.++...|..||+..
T Consensus 95 e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999998883 21 1122 245666777777777643
Q ss_pred -------------------ceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 140 -------------------VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 140 -------------------ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
++|||++|.||+++++.. +.++||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRF--SGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEE--EEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcE--EEEEcchhccc
Confidence 999999999999976532 56999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.43 E-value=8.1e-13 Score=103.24 Aligned_cols=140 Identities=14% Similarity=0.214 Sum_probs=105.2
Q ss_pred eeeccccCcCceEEEEEEECCCCcEEEEEEec--cCc--ccCHHHHHHHHHHHhCCC--CcEeEEEEEEEcC---CeEEE
Q 027738 26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGD--KIDENVQREIINHRSLRH--PNIVRFKEVILTP---THLAI 96 (219)
Q Consensus 26 ~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~--~~~--~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~l 96 (219)
...+.++.|.+..+|++... +..+++|+.. ... .....+.+|..+++.+.. ..+++++.++... +..++
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678888999999998875 4678889765 322 223578889999988863 4578888888776 45899
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------------------------------------- 137 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--------------------------------------- 137 (219)
+||+++|..+.+. ....++..+...++.++...|..||+
T Consensus 119 vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999999877431 12236788889999999999999997
Q ss_pred -------------------CCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 138 -------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 138 -------------------~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
..++|||++|.||++++++...+.++||+.+.
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999987654335899999875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=4.1e-09 Score=78.92 Aligned_cols=140 Identities=17% Similarity=0.192 Sum_probs=95.0
Q ss_pred CccceeeccccCcCc-eEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEe
Q 027738 22 SDRYDFVRDIGSGNF-GVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~-~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 99 (219)
...|+.. .+..|.. ..+|+......+..+++|+-... ....+..|...++.+. +--+++++.++...+..+++|+
T Consensus 24 l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 24 LYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp HTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 3344432 3333444 36899888777778999975432 2356788888888774 3347888999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM----------------------------------------- 138 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~----------------------------------------- 138 (219)
+++|.++.+..... ......+..++...|..||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99998877655432 122233444555555555521
Q ss_pred -----------------CceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 139 -----------------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 139 -----------------~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
.++|||+.|.||++++++. +-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeE--EEEEECccccc
Confidence 2689999999999986543 56999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=7.2e-09 Score=79.12 Aligned_cols=134 Identities=19% Similarity=0.136 Sum_probs=91.1
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCC---cEeEEEEEEE-cCCeEEEEEeccCC
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG 103 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e~~~~ 103 (219)
.+.++.|....+|++ +..+++|+.. .......+..|...++.+.+. .+++++.+.. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 455777888889988 4567889742 222346788999999988642 3667777775 45567899999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------------------------------------------- 138 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--------------------------------------------- 138 (219)
.++...... .++..+...++.++...|..||+.
T Consensus 98 ~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 888653221 234445555555555555555532
Q ss_pred ---------------CceeccCCCCCEEecC---CCCCcEEEeecccccc
Q 027738 139 ---------------QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKS 170 (219)
Q Consensus 139 ---------------~ivh~dl~p~nili~~---~~~~~v~l~dfg~a~~ 170 (219)
.++|+|++|.||++++ ++. .+.++||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcCC
Confidence 3599999999999986 232 247999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.1e-09 Score=83.43 Aligned_cols=136 Identities=17% Similarity=0.127 Sum_probs=97.0
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCc--EeEEEEEEEcCC---eEEEEEecc
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN--IVRFKEVILTPT---HLAIVMEYA 101 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv~e~~ 101 (219)
.+.++.|....+|++. ..+++|+.... .....+.+|...++.+. +.. +++++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4558889989888763 45888975432 23467889999998773 322 455555544333 348899999
Q ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 027738 102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-------------------------------------------- 137 (219)
Q Consensus 102 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-------------------------------------------- 137 (219)
+|.++...... .++..+...++.++...|..||+
T Consensus 99 ~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 99988654332 36788888888888888888886
Q ss_pred --------------CCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 138 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 138 --------------~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
..++|||++|.||+++++....+.++||+.+...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1369999999999998742223789999987643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=1.1e-07 Score=75.02 Aligned_cols=77 Identities=16% Similarity=0.035 Sum_probs=50.1
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEeccCc--------ccCHHHHHHHHHHHhCCC---CcEeEEEEEEEcCCeEE
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------KIDENVQREIINHRSLRH---PNIVRFKEVILTPTHLA 95 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--------~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~~~ 95 (219)
-.+.+|.|..+.+|++....+++.+++|...+.. ...+++..|.+.++.+.. ..+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568899999999999766567789999764321 123456778888876632 345566654 344568
Q ss_pred EEEeccCCCc
Q 027738 96 IVMEYASGGE 105 (219)
Q Consensus 96 lv~e~~~~~~ 105 (219)
++||++++..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999997743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=5.2e-08 Score=75.85 Aligned_cols=81 Identities=9% Similarity=0.092 Sum_probs=55.6
Q ss_pred eeeccc-cCcCceEEEEEEEC--C----CCcEEEEEEeccCc---c-cCHHHHHHHHHHHhCCC---CcEeEEEEEEEcC
Q 027738 26 DFVRDI-GSGNFGVARLMRDK--V----TKELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILTP 91 (219)
Q Consensus 26 ~~~~~l-~~g~~~~v~~~~~~--~----~~~~v~~K~~~~~~---~-~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~ 91 (219)
...+.| +.|....+|++... . ++..+++|+..... . ....+..|...++.+.. ..+++++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 78888899988653 1 15678899765432 1 23567888888887742 3577788877655
Q ss_pred ---CeEEEEEeccCCCcH
Q 027738 92 ---THLAIVMEYASGGEL 106 (219)
Q Consensus 92 ---~~~~lv~e~~~~~~L 106 (219)
+..+++||+++|.++
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.42 E-value=3.2e-06 Score=65.14 Aligned_cols=74 Identities=15% Similarity=0.200 Sum_probs=42.1
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCC--CcEeEEEE------EEEcCCeEEEEEe
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKE------VILTPTHLAIVME 99 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~------~~~~~~~~~lv~e 99 (219)
.+.|+.|....+|++... +..+++|+.... .+.+..|...++.+.. -.+++++. +....+..+++++
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 345666677899998864 345889988652 2344455555554431 12344443 1234567899999
Q ss_pred ccCCCcH
Q 027738 100 YASGGEL 106 (219)
Q Consensus 100 ~~~~~~L 106 (219)
|++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9998643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.34 E-value=2e-06 Score=65.30 Aligned_cols=71 Identities=13% Similarity=0.095 Sum_probs=44.3
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcE-eEEEEEEEcCCeEEEEEecc-CCCc
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE 105 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~-~~~~ 105 (219)
.+.|+.|....+|++ ..+++|+........-+..+|...++.+...++ ++++... ...-+++++|+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 778888999999998 458889776532222234567777766642222 5666543 33356899999 7655
Q ss_pred H
Q 027738 106 L 106 (219)
Q Consensus 106 L 106 (219)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.4e-05 Score=63.57 Aligned_cols=73 Identities=12% Similarity=0.185 Sum_probs=45.0
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEeccC-----cc-----cCHHHHHHHHHHH-hCCCCcEeEEEEEEEcCCeEE
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DK-----IDENVQREIINHR-SLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~-----~~-----~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~ 95 (219)
-.+.++.|....+|++.. +++.+++|...+. +. .+..++.|+..+. ......+++++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 356788899999999964 4677999943211 11 1123344443332 22234567777765 46678
Q ss_pred EEEecc-CC
Q 027738 96 IVMEYA-SG 103 (219)
Q Consensus 96 lv~e~~-~~ 103 (219)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.16 E-value=2.7e-05 Score=59.35 Aligned_cols=76 Identities=18% Similarity=0.120 Sum_probs=58.8
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC---CCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
-.+.|+.|....+|++... +..+++|+.... ....+..|...++.+. ...+++++.+....+..+++|||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE--VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEESS--SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEEC--CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3567888999999999863 667888976532 2456788888887773 35688899998888889999999988
Q ss_pred CcH
Q 027738 104 GEL 106 (219)
Q Consensus 104 ~~L 106 (219)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.8e-05 Score=61.99 Aligned_cols=142 Identities=16% Similarity=0.133 Sum_probs=81.0
Q ss_pred ccceeeccccCcCceEEEEEEECC-------CCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHL 94 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 94 (219)
+..+ .+.+..|-...+|++.... .++.+++|+.-........+.+|..+++.+. +.-.+++++.+..
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---- 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE---- 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence 3344 4556667778889988642 3467999986432223456678888887774 3334667766543
Q ss_pred EEEEeccCCCcHHH----------HH-------Hhc-----CCC--CHHHHHHHHHHHHH-------------------H
Q 027738 95 AIVMEYASGGELFE----------RI-------CNA-----GRF--SEDEARFFFQQLIS-------------------G 131 (219)
Q Consensus 95 ~lv~e~~~~~~L~~----------~~-------~~~-----~~~--~~~~~~~~~~~l~~-------------------~ 131 (219)
.+|+||++|.++.. .+ +.. .+. ...++..+..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 28999998865421 11 111 011 12445555543321 1
Q ss_pred HHH----HHH----CCceeccCCCCCEEecCCC--CCcEEEeeccccc
Q 027738 132 VSY----CHA----MQVCHRDLKLENTLLDGSP--APRLKICDFGYSK 169 (219)
Q Consensus 132 l~~----lh~----~~ivh~dl~p~nili~~~~--~~~v~l~dfg~a~ 169 (219)
+.. |.+ ..++|+|+.+.||+++++. ...+.++||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 322 2589999999999998761 1248999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.94 E-value=1.4e-05 Score=61.11 Aligned_cols=138 Identities=16% Similarity=0.110 Sum_probs=75.4
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc--EeEEEEE------EEcCCeEEEEE
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVM 98 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv~ 98 (219)
-.+.|+.|....+|++... ++ .+++|+.... ...+.+..|..++..+...+ +++++.. ....+..++++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3566777888889998765 33 5888987652 23355667777776664222 3333321 12245678999
Q ss_pred eccCCCcHHH--------------HHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHH---
Q 027738 99 EYASGGELFE--------------RICNA-GRF--------SEDEARFF---------------FQQLISGVSYCHA--- 137 (219)
Q Consensus 99 e~~~~~~L~~--------------~~~~~-~~~--------~~~~~~~~---------------~~~l~~~l~~lh~--- 137 (219)
++++|..+.. .++.. ..+ ....-... ...+-..+..+.+
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998854310 11110 010 10000000 0112333444442
Q ss_pred ----CCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 138 ----MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 138 ----~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
.+++|+|+.+.||+++++.. +.++||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 36999999999999986532 4799999874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.93 E-value=3e-05 Score=59.39 Aligned_cols=75 Identities=9% Similarity=0.058 Sum_probs=47.5
Q ss_pred ccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc--EeEEEEE-----EEcCCeEEEEEecc
Q 027738 29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYA 101 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv~e~~ 101 (219)
..++ |....+|++... +|+.+++|+..+.....+.+..|..+++.+...+ +++++.. ....+..+.+++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3455 677788987654 4567899988654334466777888777664222 3444432 12245668899999
Q ss_pred CCCc
Q 027738 102 SGGE 105 (219)
Q Consensus 102 ~~~~ 105 (219)
+|.+
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00027 Score=54.25 Aligned_cols=138 Identities=14% Similarity=0.102 Sum_probs=69.8
Q ss_pred eccccCcCceE-EEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCC--CcEeEEEEEEEcCCeEEEEEeccCCC
Q 027738 28 VRDIGSGNFGV-ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 28 ~~~l~~g~~~~-v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (219)
.+.|..|.... +|++... +++.+++|...+.. .+.+..|+.+++.+.. -.+++++.+....+ ++++|++++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 34565554443 5566532 35667777543321 1344556666665532 23566776643333 6899998776
Q ss_pred cHHHHHHhc--------------------------CCCCHHHHHH--------HH------------HHHHHHHHHH---
Q 027738 105 ELFERICNA--------------------------GRFSEDEARF--------FF------------QQLISGVSYC--- 135 (219)
Q Consensus 105 ~L~~~~~~~--------------------------~~~~~~~~~~--------~~------------~~l~~~l~~l--- 135 (219)
.+.+.+... ..+....... +. ..+...+..+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 665433211 1122211110 00 0111112222
Q ss_pred ---HHCCceeccCCCCCEEecCCC--CCcEEEeecccccc
Q 027738 136 ---HAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS 170 (219)
Q Consensus 136 ---h~~~ivh~dl~p~nili~~~~--~~~v~l~dfg~a~~ 170 (219)
+...++|||+.+.||+++++. ...+.++||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 134699999999999997641 12489999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.86 E-value=3.9e-05 Score=61.18 Aligned_cols=74 Identities=14% Similarity=0.081 Sum_probs=48.6
Q ss_pred eccccCcCceEEEEEEECC-------CCcEEEEEEeccCcccCHHHHHHHHHHHhCCCC-cEeEEEEEEEcCCeEEEEEe
Q 027738 28 VRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 99 (219)
.+.|+.|....+|++.... .++.+++|+.... ...+.+..|...++.+... -.+++++.+.. .++++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 5667778888999998652 2567899987432 1115566788888777432 23667766542 28899
Q ss_pred ccCCCcH
Q 027738 100 YASGGEL 106 (219)
Q Consensus 100 ~~~~~~L 106 (219)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00022 Score=53.63 Aligned_cols=77 Identities=12% Similarity=0.038 Sum_probs=54.1
Q ss_pred cceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCC---CcEeEEEEEEEcCCeEEEEEe
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRH---PNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~~~lv~e 99 (219)
+..-++.+|.|..+.||+++.. +|+.+++|+...... ....+..|+..++.+.. --+++++.+. ..++++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 4556788899999999999875 788899997654332 23567889998887742 2345565542 2468899
Q ss_pred ccCCCc
Q 027738 100 YASGGE 105 (219)
Q Consensus 100 ~~~~~~ 105 (219)
++.+..
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=7.7e-05 Score=58.20 Aligned_cols=74 Identities=14% Similarity=0.010 Sum_probs=43.5
Q ss_pred eccccCcCceEEEEEEECC--------CCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc-EeEEEEEEEcCCeEEEEE
Q 027738 28 VRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~--------~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~ 98 (219)
.+.++.|....+|++.... .+..+++|+.........+...|...++.+...+ .+++++.+ . -++++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4566777778899998652 1267889977543222223467777777664323 45666554 2 26899
Q ss_pred eccCCCc
Q 027738 99 EYASGGE 105 (219)
Q Consensus 99 e~~~~~~ 105 (219)
+|++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00071 Score=54.36 Aligned_cols=75 Identities=15% Similarity=0.078 Sum_probs=47.8
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc-EeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
.+.|+.|-...+|++.....+..+++|+........-+...|..+++.+...+ .+++++.+. + ..+++|++|.++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCccC
Confidence 45677788889999987643578899987543222122367888888776433 367777763 2 259999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0014 Score=50.58 Aligned_cols=31 Identities=23% Similarity=0.438 Sum_probs=26.0
Q ss_pred CCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 138 ~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
..++|||+.|.||++++++. +.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCee
Confidence 36999999999999986555 89999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0013 Score=52.22 Aligned_cols=75 Identities=13% Similarity=-0.016 Sum_probs=47.6
Q ss_pred eccccCcCceEEEEEEECCC-------CcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEe
Q 027738 28 VRDIGSGNFGVARLMRDKVT-------KELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~-------~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 99 (219)
++.+..|-...+|++..... ++.+++|+........-+..+|..+++.+. +.-.+++++.+. -+.|++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 45666677788999987521 577999986443222223467888777764 333456665432 268899
Q ss_pred ccCCCcH
Q 027738 100 YASGGEL 106 (219)
Q Consensus 100 ~~~~~~L 106 (219)
|++|.++
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.043 Score=43.20 Aligned_cols=30 Identities=37% Similarity=0.586 Sum_probs=23.7
Q ss_pred ceeccCCCCCEEecCC----CCCcEEEeeccccc
Q 027738 140 VCHRDLKLENTLLDGS----PAPRLKICDFGYSK 169 (219)
Q Consensus 140 ivh~dl~p~nili~~~----~~~~v~l~dfg~a~ 169 (219)
++|+|+.+.||++.++ ....+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999532 22349999999985
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.36 E-value=0.0032 Score=45.02 Aligned_cols=96 Identities=14% Similarity=0.030 Sum_probs=58.6
Q ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCCC
Q 027738 104 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181 (219)
Q Consensus 104 ~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~~ 181 (219)
-+|.+.+.. ..+++++++|.++.|++..|..+-. ..-...=..|..|++..+|. |.+.+ ..+ ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------DA 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------cc
Confidence 378888864 4579999999999999999887632 22123344578888988887 54432 100 01
Q ss_pred CCCCCCCchhhccccccceeeEEEEEEEEeecC
Q 027738 182 GTPAYIAPEVLLRHEYDGKVYFYSITQMSLQST 214 (219)
Q Consensus 182 ~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~ 214 (219)
....+.+||... ...+.+.-|||||+++|..+
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHH
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHh
Confidence 122466777763 23356678999999887654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.36 E-value=3.3 Score=29.56 Aligned_cols=83 Identities=16% Similarity=0.097 Sum_probs=58.3
Q ss_pred CCCcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC
Q 027738 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156 (219)
Q Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~ 156 (219)
.+|++ -..+-...+.+.+.++.-++..-+..+. .++..+.++++.+++.... -|...-+|--+.|+|++++.+.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCCC
Confidence 57888 3444467777777777654433334443 3689999999998877444 1234567788999999999888
Q ss_pred CCcEEEeeccc
Q 027738 157 APRLKICDFGY 167 (219)
Q Consensus 157 ~~~v~l~dfg~ 167 (219)
. +++.-.|+
T Consensus 122 ~--p~i~hRGi 130 (219)
T 4ano_A 122 E--PFFLHVGV 130 (219)
T ss_dssp C--EEESCCEE
T ss_pred c--EEEEEcCC
Confidence 7 88887775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.33 E-value=2.3 Score=30.19 Aligned_cols=83 Identities=11% Similarity=0.087 Sum_probs=57.8
Q ss_pred CCCcEeEEEEEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC
Q 027738 77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156 (219)
Q Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~ 156 (219)
.+|++++. .+-...+.+.+.++.-+...=+..+ +..+..+.++++.+++.... |...-+|--++|+|++++.+.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~--~~~~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEE--VNRTRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGG--GGGSSEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHH--HhcCceEEEEecceEEEcCCC
Confidence 58888876 5666667766666654422222223 23688999999999988663 334456778999999999888
Q ss_pred CCcEEEeeccc
Q 027738 157 APRLKICDFGY 167 (219)
Q Consensus 157 ~~~v~l~dfg~ 167 (219)
. +++.--|+
T Consensus 117 ~--p~i~~RGi 125 (215)
T 4ann_A 117 L--PIAKTRGL 125 (215)
T ss_dssp C--EEESCCEE
T ss_pred C--EEEEEccC
Confidence 7 78877665
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 219 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-43 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-42 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-39 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-38 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-14 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 180 bits (458), Expect = 2e-56
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 2/186 (1%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 81
D YD + ++GSG FGV +K T + K+I +D V+ EI L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQV 140
+ + + +++E+ SGGELF+RI + SE E + +Q G+ + H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
H D+K EN + + A +KI DFG + K T T + APE++ R
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 201 VYFYSI 206
++I
Sbjct: 209 TDMWAI 214
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-56
Identities = 54/187 (28%), Positives = 89/187 (47%), Gaps = 6/187 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
D ++ + ++G+GN GV + K + ++A K I E I + RE+ P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ- 139
IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 200 KVYFYSI 206
+ +S+
Sbjct: 183 QSDIWSM 189
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (453), Expect = 1e-55
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 2/195 (1%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIIN 72
+++ H D YD ++G+G FGV + ++ T A K++ + D E V++EI
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 131
LRHP +V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ + H H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 192 LLRHEYDGKVYFYSI 206
+S+
Sbjct: 197 AEGKPVGYYTDMWSV 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-55
Identities = 67/183 (36%), Positives = 104/183 (56%), Gaps = 7/183 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
+ +D V+ +G G +G +L ++VT+E VAVK + +R EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
+V+F + +EY SGGELF+RI E +A+ FF QL++GV Y H + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEY 197
HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L R E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 198 DGK 200
+
Sbjct: 183 HAE 185
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-54
Identities = 59/188 (31%), Positives = 99/188 (52%), Gaps = 7/188 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLRH 78
+ ++ R +G G FG L R+K +K ++A+K + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
PNI+R T + +++EYA G ++ + +F E + +L + +SYCH+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 199 GKVYFYSI 206
KV +S+
Sbjct: 183 EKVDLWSL 190
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (434), Expect = 2e-53
Identities = 69/188 (36%), Positives = 102/188 (54%), Gaps = 3/188 (1%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
D YDF +G+G F L DK T++LVA+K I + + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV ++ + HL ++M+ SGGELF+RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 140 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ HRDLK EN L ++ I DFG SK S + GTP Y+APEVL + Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 199 GKVYFYSI 206
V +SI
Sbjct: 188 KAVDCWSI 195
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-53
Identities = 54/193 (27%), Positives = 94/193 (48%), Gaps = 5/193 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
D ++ + ++G G FG ++K T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
IV+ + +L I++E+ +GG + + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 199 GKVYFYSITQMSL 211
+ Y Y SL
Sbjct: 189 DRPYDYKADVWSL 201
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 3e-52
Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 12/192 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR 77
+ +R+IG G+FG RD E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HPN ++++ L +VMEY G + E E + G++Y H+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-- 195
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 196 -EYDGKVYFYSI 206
+YDGKV +S+
Sbjct: 189 GQYDGKVDVWSL 200
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-52
Identities = 44/185 (23%), Positives = 82/185 (44%), Gaps = 1/185 (0%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
++Y D+G G FG+ + +K+ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 83 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
E + L ++ E+ SG ++FERI +A +E E + Q+ + + H+ +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKV 201
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 202 YFYSI 206
+S+
Sbjct: 185 DMWSL 189
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 6e-52
Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 9/191 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRH 78
+ + F + +G G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRH 195
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 196 EYDGKVYFYSI 206
+++
Sbjct: 186 SACKSSDLWAL 196
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-50
Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 5/187 (2%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
+Y IG G G D T + VA++ + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
IV + + L L +VMEY +GG L + + E + ++ + + + H+ QV
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ R Y
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 200 KVYFYSI 206
KV +S+
Sbjct: 196 KVDIWSL 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 1e-48
Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 23 DRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
D Y +G G G + +K T+E A+K ++ K +RE+ ++ R+ + P+
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQCPH 66
Query: 81 IVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 134
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 135 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
H++ + HRD+K EN L P LK+ DFG++K + H+ + TP Y+APEVL
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 194 RHEYDGKVYFYSITQM 209
+YD +S+ +
Sbjct: 187 PEKYDKSCDMWSLGVI 202
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 3e-48
Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 9/194 (4%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
D YD ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
H++Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 193 LRHEYDGKVYFYSI 206
+ +SI
Sbjct: 189 NYEPLGLEADMWSI 202
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-48
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
+ Y+ + IG+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 80 NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
NIVR+ + I+ T T L IVMEY GG+L I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 134 YCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYI 187
CH V HRDLK N LDG +K+ DFG ++ + GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 188 APEVLLRHEYDGKVYFYSI 206
+PE + R Y+ K +S+
Sbjct: 182 SPEQMNRMSYNEKSDIWSL 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 4e-48
Identities = 56/192 (29%), Positives = 87/192 (45%), Gaps = 13/192 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREIIN 72
+ Y+ +G G V R K T + AVK I E ++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 73 HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
R + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 192 LLRHEYDGKVYF 203
+ D +
Sbjct: 181 IECSMNDNHPGY 192
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (391), Expect = 3e-47
Identities = 50/196 (25%), Positives = 76/196 (38%), Gaps = 10/196 (5%)
Query: 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRS 75
H SDRY+ +G G L RD VAVK + R +RE N +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 76 LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
L HP IV + T IVMEY G L + + G + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 189
+++ H + HRD+K N ++ + A ++ + S +Q + +GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 190 EVLLRHEYDGKVYFYS 205
E D + YS
Sbjct: 184 EQARGDSVDARSDVYS 199
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-47
Identities = 58/190 (30%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DKIDENVQREIINHRSLR 77
+ + + +G G+FG L K T + A+K +++ D ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
HP + T +L VMEY +GG+L I + +F A F+ ++I G+ + H+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE 196
+ +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+LL +
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 197 YDGKVYFYSI 206
Y+ V ++S
Sbjct: 180 YNHSVDWWSF 189
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-46
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 12/198 (6%)
Query: 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHR 74
+ +D F +IG G+F D T VA ++ + + E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 75 SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130
L+HPNIVRF + + + +V E + G L + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 131 GVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
G+ + H + HRDLK +N + G P +KI D G + S K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 189 PEVLLRHEYDGKVYFYSI 206
PE+ +YD V Y+
Sbjct: 182 PEM-YEEKYDESVDVYAF 198
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-44
Identities = 43/188 (22%), Positives = 80/188 (42%), Gaps = 6/188 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D F++++G+G FGV + + + + VA+K I+ G ++ E +L H
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQ 139
+V+ V + I+ EY + G L + RF + + + + Y + Q
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEY 197
HRDL N L++ +K+ DFG S+ + S + PEVL+ ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 198 DGKVYFYS 205
K ++
Sbjct: 179 SSKSDIWA 186
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (370), Expect = 1e-43
Identities = 54/188 (28%), Positives = 95/188 (50%), Gaps = 8/188 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
+ +R +G+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 199 GKVYFYSI 206
+ ++S
Sbjct: 180 KSIDWWSF 187
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 147 bits (371), Expect = 2e-43
Identities = 55/192 (28%), Positives = 92/192 (47%), Gaps = 11/192 (5%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-------S 75
+ + R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
H V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL +
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180
Query: 196 E-YDGKVYFYSI 206
YD ++S+
Sbjct: 181 VAYDSSADWFSL 192
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-43
Identities = 50/189 (26%), Positives = 73/189 (38%), Gaps = 10/189 (5%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ ++ IG G FG L + VAVK I + D + E LRH N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KNDATAQAFLAEASVMTQLRHSN 61
Query: 81 IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
+V+ VI+ L IV EY + G L + + + GR D F + + Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
HRDL N L+ K+ DFG +K S + + APE L ++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 198 DGKVYFYSI 206
K +S
Sbjct: 178 STKSDVWSF 186
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-42
Identities = 51/196 (26%), Positives = 79/196 (40%), Gaps = 16/196 (8%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLR 77
+ + IGSG+FG + VAVK + + +Q E+ R R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 78 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 136
H NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
A + HRDLK N L +KI DFG + Q + G+ ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFLHED--LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 194 RHE---YDGKVYFYSI 206
+ Y + Y+
Sbjct: 180 MQDKNPYSFQSDVYAF 195
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (359), Expect = 3e-42
Identities = 40/190 (21%), Positives = 73/190 (38%), Gaps = 6/190 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G +G K VAVK ++ E +E + ++HPN
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM 138
+V+ V I+ E+ + G L + + R S + Q+ S + Y
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHE 196
HRDL N L+ + +K+ DFG S+ + ++ + APE L ++
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 197 YDGKVYFYSI 206
+ K ++
Sbjct: 193 FSIKSDVWAF 202
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-42
Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 12/188 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-------VQREIINHRS 75
+Y +GSG FG VA+K++E+ D V E++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 76 LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 132
+ ++R + P +++E +LF+ I G E+ AR FF Q++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
+CH V HRD+K EN L+D + LK+ DFG + + GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGA-LLKDTVYTDFDGTRVYSPPEWI 181
Query: 193 LRHEYDGK 200
H Y G+
Sbjct: 182 RYHRYHGR 189
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-42
Identities = 50/188 (26%), Positives = 79/188 (42%), Gaps = 6/188 (3%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
D FV++IGSG FG+ L K+ VA+K I G +E+ E L HP
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+V+ V L + +V E+ G L + G F+ + + G++Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 198 DGKVYFYS 205
K +S
Sbjct: 180 SSKSDVWS 187
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-41
Identities = 64/189 (33%), Positives = 102/189 (53%), Gaps = 7/189 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRH 78
+ +D+++ +G G FG L+R+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y H+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEY 197
V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL ++Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 198 DGKVYFYSI 206
V ++ +
Sbjct: 183 GRAVDWWGL 191
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 1e-41
Identities = 55/187 (29%), Positives = 105/187 (56%), Gaps = 8/187 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
D++D ++ +G+G+FG L++ K + A+K +++ + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
+ +RDLK EN L+D +++ DFG++K + + GTP +APE++L Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 199 GKVYFYS 205
V +++
Sbjct: 217 KAVDWWA 223
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 140 bits (353), Expect = 5e-41
Identities = 42/181 (23%), Positives = 86/181 (47%), Gaps = 9/181 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 81
D Y VR +G G + + E V VK ++ K + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 82 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
+ +++ P A+V E+ + + + ++ + RF+ +++ + YCH+M
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
+ HRD+K N ++D +L++ D+G ++ + V + + PE+L+ ++
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 200 K 200
Sbjct: 209 Y 209
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-40
Identities = 51/177 (28%), Positives = 79/177 (44%), Gaps = 9/177 (5%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRF 84
+G G F RDK T ++VA+K I+ G D I+ REI + L HPNI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
+ +++++V ++ N+ + + + + G+ Y H + HRD
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
LK N LLD + LK+ DFG +KS + V T Y APE+L G
Sbjct: 126 LKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (343), Expect = 6e-40
Identities = 48/203 (23%), Positives = 80/203 (39%), Gaps = 14/203 (6%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH 73
M++ + +RY R IGSG+FG L D E VA+K +E + E +
Sbjct: 1 MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56
Query: 74 RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
+ ++ I + + +VME + +FS Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 133 SYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 183
Y H+ HRD+K +N L+ G + I DFG +K + + + K+ GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 184 PAYIAPEVLLRHEYDGKVYFYSI 206
Y + L E + S+
Sbjct: 177 ARYASINTHLGIEQSRRDDLESL 199
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-40
Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 19/209 (9%)
Query: 14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREI 70
++ P + +Y+ + IG G FG R + T + VA+K + + REI
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 71 INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 122
+ L+H N+V E+ T + +V ++ +F+ E +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 177
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ + ++
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRY 178
Query: 178 KSTVGTPAYIAPEVLL-RHEYDGKVYFYS 205
+ V T Y PE+LL +Y + +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWG 207
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 9e-40
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 9 TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR 68
T G D P Y + IG+G+FGV + + ELVA+K + + R
Sbjct: 9 TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62
Query: 69 EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 119
E+ R L H NIVR + + +L +V++Y
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
+ + QL ++Y H+ +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 180 TVGTPAYIAPEVLL-RHEYDGKVYFYSITQM 209
+ + Y APE++ +Y + +S +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCV 212
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-39
Identities = 44/190 (23%), Positives = 75/190 (39%), Gaps = 8/190 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAM 138
+V+ V+ + + IV EY S G L + + + Q+ SG++Y M
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHE 196
HRDL+ N L+ + K+ DFG ++ ++ + + APE L
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 197 YDGKVYFYSI 206
+ K +S
Sbjct: 191 FTIKSDVWSF 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-39
Identities = 40/189 (21%), Positives = 74/189 (39%), Gaps = 8/189 (4%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
+ V +G+G FG + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 81 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAM 138
+VR V+ T + I+ EY G L + + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHE 196
HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 197 YDGKVYFYS 205
+ K +S
Sbjct: 187 FTIKSDVWS 195
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 5e-39
Identities = 44/198 (22%), Positives = 79/198 (39%), Gaps = 14/198 (7%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG--DKIDENVQREIINHRS 75
D + IG+G FG K+ + VA+K ++ G +K + E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 134
HPN++ + V+ T + I+ E+ G L N G+F+ + + + +G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 188
M HRDL N L++ + K+ DFG S+ S ++ + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 189 PEVLLRHEYDGKVYFYSI 206
PE + ++ +S
Sbjct: 202 PEAIQYRKFTSASDVWSY 219
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-38
Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 15/195 (7%)
Query: 23 DRYDFV---RDIGSGNFGVARL--MRDKVTKELVAVKYIERG---DKIDENVQREIINHR 74
DR +++GSGNFG + + K + VAVK ++ + + + E +
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 64 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 190
HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 191 VLLRHEYDGKVYFYS 205
+ +++ K +S
Sbjct: 181 CINYYKFSSKSDVWS 195
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-38
Identities = 39/199 (19%), Positives = 74/199 (37%), Gaps = 12/199 (6%)
Query: 16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI------ERGDKIDENVQRE 69
+ I+ +++ + ++ +GSG FG E V + K ++ + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 70 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
S+ +P++ R + LT T I G L + + Q+
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 186
G++Y ++ HRDL N L+ +KI DFG +K + + +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 187 IAPEVLLRHEYDGKVYFYS 205
+A E +L Y + +S
Sbjct: 180 MALESILHRIYTHQSDVWS 198
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-38
Identities = 44/220 (20%), Positives = 74/220 (33%), Gaps = 36/220 (16%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKEL-----VAVKYI--ERGDKIDENVQREIINH 73
+ +F + +GSG FG + VAVK + + E + E+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 74 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 110
L H NIV + ++ EY G+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 111 -CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
+ + ++ F Q+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 170 ---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
S + + ++APE L Y K +S
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-38
Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 15/203 (7%)
Query: 16 MPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKID----ENVQR 68
+ + + +G G+FGV VAVK ++ ++ R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 69 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 127
E+ SL H N++R V+LTP + +V E A G L +R+ + G F + Q
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGT 183
+ G+ Y + + HRDL N LL +KI DFG + + + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 184 PAYIAPEVLLRHEYDGKVYFYSI 206
A+ APE L + +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMF 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (331), Expect = 4e-38
Identities = 37/196 (18%), Positives = 72/196 (36%), Gaps = 13/196 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
Y R IG G+FGV + + + VA+K+ R ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 82 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 142 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 190
+RD+K +N L+ + + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 191 VLLRHEYDGKVYFYSI 206
L E + ++
Sbjct: 184 THLGREQSRRDDLEAL 199
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-38
Identities = 45/193 (23%), Positives = 79/193 (40%), Gaps = 11/193 (5%)
Query: 21 DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRS 75
+R + R IG G FG M + VA+K + D + E +E + R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 134
HP+IV+ VI T + I+ME + GEL + + QL + ++Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
+ + HRD+ N L+ + +K+ DFG S+ + K++ ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 193 LRHEYDGKVYFYS 205
+ +
Sbjct: 182 NFRRFTSASDVWM 194
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 6e-38
Identities = 49/195 (25%), Positives = 78/195 (40%), Gaps = 15/195 (7%)
Query: 23 DRYDFV---RDIGSGNFGVARLMRDKVTKE--LVAVKYIERGDKID--ENVQREIINHRS 75
R + + ++G GNFG R ++ K+ VA+K +++G + E + RE
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSY 134
L +P IVR V L +VME A GG L + + Q+ G+ Y
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 190
HRDL N LL + I DFG SK ++ + + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 191 VLLRHEYDGKVYFYS 205
+ ++ + +S
Sbjct: 183 CINFRKFSSRSDVWS 197
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 8e-38
Identities = 56/188 (29%), Positives = 83/188 (44%), Gaps = 13/188 (6%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
RY + IG G +G+ D V K VA+K I + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 81 IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
I+ ++I PT ++ + G +L++ + S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 192
+ V HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 193 LRHEYDGK 200
L + K
Sbjct: 185 LNSKGYTK 192
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-37
Identities = 50/187 (26%), Positives = 81/187 (43%), Gaps = 15/187 (8%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
Y ++ +GSG +G D T VA+K + R + + RE+ + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 80 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
N++ +V T +VM + G ++ + ED +F Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y HA + HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 194 RHEYDGK 200
+
Sbjct: 192 NWMRYTQ 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 7e-37
Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 8/190 (4%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
+ + V IG G +GV R+K+T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 80 NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
NIV+ +VI T L +V E+ + F + + QL+ G+++CH+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
+V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL +Y
Sbjct: 122 RVLHRDLKPQNLLINTE--GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 198 DG-KVYFYSI 206
V +S+
Sbjct: 180 YSTAVDIWSL 189
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-36
Identities = 50/182 (27%), Positives = 88/182 (48%), Gaps = 6/182 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHP 79
+Y+ + IG G +G +++ T E+VA+K + D + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIVR +V+ + L +V E+ G + + F QL+ G+ +CH+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEYD 198
V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 199 GK 200
Sbjct: 180 ST 181
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-36
Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 15/197 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYI---ERGDKIDENVQREIINHRSL-- 76
+Y+ V +IG G +G RD VA+K + + + + RE+ R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 77 -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 129
HPN+VR +V T L +V E+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
G+ + H+ +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 190 EVLLRHEYDGKVYFYSI 206
EVLL+ Y V +S+
Sbjct: 185 EVLLQSSYATPVDLWSV 201
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 3e-36
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 36/217 (16%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYI--ERGDKIDENVQREIINHRS 75
+ ++VRDIG G FG R +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 115
+PNIV+ V + ++ EY + G+L E + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 116 ----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 169
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNI 190
Query: 170 -SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYS 205
S+ + + ++ PE + + Y + ++
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (315), Expect = 6e-36
Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 7/182 (3%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
++Y + IG G +GV ++ E A+K I + + I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
NIV+ +VI T L +V E+ G A+ F QL++G++YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 199 GK 200
Sbjct: 179 ST 180
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-35
Identities = 48/206 (23%), Positives = 72/206 (34%), Gaps = 23/206 (11%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKID--ENVQREIINHRSL 76
D + F IG GNFG R K A+K ++ D + E+ L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 77 -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 119
HPNI+ +L + +EYA G L + + A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
+ F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 180 TVGTPAYIAPEVLLRHEYDGKVYFYS 205
++A E L Y +S
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWS 211
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-35
Identities = 53/207 (25%), Positives = 77/207 (37%), Gaps = 28/207 (13%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
+ IG G FG + E VAVK ++ + EI LRH NI
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 82 VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
+ F T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 138 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 184
+ HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 185 AYIAPEVLL------RHEYDGKVYFYS 205
Y+APEVL E + Y+
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYA 203
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 5e-35
Identities = 44/214 (20%), Positives = 73/214 (34%), Gaps = 31/214 (14%)
Query: 21 DSDRYDFVRDIGSGNFGV-----ARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
+R F + +G+G FG A + VAVK ++ + E + E+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 74 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 114
L H NIV ++ EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174
++ F Q+ G+++ + HRDL N LL KICDFG ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198
Query: 175 SQPKST---VGTPAYIAPEVLLRHEYDGKVYFYS 205
S ++APE + Y + +S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-34
Identities = 45/204 (22%), Positives = 75/204 (36%), Gaps = 14/204 (6%)
Query: 15 DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDE--NVQRE 69
+ I S F IG G+FG L+ + K AVK + R I E E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 70 IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 127
I + HPN++ + L + +V+ Y G+L + + F Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 182
+ G+ + + + HRDL N +LD +K+ DFG ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 183 TPAYIAPEVLLRHEYDGKVYFYSI 206
++A E L ++ K +S
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSF 220
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-34
Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 14/196 (7%)
Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
RY ++ IGSG G+ D V VA+K + R + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 80 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
NI+ V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
+ H+ + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 194 RHEYDGKVYFYSITQM 209
Y V +S+ +
Sbjct: 192 GMGYKENVDIWSVGCI 207
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 5e-33
Identities = 44/196 (22%), Positives = 73/196 (37%), Gaps = 13/196 (6%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG--DKIDENVQREIINHR 74
+ IG+G FG K + VA+K ++ G +K + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 75 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 133
H NI+R + VI + I+ EY G L + + G FS + + + +G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 189
Y M HRDL N L++ + K+ DFG S+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 190 EVLLRHEYDGKVYFYS 205
E + ++ +S
Sbjct: 183 EAISYRKFTSASDVWS 198
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-32
Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 13/187 (6%)
Query: 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRH 78
+RY + +GSG +G D T VAVK + R + + RE+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 79 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
N++ +V L ++ + G I + ++D +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
Y H+ + HRDLK N ++ LKI DFG ++ + V T Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 194 RHEYDGK 200
+ +
Sbjct: 192 NWMHYNQ 198
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-32
Identities = 46/195 (23%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 23 DRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGD-----KIDENVQREIINHR 74
+ ++ ++ +G+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 75 SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
+R P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
+ H + + +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 194 RHE--YDGKVYFYSI 206
+ +D V ++S+
Sbjct: 204 GGDSGHDKAVDWWSL 218
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-32
Identities = 36/209 (17%), Positives = 78/209 (37%), Gaps = 22/209 (10%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKIDE--NVQREIINH 73
++ R++G G+FG+ K + VA+K + + E E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 74 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 123
+ ++VR V+ ++ME + G+L + + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
++ G++Y +A + HRDL N ++ +KI DFG ++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQM 209
+ +++PE L + +S +
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVV 224
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 5e-31
Identities = 40/213 (18%), Positives = 73/213 (34%), Gaps = 27/213 (12%)
Query: 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE-------LVAVKYI--ERGDKIDENVQREII 71
DR + +G G FG L + VAVK + + +K ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 72 NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 114
+ + +H NI+ L +++EYAS G L E +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 173
+ S + Q+ G+ Y + + HRDL N L+ ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
+ + + ++APE L Y + +S
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 223
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 7e-31
Identities = 43/214 (20%), Positives = 75/214 (35%), Gaps = 30/214 (14%)
Query: 21 DSDRYDFVRDIGSGNFGV-----ARLMRDKVTKELVAVKYIERGDKIDEN---VQREIIN 72
DR + +G G FG A + T VAVK ++ G E+ + I
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 73 HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 115
H N+V P L +++E+ G L + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 116 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
+ + + Q+ G+ + + + HRDL N LL +KICDFG ++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSI 206
+ + ++APE + Y + +S
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 222
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (255), Expect = 1e-26
Identities = 43/201 (21%), Positives = 73/201 (36%), Gaps = 19/201 (9%)
Query: 24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 83
RY VR +G G+F L +D V VA+K + E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 84 ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 127
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 128 LISGVSYCHAMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
L+ G+ Y H + H D+K EN L++ SP ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 185 AYIAPEVLLRHEYDGKVYFYS 205
Y +PEVLL + +S
Sbjct: 194 EYRSPEVLLGAPWGCGADIWS 214
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.0 bits (160), Expect = 4e-14
Identities = 22/155 (14%), Positives = 43/155 (27%), Gaps = 26/155 (16%)
Query: 31 IGSGNFGVARLMRDKVTKELVAVKYIERG-----------DKIDENVQREIINHRSLRHP 79
+G G + VK+ + G D D + I
Sbjct: 8 MGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 80 NIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
+ + + + + + A++ME R + ++ V+
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
+ + H DL N L+ + I DF S
Sbjct: 120 YHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 219 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.01 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.97 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.73 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.55 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=316.71 Aligned_cols=196 Identities=35% Similarity=0.532 Sum_probs=173.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 35789999999999999999999999999999999865432 3456889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC---
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 175 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~--- 175 (219)
|||++++|.+.+.....+++.+++.++.|++.||.|||++||+|+||||+||++++++. ++|+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRER 160 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEEC
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCccc
Confidence 99999999999988888999999999999999999999999999999999999988876 9999999997543322
Q ss_pred CCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......||+.|+|||.+.+..+ +.++|||||||++|||++|..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~ 204 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 204 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCC
Confidence 2344579999999999988776 678999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=312.97 Aligned_cols=195 Identities=30% Similarity=0.540 Sum_probs=177.4
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++.+.||+|+||+||++++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 467999999999999999999999999999999998642 2334678899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
|||||++++|.+.+.+.+.+++.+++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||+|+... ...
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~-~~~ 160 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSR 160 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCC-CCC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecC-CCc
Confidence 9999999999999998889999999999999999999999999999999999999998876 9999999997543 233
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....||+.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~ 202 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCC
Confidence 345578999999999999999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=312.06 Aligned_cols=194 Identities=28% Similarity=0.467 Sum_probs=175.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++..++.+++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4689999999999999999999999999999999875443 346789999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~ 179 (219)
|++++|.+.+.+ ..+++.+++.++.|++.||.|||++||+|+||||+||+++.++. ++|+|||+|+...... ....
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence 999999987765 46999999999999999999999999999999999999988876 9999999998654333 3345
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..|++.|+|||.+.+..++.++|||||||++|+|++|..
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 579999999999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=313.27 Aligned_cols=196 Identities=29% Similarity=0.431 Sum_probs=175.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 457899999999999999999999999999999998643 2233678899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~- 175 (219)
|||||++++|.+.+...+.+++.+++.++.|++.||.|||+++|+|+||||+||++++++. ++|+|||+|+......
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK 163 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC----
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCc
Confidence 9999999999999999899999999999999999999999999999999999999998877 9999999997553322
Q ss_pred --CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 --QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCC
Confidence 2234579999999999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-51 Score=313.86 Aligned_cols=197 Identities=35% Similarity=0.554 Sum_probs=160.9
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999999999999999987543 223567889999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC-CCCcEEEeecccccccccCCCCC
Q 027738 100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~-~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
||+|++|.+.+...+.+++.++..++.|++.||.|||+++++|+||||+||++... ..+.++|+|||+++.........
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 99999999999988899999999999999999999999999999999999999642 22349999999998766555556
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...||+.|+|||.+.+..+++++|||||||++|||++|..
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 207 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCC
Confidence 6789999999999999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=317.06 Aligned_cols=195 Identities=27% Similarity=0.400 Sum_probs=175.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
..++|++.+.||+|+||+||++++..+++.||+|++.... ...+.+.+|+.+++.++||||++++++|.+++.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4679999999999999999999999999999999987542 22467889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
||+++++|.+.+.+.+.+++.+++.++.|++.||.|||+ +||+||||||+||++++++. ++|+|||+|+.... ...
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~ 160 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 160 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-Ccc
Confidence 999999999999988899999999999999999999997 49999999999999988876 99999999975543 234
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....||+.|+|||++.+..++.++||||+||++|||++|..
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~ 201 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 45689999999999999999999999999999999999964
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-51 Score=317.39 Aligned_cols=199 Identities=30% Similarity=0.474 Sum_probs=178.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.-.++|++.+.||+|+||.||+|++..+|+.||+|++...... .+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999999999999999998764432 356789999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|||++++|.+.+.. ...+++.++..++.|++.||.|||++|++|+||||+||+++.+..+.++|+|||+++........
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 99999999998854 45699999999999999999999999999999999999997655456999999999876655555
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+|+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~ 223 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 223 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCC
Confidence 56689999999999999999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=314.21 Aligned_cols=197 Identities=32% Similarity=0.536 Sum_probs=178.9
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
.+.++|++++.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++.++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 3568999999999999999999999999999999998643 223366789999999999999999999999999999
Q ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-
Q 027738 96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~- 174 (219)
+||||+++++|...+.+.+.+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||+|+.....
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999998876 999999999865433
Q ss_pred CCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+||+.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~ 203 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCC
Confidence 33345678999999999999999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=306.26 Aligned_cols=197 Identities=32% Similarity=0.552 Sum_probs=179.4
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc-------ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
.++|++.+.||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999999999999999986432 1236789999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCC--cEEEeecccccccc
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKSSV 172 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~--~v~l~dfg~a~~~~ 172 (219)
++|||||++++|.+.+...+.+++.+++.++.|++.||+|||+++++|+||||+||+++.++.. .++++|||++....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 9999999999999999988899999999999999999999999999999999999999866542 49999999998776
Q ss_pred cCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.........+++.|+|||.+.+..++.++|||||||++|||++|..
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~ 214 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 214 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCC
Confidence 6666666788999999999999999999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-50 Score=308.95 Aligned_cols=194 Identities=28% Similarity=0.508 Sum_probs=177.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 457899999999999999999999999999999998643 2234678899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
||||++|+++...+.....++..+++.++.|++.||.+||++||+|+||||+||+++.++. ++|+|||+|+... ..
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~--~~ 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVP--DV 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECS--SC
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEec--cc
Confidence 9999999999999999999999999999999999999999999999999999999998876 9999999997643 33
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~ 199 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCC
Confidence 445679999999999999999999999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.7e-51 Score=314.91 Aligned_cols=198 Identities=27% Similarity=0.435 Sum_probs=177.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
-.++|++.+.||+|+||.||+|++..+++.||+|++...... .+.+.+|+.+++.++||||++++++|.+++.+++|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357899999999999999999999999999999998765432 3567899999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 100 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
||++++|.+.+.... ++++.+++.++.|++.||.|||++||+|+||||+|||++....+.++|+|||+|+.........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 999999988776544 6999999999999999999999999999999999999985554569999999998776555555
Q ss_pred CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...+++.|+|||.+.+..++.++|||||||++|+|++|..
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~ 226 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 226 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCC
Confidence 6678999999999999999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=306.71 Aligned_cols=195 Identities=27% Similarity=0.437 Sum_probs=172.5
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc-ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.+.|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 357999999999999999999999999999999987543 3346789999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CCCC
Q 027738 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 178 (219)
Q Consensus 101 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~~~ 178 (219)
|++++|.+.+.+ .+.+++.++..++.|++.||.|||++||+|+||||+||+++.++. ++|+|||+|+..... ....
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHT
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCccccc
Confidence 999999998765 456999999999999999999999999999999999999998877 999999998644322 2234
Q ss_pred CCCCCCCCCCchhhc-----cccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLL-----RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...|++.|+|||.+. +..++.++|||||||++|||++|..
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~ 213 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCC
Confidence 567899999999984 4567899999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=312.03 Aligned_cols=197 Identities=22% Similarity=0.376 Sum_probs=179.8
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEecc
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 101 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 101 (219)
.++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.++||||+++++++.+++.+++|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 57899999999999999999999999999999999776555567889999999999999999999999999999999999
Q ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCCCC
Q 027738 102 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180 (219)
Q Consensus 102 ~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~~~ 180 (219)
+|++|.+.+...+ .+++.+++.++.|++.||.|||++||+|+||||+||+++.++...++|+|||+++...........
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~ 163 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence 9999999997665 699999999999999999999999999999999999998776667999999999866544444556
Q ss_pred CCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 181 VGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 181 ~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.+++.|+|||.+.+..++.++|+|||||++|+|++|..
T Consensus 164 ~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~ 201 (321)
T d1tkia_ 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccchhccCCCCCchhhcccHHHHHHHHHhCCC
Confidence 78999999999999999999999999999999999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-50 Score=305.75 Aligned_cols=197 Identities=20% Similarity=0.258 Sum_probs=176.5
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++.......+++.+|+.++++++||||+++++++.+++..+++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 46789999999999999999999999899999999998776666889999999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+++|+|.+.+... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++. +||+|||+|+........
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCce
Confidence 99999999998754 45899999999999999999999999999999999999988876 999999999755433222
Q ss_pred --CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 --KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~ 214 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 22246788999999999999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=304.44 Aligned_cols=196 Identities=31% Similarity=0.504 Sum_probs=162.2
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEc--CCeEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 95 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 95 (219)
..++|++.+.||+|+||+||++++..+++.||+|.+...... .+.+.+|++++++++||||+++++++.+ ++.++
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 468999999999999999999999999999999998765332 2457899999999999999999999965 45689
Q ss_pred EEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCCEEecCCCCCcEEEeecc
Q 027738 96 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 166 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~-----ivh~dl~p~nili~~~~~~~v~l~dfg 166 (219)
+|||||++++|.+.+.+ ...+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++. ++|+|||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG 159 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 159 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeecc
Confidence 99999999999998863 356999999999999999999999976 999999999999998876 9999999
Q ss_pred cccccccCC-CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 167 YSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 167 ~a~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
+|+...... ......+++.|+|||.+.+..++.++|||||||++|||+||..
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~ 212 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCC
Confidence 997654332 2344578999999999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-50 Score=305.99 Aligned_cols=191 Identities=30% Similarity=0.466 Sum_probs=171.7
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
+.|+.++.||+|+||+||+|++..+++.||+|++...... .+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999998764332 245789999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCCC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~~ 178 (219)
|||.++++........++++.+++.++.|++.||.|||++||+|+||||+|||++.++. ++|+|||+|.... ...
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~---~~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---PAN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---SBC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccC---CCC
Confidence 99999999888888888999999999999999999999999999999999999998876 9999999987543 334
Q ss_pred CCCCCCCCCCchhhcc---ccccceeeEEEEEEEEeecCCCCC
Q 027738 179 STVGTPAYIAPEVLLR---HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 179 ~~~~~~~~~aPE~~~~---~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...||+.|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~ 212 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCC
Confidence 5679999999999964 458899999999999999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=298.87 Aligned_cols=196 Identities=26% Similarity=0.383 Sum_probs=166.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.+.++|++.+.||+|+||+||++.+. +++.||+|++.......+++.+|++.+++++||||+++++++..++..++|+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 35678999999999999999999986 56789999998776667889999999999999999999999999999999999
Q ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC-
Q 027738 100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~- 177 (219)
|+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||++++++. +||+|||+++........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCcee
Confidence 99999999988655 45899999999999999999999999999999999999998877 999999999755433222
Q ss_pred -CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 -KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 -~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++||||||+++|||+|++.
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~ 200 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCC
Confidence 23467899999999999999999999999999999999653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=297.67 Aligned_cols=192 Identities=27% Similarity=0.408 Sum_probs=167.4
Q ss_pred ccc-eeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEc----CCeE
Q 027738 23 DRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 94 (219)
Q Consensus 23 ~~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 94 (219)
++| ++.++||+|+||+||++.+..+++.||+|.+..... ..+.+.+|++++++++||||+++++++.. +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 455 788899999999999999999999999999865432 23567899999999999999999999875 3468
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCCEEecC-CCCCcEEEeeccccccc
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 171 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--ivh~dl~p~nili~~-~~~~~v~l~dfg~a~~~ 171 (219)
++||||+++++|.+.+.+...+++.+++.++.|++.||+|||+++ |+|+||||+||++++ ++. ++|+|||+|+..
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK 165 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGC
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcceec
Confidence 999999999999999998889999999999999999999999998 999999999999964 455 999999999743
Q ss_pred ccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
. ........||+.|+|||.+.+ .++.++|||||||++|||++|..
T Consensus 166 ~-~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~ 210 (270)
T d1t4ha_ 166 R-ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 210 (270)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred c-CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCC
Confidence 2 233345679999999999865 58999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=308.51 Aligned_cols=194 Identities=29% Similarity=0.526 Sum_probs=177.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
..++|++++.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++......++
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 358999999999999999999999999999999998643 2233567899999999999999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
++|++.+++|...+.+.+.+++.+++.++.|++.||.|||+++|+|+||||+|||++.++. ++|+|||+|+... ..
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~--~~ 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK--GR 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS--SC
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeecc--cc
Confidence 9999999999999999889999999999999999999999999999999999999988876 9999999997653 23
Q ss_pred CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....|++.|+|||++.+..++.++|+|||||++|||++|..
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~ 236 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCC
Confidence 345678999999999999999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=296.60 Aligned_cols=202 Identities=19% Similarity=0.266 Sum_probs=174.1
Q ss_pred CCCCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 13 ~~~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
...-..-...++|++.+.||+|+||.||+|.++ +++.||+|++.......+.+.+|+.++++++||||+++++++.+ +
T Consensus 3 ~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CCCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 333444456789999999999999999999986 67789999998776667889999999999999999999998755 5
Q ss_pred eEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
..++||||+++++|.+.+... .+++..++..++.|++.||.|||+++++||||||+||++++++. ++|+|||+|+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~ 158 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARL 158 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEE
Confidence 678999999999998876543 35899999999999999999999999999999999999998877 99999999976
Q ss_pred cccCC--CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..... ......+++.|+|||.+.+..++.++||||||+++|||+||+.
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~ 208 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTC
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCC
Confidence 54322 2234467889999999998899999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.1e-49 Score=295.08 Aligned_cols=195 Identities=29% Similarity=0.415 Sum_probs=176.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----------CHHHHHHHHHHHhCC-CCcEeEEEEEEEc
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------DENVQREIINHRSLR-HPNIVRFKEVILT 90 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----------~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 90 (219)
.++|++.+.||+|++|+||+|++..+++.||+|++...... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47999999999999999999999999999999998754321 135778999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
++..++||||+++++|.+.+...+++++.+++.++.|++.||+|||++|++|+||||+||+++.++. ++|+|||+++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence 9999999999999999999998889999999999999999999999999999999999999988877 99999999987
Q ss_pred cccCCCCCCCCCCCCCCCchhhcc------ccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLR------HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........+++.|.|||.+.+ ..++.++|+||+||++|+|++|..
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence 766656666789999999999873 346789999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=299.11 Aligned_cols=195 Identities=30% Similarity=0.481 Sum_probs=172.4
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC----cccCHHHHHHHHHH-HhCCCCcEeEEEEEEEcCCeEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+..|...+ +.++||||+++++++.+++..++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 36899999999999999999999999999999998643 22224455555554 57899999999999999999999
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
||||+++++|..++.....+++.+++.++.|++.||.|||+++++|+||||+||++++++. ++|+|||+++.......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhcccccc
Confidence 9999999999999999889999999999999999999999999999999999999998877 99999999975543333
Q ss_pred -CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 -PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 201 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCC
Confidence 334578999999999999999999999999999999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-48 Score=294.84 Aligned_cols=195 Identities=26% Similarity=0.362 Sum_probs=167.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc----CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC----e
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT----H 93 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 93 (219)
.++|++.+.||+|+||+||+|++..+++.||+|++...... .+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 57899999999999999999999999999999999754332 245789999999999999999999998643 4
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++||||++|++|...+...+.+++.+++.++.|++.||.+||++|++|+||||+||+++.++. ++++|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence 8999999999999999999889999999999999999999999999999999999999998887 89999998764332
Q ss_pred CC----CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HS----QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. ......|++.|+|||.+.+..+++++||||||+++|||+||..
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~ 212 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCC
Confidence 22 2233468999999999999999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=300.31 Aligned_cols=195 Identities=31% Similarity=0.450 Sum_probs=171.6
Q ss_pred cCCccceeec-cccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHH-hCCCCcEeEEEEEEEc----CCe
Q 027738 20 HDSDRYDFVR-DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-SLRHPNIVRFKEVILT----PTH 93 (219)
Q Consensus 20 ~~~~~y~~~~-~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~----~~~ 93 (219)
.-.++|++++ .||+|+||+||+|++..+++.||+|++.. .+.+.+|+.++. ..+||||++++++|.+ ...
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 3457999886 59999999999999999999999999853 356778888765 5589999999999975 456
Q ss_pred EEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeecccccc
Q 027738 94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 170 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~ 170 (219)
+++|||||+||+|.+++... ..+++.+++.++.|++.||+|||++|++||||||+||+++.+. ...++|+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 89999999999999999764 3699999999999999999999999999999999999998643 33599999999987
Q ss_pred cccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...........|++.|+|||.+.+..++.++|+|||||++|+|+||..
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 766666677789999999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-48 Score=304.24 Aligned_cols=195 Identities=28% Similarity=0.433 Sum_probs=170.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc----ccCHHHHH---HHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQR---EIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~---e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
+.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+ ++.+++.++||||+++++++..++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4679999999999999999999999999999999986422 11223333 3566677789999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
+++||||+++++|.+.+.....+++.+++.++.|++.||.|||++|++|+||||+|||++.++. ++|+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC
Confidence 9999999999999999999889999999999999999999999999999999999999988877 99999999975543
Q ss_pred CCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.......|++.|+|||.+.+ ..++.++|||||||++|||+||..
T Consensus 160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~ 204 (364)
T d1omwa3 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 204 (364)
T ss_dssp -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCC
Confidence 33455679999999999974 568999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=288.03 Aligned_cols=193 Identities=22% Similarity=0.368 Sum_probs=172.8
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
+.++|++.++||+|+||+||+++.+ +++.||+|.+.......+++.+|+.++++++||||+++++++.+++.+++|+||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 4579999999999999999999985 778899999988777778899999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC--
Q 027738 101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 177 (219)
Q Consensus 101 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~-- 177 (219)
++++++...+.. ...+++..+..++.|++.||+|||+.|++|+||||+||++++++. ++|+|||+++........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceee
Confidence 999999888654 456899999999999999999999999999999999999998776 999999999754433322
Q ss_pred CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
....+++.|+|||.+.+..++.++||||||+++|||+|+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~ 197 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 197 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhc
Confidence 234578899999999999999999999999999999984
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-48 Score=293.99 Aligned_cols=197 Identities=21% Similarity=0.304 Sum_probs=160.3
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCc---EEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..+.++|++.+.||+|+||+||+|.+..+++ .|++|.+..... ..+.+.+|+.++++++||||+++++++..++.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 3456889999999999999999999876654 588888765322 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
.+++|||+++++|.+++... +.+++.++..++.|++.||.|||+++++||||||+||+++.++. +||+|||+++...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLE 179 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEcc
Confidence 99999999999999988764 46999999999999999999999999999999999999998877 9999999997554
Q ss_pred cCCCCC------CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 173 LHSQPK------STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 173 ~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
...... ...+++.|+|||.+.+..++.++|||||||++|||+| |.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~ 231 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCC
Confidence 332221 1246788999999999999999999999999999998 54
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=289.08 Aligned_cols=193 Identities=26% Similarity=0.318 Sum_probs=162.1
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 96 (219)
.+.++|++.+.||+|+||+||+++.+ ..||+|++..... ..+.+.+|+.++++++||||+++++++.. +.+++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 45789999999999999999999764 3599999865432 23678899999999999999999998754 56899
Q ss_pred EEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
|+||+++++|.+++... ..++..++..++.|++.||+|||+++|+||||||+||+++.++. +||+|||+|+......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC-----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccC
Confidence 99999999999999754 46999999999999999999999999999999999999998877 9999999987543322
Q ss_pred ---CCCCCCCCCCCCCchhhcc---ccccceeeEEEEEEEEeecCCCCC
Q 027738 176 ---QPKSTVGTPAYIAPEVLLR---HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 ---~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......+++.|+|||.+.+ ..++.++||||||+++|||+||..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~ 207 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCC
Confidence 2234568999999999974 357889999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=288.10 Aligned_cols=195 Identities=23% Similarity=0.292 Sum_probs=166.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEe
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.+.++|++.+.||+|+||.||+|+++.+ +.||+|++.......+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 4678999999999999999999999744 569999998776666889999999999999999999999854 56789999
Q ss_pred ccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCCC
Q 027738 100 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177 (219)
Q Consensus 100 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~~ 177 (219)
|+++|++.+.+.. ...+++.++..++.+++.||++||+++++|+||||+||++++++. ++|+|||+++........
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCce
Confidence 9999999888754 346999999999999999999999999999999999999988876 999999999765433322
Q ss_pred --CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 178 --KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 --~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~ 212 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCC
Confidence 23467899999999999999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=292.27 Aligned_cols=196 Identities=23% Similarity=0.317 Sum_probs=167.6
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCc-----EEEEEEeccC--cccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (219)
.+.++|++.+.||+|+||+||+|++..+++ .||+|.+... ......+.+|+..+.++ +||||+++++++...
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 456899999999999999999999875443 5899988543 33456788999999887 899999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 027738 92 THLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~ 148 (219)
+..++|||||++|+|.+++...+ .++..++..++.|++.||+|||+++|+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999997542 3788999999999999999999999999999999
Q ss_pred CEEecCCCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 149 nili~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
||+++.++. ++|+|||+|+........ ....+++.|+|||.+.+..++.++|||||||++|||+| |.
T Consensus 194 Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 194 NVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp GEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred ccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 999988876 999999999765443332 22346889999999999999999999999999999998 54
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=290.96 Aligned_cols=190 Identities=27% Similarity=0.364 Sum_probs=164.8
Q ss_pred eeccccCcCceEEEEEEECCCCcEEEEEEeccCcc------cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEec
Q 027738 27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 27 ~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.++.||+|+||+||+|.+..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46889999999999999999999999999865322 235688999999999999999999999999999999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CCCC
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 179 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~~~ 179 (219)
+.++++.........+++.++..++.|++.||+|||++|++|+||||+||+++.++. ++|+|||+|+...... ....
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence 999888777766777999999999999999999999999999999999999998877 9999999997554332 2344
Q ss_pred CCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 180 TVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..+++.|+|||.+.+ ..++.++|||||||++|||++|..
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence 578999999999875 467999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=286.82 Aligned_cols=196 Identities=26% Similarity=0.371 Sum_probs=169.3
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-------cCHHHHHHHHHHHhCC--CCcEeEEEEEEEcC
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTP 91 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 91 (219)
-.++|++.+.||+|+||+||+|++..+++.||+|++..... ....+.+|+.++++++ ||||+++++++..+
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 35789999999999999999999999999999999865321 1234678999999886 89999999999999
Q ss_pred CeEEEEEeccCC-CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccc
Q 027738 92 THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170 (219)
Q Consensus 92 ~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~ 170 (219)
+..++|+|++.+ +++.+.+.....+++.+++.++.|++.||.+||+++++|+||||+||+++.+.. .++|+|||+|+.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~-~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGAL 160 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC-eEEECcccccee
Confidence 999999999975 678888888888999999999999999999999999999999999999985532 399999999975
Q ss_pred cccCCCCCCCCCCCCCCCchhhccccc-cceeeEEEEEEEEeecCCCCC
Q 027738 171 SVLHSQPKSTVGTPAYIAPEVLLRHEY-DGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 171 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. ........||+.|+|||.+.+..+ +.++|+|||||++|||++|..
T Consensus 161 ~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (273)
T d1xwsa_ 161 LK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208 (273)
T ss_dssp CC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred cc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCC
Confidence 43 233345678999999999987665 677899999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-47 Score=286.97 Aligned_cols=195 Identities=30% Similarity=0.435 Sum_probs=167.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.|+|++++.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 479999999999999999999999999999999986532 23577889999999999999999999999999999999
Q ss_pred eccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC-CC
Q 027738 99 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 176 (219)
Q Consensus 99 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~-~~ 176 (219)
||+.++.+..... ....+++.+++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||+|+..... ..
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRT 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBC
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCccc
Confidence 9997754443333 3446999999999999999999999999999999999999988776 999999999755433 33
Q ss_pred CCCCCCCCCCCCchhhcccc-ccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRHE-YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.... ++.++|+||||+++|+|++|..
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~ 201 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCC
Confidence 34457899999999987655 5789999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=284.74 Aligned_cols=196 Identities=22% Similarity=0.278 Sum_probs=163.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCC----cEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~----~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
..+.|++.+.||+|+||.||+|....++ ..||+|++..... ...++.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 4568999999999999999999877544 4699999865432 234678999999999999999999999999999
Q ss_pred EEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
++++|++.++++.+.+... ..++..++..++.|++.||+|||+++|+|+||||+||+++.++. +||+|||+++....
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLED 162 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccC
Confidence 9999999999998877654 56999999999999999999999999999999999999998877 99999999975443
Q ss_pred CCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 174 HSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 174 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.... ....+++.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~ 211 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 211 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCC
Confidence 3221 22357889999999999999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=283.81 Aligned_cols=196 Identities=26% Similarity=0.330 Sum_probs=166.1
Q ss_pred ccCCccceeecc-ccCcCceEEEEEEECC--CCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRD-IGSGNFGVARLMRDKV--TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~-l~~g~~~~v~~~~~~~--~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
....++|.+.+. ||+|+||.||+|.+.. ++..||+|.+..... ..+++.+|++++++++||||+++++++.. +.
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 345678888884 9999999999998753 345799999875432 23678899999999999999999999875 45
Q ss_pred EEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
+++||||+++++|.+++... ..+++.++..++.|++.||+|||+++++|+||||+||+++.++. ++|+|||+++...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccc
Confidence 78999999999999987654 56999999999999999999999999999999999999998776 9999999997544
Q ss_pred cCCC----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 173 LHSQ----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 173 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
.... .....+++.|+|||.+.+..++.++||||||+++|||+| |.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~ 210 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCC
Confidence 3322 223357889999999998999999999999999999998 54
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=284.68 Aligned_cols=186 Identities=24% Similarity=0.313 Sum_probs=158.4
Q ss_pred ccccCcCceEEEEEEEC--CCCcEEEEEEeccCcc---cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEEeccCC
Q 027738 29 RDIGSGNFGVARLMRDK--VTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 103 (219)
Q Consensus 29 ~~l~~g~~~~v~~~~~~--~~~~~v~~K~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (219)
++||+|+||+||+|... .+++.||+|++..... ..+.+.+|+.++++++||||+++++++..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 47999999999999764 3457899999865332 235688999999999999999999998654 57899999999
Q ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC----CCC
Q 027738 104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKS 179 (219)
Q Consensus 104 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~----~~~ 179 (219)
++|.+++.....+++.++..++.|++.||+|||+++++|+||||+||+++.++. ++++|||+++....... ...
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC---
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccc
Confidence 999999999889999999999999999999999999999999999999998876 99999999975433222 123
Q ss_pred CCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CC
Q 027738 180 TVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PN 217 (219)
Q Consensus 180 ~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~ 217 (219)
..+++.|+|||.+.+..++.++||||||+++|||+| |.
T Consensus 170 ~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~ 208 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCC
Confidence 457889999999999999999999999999999998 54
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=285.19 Aligned_cols=198 Identities=24% Similarity=0.285 Sum_probs=171.3
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcE--EEEEEeccC--cccCHHHHHHHHHHHhC-CCCcEeEEEEEEEcCCe
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 93 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~--v~~K~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 93 (219)
..+.++|++.+.||+|+||.||+|.+..++.. |++|.+... ....+.+.+|+.+++++ +||||+++++++..++.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 35678999999999999999999999877764 677776532 22346789999999998 79999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCC
Q 027738 94 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~ 157 (219)
.++|+||+++|+|.+++... ..++..++..++.|++.||.++|+++++||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 99999999999999998654 45899999999999999999999999999999999999988876
Q ss_pred CcEEEeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 158 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 158 ~~v~l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++|+|||+++............++..|+|||.+.+..++.++||||||+++|||++|..
T Consensus 166 --~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~ 224 (309)
T d1fvra_ 166 --AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224 (309)
T ss_dssp --EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred --eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCC
Confidence 99999999986665555666678999999999999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=284.36 Aligned_cols=198 Identities=28% Similarity=0.381 Sum_probs=167.2
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCC-CcEEEEEEeccCc---ccCHHHHHHHHHHHhC---CCCcEeEEEEEEEc-
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT- 90 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~- 90 (219)
+...++|++++.||+|+||+||+|++..+ ++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 34568999999999999999999999655 6779999986432 2234566777776654 79999999999863
Q ss_pred ----CCeEEEEEeccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeec
Q 027738 91 ----PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 91 ----~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
....++++|++.++.+..... ....+++..++.++.|++.||+|||+++|+|+||||+|||+++++. ++|+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~df 160 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADF 160 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSC
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecch
Confidence 346899999998877654443 3345899999999999999999999999999999999999988877 999999
Q ss_pred ccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 166 g~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|+++............||+.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~ 213 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCC
Confidence 99886665666667789999999999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6e-46 Score=281.12 Aligned_cols=194 Identities=29% Similarity=0.429 Sum_probs=168.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCc---ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
.++|++++.||+|+||+||+|+++ +++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 479999999999999999999986 78899999986542 23477899999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC-CC
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~-~~ 177 (219)
+++.++.+.......+.+++.++..++.|++.||++||+.+|+|+||||+||+++.++. ++++|||.+....... ..
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCcccc
Confidence 99998877777777788999999999999999999999999999999999999988877 9999999987543322 23
Q ss_pred CCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+ ..++.++|+||||++++||++|..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~ 199 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCC
Confidence 44468899999999976 456899999999999999999974
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=277.73 Aligned_cols=192 Identities=26% Similarity=0.344 Sum_probs=161.5
Q ss_pred ccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEc-CCeEEEE
Q 027738 19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIV 97 (219)
Q Consensus 19 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 97 (219)
..+.++|++.+.||+|+||.||++..+ +..||+|+++.+ ...+.+.+|+.++++++||||+++++++.+ ++.+++|
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 356789999999999999999999985 778999999654 345789999999999999999999999865 4568999
Q ss_pred EeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCC
Q 027738 98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~ 175 (219)
+||+++++|.+++.+.. .++..+++.++.|++.||.|||+.+++|+||+|+||+++.++. ++++|||+++... .
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~--~ 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS--S 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecC--C
Confidence 99999999999986543 4899999999999999999999999999999999999998887 9999999987543 2
Q ss_pred CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 176 QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 176 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
......++..|+|||.+.+..+++++||||||+++|||+|++
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~ 197 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCC
Confidence 333446788999999999999999999999999999999854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=277.95 Aligned_cols=194 Identities=21% Similarity=0.273 Sum_probs=156.2
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCC---cEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 94 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~---~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 94 (219)
.+.++|++.+.||+|+||.||+|++..++ ..|++|.+..... ..+.+.+|+.++++++||||+++++++. .+.+
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 45689999999999999999999986543 4588888764332 2356889999999999999999999986 4678
Q ss_pred EEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccccc
Q 027738 95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~ 173 (219)
++|+||++++++...+... ..+++.++..++.|++.||.|||+++++|+||||+||++++++. +||+|||+|+....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED 160 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC---------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccC
Confidence 9999999999999887654 46899999999999999999999999999999999999998876 99999999975443
Q ss_pred CCC--CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCC
Q 027738 174 HSQ--PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSP 216 (219)
Q Consensus 174 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g 216 (219)
... .....+++.|+|||.+.+..++.++||||||+++|||+++
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~ 205 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 205 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhc
Confidence 222 2334578899999999999999999999999999999884
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=280.96 Aligned_cols=202 Identities=24% Similarity=0.358 Sum_probs=170.7
Q ss_pred CCCcccCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccC---cccCHHHHHHHHHHHhCCCCcEeEEEEEEEc-
Q 027738 15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT- 90 (219)
Q Consensus 15 ~~~~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 90 (219)
+-+.+.+.++|++++.||+|+||+||+|++..+++.||+|++... +....++.+|+.+++.++|||++++++++..
T Consensus 2 ~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~ 81 (318)
T d3blha1 2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 81 (318)
T ss_dssp CCTTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCCCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence 345677889999999999999999999999999999999998643 2334678899999999999999999999865
Q ss_pred -------CCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEe
Q 027738 91 -------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC 163 (219)
Q Consensus 91 -------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~ 163 (219)
++..++++|+++++.+.........+++.+++.++.|++.||.|||++||+||||||+||+++.++. ++++
T Consensus 82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~ 159 (318)
T d3blha1 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLA 159 (318)
T ss_dssp ---------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEEC
T ss_pred cccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEee
Confidence 3458999999988777666666677999999999999999999999999999999999999998877 9999
Q ss_pred ecccccccccCC-----CCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 164 DFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 164 dfg~a~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
|||+++...... ......+|+.|+|||.+.+. .+++++|+|||||+++||++|..
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~ 220 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCC
Confidence 999986443222 22334689999999999864 68999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=275.29 Aligned_cols=195 Identities=26% Similarity=0.443 Sum_probs=173.2
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 98 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 98 (219)
+++|++++.||+|+||+||+|++..+++.||+|+++..... .+.+.+|+.+++.++||||+++++++......++++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 46999999999999999999999999999999998654322 367789999999999999999999999999999999
Q ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC-C
Q 027738 99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 177 (219)
Q Consensus 99 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~-~ 177 (219)
+++.++++.......+.+++.+++.++.|++.||+|||+++|+|+||||+||+++.++. ++|+|||.++....... .
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccc
Confidence 99999999998888889999999999999999999999999999999999999987776 99999999976544332 3
Q ss_pred CCCCCCCCCCCchhhcccc-ccceeeEEEEEEEEeecCCCCC
Q 027738 178 KSTVGTPAYIAPEVLLRHE-YDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 178 ~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
....+++.|+|||.+.+.. ++.++|+|||||+++||++|+.
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~ 200 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCC
Confidence 3345677899999988654 6899999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=280.79 Aligned_cols=193 Identities=20% Similarity=0.276 Sum_probs=160.8
Q ss_pred CccceeeccccCcCceEEEEEEECCCCc----EEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCCeEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 95 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 95 (219)
.++|++.+.||+|+||+||+|.+..+++ .||+|.+.... ...+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 4679999999999999999999887765 58888876432 3346789999999999999999999999875 456
Q ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 96 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
++++++.+++|.+.+... ..++..++..++.|++.||.|||+++++||||||+||+++.++. ++|+|||+|+.....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecccc
Confidence 777888888998877654 56999999999999999999999999999999999999998876 999999999755433
Q ss_pred CCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 175 SQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 175 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
... ....+++.|+|||.+.+..++.++||||||+++|||+|++
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g 210 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 210 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCC
Confidence 322 2235789999999999999999999999999999999954
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-45 Score=280.57 Aligned_cols=195 Identities=24% Similarity=0.359 Sum_probs=168.4
Q ss_pred CCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCccc--CHHHHHHHHHHHhCCCCcEeEEEEEEEcCCe
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 93 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 93 (219)
..++|++.+.||+|+||+||+|+.. .+++.||+|++...... .+++.+|+.++++++|||++++++++.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3678999999999999999999875 35678999998754322 3568999999999999999999999999999
Q ss_pred EEEEEeccCCCcHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCC
Q 027738 94 LAIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149 (219)
Q Consensus 94 ~~lv~e~~~~~~L~~~~~~~~------------------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~n 149 (219)
.++++|++++++|.+++.... .++..++..++.|++.||+|||+++++||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 999999999999999986432 37889999999999999999999999999999999
Q ss_pred EEecCCCCCcEEEeecccccccccCC---CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 150 TLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 150 ili~~~~~~~v~l~dfg~a~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
|+++.++. +||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|||++|+
T Consensus 171 ILld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 171 CLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp EEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eEECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 99998776 9999999987443322 223345778999999999999999999999999999999885
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=282.00 Aligned_cols=194 Identities=27% Similarity=0.405 Sum_probs=165.7
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcC------CeE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~ 94 (219)
..-+|+..+.||+|+||+||+|++..+++.||+|++..... ...+|+.+++.++||||++++++|... ..+
T Consensus 18 ~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred ccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 34479999999999999999999999999999999976442 234799999999999999999999643 347
Q ss_pred EEEEeccCCCcHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 95 AIVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
++||||++++.+.... .....+++.+++.++.|++.||+|||++||+||||||+||+++.++. .++|+|||+++..
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEEC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhc
Confidence 8999999876433332 34556999999999999999999999999999999999999987653 3899999999876
Q ss_pred ccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
..........+++.|+|||.+.+ ..++.++|+|||||++|||++|..
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~ 221 (350)
T d1q5ka_ 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221 (350)
T ss_dssp CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSC
T ss_pred cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCC
Confidence 66666667789999999999875 568999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.5e-45 Score=279.79 Aligned_cols=193 Identities=23% Similarity=0.436 Sum_probs=170.0
Q ss_pred cCCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcC--CeEEE
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAI 96 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~l 96 (219)
...++|+++++||+|+||+||+|++..+++.||+|++... ..+++.+|+.+++.++ ||||+++++++... ...++
T Consensus 32 ~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 3568999999999999999999999999999999998653 3467889999999985 99999999999854 56899
Q ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
||||+++++|... .+.+++.+++.++.|++.||.+||++||+|+||||+||+++.++. .++|+|||+|........
T Consensus 110 v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 110 VFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp EEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCC
T ss_pred EEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCc
Confidence 9999999998664 346999999999999999999999999999999999999986554 389999999987766666
Q ss_pred CCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 177 PKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....+++.|+|||.+.+. .++.++|+||+||++++|++|..
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~ 228 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCC
Confidence 6777889999999998864 57999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=276.14 Aligned_cols=199 Identities=22% Similarity=0.282 Sum_probs=165.1
Q ss_pred cccCCccceeeccccCcCceEEEEEEECCCC-------cEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEE
Q 027738 18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTK-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEV 87 (219)
Q Consensus 18 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~-------~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~ 87 (219)
+..+.++|++.+.||+|+||.||+|+...++ ..||+|++..... ....+.+|...+.++ +||||++++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 3356789999999999999999999876544 3699999866443 235667788888777 79999999999
Q ss_pred EEcCCeEEEEEeccCCCcHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEE
Q 027738 88 ILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151 (219)
Q Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nil 151 (219)
+.+++..++||||+.+++|.+++.... .++..++..++.|++.||+|||+.+++||||||+||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 999999999999999999999996543 4899999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 152 LDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 152 i~~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++.++. ++|+|||+++........ ....+++.|+|||.+.+..++.++||||||+++|||++++.
T Consensus 168 l~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~ 235 (299)
T d1fgka_ 168 VTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235 (299)
T ss_dssp ECTTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ecCCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCC
Confidence 998877 999999998755443322 33467889999999999999999999999999999998543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=277.68 Aligned_cols=197 Identities=21% Similarity=0.307 Sum_probs=156.8
Q ss_pred cCCccceeeccccCcCceEEEEEEECC-----CCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEEEcC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (219)
...++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ..+.+.+|...+.++ +|+||+.+++++...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 456899999999999999999998753 446899999865432 234566677777665 689999999998764
Q ss_pred -CeEEEEEeccCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecC
Q 027738 92 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG 154 (219)
Q Consensus 92 -~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~ 154 (219)
..++++||||++++|.+++... ..+++.++..++.|++.||.|||+++|+||||||+||++++
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 4689999999999999998653 23789999999999999999999999999999999999988
Q ss_pred CCCCcEEEeecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 155 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 155 ~~~~~v~l~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++. +||+|||+|+....... .....+++.|+|||.+.+..++.++|||||||++|||+||+.
T Consensus 170 ~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 170 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp GGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence 877 99999999975433222 233468899999999999999999999999999999998753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=278.83 Aligned_cols=195 Identities=30% Similarity=0.456 Sum_probs=161.9
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc--cCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC----eE
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT----HL 94 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~ 94 (219)
-.++|++++.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.+++.++|||++++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 35689999999999999999999999999999999975432 2356789999999999999999999997653 23
Q ss_pred EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccC
Q 027738 95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174 (219)
Q Consensus 95 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~ 174 (219)
+++++++.+++|.+++... .+++.+++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||+++.....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 162 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCC
Confidence 4444556688999998654 6999999999999999999999999999999999999988776 999999998754433
Q ss_pred CC----CCCCCCCCCCCCchhhc-cccccceeeEEEEEEEEeecCCCCC
Q 027738 175 SQ----PKSTVGTPAYIAPEVLL-RHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 175 ~~----~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. .....+++.|+|||.+. +..++.++|+||+|+++|+|++|..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~ 211 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 211 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCC
Confidence 22 23456889999999985 4567889999999999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=272.32 Aligned_cols=196 Identities=24% Similarity=0.340 Sum_probs=156.7
Q ss_pred cCCccceeeccccCcCceEEEEEEECC-CC--cEEEEEEeccCc----ccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-TK--ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-~~--~~v~~K~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
.+.++|++.+.||+|+||.||+|+... ++ ..||+|++.... ...+++.+|+.++++++||||+++++++.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 456789999999999999999998653 33 358999886542 223568899999999999999999999976 4
Q ss_pred eEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
..++|+||++++++.+.+... .+++...+..++.|++.||.|||+++++|+||||+||+++.++. ++|+|||+++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhc
Confidence 678999999999998877654 46999999999999999999999999999999999999998776 999999999755
Q ss_pred ccCCCC----CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCC-CCC
Q 027738 172 VLHSQP----KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTS-PND 218 (219)
Q Consensus 172 ~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~-g~~ 218 (219)
...... ....++..|+|||.+.+..++.++||||||+++|||+| |..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~ 213 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCC
Confidence 333221 22346778999999999999999999999999999998 553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.4e-44 Score=270.19 Aligned_cols=195 Identities=21% Similarity=0.237 Sum_probs=168.5
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCC-CcEeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 100 (219)
.++|++.+.||+|+||+||+|++..+++.||+|++... ...+.+.+|++.++.++| +|++.+++++..+...++|||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 47899999999999999999999999999999987553 334567889999999976 8999999999999999999999
Q ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCC---CCCcEEEeecccccccccCC-
Q 027738 101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLHS- 175 (219)
Q Consensus 101 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~---~~~~v~l~dfg~a~~~~~~~- 175 (219)
+ +++|.+.+.... .++..++..++.|++.+|.+||++|++|+||||+||+++.. ....++|+|||+|+......
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9 568888886644 69999999999999999999999999999999999999753 22349999999997543322
Q ss_pred -------CCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 176 -------QPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 176 -------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
......||+.|+|||.+.+..+++++|+||||+++|||+||..
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~ 211 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 211 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCC
Confidence 2233468999999999999999999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-44 Score=271.74 Aligned_cols=196 Identities=23% Similarity=0.188 Sum_probs=164.4
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCc-EeEEEEEEEcCCeEEEEEec
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY 100 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~ 100 (219)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ..+++..|+++++.++|++ ++.+..++..+...++|+|+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 368999999999999999999999999999999876643 3456889999999998654 66677777888899999999
Q ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCC-CCcEEEeecccccccccCCC---
Q 027738 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ--- 176 (219)
Q Consensus 101 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~-~~~v~l~dfg~a~~~~~~~~--- 176 (219)
++++.+.........++..++..++.|++.+|++||++||+|+||||+||+++..+ ...++++|||+|+.......
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 96644444445566799999999999999999999999999999999999985432 23499999999986543322
Q ss_pred -----CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 -----PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 -----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.....|++.|+|||.+.+..+++++||||||++++||++|..
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~ 211 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 211 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCC
Confidence 233468999999999999999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=278.70 Aligned_cols=193 Identities=28% Similarity=0.414 Sum_probs=161.1
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcCC-----
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT----- 92 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 92 (219)
-.++|++++.||+|+||+||+|.+..+++.||+|++...... .+.+.+|+.+++.++|||+++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 468999999999999999999999999999999999754322 246788999999999999999999998765
Q ss_pred -eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 93 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
.++++|||+ +.+|.... +...+++..++.++.|++.||.+||++||+|+||||+||+++.++. ++++|||+|+..
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc
Confidence 479999999 45666655 4457999999999999999999999999999999999999998877 999999999754
Q ss_pred ccCCCCCCCCCCCCCCCchhhcc-ccccceeeEEEEEEEEeecCCCCCC
Q 027738 172 VLHSQPKSTVGTPAYIAPEVLLR-HEYDGKVYFYSITQMSLQSTSPNDL 219 (219)
Q Consensus 172 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slg~~~~~~~~g~~l 219 (219)
. .......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..+
T Consensus 172 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~p 218 (346)
T d1cm8a_ 172 D--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218 (346)
T ss_dssp C--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred C--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCC
Confidence 3 33445678999999999986 4568999999999999999999753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=274.57 Aligned_cols=192 Identities=26% Similarity=0.300 Sum_probs=158.6
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEEEEEEEcCC----eEEEE
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIV 97 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 97 (219)
.++|.+.+.||+|+||.||+++. +++.||+|++..........+.|+..++.++||||+++++++...+ .+++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 46899999999999999999987 4889999998654432233344555556789999999999998654 57999
Q ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--------~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
|||+++++|.+++.+. .++..++..++.+++.+|.++|+ ++|+|+||||+||++++++. +||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCccc
Confidence 9999999999999765 58999999999999999999996 59999999999999988876 9999999987
Q ss_pred ccccCC-----CCCCCCCCCCCCCchhhccc------cccceeeEEEEEEEEeecCCCCC
Q 027738 170 SSVLHS-----QPKSTVGTPAYIAPEVLLRH------EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 170 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
...... ......+++.|+|||.+.+. .++.++||||||+++|||+||..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~ 216 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCC
Confidence 554332 22345689999999998754 36778999999999999999853
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=276.07 Aligned_cols=196 Identities=27% Similarity=0.488 Sum_probs=170.5
Q ss_pred CCccceeeccccCcCceEEEEEEE---CCCCcEEEEEEeccCc-----ccCHHHHHHHHHHHhCCC-CcEeEEEEEEEcC
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRD---KVTKELVAVKYIERGD-----KIDENVQREIINHRSLRH-PNIVRFKEVILTP 91 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~---~~~~~~v~~K~~~~~~-----~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 91 (219)
..++|++.+.||+|+||+||+|.+ +.+++.||+|++.... ...+.+.+|+.++++++| |||+++++++...
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 468999999999999999999987 3468899999986432 234567899999999976 8999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeeccccccc
Q 027738 92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~ 171 (219)
...++++||+.+++|.+.+...+.+++..+..++.|++.||.++|+++++|+||||+||+++.++. ++|+|||+++..
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEF 179 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEEC
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhh
Confidence 999999999999999999999999999999999999999999999999999999999999998876 999999998754
Q ss_pred ccC--CCCCCCCCCCCCCCchhhccc--cccceeeEEEEEEEEeecCCCCC
Q 027738 172 VLH--SQPKSTVGTPAYIAPEVLLRH--EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 172 ~~~--~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
... .......+++.|+|||.+.+. .++.++|||||||++|+|++|..
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~ 230 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCC
Confidence 332 223445689999999999753 46889999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=273.02 Aligned_cols=196 Identities=22% Similarity=0.285 Sum_probs=169.7
Q ss_pred cCCccceeeccccCcCceEEEEEEEC-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHHhC-CCCcEeEEEEEEEcC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 91 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~~K~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 91 (219)
.+.++|++.+.||+|+||.||+|+.. .+++.||+|++..... ....+.+|+..++.+ +||||+++++++..+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 45689999999999999999999853 4667899999975432 234578899999988 699999999999999
Q ss_pred CeEEEEEeccCCCcHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEec
Q 027738 92 THLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153 (219)
Q Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~ 153 (219)
...+++||||++++|.+++.... .++..++..++.|++.||++||+++++|+||||+||+++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999987543 488999999999999999999999999999999999998
Q ss_pred CCCCCcEEEeecccccccccCCCC---CCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 154 GSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 154 ~~~~~~v~l~dfg~a~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
.++. ++++|||.++........ ....+++.|+|||.+.+..++.++||||||++++||+|++
T Consensus 180 ~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 180 HGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp TTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred ccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence 8776 999999999755433222 2245788999999999999999999999999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-44 Score=276.53 Aligned_cols=192 Identities=26% Similarity=0.378 Sum_probs=156.7
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcC------C
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP------T 92 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 92 (219)
.++|++++.||+|+||+||+|++..+++.||+|++...... ..++.+|+.++++++||||++++++|... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 46899999999999999999999999999999999754322 24578999999999999999999999643 5
Q ss_pred eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
.+++|+||+.++ +...+ ...+++.+++.++.|++.||.+||++||+|+||||+||+++.++. ++++|||+++...
T Consensus 96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~ 170 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 170 (355)
T ss_dssp EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccc
Confidence 789999999775 44444 345899999999999999999999999999999999999998877 9999999987666
Q ss_pred cCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.........+++.|+|||.+.+..+++++|+||+||++++|++|..
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~ 216 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCC
Confidence 6555666678999999999999999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=268.58 Aligned_cols=193 Identities=21% Similarity=0.244 Sum_probs=161.8
Q ss_pred cceeeccccCcCceEEEEEEECCCC---cEEEEEEeccCc--ccCHHHHHHHHHHHhCCCCcEeEEEEEEEc-CCeEEEE
Q 027738 24 RYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIV 97 (219)
Q Consensus 24 ~y~~~~~l~~g~~~~v~~~~~~~~~---~~v~~K~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 97 (219)
.+++.++||+|+||+||+|....++ ..||+|+++... ...+++.+|++++++++||||+++++++.. ++..++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 3344688999999999999986443 358999986432 223678999999999999999999999875 5689999
Q ss_pred EeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccccCCC
Q 027738 98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176 (219)
Q Consensus 98 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~~~~~ 176 (219)
+|||++++|.+++.... ..+..++..++.|++.||.|+|+.+++||||||+|||+++++. ++|+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEF 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhcccccc
Confidence 99999999999887544 4778899999999999999999999999999999999988776 99999999975543322
Q ss_pred CC-----CCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 177 PK-----STVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 177 ~~-----~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.. ...+++.|+|||.+.+..++.++||||||+++|||+||+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~ 232 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCC
Confidence 22 2357889999999999999999999999999999999753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=270.76 Aligned_cols=196 Identities=18% Similarity=0.248 Sum_probs=169.3
Q ss_pred cCCccceeeccccCcCceEEEEEEECC-----CCcEEEEEEeccCcccC--HHHHHHHHHHHhCCCCcEeEEEEEEEcCC
Q 027738 20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTPT 92 (219)
Q Consensus 20 ~~~~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~~K~~~~~~~~~--~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 92 (219)
.+.++|++.+.||+|+||.||+|.+.. ++..||+|++....... ..+.+|+.++++++||||+++++++..+.
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 456899999999999999999998752 35679999997543222 45789999999999999999999999999
Q ss_pred eEEEEEeccCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEE
Q 027738 93 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l 162 (219)
..++|+|++++|+|.+++... ..++..++..++.+++.||.+||+++++||||||+|||++.++. +||
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl 174 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKI 174 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEE
Confidence 999999999999999888643 23688999999999999999999999999999999999988876 999
Q ss_pred eecccccccccCCC---CCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCC
Q 027738 163 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPN 217 (219)
Q Consensus 163 ~dfg~a~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~ 217 (219)
+|||+|+....... .....+++.|+|||.+.+..++.++|+||||++++||+||.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 99999975433322 23345789999999999999999999999999999999885
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=272.19 Aligned_cols=193 Identities=25% Similarity=0.397 Sum_probs=162.0
Q ss_pred CCccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc---CHHHHHHHHHHHhCCCCcEeEEEEEEEcC-----C
Q 027738 21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP-----T 92 (219)
Q Consensus 21 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 92 (219)
-.++|++++.||+|+||+||+|++..+++.||+|++...... .+.+.+|+.+++.++|||++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 367999999999999999999999999999999999754332 24578999999999999999999999743 3
Q ss_pred eEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeecccccccc
Q 027738 93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172 (219)
Q Consensus 93 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~~~~ 172 (219)
..+++++++.+++|.+++.. +.+++.+++.++.|++.||.+||++||+||||||+||+++.++. ++++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC
Confidence 34666677789999988754 56999999999999999999999999999999999999998877 9999999986443
Q ss_pred cCCCCCCCCCCCCCCCchhhccc-cccceeeEEEEEEEEeecCCCCC
Q 027738 173 LHSQPKSTVGTPAYIAPEVLLRH-EYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 173 ~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
.......+++.|+|||...+. .++.++|+||||+++|+|++|..
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~ 217 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCC
Confidence 333445678899999998765 46889999999999999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-37 Score=242.88 Aligned_cols=194 Identities=24% Similarity=0.350 Sum_probs=157.8
Q ss_pred ccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCC-----------CCcEeEEEEEEEcC
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVILTP 91 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~~ 91 (219)
++|+++++||+|+||+||+|++..+++.||+|+++......+.+.+|+.+++.+. |+|++++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5799999999999999999999999999999999876555567788888887764 57899999988653
Q ss_pred --CeEEEEEeccCCCc-HHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCCEEecCCCCC----cEE
Q 027738 92 --THLAIVMEYASGGE-LFERI--CNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP----RLK 161 (219)
Q Consensus 92 --~~~~lv~e~~~~~~-L~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~ivh~dl~p~nili~~~~~~----~v~ 161 (219)
...++++.++.... ..... .....+++..+..++.|++.||++||+ .||+|+||||+||+++.++.. .++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 44555555543332 22222 233468999999999999999999998 899999999999999765542 389
Q ss_pred EeecccccccccCCCCCCCCCCCCCCCchhhccccccceeeEEEEEEEEeecCCCCC
Q 027738 162 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKVYFYSITQMSLQSTSPND 218 (219)
Q Consensus 162 l~dfg~a~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slg~~~~~~~~g~~ 218 (219)
++|||.+.... .......+++.|+|||.+.+..++.++|+||+|+++++|++|..
T Consensus 173 l~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 173 IADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp ECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred Eeecccccccc--cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCC
Confidence 99999986432 34455678999999999999999999999999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=5.9e-25 Score=155.81 Aligned_cols=159 Identities=15% Similarity=0.117 Sum_probs=116.5
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCccc-------------------CHHHHHHHHHHHhCCCCcEeEEE
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-------------------DENVQREIINHRSLRHPNIVRFK 85 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~-------------------~~~~~~e~~~l~~l~~~~i~~~~ 85 (219)
+.+.++||+|++|+||+|++. +|+.||+|++...... ......|...+.++.+++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999986 7889999987532110 12234678888899999998887
Q ss_pred EEEEcCCeEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCCEEecCCCCCcEEEeec
Q 027738 86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF 165 (219)
Q Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ivh~dl~p~nili~~~~~~~v~l~df 165 (219)
++.. .+++||++++..+.. ++......++.|++.++.+||++|++|+||||+||++++++ ++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 6632 379999998865532 45566778999999999999999999999999999998543 899999
Q ss_pred ccccccccCCCCCCCCCCCCCCCc------hhhccccccceeeEEEE
Q 027738 166 GYSKSSVLHSQPKSTVGTPAYIAP------EVLLRHEYDGKVYFYSI 206 (219)
Q Consensus 166 g~a~~~~~~~~~~~~~~~~~~~aP------E~~~~~~~~~~~Dv~sl 206 (219)
|.|+....... ..|... +.+ ...|+.++|+||+
T Consensus 147 G~a~~~~~~~~-------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~ 185 (191)
T d1zara2 147 PQSVEVGEEGW-------REILERDVRNIITYF-SRTYRTEKDINSA 185 (191)
T ss_dssp TTCEETTSTTH-------HHHHHHHHHHHHHHH-HHHHCCCCCHHHH
T ss_pred CCcccCCCCCc-------HHHHHHHHHHHHHHH-cCCCCCcccHHHH
Confidence 99864321110 011111 111 3567888999985
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.01 E-value=2.8e-09 Score=77.60 Aligned_cols=86 Identities=16% Similarity=0.071 Sum_probs=62.1
Q ss_pred CccceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcc-cCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeEEEEEe
Q 027738 22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 99 (219)
Q Consensus 22 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 99 (219)
.+.|+..+..+.++.+.+|++.. +++.+++|+...... ....+.+|...+..+. +--+++++.+...++..+++++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 45777777766566678998864 466678887754432 3345778888887664 3346888888888899999999
Q ss_pred ccCCCcHHHH
Q 027738 100 YASGGELFER 109 (219)
Q Consensus 100 ~~~~~~L~~~ 109 (219)
+++|.++...
T Consensus 91 ~l~G~~~~~~ 100 (263)
T d1j7la_ 91 EADGVLCSEE 100 (263)
T ss_dssp CCSSEEHHHH
T ss_pred eccccccccc
Confidence 9999877543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.58 E-value=2.3e-07 Score=71.32 Aligned_cols=77 Identities=17% Similarity=0.079 Sum_probs=49.2
Q ss_pred eccccCcCceEEEEEEECCCCcEEEEEEeccC--------cccCHHHHHHHHHHHhCC-C--CcEeEEEEEEEcCCeEEE
Q 027738 28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERG--------DKIDENVQREIINHRSLR-H--PNIVRFKEVILTPTHLAI 96 (219)
Q Consensus 28 ~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~--------~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~~~~~l 96 (219)
.+.+|.|....||++.+..+++.+++|.-.+. +...++...|.+.++.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55789999999999998877888999965321 112244566777776552 2 346666654 3445678
Q ss_pred EEeccCCCcH
Q 027738 97 VMEYASGGEL 106 (219)
Q Consensus 97 v~e~~~~~~L 106 (219)
+||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.47 E-value=1.2e-06 Score=62.92 Aligned_cols=72 Identities=14% Similarity=0.074 Sum_probs=50.6
Q ss_pred cCcC-ceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCC--CcEeEEEEEEEcCCeEEEEEeccCCCcH
Q 027738 32 GSGN-FGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGEL 106 (219)
Q Consensus 32 ~~g~-~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (219)
..|. .+.||++... .+..+++|...... ...+..|...++.+.. -.+++++.+..+++..++++++++|.++
T Consensus 19 ~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3344 3578988765 56668889654432 3456778887776633 3367788888888899999999988655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.97 E-value=8e-06 Score=60.88 Aligned_cols=68 Identities=10% Similarity=0.064 Sum_probs=45.4
Q ss_pred ceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEeEE-------EEEEEcCCeEEEEEeccCCC
Q 027738 36 FGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF-------KEVILTPTHLAIVMEYASGG 104 (219)
Q Consensus 36 ~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~-------~~~~~~~~~~~lv~e~~~~~ 104 (219)
.-.||++... +|..|++|+..+.....+.+..|...+..+...+++.. -..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 3578998875 78889999887665566778888888876643222211 11223456688899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.73 E-value=5.6e-05 Score=57.71 Aligned_cols=78 Identities=13% Similarity=0.090 Sum_probs=51.0
Q ss_pred ccceeeccccCcCceEEEEEEECC-------CCcEEEEEEeccCcccCHHHHHHHHHHHhCC-CCcEeEEEEEEEcCCeE
Q 027738 23 DRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHL 94 (219)
Q Consensus 23 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 94 (219)
+..+ ++.|+.|-.-.+|++.... ..+.+++++.-.. ...-...+|..+++.+. +.-.+++++++..
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 3444 4567778888999998653 2456888876532 23345667888887774 4445677777643
Q ss_pred EEEEeccCCCcH
Q 027738 95 AIVMEYASGGEL 106 (219)
Q Consensus 95 ~lv~e~~~~~~L 106 (219)
..|++|++|.++
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 578899887544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.55 E-value=9.4e-05 Score=54.53 Aligned_cols=140 Identities=15% Similarity=0.080 Sum_probs=70.7
Q ss_pred ceeeccccCcCceEEEEEEECCCCcEEEEEEeccCcccCHHHHHHHHHHHhCCCCcEe--EEEE------EEEcCCeEEE
Q 027738 25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV--RFKE------VILTPTHLAI 96 (219)
Q Consensus 25 y~~~~~l~~g~~~~v~~~~~~~~~~~v~~K~~~~~~~~~~~~~~e~~~l~~l~~~~i~--~~~~------~~~~~~~~~l 96 (219)
..-.+.|..|-.-+.|.+... +..+++|++... ...+++..++.++..+...+++ ..+. +.........
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~ 96 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 96 (316)
T ss_dssp EEEEEEECC---EEEEEEEES--SCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred ceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence 333455666777788998876 334899988543 3445667777777665432221 1110 1122344555
Q ss_pred EEeccCCCcHH-----HH---------HHhc---------CCC------------------CHHHHHHHHHHHHHHHHHH
Q 027738 97 VMEYASGGELF-----ER---------ICNA---------GRF------------------SEDEARFFFQQLISGVSYC 135 (219)
Q Consensus 97 v~e~~~~~~L~-----~~---------~~~~---------~~~------------------~~~~~~~~~~~l~~~l~~l 135 (219)
++.+..+.... .. ++.. ... ........+......+...
T Consensus 97 ~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (316)
T d2ppqa1 97 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 176 (316)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred eeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhcc
Confidence 66655442210 00 0000 000 1111222222233333333
Q ss_pred H----HCCceeccCCCCCEEecCCCCCcEEEeeccccc
Q 027738 136 H----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169 (219)
Q Consensus 136 h----~~~ivh~dl~p~nili~~~~~~~v~l~dfg~a~ 169 (219)
. ..|++|+|+.++|++++++.. .-++||+.+.
T Consensus 177 ~~~~L~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 177 WPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred CccccccccccCCcchhhhhcccccc--eeEecccccc
Confidence 2 237999999999999986643 5899999875
|